,CUI1,CUI2,label
0,Pediatric Neoplasm,Recurrent Uveal Melanoma,0
1,Benign Neoplasm,Giant cell angiofibroma,0
2,Oral cavity,Serous cystadenocarcinoma ovary,0
3,Known,Lipoma of small intestine,0
4,incidence of cases,Cerebral Primitive Neuroectodermal Tumor,0
5,Mammal liver preparation,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6,Cancer Genus,Ichthyoses,0
7,Singular,Mucinous adenocarcinoma gastric,0
8,Lymphoma,Advanced Uterine Corpus Carcinosarcoma,0
9,Skin,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10,Non-small cell carcinoma,Colorectal Neuroendocrine Tumor G2,0
11,X-Ray Computed Tomography,Childhood Fibrillary Astrocytoma,0
12,Neutral Charge,Medulloblastoma,0
13,Left,Anterior Urethral Malignant Neoplasm,0
14,Function Axis,Primary Cutaneous Plasmablastic Lymphoma,0
15,Exposure to,Benign neoplasm of thorax,0
16,Screening - general NOS (finding),Xeroderma pigmentosum,0
17,Malignant Neoplasms,Intestinal Metaplasia of Bladder Urothelium,0
18,Urinary tract infection,Non-Metastatic Gestational Trophoblastic Tumor,0
19,status - In progress,Lung squamous cell carcinoma stage I,0
20,Liquid substance,Ovarian germ cell choriocarcinoma stage IV,0
21,Pain,Granular Cell Leiomyosarcoma,0
22,Modify status - jump,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23,Common Specifications in HL7 V3 Publishing,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24,Biological Response Modifiers,Mucinous adenocarcinoma gastric,0
25,Spinal Cord Injuries,Leiomyoma of Gallbladder,0
26,DNA,Intestinal Metaplasia of Bladder Urothelium,0
27,Complete excision,Low Grade Squamous Intraepithelial Neoplasia,0
28,common types,Cerebral Primitive Neuroectodermal Tumor,0
29,Tumor type,Endometrial Small Cell Carcinoma,0
30,Ancestry-Informative Marker,Chronic Myelomonocytic Leukemia-2,0
31,Laboratory Procedures,Clonal Hematopoiesis of Indeterminate Potential,0
32,Referral placed,Intestinal Metaplasia of Bladder Urothelium,0
33,Excessive,embryonal rhabdomyosarcoma of prostate,0
34,Carcinoma,Recurrent Testicular Lymphoma,0
35,Usually Need Help from Another Person for Arising,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
36,Increased risk for cancer,Thymic Clear Cell Carcinoma,0
37,Image Feature,FIGO Stage II Ovarian Cancer,0
38,Hip structure,Hodgkin lymphoma,0
39,Spongiosis,Benign Carotid Body Paraganglioma,0
40,Medical service,Female Breast Carcinoma,0
41,Methods aspects,Acute Undifferentiated Leukemia,0
42,Males,Undifferentiated Neuroblastoma,0
43,diagnostic procedure,Colorectal Neuroendocrine Tumor G2,0
44,Air (substance),Xeroderma pigmentosum,0
45,Followed by,Unresectable Rhabdomyosarcoma,0
46,Suspected qualifier,Botryoid-Type Embryonal Rhabdomyosarcoma,0
47,Symptoms aspect,Stage IB Lung Cancer AJCC v7,0
48,Neoplasms,FIGO Stage II Ovarian Cancer,0
49,Problems - What subject filter,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
50,Melanoma Pathway,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
51,Uveal melanoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
52,disease transmission,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
53,Often - answer to question,Neonatal leukemia,0
54,Leukemia,Benign tumor of eyelid,0
55,include - SetOperator,Rhabdomyosarcoma with ganglionic differentiation,0
56,Initially,Platinum-Resistant Lung Small Cell Carcinoma,0
57,PREVENT (product),ALK positive large B-cell lymphoma,0
58,Estimated,Mixed parotid tumor,0
59,TP53 gene,Xeroderma pigmentosum,0
60,React,Thymic Clear Cell Carcinoma,0
61,Proton Pump Inhibitors [MoA],Precursor T-lymphoblastic lymphoma/leukemia stage III,0
62,Tumor Mass,Benign Apocrine Neoplasm,0
63,Positive Selection,Acantholytic squamous cell carcinoma,0
64,Different,Maxillary Sinus Adenocarcinoma,0
65,Probability,Malignant melanoma of eyelid,0
66,Biomaterial Treatment,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
67,Qualitative form,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
68,Present,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
69,Classification of information,Benign Apocrine Neoplasm,0
70,Thyroid Gland,Childhood Choriocarcinoma,0
71,Etiology aspects,Unresectable Rhabdomyosarcoma,0
72,Tumor cells,Breast Ductal Adenoma,0
73,Therapeutic procedure,Familial Adenomatous Polyposis Associated Medulloblastoma,0
74,Levels (qualifier value),Benign Carotid Body Paraganglioma,0
75,Tickling sensation quality,Clonal Hematopoiesis of Indeterminate Potential,0
76,Appearance,mucinous adenocarcinoma of gallbladder,0
77,Embryonic Development,Choroid Necrotic Melanoma,0
78,Feelings,Malignant Neoplasm of Lung - Multiple Primary Sites,0
79,90%,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
80,Usual,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
81,Aggressive Non-Hodgkin Lymphoma,Adult Alveolar Soft Part Sarcoma,0
82,Pharyngeal structure,Cerebral hemangioma,0
83,Chemotherapy Regimen,GIANT PIGMENTED HAIRY NEVUS,0
84,Average,Recurrent Testicular Lymphoma,0
85,various allergen extracts,Tonsillar Carcinoma,0
86,1000000,Localized Ewing Sarcoma,0
87,therapeutic aspects,Malignant Testicular Sertoli Cell Tumor,0
88,Teens,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
89,Example,Locally Advanced Soft Tissue Sarcoma,0
90,Mental blocking,Acute Undifferentiated Leukemia,0
91,Cover (physical object),Intestinal Metaplasia of Bladder Urothelium,0
92,SPINK5 gene,Recurrent Uveal Melanoma,0
93,Hereditary,adenoid cystic carcinoma of lung,0
94,Gonadal structure,Hodgkin lymphoma,0
95,per year,Clonal Hematopoiesis of Indeterminate Potential,0
96,Vagina,Cartilaginous exostosis,0
97,combination - answer to question,Intraepithelial Melanocytic Hyperplasia,0
98,Primary malignant neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
99,Set of muscles,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
100,Cells,Liver Cavernous Hemangioma,0
101,Blink Reflexes,Grade 3a Malignant Neoplasm,0
102,Known,Cerebral Primitive Neuroectodermal Tumor,0
103,Specimen Source Codes - Respiratory,Localized Askin Tumor,0
104,Fever symptoms (finding),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
105,Age of onset of symptoms:Time:Pt:^Patient:Qn,Malignant neoplasm of thalamus,0
106,Physical shape,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
107,Hematologic Neoplasms,Unfavorable Non-Hodgkin Lymphoma,0
108,Science of Etiology,Thymic Clear Cell Carcinoma,0
109,Symptoms aspect,Mucinous adenocarcinoma gastric,0
110,various other agents for local oral treatment in ATC,Refractory Barrett Esophagus,0
111,Rare Lesion,Endometrial Small Cell Carcinoma,0
112,Disease,Spermatocytic seminoma,0
113,Greater Than,Acute Undifferentiated Leukemia,0
114,Biopsy,Ovarian germ cell choriocarcinoma stage IV,0
115,Malignant Cell Count,Recurrent Testicular Lymphoma,0
116,Symptoms aspect,Angiosarcoma of liver,0
117,Elevated,Mucinous adenocarcinoma gastric,0
118,Certain (qualifier value),Methotrexate-Associated Hodgkin Lymphoma,0
119,Occupations,Testicular cancer metastatic,0
120,Negative Surgical Margin,Acute lymphadenitis,0
121,Have Weight Loss,Giant cell angiofibroma,0
122,Retinoic Acid Response Element,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
123,Basis - conceptual entity,Leiomyoma of Gallbladder,0
124,Different,Atypical Lobular Breast Hyperplasia,0
125,Togo,squamous cell carcinoma of the thyroid gland,0
126,skin color,FIGO Stage II Ovarian Cancer,0
127,Nuclear hyperchromasia,Botryoid-Type Embryonal Rhabdomyosarcoma,0
128,Pediculus humanus capitis (eukaryote),Neonatal leukemia,0
129,Manufactured form,Advanced Uterine Corpus Carcinosarcoma,0
130,Rate,Malignant neoplasm of thalamus,0
131,40%,Undifferentiated Neuroblastoma,0
132,NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology,Grade 1 Clear Cell Renal Cell Carcinoma,0
133,Mature,Ampulla of Vater Tubular Adenoma,0
134,Term (lexical),Stage 0 Penile Cancer AJCC v8,0
135,Type - attribute,Acantholytic squamous cell carcinoma,0
136,Branch of,Metastatic Lung Small Cell Carcinoma,0
137,Initially,Bladder squamous cell carcinoma stage I,0
138,Process,Colorectal High Grade B-Cell Lymphoma,0
139,include - SetOperator,mucinous adenocarcinoma of gallbladder,0
140,Qualitative form,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
141,Latin America,adenosquamous carcinoma of breast,0
142,Malignant Neoplasms,Recurrent Uveal Melanoma,0
143,Lumpectomy of breast,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
144,low confidentiality,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
145,Biogenic Amines,Heavy Chain Deposition Disease,0
146,Osteogenesis,Malignant melanoma of eyelid,0
147,Structure of lumen of body system,Adult Hepatocellular Carcinoma,0
148,Primitive,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
149,physiological aspects,Diffuse malignant mesothelioma,0
150,Entire great blood vessel (organ),Thymic Atypical Carcinoid Tumor,0
151,Take,Childhood Thyroid Gland Follicular Carcinoma,0
152,Financial Account,Diffuse malignant mesothelioma,0
153,Affecting,Unfavorable Non-Hodgkin Lymphoma,0
154,Involvement with,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
155,Irritant behavior,Acantholytic squamous cell carcinoma,0
156,Case unit dose,FIGO Stage II Ovarian Cancer,0
157,Used by,Malignant melanoma of eyelid,0
158,Phenotype determination,Intraepithelial Melanocytic Hyperplasia,0
159,Persons,Adenocarcinoma,0
160,Xeroderma Pigmentosum,embryonal rhabdomyosarcoma of prostate,0
161,Swab specimen,Digestive System Hodgkin Lymphoma,0
162,Biomaterial Treatment,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
163,Immunotherapy,Liver Lymphangioma,0
164,Degree Unit of Plane Angle,Stage III Adult Immunoblastic Lymphoma,0
165,blood forming organ,Benign tumor of eyelid,0
166,Site of,Anterior Urethral Malignant Neoplasm,0
167,Cerebrum,Blepharal carcinoma,0
168,Biopsy,Localized Askin Tumor,0
169,analysis aspect,Spongiotic dermatitis,0
170,potential,papillary carcinoma of penis,0
171,Classification,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
172,Cancer Genus,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
173,Cessation of life,Diffuse malignant mesothelioma,0
174,gene therapy,FIGO Stage II Ovarian Cancer,0
175,Visceral,Digestive System Hodgkin Lymphoma,0
176,Therapeutic procedure,Bladder squamous cell carcinoma stage I,0
177,Condition:Find:Pt:^Patient:Nom,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
178,therapeutic aspects,Malignant Neoplasm with Regional Lymph Node Involvement,0
179,Entity Name Part Qualifier - birth,Tonsillar Carcinoma,0
180,Negative Surgical Margin,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
181,Upper genitourinary tract structure,Platinum-Resistant Lung Small Cell Carcinoma,0
182,Lymphoid Cells,Recurrent Testicular Lymphoma,0
183,Complication,Liver Lymphangioma,0
184,Poor function,Intestinal Neuroendocrine Carcinoma,0
185,Speaking (activity),Childhood Lymphoma,0
186,Disease,Primary Cutaneous Plasmablastic Lymphoma,0
187,Greeks,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
188,Experimental Result,embryonal rhabdomyosarcoma of prostate,0
189,Togo,Refractory Barrett Esophagus,0
190,Cell Count,Adenocarcinoma,0
191,Headache,Stage 0 Lip Carcinoma,0
192,various allergen extracts,Benign tumor of eyelid,0
193,Formations,BRCA2 Syndrome,0
194,Frequently,Medulloblastoma,0
195,High Grade Astrocytic Tumor,Metastatic Lung Small Cell Carcinoma,0
196,Study,Stage II Carcinoma of Penis,0
197,Hemopoietic stem cell transplant,Liver Lymphangioma,0
198,How Much Distress Cough,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
199,Different,Pancreatic Intraepithelial Neoplasia-3,0
200,Laboratory,Malignant melanoma of eyelid,0
201,Human Papillomavirus,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
202,Carcinoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
203,various allergen extracts,Colorectal cancer,0
204,Separate,Grade 3a Malignant Neoplasm,0
205,Gravidity,Grade 3a Malignant Neoplasm,0
206,Pelvis+,Extra-Adrenal Paraganglioma,0
207,International Aspects,Platinum-Resistant Lung Small Cell Carcinoma,0
208,CYREN gene,Advanced Lung Carcinoma,0
209,Child,Recurrent Testicular Lymphoma,0
210,Bayer Corneal Epitheliopathy Grade 3,Metastatic Ductal Breast Carcinoma,0
211,Frequently,Acute Undifferentiated Leukemia,0
212,Ability,Childhood Central Nervous System Immature Teratoma,0
213,Diagnostic Imaging,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
214,Smear - instruction imperative,Pilocytic astrocytoma of cerebellum,0
215,Slight (qualifier value),Adult Fibrolamellar Carcinoma,0
216,Sometimes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
217,risk factors - observation list,Stage IB Pancreatic Cancer AJCC v8,0
218,Replaced by,Human Papillomavirus-Related Carcinoma,0
219,Malignant neoplasm of ovary,Intraepithelial Melanocytic Hyperplasia,0
220,Requirement,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
221,Human body,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
222,Neoplasms,Granular Cell Leiomyosarcoma,0
223,Cancer/Testis Antigen,Maxillary Sinus Adenocarcinoma,0
224,Different,Refractory Barrett Esophagus,0
225,Site of,Uterine Cancer,0
226,Head and Neck Carcinoma,FIGO Stage II Ovarian Cancer,0
227,hormone problem,Stage IV Childhood Non-Hodgkin Lymphoma,0
228,Viola <angiosperm>,Liver Cavernous Hemangioma,0
229,Characterization,Intraepithelial Melanocytic Hyperplasia,0
230,Benign Neoplasm,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
231,Linear,Bladder squamous cell carcinoma stage I,0
232,Adenocarcinoma,FIGO Stage II Ovarian Cancer,0
233,Characterization,Angiosarcoma of liver,0
234,Membrane Device,Stage 0 Penile Cancer AJCC v8,0
235,Fishes,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
236,Discover,Metastatic Malignant Neoplasm in the Sellar Region,0
237,Definitely Related to Intervention,Atypical Mesothelial Hyperplasia,0
238,Tests (qualifier value),Unresectable Rhabdomyosarcoma,0
239,Combined,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
240,Physical findings,Pancreatic Intraepithelial Neoplasia-3,0
241,Papanicolaou Test,Stage IB Pancreatic Cancer AJCC v8,0
242,Tissue Specimen Code,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
243,Neoplasms,Germinoma,0
244,Medical Device Emits Smoke,Methotrexate-Associated Hodgkin Lymphoma,0
245,Immune System Finding,Advanced Uterine Corpus Carcinosarcoma,0
246,Biological Response Modifier Therapy,Extra-Adrenal Paraganglioma,0
247,shared attribute,Malignant melanoma of eyelid,0
248,Genetic Heterogeneity,Anterior Urethral Malignant Neoplasm,0
249,Fourth,Stage III Adult Immunoblastic Lymphoma,0
250,Human Cells,Unfavorable Non-Hodgkin Lymphoma,0
251,Europe,GIANT PIGMENTED HAIRY NEVUS,0
252,World Health Organization,Endometrial Small Cell Carcinoma,0
253,Species,Stage II Hepatocellular Carcinoma AJCC v8,0
254,Adenocarcinoma,Malignant Testicular Sertoli Cell Tumor,0
255,Ulceration,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
256,unknown vaccine or immune globulin,High Grade Glandular Intraepithelial Neoplasia,0
257,Reported Term,Atypical Mesothelial Hyperplasia,0
258,combination of objects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
259,Visible,Secondary malignant neoplasm of lymph node,0
260,transmission process,Undifferentiated Endocervical Sarcoma,0
261,Including (qualifier),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
262,Increase,Recurrent Testicular Lymphoma,0
263,Name,Female Breast Carcinoma,0
264,VIPR1 wt Allele,FIGO Stage II Ovarian Cancer,0
265,Structure of parenchyma of lung,Lipoma of small intestine,0
266,Heterogeneity,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
267,Bone Marrow Examination,Maxillary Sinus Adenocarcinoma,0
268,various allergen extracts,Bladder squamous cell carcinoma stage I,0
269,Continuous,BRCA2 Syndrome,0
270,Local disease,adenoid cystic carcinoma of lung,0
271,Immune,Stage II Hepatocellular Carcinoma AJCC v8,0
272,various other nasal preparations in ATC,Diffuse malignant mesothelioma,0
273,bacteria aspects,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
274,Rating (action),Acute Undifferentiated Leukemia,0
275,Usual,Digestive System Hodgkin Lymphoma,0
276,United States,Pancreatic Intraepithelial Neoplasia-3,0
277,Tissue of urinary bladder,Chronic Myelomonocytic Leukemia-2,0
278,Include (action),Recurrent Uveal Melanoma,0
279,High,Localized Ewing Sarcoma,0
280,Cancer Genus,Liver Lymphangioma,0
281,Result,Refractory Barrett Esophagus,0
282,Sex Cord-Stromal Tumor,Anterior Urethral Malignant Neoplasm,0
283,peripheral blood,Uterine Cancer,0
284,Room of building - Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
285,Pilomyxoid astrocytoma,Stage IV Penile Cancer AJCC v7,0
286,Result,Childhood Central Nervous System Immature Teratoma,0
287,Usually Need Help from Another Person for Reach,Malignant Neoplasm of Lung - Multiple Primary Sites,0
288,Cancer Genus,Chronic Myelomonocytic Leukemia-2,0
289,Ovary,Cerebral Primitive Neuroectodermal Tumor,0
290,First (number),Unresectable Rhabdomyosarcoma,0
291,Smear - instruction imperative,adenosquamous carcinoma of breast,0
292,Basis - conceptual entity,Digestive System Hodgkin Lymphoma,0
293,Type - attribute,Clonal Hematopoiesis of Indeterminate Potential,0
294,N+ (tumor staging),Choroid Necrotic Melanoma,0
295,Nausea,Childhood Thyroid Gland Follicular Carcinoma,0
296,Various patch test substance,Recurrent Uveal Melanoma,0
297,Nasal sinus,FIGO Stage II Ovarian Cancer,0
298,Enlarged,Leptomeningeal sarcoma,0
299,week,Stage I Adult Non-Hodgkin Lymphoma,0
300,radiotherapeutic,Advanced Uterine Corpus Carcinosarcoma,0
301,Nucleotide Excision Repair Pathway,Anterior Urethral Malignant Neoplasm,0
302,Diagnosis Study,Benign tumor of eyelid,0
303,Primary malignant neoplasm,gliosarcoma,0
304,Effective,Diffuse malignant mesothelioma,0
305,Salivary Glands,Low Grade Squamous Intraepithelial Neoplasia,0
306,Abdominal hysterectomy,Human Papillomavirus-Related Carcinoma,0
307,Tryptophanase,squamous cell carcinoma of the thyroid gland,0
308,Approximate,embryonal rhabdomyosarcoma of prostate,0
309,Genome - anatomical entity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
310,Secondary to,Noninfiltrating Intraductal Carcinoma,0
311,Early Therapy,Undifferentiated Endocervical Sarcoma,0
312,Developing Countries,Familial Adenomatous Polyposis Associated Medulloblastoma,0
313,shared attribute,Familial Adenomatous Polyposis Associated Medulloblastoma,0
314,Oral cavity,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
315,Process,papillary carcinoma of penis,0
316,Calcium Channel Antagonists [MoA],Stage IB Pancreatic Cancer AJCC v8,0
317,Basis - conceptual entity,Intraepithelial Melanocytic Hyperplasia,0
318,Cell Lineage,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
319,ITGBL1 gene,Adult Alveolar Soft Part Sarcoma,0
320,Genitalia,Intraepithelial Melanocytic Hyperplasia,0
321,Parameterized Data Type - Set,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
322,Fresh Water,Recurrent Testicular Lymphoma,0
323,Respiration,Stage 0 Lip Carcinoma,0
324,International Classification of Disease for Oncology,Testicular cancer metastatic,0
325,Yolk Sac Tumor,Neoplasms,0
326,cure of disease,Giant cell angiofibroma,0
327,Oral region,Malignant Neoplasm with Regional Lymph Node Involvement,0
328,Tryptophanase,Cerebral hemangioma,0
329,other medicated shampoos in ATC,Serous cystadenocarcinoma ovary,0
330,Cervical lymph node group,Non-Metastatic Gestational Trophoblastic Tumor,0
331,Form of uterus,Extracranial Neuroblastoma,0
332,Biological Response Modifiers,Lipoma of small intestine,0
333,Following,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
334,Vaginal intraepithelial neoplasia,Acantholytic squamous cell carcinoma,0
335,Ulceration,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
336,Surrounding (qualifier value),Unresectable Rhabdomyosarcoma,0
337,More,Endometrial Small Cell Carcinoma,0
338,Science of Etiology,Angiosarcoma of liver,0
339,Neuroectodermal Tumor,Localized Ewing Sarcoma,0
340,Malignant neoplasm of lung,Childhood Fibrillary Astrocytoma,0
341,Patients,Extracranial Neuroblastoma,0
342,Often - answer to question,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
343,Abnormal Cell Count,Cancer of Urinary Tract,0
344,Sunscreening Agents,Stage IV Childhood Non-Hodgkin Lymphoma,0
345,Cosmetics,Advanced Lung Carcinoma,0
346,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
347,Call (Instruction),Malignant neoplasm of choroid,0
348,Patient need for (contextual qualifier),Digestive System Hodgkin Lymphoma,0
349,Associated topography,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
350,Metastatic Disease Clinical Trial Setting,Rhabdomyosarcoma with ganglionic differentiation,0
351,Air,Acute Undifferentiated Leukemia,0
352,Oils,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
353,Drop measurement,Cartilaginous exostosis,0
354,Affect (mental function),Botryoid-Type Embryonal Rhabdomyosarcoma,0
355,Academic degree,Collecting Duct Carcinoma of the Kidney,0
356,Medical Imaging,Leiomyoma of Gallbladder,0
357,Continuous,Ichthyosis,0
358,Occur (action),Anterior Urethral Malignant Neoplasm,0
359,Collections (publication),Undifferentiated Endocervical Sarcoma,0
360,To,embryonal rhabdomyosarcoma of prostate,0
361,include - SetOperator,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
362,ovarian,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
363,Public Domain,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
364,To,Benign tumor of eyelid,0
365,Feelings,Botryoid-Type Embryonal Rhabdomyosarcoma,0
366,Main,Recurrent Uveal Melanoma,0
367,Geographic Locations,Prostate Lymphoma,0
368,Third,Adult Brain Stem Mixed Glioma,0
369,Old,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
370,Part of,Clonal Hematopoiesis of Indeterminate Potential,0
371,Acute leukemia,Acantholytic squamous cell carcinoma,0
372,Pharmaceutical Preparations,Cancer of Urinary Tract,0
373,Magnetic Resonance Imaging,Uterine Cancer,0
374,Neoplasms,Non-Metastatic Gestational Trophoblastic Tumor,0
375,Microscopic description,Clonal Hematopoiesis of Indeterminate Potential,0
376,Tryptophanase,malignant lymphoma of pancreatic lymph nodes,0
377,Right,Larynx carcinoma recurrent,0
378,Malignancy,Digestive System Hodgkin Lymphoma,0
379,Rare,FIGO Stage II Ovarian Cancer,0
380,Concept History,Stage I Adult Non-Hodgkin Lymphoma,0
381,Rare,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
382,Left sided,Undifferentiated Endocervical Sarcoma,0
383,Oral (intended site),Benign Carotid Body Paraganglioma,0
384,Supratentorial,BRCA2 Syndrome,0
385,Smaller,Stage II Hepatocellular Carcinoma AJCC v8,0
386,Human papilloma virus infection,Cartilaginous exostosis,0
387,Death NOS,Ovarian Carcinoid Tumor,0
388,Induce (action),sarcoma of spinal cord,0
389,Tumor cells,Tonsillar Carcinoma,0
390,Malignant neoplasm of breast,Breast Ductal Adenoma,0
391,Acquired Name,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
392,Primary operation,Familial Hemophagocytic Lymphocytosis,0
393,Approach,Undifferentiated Neuroblastoma,0
394,Skin,Cancer of Urinary Tract,0
395,Patient Caretaker,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
396,Symptoms,Benign tumor of eyelid,0
397,Testis,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
398,Female Phenotype,Acute Undifferentiated Leukemia,0
399,Back Pain,Mucinous adenocarcinoma gastric,0
400,potential,Diffuse malignant mesothelioma,0
401,Persons,Small cell neuroendocrine carcinoma of bladder,0
402,Two,Carcinoma ex pleomorphic adenoma of parotid gland,0
403,Table Cell Vertical Align - middle,Rhabdomyosarcoma with ganglionic differentiation,0
404,Adrenal Cancer,Ovarian germ cell choriocarcinoma stage IV,0
405,Diagnosis Study,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
406,Mental association,Uterine Cancer,0
407,Woman,Localized Askin Tumor,0
408,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Spongiotic dermatitis,0
409,80%,Breast Ductal Adenoma,0
410,Biomaterial Treatment,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
411,Greater,Adult Hepatocellular Carcinoma,0
412,Manufactured sign,Breast Ductal Adenoma,0
413,Measurement,Human Papillomavirus-Related Carcinoma,0
414,Togo,Xeroderma pigmentosum,0
415,Surgical Replantation,Medulloblastoma,0
416,Polypeptide Hormones,Mucinous adenocarcinoma gastric,0
417,Time,Botryoid-Type Embryonal Rhabdomyosarcoma,0
418,Skin,Liver Lymphangioma,0
419,Approximate,FIGO Stage II Ovarian Cancer,0
420,Neurofibromatosis 1,Testicular cancer metastatic,0
421,Ability,Metastatic Kidney Carcinoma,0
422,geographic population,adenosquamous carcinoma of breast,0
423,Surrounding (qualifier value),Heavy Chain Deposition Disease,0
424,Body tissue,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
425,Diagnosis,Low Grade Squamous Intraepithelial Neoplasia,0
426,Linear,Mucinous neoplasm,0
427,Biopsy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
428,1+ Score,Heavy Chain Deposition Disease,0
429,International Classification of Diseases,Cancer of Urinary Tract,0
430,PSA Level Greater than Fifty,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
431,Excision,Recurrent Testicular Lymphoma,0
432,Low Mitosis-Karyorrhexis Index,Mucinous adenocarcinoma gastric,0
433,Localized,Acantholytic squamous cell carcinoma,0
434,described,Carcinoma of urinary bladder,0
435,Lymphoid Tissue,Cerebral Primitive Neuroectodermal Tumor,0
436,Pancreas,High Grade Glandular Intraepithelial Neoplasia,0
437,Gender Status - Intact,Stage IB Pancreatic Cancer AJCC v8,0
438,LYMPHOID Cancers,Serous cystadenocarcinoma ovary,0
439,Treating,Intracortical osteosarcoma,0
440,Cerebrum,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
441,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Uveal Melanoma,0
442,risk factors - observation list,Leptomeningeal sarcoma,0
443,Carcinoma,mucinous adenocarcinoma of gallbladder,0
444,Often - answer to question,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
445,Thymic epithelial tumor,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
446,% of total,Papillary cystic tumor,0
447,Asians,Clonal Hematopoiesis of Indeterminate Potential,0
448,Point,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
449,Traumatic injury,Stage IB Pancreatic Cancer AJCC v8,0
450,Myasthenia Gravis,Unresectable Rhabdomyosarcoma,0
451,sex,Placental aromatase deficiency,0
452,Weather,Recurrent Diffuse Intrinsic Pontine Glioma,0
453,Testing,Benign Apocrine Neoplasm,0
454,gastrointestinal,Methotrexate-Associated Hodgkin Lymphoma,0
455,Usually,Rhabdomyosarcoma with ganglionic differentiation,0
456,Poor function,Mucinous adenocarcinoma gastric,0
457,Hepatitis C Virus Infection,Metastatic Ductal Breast Carcinoma,0
458,Widening,Diffuse malignant mesothelioma,0
459,Type A,Cartilaginous exostosis,0
460,Up,Neoplasms,0
461,Melanocytic nevus of skin,Cancer of Urinary Tract,0
462,Skin,Clonal Hematopoiesis of Indeterminate Potential,0
463,Increasing,Thymic Clear Cell Carcinoma,0
464,Family history,Malignant Testicular Sertoli Cell Tumor,0
465,Brain Neoplasms,Acantholytic squamous cell carcinoma,0
466,brain cell,BRCA2 Syndrome,0
467,Vision,Xeroderma pigmentosum,0
468,Histamine Antagonists,FIGO Stage II Ovarian Cancer,0
469,Give - dosing instruction imperative,Non-Metastatic Gestational Trophoblastic Tumor,0
470,Antidepressant Measurement,Mucinous adenocarcinoma gastric,0
471,Distal (qualifier value),Digestive System Hodgkin Lymphoma,0
472,THM gene,Human Papillomavirus-Related Carcinoma,0
473,Base - General Qualifier,Small cell neuroendocrine carcinoma of bladder,0
474,Genitalia,Pancreatic Intraepithelial Neoplasia-3,0
475,83,Spongiotic dermatitis,0
476,Chemotherapy,embryonal rhabdomyosarcoma of prostate,0
477,Internal medicine specialty,Anterior Urethral Malignant Neoplasm,0
478,Study Site,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
479,Tryptophanase,Blepharal carcinoma,0
480,Variety (taxon),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
481,Specialized Stand Alone Plan - Vision,Pancreatic Intraepithelial Neoplasia-3,0
482,Then,Childhood Lymphoma,0
483,Lymphocyte component of blood,Mucinous neoplasm,0
484,Cessation of life,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
485,Singular,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
486,Pain,Cancer of Urinary Tract,0
487,Cell Count,Mucinous adenocarcinoma gastric,0
488,Rate,Hodgkin lymphoma,0
489,Papillomavirus,Neoplasms,0
490,Smear - instruction imperative,Grade 1 Clear Cell Renal Cell Carcinoma,0
491,Population Group,Stage IV Penile Cancer AJCC v7,0
492,IgY,non-Hodgkin's lymphoma of spleen,0
493,treatment - ActInformationManagementReason,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
494,Progress,Neoplasms,0
495,Areas <moth>,Intraepithelial Melanocytic Hyperplasia,0
496,Including (qualifier),Botryoid-Type Embryonal Rhabdomyosarcoma,0
497,Column (anatomic),Intestinal Metaplasia of Bladder Urothelium,0
498,Actual Aspiration,Diffuse malignant mesothelioma,0
499,What subject filter - Result,Unfavorable Non-Hodgkin Lymphoma,0
500,Have Pain,Extra-Adrenal Paraganglioma,0
501,Decision,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
502,Event Seriousness - Significant,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
503,Breast Cancer Type 1 Susceptibility Protein Measurement,de novo Myelodysplastic Syndrome,0
504,Persons,Testicular cancer metastatic,0
505,Reported Term,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
506,Diagnosis Study,Diffuse malignant mesothelioma,0
507,Body Site Modifier - Lower,Primary Cutaneous Plasmablastic Lymphoma,0
508,Common Specifications in HL7 V3 Publishing,Advanced Uterine Corpus Carcinosarcoma,0
509,Malignant Neoplasms,Extra-Adrenal Paraganglioma,0
510,IPSS Risk Category High,Cancer of Urinary Tract,0
511,Togo,Heavy Chain Deposition Disease,0
512,Clonality,Mixed parotid tumor,0
513,Function Axis,Unresectable Rhabdomyosarcoma,0
514,Carcinoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
515,Five-year Survival Rate,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
516,Therapeutic procedure,Choroid Necrotic Melanoma,0
517,Squamous cell carcinoma,Granular Cell Leiomyosarcoma,0
518,Development,High Grade Glandular Intraepithelial Neoplasia,0
519,Operative Surgical Procedures,mucinous adenocarcinoma of gallbladder,0
520,The Sun,sarcoma of spinal cord,0
521,Headache,Mastocytosis,0
522,Skin Pigmentation,Human Papillomavirus-Related Carcinoma,0
523,Levels (qualifier value),Chronic Myelomonocytic Leukemia-2,0
524,Face (spatial concept),Placental aromatase deficiency,0
525,Management procedure,Ovarian germ cell choriocarcinoma stage IV,0
526,Singular,embryonal rhabdomyosarcoma of prostate,0
527,H2 receptor blockers,Thymic Clear Cell Carcinoma,0
528,Decrease,Cancer of Urinary Tract,0
529,Histologic,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
530,How Much Distress Pain,Lipoma of small intestine,0
531,Known,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
532,Squamous cell carcinoma - category,Localized Askin Tumor,0
533,epidemiologic,Bladder squamous cell carcinoma stage I,0
534,Polycythemia,Chronic Myelomonocytic Leukemia-2,0
535,Malignant neoplasm of skin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
536,Dental caries,Lipoma of small intestine,0
537,Html Link Type - index,Unfavorable Non-Hodgkin Lymphoma,0
538,Age-Years,High Grade Glandular Intraepithelial Neoplasia,0
539,Lower (action),Non-Metastatic Gestational Trophoblastic Tumor,0
540,Body tissue,Recurrent Uveal Melanoma,0
541,Derivative,Small cell neuroendocrine carcinoma of bladder,0
542,Increased risk,Placental aromatase deficiency,0
543,Endoscopy of stomach,Human Papillomavirus-Related Carcinoma,0
544,Malignant neoplasm of kidney,Chondrosarcoma,0
545,described,Localized Askin Tumor,0
546,Negation,Unfavorable Non-Hodgkin Lymphoma,0
547,Present,Metastatic Ductal Breast Carcinoma,0
548,Class,Human Papillomavirus-Related Carcinoma,0
549,Third,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
550,Long,Platinum-Resistant Lung Small Cell Carcinoma,0
551,various other agents for local oral treatment in ATC,Refractory Barrett Esophagus,0
552,Usual Severity Weight Loss,Xeroderma pigmentosum,0
553,described,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
554,Cell Proliferation,Adult Alveolar Soft Part Sarcoma,0
555,Body tissue,Female Breast Carcinoma,0
556,Entity Determiner - specific,Anaplastic large cell lymphoma,0
557,PREVENT (product),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
558,Devices,Adenocarcinoma,0
559,Related personal status,Non-Metastatic Gestational Trophoblastic Tumor,0
560,Screening Study,Childhood Fibrillary Astrocytoma,0
561,Elevated alpha-fetoprotein,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
562,Usual,Spongiotic dermatitis,0
563,Case (situation),Collecting Duct Carcinoma of the Kidney,0
564,Human body,Acute Undifferentiated Leukemia,0
565,Palmitic Acid,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
566,CDISC SDTM Disease Outcome Terminology,Testicular cancer metastatic,0
567,Multiplication,Clonal Hematopoiesis of Indeterminate Potential,0
568,Term (lexical),Endometrial Small Cell Carcinoma,0
569,Neoplasms,Mucinous adenocarcinoma gastric,0
570,Term (temporal),Angiosarcoma of liver,0
571,Manufactured form,Recurrent Testicular Lymphoma,0
572,Diagnosis,gliosarcoma,0
573,Rare,adenosquamous carcinoma of breast,0
574,Clone,Acute Undifferentiated Leukemia,0
575,Biological Markers,mucinous adenocarcinoma of gallbladder,0
576,Qualifier (concept),Intestinal Metaplasia of Bladder Urothelium,0
577,Aggressive behavior,mucinous adenocarcinoma of gallbladder,0
578,health and disease,Advanced Uterine Corpus Carcinosarcoma,0
579,Most,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
580,Space - property,Lipoma of small intestine,0
581,Decreased,Intraepithelial Melanocytic Hyperplasia,0
582,Slight (qualifier value),Intracortical osteosarcoma,0
583,prior radiation therapy,Chronic Myelomonocytic Leukemia-2,0
584,Organ,Pancreatic Intraepithelial Neoplasia-3,0
585,Visual Impairment,Rhabdomyosarcoma with ganglionic differentiation,0
586,respiratory,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
587,Abdomen+,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
588,Weight,Recurrent Testicular Lymphoma,0
589,Bruising,non-Hodgkin's lymphoma of spleen,0
590,treatment - ActInformationManagementReason,Atypical Lobular Breast Hyperplasia,0
591,Primary malignant neoplasm,Fourth Ventricle and Brain Stem Ependymal Tumor,0
592,Old,Endometrial Small Cell Carcinoma,0
593,Experimental Result,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
594,Event Seriousness - Significant,Localized Ewing Sarcoma,0
595,Fertility Domain,Hodgkin lymphoma,0
596,Characterization,Angiosarcoma of liver,0
597,Aggressive course,Colorectal Neuroendocrine Tumor G2,0
598,Interested,Recurrent Testicular Lymphoma,0
599,Skin Pigmentation,non-Hodgkin's lymphoma of spleen,0
600,Treating,Refractory Barrett Esophagus,0
601,Does communicate,Malignant neoplasm of thalamus,0
602,Discharge,Giant cell angiofibroma,0
603,Egg of order Phthiraptera,Medulloblastoma,0
604,CD69 wt Allele,embryonal rhabdomyosarcoma of prostate,0
605,Histopathological aspects,Colorectal High Grade B-Cell Lymphoma,0
606,Blood Cells,Botryoid-Type Embryonal Rhabdomyosarcoma,0
607,Prognosis:Find:Pt:^Patient:Nom,sarcoma of spinal cord,0
608,Tests (qualifier value),Giant cell angiofibroma,0
609,Relationships,Thymic Clear Cell Carcinoma,0
610,Medical,Recurrent Testicular Lymphoma,0
611,Malignant Female Reproductive System Neoplasm,Endometrial Small Cell Carcinoma,0
612,Abnormal Virilization,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
613,diagnosis aspect,Medulloblastoma,0
614,Primary malignant neoplasm,Cerebral Primitive Neuroectodermal Tumor,0
615,Body part,Anterior Urethral Malignant Neoplasm,0
616,Data Transformation,Intestinal Metaplasia of Bladder Urothelium,0
617,Bilateral cataracts (disorder),Acute Undifferentiated Leukemia,0
618,EPO protein,Bladder squamous cell carcinoma stage I,0
619,photoreactivating enzyme activity,Ovarian germ cell choriocarcinoma stage IV,0
620,Polypeptide Hormones,Recurrent Testicular Lymphoma,0
621,Three,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
622,Sacrifice,Localized Ewing Sarcoma,0
623,risk factors,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
624,Nine,Hodgkin lymphoma,0
625,Monocytes,Platinum-Resistant Lung Small Cell Carcinoma,0
626,Base - General Qualifier,Tonsillar Carcinoma,0
627,Proteins,Malignant melanoma of eyelid,0
628,Lymphatic vessel,Female Breast Carcinoma,0
629,Condition:Find:Pt:^Patient:Nom,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
630,Person Name,Acute Undifferentiated Leukemia,0
631,Drain device,Mucinous adenocarcinoma gastric,0
632,Including (qualifier),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
633,Large,Medulloblastoma,0
634,To,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
635,Dependent for bathing,Malignant melanoma of eyelid,0
636,Condition,Stage II Carcinoma of Penis,0
637,Cancer Other,FIGO Stage II Ovarian Cancer,0
638,Local disease,Angiosarcoma of liver,0
639,symbol - solid dosage form,Mucinous adenocarcinoma gastric,0
640,American College of Cardiology/American Heart Association Lesion Complexity Score C,Cartilaginous exostosis,0
641,Qualitative form,Pancreatic Intraepithelial Neoplasia-3,0
642,Mechanism (attribute),Lipoma of small intestine,0
643,Agreement,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
644,Congestive heart failure,Malignant melanoma of eyelid,0
645,Down Syndrome,Spongiotic dermatitis,0
646,Frequently,Lipoma of small intestine,0
647,potential,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
648,Communicable Diseases,embryonal rhabdomyosarcoma of prostate,0
649,Arsenic measurement,Localized Askin Tumor,0
650,Cervical lymph node group,Xeroderma pigmentosum,0
651,animal allergen extracts,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
652,Chemotherapy,Human Papillomavirus-Related Carcinoma,0
653,Biopsy,Deep Leiomyoma,0
654,Tobacco smoking behavior,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
655,Introduces,Metastatic Lung Small Cell Carcinoma,0
656,Maintaining (action),Primary Cutaneous Plasmablastic Lymphoma,0
657,Lung,Intraepithelial Melanocytic Hyperplasia,0
658,Affecting,Acantholytic squamous cell carcinoma,0
659,Radioactive Seed Implant Dosing Unit,embryonal rhabdomyosarcoma of prostate,0
660,Disease Screening,Childhood Thyroid Gland Follicular Carcinoma,0
661,Source,Ovarian germ cell choriocarcinoma stage IV,0
662,Automobile Driving,embryonal rhabdomyosarcoma of prostate,0
663,<3 (qualifier value),Cancer of Urinary Tract,0
664,cell type,Malignant melanoma of eyelid,0
665,Second Suffix,Childhood Central Nervous System Immature Teratoma,0
666,Entity Determiner - specific,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
667,Urine for culture,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
668,Operative Surgical Procedures,Stage II Hepatocellular Carcinoma AJCC v8,0
669,Scientific Publication,Serous cystadenocarcinoma ovary,0
670,Dietary Lead,FIGO Stage II Ovarian Cancer,0
671,European Viper,Uterine Cancer,0
672,device aspects,Undifferentiated Neuroblastoma,0
673,Physical Activity Measurement,gliosarcoma,0
674,shared attribute,Liver Cavernous Hemangioma,0
675,Lymphatic System,Hemangioma,0
676,Germ cell tumor,Mucinous neoplasm,0
677,Genetic screening method,Refractory Barrett Esophagus,0
678,breast.duct,Malignant Neoplasm of Lung - Multiple Primary Sites,0
679,Removing (action),Acute Undifferentiated Leukemia,0
680,Pyelonephritis,Tonsillar Carcinoma,0
681,respiratory gaseous exchange in organisms,Recurrent Testicular Lymphoma,0
682,Fluid behavior,Recurrent Uveal Melanoma,0
683,Pitch (deviation),Extracranial Neuroblastoma,0
684,Dorsal,Endometrial Small Cell Carcinoma,0
685,Effusion of blood,GIANT PIGMENTED HAIRY NEVUS,0
686,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Intestinal Metaplasia of Bladder Urothelium,0
687,Males,squamous cell carcinoma of the thyroid gland,0
688,The Sun,Deep Leiomyoma,0
689,Area,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
690,International Classification of Disease for Oncology,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
691,Occur (action),Benign neoplasm of thorax,0
692,Personal appearance,adenoid cystic carcinoma of lung,0
693,Cancer Genus,Werner Syndrome,0
694,Epithelium,Carcinoma of urinary bladder,0
695,Patient Problem,Intestinal Metaplasia of Bladder Urothelium,0
696,Malignant Neoplasms,Malignant Testicular Sertoli Cell Tumor,0
697,Physical findings,FIGO Stage II Ovarian Cancer,0
698,Including (qualifier),Unresectable Rhabdomyosarcoma,0
699,Blood,Acute Undifferentiated Leukemia,0
700,Contain (action),Stage I Adult Non-Hodgkin Lymphoma,0
701,Characterization,Blepharal carcinoma,0
702,Usual Severity Weight Loss,Atypical Lobular Breast Hyperplasia,0
703,Five,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
704,Breast Carcinoma,Stage IB Pancreatic Cancer AJCC v8,0
705,Decision,Adult Alveolar Soft Part Sarcoma,0
706,Thymus Gland,Mucinous adenocarcinoma gastric,0
707,SLC35G1 gene,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
708,Form of bone,Female Breast Carcinoma,0
709,High,Breast Ductal Adenoma,0
710,Science of Etiology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
711,Rapid,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
712,Stomach,Thymic Atypical Carcinoid Tumor,0
713,Front of neck,Bladder squamous cell carcinoma stage I,0
714,Used by,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
715,Very Much,Pancreatic Intraepithelial Neoplasia-3,0
716,Diagnosis Study,Airway Hemangioma,0
717,ADCY10 gene,Benign tumor of eyelid,0
718,Cancer Other,embryonal rhabdomyosarcoma of prostate,0
719,Palpebronasal fold,Female Breast Carcinoma,0
720,Cells,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
721,Tumor stage,Human Papillomavirus-Related Carcinoma,0
722,Glioma,Non-Metastatic Gestational Trophoblastic Tumor,0
723,Adult Non-Hodgkin Lymphoma,Maxillary Sinus Adenocarcinoma,0
724,One,FIGO Stage II Ovarian Cancer,0
725,Account number:Identifier:Point in time:^Patient:Nominal,Adult Hepatocellular Carcinoma,0
726,Diarrhea,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
727,Weight decreased,Locally Advanced Soft Tissue Sarcoma,0
728,Make - Instruction Imperative,Choroid Necrotic Melanoma,0
729,Removed,Adenocarcinoma,0
730,Age,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
731,various antiinfectives and antiseptics for local oral treatment,Atypical Mesothelial Hyperplasia,0
732,Lip and Oral Cavity Carcinoma,Localized Ewing Sarcoma,0
733,Often - answer to question,Digestive System Hodgkin Lymphoma,0
734,H NOS Antibodies,Undifferentiated Endocervical Sarcoma,0
735,Type A,Pancreatic Intraepithelial Neoplasia-3,0
736,Therapeutic procedure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
737,therapeutic aspects,Uterine Cancer,0
738,Childhood Embryonal Rhabdomyosarcoma,Xeroderma pigmentosum,0
739,operate <remove>,Colorectal Neuroendocrine Tumor G2,0
740,Body tissue,Colorectal High Grade B-Cell Lymphoma,0
741,Categories,Small cell neuroendocrine carcinoma of bladder,0
742,therapeutic aspects,Adrenal Rest Tumor,0
743,Aggressive course,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
744,Due to,Leiomyoma of Gallbladder,0
745,Rating (action),Ovarian germ cell choriocarcinoma stage IV,0
746,Liquid substance,Refractory Barrett Esophagus,0
747,Squamous cell carcinoma - category,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
748,Following,Colorectal cancer,0
749,Qualitative form,Familial Adenomatous Polyposis Associated Medulloblastoma,0
750,Infrequent,Carcinoma ex pleomorphic adenoma of parotid gland,0
751,Therapeutic radiology procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
752,biopsy characteristics,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
753,Lymphoid Tissue,Thymic Clear Cell Carcinoma,0
754,month,Choroid Necrotic Melanoma,0
755,Hyperlink,Mucinous adenocarcinoma gastric,0
756,Y protein,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
757,Poor function,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
758,Occurrence,Methotrexate-Associated Hodgkin Lymphoma,0
759,Most,Liver Lymphangioma,0
760,Two,Lipoma of small intestine,0
761,Pharyngitis,FIGO Stage II Ovarian Cancer,0
762,Neoplasm Metastasis,Choroid Necrotic Melanoma,0
763,per period (qualifier value),Cancer of Urinary Tract,0
764,Labium,Human Papillomavirus-Related Carcinoma,0
765,Including (qualifier),Childhood Choriocarcinoma,0
766,Numerous,Stage III Adult Immunoblastic Lymphoma,0
767,Primary malignant neoplasm of endometrium,non-Hodgkin's lymphoma of spleen,0
768,Developed Countries,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
769,Qualitative form,Stage IV Childhood Non-Hodgkin Lymphoma,0
770,Fatigue,High Grade Glandular Intraepithelial Neoplasia,0
771,Genus Chalazion,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
772,Covered (qualifier value),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
773,Immune System Finding,Locally Advanced Soft Tissue Sarcoma,0
774,Stem of plant,Adult Hepatocellular Carcinoma,0
775,Pruritus,Cartilaginous exostosis,0
776,Disks (device),Childhood Fibrillary Astrocytoma,0
777,Body tissue,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
778,Togo,Adenocarcinoma,0
779,Early stage,Primary Cutaneous Plasmablastic Lymphoma,0
780,Related personal status,Digestive System Hodgkin Lymphoma,0
781,Antibody Formation,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
782,Europe,Adult Fibrolamellar Carcinoma,0
783,Surgical service,Human Papillomavirus-Related Carcinoma,0
784,Amount type - Percentage,Cancer of Urinary Tract,0
785,Head and neck structure,Heavy Chain Deposition Disease,0
786,Freckles,Benign tumor of eyelid,0
787,chance,Recurrent Diffuse Intrinsic Pontine Glioma,0
788,Only - dosing instruction fragment,Extracranial Neuroblastoma,0
789,Extrinsic,Stage IV Childhood Non-Hodgkin Lymphoma,0
790,Occur (action),Stage IB Pancreatic Cancer AJCC v8,0
791,Universities,Airway Hemangioma,0
792,Contrast,Diffuse malignant mesothelioma,0
793,Onset of (contextual qualifier),High Grade Glandular Intraepithelial Neoplasia,0
794,What subject filter - Result,FIGO Stage II Ovarian Cancer,0
795,To,Adult Hepatocellular Carcinoma,0
796,Both kidneys,Intestinal Neuroendocrine Carcinoma,0
797,Decision,Primary Cutaneous Plasmablastic Lymphoma,0
798,Bone Pain,Anaplastic large cell lymphoma,0
799,Neoadjuvant Therapy,Xeroderma pigmentosum,0
800,Scheme,Metastatic Ductal Breast Carcinoma,0
801,Basal cell carcinoma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
802,Occurrence Indicator,Xeroderma pigmentosum,0
803,Base Pair Unit,Choroid Necrotic Melanoma,0
804,Cultured Cell Line,Noninfiltrating Intraductal Carcinoma,0
805,Togo,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
806,Process (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
807,risk factors - observation list,Acute Undifferentiated Leukemia,0
808,Feelings,Testicular cancer metastatic,0
809,Result,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
810,Adenocarcinoma of pancreas,mucinous adenocarcinoma of gallbladder,0
811,Overall,Diffuse malignant mesothelioma,0
812,Due to,Recurrent Testicular Lymphoma,0
813,thymocyte,Diffuse malignant mesothelioma,0
814,Range,adenoid cystic carcinoma of lung,0
815,Frequently,Cartilaginous exostosis,0
816,Administration procedure,Undifferentiated Endocervical Sarcoma,0
817,Red Blood Cell Count measurement,Noninfiltrating Intraductal Carcinoma,0
818,risk factors - observation list,mucinous adenocarcinoma of gallbladder,0
819,Frequently,Metastatic Carcinoma in the Lung,0
820,Primary malignant neoplasm,Chondrosarcoma,0
821,Enlargement procedure,Leiomyoma of Gallbladder,0
822,Time,Primary Cutaneous Plasmablastic Lymphoma,0
823,treatment - ActInformationManagementReason,Carcinoma of urinary bladder,0
824,Blood Products Laboratory Testing,Benign neoplasm of thorax,0
825,Neoplasm Metastasis,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
826,Adult,Ovarian germ cell choriocarcinoma stage IV,0
827,Feature,malignant lymphoma of pancreatic lymph nodes,0
828,Coloring Excipient,Stage IV Penile Cancer AJCC v7,0
829,Intention - mental process,adenosquamous carcinoma of breast,0
830,Biomaterial Treatment,benign mature teratoma of pancreas,0
831,Vaccines,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
832,More,adenoid cystic carcinoma of lung,0
833,Original,Botryoid-Type Embryonal Rhabdomyosarcoma,0
834,Singular,Stage II Hepatocellular Carcinoma AJCC v8,0
835,Capecitabine/Cisplatin Regimen,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
836,Adult Glioblastoma,BRCA2 Syndrome,0
837,Characterization,Medulloblastoma,0
838,Related personal status,Leptomeningeal sarcoma,0
839,Qualitative form,malignant lymphoma of pancreatic lymph nodes,0
840,Ultraviolet Rays,Advanced Uterine Corpus Carcinosarcoma,0
841,Increased frequency of micturition,Bladder squamous cell carcinoma stage I,0
842,To,Mucinous adenocarcinoma gastric,0
843,year,Uterine Cancer,0
844,Current (present time),Endometrial Small Cell Carcinoma,0
845,Morphology,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
846,lymph nodes,Adult Brain Stem Mixed Glioma,0
847,Recommendation,Giant cell angiofibroma,0
848,Tumor cells,Uterine Cancer,0
849,Various patch test substance,Recurrent Uveal Melanoma,0
850,Certain (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
851,Sometimes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
852,Similarity,Thymic Atypical Carcinoid Tumor,0
853,Basis - conceptual entity,Adult Hepatocellular Carcinoma,0
854,Call (Instruction),Endometrial Small Cell Carcinoma,0
855,Measures,Undifferentiated Endocervical Sarcoma,0
856,Ploidies,Stage IV Childhood Non-Hodgkin Lymphoma,0
857,Patient observation,Testicular cancer metastatic,0
858,Dyspareunia (female),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
859,Lymphoma,Non-Metastatic Gestational Trophoblastic Tumor,0
860,Supratentorial Embryonal Tumor,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
861,Abundance,Contact dermatitis due to alkali,0
862,Free of (attribute),Benign Apocrine Neoplasm,0
863,What subject filter - Result,Localized Askin Tumor,0
864,High Risk Acute Leukemia,Carcinoma of urinary bladder,0
865,Injury due to exposure to external cause,Methotrexate-Associated Hodgkin Lymphoma,0
866,cell growth,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
867,Percent of Abnormal Cells,Methotrexate-Associated Hodgkin Lymphoma,0
868,Strawberry nevus of skin,Pilocytic astrocytoma of cerebellum,0
869,Concept Relationship,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
870,Greater,Xeroderma pigmentosum,0
871,majority,Clonal Hematopoiesis of Indeterminate Potential,0
872,bony process,Stage II Carcinoma of Penis,0
873,Category Type,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
874,Nine,Intestinal Neuroendocrine Carcinoma,0
875,Observation in research,Breast Ductal Adenoma,0
876,Involvement with,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
877,In Blood,Unfavorable Non-Hodgkin Lymphoma,0
878,Skin,Angiosarcoma of liver,0
879,Complete,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
880,New,Liver Lymphangioma,0
881,Massive,Recurrent Testicular Lymphoma,0
882,Study,Chronic Myelomonocytic Leukemia-2,0
883,High,Familial Adenomatous Polyposis Associated Medulloblastoma,0
884,Only - dosing instruction fragment,Bladder squamous cell carcinoma stage I,0
885,<50,Chronic Myelomonocytic Leukemia-2,0
886,Case (situation),Angiosarcoma of liver,0
887,Form of joint,Neoplasms,0
888,Brain,Stage III Adult Immunoblastic Lymphoma,0
889,Usual Severity Shortness of Breath,Acute Undifferentiated Leukemia,0
890,Fever,Localized Askin Tumor,0
891,Malignant - descriptor,Neonatal leukemia,0
892,Qualitative form,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
893,<90,Larynx carcinoma recurrent,0
894,risk factors,Ovarian germ cell choriocarcinoma stage IV,0
895,Small cell carcinoma of lung,Undifferentiated Endocervical Sarcoma,0
896,Screening Study,Intraepithelial Melanocytic Hyperplasia,0
897,Line Unit of Length,Metastatic Malignant Neoplasm in the Sellar Region,0
898,Country number:Find:Pt:^Patient:Nom,Ichthyosis,0
899,Often - answer to question,embryonal rhabdomyosarcoma of prostate,0
900,Lymphocyte,Benign Apocrine Neoplasm,0
901,Pruritus,Female Breast Carcinoma,0
902,Form:Finding:Point in time:{Setting}:Document:{Role},Uterine Cancer,0
903,Call (Instruction),Childhood Thyroid Gland Follicular Carcinoma,0
904,Disease,Lipoma of small intestine,0
905,World,embryonal rhabdomyosarcoma of prostate,0
906,Lymphocyte,Cerebral Primitive Neuroectodermal Tumor,0
907,soft tissue,Human Papillomavirus-Related Carcinoma,0
908,Childhood diseases,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
909,Long Term Survivorship,Localized Askin Tumor,0
910,Dependent for Toilet Use,Recurrent Uveal Melanoma,0
911,Rare,Familial Adenomatous Polyposis Associated Medulloblastoma,0
912,60%,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
913,Basis - conceptual entity,Acute Undifferentiated Leukemia,0
914,Most,Diffuse malignant mesothelioma,0
915,Gender,Endometrial Small Cell Carcinoma,0
916,Bottom,Acute Undifferentiated Leukemia,0
917,Anatomic Structure,Carcinoma ex pleomorphic adenoma of parotid gland,0
918,Mixed Salivary Gland Tumor,Human Papillomavirus-Related Carcinoma,0
919,Childhood Germ Cell Tumor,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
920,Common (qualifier value),Intracortical osteosarcoma,0
921,Malignant - descriptor,Stage II Carcinoma of Penis,0
922,Molecular Mass,Spongiotic dermatitis,0
923,drug companies,Diffuse malignant mesothelioma,0
924,Lymphocyte component of blood,Uterine Cancer,0
925,Person Name,Bladder squamous cell carcinoma stage I,0
926,Classification,Chronic Myelomonocytic Leukemia-2,0
927,Occur (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
928,Extremely Agree,Diffuse malignant mesothelioma,0
929,Bound (value),Breast Ductal Adenoma,0
930,Second Suffix,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
931,Tryptophanase,Thymic Clear Cell Carcinoma,0
932,Have Weight Loss,Malignant neoplasm of thalamus,0
933,Biomaterial Treatment,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
934,Proliferation (morphologic abnormality),Localized Ewing Sarcoma,0
935,Beginning,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
936,Possible diagnosis,Acute Undifferentiated Leukemia,0
937,Process,Refractory Barrett Esophagus,0
938,Sunlight,Familial Adenomatous Polyposis Associated Medulloblastoma,0
939,Protocol Agent,Digestive System Hodgkin Lymphoma,0
940,Communicable Diseases,Methotrexate-Associated Hodgkin Lymphoma,0
941,Tryptophanase,Colorectal Neuroendocrine Tumor G2,0
942,Medical Imaging,Anterior Urethral Malignant Neoplasm,0
943,Normal,Benign tumor of eyelid,0
944,immunoglobulin activity,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
945,Night sweats,Pilocytic astrocytoma of cerebellum,0
946,3+ Score,Endometrial Small Cell Carcinoma,0
947,Estrogen (disposition),Clonal Hematopoiesis of Indeterminate Potential,0
948,peripheral blood,Malignant melanoma of eyelid,0
949,Family history,Unresectable Rhabdomyosarcoma,0
950,Mature Lymphocyte,Metastatic Ductal Breast Carcinoma,0
951,Childhood Diffuse Large B-Cell Lymphoma,Mucinous adenocarcinoma gastric,0
952,Physical findings,Female Breast Carcinoma,0
953,diagnosis aspect,papillary carcinoma of penis,0
954,Large,Maxillary Sinus Adenocarcinoma,0
955,Tissue Donors,Neonatal leukemia,0
956,Expression procedure,Cancer of Urinary Tract,0
957,Cancer Genus,Recurrent Uveal Melanoma,0
958,Cancer Genus,Locally Advanced Soft Tissue Sarcoma,0
959,Genus Homo,Carcinoma ex pleomorphic adenoma of parotid gland,0
960,Histologic,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
961,General surgery specialty,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
962,Unspecified,sarcoma of spinal cord,0
963,Down Syndrome,Pancreatic Intraepithelial Neoplasia-3,0
964,Intestines,Recurrent Uveal Melanoma,0
965,Present,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
966,Infant,Tonsillar Carcinoma,0
967,Person Observer,Refractory Barrett Esophagus,0
968,ITGBL1 gene,Blepharal carcinoma,0
969,Hematological Disease,Ichthyoses,0
970,peripheral blood,gliosarcoma,0
971,Formation,Noninfiltrating Intraductal Carcinoma,0
972,Process (qualifier value),squamous cell carcinoma of the thyroid gland,0
973,Tumor cells,FIGO Stage II Ovarian Cancer,0
974,Pharmacotherapy,Bladder squamous cell carcinoma stage I,0
975,Cessation of life,Lipoma of small intestine,0
976,Including (qualifier),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
977,One,Testicular cancer metastatic,0
978,Covers (device),FIGO Stage II Ovarian Cancer,0
979,To,Heavy Chain Deposition Disease,0
980,Surgical repair,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
981,Science of Statistics,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
982,Lead,Uterine Cancer,0
983,Aggressive behavior,Acute lymphadenitis,0
984,Cancer Histology,Lipoma of small intestine,0
985,Term (temporal),Primary Cutaneous Plasmablastic Lymphoma,0
986,Unusual,Activated B-cell type diffuse large B-cell lymphoma,0
987,Tryptophanase,Stage IB Pancreatic Cancer AJCC v8,0
988,Xeroderma Pigmentosum,Acantholytic squamous cell carcinoma,0
989,Local disease,Thymic Clear Cell Carcinoma,0
990,Biomaterial Treatment,Liver Lymphangioma,0
991,Sweating,Colorectal High Grade B-Cell Lymphoma,0
992,Most,Mucinous adenocarcinoma gastric,0
993,Tentorium cerebelli,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
994,Breast Feeding,Noninfiltrating Intraductal Carcinoma,0
995,Decade,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
996,Occurrence,Intestinal Metaplasia of Bladder Urothelium,0
997,Survival Rate,Airway Hemangioma,0
998,Thorotrast,Childhood Choriocarcinoma,0
999,Include (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1000,include - SetOperator,Leiomyoma of Gallbladder,0
1001,Subgroup A Nepoviruses,Intestinal Neuroendocrine Carcinoma,0
1002,Body part,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1003,Acute Undifferentiated Leukemia,Leiomyoma of Gallbladder,0
1004,Neck of organ,Recurrent Uveal Melanoma,0
1005,Tumor cells,Neoplasms,0
1006,Lymphatic,Neoplasms,0
1007,Etiology,Colorectal cancer,0
1008,Approximate,Malignant neoplasm of thalamus,0
1009,First sign,Benign Carotid Body Paraganglioma,0
1010,Net (qualifier),Benign neoplasm of thorax,0
1011,Gram per Deciliter,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1012,Used by,Metastatic Neoplasm to the Gallbladder,0
1013,Disease remission,Heavy Chain Deposition Disease,0
1014,Condition,Pancreatic Intraepithelial Neoplasia-3,0
1015,Have Weight Loss,Secondary malignant neoplasm of lymph node,0
1016,Enzymes,Ovarian germ cell choriocarcinoma stage IV,0
1017,Females,Cerebral hemangioma,0
1018,Lung,Intraepithelial Melanocytic Hyperplasia,0
1019,Often - answer to question,Bladder squamous cell carcinoma stage I,0
1020,diagnosis aspect,Acute lymphadenitis,0
1021,Smoking,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1022,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1023,Female Reproductive System,Malignant neoplasm of thalamus,0
1024,Malignant Neoplasms,Mucinous adenocarcinoma gastric,0
1025,*Type - Kind of quantity,Grade 3a Malignant Neoplasm,0
1026,Carcinoma,Clonal Hematopoiesis of Indeterminate Potential,0
1027,Europe,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1028,Time,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1029,Diffuse Large B-Cell Lymphoma,Benign Carotid Body Paraganglioma,0
1030,55,Human Papillomavirus-Related Carcinoma,0
1031,eTMF Content Model Code,Intraepithelial Melanocytic Hyperplasia,0
1032,Before,Atypical Mesothelial Hyperplasia,0
1033,Cervical lymph node group,Stage III Adult Immunoblastic Lymphoma,0
1034,Involvement with,High Grade Glandular Intraepithelial Neoplasia,0
1035,Often - answer to question,Low Grade Squamous Intraepithelial Neoplasia,0
1036,In Blood,Malignant neoplasm of thalamus,0
1037,Common (qualifier value),Methotrexate-Associated Hodgkin Lymphoma,0
1038,Primary malignant neoplasm,Ichthyosis,0
1039,Others - Allergy,Mixed parotid tumor,0
1040,Vaginal,Noninfiltrating Intraductal Carcinoma,0
1041,Usual,mucinous adenocarcinoma of gallbladder,0
1042,Dyspnea,Intestinal Metaplasia of Bladder Urothelium,0
1043,GORAB gene,Acute lymphadenitis,0
1044,Common (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1045,Dysplasia,Testicular cancer metastatic,0
1046,Person Name,Benign tumor of eyelid,0
1047,Western World,Locally Advanced Soft Tissue Sarcoma,0
1048,Tumor Mass,Ovarian germ cell choriocarcinoma stage IV,0
1049,Variant,Intraepithelial Melanocytic Hyperplasia,0
1050,Analysis of substances,Ovarian germ cell choriocarcinoma stage IV,0
1051,Account number:Identifier:Point in time:^Patient:Nominal,Uterine Cancer,0
1052,Brain,Acantholytic squamous cell carcinoma,0
1053,Moll's gland cyst,Heavy Chain Deposition Disease,0
1054,Acute lymphocytic leukemia,Ichthyosis,0
1055,Consistency,Chondrosarcoma,0
1056,Negation,Human Papillomavirus-Related Carcinoma,0
1057,Receptors,Stage IB Pancreatic Cancer AJCC v8,0
1058,Possible diagnosis,malignant lymphoma of pancreatic lymph nodes,0
1059,Etiology aspects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1060,Term Birth,Acantholytic squamous cell carcinoma,0
1061,To,Cancer of Urinary Tract,0
1062,Contrast,Diffuse malignant mesothelioma,0
1063,Malignant neoplasm of endometrium,Ovarian germ cell choriocarcinoma stage IV,0
1064,Carcinoma,Placental aromatase deficiency,0
1065,Benign condition,papillary carcinoma of penis,0
1066,Condition:Find:Pt:^Patient:Nom,Localized Ewing Sarcoma,0
1067,Fallopian Tubes,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1068,Feel Tired question,malignant lymphoma of pancreatic lymph nodes,0
1069,Presence (property),Intestinal Metaplasia of Bladder Urothelium,0
1070,Portion of urine,Malignant Testicular Sertoli Cell Tumor,0
1071,Lymphoid neoplasm,Xeroderma pigmentosum,0
1072,Giant Cells,Primary Cutaneous Plasmablastic Lymphoma,0
1073,Rare,Choroid Necrotic Melanoma,0
1074,Fresh Specimen,adenoid cystic carcinoma of lung,0
1075,Mature,sarcoma of spinal cord,0
1076,Malignant neoplasm of liver,Benign Apocrine Neoplasm,0
1077,Domain (area of knowledge),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1078,regional,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1079,Including (qualifier),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1080,Severe (severity modifier),Non-Metastatic Gestational Trophoblastic Tumor,0
1081,Image Feature,mucinous adenocarcinoma of gallbladder,0
1082,Inspiration function,Mucinous adenocarcinoma gastric,0
1083,Fibrosis,adenosquamous carcinoma of breast,0
1084,Sexual Partners,Recurrent Testicular Lymphoma,0
1085,Treatment Epoch,GIANT PIGMENTED HAIRY NEVUS,0
1086,Retinoic Acid Response Element,Benign Carotid Body Paraganglioma,0
1087,Infant,Carcinoma ex pleomorphic adenoma of parotid gland,0
1088,Biologic Development,Mucinous adenocarcinoma gastric,0
1089,Most,Primary Cutaneous Plasmablastic Lymphoma,0
1090,Five,Medulloblastoma,0
1091,Flushing,Mucinous adenocarcinoma gastric,0
1092,Examination,Mucinous adenocarcinoma gastric,0
1093,700,Digestive System Hodgkin Lymphoma,0
1094,Specimen Type - Serum,Ovarian Carcinoid Tumor,0
1095,Egg of order Phthiraptera,Acute Undifferentiated Leukemia,0
1096,shared attribute,Acute Undifferentiated Leukemia,0
1097,Involvement with,Carcinoma of urinary bladder,0
1098,Tobacco smoking behavior,Xeroderma pigmentosum,0
1099,Symptoms aspect,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1100,Gestational Trophoblastic Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1101,Category Type,Low Grade Squamous Intraepithelial Neoplasia,0
1102,Negation,embryonal rhabdomyosarcoma of prostate,0
1103,include - SetOperator,Localized Askin Tumor,0
1104,Body tissue,Acantholytic squamous cell carcinoma,0
1105,Clear cell carcinoma of lung,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1106,Leukemia,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1107,Location,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1108,Chemotherapy Regimen,Metastatic Malignant Neoplasm in the Sellar Region,0
1109,Occurrence Indicator,embryonal rhabdomyosarcoma of prostate,0
1110,{Setting},mucinous adenocarcinoma of gallbladder,0
1111,Retraction (finding),Methotrexate-Associated Hodgkin Lymphoma,0
1112,Hereditary,High Grade Glandular Intraepithelial Neoplasia,0
1113,Upper gastrointestinal tract series,Pancreatic Intraepithelial Neoplasia-3,0
1114,Absent,Pilocytic astrocytoma of cerebellum,0
1115,include - SetOperator,Blepharal carcinoma,0
1116,Causing,Mucinous cystadenofibroma,0
1117,cell growth pattern,Xeroderma pigmentosum,0
1118,Four,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1119,Contain (action),Intestinal Metaplasia of Bladder Urothelium,0
1120,Plasma Cells,BRCA2 Syndrome,0
1121,Weight Loss,Ichthyosis,0
1122,Molecular Mass,Stage IV Childhood Non-Hodgkin Lymphoma,0
1123,One,Heavy Chain Deposition Disease,0
1124,various antiseptic throat preparations,Undifferentiated Endocervical Sarcoma,0
1125,Sequence of Planned Assessment Schedule,Atypical Mesothelial Hyperplasia,0
1126,Macrophage Activation Syndrome,GIANT PIGMENTED HAIRY NEVUS,0
1127,Dilated,adenoid cystic carcinoma of lung,0
1128,First (number),Mucinous adenocarcinoma gastric,0
1129,Approximate,Unresectable Rhabdomyosarcoma,0
1130,Togo,Intraepithelial Melanocytic Hyperplasia,0
1131,Uncertain - Response,Primary Cutaneous Plasmablastic Lymphoma,0
1132,Eye,Primary Cutaneous Plasmablastic Lymphoma,0
1133,Classical (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
1134,Basis - conceptual entity,Ovarian Carcinoid Tumor,0
1135,Blood,FIGO Stage II Ovarian Cancer,0
1136,Lymphoma,Mucinous adenocarcinoma gastric,0
1137,Weight Loss,High Grade Glandular Intraepithelial Neoplasia,0
1138,Yellow complexion,Intestinal Metaplasia of Bladder Urothelium,0
1139,Factor,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
1140,Bladder Cancer Pathway,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1141,Low Mitosis-Karyorrhexis Index,Adult Hepatocellular Carcinoma,0
1142,Primary malignant neoplasm,Mastocytosis,0
1143,include - SetOperator,High Grade Glandular Intraepithelial Neoplasia,0
1144,Term (temporal),Neonatal leukemia,0
1145,Togo,Activated B-cell type diffuse large B-cell lymphoma,0
1146,Gender,Liver Cavernous Hemangioma,0
1147,Aromatase,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1148,Result,Giant cell angiofibroma,0
1149,Excision,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1150,Stage Grouping,Noninfiltrating Intraductal Carcinoma,0
1151,General surgery specialty,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1152,Human body,FIGO Stage II Ovarian Cancer,0
1153,Limited stage (cancer stage),Recurrent Testicular Lymphoma,0
1154,Thyroid carcinoma,Stage 0 Penile Cancer AJCC v8,0
1155,High Level,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1156,Immunoglobulin Heavy Chain Variable Domain,Intraepithelial Melanocytic Hyperplasia,0
1157,year,BRCA2 Syndrome,0
1158,Brain Neoplasms,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1159,combination - answer to question,Adult Hepatocellular Carcinoma,0
1160,Cancer Genus,Unfavorable Non-Hodgkin Lymphoma,0
1161,10%,squamous cell carcinoma of the thyroid gland,0
1162,Plant nodule,Urethral Carcinoma,0
1163,high - ActExposureLevelCode,Undifferentiated Neuroblastoma,0
1164,Stem of plant,Neonatal leukemia,0
1165,Account number:Identifier:Point in time:^Patient:Nominal,Platinum-Resistant Lung Small Cell Carcinoma,0
1166,Decrease,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1167,Ability,Atypical Mesothelial Hyperplasia,0
1168,Hemangioma,FIGO Stage II Ovarian Cancer,0
1169,Survey Foot,FIGO Stage II Ovarian Cancer,0
1170,Environmental risk factor,Female Breast Carcinoma,0
1171,Negation,Breast Ductal Adenoma,0
1172,Therapeutic procedure,Metastatic Malignant Neoplasm in the Sellar Region,0
1173,Vomiting,Unresectable Rhabdomyosarcoma,0
1174,Tryptophanase,Localized Askin Tumor,0
1175,Adverse Event Associated with Vascular,Mucinous adenocarcinoma gastric,0
1176,Hoods,Stage IV Penile Cancer AJCC v7,0
1177,Cardiac Lead Procedure,Malignant Testicular Sertoli Cell Tumor,0
1178,In Blood,Benign Carotid Body Paraganglioma,0
1179,Type A,embryonal rhabdomyosarcoma of prostate,0
1180,Involvement with,Contact dermatitis due to alkali,0
1181,Smear - instruction imperative,Stage 0 Lip Carcinoma,0
1182,Spinal Cord,Liver Cavernous Hemangioma,0
1183,Angioma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1184,Neoadjuvant Therapy Clinical Trial Setting,Small cell neuroendocrine carcinoma of bladder,0
1185,year,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1186,Treatment intent,squamous cell carcinoma of the thyroid gland,0
1187,Dietary Lead,Acute Undifferentiated Leukemia,0
1188,Pulmonary aspiration,Recurrent Uveal Melanoma,0
1189,Science of Etiology,adenosquamous carcinoma of breast,0
1190,Occurrence,Small cell neuroendocrine carcinoma of bladder,0
1191,Skin,Clonal Hematopoiesis of Indeterminate Potential,0
1192,Lymphocyte,Intraepithelial Melanocytic Hyperplasia,0
1193,Most,Stage IB Lung Cancer AJCC v7,0
1194,Both ovaries,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1195,Occurrence,Malignant neoplasm of thalamus,0
1196,Occurrence,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1197,Call (Instruction),Digestive System Hodgkin Lymphoma,0
1198,Examination of skin,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1199,immunologist,Platinum-Resistant Lung Small Cell Carcinoma,0
1200,Increasing,Refractory Barrett Esophagus,0
1201,Common (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
1202,80%,Small cell neuroendocrine carcinoma of bladder,0
1203,shared attribute,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1204,Person Name,Human Papillomavirus-Related Carcinoma,0
1205,Participation Type - origin,Malignant melanoma of eyelid,0
1206,Angioma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1207,Screening procedure,Deep Leiomyoma,0
1208,Symptoms aspect,Cerebral Primitive Neuroectodermal Tumor,0
1209,Tissue Type Code - Basal cell carcinoma,Medulloblastoma,0
1210,Asia,Lipoma of small intestine,0
1211,System - kit,Mucinous adenocarcinoma gastric,0
1212,Surgery specialty,Metastatic Neoplasm to the Gallbladder,0
1213,Make - Instruction Imperative,Mucinous adenocarcinoma gastric,0
1214,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Female Breast Carcinoma,0
1215,removal technique,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1216,Adult Hodgkin Lymphoma,Low Grade Squamous Intraepithelial Neoplasia,0
1217,Abnormal Reference Range,Xeroderma pigmentosum,0
1218,Entity,Endometrial Small Cell Carcinoma,0
1219,Cell Count,Mucinous neoplasm,0
1220,Body Site Modifier - Lower,Recurrent Uveal Melanoma,0
1221,Device Motor,Anaplastic large cell lymphoma,0
1222,1960s,Acute Undifferentiated Leukemia,0
1223,Excision,mucinous adenocarcinoma of gallbladder,0
1224,Leads (device),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1225,T-Cell Marker,Pilocytic astrocytoma of cerebellum,0
1226,Adult Teratoma,Bladder squamous cell carcinoma stage I,0
1227,Mutation Abnormality,Stage IV Childhood Non-Hodgkin Lymphoma,0
1228,Urethral Carcinoma,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
1229,90%,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1230,Frequently,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1231,Categories,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1232,Numbers,Undifferentiated Endocervical Sarcoma,0
1233,Adipose tissue,Granular Cell Leiomyosarcoma,0
1234,Central African Republic,Cerebral hemangioma,0
1235,Often - answer to question,Methotrexate-Associated Hodgkin Lymphoma,0
1236,Dropping,Undifferentiated Neuroblastoma,0
1237,Changed status,Acantholytic squamous cell carcinoma,0
1238,Malignant Neoplasms,Malignant melanoma of eyelid,0
1239,Occurrence Indicator,Testicular cancer metastatic,0
1240,Administration procedure,Angiosarcoma of liver,0
1241,shared attribute,Stage 0 Penile Cancer AJCC v8,0
1242,Medical Device Emits Smoke,Pancreatic Intraepithelial Neoplasia-3,0
1243,Frequently,Localized Askin Tumor,0
1244,Disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1245,Infrequent,Diffuse malignant mesothelioma,0
1246,Brain,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1247,Upper arm,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1248,Biopsy,Acantholytic squamous cell carcinoma,0
1249,% volume (qualifier value),Childhood Lymphoma,0
1250,Basis - conceptual entity,Human Papillomavirus-Related Carcinoma,0
1251,Levels (qualifier value),Heavy Chain Deposition Disease,0
1252,Vaginal,Localized Askin Tumor,0
1253,Diabetes,Medulloblastoma,0
1254,Common Specifications in HL7 V3 Publishing,Blepharal carcinoma,0
1255,Additional,Stage II Hepatocellular Carcinoma AJCC v8,0
1256,Diagnosis,Small cell neuroendocrine carcinoma of bladder,0
1257,End,benign mature teratoma of pancreas,0
1258,Symptoms aspect,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1259,Inguinal region,squamous cell carcinoma of the thyroid gland,0
1260,cervical cancer,embryonal rhabdomyosarcoma of prostate,0
1261,Secondary Neoplasm,Childhood Fibrillary Astrocytoma,0
1262,include - SetOperator,gliosarcoma,0
1263,Spreading (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
1264,Form:Finding:Point in time:{Setting}:Document:{Role},Stage 0 Penile Cancer AJCC v8,0
1265,Cause of death:Find:Pt:^Patient:Nom,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1266,Primary malignant neoplasm,Acantholytic squamous cell carcinoma,0
1267,Endocrine system,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1268,Life Expectancy Greater than Twenty Years,Recurrent Testicular Lymphoma,0
1269,Process,Locally Advanced Soft Tissue Sarcoma,0
1270,Treating,Chondrosarcoma,0
1271,Name,Primary Cutaneous Plasmablastic Lymphoma,0
1272,Pediculus (eukaryote),Refractory Barrett Esophagus,0
1273,Uterine Corpus Sarcoma,adenosquamous carcinoma of breast,0
1274,Obesity,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1275,therapeutic aspects,Malignant neoplasm of thalamus,0
1276,Malignant neoplasm of brain,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1277,More,Stage I Adult Non-Hodgkin Lymphoma,0
1278,Structure of left half of body,Cerebral Primitive Neuroectodermal Tumor,0
1279,Live - Specimen Condition,Female Breast Carcinoma,0
1280,Sequence Data Type,Adult Alveolar Soft Part Sarcoma,0
1281,Unknown GENC,Human Papillomavirus-Related Carcinoma,0
1282,Term (lexical),mucinous adenocarcinoma of gallbladder,0
1283,melanocyte,Intraepithelial Melanocytic Hyperplasia,0
1284,Blood Platelets,Unfavorable Non-Hodgkin Lymphoma,0
1285,Array Feature,Malignant Neoplasm with Regional Lymph Node Involvement,0
1286,pharmacotherapeutic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1287,Pregnancy,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1288,Present,Methotrexate-Associated Hodgkin Lymphoma,0
1289,Body cavities,Secondary malignant neoplasm of lymph node,0
1290,Preventive intent,Cerebral Primitive Neuroectodermal Tumor,0
1291,Linear,malignant lymphoma of pancreatic lymph nodes,0
1292,How Much Distress Weight Loss,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1293,Severe (severity modifier),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1294,Only - dosing instruction fragment,Bladder squamous cell carcinoma stage I,0
1295,Type - attribute,squamous cell carcinoma of the thyroid gland,0
1296,Unmarried,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1297,Fourth ventricle structure,Carcinoma of urinary bladder,0
1298,Susceptibility (property) (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
1299,Childhood Hodgkin Lymphoma,Extra-Adrenal Paraganglioma,0
1300,40%,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1301,Occurrence,Endometrial Small Cell Carcinoma,0
1302,Infection,Cancer of Urinary Tract,0
1303,Surface of cervix,Neoplasms,0
1304,Usual Severity Itching,Adult Alveolar Soft Part Sarcoma,0
1305,Malignant tumor of colon,Uterine Cancer,0
1306,To,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1307,1+,Localized Askin Tumor,0
1308,Complication,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1309,Third,Ichthyosis,0
1310,Retraction (finding),Refractory Barrett Esophagus,0
1311,Primary malignant neoplasm,Stage IV Penile Cancer AJCC v7,0
1312,survival aspects,Localized Ewing Sarcoma,0
1313,Pale color,Non-Metastatic Gestational Trophoblastic Tumor,0
1314,Most,Tonsillar Carcinoma,0
1315,Hematologic Tests,malignant lymphoma of pancreatic lymph nodes,0
1316,Skin Specimen,Atypical Lobular Breast Hyperplasia,0
1317,Formation,Primary Cutaneous Plasmablastic Lymphoma,0
1318,Feel Pain,Methotrexate-Associated Hodgkin Lymphoma,0
1319,*Type - Kind of quantity,Anterior Urethral Malignant Neoplasm,0
1320,Tanning of leather,Metastatic Carcinoma in the Lung,0
1321,Bone structure of cranium,Childhood Thyroid Gland Follicular Carcinoma,0
1322,Thick,Metastatic Carcinoma in the Lung,0
1323,International Classification of Diseases for Oncology,Stage IB Pancreatic Cancer AJCC v8,0
1324,Adult Non-Hodgkin Lymphoma,Thymoma malignant recurrent,0
1325,Therapeutic tactile stimulation,Chronic Myelomonocytic Leukemia-2,0
1326,Singular,Ovarian germ cell choriocarcinoma stage IV,0
1327,Effective,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1328,Usual,Placental aromatase deficiency,0
1329,Smaller,Xeroderma pigmentosum,0
1330,Type A,Xeroderma pigmentosum,0
1331,Growth,Stage I Adult Non-Hodgkin Lymphoma,0
1332,Affecting,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1333,High,Xeroderma pigmentosum,0
1334,Body tissue,Digestive System Hodgkin Lymphoma,0
1335,NCI CTEP SDC Melanoma Sub-Category Terminology,Heavy Chain Deposition Disease,0
1336,Disease,Cerebral Primitive Neuroectodermal Tumor,0
1337,Primary operation,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1338,Form:Finding:Point in time:{Setting}:Document:{Role},Anterior Urethral Malignant Neoplasm,0
1339,Appearance,Adult Hepatocellular Carcinoma,0
1340,Birth,Thymic Clear Cell Carcinoma,0
1341,Usual Severity Weight Loss,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1342,Initially,Bladder squamous cell carcinoma stage I,0
1343,400,Small cell neuroendocrine carcinoma of bladder,0
1344,shared attribute,Chondrosarcoma,0
1345,Responsible to,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1346,Growth,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1347,Variant,Platinum-Resistant Lung Small Cell Carcinoma,0
1348,Usually Need Help from Another Person for Arising,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1349,Cancer Genus,Intraepithelial Melanocytic Hyperplasia,0
1350,status - In progress,Recurrent Uveal Melanoma,0
1351,Red color,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1352,Malignant Neoplasms,Diffuse malignant mesothelioma,0
1353,Itchiness,Primary Cutaneous Plasmablastic Lymphoma,0
1354,Tryptophanase,Serous cystadenocarcinoma ovary,0
1355,Hepatitis B,Choroid Necrotic Melanoma,0
1356,Caucasoid Race,Diffuse malignant mesothelioma,0
1357,Anemia,Recurrent Testicular Lymphoma,0
1358,Tryptophanase,Platinum-Resistant Lung Small Cell Carcinoma,0
1359,Definition,Breast Ductal Adenoma,0
1360,Late,Giant cell angiofibroma,0
1361,Out (direction),sarcoma of spinal cord,0
1362,Dangerousness,Heavy Chain Deposition Disease,0
1363,Large,Anterior Urethral Malignant Neoplasm,0
1364,Experimental Result,Human Papillomavirus-Related Carcinoma,0
1365,Females,Stage 0 Penile Cancer AJCC v8,0
1366,Present,Mucinous adenocarcinoma gastric,0
1367,Singular,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1368,Small cell carcinoma of lung,non-Hodgkin's lymphoma of spleen,0
1369,Medical Devices,non-Hodgkin's lymphoma of spleen,0
1370,Comparison,Pilocytic astrocytoma of cerebellum,0
1371,Presentation,Cerebral Primitive Neuroectodermal Tumor,0
1372,Ependyma,Liver Lymphangioma,0
1373,Common Specifications in HL7 V3 Publishing,Undifferentiated Endocervical Sarcoma,0
1374,<90,embryonal rhabdomyosarcoma of prostate,0
1375,B-Lymphocytes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1376,lobe,Chronic Myelomonocytic Leukemia-2,0
1377,Mass of body structure,Adult Alveolar Soft Part Sarcoma,0
1378,Incidental,Localized Ewing Sarcoma,0
1379,Benign Smooth Muscle Neoplasm,Cancer of Urinary Tract,0
1380,Tumor Necrosis Factor Receptor Superfamily Member 8,sarcoma of spinal cord,0
1381,Enzyme (disposition),adenoid cystic carcinoma of lung,0
1382,Followed by,Anterior Urethral Malignant Neoplasm,0
1383,Five,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1384,Brain,Intestinal Neuroendocrine Carcinoma,0
1385,Disease,Leiomyoma of Gallbladder,0
1386,Malignant Neoplasms,Human Papillomavirus-Related Carcinoma,0
1387,30%,Stage II Fallopian Tube Cancer,0
1388,Lymphocyte Activation,Intestinal Metaplasia of Bladder Urothelium,0
1389,Human papillomavirus 16,Advanced Lung Carcinoma,0
1390,Body part,Xeroderma pigmentosum,0
1391,Diffuse Large B-Cell Lymphoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1392,Cessation of life,Benign tumor of eyelid,0
1393,Unknown,Pilocytic astrocytoma of cerebellum,0
1394,lymph nodes,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1395,Distant,Advanced Lung Carcinoma,0
1396,risk factors - observation list,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1397,Pancreas,Cerebral Primitive Neuroectodermal Tumor,0
1398,Childhood Hodgkin Lymphoma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1399,Squamocolumnar junction of cervix,Chronic Myelomonocytic Leukemia-2,0
1400,Follow-up status,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1401,Average of Value Derivation Technique,Extra-Adrenal Paraganglioma,0
1402,Contact with,Mixed parotid tumor,0
1403,Liver Flavor,Stage III Adult Immunoblastic Lymphoma,0
1404,Lymphoma,Adenocarcinoma,0
1405,Sarcoma,Cancer of Urinary Tract,0
1406,Bone Marrow,Stage III Adult Immunoblastic Lymphoma,0
1407,Neoplasms,Methotrexate-Associated Hodgkin Lymphoma,0
1408,Occurrence Indicator,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1409,Paraganglioma,Malignant neoplasm of thalamus,0
1410,Symptoms,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1411,Neoplasms,Unresectable Rhabdomyosarcoma,0
1412,Obesity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1413,Early,Heavy Chain Deposition Disease,0
1414,General surgery specialty,Noninfiltrating Intraductal Carcinoma,0
1415,risk factors,Carcinoma of urinary bladder,0
1416,Persons,Acute lymphadenitis,0
1417,Cervical lymph node group,Extracranial Neuroblastoma,0
1418,Common Specifications in HL7 V3 Publishing,BRCA2 Syndrome,0
1419,Sequence Arm,Female Breast Carcinoma,0
1420,dendritic spine neck,Recurrent Testicular Lymphoma,0
1421,HL7PublishingSubSection <practice>,Colorectal cancer,0
1422,Singular,Ovarian germ cell choriocarcinoma stage IV,0
1423,Nicotiana tabacum,Bladder squamous cell carcinoma stage I,0
1424,Diagnostic Imaging,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1425,shared attribute,Benign tumor of eyelid,0
1426,Tryptophanase,Mucinous neoplasm,0
1427,Transurethral Resection,squamous cell carcinoma of the thyroid gland,0
1428,Primary malignant neoplasm,embryonal rhabdomyosarcoma of prostate,0
1429,Respiration,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1430,Case (situation),Metastatic Carcinoma in the Lung,0
1431,Chemotherapy,Extra-Adrenal Paraganglioma,0
1432,SPG21 gene,Pancreatic Intraepithelial Neoplasia-3,0
1433,Condition:Find:Pt:^Patient:Nom,Malignant Testicular Sertoli Cell Tumor,0
1434,Swollen Lymph Node,Malignant melanoma of eyelid,0
1435,Hormonal,Medulloblastoma,0
1436,Fatigue,Tonsillar Carcinoma,0
1437,Involvement with,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1438,Compleat Liquid Nutrition,Metastatic Carcinoma in the Lung,0
1439,Cessation of life,Metastatic Carcinoma in the Lung,0
1440,Timepoint,Non-Metastatic Gestational Trophoblastic Tumor,0
1441,Firstly,Human Papillomavirus-Related Carcinoma,0
1442,Anorexia,High Grade Glandular Intraepithelial Neoplasia,0
1443,Usually Need Help from Another Person for Reach,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1444,Usual Severity Itching,Heavy Chain Deposition Disease,0
1445,3+ Answer to Question,BRCA2 Syndrome,0
1446,Total,Clonal Hematopoiesis of Indeterminate Potential,0
1447,Presentation,Diffuse malignant mesothelioma,0
1448,Containing (qualifier),Human Papillomavirus-Related Carcinoma,0
1449,Diagnosis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1450,In Blood,Stage 0 Penile Cancer AJCC v8,0
1451,Smaller,Mucinous adenocarcinoma gastric,0
1452,Cardiac Lead Procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1453,Negation,Non-Metastatic Gestational Trophoblastic Tumor,0
1454,Molecule,Blepharal carcinoma,0
1455,Armpit,FIGO Stage II Ovarian Cancer,0
1456,Cause of death.underlying,Angiosarcoma of liver,0
1457,Geographic Locations,Endometrial Small Cell Carcinoma,0
1458,Groups,Clonal Hematopoiesis of Indeterminate Potential,0
1459,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Extracranial Neuroblastoma,0
1460,Neuroblastoma,Adult Hepatocellular Carcinoma,0
1461,Leakage,Hemangioma,0
1462,Etiology aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1463,Type - attribute,mucinous adenocarcinoma of gallbladder,0
1464,Case (situation),Liver Lymphangioma,0
1465,Imaging Techniques,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1466,Beginning,Xeroderma pigmentosum,0
1467,A Codes,Endometrial Small Cell Carcinoma,0
1468,Neck,Mastocytosis,0
1469,Qualitative form,Xeroderma pigmentosum,0
1470,Symptoms aspect,Metastatic Malignant Neoplasm in the Sellar Region,0
1471,other medicated shampoos in ATC,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
1472,Medical problem:Finding:Point in time:^Patient:Nominal,Chronic Myelomonocytic Leukemia-2,0
1473,Diagnosis,Extra-Adrenal Paraganglioma,0
1474,Pharmaceutical Preparations,Angiosarcoma of liver,0
1475,Imaging Techniques,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
1476,Same,FIGO Stage II Ovarian Cancer,0
1477,Expiration,Localized Ewing Sarcoma,0
1478,Epithelium of large intestine,Stage 0 Lip Carcinoma,0
1479,Throat,Intestinal Metaplasia of Bladder Urothelium,0
1480,Mutation,Giant cell angiofibroma,0
1481,Cerebellum,Angiosarcoma of liver,0
1482,Hemangioma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1483,Suspected diagnosis,Acute Undifferentiated Leukemia,0
1484,Complete excision,FIGO Stage II Ovarian Cancer,0
1485,Can Do Very Little,Advanced Uterine Corpus Carcinosarcoma,0
1486,Mammary Gland Parenchyma,Intracortical osteosarcoma,0
1487,Include (action),Unresectable Rhabdomyosarcoma,0
1488,First (number),Female Breast Carcinoma,0
1489,Covers (device),Malignant neoplasm of thalamus,0
1490,Cancer Genus,Liver Cavernous Hemangioma,0
1491,monomer,Ovarian germ cell choriocarcinoma stage IV,0
1492,Obesity,adenosquamous carcinoma of breast,0
1493,include - SetOperator,Recurrent Testicular Lymphoma,0
1494,Chest pain:Finding:Point in time:^Patient:Ordinal,Xeroderma pigmentosum,0
1495,Pharmacokinetics: Excretion,gliosarcoma,0
1496,Appearance,Breast Ductal Adenoma,0
1497,Excision,Testicular cancer metastatic,0
1498,System,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1499,Patient Reported Outcome Stem,High Grade Glandular Intraepithelial Neoplasia,0
1500,physiological aspects,Uterine Cancer,0
1501,Injury due to exposure to external cause,Malignant Testicular Sertoli Cell Tumor,0
1502,Subject -direct target,Carcinoma of urinary bladder,0
1503,Human papillomavirus typing (procedure),Cerebral hemangioma,0
1504,BRCA2 gene,Xeroderma pigmentosum,0
1505,Able (finding),Breast Ductal Adenoma,0
1506,Name Given at Birth,Intraepithelial Melanocytic Hyperplasia,0
1507,Atypical Teratoid Rhabdoid Tumor,Stage IB Pancreatic Cancer AJCC v8,0
1508,eTMF Content Model Code,adenosquamous carcinoma of breast,0
1509,African American,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1510,Malignant neoplasm of ovary,Intestinal Metaplasia of Bladder Urothelium,0
1511,Characteristics,Cancer of Urinary Tract,0
1512,Similarity,Advanced Lung Carcinoma,0
1513,Exist,Cancer of Urinary Tract,0
1514,Breast collecting duct,Anaplastic large cell lymphoma,0
1515,Have Weight Loss,Bladder squamous cell carcinoma stage I,0
1516,Body part,Chondrosarcoma,0
1517,Table Cell Horizontal Align - left,Diffuse malignant mesothelioma,0
1518,Test Result,Carcinoma of urinary bladder,0
1519,Approximate,Metastatic Ductal Breast Carcinoma,0
1520,Eczema,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1521,Prevalence aspects,Recurrent Uveal Melanoma,0
1522,Vomiting,Werner Syndrome,0
1523,Stem cells,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1524,Sequence Data Type,Recurrent Testicular Lymphoma,0
1525,Togo,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1526,Aldosterone,Breast Ductal Adenoma,0
1527,Type A,Digestive System Hodgkin Lymphoma,0
1528,*Type - Kind of quantity,Angiosarcoma of liver,0
1529,Feelings,Malignant Testicular Sertoli Cell Tumor,0
1530,Extraction,Deep Leiomyoma,0
1531,Involvement with,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1532,Iodides,sarcoma of spinal cord,0
1533,Often - answer to question,Intracortical osteosarcoma,0
1534,Diagnosis,Undifferentiated Endocervical Sarcoma,0
1535,Unintentional,Clonal Hematopoiesis of Indeterminate Potential,0
1536,Less Than,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1537,Followed by,Atypical Lobular Breast Hyperplasia,0
1538,low,Stage IB Pancreatic Cancer AJCC v8,0
1539,Concept History,Xeroderma pigmentosum,0
1540,>90,Cerebral Primitive Neuroectodermal Tumor,0
1541,Lacrimal gland structure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1542,Presentation,Recurrent Testicular Lymphoma,0
1543,Usual Severity Weight Loss,Sarcomatoid Renal Cell Carcinoma,0
1544,Well Being Visual Analogue Scale,Stage IV Childhood Non-Hodgkin Lymphoma,0
1545,century,Leiomyoma of Gallbladder,0
1546,Removed,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1547,regional,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1548,800,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1549,Fever,Maxillary Sinus Adenocarcinoma,0
1550,Feature,Cerebral Primitive Neuroectodermal Tumor,0
1551,Adult Hodgkin Lymphoma,Malignant melanoma of eyelid,0
1552,Covered (qualifier value),Metastatic Malignant Neoplasm in the Sellar Region,0
1553,Occurrence,Giant cell angiofibroma,0
1554,Thymectomy,Grade 3a Malignant Neoplasm,0
1555,Have Difficulty Swallowing,Mucinous neoplasm,0
1556,First sign,Localized Askin Tumor,0
1557,DNA,Malignant Testicular Sertoli Cell Tumor,0
1558,Deficiency of sulfatase,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
1559,spinal,Angiosarcoma of liver,0
1560,Exception - Property or Attribute,Colorectal High Grade B-Cell Lymphoma,0
1561,Virus,Choroid Necrotic Melanoma,0
1562,Function (attribute),FIGO Stage II Ovarian Cancer,0
1563,Pickle,Tonsillar Carcinoma,0
1564,Symptoms aspect,Bladder squamous cell carcinoma stage I,0
1565,hiv-infection/aids,Recurrent Uveal Melanoma,0
1566,Most,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1567,Shortness of breath:-:Point in time:^Patient:-,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1568,One,Colorectal Neuroendocrine Tumor G2,0
1569,Weight Loss,Bladder squamous cell carcinoma stage I,0
1570,Parameterized Data Type - Set,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1571,To,Heavy Chain Deposition Disease,0
1572,Lymphatic obstruction,Noninfiltrating Intraductal Carcinoma,0
1573,Chest,Recurrent Testicular Lymphoma,0
1574,Persons,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1575,Study,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1576,Affect (mental function),Spongiotic dermatitis,0
1577,Case (situation),Uterine Cancer,0
1578,Symptoms,Intraepithelial Melanocytic Hyperplasia,0
1579,Linear,Intraepithelial Melanocytic Hyperplasia,0
1580,Daily,Localized Askin Tumor,0
1581,Smear - instruction imperative,Localized Askin Tumor,0
1582,Asymptomatic Diseases,Adult Alveolar Soft Part Sarcoma,0
1583,Relationship by association,Chondrosarcoma,0
1584,Neoplasms,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1585,History,Lipoma of small intestine,0
1586,IPSS Risk Category High,Carcinoma of urinary bladder,0
1587,Removing (action),Stage IB Lung Cancer AJCC v7,0
1588,Poor - grade value,Spongiotic dermatitis,0
1589,Specimen,Extra-Adrenal Paraganglioma,0
1590,Special,Unresectable Rhabdomyosarcoma,0
1591,Tumor Mass,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1592,To,Collecting Duct Carcinoma of the Kidney,0
1593,regional,Intraepithelial Melanocytic Hyperplasia,0
1594,Widening,Malignant neoplasm of choroid,0
1595,Confirmed by,Adult Brain Stem Mixed Glioma,0
1596,Mesothelial hyperplasia,FIGO Stage II Ovarian Cancer,0
1597,Urine,Tonsillar Carcinoma,0
1598,Older child,Methotrexate-Associated Hodgkin Lymphoma,0
1599,Hyperplasia,Stage IB Pancreatic Cancer AJCC v8,0
1600,Pressure - action,Acantholytic squamous cell carcinoma,0
1601,Pediculus (eukaryote),Spermatocytic seminoma,0
1602,Lymphoma,Benign Carotid Body Paraganglioma,0
1603,Time (foundation metadata concept),Carcinoma ex pleomorphic adenoma of parotid gland,0
1604,Chemotherapy,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1605,Cancer Genus,Mucinous adenocarcinoma gastric,0
1606,To,Clonal Hematopoiesis of Indeterminate Potential,0
1607,Biological Response Modifiers,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1608,Increased,malignant lymphoma of pancreatic lymph nodes,0
1609,Then,Breast Ductal Adenoma,0
1610,Extra-location,Cancer of Urinary Tract,0
1611,Probable diagnosis,Malignant melanoma of eyelid,0
1612,Science of Etiology,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1613,Strong,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1614,Vascular,Benign Carotid Body Paraganglioma,0
1615,Feelings,Female Breast Carcinoma,0
1616,Unmarried,Diffuse malignant mesothelioma,0
1617,Usual,Grade 3a Malignant Neoplasm,0
1618,Cell (compartment),Uterine Cancer,0
1619,PREVENT (product),Unresectable Rhabdomyosarcoma,0
1620,Abdomen+,Childhood Fibrillary Astrocytoma,0
1621,Hyperestrogenism,Benign Carotid Body Paraganglioma,0
1622,Metastasis,Angiosarcoma of liver,0
1623,Epithelium of vagina,Giant cell angiofibroma,0
1624,Cells,GIANT PIGMENTED HAIRY NEVUS,0
1625,Front of neck,ALK positive large B-cell lymphoma,0
1626,Cell Count,Localized Askin Tumor,0
1627,Slightly Agree,Neonatal leukemia,0
1628,Hyperlink,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1629,20%,malignant lymphoma of pancreatic lymph nodes,0
1630,Neoplastic disease,Chronic Myelomonocytic Leukemia-2,0
1631,Before values,Stage 0 Penile Cancer AJCC v8,0
1632,PSA Level Less than Two,Cartilaginous exostosis,0
1633,Known,Testicular cancer metastatic,0
1634,Secondary Neoplasm,Recurrent Uveal Melanoma,0
1635,Organ,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1636,Sufficiently defined concept definition status (core metadata concept),Botryoid-Type Embryonal Rhabdomyosarcoma,0
1637,diagnosis aspect,Acantholytic squamous cell carcinoma,0
1638,<50,Blepharal carcinoma,0
1639,Workplace,Refractory Barrett Esophagus,0
1640,treatment - ActInformationManagementReason,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1641,Cessation of life,Thymic Clear Cell Carcinoma,0
1642,Singular,Ovarian germ cell choriocarcinoma stage IV,0
1643,Major,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1644,Specific qualifier value,Breast Ductal Adenoma,0
1645,Standard Treatment,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1646,Back,Chronic Myelomonocytic Leukemia-2,0
1647,Either,Mucinous adenocarcinoma gastric,0
1648,True primary (qualifier value),Spongiotic dermatitis,0
1649,Usual,Localized Askin Tumor,0
1650,To,Endometrial Small Cell Carcinoma,0
1651,Subtype (attribute),BRCA2 Syndrome,0
1652,Capillary Action,Localized Ewing Sarcoma,0
1653,Sequence Data Type,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1654,Detected (finding),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1655,Phimosis,Benign tumor of eyelid,0
1656,Retinoic Acid Response Element,embryonal rhabdomyosarcoma of prostate,0
1657,Unknown GENC,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1658,0%,Lung squamous cell carcinoma stage I,0
1659,Percent normal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1660,removal technique,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1661,Occurrence Indicator,Atypical Mesothelial Hyperplasia,0
1662,Excision,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1663,Delayed Puberty,Diffuse malignant mesothelioma,0
1664,Human papilloma virus infection,Colorectal High Grade B-Cell Lymphoma,0
1665,Negative Number,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1666,Occur (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1667,Chemotherapy Regimen,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1668,Recent,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1669,Twice - dosing instruction fragment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1670,Occur (action),adenoid cystic carcinoma of lung,0
1671,Definitely Related to Intervention,Cancer of Urinary Tract,0
1672,Neck,Human Papillomavirus-Related Carcinoma,0
1673,Screening Study,Mucinous adenocarcinoma gastric,0
1674,Primary malignant neoplasm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1675,Numbers,Spongiotic dermatitis,0
1676,Use of,Granular Cell Leiomyosarcoma,0
1677,chronic,Angiosarcoma of liver,0
1678,Togo,Intraepithelial Melanocytic Hyperplasia,0
1679,Stem cell transplant,Neoplasms,0
1680,cancer classification,sarcoma of spinal cord,0
1681,Symptoms,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1682,Assisted (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
1683,Two,Anterior Urethral Malignant Neoplasm,0
1684,Characterization,Low Grade Squamous Intraepithelial Neoplasia,0
1685,various other agents for local oral treatment in ATC,Collecting Duct Carcinoma of the Kidney,0
1686,Uterine Corpus Sarcoma,Neoplasms,0
1687,High Level,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1688,Manufactured form,Refractory Barrett Esophagus,0
1689,Malignant Neoplasms,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
1690,Sometimes,Liver Lymphangioma,0
1691,Chemotherapy Regimen,Metastatic Carcinoma in the Lung,0
1692,Experimental Result,Lung Mucinous Cystadenoma,0
1693,Completely - dosing instruction fragment,Prostate Lymphoma,0
1694,Membrane,Stage 0 Penile Cancer AJCC v8,0
1695,Treatment Epoch,High Grade Glandular Intraepithelial Neoplasia,0
1696,Involvement with,Neoplasms,0
1697,Hereditary,Benign tumor of eyelid,0
1698,Body structure,Ovarian Carcinoid Tumor,0
1699,Only - dosing instruction fragment,Malignant Neoplasm with Regional Lymph Node Involvement,0
1700,Room of building - Study,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1701,Disease Management,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1702,Mechanism (attribute),Spongiotic dermatitis,0
1703,New,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1704,Twice (Numerical Qualifier),Neonatal leukemia,0
1705,Very High Level,Urethral Carcinoma,0
1706,Disease,Granular Cell Leiomyosarcoma,0
1707,Age,Malignant Neoplasm with Regional Lymph Node Involvement,0
1708,Recurrence,embryonal rhabdomyosarcoma of prostate,0
1709,Percent of Abnormal Cells,Human Papillomavirus-Related Carcinoma,0
1710,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Cerebral Primitive Neuroectodermal Tumor,0
1711,Plasma cell dyscrasia,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1712,Birth,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1713,All of the Time,Intracortical osteosarcoma,0
1714,Carcinoid Tumor,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1715,West (direction),Malignant Neoplasm with Regional Lymph Node Involvement,0
1716,Therapeutic radiology procedure,Female Breast Carcinoma,0
1717,Supportive assistance,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1718,Oral cavity,Adult Alveolar Soft Part Sarcoma,0
1719,Detection,Localized Ewing Sarcoma,0
1720,radiotherapeutic,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1721,Histology:Find:Pt:Cancer.XXX:Nar,Leptomeningeal sarcoma,0
1722,30%,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1723,Etiology aspects,Lipoma of small intestine,0
1724,Very large,Clonal Hematopoiesis of Indeterminate Potential,0
1725,Approximate,Human Papillomavirus-Related Carcinoma,0
1726,Science of Etiology,Recurrent Testicular Lymphoma,0
1727,Pediculus (eukaryote),Acute Undifferentiated Leukemia,0
1728,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Thymic Clear Cell Carcinoma,0
1729,Vestigium,Thymic Clear Cell Carcinoma,0
1730,Either,Ichthyoses,0
1731,Encode (action),Acantholytic squamous cell carcinoma,0
1732,Symptoms,Testicular cancer metastatic,0
1733,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1734,eTMF Content Model Code,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1735,Status post,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1736,List,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1737,Left sided,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1738,Primary,Lipoma of small intestine,0
1739,Gene Mutation,BRCA2 Syndrome,0
1740,Protocol Agent,Ichthyosis,0
1741,Four,Prostate Lymphoma,0
1742,Stage,Anterior Urethral Malignant Neoplasm,0
1743,Vitamin B 12 Deficiency,BRCA2 Syndrome,0
1744,Bilateral complete salpingectomy,Recurrent Testicular Lymphoma,0
1745,Area,Choroid Necrotic Melanoma,0
1746,Spreading (qualifier value),Recurrent Uveal Melanoma,0
1747,Known,Mastocytosis,0
1748,Breast,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1749,Mass,Childhood Fibrillary Astrocytoma,0
1750,Personal appearance,Stage IV Penile Cancer AJCC v7,0
1751,English [International Organization for Standardization 639-1 code en] language reference set,Unresectable Rhabdomyosarcoma,0
1752,Most,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1753,CEL gene,Liver Cavernous Hemangioma,0
1754,soft tissue,Ovarian germ cell choriocarcinoma stage IV,0
1755,Pediculus humanus capitis (eukaryote),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1756,Primary,Digestive System Hodgkin Lymphoma,0
1757,Usually,Ovarian germ cell choriocarcinoma stage IV,0
1758,Partial,Choroid Necrotic Melanoma,0
1759,Dairy Cream,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1760,treatment - ActInformationManagementReason,Locally Advanced Soft Tissue Sarcoma,0
1761,various other intestinal adsorbents in ATC,embryonal rhabdomyosarcoma of prostate,0
1762,Optimistic,Platinum-Resistant Lung Small Cell Carcinoma,0
1763,Line Unit of Length,Uterine Cancer,0
1764,Very,de novo Myelodysplastic Syndrome,0
1765,second (number),Granular Cell Leiomyosarcoma,0
1766,Most,Localized Askin Tumor,0
1767,Hereditary Diseases,Cancer of Urinary Tract,0
1768,risk factors,Low Grade Squamous Intraepithelial Neoplasia,0
1769,Have Shortness of Breath question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1770,United States Military Commissioned Officer O4,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1771,In situ,Maxillary Sinus Adenocarcinoma,0
1772,Hematuria,Stage III Adult Immunoblastic Lymphoma,0
1773,Head,Uterine Cancer,0
1774,Name (property) (qualifier value),Acantholytic squamous cell carcinoma,0
1775,Including (qualifier),Recurrent Testicular Lymphoma,0
1776,Contusions,Extra-Adrenal Paraganglioma,0
1777,Precursor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1778,Give - dosing instruction imperative,Uterine Cancer,0
1779,Intraepithelial Neoplasia,Ovarian Carcinoid Tumor,0
1780,Common (qualifier value),Metastatic Kidney Carcinoma,0
1781,status - In progress,Leptomeningeal sarcoma,0
1782,Critical,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1783,Before,Stage III Adult Immunoblastic Lymphoma,0
1784,Childhood Rhabdomyosarcoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1785,Type of complication:Type:Pt:^Patient:Nom,Advanced Uterine Corpus Carcinosarcoma,0
1786,regional,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1787,Screening,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1788,Childhood Diffuse Large B-Cell Lymphoma,Chondrosarcoma,0
1789,Before,Stage I Adult Non-Hodgkin Lymphoma,0
1790,Classification,Malignant Neoplasm with Regional Lymph Node Involvement,0
1791,Occurrence Indicator,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1792,Person Observer,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1793,Benign Neoplasm,Clonal Hematopoiesis of Indeterminate Potential,0
1794,Vaginal intraepithelial neoplasia,Adenocarcinoma,0
1795,Cardiac Lead Procedure,Female Breast Carcinoma,0
1796,>90,Diffuse malignant mesothelioma,0
1797,Case unit dose,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1798,2+ Score,Endometrial Small Cell Carcinoma,0
1799,Unknown GENC,Spongiotic dermatitis,0
1800,Fatal,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1801,Due to,Malignant melanoma of eyelid,0
1802,Males,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1803,Extrinsic,BRCA2 Syndrome,0
1804,X-Ray Computed Tomography,Thymic Clear Cell Carcinoma,0
1805,Body part,Malignant Testicular Sertoli Cell Tumor,0
1806,Science of Etiology,Liver Lymphangioma,0
1807,Semilunar fold of fauces,Malignant Testicular Sertoli Cell Tumor,0
1808,Center of town,Secondary malignant neoplasm of lymph node,0
1809,Consistency,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
1810,Valid,Neoplasms,0
1811,Enzyme Unit,Anterior Urethral Malignant Neoplasm,0
1812,Most,Diffuse malignant mesothelioma,0
1813,Primary operation,Low Grade Squamous Intraepithelial Neoplasia,0
1814,Stage Grouping,sarcoma of spinal cord,0
1815,Milliampere second,Diffuse malignant mesothelioma,0
1816,Secondary to,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1817,Series,Refractory Barrett Esophagus,0
1818,Various patch test substance,Uterine Cancer,0
1819,Pharmacotherapy,Female Breast Carcinoma,0
1820,Pharmacotherapy,Human Papillomavirus-Related Carcinoma,0
1821,Abdomen,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1822,Support,Xeroderma pigmentosum,0
1823,Receive,Metastatic Carcinoma in the Lung,0
1824,Severe (severity modifier),Botryoid-Type Embryonal Rhabdomyosarcoma,0
1825,Similarity,Locally Advanced Soft Tissue Sarcoma,0
1826,Folded structure,de novo Myelodysplastic Syndrome,0
1827,To,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1828,76,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1829,Bronchi,Refractory Barrett Esophagus,0
1830,Affect (mental function),Lung squamous cell carcinoma stage I,0
1831,Life,malignant lymphoma of pancreatic lymph nodes,0
1832,Inflammation,Tonsillar Carcinoma,0
1833,Receptors,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1834,Take,adenosquamous carcinoma of breast,0
1835,Occurrence Indicator,Cerebral Primitive Neuroectodermal Tumor,0
1836,Family history,High Grade Glandular Intraepithelial Neoplasia,0
1837,Firstly,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1838,Qualitative form,Childhood Fibrillary Astrocytoma,0
1839,Coitus,Anaplastic large cell lymphoma,0
1840,Has difficulty doing (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
1841,Early,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1842,Specific qualifier value,Ichthyosis,0
1843,Closed,Endometrial Small Cell Carcinoma,0
1844,Reported Term,Diffuse malignant mesothelioma,0
1845,Shortened,Stage IV Childhood Non-Hodgkin Lymphoma,0
1846,Body Site Modifier - Lower,Primary Cutaneous Plasmablastic Lymphoma,0
1847,Term (temporal),Undifferentiated Endocervical Sarcoma,0
1848,Location of Pharyngeal Residue Following Swallowing,Benign tumor of eyelid,0
1849,pharmacotherapeutic,Mucinous cystadenofibroma,0
1850,Characterization,Ovarian germ cell choriocarcinoma stage IV,0
1851,Common Specifications in HL7 V3 Publishing,BRCA2 Syndrome,0
1852,Pleomorphic,Fourth Ventricle and Brain Stem Ependymal Tumor,0
1853,Usual,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1854,Spreading (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
1855,shared attribute,Clonal Hematopoiesis of Indeterminate Potential,0
1856,Radiation Ionizing Radiotherapy,Benign Carotid Body Paraganglioma,0
1857,Make - Instruction Imperative,Metastatic Neoplasm to the Gallbladder,0
1858,A Codes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1859,North America,Malignant melanoma of eyelid,0
1860,Term (temporal),Adenocarcinoma,0
1861,Make - Instruction Imperative,Mucinous adenocarcinoma gastric,0
1862,Have Sweats,Localized Ewing Sarcoma,0
1863,Extension,adenosquamous carcinoma of breast,0
1864,Further,Maxillary Sinus Adenocarcinoma,0
1865,Dysuria,Acantholytic squamous cell carcinoma,0
1866,pharmacotherapeutic,Lipoma of small intestine,0
1867,Human Cells,Intraepithelial Melanocytic Hyperplasia,0
1868,Malignant Neoplasms,Localized Askin Tumor,0
1869,Mobility aid,Acantholytic squamous cell carcinoma,0
1870,Genetic Predisposition to Disease,Malignant neoplasm of thalamus,0
1871,More,Medulloblastoma,0
1872,contextual factors,Mucinous adenocarcinoma gastric,0
1873,Occurrence Indicator,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1874,Fever,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1875,Occurrence,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1876,Response (communication),Recurrent Testicular Lymphoma,0
1877,What subject filter - Result,Female Breast Carcinoma,0
1878,Affect (mental function),Colorectal cancer,0
1879,development aspects,Human Papillomavirus-Related Carcinoma,0
1880,Fever,Benign Apocrine Neoplasm,0
1881,Symptoms,Tonsillar Carcinoma,0
1882,Extrinsic,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1883,Stem of plant,Benign neoplasm of thorax,0
1884,Usually,Advanced Lung Carcinoma,0
1885,Therapeutic procedure,Advanced Lung Carcinoma,0
1886,Frequently,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1887,Nutrients,Placental aromatase deficiency,0
1888,What subject filter - Result,Extracranial Neuroblastoma,0
1889,Glioblastoma Multiforme,Colorectal High Grade B-Cell Lymphoma,0
1890,Platelets Product,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
1891,Sometimes,Benign neoplasm of thorax,0
1892,patient condition,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1893,Grade three rank,Metastatic Neoplasm to the Gallbladder,0
1894,NCI CTEP SDC Adrenal Cancer Sub-Category Terminology,Adult Alveolar Soft Part Sarcoma,0
1895,Obesity,Adult Alveolar Soft Part Sarcoma,0
1896,Head - Component of Device,Methotrexate-Associated Hodgkin Lymphoma,0
1897,various other intestinal adsorbents in ATC,High Grade Glandular Intraepithelial Neoplasia,0
1898,Persons,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1899,Sibling,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1900,Singular,embryonal rhabdomyosarcoma of prostate,0
1901,Australia,Advanced Uterine Corpus Carcinosarcoma,0
1902,seen,Childhood Cerebellar Neoplasm,0
1903,Occurrence,Giant cell angiofibroma,0
1904,Manufactured form,Xeroderma pigmentosum,0
1905,Cancer Genus,Neoplasms,0
1906,Body structure,Cancer of Urinary Tract,0
1907,Immature Lymphocytes Measurement,Lung squamous cell carcinoma stage I,0
1908,Improving (qualifier value),Mixed parotid tumor,0
1909,Age,benign mature teratoma of pancreas,0
1910,Person Observer,Placental aromatase deficiency,0
1911,Ectodermal,embryonal rhabdomyosarcoma of prostate,0
1912,One,Diffuse malignant mesothelioma,0
1913,Brain,Childhood Fibrillary Astrocytoma,0
1914,Levels (qualifier value),Spermatocytic seminoma,0
1915,Beginning,Intraepithelial Melanocytic Hyperplasia,0
1916,Overweight,Granular Cell Leiomyosarcoma,0
1917,Symptoms aspect,Cancer of Urinary Tract,0
1918,Major,Adult Alveolar Soft Part Sarcoma,0
1919,Intestines,Digestive System Hodgkin Lymphoma,0
1920,Choose (action),Pilocytic astrocytoma of cerebellum,0
1921,Rare,Acute Undifferentiated Leukemia,0
1922,Critical,Carcinoma ex pleomorphic adenoma of parotid gland,0
1923,<3 (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
1924,Negation,Breast Ductal Adenoma,0
1925,Hemangioma,Blepharal carcinoma,0
1926,Factory,Stage IV Penile Cancer AJCC v7,0
1927,Brain,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1928,Adult Pilocytic Astrocytoma,adenoid cystic carcinoma of lung,0
1929,Chickenpox Vaccine,Mucinous adenocarcinoma gastric,0
1930,Greater,Methotrexate-Associated Hodgkin Lymphoma,0
1931,Primary,Breast Ductal Adenoma,0
1932,cardiovascular disorder risk,Lung squamous cell carcinoma stage I,0
1933,Common Specifications in HL7 V3 Publishing,Adult Hepatocellular Carcinoma,0
1934,Tumor cells,Low Grade Squamous Intraepithelial Neoplasia,0
1935,Chemotherapy Regimen,Diffuse malignant mesothelioma,0
1936,Autosomal dominant inheritance,Digestive System Hodgkin Lymphoma,0
1937,Enneking High Surgical Grade,GIANT PIGMENTED HAIRY NEVUS,0
1938,Contribution,Benign neoplasm of thorax,0
1939,Incidence Rate,Recurrent Testicular Lymphoma,0
1940,dendritic spine neck,Acute Undifferentiated Leukemia,0
1941,Including (qualifier),Acute Undifferentiated Leukemia,0
1942,Large,Human Papillomavirus-Related Carcinoma,0
1943,Due to,Pilocytic astrocytoma of cerebellum,0
1944,Laboratory Procedures,Serous cystadenocarcinoma ovary,0
1945,Group A (qualifier value),Mastocytosis,0
1946,Term (lexical),Ovarian germ cell choriocarcinoma stage IV,0
1947,Antibiotics for systemic use,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1948,Including (qualifier),Xeroderma pigmentosum,0
1949,Cultured Cell Line,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1950,National origin,Uterine Cancer,0
1951,Congenital defects,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1952,Lymphoma,Tonsillar Carcinoma,0
1953,inflammatory,Testicular cancer metastatic,0
1954,+5,Mucinous adenocarcinoma gastric,0
1955,0%,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1956,combination of objects,Endometrial Small Cell Carcinoma,0
1957,Light Microscopy,Stage IB Pancreatic Cancer AJCC v8,0
1958,Development,Stage IB Pancreatic Cancer AJCC v8,0
1959,Death (finding),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1960,Benign tumor of salivary gland,Adrenal Rest Tumor,0
1961,Malignant Neoplasms,Ovarian germ cell choriocarcinoma stage IV,0
1962,1+ Score,Intracortical osteosarcoma,0
1963,Entity Determiner - specific,Lipoma of small intestine,0
1964,year,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1965,Back structure,Ichthyosis,0
1966,Megakaryocytes,FIGO Stage II Ovarian Cancer,0
1967,Urine,Testicular cancer metastatic,0
1968,Testing,Giant cell angiofibroma,0
1969,Clinical,Tonsillar Carcinoma,0
1970,First (number),Mucinous cystadenofibroma,0
1971,Interpretation Process,Stage IV Penile Cancer AJCC v7,0
1972,Lack of exercise finding,Carcinoma of urinary bladder,0
1973,Prophylactic behavior,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1974,Antibiotics,Adult Hepatocellular Carcinoma,0
1975,various antiseptic throat preparations,Medulloblastoma,0
1976,Unknown,Acute Undifferentiated Leukemia,0
1977,Biological Response Modifiers,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1978,How Much Distress Weight Loss,Thymic Clear Cell Carcinoma,0
1979,Night time,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
1980,Adult Pilocytic Astrocytoma,Metastatic Ductal Breast Carcinoma,0
1981,Known,Acute Undifferentiated Leukemia,0
1982,Treating,Deep Leiomyoma,0
1983,posterior fossa,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1984,Diagnosis,Recurrent Testicular Lymphoma,0
1985,Intestines,Malignant neoplasm of thalamus,0
1986,Living quarters,Endometrial Small Cell Carcinoma,0
1987,Treatment Epoch,Intraepithelial Melanocytic Hyperplasia,0
1988,90%,Cancer of Urinary Tract,0
1989,Bothered by Night Sweats,Mucinous adenocarcinoma gastric,0
1990,Body tissue,Recurrent Testicular Lymphoma,0
1991,Including (qualifier),Childhood Fibrillary Astrocytoma,0
1992,structure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1993,Case unit dose,mucinous adenocarcinoma of gallbladder,0
1994,Chronic inflammation,Noninfiltrating Intraductal Carcinoma,0
1995,Involvement with,ALK positive large B-cell lymphoma,0
1996,Skin,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1997,Soft Tissue Route of Drug Administration,Refractory Barrett Esophagus,0
1998,Childhood Medulloblastoma,Airway Hemangioma,0
1999,Head,Contact dermatitis due to alkali,0
2000,Greater than one,Sarcomatoid Renal Cell Carcinoma,0
2001,Telephone Extension Number,Angiosarcoma of liver,0
2002,Age of Onset,Adult Alveolar Soft Part Sarcoma,0
2003,radiotherapeutic,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2004,Smear - instruction imperative,Metastatic Neoplasm to the Gallbladder,0
2005,Spreading (qualifier value),Breast Ductal Adenoma,0
2006,Chemotherapy,Cancer of Urinary Tract,0
2007,Body structure,Chronic Myelomonocytic Leukemia-2,0
2008,Adult human body,Undifferentiated Endocervical Sarcoma,0
2009,Involvement with,Carcinoma of urinary bladder,0
2010,Obese build,Methotrexate-Associated Hodgkin Lymphoma,0
2011,Fever,Breast Ductal Adenoma,0
2012,Form:Finding:Point in time:{Setting}:Document:{Role},Testicular cancer metastatic,0
2013,Tissue Specimen Code,Recurrent Uveal Melanoma,0
2014,peripheral blood,Leptomeningeal sarcoma,0
2015,Abnormal Cell Count,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2016,Including (qualifier),Recurrent Uveal Melanoma,0
2017,Rate,Stage II Hepatocellular Carcinoma AJCC v8,0
2018,Obesity,Unfavorable Non-Hodgkin Lymphoma,0
2019,Togo,Childhood Thyroid Gland Follicular Carcinoma,0
2020,Term Birth,Cartilaginous exostosis,0
2021,Togo,Cerebral Primitive Neuroectodermal Tumor,0
2022,Tired,Testicular cancer metastatic,0
2023,80%,Metastatic Ductal Breast Carcinoma,0
2024,Laser plant,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2025,To,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2026,Body structure,Chronic Myelomonocytic Leukemia-2,0
2027,GDF15 protein,Atypical Lobular Breast Hyperplasia,0
2028,Therapeutic procedure,Endometrial Small Cell Carcinoma,0
2029,Either,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2030,Benign neoplasm of paraganglion,Diffuse malignant mesothelioma,0
2031,Infected,Noninfiltrating Intraductal Carcinoma,0
2032,Known,Malignant melanoma of eyelid,0
2033,English [International Organization for Standardization 639-1 code en] language reference set,Recurrent Uveal Melanoma,0
2034,Malignant Neoplasms,Cartilaginous exostosis,0
2035,Code,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2036,Negation,Bladder squamous cell carcinoma stage I,0
2037,Country,Benign tumor of eyelid,0
2038,4+ Answer to question,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2039,<90,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2040,Patient Reported Outcome Stem,Acute lymphadenitis,0
2041,use of ultrasonography,Low Grade Squamous Intraepithelial Neoplasia,0
2042,shared attribute,Human Papillomavirus-Related Carcinoma,0
2043,National origin,Heavy Chain Deposition Disease,0
2044,Fever symptoms (finding),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2045,Tumor type,Adenocarcinoma,0
2046,Occurrence Indicator,Cerebral Primitive Neuroectodermal Tumor,0
2047,intent,Endometrial Small Cell Carcinoma,0
2048,Logical Condition,Lung squamous cell carcinoma stage I,0
2049,Disease,Placental aromatase deficiency,0
2050,Surrounding (qualifier value),Acute Undifferentiated Leukemia,0
2051,Spreading (qualifier value),Recurrent Testicular Lymphoma,0
2052,Associated with,Malignant Neoplasm with Regional Lymph Node Involvement,0
2053,Ulceration,Acute Undifferentiated Leukemia,0
2054,Fever,Liver Lymphangioma,0
2055,Two,Human Papillomavirus-Related Carcinoma,0
2056,+2,Giant cell angiofibroma,0
2057,Arising in,Acute Undifferentiated Leukemia,0
2058,320,Unfavorable Non-Hodgkin Lymphoma,0
2059,Bacteria,Spermatocytic seminoma,0
2060,Adjacent,Acantholytic squamous cell carcinoma,0
2061,Screening Study,Stage II Carcinoma of Penis,0
2062,Treating,Primary Cutaneous Plasmablastic Lymphoma,0
2063,Location of Pharyngeal Residue Following Swallowing,Bladder squamous cell carcinoma stage I,0
2064,English race,Adenocarcinoma,0
2065,Probability,embryonal rhabdomyosarcoma of prostate,0
2066,Abnormal Reference Range,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2067,oncology field,Malignant melanoma of eyelid,0
2068,Able to Concentrate Question,High Grade Glandular Intraepithelial Neoplasia,0
2069,Fatigue,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2070,Apply,Chondrosarcoma,0
2071,Small,Granular Cell Leiomyosarcoma,0
2072,Outer cortex of kidney,Cancer of Urinary Tract,0
2073,Persons,Extra-Adrenal Paraganglioma,0
2074,Age,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2075,Taxonomic,FIGO Stage II Ovarian Cancer,0
2076,Minor (value),Stage IB Pancreatic Cancer AJCC v8,0
2077,Specimen Source Codes - Tube,Unfavorable Non-Hodgkin Lymphoma,0
2078,Characteristics,Digestive System Hodgkin Lymphoma,0
2079,Taxonomic,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2080,North America,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2081,Lesion,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2082,Early,Chronic Myelomonocytic Leukemia-2,0
2083,Rapid,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2084,To,Clonal Hematopoiesis of Indeterminate Potential,0
2085,Deglutition Disorders,Neoplasms,0
2086,Frequently,Medulloblastoma,0
2087,Optic Chiasms,Childhood Fibrillary Astrocytoma,0
2088,Organ,Malignant melanoma of eyelid,0
2089,second (number),Airway Hemangioma,0
2090,primary tumor,Lipoma of small intestine,0
2091,10%,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2092,List,Placental aromatase deficiency,0
2093,Observation of color of skin,Benign tumor of eyelid,0
2094,Togo,Noninfiltrating Intraductal Carcinoma,0
2095,treatment - ActInformationManagementReason,FIGO Stage II Ovarian Cancer,0
2096,Specific qualifier value,Acute Undifferentiated Leukemia,0
2097,Diagnosis,BRCA2 Syndrome,0
2098,Uterine Cancer,Airway Hemangioma,0
2099,Phase,Stage 0 Penile Cancer AJCC v8,0
2100,Melanocytic nevus,Pancreatic Intraepithelial Neoplasia-3,0
2101,What subject filter - Result,Diffuse malignant mesothelioma,0
2102,Post,Stage 0 Penile Cancer AJCC v8,0
2103,Mass,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2104,Adult Lymphoma,Metastatic Malignant Neoplasm in the Sellar Region,0
2105,Techniques,Metastatic Neoplasm to the Gallbladder,0
2106,Africa,Grade 1 Clear Cell Renal Cell Carcinoma,0
2107,Include (action),Bladder squamous cell carcinoma stage I,0
2108,Recommendation,Mastocytosis,0
2109,Occurrence,Carcinoma of urinary bladder,0
2110,Response process,Localized Ewing Sarcoma,0
2111,status - In progress,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2112,white blood cell type,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2113,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Carcinoma of urinary bladder,0
2114,Type A,Adult Hepatocellular Carcinoma,0
2115,Infiltration,Tonsillar Carcinoma,0
2116,Subtype (attribute),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2117,Vision,Undifferentiated Endocervical Sarcoma,0
2118,Critical,Childhood Fibrillary Astrocytoma,0
2119,Numbness,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2120,Larynx,Adenocarcinoma of the prostate metastatic,0
2121,<90,Mucinous adenocarcinoma gastric,0
2122,Dysphagia,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2123,Not Applicable,Acantholytic squamous cell carcinoma,0
2124,Disease,Atypical Mesothelial Hyperplasia,0
2125,Type - attribute,Mucinous adenocarcinoma gastric,0
2126,Excision biopsy,Childhood Lymphoma,0
2127,Effectiveness,Blepharal carcinoma,0
2128,Science of Etiology,Recurrent Testicular Lymphoma,0
2129,Infertility study,Activated B-cell type diffuse large B-cell lymphoma,0
2130,Greater Than,Colorectal High Grade B-Cell Lymphoma,0
2131,brain cell,Thymic Clear Cell Carcinoma,0
2132,Ibrutinib,Heavy Chain Deposition Disease,0
2133,35,papillary carcinoma of penis,0
2134,Spreading (qualifier value),Female Breast Carcinoma,0
2135,Tumor stage,Locally Advanced Soft Tissue Sarcoma,0
2136,Developed Countries,Spongiotic dermatitis,0
2137,Case (situation),Clonal Hematopoiesis of Indeterminate Potential,0
2138,Adenocarcinoma,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2139,Show,squamous cell carcinoma of the thyroid gland,0
2140,International Statistical Classification of Diseases and Related Health Problems,FIGO Stage II Ovarian Cancer,0
2141,Biomaterial Treatment,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2142,Trial Screening,Intraepithelial Melanocytic Hyperplasia,0
2143,Forecast of outcome,Xeroderma pigmentosum,0
2144,Catch - Finding of sensory dimension of pain,Mucinous neoplasm,0
2145,Appearance Distress Question,Stage 0 Penile Cancer AJCC v8,0
2146,Specimen Source Codes - tumor,Anaplastic large cell lymphoma,0
2147,60%,Thymic Atypical Carcinoid Tumor,0
2148,Case (situation),BRCA2 Syndrome,0
2149,Containing (qualifier),Undifferentiated Neuroblastoma,0
2150,Make - Instruction Imperative,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2151,Contain (action),Stage III Adult Immunoblastic Lymphoma,0
2152,Statistical Significance,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2153,Followed by,Breast Ductal Adenoma,0
2154,Early,Hair nevus,0
2155,Central Nervous System Neoplasms,Tonsillar Carcinoma,0
2156,Specimen Source Codes - Respiratory,Spongiotic dermatitis,0
2157,Occurrence Indicator,Cerebral Primitive Neuroectodermal Tumor,0
2158,Serving,Cerebral hemangioma,0
2159,CDISC SEND Tumor Findings Results Terminology,Endometrial Small Cell Carcinoma,0
2160,Normal,Acute Undifferentiated Leukemia,0
2161,Term (temporal),Recurrent Uveal Melanoma,0
2162,North America,Cancer of Urinary Tract,0
2163,Call (Instruction),Primary Cutaneous Plasmablastic Lymphoma,0
2164,Treating,Recurrent Uveal Melanoma,0
2165,1960s,Benign Apocrine Neoplasm,0
2166,Neoplasms,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2167,Account number:Identifier:Point in time:^Patient:Nominal,Contact dermatitis due to alkali,0
2168,Chest wall structure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2169,Abdominal Distension,Pilocytic astrocytoma of cerebellum,0
2170,Worse,Ovarian germ cell choriocarcinoma stage IV,0
2171,International Classification of Disease for Oncology,Leptomeningeal sarcoma,0
2172,Sequence Data Type,Localized Ewing Sarcoma,0
2173,Exposure to,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2174,Skeletal bone,Localized Askin Tumor,0
2175,year,Heavy Chain Deposition Disease,0
2176,Primary malignant neoplasm,High Grade Glandular Intraepithelial Neoplasia,0
2177,Previous,Recurrent Testicular Lymphoma,0
2178,Therapeutic procedure,Grade 1 Clear Cell Renal Cell Carcinoma,0
2179,Greater Than,Unfavorable Non-Hodgkin Lymphoma,0
2180,Healthy,Malignant Neoplasm with Regional Lymph Node Involvement,0
2181,Colloids,Malignant neoplasm of thalamus,0
2182,Term Birth,Colorectal High Grade B-Cell Lymphoma,0
2183,Deterioration of status,Intraepithelial Melanocytic Hyperplasia,0
2184,Stop brand of fluoride,Recurrent Uveal Melanoma,0
2185,Lower - spatial qualifier,Human Papillomavirus-Related Carcinoma,0
2186,pharmacotherapeutic,Unresectable Rhabdomyosarcoma,0
2187,Botswana,Acantholytic squamous cell carcinoma,0
2188,<90,Maxillary Sinus Adenocarcinoma,0
2189,Therapeutic procedure,Lung squamous cell carcinoma stage I,0
2190,Synonym,Neonatal leukemia,0
2191,Primary malignant neoplasm,Cancer of Urinary Tract,0
2192,control substance,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2193,Togo,Acantholytic squamous cell carcinoma,0
2194,set (group),Thymic Clear Cell Carcinoma,0
2195,bony process,Uterine Cancer,0
2196,Myasthenia Gravis,Acute Undifferentiated Leukemia,0
2197,shared attribute,Recurrent Testicular Lymphoma,0
2198,To,Unfavorable Non-Hodgkin Lymphoma,0
2199,High,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2200,Involvement with,Clonal Hematopoiesis of Indeterminate Potential,0
2201,Science of Etiology,Adult Alveolar Soft Part Sarcoma,0
2202,Mucous Membrane,FIGO Stage II Ovarian Cancer,0
2203,Pallor of skin,Malignant melanoma of eyelid,0
2204,World,Lipoma of small intestine,0
2205,risk factors,Intestinal Metaplasia of Bladder Urothelium,0
2206,Including (qualifier),Carcinoma of urinary bladder,0
2207,Wound Healing,Mucinous adenocarcinoma gastric,0
2208,Pancreatic Cancer Pathway,Tonsillar Carcinoma,0
2209,primary tumor,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2210,To,Refractory Barrett Esophagus,0
2211,Increase,Carcinoma of urinary bladder,0
2212,Type - attribute,Childhood Fibrillary Astrocytoma,0
2213,Neuroglia,Ovarian Carcinoid Tumor,0
2214,Blood,Colorectal Neuroendocrine Tumor G2,0
2215,Manufactured form,Non-Metastatic Gestational Trophoblastic Tumor,0
2216,Fever symptoms (finding),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2217,Smear - instruction imperative,mucinous adenocarcinoma of gallbladder,0
2218,Regimen - CHV concept,Malignant Testicular Sertoli Cell Tumor,0
2219,Growth action,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2220,Manufactured form,Platinum-Resistant Lung Small Cell Carcinoma,0
2221,Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2222,Tryptophanase,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2223,W stress,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2224,Knee,Intraepithelial Melanocytic Hyperplasia,0
2225,Affecting,Uterine Cancer,0
2226,Site of primary lesion,Bladder squamous cell carcinoma stage I,0
2227,Symptoms aspect,Undifferentiated Endocervical Sarcoma,0
2228,False Discovery Rate,Ovarian germ cell choriocarcinoma stage IV,0
2229,Consistency,Benign Apocrine Neoplasm,0
2230,Pharmaceutical Preparations,Malignant melanoma of eyelid,0
2231,Usual,Localized Ewing Sarcoma,0
2232,Primary,Recurrent Uveal Melanoma,0
2233,Dyspnea,FIGO Stage II Ovarian Cancer,0
2234,Symptoms,Xeroderma pigmentosum,0
2235,Both ovaries,Spongiotic dermatitis,0
2236,Manufactured form,Thymic Clear Cell Carcinoma,0
2237,Five,Malignant Testicular Sertoli Cell Tumor,0
2238,Cells,Refractory Barrett Esophagus,0
2239,Estrogen [EPC],Hemangioma,0
2240,Pale color saturation,embryonal rhabdomyosarcoma of prostate,0
2241,Study of epidemiology,Bladder squamous cell carcinoma stage I,0
2242,Large,Stage I Adult Non-Hodgkin Lymphoma,0
2243,unknown vaccine or immune globulin,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2244,Firstly,Human Papillomavirus-Related Carcinoma,0
2245,Numbers,Atypical Mesothelial Hyperplasia,0
2246,Occur (action),Intraepithelial Melanocytic Hyperplasia,0
2247,Supportive assistance,Intestinal Neuroendocrine Carcinoma,0
2248,1+,FIGO Stage II Ovarian Cancer,0
2249,Thin (qualifier value),Stage III Adult Immunoblastic Lymphoma,0
2250,Characterization,Lipoma of small intestine,0
2251,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Acantholytic squamous cell carcinoma,0
2252,Antibodies,Testicular cancer metastatic,0
2253,Present,Stage IV Childhood Non-Hodgkin Lymphoma,0
2254,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Low Grade Squamous Intraepithelial Neoplasia,0
2255,Time (foundation metadata concept),Endometrial Small Cell Carcinoma,0
2256,Five,High Grade Glandular Intraepithelial Neoplasia,0
2257,European race,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2258,Term (lexical),Botryoid-Type Embryonal Rhabdomyosarcoma,0
2259,Aim,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
2260,Decision,Stage IB Lung Cancer AJCC v7,0
2261,Population Group,Cerebral Primitive Neuroectodermal Tumor,0
2262,Tobacco smoking behavior,Liver Cavernous Hemangioma,0
2263,Widening,Digestive System Hodgkin Lymphoma,0
2264,Platelets Product,papillary carcinoma of penis,0
2265,Numerous,Intraepithelial Melanocytic Hyperplasia,0
2266,Occurrence Indicator,Malignant Neoplasm with Regional Lymph Node Involvement,0
2267,To,Methotrexate-Associated Hodgkin Lymphoma,0
2268,Significant,Diffuse malignant mesothelioma,0
2269,Retinoic Acid Response Element,Adult Hepatocellular Carcinoma,0
2270,Macrophage Activation Syndrome,Xeroderma pigmentosum,0
2271,1870s,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2272,Negation,Childhood Cerebellar Neoplasm,0
2273,Antibiotic throat preparations,Primary Cutaneous Plasmablastic Lymphoma,0
2274,30%,Noninfiltrating Intraductal Carcinoma,0
2275,Lymphoma,Familial Hemophagocytic Lymphocytosis,0
2276,ancestors,Malignant melanoma of eyelid,0
2277,Paraganglioma,Liver Lymphangioma,0
2278,Subject is Randomized,Mucinous adenocarcinoma gastric,0
2279,West Haven Hepatic Encephalopathy Grade 3,Stage II Carcinoma of Penis,0
2280,Wound Healing,Thymoma malignant recurrent,0
2281,Usually Need Help from Another Person for Arising,Human Papillomavirus-Related Carcinoma,0
2282,Certain (qualifier value),Bladder squamous cell carcinoma stage I,0
2283,95,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2284,Near,Stage III Adult Immunoblastic Lymphoma,0
2285,Neoplasms,Adult Hepatocellular Carcinoma,0
2286,Mole,Small cell neuroendocrine carcinoma of bladder,0
2287,Tryptophanase,Extra-Adrenal Paraganglioma,0
2288,colon function,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2289,Adrenal Gland Neoplasms,Stage 0 Lip Carcinoma,0
2290,geographic population,Recurrent Testicular Lymphoma,0
2291,Urine,Blepharal carcinoma,0
2292,Body tissue,Intestinal Metaplasia of Bladder Urothelium,0
2293,Malignant neoplasm of ovary,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2294,Body site,Localized Askin Tumor,0
2295,Occur (action),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
2296,Average of Value Derivation Technique,Cancer of Urinary Tract,0
2297,Primary operation,Xeroderma pigmentosum,0
2298,Smear - instruction imperative,Stage IB Lung Cancer AJCC v7,0
2299,Age at menopause,Testicular cancer metastatic,0
2300,include - SetOperator,Testicular cancer metastatic,0
2301,Easy bleeding,Undifferentiated Endocervical Sarcoma,0
2302,Tumor cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2303,Chemotherapy,Intestinal Metaplasia of Bladder Urothelium,0
2304,classical example,Angiosarcoma of liver,0
2305,Symptoms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2306,Manufactured form,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2307,<50,embryonal rhabdomyosarcoma of prostate,0
2308,Enlargement procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2309,Numerous,Cancer of Urinary Tract,0
2310,Arising,mucinous adenocarcinoma of gallbladder,0
2311,Tired,embryonal rhabdomyosarcoma of prostate,0
2312,X-Ray Computed Tomography,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
2313,brain cell,Lipoma of small intestine,0
2314,Stem of plant,Uterine Cancer,0
2315,Classification of information,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2316,Human body structure,Childhood Cerebellar Neoplasm,0
2317,Qualitative form,Mucinous adenocarcinoma gastric,0
2318,style,Acute Undifferentiated Leukemia,0
2319,Affecting,Medulloblastoma,0
2320,Infratentorial,Diffuse malignant mesothelioma,0
2321,therapeutic aspects,Undifferentiated Endocervical Sarcoma,0
2322,radiotherapeutic,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2323,Diagnosis Study,Carcinoma ex pleomorphic adenoma of parotid gland,0
2324,Ability,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
2325,Type A,Mixed parotid tumor,0
2326,Use of,Acantholytic squamous cell carcinoma,0
2327,Disease,sarcoma of spinal cord,0
2328,Times,Stage I Adult Non-Hodgkin Lymphoma,0
2329,Malignant Neoplasms,Refractory Glioma,0
2330,Four,Xeroderma pigmentosum,0
2331,P450-aromatase Deficiency,Angiosarcoma of liver,0
2332,Caucasians,Intestinal Neuroendocrine Carcinoma,0
2333,Infrequent,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2334,Large,Platinum-Resistant Lung Small Cell Carcinoma,0
2335,Portion of urine,Anaplastic large cell lymphoma,0
2336,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
2337,Disseminated Malignant Neoplasm,Locally Advanced Soft Tissue Sarcoma,0
2338,error,BRCA2 Syndrome,0
2339,Chronic inflammation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2340,Traumatic injury,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2341,Skin tanning,Ichthyoses,0
2342,Major <insect>,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2343,Classification,Stage IV Penile Cancer AJCC v7,0
2344,shared attribute,Lipoma of small intestine,0
2345,Symptoms,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2346,Disc - Body Part,Testicular cancer metastatic,0
2347,Adapt (substance),Leiomyoma of Gallbladder,0
2348,Microscopic,Stage III Adult Immunoblastic Lymphoma,0
2349,Hodgkin Disease,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2350,Malignant Neoplasms,Acute lymphadenitis,0
2351,Junonia,Extracranial Neuroblastoma,0
2352,Cell (compartment),Adult Alveolar Soft Part Sarcoma,0
2353,Occurrence,gliosarcoma,0
2354,Neoplasm Metastasis,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2355,Mass of body structure,Childhood Lymphoma,0
2356,Swollen Lymph Node,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2357,Loss of Appetite question,Giant cell angiofibroma,0
2358,Manufactured form,malignant lymphoma of pancreatic lymph nodes,0
2359,Cells,Childhood Lymphoma,0
2360,Common Specifications in HL7 V3 Publishing,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2361,Disease Screening,Placental aromatase deficiency,0
2362,Bodily secretions,Recurrent Testicular Lymphoma,0
2363,Injury due to exposure to external cause,Digestive System Hodgkin Lymphoma,0
2364,Malignant neoplasm of urinary bladder,Recurrent Testicular Lymphoma,0
2365,therapeutic aspects,Ovarian germ cell choriocarcinoma stage IV,0
2366,Condition:Find:Pt:^Patient:Nom,Colorectal High Grade B-Cell Lymphoma,0
2367,Frequently,Stage 0 Lip Carcinoma,0
2368,ISOLATE COMPOUND,Pilocytic astrocytoma of cerebellum,0
2369,Diagnosis Study,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2370,Specific qualifier value,Medulloblastoma,0
2371,Alcohols,Choroid Necrotic Melanoma,0
2372,Loss of Appetite question,Stage IB Pancreatic Cancer AJCC v8,0
2373,Therapeutic procedure,Atypical Lobular Breast Hyperplasia,0
2374,Numerous,Female Breast Carcinoma,0
2375,Human body structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2376,Dyspareunia,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2377,84,Benign tumor of eyelid,0
2378,Hormonal Contraception,Adult Alveolar Soft Part Sarcoma,0
2379,Containing (qualifier),Anterior Urethral Malignant Neoplasm,0
2380,Study Site,Stage IV Childhood Non-Hodgkin Lymphoma,0
2381,Linear,sarcoma of spinal cord,0
2382,Surgery specialty,Recurrent Testicular Lymphoma,0
2383,Before,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2384,Bladder Continence Question,sarcoma of spinal cord,0
2385,Worsening pattern,Localized Askin Tumor,0
2386,Removed,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2387,Egg of order Phthiraptera,Acute lymphadenitis,0
2388,Immune System Finding,Ovarian germ cell choriocarcinoma stage IV,0
2389,Followed by,Cerebral Primitive Neuroectodermal Tumor,0
2390,Experimental Result,Primary Cutaneous Plasmablastic Lymphoma,0
2391,various other intestinal adsorbents in ATC,Hemangioma,0
2392,Pleomorphism (morphologic abnormality),Locally Advanced Soft Tissue Sarcoma,0
2393,<3 (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2394,Abnormal cell,Colorectal cancer,0
2395,Myeloproliferation,FIGO Stage II Ovarian Cancer,0
2396,Including (qualifier),Botryoid-Type Embryonal Rhabdomyosarcoma,0
2397,Persons,Extracranial Neuroblastoma,0
2398,Diagnosis,Cerebral Primitive Neuroectodermal Tumor,0
2399,Proximal,Blepharal carcinoma,0
2400,Taxonomic,Ichthyoses,0
2401,Infiltration Route of Drug Administration,Ovarian germ cell choriocarcinoma stage IV,0
2402,Resulting in,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2403,Woman,Localized Askin Tumor,0
2404,Plasma,Ovarian germ cell choriocarcinoma stage IV,0
2405,Negation,Anterior Urethral Malignant Neoplasm,0
2406,Call (Instruction),Human Papillomavirus-Related Carcinoma,0
2407,described,Heavy Chain Deposition Disease,0
2408,acute,Acute lymphadenitis,0
2409,Oral contraception,Benign neoplasm of thorax,0
2410,Unique,Malignant melanoma of eyelid,0
2411,Referring,Blepharal carcinoma,0
2412,Leading,non-Hodgkin's lymphoma of spleen,0
2413,Continuous,Chondrosarcoma,0
2414,Fever,Pancreatic Intraepithelial Neoplasia-3,0
2415,Back structure,Choroid Necrotic Melanoma,0
2416,Biological Response Modifiers,Malignant neoplasm of choroid,0
2417,Blood group antibody I,Stage 0 Penile Cancer AJCC v8,0
2418,Version,Human Papillomavirus-Related Carcinoma,0
2419,Tobacco smoking behavior,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2420,Derivation,Cerebral Primitive Neuroectodermal Tumor,0
2421,described,Childhood Thyroid Gland Follicular Carcinoma,0
2422,Specimen Source Codes - Tube,Mucinous adenocarcinoma gastric,0
2423,Lower - spatial qualifier,benign mature teratoma of pancreas,0
2424,Esophageal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2425,Decreasing,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2426,Due to,Stage 0 Penile Cancer AJCC v8,0
2427,Bilateral salpingectomy with oophorectomy,Ovarian germ cell choriocarcinoma stage IV,0
2428,Usual Severity Pain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2429,% index,Maxillary Sinus Adenocarcinoma,0
2430,Case unit dose,Anaplastic large cell lymphoma,0
2431,3+ Answer to Question,Liver Lymphangioma,0
2432,Most,Localized Ewing Sarcoma,0
2433,Complication,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2434,Science of Morphology,Adrenal Rest Tumor,0
2435,Five,Female Breast Carcinoma,0
2436,Treating,Low Grade Squamous Intraepithelial Neoplasia,0
2437,Classification,Extracranial Neuroblastoma,0
2438,Notable,mucinous adenocarcinoma of gallbladder,0
2439,Target,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2440,Known,adenosquamous carcinoma of breast,0
2441,per year,Cerebral Primitive Neuroectodermal Tumor,0
2442,Code,adenoid cystic carcinoma of lung,0
2443,Retinoic Acid Response Element,BRCA2 Syndrome,0
2444,Nephrons,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2445,CDISC SEND Tumor Findings Results Terminology,Colorectal High Grade B-Cell Lymphoma,0
2446,Difficult (qualifier value),Stage IV Penile Cancer AJCC v7,0
2447,mucus layer,Noninfiltrating Intraductal Carcinoma,0
2448,Sequence Data Type,Leptomeningeal sarcoma,0
2449,Malignant Neoplasms,Metastatic Malignant Neoplasm in the Sellar Region,0
2450,Spreading (qualifier value),Mucinous adenocarcinoma gastric,0
2451,Pediatrics,malignant lymphoma of pancreatic lymph nodes,0
2452,White color,Cartilaginous exostosis,0
2453,Medical service,Extra-Adrenal Paraganglioma,0
2454,Assisted (qualifier value),Stage III Adult Immunoblastic Lymphoma,0
2455,Occurrence Indicator,Clonal Hematopoiesis of Indeterminate Potential,0
2456,Stomach,Colorectal cancer,0
2457,cervical cancer,Acute lymphadenitis,0
2458,Qualitative form,Undifferentiated Neuroblastoma,0
2459,Reduced,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2460,Malignant neoplasm of soft tissue,Placental aromatase deficiency,0
2461,Cancer Genus,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2462,Neoplasms,Mixed parotid tumor,0
2463,Old,Stage II Carcinoma of Penis,0
2464,Pseudomyxoma Peritonei,Adult Hepatocellular Carcinoma,0
2465,pre-surgery,Liver Lymphangioma,0
2466,memory b cell,Primary Cutaneous Plasmablastic Lymphoma,0
2467,Angioimmunoblastic Lymphadenopathy,Colorectal High Grade B-Cell Lymphoma,0
2468,newly,Stage IV Penile Cancer AJCC v7,0
2469,Confirmed by,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2470,Glycation End Products,Stage IV Penile Cancer AJCC v7,0
2471,Occurrence Indicator,Small cell neuroendocrine carcinoma of bladder,0
2472,Neoplastic disease,Malignant neoplasm of thalamus,0
2473,Telencephalon,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2474,Diabetes,Intraepithelial Melanocytic Hyperplasia,0
2475,Compression - action,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2476,Throat,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2477,Abnormally high,Pancreatic Intraepithelial Neoplasia-3,0
2478,Choriocarcinoma,Acute lymphadenitis,0
2479,20s,Diffuse malignant mesothelioma,0
2480,Reported Term,Spongiotic dermatitis,0
2481,Can Do Very Little,Ovarian Carcinoid Tumor,0
2482,Package Type Not Applicable,Contact dermatitis due to alkali,0
2483,Form:Finding:Point in time:{Setting}:Document:{Role},embryonal rhabdomyosarcoma of prostate,0
2484,Japan,Cerebral Primitive Neuroectodermal Tumor,0
2485,Cyperus papyrus,Refractory Barrett Esophagus,0
2486,United States,Ovarian germ cell choriocarcinoma stage IV,0
2487,Metastatic malignant neoplasm to brain,Endometrial Small Cell Carcinoma,0
2488,Case unit dose,Recurrent Testicular Lymphoma,0
2489,Count of entities,benign mature teratoma of pancreas,0
2490,Eyelash,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2491,Enhance (action),Mucinous adenocarcinoma gastric,0
2492,family of origin,Refractory Barrett Esophagus,0
2493,Active License,Breast Ductal Adenoma,0
2494,Woman,Cancer of Urinary Tract,0
2495,Childhood Rhabdomyosarcoma,Low Grade Squamous Intraepithelial Neoplasia,0
2496,Affecting,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2497,aromatase activity,Undifferentiated Endocervical Sarcoma,0
2498,Prior Medication Usage,Blepharal carcinoma,0
2499,include - SetOperator,non-Hodgkin's lymphoma of spleen,0
2500,Stem of plant,Stage II Hepatocellular Carcinoma AJCC v8,0
2501,Cystic duct structure,Acute Undifferentiated Leukemia,0
2502,Adult Non-Hodgkin Lymphoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2503,Tobacco smoking behavior,Cartilaginous exostosis,0
2504,Including (qualifier),Ichthyosis,0
2505,>5,Thymic Clear Cell Carcinoma,0
2506,Cervix carcinoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2507,Synonym (core metadata concept),Stage IB Pancreatic Cancer AJCC v8,0
2508,Result,Atypical Lobular Breast Hyperplasia,0
2509,biopsy characteristics,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2510,Feel Tired question,Bladder squamous cell carcinoma stage I,0
2511,Certain (qualifier value),Blepharal carcinoma,0
2512,Dental caries,Breast Ductal Adenoma,0
2513,Hardness,Childhood Fibrillary Astrocytoma,0
2514,Cyst,Childhood Fibrillary Astrocytoma,0
2515,Approximate,Mucinous cystadenofibroma,0
2516,Cell (compartment),Acantholytic squamous cell carcinoma,0
2517,Occurrence,Mucinous adenocarcinoma gastric,0
2518,Medical Devices,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2519,Type - attribute,Spongiotic dermatitis,0
2520,Medulla Oblongata,Endometrial Small Cell Carcinoma,0
2521,Occurrence,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2522,Condition:Find:Pt:^Patient:Nom,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2523,Ankle,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2524,Affecting,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2525,Erythropoiesis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2526,Variety (taxon),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2527,Increased erythropoietin,Unresectable Rhabdomyosarcoma,0
2528,Exist,Choroid Necrotic Melanoma,0
2529,lymph nodes,Liver Cavernous Hemangioma,0
2530,cancer risk,FIGO Stage II Ovarian Cancer,0
2531,Pharyngeal structure,Tonsillar Carcinoma,0
2532,Rating (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2533,Approximate,Recurrent Testicular Lymphoma,0
2534,Hour Times Percent,Stage IB Lung Cancer AJCC v7,0
2535,Secretory Vesicles,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2536,Ethanol,Stage IB Lung Cancer AJCC v7,0
2537,Early,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2538,Proline measurement,Undifferentiated Endocervical Sarcoma,0
2539,Antibiotic throat preparations,Human Papillomavirus-Related Carcinoma,0
2540,Colon structure (body structure),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2541,include - SetOperator,Intraepithelial Melanocytic Hyperplasia,0
2542,Main,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2543,PSA Level Greater than Fifty,FIGO Stage II Ovarian Cancer,0
2544,Specimen Source Codes - tumor,Cerebral Primitive Neuroectodermal Tumor,0
2545,Occurrence,Carcinoma of urinary bladder,0
2546,Carcinoma in Situ,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2547,Consistency,Cerebral Primitive Neuroectodermal Tumor,0
2548,Proliferation (morphologic abnormality),Intraepithelial Melanocytic Hyperplasia,0
2549,Effectiveness,Malignant melanoma of eyelid,0
2550,Targeted Therapy,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2551,Body tissue,Malignant melanoma of eyelid,0
2552,Tissue damage,Hemangioma,0
2553,Germinoma,Adult Alveolar Soft Part Sarcoma,0
2554,Presence (property),Localized Askin Tumor,0
2555,Females,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2556,User Group,Testicular cancer metastatic,0
2557,Human Papillomavirus,Intraepithelial Melanocytic Hyperplasia,0
2558,Clonality,Recurrent Uveal Melanoma,0
2559,Age,Diffuse malignant mesothelioma,0
2560,Cells,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2561,Major <insect>,Stage 0 Lip Carcinoma,0
2562,Form:Finding:Point in time:{Setting}:Document:{Role},Carcinoma of urinary bladder,0
2563,System - kit,Atypical Mesothelial Hyperplasia,0
2564,white blood cell type,Recurrent Uveal Melanoma,0
2565,Hemangioma,Pancreatic Intraepithelial Neoplasia-3,0
2566,Cancer Other,Endometrial Small Cell Carcinoma,0
2567,Treatment Epoch,Stage IB Pancreatic Cancer AJCC v8,0
2568,Rest,Localized Askin Tumor,0
2569,Therapeutic procedure,Unresectable Rhabdomyosarcoma,0
2570,Tests (qualifier value),Chronic Myelomonocytic Leukemia-2,0
2571,Before,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2572,Evidence,Low Grade Squamous Intraepithelial Neoplasia,0
2573,Orchitis,Thymoma malignant recurrent,0
2574,Invasive Lesion,Adrenal Rest Tumor,0
2575,Needs,Ichthyosis,0
2576,Nodular (qualifier value),Hodgkin lymphoma,0
2577,All extremities,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2578,300,Neonatal leukemia,0
2579,Mean Percent of Normal,Undifferentiated Neuroblastoma,0
2580,Then,Stage IB Pancreatic Cancer AJCC v8,0
2581,Lethal,squamous cell carcinoma of the thyroid gland,0
2582,Tactile,Digestive System Hodgkin Lymphoma,0
2583,Physical findings,Recurrent Uveal Melanoma,0
2584,Effect,Anterior Urethral Malignant Neoplasm,0
2585,suggestion,Medulloblastoma,0
2586,Aggressive course,Refractory Barrett Esophagus,0
2587,Meaning,Choroid Necrotic Melanoma,0
2588,Males,Malignant melanoma of eyelid,0
2589,Asia,Unresectable Rhabdomyosarcoma,0
2590,Decision,Lung squamous cell carcinoma stage I,0
2591,Often - answer to question,adenoid cystic carcinoma of lung,0
2592,2+ Score,papillary carcinoma of penis,0
2593,Main,Mucinous cystadenofibroma,0
2594,Immunization Programs,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2595,SMIM10L2A gene,Blepharal carcinoma,0
2596,Abundance,Advanced Lung Carcinoma,0
2597,Headache,Digestive System Hodgkin Lymphoma,0
2598,Anatomic Site,Chondrosarcoma,0
2599,Experimental Organism Basal Cell Carcinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2600,Stroma,Uterine Cancer,0
2601,Five,Thymic Clear Cell Carcinoma,0
2602,Body surface,Larynx carcinoma recurrent,0
2603,Morphology,Localized Ewing Sarcoma,0
2604,Aspects of signs,Rhabdomyosarcoma with ganglionic differentiation,0
2605,Obsolete - EditStatus,Malignant melanoma of eyelid,0
2606,Specific qualifier value,Spongiotic dermatitis,0
2607,Manufactured sign,Larynx carcinoma recurrent,0
2608,Heart,Metastatic Lung Small Cell Carcinoma,0
2609,Synonym (core metadata concept),Tonsillar Carcinoma,0
2610,Very,Intracortical osteosarcoma,0
2611,Including (qualifier),Heavy Chain Deposition Disease,0
2612,Usual,Undifferentiated Neuroblastoma,0
2613,Hereditary Diseases,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2614,Categories,Spongiotic dermatitis,0
2615,Base - General Qualifier,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2616,Large,Mucinous neoplasm,0
2617,Blast (physical force),Benign Apocrine Neoplasm,0
2618,Adult Lymphoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2619,Functional disorder,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
2620,Vertebral column,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2621,<90,Benign Apocrine Neoplasm,0
2622,High Mitosis-Karyorrhexis Index,Mucinous cystadenofibroma,0
2623,Common (qualifier value),Metastatic Neoplasm to the Gallbladder,0
2624,Death (finding),Diffuse malignant mesothelioma,0
2625,Right lymphatic duct,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2626,Neoplasm Metastasis,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2627,Cancer Genus,Tonsillar Carcinoma,0
2628,Survival Rate,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2629,Reported Term,Angiosarcoma of liver,0
2630,Exposure to Agent Orange,Testicular cancer metastatic,0
2631,Most,Extra-Adrenal Paraganglioma,0
2632,Small,gliosarcoma,0
2633,Cancer Remission,Childhood Choriocarcinoma,0
2634,English Language,Unfavorable Non-Hodgkin Lymphoma,0
2635,Appearance,Giant cell angiofibroma,0
2636,Spreading (qualifier value),Prostate Lymphoma,0
2637,Biological Transport,Familial Hemophagocytic Lymphocytosis,0
2638,Qualitative form,Hemangioma,0
2639,Females,Neonatal leukemia,0
2640,*Activity (kind of quantity),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2641,Subject Risk,Malignant Testicular Sertoli Cell Tumor,0
2642,Pediculus (eukaryote),Fourth Ventricle and Brain Stem Ependymal Tumor,0
2643,Childhood Non-Hodgkin Lymphoma,papillary carcinoma of penis,0
2644,Digital Content Category,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2645,Primary malignant neoplasm,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2646,Leukocytes,Secondary malignant neoplasm of lymph node,0
2647,Poor - grade value,BRCA2 Syndrome,0
2648,Application Context,Metastatic Malignant Neoplasm in the Sellar Region,0
2649,Cell Device,Stage II Carcinoma of Penis,0
2650,Reduction procedure,Maxillary Sinus Adenocarcinoma,0
2651,Subtype (attribute),Small cell neuroendocrine carcinoma of bladder,0
2652,Personal appearance,Liver Lymphangioma,0
2653,Act Mood - intent,mucinous adenocarcinoma of gallbladder,0
2654,Process,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2655,Present,Stage III Adult Immunoblastic Lymphoma,0
2656,Old,Childhood Lymphoma,0
2657,Ancestry-Informative Marker,Malignant neoplasm of thalamus,0
2658,Cancer Genus,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2659,Block (unit of presentation),Malignant melanoma of eyelid,0
2660,Virus,Undifferentiated Endocervical Sarcoma,0
2661,Carcinoma of lung,Acantholytic squamous cell carcinoma,0
2662,Genes,Platinum-Resistant Lung Small Cell Carcinoma,0
2663,RBC count low,Endometrial Small Cell Carcinoma,0
2664,Enneking High Surgical Grade,Liver Cavernous Hemangioma,0
2665,Negation,papillary carcinoma of penis,0
2666,Sunlight,Malignant Testicular Sertoli Cell Tumor,0
2667,Morbidity - disease rate,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2668,2+ Score,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2669,Cover (physical object),Bladder squamous cell carcinoma stage I,0
2670,Continuance of life,Carcinoma of urinary bladder,0
2671,Mucosa-Associated Lymphoid Tissue Lymphoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2672,dendritic spine neck,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2673,Staining (finding),Stage 0 Lip Carcinoma,0
2674,Rare,Clonal Hematopoiesis of Indeterminate Potential,0
2675,Jumping,Human Papillomavirus-Related Carcinoma,0
2676,Mass of body structure,Cerebral Primitive Neuroectodermal Tumor,0
2677,Type A,Small cell neuroendocrine carcinoma of bladder,0
2678,Diagnosis Study,Anterior Urethral Malignant Neoplasm,0
2679,Fall,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2680,What subject filter - Result,Recurrent Uveal Melanoma,0
2681,Term Birth,Xeroderma pigmentosum,0
2682,Analysis,Intraepithelial Melanocytic Hyperplasia,0
2683,Large,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2684,Aspects of signs,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2685,CD44 wt Allele,Airway Hemangioma,0
2686,Manufactured sign,Digestive System Hodgkin Lymphoma,0
2687,Gastric Content,Benign Apocrine Neoplasm,0
2688,Secondary Neoplasm,Adult Alveolar Soft Part Sarcoma,0
2689,Etiology aspects,Intraepithelial Melanocytic Hyperplasia,0
2690,Abnormal Cell Count,Acute Undifferentiated Leukemia,0
2691,Leading,Thymoma malignant recurrent,0
2692,Unknown GENC,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2693,Stomach structure,Malignant Testicular Sertoli Cell Tumor,0
2694,Diagnosis,Digestive System Hodgkin Lymphoma,0
2695,Result,Heavy Chain Deposition Disease,0
2696,Much,Choroid Necrotic Melanoma,0
2697,Etiology,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2698,Usually,Clonal Hematopoiesis of Indeterminate Potential,0
2699,Immunotherapy,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2700,Associated with,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2701,Formed,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2702,CYP19A1 protein,Cerebral hemangioma,0
2703,Type A,Advanced Lung Carcinoma,0
2704,Supportive assistance,Childhood Central Nervous System Immature Teratoma,0
2705,Biopsy,Human Papillomavirus-Related Carcinoma,0
2706,Admission Level of Care Code - Improved,Female Breast Carcinoma,0
2707,Symptoms aspect,Carcinoma of urinary bladder,0
2708,IPSS Risk Category High,Recurrent Uveal Melanoma,0
2709,Biomaterial Treatment,Localized Ewing Sarcoma,0
2710,Natural History,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2711,Therapeutic procedure,Extracranial Neuroblastoma,0
2712,hand - unit of measure,BRCA2 Syndrome,0
2713,Further,Female Breast Carcinoma,0
2714,Abdomen,Colorectal High Grade B-Cell Lymphoma,0
2715,Digital Content Category,Hemangioma,0
2716,Togo,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2717,Dermatologist,Extra-Adrenal Paraganglioma,0
2718,Common Specifications in HL7 V3 Publishing,Pilocytic astrocytoma of cerebellum,0
2719,Morphology,Adult Alveolar Soft Part Sarcoma,0
2720,Tissue Specimen Code,Adult Alveolar Soft Part Sarcoma,0
2721,Known,Malignant melanoma of eyelid,0
2722,Intermediate Mitosis-Karyorrhexis Index,Metastatic Ductal Breast Carcinoma,0
2723,Use of,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2724,Patients,Pancreatic Intraepithelial Neoplasia-3,0
2725,CD5L wt Allele,Cancer of Urinary Tract,0
2726,Human Cells,BRCA2 Syndrome,0
2727,World Health Organization,non-Hodgkin's lymphoma of spleen,0
2728,Endocrine,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2729,Endometrial Carcinoma,Medulloblastoma,0
2730,Acral,Extra-Adrenal Paraganglioma,0
2731,Adult Diffuse Large B-Cell Lymphoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2732,Mixed Cell Morphology,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2733,Ulceration,Acute Undifferentiated Leukemia,0
2734,Malignant Head and Neck Neoplasm,Uterine Cancer,0
2735,Carcinoma of bladder,Chondrosarcoma,0
2736,CDISC SEND Tumor Findings Results Terminology,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2737,Electrolyte [EPC],FIGO Stage II Ovarian Cancer,0
2738,treatment - ActInformationManagementReason,Thymic Clear Cell Carcinoma,0
2739,Dorsal,Colorectal High Grade B-Cell Lymphoma,0
2740,Diagnosis,Liver Lymphangioma,0
2741,shared attribute,Bladder squamous cell carcinoma stage I,0
2742,Adjacent,Colorectal High Grade B-Cell Lymphoma,0
2743,Skin Specimen,Endometrial Small Cell Carcinoma,0
2744,Togo,Neoplasms,0
2745,Cure (remedy),BRCA2 Syndrome,0
2746,Communicable Diseases,Benign neoplasm of thorax,0
2747,Unknown,Pancreatic Intraepithelial Neoplasia-3,0
2748,Diagnosis,Localized Ewing Sarcoma,0
2749,Spreading (qualifier value),Tonsillar Carcinoma,0
2750,UV Radiation Exposure,Malignant neoplasm of choroid,0
2751,Mass of body structure,Localized Ewing Sarcoma,0
2752,Valid,Stage IB Pancreatic Cancer AJCC v8,0
2753,Frequently,Colorectal High Grade B-Cell Lymphoma,0
2754,Have Sweats,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
2755,Liver,Testicular cancer metastatic,0
2756,Secondary to,Adult Hepatocellular Carcinoma,0
2757,Relationships,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2758,Lower (action),Angiosarcoma of liver,0
2759,Chemotherapy Regimen,BRCA2 Syndrome,0
2760,Unspecified,Cartilaginous exostosis,0
2761,Pancreas,Female Breast Carcinoma,0
2762,Pericardial sac structure,Stage III Adult Immunoblastic Lymphoma,0
2763,Adult Lymphoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2764,Clear fluid,Methotrexate-Associated Hodgkin Lymphoma,0
2765,Angiosarcoma of liver,High Grade Glandular Intraepithelial Neoplasia,0
2766,Initially,Benign Carotid Body Paraganglioma,0
2767,Risk,Recurrent Testicular Lymphoma,0
2768,Cessation of life,Stage II Carcinoma of Penis,0
2769,Fraction of,Hodgkin lymphoma,0
2770,pharmacotherapeutic,Granular Cell Leiomyosarcoma,0
2771,Frequently,Breast Ductal Adenoma,0
2772,Disease,Childhood Thyroid Gland Follicular Carcinoma,0
2773,Hemangioma,Undifferentiated Endocervical Sarcoma,0
2774,Less often,High Grade Glandular Intraepithelial Neoplasia,0
2775,Referral placed,Low Grade Squamous Intraepithelial Neoplasia,0
2776,Homo sapiens,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2777,per year,Acantholytic squamous cell carcinoma,0
2778,Immune System Finding,Recurrent Uveal Melanoma,0
2779,Adult Germ Cell Tumor,Recurrent Uveal Melanoma,0
2780,Salivary Glands,Thymic Atypical Carcinoid Tumor,0
2781,Ability,Cerebral Primitive Neuroectodermal Tumor,0
2782,List,Advanced Uterine Corpus Carcinosarcoma,0
2783,Dual,Adult Alveolar Soft Part Sarcoma,0
2784,Include (action),Low Grade Squamous Intraepithelial Neoplasia,0
2785,Invasive,Acute Undifferentiated Leukemia,0
2786,Prophylactic behavior,benign mature teratoma of pancreas,0
2787,Long Variable,Angiosarcoma of liver,0
2788,Lymphocyte,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2789,DUOXA1 gene,Acute Undifferentiated Leukemia,0
2790,To,Adult Alveolar Soft Part Sarcoma,0
2791,Tissue damage,Stage IV Childhood Non-Hodgkin Lymphoma,0
2792,Associated topography,Liver Cavernous Hemangioma,0
2793,artesunate,Testicular cancer metastatic,0
2794,migrated,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2795,Isolated,Mixed parotid tumor,0
2796,Symptoms aspect,Metastatic Malignant Neoplasm in the Sellar Region,0
2797,Life Threatening or Disabling Adverse Event,Adenocarcinoma of the prostate metastatic,0
2798,Glioblastoma Multiforme Pathway,Ichthyosis,0
2799,Chromosomes,Acantholytic squamous cell carcinoma,0
2800,artesunate,Acantholytic squamous cell carcinoma,0
2801,English Language,Airway Hemangioma,0
2802,Common (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
2803,survive,non-Hodgkin's lymphoma of spleen,0
2804,Symptoms aspect,Acantholytic squamous cell carcinoma,0
2805,Band form,Xeroderma pigmentosum,0
2806,Occurrence,Unfavorable Non-Hodgkin Lymphoma,0
2807,Transitional epithelium,Undifferentiated Endocervical Sarcoma,0
2808,Infrequent,Testicular cancer metastatic,0
2809,Science of Morphology,Acute Undifferentiated Leukemia,0
2810,Variable (uniformity),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2811,Chemicals,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2812,Hemoptysis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2813,Unknown,mucinous adenocarcinoma of gallbladder,0
2814,newly,Recurrent Testicular Lymphoma,0
2815,Neoplasms,Localized Ewing Sarcoma,0
2816,Hemorrhage,Anterior Urethral Malignant Neoplasm,0
2817,Joints,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2818,Web Site,Atypical Lobular Breast Hyperplasia,0
2819,Pediatric Neoplasm,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2820,IPSS Risk Category High,Blepharal carcinoma,0
2821,Referring,mucinous adenocarcinoma of gallbladder,0
2822,Heterogeneity,Pancreatic Intraepithelial Neoplasia-3,0
2823,Most,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2824,Shortened,Stage I Adult Non-Hodgkin Lymphoma,0
2825,Night sweats,Stage I Adult Non-Hodgkin Lymphoma,0
2826,Poor oral hygiene,Primary Cutaneous Plasmablastic Lymphoma,0
2827,Metastatic Neoplasm,embryonal rhabdomyosarcoma of prostate,0
2828,Congenital Disorders,Bladder squamous cell carcinoma stage I,0
2829,Probable diagnosis,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2830,Manufactured form,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2831,One,Hodgkin lymphoma,0
2832,capsule (pharmacologic),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
2833,Biomaterial Treatment,Malignant melanoma of eyelid,0
2834,Type A,Recurrent Testicular Lymphoma,0
2835,Urine,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2836,Common Specifications in HL7 V3 Publishing,Stage III Adult Immunoblastic Lymphoma,0
2837,Spreading (qualifier value),Carcinoma of urinary bladder,0
2838,1000000,Neoplasms,0
2839,Skin Specimen,Unfavorable Non-Hodgkin Lymphoma,0
2840,80%,Benign Carotid Body Paraganglioma,0
2841,Brain part,Medulloblastoma,0
2842,Melanins,Hemangioma,0
2843,Complication Aspects,Intraepithelial Melanocytic Hyperplasia,0
2844,Metabolic Inhibition,Rhabdomyosarcoma with ganglionic differentiation,0
2845,Therapeutic radiology procedure,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2846,Malignant Neoplasms,Stage III Adult Immunoblastic Lymphoma,0
2847,treatment - ActInformationManagementReason,Collecting Duct Carcinoma of the Kidney,0
2848,Down Syndrome,Unfavorable Non-Hodgkin Lymphoma,0
2849,Fatigue,Human Papillomavirus-Related Carcinoma,0
2850,Collection (action),Human Papillomavirus-Related Carcinoma,0
2851,Highest,Cancer of Urinary Tract,0
2852,Old,Benign Apocrine Neoplasm,0
2853,Occur (action),Werner Syndrome,0
2854,Urinary Bladder,Malignant melanoma of eyelid,0
2855,Intravascular line,High Grade Glandular Intraepithelial Neoplasia,0
2856,Due to,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
2857,Morphology,Anterior Urethral Malignant Neoplasm,0
2858,Body tissue,Colorectal Neuroendocrine Tumor G2,0
2859,Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire,Metastatic Malignant Neoplasm in the Sellar Region,0
2860,100%,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2861,Overall Publication Type,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2862,Morphology,Contact dermatitis due to alkali,0
2863,Formation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2864,Group A (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
2865,Very Much,Maxillary Sinus Adenocarcinoma,0
2866,Fever,Endometrial Small Cell Carcinoma,0
2867,invasive cancer,Lipoma of small intestine,0
2868,See,Stage 0 Penile Cancer AJCC v8,0
2869,NCI CTEP SDC Small Cell Lung Cancer Sub-Category Terminology,Extracranial Neuroblastoma,0
2870,Triggered by,Lipoma of small intestine,0
2871,Medical Imaging,Diffuse malignant mesothelioma,0
2872,Self,Recurrent Testicular Lymphoma,0
2873,Aggressive course,Methotrexate-Associated Hodgkin Lymphoma,0
2874,Non-Small Cell Lung Carcinoma,Ovarian germ cell choriocarcinoma stage IV,0
2875,Primary malignant neoplasm,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2876,Science of genetics,Serous cystadenocarcinoma ovary,0
2877,Urine,Intestinal Metaplasia of Bladder Urothelium,0
2878,Examination of pharynx,Familial Hemophagocytic Lymphocytosis,0
2879,Percent (qualifier value),non-Hodgkin's lymphoma of spleen,0
2880,Social group,Liver Lymphangioma,0
2881,Name (property) (qualifier value),Locally Advanced Soft Tissue Sarcoma,0
2882,Offspring,Platinum-Resistant Lung Small Cell Carcinoma,0
2883,Include (action),Uterine Cancer,0
2884,Lesion,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2885,Ancestry-Informative Marker,Unfavorable Non-Hodgkin Lymphoma,0
2886,Experimental Result,Undifferentiated Endocervical Sarcoma,0
2887,Bone Marrow,Breast Ductal Adenoma,0
2888,Function (attribute),adenoid cystic carcinoma of lung,0
2889,Metaplasia,Colorectal High Grade B-Cell Lymphoma,0
2890,Units Of Measure - bel,Atypical Lobular Breast Hyperplasia,0
2891,Formation,Chronic Myelomonocytic Leukemia-2,0
2892,Physical Appearance,Recurrent Testicular Lymphoma,0
2893,Pelvis+,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2894,Cardiovascular system,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2895,No status change,Undifferentiated Endocervical Sarcoma,0
2896,removal technique,Stage I Adult Non-Hodgkin Lymphoma,0
2897,Nicotiana,Pancreatic Intraepithelial Neoplasia-3,0
2898,CD69 wt Allele,adenosquamous carcinoma of breast,0
2899,Relationships,BRCA2 Syndrome,0
2900,Separated from cohabitee,Lipoma of small intestine,0
2901,Physical findings,Advanced Uterine Corpus Carcinosarcoma,0
2902,Body tissue,Mucinous adenocarcinoma gastric,0
2903,Pelvic Pain,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2904,Genus Homo,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2905,Deeply,Stage IB Pancreatic Cancer AJCC v8,0
2906,Include (action),carcinoma of middle ear,0
2907,Assortment,Leiomyoma of Gallbladder,0
2908,Neuroendocrine Tumors,Thymic Atypical Carcinoid Tumor,0
2909,Changing,Unfavorable Non-Hodgkin Lymphoma,0
2910,1950s,Localized Ewing Sarcoma,0
2911,Fasting,embryonal rhabdomyosarcoma of prostate,0
2912,Human body structure,Granular Cell Leiomyosarcoma,0
2913,corticosteroids cream,Mucinous adenocarcinoma gastric,0
2914,Negation,Stage IV Childhood Non-Hodgkin Lymphoma,0
2915,Formation,Stage IV Penile Cancer AJCC v7,0
2916,Swollen Lymph Node,Medulloblastoma,0
2917,Incidence,Malignant melanoma of eyelid,0
2918,Orthologous Gene,Childhood Choriocarcinoma,0
2919,Category Type,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2920,Negation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2921,Occurrence,Neonatal leukemia,0
2922,Therapeutic procedure,Breast Ductal Adenoma,0
2923,Term (temporal),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2924,Medical Imaging,Cerebral Primitive Neuroectodermal Tumor,0
2925,Possibly Related to Intervention,Childhood Lymphoma,0
2926,Version (morphologic abnormality),Lipoma of small intestine,0
2927,Cell Count,Serous cystadenocarcinoma ovary,0
2928,Topical form corticosteroids,Unresectable Rhabdomyosarcoma,0
2929,Alcohol consumption,Diffuse malignant mesothelioma,0
2930,Symptoms,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2931,Variable (uniformity),Sarcomatoid Renal Cell Carcinoma,0
2932,Response to treatment,Acantholytic squamous cell carcinoma,0
2933,Occur (action),Childhood Lymphoma,0
2934,What subject filter - Result,Lipoma of small intestine,0
2935,Future,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2936,Junction Device,malignant lymphoma of pancreatic lymph nodes,0
2937,Cerebrospinal Fluid,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2938,Mucoepidermoid Carcinoma,benign mature teratoma of pancreas,0
2939,Childhood Non-Hodgkin Lymphoma,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2940,Tired,Thymic Atypical Carcinoid Tumor,0
2941,Act Mood - intent,Acute Undifferentiated Leukemia,0
2942,Most,Primary Cutaneous Plasmablastic Lymphoma,0
2943,Common Specifications in HL7 V3 Publishing,Pilocytic astrocytoma of cerebellum,0
2944,Bone Infection,Anaplastic large cell lymphoma,0
2945,Cancer Genus,Acute Undifferentiated Leukemia,0
2946,combination - answer to question,Localized Askin Tumor,0
2947,Translocation of object,Recurrent Uveal Melanoma,0
2948,Person 2,Blepharal carcinoma,0
2949,Injury due to exposure to external cause,Adult Alveolar Soft Part Sarcoma,0
2950,Appearance,Malignant neoplasm of thalamus,0
2951,Name (property) (qualifier value),Undifferentiated Endocervical Sarcoma,0
2952,Etiology aspects,Clonal Hematopoiesis of Indeterminate Potential,0
2953,Usually,Digestive System Hodgkin Lymphoma,0
2954,Woman,Rhabdomyosarcoma with ganglionic differentiation,0
2955,New Zealand,Malignant melanoma of eyelid,0
2956,Usual,Breast Ductal Adenoma,0
2957,Skin,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2958,treatment - ActInformationManagementReason,Placental aromatase deficiency,0
2959,Body structure,Pancreatic Intraepithelial Neoplasia-3,0
2960,<90,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2961,Rare,FIGO Stage II Ovarian Cancer,0
2962,Solid,Pancreatic Intraepithelial Neoplasia-3,0
2963,Specific qualifier value,Blepharal carcinoma,0
2964,Characteristics,Childhood Central Nervous System Immature Teratoma,0
2965,*Type - Kind of quantity,Testicular cancer metastatic,0
2966,Social group,Malignant neoplasm of choroid,0
2967,Pancreatic Intraductal Papillary Mucinous Neoplasm,Cerebral hemangioma,0
2968,Severe (severity modifier),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2969,Excretory function,Non-Metastatic Gestational Trophoblastic Tumor,0
2970,Basal Cell Cancer,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2971,Characteristics,Colorectal Neuroendocrine Tumor G2,0
2972,Levels (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
2973,Activities,Thymic Clear Cell Carcinoma,0
2974,site,Stage IV Childhood Non-Hodgkin Lymphoma,0
2975,Child,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2976,Excessive,Digestive System Hodgkin Lymphoma,0
2977,Glandular,Heavy Chain Deposition Disease,0
2978,Breathing Distress Question,Maxillary Sinus Adenocarcinoma,0
2979,flower allergenic extracts,Anaplastic large cell lymphoma,0
2980,Sweating,Stage III Adult Immunoblastic Lymphoma,0
2981,avoidance,Maxillary Sinus Adenocarcinoma,0
2982,Vaginal intraepithelial neoplasia,Refractory Barrett Esophagus,0
2983,Cover - action,Endometrial Small Cell Carcinoma,0
2984,Usual,Human Papillomavirus-Related Carcinoma,0
2985,Intermediate,Recurrent Testicular Lymphoma,0
2986,Central,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2987,Have Been Vomiting,Mucinous adenocarcinoma gastric,0
2988,Continuance of life,Ichthyoses,0
2989,Manufactured form,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2990,Lineage,Serous cystadenocarcinoma ovary,0
2991,Null cell,Undifferentiated Neuroblastoma,0
2992,Type - attribute,Blepharal carcinoma,0
2993,Mammal liver preparation,malignant lymphoma of pancreatic lymph nodes,0
2994,Usually,Uterine Cancer,0
2995,International Statistical Classification of Diseases and Related Health Problems,Undifferentiated Neuroblastoma,0
2996,Cell Communication,Low Grade Squamous Intraepithelial Neoplasia,0
2997,Type A,Breast Ductal Adenoma,0
2998,Type - attribute,Cerebral Primitive Neuroectodermal Tumor,0
2999,Excision,Leiomyoma of Gallbladder,0
3000,majority,Stage 0 Lip Carcinoma,0
3001,Intestines,Ichthyosis,0
3002,<90,Larynx carcinoma recurrent,0
3003,Males,Human Papillomavirus-Related Carcinoma,0
3004,Financial Account,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3005,Occur (action),Colorectal Neuroendocrine Tumor G2,0
3006,eTMF Content Model Code,Ichthyoses,0
3007,Seventh,Noninfiltrating Intraductal Carcinoma,0
3008,Multiplication,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3009,health and disease,Thymoma malignant recurrent,0
3010,Subject Risk,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3011,Beginning,Cerebral hemangioma,0
3012,Cancer Genus,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3013,Therapeutic procedure,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
3014,Grade,Spermatocytic seminoma,0
3015,depend,Human Papillomavirus-Related Carcinoma,0
3016,Cell Count,Cancer of Urinary Tract,0
3017,SLC6A2 protein,Testicular cancer metastatic,0
3018,Embryonic tissue,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3019,include - SetOperator,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3020,mast cell,squamous cell carcinoma of the thyroid gland,0
3021,Symptoms aspect,Acantholytic squamous cell carcinoma,0
3022,insensitivity,malignant lymphoma of pancreatic lymph nodes,0
3023,Count of entities,Endometrial Small Cell Carcinoma,0
3024,Therapeutic radiology procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3025,Confirmed by,FIGO Stage II Ovarian Cancer,0
3026,Body surface,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3027,How Often Weight Loss,Intraepithelial Melanocytic Hyperplasia,0
3028,Human body,Neoplasms,0
3029,Cells panel,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3030,Logical Condition,Mastocytosis,0
3031,Dental caries,Non-Metastatic Gestational Trophoblastic Tumor,0
3032,Squamous cell carcinoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3033,depend,Localized Askin Tumor,0
3034,Chemotherapy,non-Hodgkin's lymphoma of spleen,0
3035,Pylorus,Anterior Urethral Malignant Neoplasm,0
3036,Pilocytic Astrocytoma,Refractory Barrett Esophagus,0
3037,System - kit,Intestinal Metaplasia of Bladder Urothelium,0
3038,Anterior portion of neck,Extracranial Neuroblastoma,0
3039,Abnormal,papillary carcinoma of penis,0
3040,Including (qualifier),Platinum-Resistant Lung Small Cell Carcinoma,0
3041,Benign Neoplasm,Recurrent Uveal Melanoma,0
3042,1+ Score,Digestive System Hodgkin Lymphoma,0
3043,Therapeutic procedure,Locally Advanced Soft Tissue Sarcoma,0
3044,Several,Stage IV Childhood Non-Hodgkin Lymphoma,0
3045,CDISC SEND Tumor Findings Results Terminology,Malignant Testicular Sertoli Cell Tumor,0
3046,+5,Acute lymphadenitis,0
3047,Humor therapy,FIGO Stage II Ovarian Cancer,0
3048,Precancerous Conditions,squamous cell carcinoma of the thyroid gland,0
3049,Diameter (qualifier value),Acantholytic squamous cell carcinoma,0
3050,Rare,Stage I Adult Non-Hodgkin Lymphoma,0
3051,Pancreas,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
3052,Form:Finding:Point in time:{Setting}:Document:{Role},Childhood Fibrillary Astrocytoma,0
3053,Building caretaker,Uterine Cancer,0
3054,Symptoms,Rhabdomyosarcoma with ganglionic differentiation,0
3055,Obesity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3056,Cessation of life,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3057,Recurrence,Xeroderma pigmentosum,0
3058,Entity Determiner - specific,Endometrial Small Cell Carcinoma,0
3059,Supernumerary,BRCA2 Syndrome,0
3060,Cancer Remission,Low Grade Squamous Intraepithelial Neoplasia,0
3061,Color,adenoid cystic carcinoma of lung,0
3062,Secondary tumor site,Digestive System Hodgkin Lymphoma,0
3063,oncology field,Stage IB Pancreatic Cancer AJCC v8,0
3064,Acquired phimosis,Choroid Necrotic Melanoma,0
3065,melanoma,Contact dermatitis due to alkali,0
3066,Face,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3067,Common Specifications in HL7 V3 Publishing,Neonatal leukemia,0
3068,Base - General Qualifier,Placental aromatase deficiency,0
3069,Pressure (property),Neonatal leukemia,0
3070,Beginning,Female Breast Carcinoma,0
3071,size,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3072,Stop brand of fluoride,Malignant Testicular Sertoli Cell Tumor,0
3073,Financial Account,Acute Undifferentiated Leukemia,0
3074,Targeted Therapy,Diffuse malignant mesothelioma,0
3075,Overall Publication Type,Atypical Mesothelial Hyperplasia,0
3076,Intestinal metaplasia,Carcinoma of urinary bladder,0
3077,Neuroendocrine Tumors,Stage I Adult Non-Hodgkin Lymphoma,0
3078,United States Food and Drug Administration,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3079,Discover,Acantholytic squamous cell carcinoma,0
3080,Very Much,Chronic Myelomonocytic Leukemia-2,0
3081,Form:Finding:Point in time:{Setting}:Document:{Role},Carcinoma ex pleomorphic adenoma of parotid gland,0
3082,Superkingdom (taxonomic category),Primary Cutaneous Plasmablastic Lymphoma,0
3083,Measurement,Malignant neoplasm of choroid,0
3084,Including (qualifier),Childhood Thyroid Gland Follicular Carcinoma,0
3085,Numbers,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3086,Anatomic Node,Stage I Adult Non-Hodgkin Lymphoma,0
3087,Biologist (general),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3088,Country number:Find:Pt:^Patient:Nom,Placental aromatase deficiency,0
3089,Neck,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3090,Defense,Angiosarcoma of liver,0
3091,Hematologic Tests,Choroid Necrotic Melanoma,0
3092,Lymphoid Tissue,Testicular cancer metastatic,0
3093,radiotherapeutic,Serous cystadenocarcinoma ovary,0
3094,Common (qualifier value),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3095,Account number:Identifier:Point in time:^Patient:Nominal,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3096,Papillomaviridae,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3097,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Carcinoma of urinary bladder,0
3098,Inguinal region,Airway Hemangioma,0
3099,Sacrifice,Mucinous adenocarcinoma gastric,0
3100,risk factors,Chondrosarcoma,0
3101,{Setting},Primary Cutaneous Plasmablastic Lymphoma,0
3102,Death (finding),sarcoma of spinal cord,0
3103,Tiredness Visual Analogue Scale,Undifferentiated Endocervical Sarcoma,0
3104,research,Thymic Clear Cell Carcinoma,0
3105,Estrogens,Stage IV Penile Cancer AJCC v7,0
3106,Body tissue,Adult Alveolar Soft Part Sarcoma,0
3107,shared attribute,Endometrial Small Cell Carcinoma,0
3108,risk factors - observation list,Digestive System Hodgkin Lymphoma,0
3109,Formation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3110,Involvement with,sarcoma of spinal cord,0
3111,How Much Distress Sweats,Leiomyoma of Gallbladder,0
3112,Syphilis,embryonal rhabdomyosarcoma of prostate,0
3113,Primary operation,Xeroderma pigmentosum,0
3114,Does swallow,sarcoma of spinal cord,0
3115,Occur (action),malignant lymphoma of pancreatic lymph nodes,0
3116,2+,adenosquamous carcinoma of breast,0
3117,Tumor Mass,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3118,Ovarian Germ Cell Tumor,FIGO Stage II Ovarian Cancer,0
3119,Males,adenoid cystic carcinoma of lung,0
3120,Known,Stage 0 Penile Cancer AJCC v8,0
3121,LATS1 gene,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3122,3+ Answer to Question,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3123,Base - General Qualifier,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3124,Object Class,Cancer of Urinary Tract,0
3125,Clear,Liver Lymphangioma,0
3126,80%,Larynx carcinoma recurrent,0
3127,Unit - NCI Thesaurus Property,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3128,Anorectal Malformations,Adrenal Rest Tumor,0
3129,form name,squamous cell carcinoma of the thyroid gland,0
3130,Original Regulatory Submission,Adenocarcinoma,0
3131,Cells,Airway Hemangioma,0
3132,Special,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3133,Cancer stage iv,Refractory Barrett Esophagus,0
3134,Diagnosis,Uterine Cancer,0
3135,Cancer Other,Stage IV Childhood Non-Hodgkin Lymphoma,0
3136,Beginning,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3137,Carcinoma in Situ,Low Grade Squamous Intraepithelial Neoplasia,0
3138,Shortness of Breath Visual Analogue Scale,Colorectal cancer,0
3139,Referring,GIANT PIGMENTED HAIRY NEVUS,0
3140,Diagnosis Study,Childhood Thyroid Gland Follicular Carcinoma,0
3141,Progress,Intraepithelial Melanocytic Hyperplasia,0
3142,Treatment Epoch,Localized Askin Tumor,0
3143,Mutation Abnormality,FIGO Stage II Ovarian Cancer,0
3144,Biologic Development,Ichthyosis,0
3145,Capsule (unit of presentation),Ovarian germ cell choriocarcinoma stage IV,0
3146,Basis - conceptual entity,Anaplastic large cell lymphoma,0
3147,Recent,Refractory Barrett Esophagus,0
3148,Exposure to radiation,Colorectal Neuroendocrine Tumor G2,0
3149,Sore Throat,Liver Cavernous Hemangioma,0
3150,Most,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3151,Pallor of skin,Undifferentiated Neuroblastoma,0
3152,Birth,Undifferentiated Neuroblastoma,0
3153,Site,Ichthyosis,0
3154,Liver Flavor,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3155,Intestines,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3156,Young Adult,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3157,Surface of brain,Airway Hemangioma,0
3158,shared attribute,Intracortical osteosarcoma,0
3159,Malignant Squamous Cell Neoplasm,Acute lymphadenitis,0
3160,Analysis,Mucinous adenocarcinoma gastric,0
3161,Malignant neoplasm of soft tissue,Extra-Adrenal Paraganglioma,0
3162,Lung,Ovarian germ cell choriocarcinoma stage IV,0
3163,Superkingdom (taxonomic category),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3164,Anatomic structures,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3165,Symptoms aspect,Anaplastic large cell lymphoma,0
3166,Activation action,Cerebral Primitive Neuroectodermal Tumor,0
3167,Carcinoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3168,Variant,Neoplasms,0
3169,Occur (action),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3170,Etiology aspects,mucinous adenocarcinoma of gallbladder,0
3171,contextual factors,Localized Askin Tumor,0
3172,Often - answer to question,FIGO Stage II Ovarian Cancer,0
3173,Exostoses,FIGO Stage II Ovarian Cancer,0
3174,Microplate Well,Hemangioma,0
3175,Skin lesion,Unfavorable Non-Hodgkin Lymphoma,0
3176,2+ Score,Unresectable Rhabdomyosarcoma,0
3177,Greasy skin,Thymoma malignant recurrent,0
3178,Plasma,Ovarian Carcinoid Tumor,0
3179,30%,adenosquamous carcinoma of breast,0
3180,Covers (device),Sarcomatoid Renal Cell Carcinoma,0
3181,Togo,Acantholytic squamous cell carcinoma,0
3182,Death NOS,Pilocytic astrocytoma of cerebellum,0
3183,B-Cell Lymphomas,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3184,Persons,Advanced Uterine Corpus Carcinosarcoma,0
3185,Senile Plaques,Localized Askin Tumor,0
3186,survival aspects,Mucinous cystadenofibroma,0
3187,Drain device,Benign tumor of eyelid,0
3188,HLA Class II Histocompatibility Antigen Gamma Chain,Giant cell angiofibroma,0
3189,Fasting Status Indicator,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3190,Prognosis:Find:Pt:^Patient:Nom,Placental aromatase deficiency,0
3191,Name (property) (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3192,Call (Instruction),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3193,Symptoms aspect,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3194,Serving,Digestive System Hodgkin Lymphoma,0
3195,Bruising,FIGO Stage II Ovarian Cancer,0
3196,To,Airway Hemangioma,0
3197,Response Likelihood,adenosquamous carcinoma of breast,0
3198,To,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3199,Estimated,Granular Cell Leiomyosarcoma,0
3200,Administration procedure,Extracranial Neuroblastoma,0
3201,Immune system,Xeroderma pigmentosum,0
3202,Suspected qualifier,Acute lymphadenitis,0
3203,Platelets,Stage IB Pancreatic Cancer AJCC v8,0
3204,Including (qualifier),Adenocarcinoma of the prostate metastatic,0
3205,Mature,Uterine Cancer,0
3206,dendritic spine neck,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3207,Most,Cerebral Primitive Neuroectodermal Tumor,0
3208,Smoking,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3209,Function Axis,Tonsillar Carcinoma,0
3210,Cell Count,Uterine Cancer,0
3211,Disease susceptibility,Testicular cancer metastatic,0
3212,In Blood,Intestinal Neuroendocrine Carcinoma,0
3213,Increase,Adult Hepatocellular Carcinoma,0
3214,Therapeutic radiology procedure,Anterior Urethral Malignant Neoplasm,0
3215,Childhood Soft Tissue Sarcoma,Testicular cancer metastatic,0
3216,Symptoms aspect,Recurrent Uveal Melanoma,0
3217,World Health Organization,Cartilaginous exostosis,0
3218,Tryptophanase,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3219,Stem cell transplant,Localized Askin Tumor,0
3220,Growth abnormality,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3221,Site of,FIGO Stage II Ovarian Cancer,0
3222,Hematuria,Werner Syndrome,0
3223,Chromosomes,Extracranial Neuroblastoma,0
3224,monoclonal,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3225,Cessation of life,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3226,Cell Count,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3227,Patterns,Clonal Hematopoiesis of Indeterminate Potential,0
3228,biopsy characteristics,gliosarcoma,0
3229,Decision,Neonatal leukemia,0
3230,Better,Pancreatic Intraepithelial Neoplasia-3,0
3231,Aspects of signs,Hodgkin lymphoma,0
3232,Iodides,Placental aromatase deficiency,0
3233,Importance Weight,Childhood Central Nervous System Immature Teratoma,0
3234,Several,Adrenal Rest Tumor,0
3235,GUCY2C wt Allele,BRCA2 Syndrome,0
3236,Probably,Intestinal Metaplasia of Bladder Urothelium,0
3237,Physical Medical Procedure,mucinous adenocarcinoma of gallbladder,0
3238,Easy bleeding,Carcinoma ex pleomorphic adenoma of parotid gland,0
3239,contact person,Female Breast Carcinoma,0
3240,Group A (blood group),Unfavorable Non-Hodgkin Lymphoma,0
3241,shared attribute,Secondary malignant neoplasm of lymph node,0
3242,Before,Human Papillomavirus-Related Carcinoma,0
3243,Symptoms aspect,Hemangioma,0
3244,Consistency,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3245,Penis carcinoma,Cancer of Urinary Tract,0
3246,Diagnosis Study,Non-Metastatic Gestational Trophoblastic Tumor,0
3247,Pharmaceutical Preparations,Stage IB Pancreatic Cancer AJCC v8,0
3248,Recombinant Immune Globulin,FIGO Stage II Ovarian Cancer,0
3249,Usual,Mixed parotid tumor,0
3250,Etiology aspects,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3251,Derived value,Mucinous adenocarcinoma gastric,0
3252,Advance,Benign tumor of eyelid,0
3253,Term Birth,Recurrent Testicular Lymphoma,0
3254,best (quality),Stage III Adult Immunoblastic Lymphoma,0
3255,Glycation End Products,Xeroderma pigmentosum,0
3256,Skeletal system,Unresectable Rhabdomyosarcoma,0
3257,Low Mitosis-Karyorrhexis Index,Diffuse malignant mesothelioma,0
3258,Term (lexical),Recurrent Uveal Melanoma,0
3259,Tired,Malignant melanoma of eyelid,0
3260,Wild,Methotrexate-Associated Hodgkin Lymphoma,0
3261,diagnosis aspect,Heavy Chain Deposition Disease,0
3262,How Often Felt Normal question,Chondrosarcoma,0
3263,Location,Intraepithelial Melanocytic Hyperplasia,0
3264,Mutation Abnormality,Adenocarcinoma,0
3265,Mediator brand of benfluorex hydrochloride,Secondary malignant neoplasm of lymph node,0
3266,Childhood Lymphoma,Cancer of Urinary Tract,0
3267,Has difficulty doing (qualifier value),Ovarian germ cell choriocarcinoma stage IV,0
3268,Qualitative form,Acantholytic squamous cell carcinoma,0
3269,Treating,squamous cell carcinoma of the thyroid gland,0
3270,Direct (qualifier),Testicular cancer metastatic,0
3271,Leads (device),Female Breast Carcinoma,0
3272,Covers (device),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3273,criteria,Recurrent Testicular Lymphoma,0
3274,Case unit dose,Non-Metastatic Gestational Trophoblastic Tumor,0
3275,Woman,Mucinous adenocarcinoma gastric,0
3276,High,Neonatal leukemia,0
3277,Lymphadenopathy,Acantholytic squamous cell carcinoma,0
3278,Negation,Pancreatic Intraepithelial Neoplasia-3,0
3279,Characteristics,Testicular cancer metastatic,0
3280,Referring,FIGO Stage II Ovarian Cancer,0
3281,fluid - substance,Adult Hepatocellular Carcinoma,0
3282,section sample,Cancer of Urinary Tract,0
3283,risk factors - observation list,Liver Lymphangioma,0
3284,Patient currently pregnant,Localized Ewing Sarcoma,0
3285,Empty (qualifier),Intracortical osteosarcoma,0
3286,Risk,Extracranial Neuroblastoma,0
3287,Occurrence Indicator,Airway Hemangioma,0
3288,Common Specifications in HL7 V3 Publishing,Platinum-Resistant Lung Small Cell Carcinoma,0
3289,Room of building - Study,Diffuse malignant mesothelioma,0
3290,Case (situation),Locally Advanced Soft Tissue Sarcoma,0
3291,Location,Maxillary Sinus Adenocarcinoma,0
3292,Type - attribute,Childhood Fibrillary Astrocytoma,0
3293,Intestines,Colorectal Neuroendocrine Tumor G2,0
3294,Frequently,embryonal rhabdomyosarcoma of prostate,0
3295,International Statistical Classification of Diseases and Related Health Problems,Endometrial Small Cell Carcinoma,0
3296,>5,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3297,Patient Condition Code - Stable,Locally Advanced Soft Tissue Sarcoma,0
3298,Symptoms,Cerebral Primitive Neuroectodermal Tumor,0
3299,MOSTLY,Digestive System Hodgkin Lymphoma,0
3300,Surgical extraction,Fourth Ventricle and Brain Stem Ependymal Tumor,0
3301,Treatment Epoch,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3302,contextual factors,Neoplasms,0
3303,Special,Recurrent Testicular Lymphoma,0
3304,Common Specifications in HL7 V3 Publishing,Leiomyoma of Gallbladder,0
3305,Financial Account,Tonsillar Carcinoma,0
3306,Diagnostic Neoplasm Staging,adenosquamous carcinoma of breast,0
3307,Double eyelid,Ovarian Carcinoid Tumor,0
3308,Negation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3309,Symptoms aspect,Methotrexate-Associated Hodgkin Lymphoma,0
3310,Anaplastic astrocytoma,Acantholytic squamous cell carcinoma,0
3311,Platelet Glycoprotein 4,Ovarian germ cell choriocarcinoma stage IV,0
3312,Interpretation:Impression/interpretation of study:Point in time:^Patient:Nominal,Stage III Adult Immunoblastic Lymphoma,0
3313,various other agents for local oral treatment in ATC,Testicular cancer metastatic,0
3314,Back Pain,Advanced Lung Carcinoma,0
3315,Metastasis,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3316,Patient Discharge,Giant cell angiofibroma,0
3317,Grouped (foundation metadata concept),Lipoma of small intestine,0
3318,Report (document),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3319,Long-term,Endometrial Small Cell Carcinoma,0
3320,Acetic Acid,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3321,Pruritus,Malignant Neoplasm with Regional Lymph Node Involvement,0
3322,Ultrasonic Shockwave,Leptomeningeal sarcoma,0
3323,Experimental Result,Serous cystadenocarcinoma ovary,0
3324,various antiinfectives and antiseptics for local oral treatment,sarcoma of spinal cord,0
3325,Vaginal (intended site),Metastatic Malignant Neoplasm in the Sellar Region,0
3326,Adult human body,Adult Fibrolamellar Carcinoma,0
3327,T prime,Pancreatic Intraepithelial Neoplasia-3,0
3328,65,Granular Cell Leiomyosarcoma,0
3329,Very,embryonal rhabdomyosarcoma of prostate,0
3330,Diagnosis Study,High Grade Glandular Intraepithelial Neoplasia,0
3331,Operative Surgical Procedures,Mucinous adenocarcinoma gastric,0
3332,Severe (severity modifier),squamous cell carcinoma of the thyroid gland,0
3333,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Thymic Clear Cell Carcinoma,0
3334,Monitoring Device,Recurrent Uveal Melanoma,0
3335,Often - answer to question,Diffuse malignant mesothelioma,0
3336,One,Breast Ductal Adenoma,0
3337,Semilunar fold of fauces,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3338,Worse,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3339,gene therapy,Malignant melanoma of eyelid,0
3340,Have Itch,Secondary malignant neoplasm of lymph node,0
3341,Poor - qualifier,Testicular cancer metastatic,0
3342,Kidney,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3343,NCI CTEP SDC Melanoma Sub-Category Terminology,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3344,Procedures involving the use of pharmaceuticals,Spongiotic dermatitis,0
3345,International Classification of Diseases,Adult Alveolar Soft Part Sarcoma,0
3346,cell growth,Medulloblastoma,0
3347,Measured,Platinum-Resistant Lung Small Cell Carcinoma,0
3348,Interventional procedure,Angiosarcoma of liver,0
3349,Hematologic Tests,Diffuse malignant mesothelioma,0
3350,Average,Diffuse malignant mesothelioma,0
3351,How Often Shortness of Breath,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3352,diagnosis aspect,Intestinal Metaplasia of Bladder Urothelium,0
3353,Term (lexical),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3354,Term (lexical),benign mature teratoma of pancreas,0
3355,Hyperplasia,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3356,Tissue specific,Liver Lymphangioma,0
3357,Difficult (qualifier value),Ovarian germ cell choriocarcinoma stage IV,0
3358,Advanced phase,Stage III Adult Immunoblastic Lymphoma,0
3359,Relative Survival,Endometrial Small Cell Carcinoma,0
3360,Less Than,Non-Metastatic Gestational Trophoblastic Tumor,0
3361,Vaginal,FIGO Stage II Ovarian Cancer,0
3362,Science of Etiology,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3363,10%,non-Hodgkin's lymphoma of spleen,0
3364,Abnormal Reference Range,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3365,Long-term,Neoplasms,0
3366,Chemotherapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3367,Race,Thymic Clear Cell Carcinoma,0
3368,Germ Cells,Pancreatic Intraepithelial Neoplasia-3,0
3369,Entity Determiner - specific,Heavy Chain Deposition Disease,0
3370,Due to,papillary carcinoma of penis,0
3371,various other agents for local oral treatment in ATC,Adult Alveolar Soft Part Sarcoma,0
3372,List,Platinum-Resistant Lung Small Cell Carcinoma,0
3373,Sex Behavior,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3374,Decision,Testicular cancer metastatic,0
3375,per year,Benign neoplasm of thorax,0
3376,fibroma,Stage IV Childhood Non-Hodgkin Lymphoma,0
3377,Group A (qualifier value),Diffuse malignant mesothelioma,0
3378,Metastasis,Cerebral hemangioma,0
3379,Low Grade,malignant lymphoma of pancreatic lymph nodes,0
3380,respiratory gaseous exchange in organisms,Primary Cutaneous Plasmablastic Lymphoma,0
3381,Carcinoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
3382,Adult human body,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3383,Adult Lymphoma,Pancreatic Intraepithelial Neoplasia-3,0
3384,Rate,Sarcomatoid Renal Cell Carcinoma,0
3385,Name (property) (qualifier value),Extracranial Neuroblastoma,0
3386,Present,Refractory Barrett Esophagus,0
3387,Patch (unit of presentation),Botryoid-Type Embryonal Rhabdomyosarcoma,0
3388,In Cerebrospinal Fluid,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3389,Appearance,Recurrent Testicular Lymphoma,0
3390,Include (action),Bladder squamous cell carcinoma stage I,0
3391,Diarrhea,Angiosarcoma of liver,0
3392,SLC6A2 wt Allele,Metastatic Malignant Neoplasm in the Sellar Region,0
3393,Diagnosis Study,Childhood Fibrillary Astrocytoma,0
3394,Common Cold,Spongiotic dermatitis,0
3395,Structure of collecting tubule,Extra-Adrenal Paraganglioma,0
3396,Affecting,Low Grade Squamous Intraepithelial Neoplasia,0
3397,Adverse effects,Adenocarcinoma of the prostate metastatic,0
3398,Asians,Malignant melanoma of eyelid,0
3399,Abnormal host response,Bladder squamous cell carcinoma stage I,0
3400,Application Context,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
3401,Web Site,Malignant melanoma of eyelid,0
3402,Megakaryocyte Count,Acantholytic squamous cell carcinoma,0
3403,Related personal status,Urethral Carcinoma,0
3404,Therapeutic radiology procedure,Childhood Fibrillary Astrocytoma,0
3405,Used by,Benign Apocrine Neoplasm,0
3406,Involvement with,Metastatic Neoplasm to the Gallbladder,0
3407,Usual Severity Weight Loss,Digestive System Hodgkin Lymphoma,0
3408,biopsy characteristics,embryonal rhabdomyosarcoma of prostate,0
3409,Telephone Extension Number,Giant cell angiofibroma,0
3410,What subject filter - Result,FIGO Stage II Ovarian Cancer,0
3411,Tobacco,Metastatic Ductal Breast Carcinoma,0
3412,newly,Cerebral Primitive Neuroectodermal Tumor,0
3413,Pediculus humanus capitis (eukaryote),Lung squamous cell carcinoma stage I,0
3414,ultrasound device,Acute lymphadenitis,0
3415,T-Lymphocyte,Platinum-Resistant Lung Small Cell Carcinoma,0
3416,Greater than one,squamous cell carcinoma of the thyroid gland,0
3417,CEL gene,embryonal rhabdomyosarcoma of prostate,0
3418,Pain in scrotum,Stage IV Penile Cancer AJCC v7,0
3419,Supernumerary,Recurrent Diffuse Intrinsic Pontine Glioma,0
3420,various other nasal preparations in ATC,Spongiotic dermatitis,0
3421,Cessation of life,Angiosarcoma of liver,0
3422,Lymph,Childhood Fibrillary Astrocytoma,0
3423,Part of,Stage IB Lung Cancer AJCC v7,0
3424,Affect (mental function),embryonal rhabdomyosarcoma of prostate,0
3425,Cavern,Malignant melanoma of eyelid,0
3426,Patient need for (contextual qualifier),Heavy Chain Deposition Disease,0
3427,Possible diagnosis,Ovarian germ cell choriocarcinoma stage IV,0
3428,biopsy characteristics,Grade 3a Malignant Neoplasm,0
3429,New,Intestinal Metaplasia of Bladder Urothelium,0
3430,Term (lexical),Ovarian germ cell choriocarcinoma stage IV,0
3431,Short Value,Female Breast Carcinoma,0
3432,Diagnostic tests,Intraepithelial Melanocytic Hyperplasia,0
3433,Low Level,Undifferentiated Endocervical Sarcoma,0
3434,Literature,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3435,Aspects of disease screening,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
3436,Child,Bladder squamous cell carcinoma stage I,0
3437,Phrase,Mastocytosis,0
3438,Including (qualifier),Adenocarcinoma of the prostate metastatic,0
3439,Occur (action),Undifferentiated Neuroblastoma,0
3440,shared attribute,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3441,Abdominal Cavity,Benign Apocrine Neoplasm,0
3442,CEL gene,Mucinous adenocarcinoma gastric,0
3443,Weight decreased,Ovarian germ cell choriocarcinoma stage IV,0
3444,Overall,Malignant Testicular Sertoli Cell Tumor,0
3445,Lymph,Chondrosarcoma,0
3446,year,Metastatic Malignant Neoplasm in the Sellar Region,0
3447,Prenatal care,Female Breast Carcinoma,0
3448,Comprehension,Recurrent Testicular Lymphoma,0
3449,Entire ear,Familial Hemophagocytic Lymphocytosis,0
3450,Abdomen,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3451,Usually,Thymic Clear Cell Carcinoma,0
3452,Type - attribute,Pancreatic Intraepithelial Neoplasia-3,0
3453,Reverse,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3454,Type - attribute,Anterior Urethral Malignant Neoplasm,0
3455,Adenocarcinoma,Chondrosarcoma,0
3456,Bone Pain,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3457,Common Specifications in HL7 V3 Publishing,Benign neoplasm of thorax,0
3458,Surgery specialty,Chondrosarcoma,0
3459,Platelets Product,mucinous adenocarcinoma of gallbladder,0
3460,Vaccinated (qualifier),Mucinous neoplasm,0
3461,Medical,Xeroderma pigmentosum,0
3462,Testicular Germ Cell Tumor,Acantholytic squamous cell carcinoma,0
3463,Muscle Tissue,Childhood Thyroid Gland Follicular Carcinoma,0
3464,Administration procedure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3465,Manufactured form,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3466,Case unit dose,Stage III Adult Immunoblastic Lymphoma,0
3467,Blood Vessel,Stage IV Childhood Non-Hodgkin Lymphoma,0
3468,Surrounding (qualifier value),BRCA2 Syndrome,0
3469,Muscle Tissue,Acute Undifferentiated Leukemia,0
3470,Initially,Contact dermatitis due to alkali,0
3471,Cell Invasion,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3472,VIPR1 wt Allele,Diffuse malignant mesothelioma,0
3473,Common (qualifier value),Mucinous adenocarcinoma gastric,0
3474,Pleural Effusion,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3475,Unlikely,Contact dermatitis due to alkali,0
3476,include - SetOperator,Anterior Urethral Malignant Neoplasm,0
3477,Known,Benign tumor of eyelid,0
3478,Improved,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3479,Pith - plant part,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
3480,Cancer Genus,Clonal Hematopoiesis of Indeterminate Potential,0
3481,Hemorrhage,Recurrent Testicular Lymphoma,0
3482,Involvement with,Adenocarcinoma,0
3483,Type - attribute,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3484,Greater,Papillary cystic tumor,0
3485,Literature,Acute lymphadenitis,0
3486,Tired,Testicular cancer metastatic,0
3487,Togo,Heavy Chain Deposition Disease,0
3488,Upper,embryonal rhabdomyosarcoma of prostate,0
3489,Cutaneous,Cancer of Urinary Tract,0
3490,cell growth,Clonal Hematopoiesis of Indeterminate Potential,0
3491,Symptoms,Carcinoma of urinary bladder,0
3492,Histological Techniques,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3493,Column (arrangement),sarcoma of spinal cord,0
3494,Slide (glass microscope),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3495,Decision,Prostate Lymphoma,0
3496,medication - HL7 publishing domain,Malignant Testicular Sertoli Cell Tumor,0
3497,Adrenal mass,Acantholytic squamous cell carcinoma,0
3498,Upper abdominal pain,Clonal Hematopoiesis of Indeterminate Potential,0
3499,Plasma Product,Childhood Fibrillary Astrocytoma,0
3500,Techniques,Spongiotic dermatitis,0
3501,Symptoms,Medulloblastoma,0
3502,Leads (device),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3503,Derived value,Acantholytic squamous cell carcinoma,0
3504,Abdominal Cavity,Lung Mucinous Cystadenoma,0
3505,Niobium,Locally Advanced Soft Tissue Sarcoma,0
3506,Thickened,Low Grade Squamous Intraepithelial Neoplasia,0
3507,Double eyelid,Testicular cancer metastatic,0
3508,Ki67 Measurement,mucinous adenocarcinoma of gallbladder,0
3509,Retained,Undifferentiated Endocervical Sarcoma,0
3510,Negation,Keratoderma,0
3511,Linear,Childhood Fibrillary Astrocytoma,0
3512,Tissue Specimen Code,Ovarian germ cell choriocarcinoma stage IV,0
3513,Cancer Registry,Cartilaginous exostosis,0
3514,Vaginal,Ichthyoses,0
3515,Characterization,Carcinoma of urinary bladder,0
3516,pharmacotherapeutic,Testicular cancer metastatic,0
3517,Academic degree,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3518,Killing,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3519,Reflux within Device Medical Device Problem,Undifferentiated Endocervical Sarcoma,0
3520,Simpson Grade 3,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3521,Notch Receptor Intracellular Domain,Metastatic Kidney Carcinoma,0
3522,survive,Noninfiltrating Intraductal Carcinoma,0
3523,Person Name,Methotrexate-Associated Hodgkin Lymphoma,0
3524,Feel Tired question,Benign Carotid Body Paraganglioma,0
3525,Recent,Adenocarcinoma of the prostate metastatic,0
3526,Occur (action),Refractory Barrett Esophagus,0
3527,other medicated shampoos in ATC,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3528,Malignant - descriptor,embryonal rhabdomyosarcoma of prostate,0
3529,HLA Complex,Heavy Chain Deposition Disease,0
3530,Gram per Deciliter,Testicular cancer metastatic,0
3531,Obstruction,Refractory Glioma,0
3532,Administration procedure,Stage II Carcinoma of Penis,0
3533,Term Birth,Neoplasms,0
3534,Mediate,Testicular cancer metastatic,0
3535,Including (qualifier),Stage II Hepatocellular Carcinoma AJCC v8,0
3536,Affecting,Choroid Necrotic Melanoma,0
3537,Followed by,adenoid cystic carcinoma of lung,0
3538,Endocrine Cells,Stage I Adult Non-Hodgkin Lymphoma,0
3539,Numerous,Cancer of Urinary Tract,0
3540,Hepatic Involvement,benign mature teratoma of pancreas,0
3541,Childhood Diffuse Large B-Cell Lymphoma,Rhabdomyosarcoma with ganglionic differentiation,0
3542,Ulcer,Hair nevus,0
3543,Primary,Anterior Urethral Malignant Neoplasm,0
3544,76,Chronic Myelomonocytic Leukemia-2,0
3545,therapeutic aspects,Intraepithelial Melanocytic Hyperplasia,0
3546,Europe,Tonsillar Carcinoma,0
3547,antibody (non-specific) abnormal,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3548,Coding,Human Papillomavirus-Related Carcinoma,0
3549,Entity Determiner - specific,Benign tumor of eyelid,0
3550,3+ Answer to Question,Pancreatic Intraepithelial Neoplasia-3,0
3551,Term (lexical),Angiosarcoma of liver,0
3552,Ankle joint structure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3553,Case unit dose,gliosarcoma,0
3554,Medications:-:Point in time:^Patient:-,Cancer of Urinary Tract,0
3555,Apply (instruction),Adult Hepatocellular Carcinoma,0
3556,Suspected qualifier,Primary Cutaneous Plasmablastic Lymphoma,0
3557,spinal,Malignant Neoplasm with Regional Lymph Node Involvement,0
3558,Mechanism (attribute),Pancreatic Intraepithelial Neoplasia-3,0
3559,Carcinoma,Bladder squamous cell carcinoma stage I,0
3560,Doses of vaccine,Collecting Duct Carcinoma of the Kidney,0
3561,precancerous lesions,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3562,Inflammation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3563,Pieris rapae,Recurrent Testicular Lymphoma,0
3564,Pediculus humanus capitis (eukaryote),Liver Lymphangioma,0
3565,risk factors - observation list,Clonal Hematopoiesis of Indeterminate Potential,0
3566,month,Atypical Lobular Breast Hyperplasia,0
3567,Over (spatial),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3568,>40 years,gliosarcoma,0
3569,To,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3570,Base - General Qualifier,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
3571,Breathing Distress Question,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3572,Medical,Platinum-Resistant Lung Small Cell Carcinoma,0
3573,Infrequent,Fourth Ventricle and Brain Stem Ependymal Tumor,0
3574,Type - attribute,Ovarian germ cell choriocarcinoma stage IV,0
3575,member,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3576,mouth swelling,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3577,treatment - ActInformationManagementReason,gliosarcoma,0
3578,Main,Thymic Clear Cell Carcinoma,0
3579,Distention,Stage 0 Lip Carcinoma,0
3580,Related personal status,Non-Metastatic Gestational Trophoblastic Tumor,0
3581,combination of objects,Localized Ewing Sarcoma,0
3582,Primary malignant neoplasm of endometrium,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3583,Classical Hodgkin's Lymphoma,squamous cell carcinoma of the thyroid gland,0
3584,Wound Healing,Pilocytic astrocytoma of cerebellum,0
3585,Deep (qualifier value),gliosarcoma,0
3586,gene therapy,Recurrent Testicular Lymphoma,0
3587,Cirrhosis,Xeroderma pigmentosum,0
3588,To,Digestive System Hodgkin Lymphoma,0
3589,risk factors - observation list,Atypical Lobular Breast Hyperplasia,0
3590,Age of onset of symptoms:Time:Pt:^Patient:Qn,Recurrent Uveal Melanoma,0
3591,Storage Unit,Giant cell angiofibroma,0
3592,Goblet Cells,Undifferentiated Endocervical Sarcoma,0
3593,Coding,Malignant neoplasm of thalamus,0
3594,Xeroderma Pigmentosum,Metastatic Lung Small Cell Carcinoma,0
3595,Manufactured sign,Mucinous adenocarcinoma gastric,0
3596,Known,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3597,High Mitosis-Karyorrhexis Index,Acute Undifferentiated Leukemia,0
3598,Sodium Cation,Platinum-Resistant Lung Small Cell Carcinoma,0
3599,Increased,Diffuse malignant mesothelioma,0
3600,Neoadjuvant Therapy Clinical Trial Setting,Intestinal Metaplasia of Bladder Urothelium,0
3601,Mathematical Operator,Recurrent Testicular Lymphoma,0
3602,Appearance Distress Question,Recurrent Uveal Melanoma,0
3603,Thrombocythemia,Intraepithelial Melanocytic Hyperplasia,0
3604,Unmarried,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3605,General surgery specialty,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3606,Heart,Cancer of Urinary Tract,0
3607,Intermediate Mitosis-Karyorrhexis Index,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3608,Formation,Recurrent Testicular Lymphoma,0
3609,Cartilage,Mucinous adenocarcinoma gastric,0
3610,Include (action),Stage IB Pancreatic Cancer AJCC v8,0
3611,Intravascular line,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3612,Contain (action),Blepharal carcinoma,0
3613,Family (taxonomic),Acantholytic squamous cell carcinoma,0
3614,Including (qualifier),Stage 0 Penile Cancer AJCC v8,0
3615,Frequently,Methotrexate-Associated Hodgkin Lymphoma,0
3616,Vagina,Non-Metastatic Gestational Trophoblastic Tumor,0
3617,Caucasians,Cancer of Urinary Tract,0
3618,Urinary Tract Infection,Spermatocytic seminoma,0
3619,Night time,Adult Alveolar Soft Part Sarcoma,0
3620,Operative Surgical Procedures,Xeroderma pigmentosum,0
3621,Needs,embryonal rhabdomyosarcoma of prostate,0
3622,Treating,Maxillary Sinus Adenocarcinoma,0
3623,Noninvasive,Larynx carcinoma recurrent,0
3624,Dyspnea,Metastatic Ductal Breast Carcinoma,0
3625,FDA Establishment Activity Terminology,Extracranial Neuroblastoma,0
3626,Cancer Biology,Intraepithelial Melanocytic Hyperplasia,0
3627,Tired,Xeroderma pigmentosum,0
3628,Gut,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3629,Chemotherapy Regimen,Spongiotic dermatitis,0
3630,How Often Nausea,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3631,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3632,Occur (action),Angiosarcoma of liver,0
3633,Sacral dysgenesis,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3634,Data call receiving device,Advanced Lung Carcinoma,0
3635,*Type - Kind of quantity,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3636,Enlargement procedure,Cancer of Urinary Tract,0
3637,Classification of information,Adult Fibrolamellar Carcinoma,0
3638,Unmarried,Stage IB Pancreatic Cancer AJCC v8,0
3639,Immune,Metastatic Malignant Neoplasm in the Sellar Region,0
3640,+2,Intestinal Metaplasia of Bladder Urothelium,0
3641,More,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3642,Value Above Reference Range,Cartilaginous exostosis,0
3643,Covered (qualifier value),Bladder squamous cell carcinoma stage I,0
3644,Curettage procedure,Low Grade Squamous Intraepithelial Neoplasia,0
3645,Glioblastoma,Colorectal High Grade B-Cell Lymphoma,0
3646,Hematopoiesis,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
3647,Adult Diffuse Large B-Cell Lymphoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3648,In addition to,Lipoma of small intestine,0
3649,Symptoms,Adult Hepatocellular Carcinoma,0
3650,Pale color saturation,Acantholytic squamous cell carcinoma,0
3651,Qualitative form,Thymic Clear Cell Carcinoma,0
3652,NCI CTEP SDC Wilms Tumor Sub-Category Terminology,Malignant Neoplasm with Regional Lymph Node Involvement,0
3653,Ocular orbit,Angiosarcoma of liver,0
3654,pharmacotherapeutic,Metastatic Lung Small Cell Carcinoma,0
3655,90%,Intestinal Metaplasia of Bladder Urothelium,0
3656,1+ Score,Colorectal Neuroendocrine Tumor G2,0
3657,Order (arrangement),Refractory Barrett Esophagus,0
3658,Array Feature,Cancer of Urinary Tract,0
3659,1960s,Childhood Fibrillary Astrocytoma,0
3660,DNA index 2,Cancer of Urinary Tract,0
3661,Tryptophanase,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3662,peripheral blood,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3663,Smear - instruction imperative,Malignant Testicular Sertoli Cell Tumor,0
3664,The Sun,Testicular cancer metastatic,0
3665,Neoplasms,Metastatic Malignant Neoplasm in the Sellar Region,0
3666,Done (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3667,Distant,adenoid cystic carcinoma of lung,0
3668,Spreading (qualifier value),Testicular cancer metastatic,0
3669,Time,Metastatic Carcinoma in the Lung,0
3670,Very,Diffuse malignant mesothelioma,0
3671,Involvement with,Female Breast Carcinoma,0
3672,Present,Pancreatic Intraepithelial Neoplasia-3,0
3673,Body site,Pancreatic Intraepithelial Neoplasia-3,0
3674,Organ,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3675,Ewings sarcoma,Chondrosarcoma,0
3676,foreign,Chronic Myelomonocytic Leukemia-2,0
3677,leukemia,Acantholytic squamous cell carcinoma,0
3678,Pharyngeal structure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3679,Feet,Stage 0 Penile Cancer AJCC v8,0
3680,curative treatment,gliosarcoma,0
3681,Cover - action,Hemangioma,0
3682,Coding Subtest (WAIS-IV),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3683,Usually,Bladder squamous cell carcinoma stage I,0
3684,Diagnosis Study,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3685,Including (qualifier),Childhood Lymphoma,0
3686,Type A,Maxillary Sinus Adenocarcinoma,0
3687,Smear - instruction imperative,Mastocytosis,0
3688,Hematuria,Endometrial Small Cell Carcinoma,0
3689,dependent,Heavy Chain Deposition Disease,0
3690,Cancer Registry,Stage 0 Lip Carcinoma,0
3691,Immunocompromised Host,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3692,Dysgerminoma,Cartilaginous exostosis,0
3693,Retained,Refractory Barrett Esophagus,0
3694,Average of Value Derivation Technique,Anterior Urethral Malignant Neoplasm,0
3695,Death (finding),Thymic Clear Cell Carcinoma,0
3696,Body tissue,Cerebral Primitive Neuroectodermal Tumor,0
3697,Head - Component of Device,Bladder squamous cell carcinoma stage I,0
3698,*Type - Kind of quantity,Angiosarcoma of liver,0
3699,10%,Prostate Lymphoma,0
3700,Include (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3701,Formation,Intestinal Metaplasia of Bladder Urothelium,0
3702,Providing presence (regime/therapy),Female Breast Carcinoma,0
3703,Medications,Primary Cutaneous Plasmablastic Lymphoma,0
3704,Tumor type,Colorectal Neuroendocrine Tumor G2,0
3705,Myelodysplastic-Myeloproliferative Diseases,Human Papillomavirus-Related Carcinoma,0
3706,Distant,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3707,Mechanism (attribute),Female Breast Carcinoma,0
3708,Pallor,BRCA2 Syndrome,0
3709,Smear - instruction imperative,Pancreatic Intraepithelial Neoplasia-3,0
3710,Subject Risk,Recurrent Uveal Melanoma,0
3711,Responsible to,embryonal rhabdomyosarcoma of prostate,0
3712,CDISC Findings Class,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3713,Grouped (foundation metadata concept),Refractory Barrett Esophagus,0
3714,>65 years,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3715,List,Airway Hemangioma,0
3716,Phase,Childhood Central Nervous System Immature Teratoma,0
3717,Clinical Study Case,Testicular cancer metastatic,0
3718,Inferior,Small cell neuroendocrine carcinoma of bladder,0
3719,Acetaminophen,Lipoma of small intestine,0
3720,To,Cancer of Urinary Tract,0
3721,structure,Extra-Adrenal Paraganglioma,0
3722,Approach,Liver Lymphangioma,0
3723,Common (qualifier value),Pilocytic astrocytoma of cerebellum,0
3724,Aberrant,Acute lymphadenitis,0
3725,Intercellular Junctions,Acute Undifferentiated Leukemia,0
3726,biopsy characteristics,Noninfiltrating Intraductal Carcinoma,0
3727,Low Back Pain,Liver Lymphangioma,0
3728,Blood,Acantholytic squamous cell carcinoma,0
3729,How Often Diarrhea,BRCA2 Syndrome,0
3730,Etiology aspects,Intraepithelial Melanocytic Hyperplasia,0
3731,Dysuria,Digestive System Hodgkin Lymphoma,0
3732,Symptoms aspect,Bladder squamous cell carcinoma stage I,0
3733,Skin Specimen,Bladder squamous cell carcinoma stage I,0
3734,Swallowing painful,Benign Carotid Body Paraganglioma,0
3735,prior radiation therapy,adenoid cystic carcinoma of lung,0
3736,Malignant Central Nervous System Neoplasm,Recurrent Testicular Lymphoma,0
3737,Tissue Specimen Code,Hodgkin lymphoma,0
3738,Poor function,Childhood Fibrillary Astrocytoma,0
3739,Enzyme (disposition),Recurrent Uveal Melanoma,0
3740,Occurrence,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3741,spindle assembly checkpoint,Advanced Lung Carcinoma,0
3742,biopsy characteristics,Ichthyosis,0
3743,Hypertensive disease,Recurrent Testicular Lymphoma,0
3744,Brain,Malignant melanoma of eyelid,0
3745,treatment - ActInformationManagementReason,Xeroderma pigmentosum,0
3746,Alpha-fetoprotein level - finding,Acute Undifferentiated Leukemia,0
3747,Identified,FIGO Stage II Ovarian Cancer,0
3748,Cervix Uteri,Acantholytic squamous cell carcinoma,0
3749,treatment - ActInformationManagementReason,Cancer of Urinary Tract,0
3750,Togo,Malignant melanoma of eyelid,0
3751,Responsible to,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3752,Presence (property),Hemangioma,0
3753,Several,Neonatal leukemia,0
3754,Wound Healing,Tonsillar Carcinoma,0
3755,Areas <moth>,Advanced Uterine Corpus Carcinosarcoma,0
3756,Term (lexical),Carcinoma of urinary bladder,0
3757,Support,Acute Undifferentiated Leukemia,0
3758,Object Class,Stage I Adult Non-Hodgkin Lymphoma,0
3759,cervical cancer,Adenocarcinoma of the prostate metastatic,0
3760,Ratio,Diffuse malignant mesothelioma,0
3761,Free of (attribute),mucinous adenocarcinoma of gallbladder,0
3762,Neoplasm Metastasis,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3763,Involvement with,Adult Alveolar Soft Part Sarcoma,0
3764,Pigmentary Change in Skin,Localized Ewing Sarcoma,0
3765,Beginning,non-Hodgkin's lymphoma of spleen,0
3766,CEL gene,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3767,Stage Grouping,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3768,Qualitative form,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3769,Growth,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3770,Living Alone,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3771,peripheral blood,Stage IV Childhood Non-Hodgkin Lymphoma,0
3772,Chest wall structure,Blepharal carcinoma,0
3773,Pediatric,Thymic Clear Cell Carcinoma,0
3774,Biomaterial Treatment,Testicular cancer metastatic,0
3775,Inspiration function,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3776,Binding (Molecular Function),Human Papillomavirus-Related Carcinoma,0
3777,Adult human body,Fourth Ventricle and Brain Stem Ependymal Tumor,0
3778,Dryness (characteristic),Benign Apocrine Neoplasm,0
3779,Upper,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
3780,Case (situation),gliosarcoma,0
3781,+2,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3782,Fever,Localized Ewing Sarcoma,0
3783,Gene Mutation,Adenocarcinoma of the prostate metastatic,0
3784,Related personal status,Sarcomatoid Renal Cell Carcinoma,0
3785,head of bed,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
3786,Childbirth,Werner Syndrome,0
3787,Frequently,Metastatic Malignant Neoplasm in the Sellar Region,0
3788,Elderly (population group),BRCA2 Syndrome,0
3789,Universal restriction modifier (core metadata concept),Non-Metastatic Gestational Trophoblastic Tumor,0
3790,survive,Intestinal Metaplasia of Bladder Urothelium,0
3791,Array Feature,Neonatal leukemia,0
3792,Telephone Extension Number,gliosarcoma,0
3793,Woman,Metastatic Ductal Breast Carcinoma,0
3794,Togo,Cancer of Urinary Tract,0
3795,Surgery specialty,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3796,Common Specifications in HL7 V3 Publishing,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3797,Slightly (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
3798,Experimental Result,Adrenal Rest Tumor,0
3799,Detected (finding),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3800,Pale color,Stage IB Pancreatic Cancer AJCC v8,0
3801,Form:Finding:Point in time:{Setting}:Document:{Role},Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
3802,Tissue specific,Mixed parotid tumor,0
3803,Overall,Benign tumor of eyelid,0
3804,Local disease,Small cell neuroendocrine carcinoma of bladder,0
3805,peripheral blood,Primary Cutaneous Plasmablastic Lymphoma,0
3806,Obesity,Intraepithelial Melanocytic Hyperplasia,0
3807,combination of objects,Carcinoma ex pleomorphic adenoma of parotid gland,0
3808,National origin,Adult Hepatocellular Carcinoma,0
3809,Usually Need Help from Another Person for Reach,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3810,Usually,Primary Cutaneous Plasmablastic Lymphoma,0
3811,Call (Instruction),FIGO Stage II Ovarian Cancer,0
3812,Food,Mucinous adenocarcinoma gastric,0
3813,Increased risk for cancer,Pancreatic Intraepithelial Neoplasia-3,0
3814,Punctum,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3815,Growth action,Malignant neoplasm of thalamus,0
3816,Ability,Ichthyosis,0
3817,Block (unit of measure),Malignant Neoplasm of Lung - Multiple Primary Sites,0
3818,depend,Diffuse malignant mesothelioma,0
3819,Body Fluid Discharge,Malignant melanoma of eyelid,0
3820,Tryptophanase,malignant lymphoma of pancreatic lymph nodes,0
3821,Unknown,Xeroderma pigmentosum,0
3822,Edit Action,Cancer of Urinary Tract,0
3823,Burkina Faso,Thymic Clear Cell Carcinoma,0
3824,Cell secretion,Benign tumor of eyelid,0
3825,Occur (action),Refractory Barrett Esophagus,0
3826,Classification of information,Refractory Barrett Esophagus,0
3827,Decrease,Anterior Urethral Malignant Neoplasm,0
3828,Embryonic Development,Diffuse malignant mesothelioma,0
3829,Expected,Stage 0 Penile Cancer AJCC v8,0
3830,cell growth,Ichthyosis,0
3831,photoreactivating enzyme activity,Undifferentiated Endocervical Sarcoma,0
3832,PSA Level Less than Five,Benign Carotid Body Paraganglioma,0
3833,Cancer Registry,Pancreatic Intraepithelial Neoplasia-3,0
3834,Most,Stage II Hepatocellular Carcinoma AJCC v8,0
3835,Physical findings,Malignant neoplasm of thalamus,0
3836,Chemotherapy Regimen,Human Papillomavirus-Related Carcinoma,0
3837,Version,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3838,Negation,Acute Undifferentiated Leukemia,0
3839,Plasma Product,Airway Hemangioma,0
3840,General surgery specialty,Colorectal cancer,0
3841,Type A,Medulloblastoma,0
3842,Colorectal Cancer,Acantholytic squamous cell carcinoma,0
3843,3+ Score,Colorectal High Grade B-Cell Lymphoma,0
3844,Abdomen,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3845,Widening,Ichthyosis,0
3846,Surface,Liver Lymphangioma,0
3847,diagnosis aspect,Secondary malignant neoplasm of lymph node,0
3848,risk factors,Blepharal carcinoma,0
3849,Persons,gliosarcoma,0
3850,Blood,Low Grade Squamous Intraepithelial Neoplasia,0
3851,More,Diffuse malignant mesothelioma,0
3852,Bone Marrow,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3853,Couple (action),Heavy Chain Deposition Disease,0
3854,Feelings,Female Breast Carcinoma,0
3855,Long-term Follow-up,Xeroderma pigmentosum,0
3856,Medical Imaging,Thymoma malignant recurrent,0
3857,Tumor Cell Invasion,Lipoma of small intestine,0
3858,Array Feature,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3859,Malignant epithelioma,Methotrexate-Associated Hodgkin Lymphoma,0
3860,Abdomen+,Diffuse malignant mesothelioma,0
3861,Etiology aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3862,Mutation,Acantholytic squamous cell carcinoma,0
3863,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,benign mature teratoma of pancreas,0
3864,Plasma Cells,Recurrent Testicular Lymphoma,0
3865,Primary malignant neoplasm,Low Grade Squamous Intraepithelial Neoplasia,0
3866,Neoplasm Metastasis,mucinous adenocarcinoma of gallbladder,0
3867,peripheral blood,Stage IV Childhood Non-Hodgkin Lymphoma,0
3868,Clinical Trials,Xeroderma pigmentosum,0
3869,Specimen Source Codes - tumor,Stage IV Childhood Non-Hodgkin Lymphoma,0
3870,Toxic Epidermal Necrolysis,Metastatic Neoplasm to the Gallbladder,0
3871,Reaching,Undifferentiated Endocervical Sarcoma,0
3872,Needs,Clonal Hematopoiesis of Indeterminate Potential,0
3873,Individual,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3874,Associated with,Chronic Myelomonocytic Leukemia-2,0
3875,Referring,Cancer of Urinary Tract,0
3876,Patients,Recurrent Testicular Lymphoma,0
3877,Indolent Non-Hodgkin Lymphoma,Fourth Ventricle and Brain Stem Ependymal Tumor,0
3878,Orbital region,Cartilaginous exostosis,0
3879,Chemotherapy Regimen,Ovarian germ cell choriocarcinoma stage IV,0
3880,Unknown GENC,Cerebral hemangioma,0
3881,Recurrence,embryonal rhabdomyosarcoma of prostate,0
3882,Supportive assistance,mucinous adenocarcinoma of gallbladder,0
3883,Melanoma Pathway,Malignant melanoma of eyelid,0
3884,Treated with,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3885,Patient need for (contextual qualifier),malignant lymphoma of pancreatic lymph nodes,0
3886,Tissue of urinary bladder,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3887,Term Birth,de novo Myelodysplastic Syndrome,0
3888,Cartilage,Bladder squamous cell carcinoma stage I,0
3889,Academic degree,Thymic Clear Cell Carcinoma,0
3890,Antineoplastic Agents,non-Hodgkin's lymphoma of spleen,0
3891,Therapeutic procedure,Digestive System Hodgkin Lymphoma,0
3892,Ninth,Human Papillomavirus-Related Carcinoma,0
3893,radiotherapeutic,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3894,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Giant cell angiofibroma,0
3895,Skin,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3896,Ulceration,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3897,Allergens,Cerebral Primitive Neuroectodermal Tumor,0
3898,Neoplasms,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3899,Science of Anatomy,Spongiotic dermatitis,0
3900,Square Mile,Cerebral Primitive Neuroectodermal Tumor,0
3901,Thin (qualifier value),Carcinoma of urinary bladder,0
3902,Shortened,Cancer of Urinary Tract,0
3903,Grade,Malignant Neoplasm with Regional Lymph Node Involvement,0
3904,Administration procedure,Collecting Duct Carcinoma of the Kidney,0
3905,Sarcoma of soft tissue,adenosquamous carcinoma of breast,0
3906,pump (device),Granular Cell Leiomyosarcoma,0
3907,Experimental Result,Neoplasms,0
3908,Group A (blood group),Refractory Barrett Esophagus,0
3909,Non-small cell carcinoma,Contact dermatitis due to alkali,0
3910,factor A,Clonal Hematopoiesis of Indeterminate Potential,0
3911,Central,gliosarcoma,0
3912,Therapeutic procedure,Placental aromatase deficiency,0
3913,Esophagitis,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
3914,Related personal status,Undifferentiated Endocervical Sarcoma,0
3915,Benign condition,Bladder squamous cell carcinoma stage I,0
3916,Central Nervous System,Benign neoplasm of thorax,0
3917,Child,Secondary malignant neoplasm of lymph node,0
3918,Only - dosing instruction fragment,Acute Undifferentiated Leukemia,0
3919,Appearance,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3920,Neuroglia,Mucinous adenocarcinoma gastric,0
3921,True primary (qualifier value),Adult Hepatocellular Carcinoma,0
3922,Contain (action),Malignant Testicular Sertoli Cell Tumor,0
3923,Low Level,Liver Lymphangioma,0
3924,Benign,Malignant melanoma of eyelid,0
3925,Increase,Mastocytosis,0
3926,Include (action),Human Papillomavirus-Related Carcinoma,0
3927,Adult Burkitt Lymphoma,Stage II Hepatocellular Carcinoma AJCC v8,0
3928,Eating,Anaplastic large cell lymphoma,0
3929,National Cancer Institute,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3930,Height / growth measure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3931,Form:Finding:Point in time:{Setting}:Document:{Role},Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3932,Pain,Human Papillomavirus-Related Carcinoma,0
3933,Time,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3934,Diagnosis Study,Testicular cancer metastatic,0
3935,Chemotherapy Regimen,Mucinous neoplasm,0
3936,Platelet Glycoprotein 4,Stage IB Pancreatic Cancer AJCC v8,0
3937,Target Awareness - partial,Malignant melanoma of eyelid,0
3938,Recurrent infections,Human Papillomavirus-Related Carcinoma,0
3939,Specific qualifier value,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3940,Medical Device Emits Smoke,Pancreatic Intraepithelial Neoplasia-3,0
3941,Linear,Xeroderma pigmentosum,0
3942,low,Childhood Lymphoma,0
3943,Slightly (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
3944,Increasing,Pancreatic Intraepithelial Neoplasia-3,0
3945,Exophytic,Primary Cutaneous Plasmablastic Lymphoma,0
3946,Renal pelvis,Intestinal Metaplasia of Bladder Urothelium,0
3947,Megakaryoblast Cell Count,Endometrial Small Cell Carcinoma,0
3948,How Often Weight Loss,Mixed parotid tumor,0
3949,Ear structure,Colorectal High Grade B-Cell Lymphoma,0
3950,Bayer Corneal Epitheliopathy Grade 3,Localized Askin Tumor,0
3951,various other intestinal adsorbents in ATC,Mucinous adenocarcinoma gastric,0
3952,TP53 protein,papillary carcinoma of penis,0
3953,Age of onset of symptoms:Time:Pt:^Patient:Qn,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3954,Illness: Cannot describe symptoms,Recurrent Uveal Melanoma,0
3955,Testing,Pancreatic Intraepithelial Neoplasia-3,0
3956,Lymphocyte,Grade 3a Malignant Neoplasm,0
3957,{Setting},Undifferentiated Endocervical Sarcoma,0
3958,Screening procedure,Lipoma of small intestine,0
3959,Response (statement),Metastatic Carcinoma in the Lung,0
3960,Occur (action),embryonal rhabdomyosarcoma of prostate,0
3961,Event-Free Survival,Undifferentiated Endocervical Sarcoma,0
3962,Left,Mucinous adenocarcinoma gastric,0
3963,Rare,Tonsillar Carcinoma,0
3964,Adult Hodgkin Lymphoma,papillary carcinoma of penis,0
3965,Primary malignant neoplasm,Neonatal leukemia,0
3966,Better,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3967,Upon - dosing instruction fragment,Intraepithelial Melanocytic Hyperplasia,0
3968,Hardness,Stage IB Pancreatic Cancer AJCC v8,0
3969,contextual factors,Testicular cancer metastatic,0
3970,include - SetOperator,Hemangioma,0
3971,VARIOUS DRUG CLASSES IN ATC,Childhood Thyroid Gland Follicular Carcinoma,0
3972,Only - dosing instruction fragment,BRCA2 Syndrome,0
3973,How Often Shortness of Breath,Extra-Adrenal Paraganglioma,0
3974,Interferes with,Medulloblastoma,0
3975,Carcinoma,Stage II Hepatocellular Carcinoma AJCC v8,0
3976,Vascular,Acantholytic squamous cell carcinoma,0
3977,Status post,Thymic Atypical Carcinoid Tumor,0
3978,Surgical service,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
3979,Squamous cell carcinoma,Medulloblastoma,0
3980,Lymphoma,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3981,Common (qualifier value),Refractory Barrett Esophagus,0
3982,Choroid Plexus Papilloma,Localized Ewing Sarcoma,0
3983,Negation,Atypical Lobular Breast Hyperplasia,0
3984,Two,Secondary malignant neoplasm of lymph node,0
3985,BRCA2 gene,Malignant melanoma of eyelid,0
3986,Tumor Mass,Digestive System Hodgkin Lymphoma,0
3987,Biological Transport,Ovarian germ cell choriocarcinoma stage IV,0
3988,Academic degree,Diffuse malignant mesothelioma,0
3989,Late,Non-Metastatic Gestational Trophoblastic Tumor,0
3990,Initial Usage,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3991,Infrequent,Testicular cancer metastatic,0
3992,Transurethral Resection,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3993,Colon structure (body structure),BRCA2 Syndrome,0
3994,Part of,Digestive System Hodgkin Lymphoma,0
3995,Asians,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3996,United States Military Commissioned Officer O4,Clonal Hematopoiesis of Indeterminate Potential,0
3997,Epoetin Alfa,Childhood Fibrillary Astrocytoma,0
3998,Togo,gliosarcoma,0
3999,Primary,Malignant Neoplasm with Regional Lymph Node Involvement,0
4000,Tumor stage,Methotrexate-Associated Hodgkin Lymphoma,0
4001,Median Statistical Measurement,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4002,Specimen Source Codes - Lesion,Pancreatic Intraepithelial Neoplasia-3,0
4003,Account number:Identifier:Point in time:^Patient:Nominal,Intraepithelial Melanocytic Hyperplasia,0
4004,Malignant Neoplasms,Stage 0 Penile Cancer AJCC v8,0
4005,Metastatic Disease Clinical Trial Setting,adenosquamous carcinoma of breast,0
4006,Site of,Airway Hemangioma,0
4007,Standard (document),Platinum-Resistant Lung Small Cell Carcinoma,0
4008,Beginning,Chondrosarcoma,0
4009,Surgery specialty,Cartilaginous exostosis,0
4010,Partial,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4011,White blood cell count normal,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4012,High risk of,Malignant melanoma of eyelid,0
4013,Body tissue,Adenocarcinoma of the prostate metastatic,0
4014,shared attribute,Medulloblastoma,0
4015,Pharmacotherapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4016,Persons,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4017,Sore skin,Childhood Fibrillary Astrocytoma,0
4018,Science of Etiology,Sarcomatoid Renal Cell Carcinoma,0
4019,Secondary Neoplasm,Colorectal Neuroendocrine Tumor G2,0
4020,Erythrocytes,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
4021,Classical Hodgkin's Lymphoma,Recurrent Uveal Melanoma,0
4022,Hyperplasia,embryonal rhabdomyosarcoma of prostate,0
4023,Target Lesion Identification,Malignant Testicular Sertoli Cell Tumor,0
4024,physiological aspects,Advanced Uterine Corpus Carcinosarcoma,0
4025,Acute Myeloid Leukemia Pathway,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
4026,Obesity,Recurrent Testicular Lymphoma,0
4027,Treating,FIGO Stage II Ovarian Cancer,0
4028,Qualitative form,Recurrent Uveal Melanoma,0
4029,Obesity,Cartilaginous exostosis,0
4030,Basis - conceptual entity,High Grade Glandular Intraepithelial Neoplasia,0
4031,Have Weight Loss,Benign tumor of eyelid,0
4032,various antiinfectives and antiseptics for local oral treatment,Benign Apocrine Neoplasm,0
4033,Formed,Low Grade Squamous Intraepithelial Neoplasia,0
4034,Neoplasms,de novo Myelodysplastic Syndrome,0
4035,Used by,Tonsillar Carcinoma,0
4036,melanoma,Childhood Lymphoma,0
4037,Decision,FIGO Stage II Ovarian Cancer,0
4038,Endocrine Cells,Stage III Adult Immunoblastic Lymphoma,0
4039,Urethra part,Serous cystadenocarcinoma ovary,0
4040,Mother (person),Neonatal leukemia,0
4041,Curative - procedure intent,Liver Cavernous Hemangioma,0
4042,Canis familiaris,Colorectal High Grade B-Cell Lymphoma,0
4043,VARIOUS DRUG CLASSES IN ATC,Anaplastic large cell lymphoma,0
4044,DNA Damage,Localized Askin Tumor,0
4045,Low Back Pain,Malignant Testicular Sertoli Cell Tumor,0
4046,How Often Weight Loss,Malignant Testicular Sertoli Cell Tumor,0
4047,White Blood Cell Count procedure,Advanced Uterine Corpus Carcinosarcoma,0
4048,Removed,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4049,various other intestinal adsorbents in ATC,Thymic Clear Cell Carcinoma,0
4050,Woman,Adenocarcinoma of the prostate metastatic,0
4051,Due to,Bladder squamous cell carcinoma stage I,0
4052,Known,Bladder squamous cell carcinoma stage I,0
4053,Time,Diffuse malignant mesothelioma,0
4054,Granulocytes Product,Malignant neoplasm of thalamus,0
4055,Lower - spatial qualifier,gliosarcoma,0
4056,Living Alone,Tonsillar Carcinoma,0
4057,Including (qualifier),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4058,Hematologist,Cerebral Primitive Neuroectodermal Tumor,0
4059,Togo,Undifferentiated Neuroblastoma,0
4060,Feelings,Malignant melanoma of eyelid,0
4061,Involvement with,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4062,Body Excretions,Female Breast Carcinoma,0
4063,Human gene,BRCA2 Syndrome,0
4064,Extrinsic,Xeroderma pigmentosum,0
4065,Fish (substance),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4066,Case (situation),Breast Ductal Adenoma,0
4067,Blood Platelets,Atypical Lobular Breast Hyperplasia,0
4068,Testis,Blepharal carcinoma,0
4069,Beginning,Leptomeningeal sarcoma,0
4070,Cell division,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4071,Antifungal Antibiotics,Medulloblastoma,0
4072,Liver and Intrahepatic Biliary Tract Carcinoma,Cerebral Primitive Neuroectodermal Tumor,0
4073,Person 3,Benign Apocrine Neoplasm,0
4074,How Often Difficulty Swallowing,Colorectal High Grade B-Cell Lymphoma,0
4075,Singular,Childhood Lymphoma,0
4076,High Risk Acute Leukemia,Metastatic Lung Small Cell Carcinoma,0
4077,Diagnosis Study,Extracranial Neuroblastoma,0
4078,Including (qualifier),Refractory Barrett Esophagus,0
4079,Most,Intraepithelial Melanocytic Hyperplasia,0
4080,Glycation End Products,Adrenal Rest Tumor,0
4081,Basis - conceptual entity,Leptomeningeal sarcoma,0
4082,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
4083,What subject filter - Result,Secondary malignant neoplasm of lymph node,0
4084,size,adenosquamous carcinoma of breast,0
4085,Linear,Mucinous cystadenofibroma,0
4086,eTMF Content Model Code,Metastatic Malignant Neoplasm in the Sellar Region,0
4087,Life Threatening,Testicular cancer metastatic,0
4088,melanoma,Hodgkin lymphoma,0
4089,Common Specifications in HL7 V3 Publishing,Recurrent Uveal Melanoma,0
4090,Cell (compartment),Blepharal carcinoma,0
4091,Icterus,Intraepithelial Melanocytic Hyperplasia,0
4092,Representation (action),Cartilaginous exostosis,0
4093,Individual,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4094,Tonsillar Carcinoma,Platinum-Resistant Lung Small Cell Carcinoma,0
4095,More,Blepharal carcinoma,0
4096,Etiology aspects,Metastatic Neoplasm to the Gallbladder,0
4097,Term (temporal),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4098,Mutation,Hemangioma,0
4099,Approximate,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4100,True primary (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
4101,Cardiac Lead Procedure,Diffuse malignant mesothelioma,0
4102,Neoplasms,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4103,Representation (action),GIANT PIGMENTED HAIRY NEVUS,0
4104,Clinical Effectiveness,Maxillary Sinus Adenocarcinoma,0
4105,Togo,papillary carcinoma of penis,0
4106,Possibly Related to Intervention,Bladder squamous cell carcinoma stage I,0
4107,Collection (action),Malignant Neoplasm of Lung - Multiple Primary Sites,0
4108,Metastasis,Recurrent Uveal Melanoma,0
4109,Sometimes,BRCA2 Syndrome,0
4110,lobe,Malignant melanoma of eyelid,0
4111,Neoplastic disease,Anterior Urethral Malignant Neoplasm,0
4112,Immune System Processes,Tonsillar Carcinoma,0
4113,Increase,Cerebral Primitive Neuroectodermal Tumor,0
4114,Case unit dose,Urethral Carcinoma,0
4115,shared attribute,Pancreatic Intraepithelial Neoplasia-3,0
4116,Collection (action),Ichthyosis,0
4117,Subtype (attribute),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4118,Tetrachloroethylene,Undifferentiated Endocervical Sarcoma,0
4119,How Much Distress Pain,Localized Askin Tumor,0
4120,Post Device,Digestive System Hodgkin Lymphoma,0
4121,Contraceptives,Ichthyosis,0
4122,Evidence,Breast Ductal Adenoma,0
4123,Containing (qualifier),de novo Myelodysplastic Syndrome,0
4124,Feel Tired question,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4125,Congenital Abnormality,Intracortical osteosarcoma,0
4126,Common Specifications in HL7 V3 Publishing,Liver Lymphangioma,0
4127,Experimental Result,Thymic Clear Cell Carcinoma,0
4128,Classical Hodgkin's Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
4129,Cell Device,Non-Metastatic Gestational Trophoblastic Tumor,0
4130,Infection,malignant lymphoma of pancreatic lymph nodes,0
4131,Distant,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4132,Diagnostic Imaging,Childhood Lymphoma,0
4133,Hepatitis C,Angiosarcoma of liver,0
4134,Connective Tissue,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4135,Symptoms,Xeroderma pigmentosum,0
4136,Unspecified,Anaplastic large cell lymphoma,0
4137,External lower lip,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
4138,Specific qualifier value,Intestinal Neuroendocrine Carcinoma,0
4139,Mesothelial cell count,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4140,Space - property,Stage IB Pancreatic Cancer AJCC v8,0
4141,Covers (device),Lung Mucinous Cystadenoma,0
4142,Cancer Genus,Chronic Myelomonocytic Leukemia-2,0
4143,Before,Rhabdomyosarcoma with ganglionic differentiation,0
4144,SPACA9 gene,Carcinoma of urinary bladder,0
4145,Patient Outcome,Platinum-Resistant Lung Small Cell Carcinoma,0
4146,Hormones,squamous cell carcinoma of the thyroid gland,0
4147,Speech,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4148,Problems - What subject filter,Recurrent Uveal Melanoma,0
4149,Including (qualifier),Secondary malignant neoplasm of lymph node,0
4150,day,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
4151,Further,Digestive System Hodgkin Lymphoma,0
4152,Rate,Undifferentiated Endocervical Sarcoma,0
4153,Distant,Advanced Uterine Corpus Carcinosarcoma,0
4154,Sore Throat,Thymic Clear Cell Carcinoma,0
4155,Approximate,Adult Fibrolamellar Carcinoma,0
4156,Involvement with,Rhabdomyosarcoma with ganglionic differentiation,0
4157,Tryptophanase,benign mature teratoma of pancreas,0
4158,Cover (physical object),Carcinoma of urinary bladder,0
4159,Presence (property),Heavy Chain Deposition Disease,0
4160,Including (qualifier),Localized Askin Tumor,0
4161,Digital Content Category,Testicular cancer metastatic,0
4162,Collection (action),Neonatal leukemia,0
4163,Type A,Small cell neuroendocrine carcinoma of bladder,0
4164,Term (lexical),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4165,Clone Cells,Acantholytic squamous cell carcinoma,0
4166,Overall,Advanced Uterine Corpus Carcinosarcoma,0
4167,Possible,Angiosarcoma of liver,0
4168,Stem cell transplant,Small cell neuroendocrine carcinoma of bladder,0
4169,Rare,Digestive System Hodgkin Lymphoma,0
4170,Approximate,Small cell neuroendocrine carcinoma of bladder,0
4171,3+ Score,Stage III Adult Immunoblastic Lymphoma,0
4172,Evidence,Metastatic Ductal Breast Carcinoma,0
4173,Cancer Etiology,Diffuse malignant mesothelioma,0
4174,Offspring,Adrenal Rest Tumor,0
4175,Present,Recurrent Diffuse Intrinsic Pontine Glioma,0
4176,Fracture,Clonal Hematopoiesis of Indeterminate Potential,0
4177,Frequently,adenoid cystic carcinoma of lung,0
4178,Information,Atypical Lobular Breast Hyperplasia,0
4179,Human papillomavirus 16,Adult Alveolar Soft Part Sarcoma,0
4180,Malignant neoplasm of thyroid,Adrenal Rest Tumor,0
4181,Brain Neoplasms,Medulloblastoma,0
4182,Neoplastic Glandular Cell,Stage IB Lung Cancer AJCC v7,0
4183,Pure Spanish horse breed (organism),Recurrent Testicular Lymphoma,0
4184,Nasal sinus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4185,Telencephalon,Uterine Cancer,0
4186,Contusions,embryonal rhabdomyosarcoma of prostate,0
4187,eTMF Content Model Code,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4188,Malignant neoplasm of urinary bladder,Stage IV Childhood Non-Hodgkin Lymphoma,0
4189,Compress (Compression Algorithm),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4190,Occurrence Indicator,Angiosarcoma of liver,0
4191,Metastatic Neoplasm,Benign Apocrine Neoplasm,0
4192,Togo,Adenocarcinoma of the prostate metastatic,0
4193,Result,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4194,Rate,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4195,Areas <moth>,FIGO Stage II Ovarian Cancer,0
4196,Heel Spur,Recurrent Testicular Lymphoma,0
4197,Milliampere second,Intraepithelial Melanocytic Hyperplasia,0
4198,treatment options,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4199,Rubella,Blepharal carcinoma,0
4200,oncology field,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4201,Papillary,High Grade Glandular Intraepithelial Neoplasia,0
4202,Aspect (characteristic),Refractory Barrett Esophagus,0
4203,Involvement with,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4204,65+,sarcoma of spinal cord,0
4205,Certainties,Recurrent Uveal Melanoma,0
4206,Chemotherapy,Acute Undifferentiated Leukemia,0
4207,*Type - Kind of quantity,embryonal rhabdomyosarcoma of prostate,0
4208,How Often Weight Loss,Testicular cancer metastatic,0
4209,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4210,ancestors,Female Breast Carcinoma,0
4211,Neuroepithelial,Recurrent Testicular Lymphoma,0
4212,Presentation,Ichthyosis,0
4213,Aspects of signs,Stage II Hepatocellular Carcinoma AJCC v8,0
4214,Biomaterial Treatment,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4215,animal allergen extracts,Mucinous neoplasm,0
4216,Cover - action,Platinum-Resistant Lung Small Cell Carcinoma,0
4217,Congenital Abnormality,Larynx carcinoma recurrent,0
4218,Lumpectomy of breast,Malignant neoplasm of choroid,0
4219,Age,Childhood Thyroid Gland Follicular Carcinoma,0
4220,Anterior thoracic region,Refractory Barrett Esophagus,0
4221,Abnormal result,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4222,Empty (qualifier),Angiosarcoma of liver,0
4223,Back,Hemangioma,0
4224,Present,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4225,low exposure,Hodgkin lymphoma,0
4226,Appearance,Malignant neoplasm of thalamus,0
4227,Rapid,papillary carcinoma of penis,0
4228,Include (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4229,treatment - ActInformationManagementReason,malignant lymphoma of pancreatic lymph nodes,0
4230,Thymectomy,Anterior Urethral Malignant Neoplasm,0
4231,Stage Grouping,embryonal rhabdomyosarcoma of prostate,0
4232,Site of,Neonatal leukemia,0
4233,Degree Unit of Plane Angle,Advanced Uterine Corpus Carcinosarcoma,0
4234,Responsible to,gliosarcoma,0
4235,Occur (action),Keratoderma,0
4236,Progress,FIGO Stage II Ovarian Cancer,0
4237,risk factors - observation list,Carcinoma ex pleomorphic adenoma of parotid gland,0
4238,Malignant neoplasm of breast,Extra-Adrenal Paraganglioma,0
4239,Immune system,Intraepithelial Melanocytic Hyperplasia,0
4240,Aim (idea),Unfavorable Non-Hodgkin Lymphoma,0
4241,Reaching,High Grade Glandular Intraepithelial Neoplasia,0
4242,Internal,Childhood Fibrillary Astrocytoma,0
4243,Unmarried person,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4244,Platelets Product,Cerebral hemangioma,0
4245,Numbers,Mixed parotid tumor,0
4246,Ultrasonics (sound),Hemangioma,0
4247,Tissue Specimen Code,Childhood Lymphoma,0
4248,Surgical aspects,FIGO Stage II Ovarian Cancer,0
4249,government - ActInformationManagementReason,Metastatic Neoplasm to the Gallbladder,0
4250,Transformation,Ovarian Carcinoid Tumor,0
4251,Females,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4252,Sarcomatous Component Present,Undifferentiated Neuroblastoma,0
4253,Adult human body,Serous cystadenocarcinoma ovary,0
4254,Tryptophanase,Human Papillomavirus-Related Carcinoma,0
4255,trends qualifier,Mucinous adenocarcinoma gastric,0
4256,Triggered by,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4257,Concern,Xeroderma pigmentosum,0
4258,Term (lexical),Bladder squamous cell carcinoma stage I,0
4259,Offspring,Carcinoma of urinary bladder,0
4260,Administration procedure,FIGO Stage II Ovarian Cancer,0
4261,10%,Choroid Necrotic Melanoma,0
4262,seen,Giant cell angiofibroma,0
4263,diagnosis aspect,Carcinoma of urinary bladder,0
4264,high - ActExposureLevelCode,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4265,include - SetOperator,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4266,General surgery specialty,Neonatal leukemia,0
4267,Platelet Glycoprotein 4,Carcinoma ex pleomorphic adenoma of parotid gland,0
4268,Damage,Acantholytic squamous cell carcinoma,0
4269,How Much Distress Weight Loss,Acute Undifferentiated Leukemia,0
4270,Facial swelling (finding),Granular Cell Leiomyosarcoma,0
4271,Coding,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4272,Histopathologic Grade,embryonal rhabdomyosarcoma of prostate,0
4273,Cutaneous Melanoma,Heavy Chain Deposition Disease,0
4274,Host (organism),Colorectal High Grade B-Cell Lymphoma,0
4275,diagnosis aspect,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4276,Kidney,Carcinoma of urinary bladder,0
4277,Often - answer to question,Ovarian germ cell choriocarcinoma stage IV,0
4278,Abnormal Reference Range,Malignant melanoma of eyelid,0
4279,Squamous,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4280,Cessation of life,mucinous adenocarcinoma of gallbladder,0
4281,IPSS Risk Category Low,Localized Ewing Sarcoma,0
4282,More,Contact dermatitis due to alkali,0
4283,Ninein,Cartilaginous exostosis,0
4284,Lymphadenopathy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4285,Vertebral column,Endometrial Small Cell Carcinoma,0
4286,Type A,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4287,Function (attribute),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4288,Cause of Death,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4289,Complete Agreement,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
4290,Egg of order Phthiraptera,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4291,Study Site,Cerebral Primitive Neuroectodermal Tumor,0
4292,Together,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4293,Central neuroblastoma,Metastatic Malignant Neoplasm in the Sellar Region,0
4294,Muscle Contraction,Recurrent Testicular Lymphoma,0
4295,General surgery specialty,Pilocytic astrocytoma of cerebellum,0
4296,Often - answer to question,FIGO Stage II Ovarian Cancer,0
4297,Human body,Lipoma of small intestine,0
4298,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Spongiotic dermatitis,0
4299,Hearing Loss,Blepharal carcinoma,0
4300,Have Shortness of Breath question,Angiosarcoma of liver,0
4301,Prior Chemotherapy,Extra-Adrenal Paraganglioma,0
4302,99,Refractory Barrett Esophagus,0
4303,Descending,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
4304,Aspects of disease screening,Heavy Chain Deposition Disease,0
4305,Network Device,Stage 0 Penile Cancer AJCC v8,0
4306,newly,Bladder squamous cell carcinoma stage I,0
4307,65,papillary carcinoma of penis,0
4308,Chemicals,Bladder squamous cell carcinoma stage I,0
4309,include - SetOperator,Advanced Uterine Corpus Carcinosarcoma,0
4310,Case (situation),gliosarcoma,0
4311,Enhance (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4312,Small Cell Lung Cancer Pathway,Angiosarcoma of liver,0
4313,Adrenocortical carcinoma,Thymoma malignant recurrent,0
4314,Symptoms,Female Breast Carcinoma,0
4315,>5,Malignant Neoplasm with Regional Lymph Node Involvement,0
4316,Therapeutic procedure,papillary carcinoma of penis,0
4317,Present,Refractory Barrett Esophagus,0
4318,Occurrence Indicator,High Grade Glandular Intraepithelial Neoplasia,0
4319,Breast Carcinoma,Intestinal Metaplasia of Bladder Urothelium,0
4320,Cancer Genus,Intraepithelial Melanocytic Hyperplasia,0
4321,Administration procedure,Intestinal Metaplasia of Bladder Urothelium,0
4322,AKR1A1 wt Allele,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4323,Togo,embryonal rhabdomyosarcoma of prostate,0
4324,>65 years,Chronic Myelomonocytic Leukemia-2,0
4325,Sufficiently defined concept definition status (core metadata concept),Acantholytic squamous cell carcinoma,0
4326,Lymphoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4327,National Human Genome Research Institute (U.S.),Acute Undifferentiated Leukemia,0
4328,Invasive Carcinoma,Endometrial Small Cell Carcinoma,0
4329,bony process,Thymic Atypical Carcinoid Tumor,0
4330,Vaginal Hemorrhage,Familial Hemophagocytic Lymphocytosis,0
4331,SPINK5 gene,Undifferentiated Endocervical Sarcoma,0
4332,Colon <insect>,Colorectal High Grade B-Cell Lymphoma,0
4333,Neoplastic Cell Transformation,Non-Metastatic Gestational Trophoblastic Tumor,0
4334,Orbit (brand of fungicide),Mixed parotid tumor,0
4335,Common Specifications in HL7 V3 Publishing,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4336,Age,Intestinal Metaplasia of Bladder Urothelium,0
4337,risk factors,Maxillary Sinus Adenocarcinoma,0
4338,Diagnosis Study,Cerebral Primitive Neuroectodermal Tumor,0
4339,Isolate - microorganism,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4340,Representation (action),Carcinoma of urinary bladder,0
4341,Personal appearance,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4342,Smoking,Cartilaginous exostosis,0
4343,Term (lexical),Acute lymphadenitis,0
4344,Including (qualifier),Childhood Choriocarcinoma,0
4345,Occurrence,Refractory Barrett Esophagus,0
4346,Highest,Childhood Choriocarcinoma,0
4347,Offspring,Intestinal Neuroendocrine Carcinoma,0
4348,Connect,Heavy Chain Deposition Disease,0
4349,How Much Distress Shortness of Breath,Benign tumor of eyelid,0
4350,Abdominal hysterectomy,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4351,include - SetOperator,Prostate Lymphoma,0
4352,Frequently,Ovarian germ cell choriocarcinoma stage IV,0
4353,Testing,Intraepithelial Melanocytic Hyperplasia,0
4354,leukemia,Primary Cutaneous Plasmablastic Lymphoma,0
4355,Non-Neoplastic Disorder,Unresectable Rhabdomyosarcoma,0
4356,Problems - What subject filter,Intraepithelial Melanocytic Hyperplasia,0
4357,Chemicals,Localized Ewing Sarcoma,0
4358,Pruritus,Childhood Thyroid Gland Follicular Carcinoma,0
4359,Increase,Adult Brain Stem Mixed Glioma,0
4360,Child,Non-Metastatic Gestational Trophoblastic Tumor,0
4361,Malignant Neoplasms,Refractory Glioma,0
4362,Adult,Unfavorable Non-Hodgkin Lymphoma,0
4363,Occur (action),Uterine Cancer,0
4364,Geographic Locations,Cartilaginous exostosis,0
4365,3+ Score,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4366,immunoglobulin complex location,Malignant melanoma of eyelid,0
4367,Scientific Study,Human Papillomavirus-Related Carcinoma,0
4368,Sequence Data Type,papillary carcinoma of penis,0
4369,SHORT STATURE,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4370,Childhood Lymphoma,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
4371,Guide device,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4372,Weight Loss,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4373,Feelings,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4374,Africa,Metastatic Lung Small Cell Carcinoma,0
4375,Parameterized Data Type - Set,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4376,Negation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4377,Vaginal neoplasia,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
4378,Adult Non-Hodgkin Lymphoma,Tonsillar Carcinoma,0
4379,Back structure,Intracortical osteosarcoma,0
4380,Less Than,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4381,Early,Blepharal carcinoma,0
4382,Obesity,Malignant neoplasm of thalamus,0
4383,Smear - instruction imperative,Neonatal leukemia,0
4384,IGHV@ gene cluster,Cartilaginous exostosis,0
4385,Spindle,Advanced Lung Carcinoma,0
4386,Platelets Product,Lipoma of small intestine,0
4387,Cessation of life,Colorectal Mucin Poor Hyperplastic Polyp,0
4388,depend,Cartilaginous exostosis,0
4389,Retinoic Acid Response Element,Atypical Lobular Breast Hyperplasia,0
4390,Pressure- physical agent,Testicular cancer metastatic,0
4391,include - SetOperator,Primary Cutaneous Plasmablastic Lymphoma,0
4392,Case (situation),Lipoma of small intestine,0
4393,Average of Value Derivation Technique,Spongiotic dermatitis,0
4394,Bothered by Vomiting,Recurrent Uveal Melanoma,0
4395,Hematopoietic Neoplasms,mucinous adenocarcinoma of gallbladder,0
4396,Affecting,Stage I Adult Non-Hodgkin Lymphoma,0
4397,Cachexia,Adenocarcinoma,0
4398,lymph nodes,Malignant Neoplasm with Regional Lymph Node Involvement,0
4399,Carcinogenesis,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4400,Neoplasms,Stage III Adult Immunoblastic Lymphoma,0
4401,unknown vaccine or immune globulin,Adenocarcinoma,0
4402,Main,Pancreatic Intraepithelial Neoplasia-3,0
4403,Two,Locally Advanced Soft Tissue Sarcoma,0
4404,Glioblastoma Multiforme Pathway,Lipoma of small intestine,0
4405,Mucous Membrane,Thymic Clear Cell Carcinoma,0
4406,United States,Metastatic Kidney Carcinoma,0
4407,To,Liver Lymphangioma,0
4408,IPSS Risk Category High,Grade 3a Malignant Neoplasm,0
4409,59,Placental aromatase deficiency,0
4410,Chemotherapy Regimen,Acute lymphadenitis,0
4411,Genetic Marker Expression,Childhood Fibrillary Astrocytoma,0
4412,Ovary,Benign Carotid Body Paraganglioma,0
4413,Abnormally high,Liver Lymphangioma,0
4414,Affecting,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4415,Back structure,Recurrent Uveal Melanoma,0
4416,Metastatic Neoplasm,Airway Hemangioma,0
4417,Human body structure,Stage IB Pancreatic Cancer AJCC v8,0
4418,Formation,Non-Metastatic Gestational Trophoblastic Tumor,0
4419,Pilot Projects,Childhood Fibrillary Astrocytoma,0
4420,Skin,Non-Metastatic Gestational Trophoblastic Tumor,0
4421,Shapes,Rhabdomyosarcoma with ganglionic differentiation,0
4422,Interstitial Route of Drug Administration,Heavy Chain Deposition Disease,0
4423,Surgical aspects,Adult Hepatocellular Carcinoma,0
4424,Borg Category-Ratio 10 Perceived Exertion Score 5,Mucinous adenocarcinoma gastric,0
4425,Version (morphologic abnormality),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4426,transport (device),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4427,Milliampere second,Benign Carotid Body Paraganglioma,0
4428,biopsy characteristics,Childhood Fibrillary Astrocytoma,0
4429,Trial Screening,Mucinous cystadenofibroma,0
4430,2+,Thymic Clear Cell Carcinoma,0
4431,Primary malignant neoplasm,Localized Askin Tumor,0
4432,Increased erythropoietin,Metastatic Malignant Neoplasm in the Sellar Region,0
4433,common types,Malignant Neoplasm with Regional Lymph Node Involvement,0
4434,pathologic fistula,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4435,Neoplasm Metastasis,Acute Undifferentiated Leukemia,0
4436,Fatal,Intestinal Metaplasia of Bladder Urothelium,0
4437,Asbestos,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4438,Nausea Visual Analogue Scale,Giant cell angiofibroma,0
4439,common types,Cancer of Urinary Tract,0
4440,Linear,Stage IV Penile Cancer AJCC v7,0
4441,Malignant - descriptor,Digestive System Hodgkin Lymphoma,0
4442,Science of Morphology,squamous cell carcinoma of the thyroid gland,0
4443,Most,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4444,Singular,Pancreatic Intraepithelial Neoplasia-3,0
4445,Nuclear (incident type),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4446,What subject filter - Result,Contact dermatitis due to alkali,0
4447,include - SetOperator,Low Grade Squamous Intraepithelial Neoplasia,0
4448,Neoplasms,Digestive System Hodgkin Lymphoma,0
4449,Tryptophanase,Undifferentiated Neuroblastoma,0
4450,Mast Cell Count,Cancer of Urinary Tract,0
4451,High Mitotic Activity,Small cell neuroendocrine carcinoma of bladder,0
4452,Form:Finding:Point in time:{Setting}:Document:{Role},Female Breast Carcinoma,0
4453,Cancer Genus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4454,Occurrence Indicator,Angiosarcoma of liver,0
4455,90%,Localized Askin Tumor,0
4456,survival aspects,Benign neoplasm of thorax,0
4457,shared attribute,Granular Cell Leiomyosarcoma,0
4458,Cerebellum,Endometrial Small Cell Carcinoma,0
4459,Cause of Death,Recurrent Testicular Lymphoma,0
4460,Firstly,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4461,Family history,Testicular cancer metastatic,0
4462,Genus Homo,Recurrent Testicular Lymphoma,0
4463,Primary malignant neoplasm,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
4464,Reduced,Adenocarcinoma,0
4465,Vaccination,squamous cell carcinoma of the thyroid gland,0
4466,Science of Etiology,Acute Undifferentiated Leukemia,0
4467,Secondary Neoplasm,Intraepithelial Melanocytic Hyperplasia,0
4468,Medical Device Emits Smoke,Malignant Neoplasm with Regional Lymph Node Involvement,0
4469,neck gland,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4470,Tissue Specimen Code,FIGO Stage II Ovarian Cancer,0
4471,Infected,Chronic Myelomonocytic Leukemia-2,0
4472,algorithm,Sarcomatoid Renal Cell Carcinoma,0
4473,Same,Heavy Chain Deposition Disease,0
4474,Usually,Cartilaginous exostosis,0
4475,Mixed (qualifier value),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
4476,Chemotherapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4477,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Adrenal Rest Tumor,0
4478,Contain (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4479,Deletion Mutation,Papillary cystic tumor,0
4480,Surrounding (qualifier value),Mucinous adenocarcinoma gastric,0
4481,Neurofibromatosis 2,Bladder squamous cell carcinoma stage I,0
4482,Benzene,Colorectal cancer,0
4483,Rare,gliosarcoma,0
4484,Bladder Neoplasm,Medulloblastoma,0
4485,Digestive Enzymes,Leiomyoma of Gallbladder,0
4486,Five,Cerebral Primitive Neuroectodermal Tumor,0
4487,Human body,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4488,Biological Response Modifiers,Refractory Barrett Esophagus,0
4489,Pelvic Pain,Bladder squamous cell carcinoma stage I,0
4490,Bone marrow aspiration procedure,Malignant melanoma of eyelid,0
4491,Gram per Deciliter,Metastatic Lung Small Cell Carcinoma,0
4492,Cells,Malignant melanoma of eyelid,0
4493,Count of entities,Malignant neoplasm of thalamus,0
4494,Natures,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4495,Dual,Breast Ductal Adenoma,0
4496,Present,Carcinoma ex pleomorphic adenoma of parotid gland,0
4497,Germ cell tumor,Sarcomatoid Renal Cell Carcinoma,0
4498,Infective cystitis,Xeroderma pigmentosum,0
4499,ovarian,Atypical Mesothelial Hyperplasia,0
4500,Hormonal,Choroid Necrotic Melanoma,0
4501,Malignant Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4502,AKR1A1 wt Allele,Cartilaginous exostosis,0
4503,Referring,Spongiotic dermatitis,0
4504,Gonadal Dysgenesis,Extra-Adrenal Paraganglioma,0
4505,Singular,Recurrent Uveal Melanoma,0
4506,Artificial Airways,Digestive System Hodgkin Lymphoma,0
4507,Risk,embryonal rhabdomyosarcoma of prostate,0
4508,<90,Low Grade Squamous Intraepithelial Neoplasia,0
4509,Histamine H2 Receptor Antagonists [MoA],Endometrial Small Cell Carcinoma,0
4510,Malignant - descriptor,Adenocarcinoma,0
4511,Primary,Undifferentiated Endocervical Sarcoma,0
4512,Liquid substance,Metastatic Neoplasm to the Gallbladder,0
4513,Offspring,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4514,See,Carcinoma of urinary bladder,0
4515,Tissue Growth,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4516,Sore Throat,Clonal Hematopoiesis of Indeterminate Potential,0
4517,Time,Pancreatic Intraepithelial Neoplasia-3,0
4518,Referring,BRCA2 Syndrome,0
4519,Dental White Spot,Uterine Cancer,0
4520,Adult Anaplastic Astrocytoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4521,Symptoms,Stage IB Lung Cancer AJCC v7,0
4522,Type - attribute,Rhabdomyosarcoma with ganglionic differentiation,0
4523,Term (temporal),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4524,risk factors - observation list,Uterine Cancer,0
4525,United States,Benign Carotid Body Paraganglioma,0
4526,Childhood Teratoma,Undifferentiated Neuroblastoma,0
4527,System One,Airway Hemangioma,0
4528,IPSS Risk Category Low,Liver Lymphangioma,0
4529,Feel Nausea,Childhood Lymphoma,0
4530,survival aspects,Primary Cutaneous Plasmablastic Lymphoma,0
4531,Hormonal,Chondrosarcoma,0
4532,Malignant Neoplasms,Anaplastic large cell lymphoma,0
4533,Related personal status,Adult Hepatocellular Carcinoma,0
4534,Togo,FIGO Stage II Ovarian Cancer,0
4535,Hair Specimen,Colorectal High Grade B-Cell Lymphoma,0
4536,Blood Proteins,Lipoma of small intestine,0
4537,Amount type - Percentage,Leptomeningeal sarcoma,0
4538,Esophagus,Metastatic Lung Small Cell Carcinoma,0
4539,Painless,Non-Metastatic Gestational Trophoblastic Tumor,0
4540,Fatigue,Thymic Atypical Carcinoid Tumor,0
4541,Endothelium,Medulloblastoma,0
4542,Exception - Property or Attribute,Diffuse malignant mesothelioma,0
4543,Locally,Stage I Adult Non-Hodgkin Lymphoma,0
4544,Derived value,Carcinoma ex pleomorphic adenoma of parotid gland,0
4545,Rating (action),Mucinous adenocarcinoma gastric,0
4546,Rapid,Platinum-Resistant Lung Small Cell Carcinoma,0
4547,Surgery specialty,sarcoma of spinal cord,0
4548,Larynx,Xeroderma pigmentosum,0
4549,2+,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
4550,Occur (action),Refractory Barrett Esophagus,0
4551,Dura Mater,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4552,Lung,Endometrial Small Cell Carcinoma,0
4553,Urinary Bladder,squamous cell carcinoma of the thyroid gland,0
4554,Carcinoma of lung,Adult Hepatocellular Carcinoma,0
4555,Deeply - dosing instruction fragment,Lung Mucinous Cystadenoma,0
4556,Improved - answer to question,Leiomyoma of Gallbladder,0
4557,Physical assessment findings,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4558,Tired,Acute lymphadenitis,0
4559,More,Adult Hepatocellular Carcinoma,0
4560,Tumor Mass,Unfavorable Non-Hodgkin Lymphoma,0
4561,Assortment,Intraepithelial Melanocytic Hyperplasia,0
4562,Compressing (action),Recurrent Uveal Melanoma,0
4563,Sunscreening Agents,Cancer of Urinary Tract,0
4564,Blood,High Grade Glandular Intraepithelial Neoplasia,0
4565,Neoplasms,Werner Syndrome,0
4566,Classification,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4567,risk factors,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4568,Aspects of signs,sarcoma of spinal cord,0
4569,Overall,Cancer of Urinary Tract,0
4570,Neck,Lung Mucinous Cystadenoma,0
4571,bony process,Benign Apocrine Neoplasm,0
4572,Covers (device),Stage II Hepatocellular Carcinoma AJCC v8,0
4573,Cavitation,Cancer of Urinary Tract,0
4574,Show,Uterine Cancer,0
4575,Including (qualifier),Tonsillar Carcinoma,0
4576,Running (physical activity),Collecting Duct Carcinoma of the Kidney,0
4577,Endometrium,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4578,Carcinoma,non-Hodgkin's lymphoma of spleen,0
4579,Confirmed by,Stage 0 Penile Cancer AJCC v8,0
4580,size,Intraepithelial Melanocytic Hyperplasia,0
4581,Togo,Uterine Cancer,0
4582,Relational and Item-Specific Encoding Task,Childhood Fibrillary Astrocytoma,0
4583,Thymic Tissue,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4584,1000000,Thymic Clear Cell Carcinoma,0
4585,Extreme Response,papillary carcinoma of penis,0
4586,Numerous,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4587,Average,Cancer of Urinary Tract,0
4588,Site,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4589,Hemopoietic tissue,Thymic Atypical Carcinoid Tumor,0
4590,Coughing,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4591,Experimental Result,Undifferentiated Endocervical Sarcoma,0
4592,+2,Low Grade Squamous Intraepithelial Neoplasia,0
4593,Occur (action),Childhood Lymphoma,0
4594,Adult Lymphoma,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
4595,Myeloid Leukemia,Methotrexate-Associated Hodgkin Lymphoma,0
4596,apply - action,Ovarian germ cell choriocarcinoma stage IV,0
4597,Common Specifications in HL7 V3 Publishing,Stage IB Pancreatic Cancer AJCC v8,0
4598,Malignant - descriptor,Testicular cancer metastatic,0
4599,Age at menopause:Time:Point in time:^Patient:Quantitative,Methotrexate-Associated Hodgkin Lymphoma,0
4600,Cell Count,Neoplasms,0
4601,Togo,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4602,insensitivity,Extra-Adrenal Paraganglioma,0
4603,1+ Score,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4604,Acute lymphocytic leukemia,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4605,Site,Intestinal Metaplasia of Bladder Urothelium,0
4606,Pain,FIGO Stage II Ovarian Cancer,0
4607,Nephroblastoma,Benign Apocrine Neoplasm,0
4608,Kind of quantity - Consistency,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4609,Retraction (finding),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4610,Treating,Anterior Urethral Malignant Neoplasm,0
4611,Occur (action),adenoid cystic carcinoma of lung,0
4612,Body tissue,Childhood Lymphoma,0
4613,Cervix Uteri,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4614,Malignant neoplasm of urinary bladder,Unresectable Rhabdomyosarcoma,0
4615,Disease,Adrenal Rest Tumor,0
4616,described,Human Papillomavirus-Related Carcinoma,0
4617,Structure of germinal center of lymph node,Acute lymphadenitis,0
4618,MOSTLY,Recurrent Uveal Melanoma,0
4619,Smear - instruction imperative,Neonatal leukemia,0
4620,contents - HtmlLinkType,Malignant melanoma of eyelid,0
4621,Digital Content Category,Human Papillomavirus-Related Carcinoma,0
4622,Cervix carcinoma,Malignant melanoma of eyelid,0
4623,Including (qualifier),Diffuse malignant mesothelioma,0
4624,Operative Surgical Procedures,Acantholytic squamous cell carcinoma,0
4625,Two,High Grade Glandular Intraepithelial Neoplasia,0
4626,Known,Medulloblastoma,0
4627,200,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4628,Law enforcement arrest,Platinum-Resistant Lung Small Cell Carcinoma,0
4629,Prostate,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4630,Breast Carcinoma,Stage IB Pancreatic Cancer AJCC v8,0
4631,To,Giant cell angiofibroma,0
4632,Extrinsic,Colorectal Neuroendocrine Tumor G2,0
4633,Human Cells,Uterine Cancer,0
4634,FAT1 wt Allele,Mixed parotid tumor,0
4635,Type - attribute,Bladder squamous cell carcinoma stage I,0
4636,Color change,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4637,Organ,Spongiotic dermatitis,0
4638,Infrequent,Intestinal Metaplasia of Bladder Urothelium,0
4639,Primary mucinous cystadenocarcinoma of lung,Acute Undifferentiated Leukemia,0
4640,Moveable,Acantholytic squamous cell carcinoma,0
4641,Disease,Malignant neoplasm of thalamus,0
4642,Inguinal part of abdomen,Benign tumor of eyelid,0
4643,Body tissue,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4644,Singular,Intestinal Metaplasia of Bladder Urothelium,0
4645,Cutaneous Melanoma,Unresectable Rhabdomyosarcoma,0
4646,Combined Modality Therapy,Testicular cancer metastatic,0
4647,Pharmacotherapy,Cancer of Urinary Tract,0
4648,Death (finding),Stage IB Pancreatic Cancer AJCC v8,0
4649,Feelings,Recurrent Uveal Melanoma,0
4650,Xeroderma Pigmentosum,Female Breast Carcinoma,0
4651,Therapeutic radiology procedure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
4652,Breeding,Primary Cutaneous Plasmablastic Lymphoma,0
4653,Pleura,Methotrexate-Associated Hodgkin Lymphoma,0
4654,Malignant neoplasm of stomach,Ovarian germ cell choriocarcinoma stage IV,0
4655,Recommendation,FIGO Stage II Ovarian Cancer,0
4656,Ten,Human Papillomavirus-Related Carcinoma,0
4657,combination - answer to question,Clonal Hematopoiesis of Indeterminate Potential,0
4658,Good,Acute Undifferentiated Leukemia,0
4659,Left,Benign neoplasm of thorax,0
4660,To,Acute Undifferentiated Leukemia,0
4661,combination of objects,Undifferentiated Endocervical Sarcoma,0
4662,Binding action,Unresectable Rhabdomyosarcoma,0
4663,Immediate,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4664,2+,embryonal rhabdomyosarcoma of prostate,0
4665,second (number),Contact dermatitis due to alkali,0
4666,Inguinal region,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4667,heterochromatin domain,Chondrosarcoma,0
4668,Aggressive behavior,Advanced Lung Carcinoma,0
4669,Common Specifications in HL7 V3 Publishing,papillary carcinoma of penis,0
4670,Usually,adenosquamous carcinoma of breast,0
4671,Measures,Blepharal carcinoma,0
4672,combination - answer to question,Acantholytic squamous cell carcinoma,0
4673,Result,Metastatic Malignant Neoplasm in the Sellar Region,0
4674,Three,gliosarcoma,0
4675,Exostosis,Stage 0 Lip Carcinoma,0
4676,Use of,Cerebral hemangioma,0
4677,How Often Weight Loss,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4678,Exposure to,Neonatal leukemia,0
4679,Abdominal Cavity,Neonatal leukemia,0
4680,Males,Larynx carcinoma recurrent,0
4681,Affect (mental function),Endometrial Small Cell Carcinoma,0
4682,Low Back Pain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4683,Thymoma,High Grade Glandular Intraepithelial Neoplasia,0
4684,Stat (do immediately),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4685,Cerebral Cavernous Hemangioma,Malignant melanoma of eyelid,0
4686,Idle,Undifferentiated Neuroblastoma,0
4687,Western World,Testicular cancer metastatic,0
4688,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Mucinous adenocarcinoma gastric,0
4689,Pain,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
4690,Worse,Chondrosarcoma,0
4691,High risk of,benign mature teratoma of pancreas,0
4692,Buildup,Intracortical osteosarcoma,0
4693,Togo,Endometrial Small Cell Carcinoma,0
4694,<90,Acute lymphadenitis,0
4695,Call (Instruction),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4696,Chemotherapy Regimen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4697,Statistical Prevalence,Intraepithelial Melanocytic Hyperplasia,0
4698,Tissue Growth,Acantholytic squamous cell carcinoma,0
4699,Pain NOS,Colorectal Neuroendocrine Tumor G2,0
4700,Sharing (Social Behavior),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4701,Capillary vessel,Refractory Barrett Esophagus,0
4702,Blood flow,Mucinous adenocarcinoma gastric,0
4703,Combined,Pancreatic Intraepithelial Neoplasia-3,0
4704,Inguinal part of abdomen,Diffuse malignant mesothelioma,0
4705,Treated with,Recurrent Uveal Melanoma,0
4706,Ascites,Liver Lymphangioma,0
4707,Love,Human Papillomavirus-Related Carcinoma,0
4708,Seminoma,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
4709,Abnormal cell,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4710,Confirmation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4711,Specimen Source Codes - tumor,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4712,Brain Neoplasms,Non-Metastatic Gestational Trophoblastic Tumor,0
4713,radiotherapeutic,Malignant neoplasm of thalamus,0
4714,Qualitative form,Carcinoma of urinary bladder,0
4715,Environmental risk factor,Leiomyoma of Gallbladder,0
4716,17th century,Childhood Fibrillary Astrocytoma,0
4717,Chemotherapy Regimen,Localized Ewing Sarcoma,0
4718,Possible,Familial Hemophagocytic Lymphocytosis,0
4719,Skull,Malignant Testicular Sertoli Cell Tumor,0
4720,day,Childhood Fibrillary Astrocytoma,0
4721,Occurrence,Undifferentiated Endocervical Sarcoma,0
4722,The Sun,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4723,Repair,Atypical Lobular Breast Hyperplasia,0
4724,Pleomorphism (morphologic abnormality),adenoid cystic carcinoma of lung,0
4725,respiratory,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4726,Neoplasms,Recurrent Uveal Melanoma,0
4727,status - In progress,Extra-Adrenal Paraganglioma,0
4728,Surrounding (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
4729,Earache,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4730,Case unit dose,Primary Cutaneous Plasmablastic Lymphoma,0
4731,Grouped (qualifier value),Breast Ductal Adenoma,0
4732,Administration procedure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4733,Hypesthesia,Localized Ewing Sarcoma,0
4734,Most,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4735,Occur (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4736,Heart failure,Intracortical osteosarcoma,0
4737,Limited stage (cancer stage),embryonal rhabdomyosarcoma of prostate,0
4738,Pharyngeal structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4739,Height / growth measure,Advanced Uterine Corpus Carcinosarcoma,0
4740,Marrow plasma cell,Tonsillar Carcinoma,0
4741,Smear - instruction imperative,Cerebral hemangioma,0
4742,Benign,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4743,Human body structure,High Grade Glandular Intraepithelial Neoplasia,0
4744,Vaginal (intended site),Choroid Necrotic Melanoma,0
4745,Thin (qualifier value),adenosquamous carcinoma of breast,0
4746,Minor salivary gland structure,Human Papillomavirus-Related Carcinoma,0
4747,Usual Severity Pain,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4748,Reduced,Refractory Barrett Esophagus,0
4749,Operative Surgical Procedures,papillary carcinoma of penis,0
4750,Five-year Survival Rate,malignant lymphoma of pancreatic lymph nodes,0
4751,Hematology+Oncology,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4752,NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology,Giant cell angiofibroma,0
4753,True primary (qualifier value),Thymic Atypical Carcinoid Tumor,0
4754,associated disease,Testicular cancer metastatic,0
4755,Entity Determiner - specific,Primary Cutaneous Plasmablastic Lymphoma,0
4756,Tumor Mass,Stage IV Childhood Non-Hodgkin Lymphoma,0
4757,treatment - ActInformationManagementReason,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4758,Carcinoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4759,Mature Teratoma,Uterine Cancer,0
4760,Vision,Digestive System Hodgkin Lymphoma,0
4761,examination of cervix,Thymic Clear Cell Carcinoma,0
4762,Lead,Benign neoplasm of thorax,0
4763,Adult human body,Human Papillomavirus-Related Carcinoma,0
4764,Evaluation procedure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4765,Late,Human Papillomavirus-Related Carcinoma,0
4766,Offspring,Metastatic Lung Small Cell Carcinoma,0
4767,Young,Endometrial Small Cell Carcinoma,0
4768,Plant seeds,Xeroderma pigmentosum,0
4769,General surgery specialty,Neonatal leukemia,0
4770,Two,Serous cystadenocarcinoma ovary,0
4771,various other intestinal adsorbents in ATC,Fourth Ventricle and Brain Stem Ependymal Tumor,0
4772,Overall Survival,Carcinoma of urinary bladder,0
4773,Onset of (contextual qualifier),Metastatic Lung Small Cell Carcinoma,0
4774,Time,embryonal rhabdomyosarcoma of prostate,0
4775,Case (situation),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4776,Short Value,Benign Apocrine Neoplasm,0
4777,Tobacco smoking behavior,Blepharal carcinoma,0
4778,Classical Hodgkin's Lymphoma,Childhood Thyroid Gland Follicular Carcinoma,0
4779,Plumbum metallicum,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4780,Case (situation),Thymic Clear Cell Carcinoma,0
4781,React,Benign Carotid Body Paraganglioma,0
4782,Firstly,Lung squamous cell carcinoma stage I,0
4783,Gonadal structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4784,Skin,Adult Alveolar Soft Part Sarcoma,0
4785,Malignant Neoplasms,Ovarian germ cell choriocarcinoma stage IV,0
4786,North America,Pancreatic Intraepithelial Neoplasia-3,0
4787,Classification of information,Leiomyoma of Gallbladder,0
4788,second (number),Intestinal Neuroendocrine Carcinoma,0
4789,Plant nodule,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4790,low exposure,Recurrent Testicular Lymphoma,0
4791,Pleomorphic,Stage II Carcinoma of Penis,0
4792,Qualitative form,Recurrent Uveal Melanoma,0
4793,Malignant Neoplasms,Papillary cystic tumor,0
4794,Antibiotics,Cancer of Urinary Tract,0
4795,Meibomian Cyst,Choroid Necrotic Melanoma,0
4796,Loss of appetite (finding),Neonatal leukemia,0
4797,Heartburn,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4798,Rhabdomyosarcoma,Undifferentiated Endocervical Sarcoma,0
4799,Volume 2,Placental aromatase deficiency,0
4800,Parotid Neoplasms,Familial Hemophagocytic Lymphocytosis,0
4801,Component object,benign mature teratoma of pancreas,0
4802,Table Cell Horizontal Align - left,Digestive System Hodgkin Lymphoma,0
4803,Science of Morphology,Endometrial Small Cell Carcinoma,0
4804,Case (situation),Extracranial Neuroblastoma,0
4805,Post,Acantholytic squamous cell carcinoma,0
4806,Type - attribute,adenosquamous carcinoma of breast,0
4807,Increased Immunologic Activity [PE],Secondary malignant neoplasm of lymph node,0
4808,Japanese race,Childhood Central Nervous System Immature Teratoma,0
4809,Oral region,Benign tumor of eyelid,0
4810,Call (Instruction),FIGO Stage II Ovarian Cancer,0
4811,Adult Alveolar Soft Part Sarcoma,Rhabdomyosarcoma with ganglionic differentiation,0
4812,Greatly,Human Papillomavirus-Related Carcinoma,0
4813,Time (foundation metadata concept),Malignant melanoma of eyelid,0
4814,Malignant neoplasm of lung,Angiosarcoma of liver,0
4815,Cells,Localized Askin Tumor,0
4816,40%,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4817,High risk,Cartilaginous exostosis,0
4818,Supportive assistance,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4819,Death (finding),Botryoid-Type Embryonal Rhabdomyosarcoma,0
4820,All,Undifferentiated Endocervical Sarcoma,0
4821,various antiinfectives and antiseptics for local oral treatment,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4822,Sunlight,Liver Lymphangioma,0
4823,Nausea,Giant cell angiofibroma,0
4824,Sunlight,Adult Hepatocellular Carcinoma,0
4825,chapter,Non-Metastatic Gestational Trophoblastic Tumor,0
4826,Five,Airway Hemangioma,0
4827,shared attribute,mucinous adenocarcinoma of gallbladder,0
4828,Pleura,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4829,Esthesia,mucinous adenocarcinoma of gallbladder,0
4830,Subtype (attribute),Fourth Ventricle and Brain Stem Ependymal Tumor,0
4831,SMG1 wt Allele,Diffuse malignant mesothelioma,0
4832,Image Feature,Extracranial Neuroblastoma,0
4833,Lower Extremity,High Grade Glandular Intraepithelial Neoplasia,0
4834,Entire elbow region,Anaplastic large cell lymphoma,0
4835,Heterogeneity,Benign neoplasm of thorax,0
4836,Broken skin,Chondrosarcoma,0
4837,Operative Surgical Procedures,Human Papillomavirus-Related Carcinoma,0
4838,Male population group,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4839,New,Tonsillar Carcinoma,0
4840,pharmacotherapeutic,Uterine Cancer,0
4841,Sometimes,Malignant Neoplasm with Regional Lymph Node Involvement,0
4842,United States,Diffuse malignant mesothelioma,0
4843,Interferes with,Diffuse malignant mesothelioma,0
4844,Basis - conceptual entity,embryonal rhabdomyosarcoma of prostate,0
4845,What subject filter - Result,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4846,Premalignant,Cerebral Primitive Neuroectodermal Tumor,0
4847,Treated with,Liver Cavernous Hemangioma,0
4848,Multiple Partners,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4849,Touch sensation,Metastatic Carcinoma in the Lung,0
4850,Occur (action),Recurrent Uveal Melanoma,0
4851,Granulocyte component of blood,de novo Myelodysplastic Syndrome,0
4852,Five-year Survival Rate,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4853,Retinoic Acid Response Element,Benign neoplasm of thorax,0
4854,Common (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
4855,Condition,Diffuse malignant mesothelioma,0
4856,Value Above Reference Range,Adult Alveolar Soft Part Sarcoma,0
4857,Class,Werner Syndrome,0
4858,veterans alcoholism screening test (VAST),Non-Metastatic Gestational Trophoblastic Tumor,0
4859,Case (situation),Keratoderma,0
4860,Neoplasm Metastasis,Spongiotic dermatitis,0
4861,Protons,Acute Undifferentiated Leukemia,0
4862,Small,BRCA2 Syndrome,0
4863,Palatine Tonsil,Adult Alveolar Soft Part Sarcoma,0
4864,System,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4865,Cardiac Lead Procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4866,Special,Papillary cystic tumor,0
4867,Occur (action),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4868,Reduced,Chronic Myelomonocytic Leukemia-2,0
4869,Screening procedure,Stage IB Pancreatic Cancer AJCC v8,0
4870,Name,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4871,risk factors,Undifferentiated Endocervical Sarcoma,0
4872,Negation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4873,Moist,adenoid cystic carcinoma of lung,0
4874,Females,Digestive System Hodgkin Lymphoma,0
4875,Stomach structure,BRCA2 Syndrome,0
4876,Papillomavirus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4877,2+,Acute lymphadenitis,0
4878,Unit,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4879,Negation,Adult Alveolar Soft Part Sarcoma,0
4880,mesodermal,Thymic Clear Cell Carcinoma,0
4881,Molecular Mass,Intestinal Metaplasia of Bladder Urothelium,0
4882,Firstly,Liver Cavernous Hemangioma,0
4883,Specimen Type - Macrophages,Leptomeningeal sarcoma,0
4884,chance,Unfavorable Non-Hodgkin Lymphoma,0
4885,Arranged (transportation),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4886,Cystoscopy,Unfavorable Non-Hodgkin Lymphoma,0
4887,Smaller,Carcinoma ex pleomorphic adenoma of parotid gland,0
4888,Affecting,Thymic Clear Cell Carcinoma,0
4889,Connective Tissue,Refractory Barrett Esophagus,0
4890,Rest,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4891,Plasma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4892,Breast Cancer Type 1 Susceptibility Protein Measurement,Female Breast Carcinoma,0
4893,Rating (action),Giant cell angiofibroma,0
4894,Intestines,Maxillary Sinus Adenocarcinoma,0
4895,Science of Etiology,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4896,Thinking,Methotrexate-Associated Hodgkin Lymphoma,0
4897,General surgery specialty,Uterine Cancer,0
4898,Individual,Medulloblastoma,0
4899,CD44 wt Allele,Stage II Carcinoma of Penis,0
4900,Animals,Diffuse malignant mesothelioma,0
4901,Cell Count,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4902,risk factors - observation list,Pancreatic Intraepithelial Neoplasia-3,0
4903,Domain (area of knowledge),Recurrent Uveal Melanoma,0
4904,Localized,Spermatocytic seminoma,0
4905,Recurrent infections,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4906,/40,Diffuse malignant mesothelioma,0
4907,Feel Tired question,Intraepithelial Melanocytic Hyperplasia,0
4908,Back Pain,Airway Hemangioma,0
4909,shared attribute,Serous cystadenocarcinoma ovary,0
4910,therapeutic aspects,Stage 0 Penile Cancer AJCC v8,0
4911,Surgical aspects,Localized Askin Tumor,0
4912,3+ Score,High Grade Glandular Intraepithelial Neoplasia,0
4913,Egg of order Phthiraptera,Giant cell angiofibroma,0
4914,Form of uterus,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4915,Malignant Childhood Neoplasm,Mucinous adenocarcinoma gastric,0
4916,Very,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4917,Body structure,FIGO Stage II Ovarian Cancer,0
4918,growth aspects,Cancer of Urinary Tract,0
4919,Include (action),Anterior Urethral Malignant Neoplasm,0
4920,regional,Ovarian germ cell choriocarcinoma stage IV,0
4921,Type - attribute,Mucinous cystadenofibroma,0
4922,Name,Malignant Testicular Sertoli Cell Tumor,0
4923,Common (qualifier value),Larynx carcinoma recurrent,0
4924,Treatment intent,Extracranial Neuroblastoma,0
4925,Cause of Death,Thymic Atypical Carcinoid Tumor,0
4926,% live,Stage II Carcinoma of Penis,0
4927,Dimple,Adult Fibrolamellar Carcinoma,0
4928,Presence (property),FIGO Stage II Ovarian Cancer,0
4929,Data Transformation,Childhood Fibrillary Astrocytoma,0
4930,subapical complex location,Stage 0 Penile Cancer AJCC v8,0
4931,Occur (action),Intestinal Neuroendocrine Carcinoma,0
4932,Manufactured form,Platinum-Resistant Lung Small Cell Carcinoma,0
4933,Genes,Bladder squamous cell carcinoma stage I,0
4934,Common (qualifier value),Localized Askin Tumor,0
4935,Most,Neonatal leukemia,0
4936,Often - answer to question,Childhood Fibrillary Astrocytoma,0
4937,Borg Category-Ratio 10 Perceived Exertion Score 5,Benign neoplasm of thorax,0
4938,Esophageal manometry,Malignant Neoplasm with Regional Lymph Node Involvement,0
4939,Treatment Epoch,Refractory Barrett Esophagus,0
4940,Formation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4941,week,Mucinous neoplasm,0
4942,Treated with,Tonsillar Carcinoma,0
4943,per year,Heavy Chain Deposition Disease,0
4944,Headache,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4945,One,Pilocytic astrocytoma of cerebellum,0
4946,What subject filter - Result,Acantholytic squamous cell carcinoma,0
4947,Chemotherapy Regimen,Stage 0 Penile Cancer AJCC v8,0
4948,Unmarried person,Cancer of Urinary Tract,0
4949,seen,Cancer of Urinary Tract,0
4950,Specimen Source Codes - Tears,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4951,1+ Score,Stage IB Lung Cancer AJCC v7,0
4952,various other agents for local oral treatment in ATC,Neoplasms,0
4953,Various patch test substance,Undifferentiated Endocervical Sarcoma,0
4954,Infection,Acute Undifferentiated Leukemia,0
4955,Classification of information,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4956,Contain (action),Angiosarcoma of liver,0
4957,Cancer Other,Adenocarcinoma,0
4958,Occur (action),Small cell neuroendocrine carcinoma of bladder,0
4959,seconds,Thymoma malignant recurrent,0
4960,Adenocarcinoma of large intestine,Neonatal leukemia,0
4961,Hormonal Contraception,Ichthyosis,0
4962,Evidence,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
4963,With shape,Liver Cavernous Hemangioma,0
4964,75,Mucinous adenocarcinoma gastric,0
4965,Smudge Cell Count,Malignant Testicular Sertoli Cell Tumor,0
4966,Diagnosis Study,sarcoma of spinal cord,0
4967,Associated topography,Uterine Cancer,0
4968,Leukemia,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4969,Spreading (qualifier value),Human Papillomavirus-Related Carcinoma,0
4970,How Much Distress Weight Loss,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4971,Skin tanning,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
4972,Leg,Diffuse malignant mesothelioma,0
4973,Often - answer to question,Granular Cell Leiomyosarcoma,0
4974,Late,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4975,Ephrin Type-B Receptor 1,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4976,Embryonal Rhabdomyosarcoma,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
4977,Skin Specimen,Clonal Hematopoiesis of Indeterminate Potential,0
4978,/hour,BRCA2 Syndrome,0
4979,Case unit dose,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4980,Complication,Xeroderma pigmentosum,0
4981,Abnormal Reference Range,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4982,Chemotherapy,Locally Advanced Soft Tissue Sarcoma,0
4983,Varies,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4984,Togo,Recurrent Uveal Melanoma,0
4985,physiological aspects,Benign tumor of eyelid,0
4986,Severe (severity modifier),Malignant Neoplasm with Regional Lymph Node Involvement,0
4987,Dietary Lead,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4988,Rare Diseases,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4989,Occipital,Testicular cancer metastatic,0
4990,Long,Human Papillomavirus-Related Carcinoma,0
4991,Togo,Cerebral Primitive Neuroectodermal Tumor,0
4992,Case (situation),Contact dermatitis due to alkali,0
4993,Astrocytoma,Human Papillomavirus-Related Carcinoma,0
4994,Fever,Adult Alveolar Soft Part Sarcoma,0
4995,Replacement,Endometrial Small Cell Carcinoma,0
4996,Irregular,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4997,Detection,Testicular cancer metastatic,0
4998,Following,Undifferentiated Endocervical Sarcoma,0
4999,Group A (blood group),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5000,Glioma,Prostate Lymphoma,0
5001,Physical findings,Chronic Myelomonocytic Leukemia-2,0
5002,Involvement with,Undifferentiated Endocervical Sarcoma,0
5003,Body tissue,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5004,Back structure,Undifferentiated Endocervical Sarcoma,0
5005,Obesity,Pancreatic Intraepithelial Neoplasia-3,0
5006,Carbohydrate nutrients,Colorectal High Grade B-Cell Lymphoma,0
5007,Derivative,Malignant Testicular Sertoli Cell Tumor,0
5008,Age,Stage IB Pancreatic Cancer AJCC v8,0
5009,Administration procedure,Hemangioma,0
5010,Formation,Female Breast Carcinoma,0
5011,Screening procedure,Benign Apocrine Neoplasm,0
5012,Frequently,Ovarian germ cell choriocarcinoma stage IV,0
5013,Pilocytic Astrocytoma,Cartilaginous exostosis,0
5014,Last,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5015,Acquired (qualifier value),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
5016,Logical Condition,Advanced Lung Carcinoma,0
5017,Most,Malignant Testicular Sertoli Cell Tumor,0
5018,Mother (person),Benign neoplasm of thorax,0
5019,brain shape,Undifferentiated Endocervical Sarcoma,0
5020,High Risk Acute Leukemia,BRCA2 Syndrome,0
5021,Togo,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5022,Tactile,Grade 1 Clear Cell Renal Cell Carcinoma,0
5023,Painless,Diffuse malignant mesothelioma,0
5024,Root Mean Square,adenoid cystic carcinoma of lung,0
5025,Caucasoid Race,mucinous adenocarcinoma of gallbladder,0
5026,First Intercourse,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5027,American College of Cardiology/American Heart Association Lesion Complexity Score C,Localized Ewing Sarcoma,0
5028,1+ Score,Refractory Barrett Esophagus,0
5029,Congenital meningocele,Chronic Myelomonocytic Leukemia-2,0
5030,3+ Score,Non-Metastatic Gestational Trophoblastic Tumor,0
5031,Give - dosing instruction imperative,Ovarian Carcinoid Tumor,0
5032,OTULIN gene,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5033,risk factors,Angiosarcoma of liver,0
5034,Imbrication (procedure),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5035,High Risk Acute Leukemia,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5036,History,Colorectal cancer,0
5037,Manufactured form,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
5038,dendritic spine neck,Collecting Duct Carcinoma of the Kidney,0
5039,Life,Ichthyosis,0
5040,Descent,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
5041,Thymus Gland,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5042,Function Axis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5043,Unique,Ichthyosis,0
5044,Molecule,Granular Cell Leiomyosarcoma,0
5045,Pain,Testicular cancer metastatic,0
5046,Wild flowers,Adult Alveolar Soft Part Sarcoma,0
5047,Histologic type,Undifferentiated Endocervical Sarcoma,0
5048,Malignant Neoplasms,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5049,Toxic Epidermal Necrolysis,Cerebral Primitive Neuroectodermal Tumor,0
5050,*Type - Kind of quantity,Mucinous neoplasm,0
5051,In Blood,Deep Leiomyoma,0
5052,Group A (blood group),Locally Advanced Soft Tissue Sarcoma,0
5053,Brain,Colorectal High Grade B-Cell Lymphoma,0
5054,Beginning,Adult Hepatocellular Carcinoma,0
5055,Microscopy,Spermatocytic seminoma,0
5056,Manufactured sign,Childhood Choriocarcinoma,0
5057,Common Specifications in HL7 V3 Publishing,Giant cell angiofibroma,0
5058,Internal,Cerebral Primitive Neuroectodermal Tumor,0
5059,Age,Cancer of Urinary Tract,0
5060,Beginning,Anterior Urethral Malignant Neoplasm,0
5061,Prostate,mucinous adenocarcinoma of gallbladder,0
5062,Classical Hodgkin's Lymphoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5063,Stem of Organ,Cancer of Urinary Tract,0
5064,Cause of Death,Familial Hemophagocytic Lymphocytosis,0
5065,Type - attribute,Familial Hemophagocytic Lymphocytosis,0
5066,Cancer Genus,gliosarcoma,0
5067,Symptoms aspect,Liver Lymphangioma,0
5068,Diffuse,Refractory Barrett Esophagus,0
5069,Disease Screening,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5070,Known,BRCA2 Syndrome,0
5071,Complication,Digestive System Hodgkin Lymphoma,0
5072,Result,Cancer of Urinary Tract,0
5073,Manufactured form,Malignant Testicular Sertoli Cell Tumor,0
5074,Feel Tired question,Noninfiltrating Intraductal Carcinoma,0
5075,Abdominal bloating,Angiosarcoma of liver,0
5076,Type - attribute,Intestinal Metaplasia of Bladder Urothelium,0
5077,What subject filter - Result,Neonatal leukemia,0
5078,Out (direction),Spongiotic dermatitis,0
5079,Offspring,Carcinoma ex pleomorphic adenoma of parotid gland,0
5080,Nature,adenoid cystic carcinoma of lung,0
5081,Manufactured form,Malignant neoplasm of thalamus,0
5082,Affecting,Maxillary Sinus Adenocarcinoma,0
5083,Containing (qualifier),Malignant neoplasm of thalamus,0
5084,Area,Cancer of Urinary Tract,0
5085,Cells,Acantholytic squamous cell carcinoma,0
5086,Anterior portion of neck,Cerebral Primitive Neuroectodermal Tumor,0
5087,To,Refractory Glioma,0
5088,66,Pancreatic Intraepithelial Neoplasia-3,0
5089,Vulva,Human Papillomavirus-Related Carcinoma,0
5090,Teratoma,Undifferentiated Endocervical Sarcoma,0
5091,Descending,Acute Undifferentiated Leukemia,0
5092,Including (qualifier),Malignant Neoplasm of Lung - Multiple Primary Sites,0
5093,Include (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5094,Scientific Study,Adult Fibrolamellar Carcinoma,0
5095,Pruritus,Intraepithelial Melanocytic Hyperplasia,0
5096,Top (position),Diffuse malignant mesothelioma,0
5097,seconds,Diffuse malignant mesothelioma,0
5098,Desmoplastic fibroma,Carcinoma of urinary bladder,0
5099,Involvement with,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5100,Ultraviolet Rays,Tonsillar Carcinoma,0
5101,Therapeutic radiology procedure,Stage II Carcinoma of Penis,0
5102,Death Related to Adverse Event,FIGO Stage II Ovarian Cancer,0
5103,Biopsy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5104,Pharmacotherapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5105,Operative Surgical Procedures,Endometrial Small Cell Carcinoma,0
5106,Subgroup A Nepoviruses,Recurrent Testicular Lymphoma,0
5107,Area,Neonatal leukemia,0
5108,Occur (action),Intestinal Metaplasia of Bladder Urothelium,0
5109,Decreasing,Adenocarcinoma,0
5110,Malignant tumor of colon,Pancreatic Intraepithelial Neoplasia-3,0
5111,Mutation,Familial Hemophagocytic Lymphocytosis,0
5112,Aplasia Cutis Congenita,Malignant melanoma of eyelid,0
5113,Premalignant,adenoid cystic carcinoma of lung,0
5114,Type - attribute,Airway Hemangioma,0
5115,Make - Instruction Imperative,Hodgkin lymphoma,0
5116,Difficulty walking,Female Breast Carcinoma,0
5117,diagnosis aspect,Angiosarcoma of liver,0
5118,production,Carcinoma of urinary bladder,0
5119,Formation,Atypical Lobular Breast Hyperplasia,0
5120,shared attribute,Lipoma of small intestine,0
5121,Deep Resection Margin,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
5122,Survival Rate,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5123,Name (property) (qualifier value),Childhood Choriocarcinoma,0
5124,Carcinoma,Stage IB Pancreatic Cancer AJCC v8,0
5125,Human Chorionic Gonadotropin,Malignant neoplasm of thalamus,0
5126,Current (present time),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5127,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Cerebral hemangioma,0
5128,Adenocarcinoma,Mucinous adenocarcinoma gastric,0
5129,Representation (action),Neonatal leukemia,0
5130,size,Digestive System Hodgkin Lymphoma,0
5131,Early,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5132,various other nasal preparations in ATC,Angiosarcoma of liver,0
5133,One,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5134,Area,High Grade Glandular Intraepithelial Neoplasia,0
5135,cell type,Giant cell angiofibroma,0
5136,User Group,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5137,Function (attribute),Anterior Urethral Malignant Neoplasm,0
5138,Onset of Action,Diffuse malignant mesothelioma,0
5139,Blood Vessel,Carcinoma ex pleomorphic adenoma of parotid gland,0
5140,per year,Thymic Clear Cell Carcinoma,0
5141,Connect,Rhabdomyosarcoma with ganglionic differentiation,0
5142,Hollings Cancer Center,Atypical Lobular Breast Hyperplasia,0
5143,Surgery specialty,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5144,shared attribute,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5145,Medical service,Methotrexate-Associated Hodgkin Lymphoma,0
5146,Simpson Grade 3,Recurrent Diffuse Intrinsic Pontine Glioma,0
5147,More,Clonal Hematopoiesis of Indeterminate Potential,0
5148,Neutral pH,Colorectal Mucin Poor Hyperplastic Polyp,0
5149,Lymphocyte,Localized Askin Tumor,0
5150,Adult Germ Cell Tumor,Adult Hepatocellular Carcinoma,0
5151,Common Specifications in HL7 V3 Publishing,Childhood Fibrillary Astrocytoma,0
5152,Combined,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5153,Mechanism Component of Device,Childhood Fibrillary Astrocytoma,0
5154,Biomaterial Treatment,Collecting Duct Carcinoma of the Kidney,0
5155,Forecast of outcome,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5156,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Anterior Urethral Malignant Neoplasm,0
5157,Percent (qualifier value),Adrenal Rest Tumor,0
5158,Histologic,Anterior Urethral Malignant Neoplasm,0
5159,Bothered by Night Sweats,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5160,Mild pain,Xeroderma pigmentosum,0
5161,Lymphoid Tissue,Grade 1 Clear Cell Renal Cell Carcinoma,0
5162,Malignant neoplasm of gastrointestinal tract,Anterior Urethral Malignant Neoplasm,0
5163,Lynch Syndrome,Carcinoma ex pleomorphic adenoma of parotid gland,0
5164,Science of Etiology,Human Papillomavirus-Related Carcinoma,0
5165,Individual,Placental aromatase deficiency,0
5166,Life,Metastatic Malignant Neoplasm in the Sellar Region,0
5167,Age at diagnosis,Acantholytic squamous cell carcinoma,0
5168,Transformation,embryonal rhabdomyosarcoma of prostate,0
5169,Food,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5170,Unknown,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5171,Cell Count,Childhood Fibrillary Astrocytoma,0
5172,Accumulation of fluid,Localized Askin Tumor,0
5173,Enlarged,Clonal Hematopoiesis of Indeterminate Potential,0
5174,commercial,Localized Ewing Sarcoma,0
5175,Benign,Stage I Adult Non-Hodgkin Lymphoma,0
5176,aggressive cancer,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5177,Age of Onset,Metastatic Neoplasm to the Gallbladder,0
5178,Early,Acantholytic squamous cell carcinoma,0
5179,Teens,mucinous adenocarcinoma of gallbladder,0
5180,Childhood Leukemia,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5181,FLT3LG wt Allele,Giant cell angiofibroma,0
5182,Chest Pain,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5183,Node - plant part,Extra-Adrenal Paraganglioma,0
5184,Lung,Bladder squamous cell carcinoma stage I,0
5185,Squamous cell carcinoma,Diffuse malignant mesothelioma,0
5186,Clear,Heavy Chain Deposition Disease,0
5187,Squamous cell carcinoma,Anaplastic large cell lymphoma,0
5188,Abnormal Reference Range,Lipoma of small intestine,0
5189,Cosmetic procedure,Adenocarcinoma,0
5190,Laboratory method,Recurrent Uveal Melanoma,0
5191,Coding,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
5192,Early stage,Non-Metastatic Gestational Trophoblastic Tumor,0
5193,Carrying,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5194,Item Collection,Mastocytosis,0
5195,Tryptophanase,FIGO Stage II Ovarian Cancer,0
5196,Poor - qualifier,Mucinous adenocarcinoma gastric,0
5197,To,Diffuse malignant mesothelioma,0
5198,Lymphatic duct,Tonsillar Carcinoma,0
5199,Microvolt,Localized Askin Tumor,0
5200,90 - 100%,Primary Cutaneous Plasmablastic Lymphoma,0
5201,Nervous system structure,Intestinal Metaplasia of Bladder Urothelium,0
5202,Adult Lymphoma,Maxillary Sinus Adenocarcinoma,0
5203,Malignant neoplasm of lung,Stage I Adult Non-Hodgkin Lymphoma,0
5204,Feel Tired question,Diffuse malignant mesothelioma,0
5205,Intraventricular,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5206,Trial Screening,Small cell neuroendocrine carcinoma of bladder,0
5207,Transitional cell morphology,Recurrent Testicular Lymphoma,0
5208,Bluish red color,Recurrent Uveal Melanoma,0
5209,Estimated,non-Hodgkin's lymphoma of spleen,0
5210,Complete Trisomy 21 Syndrome,Liver Lymphangioma,0
5211,cancer-predisposing genes,Refractory Barrett Esophagus,0
5212,High Level,Ovarian germ cell choriocarcinoma stage IV,0
5213,Sore sensation,carcinoma of middle ear,0
5214,Tonsil,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
5215,Cells,Intestinal Neuroendocrine Carcinoma,0
5216,Blood Cells,mucinous adenocarcinoma of gallbladder,0
5217,Vestigium,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5218,removal technique,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5219,Peritoneum,Localized Ewing Sarcoma,0
5220,Nursing interventions,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5221,Oral cavity,Stage III Adult Immunoblastic Lymphoma,0
5222,*Type - Kind of quantity,Cancer of Urinary Tract,0
5223,United States,Malignant melanoma of eyelid,0
5224,Skin Pigmentation,Non-Metastatic Gestational Trophoblastic Tumor,0
5225,Reported Term,Metastatic Neoplasm to the Gallbladder,0
5226,Southern Europe,Primary Cutaneous Plasmablastic Lymphoma,0
5227,Aspects of disease screening,Chondrosarcoma,0
5228,Tryptophanase,Granular Cell Leiomyosarcoma,0
5229,Occur (action),Neonatal leukemia,0
5230,Turner Syndrome,Primary Cutaneous Plasmablastic Lymphoma,0
5231,Three,non-Hodgkin's lymphoma of spleen,0
5232,treatment - ActInformationManagementReason,Human Papillomavirus-Related Carcinoma,0
5233,Early,Human Papillomavirus-Related Carcinoma,0
5234,Devices,FIGO Stage II Ovarian Cancer,0
5235,Patient Discharge,Uterine Cancer,0
5236,Condition:Find:Pt:^Patient:Nom,sarcoma of spinal cord,0
5237,1+,Carcinoma of urinary bladder,0
5238,per second,Colorectal High Grade B-Cell Lymphoma,0
5239,Neoplasms,Larynx carcinoma recurrent,0
5240,*Type - Kind of quantity,benign mature teratoma of pancreas,0
5241,<2 years,Pancreatic Intraepithelial Neoplasia-3,0
5242,diagnosis aspect,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
5243,Central Nervous System Neoplasms,Endometrial Small Cell Carcinoma,0
5244,Fluid Leak,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5245,Include (action),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5246,Psyche structure,Stage II Carcinoma of Penis,0
5247,various allergen extracts,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5248,*Type - Kind of quantity,sarcoma of spinal cord,0
5249,Following,Carcinoma ex pleomorphic adenoma of parotid gland,0
5250,Patient Reported Outcome Stem,Prostate Lymphoma,0
5251,Follicle,Digestive System Hodgkin Lymphoma,0
5252,AKR1A1 wt Allele,Choroid Necrotic Melanoma,0
5253,Feature,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5254,Stem of Organ,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5255,Brain,Recurrent Uveal Melanoma,0
5256,Levator palpebrae superioris structure,Angiosarcoma of liver,0
5257,Tired,Acantholytic squamous cell carcinoma,0
5258,Decision,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5259,Skin tanning,Familial Hemophagocytic Lymphocytosis,0
5260,Call (Instruction),Stage IB Pancreatic Cancer AJCC v8,0
5261,Used by,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5262,Malignant neoplasm of brain,Liver Lymphangioma,0
5263,Pharmacotherapy,Intracortical osteosarcoma,0
5264,Kininogenase,Grade 3a Malignant Neoplasm,0
5265,Frequently,Cerebral hemangioma,0
5266,Treating,Stage I Adult Non-Hodgkin Lymphoma,0
5267,Population Group,Spongiotic dermatitis,0
5268,Secretory Vesicles,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
5269,Table Rules - groups,Lung Mucinous Cystadenoma,0
5270,consider,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5271,Body part,Cartilaginous exostosis,0
5272,All of the Time,Choroid Necrotic Melanoma,0
5273,Serious,Colorectal Neuroendocrine Tumor G2,0
5274,Sarcoma,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
5275,Specimen Source Codes - Tears,Human Papillomavirus-Related Carcinoma,0
5276,Carcinoma of lung,Intraepithelial Melanocytic Hyperplasia,0
5277,Set (Psychology),Malignant Testicular Sertoli Cell Tumor,0
5278,Adult human body,Bladder squamous cell carcinoma stage I,0
5279,Call (Instruction),High Grade Glandular Intraepithelial Neoplasia,0
5280,Curative - procedure intent,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5281,Improved,Stage IB Pancreatic Cancer AJCC v8,0
5282,Spectrum,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
5283,Pharmacotherapy,Benign Carotid Body Paraganglioma,0
5284,Poverty,Adult Alveolar Soft Part Sarcoma,0
5285,Tryptophanase,Unfavorable Non-Hodgkin Lymphoma,0
5286,Term Birth,Primary Cutaneous Plasmablastic Lymphoma,0
5287,Diagnosis,Digestive System Hodgkin Lymphoma,0
5288,Singular,Locally Advanced Soft Tissue Sarcoma,0
5289,Neoplasms by Site,Cerebral Primitive Neuroectodermal Tumor,0
5290,Contribution,Primary Cutaneous Plasmablastic Lymphoma,0
5291,Logical Condition,Carcinoma of urinary bladder,0
5292,chapter,Papillary cystic tumor,0
5293,Thymus Neoplasms,Mucinous cystadenofibroma,0
5294,Free (available (qualifier)),Ovarian germ cell choriocarcinoma stage IV,0
5295,Loss of appetite (finding),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5296,Beginning,Cancer of Urinary Tract,0
5297,Times,Female Breast Carcinoma,0
5298,Histocompatibility Testing,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5299,Tunnel structure,Recurrent Testicular Lymphoma,0
5300,Numerous,Malignant melanoma of eyelid,0
5301,Trial Screening,non-Hodgkin's lymphoma of spleen,0
5302,Anatomic Site,Digestive System Hodgkin Lymphoma,0
5303,70%,Stage IB Lung Cancer AJCC v7,0
5304,Response process,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5305,Time,Adult Alveolar Soft Part Sarcoma,0
5306,Include (action),Childhood Thyroid Gland Follicular Carcinoma,0
5307,65+,Malignant melanoma of eyelid,0
5308,More,Giant cell angiofibroma,0
5309,Breast,Mucinous adenocarcinoma gastric,0
5310,Status post,Malignant neoplasm of thalamus,0
5311,Bone Pain,Atypical Mesothelial Hyperplasia,0
5312,Europe,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5313,Two,Malignant neoplasm of choroid,0
5314,Type A,Malignant melanoma of eyelid,0
5315,Second edition,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5316,Usually,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5317,Section - Geographic Area,Cartilaginous exostosis,0
5318,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Intestinal Metaplasia of Bladder Urothelium,0
5319,Previously Treated Childhood Rhabdomyosarcoma,Acantholytic squamous cell carcinoma,0
5320,Surgery specialty,Adult Alveolar Soft Part Sarcoma,0
5321,Broken skin,Adult Hepatocellular Carcinoma,0
5322,Range,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5323,Physical Medical Procedure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5324,Primary malignant neoplasm,Digestive System Hodgkin Lymphoma,0
5325,Increased,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5326,Percent (qualifier value),Mucinous cystadenofibroma,0
5327,Tryptophanase,Cerebral hemangioma,0
5328,Generation (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5329,Set scale,Mucinous adenocarcinoma gastric,0
5330,defects aspect,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
5331,Smear - instruction imperative,Endometrial Small Cell Carcinoma,0
5332,Negation,Acantholytic squamous cell carcinoma,0
5333,radiotherapeutic,Malignant neoplasm of thalamus,0
5334,Neuroendocrine Tumors,Refractory Barrett Esophagus,0
5335,cns lymphoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5336,Forecast of outcome,Localized Ewing Sarcoma,0
5337,Work,Testicular cancer metastatic,0
5338,Object Class,Neonatal leukemia,0
5339,Esophageal pH Monitoring,Undifferentiated Neuroblastoma,0
5340,Shortened,Stage IV Childhood Non-Hodgkin Lymphoma,0
5341,Knowledge,Human Papillomavirus-Related Carcinoma,0
5342,Treatment Epoch,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5343,10%,Uterine Cancer,0
5344,2+ Score,Neonatal leukemia,0
5345,Persons,Ovarian Carcinoid Tumor,0
5346,Contain (action),Mastocytosis,0
5347,Specimen Type - Macrophages,Stage IB Pancreatic Cancer AJCC v8,0
5348,Etiology aspects,Childhood Cerebellar Neoplasm,0
5349,Financial Account,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5350,Cure (remedy),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5351,Child,mucinous adenocarcinoma of gallbladder,0
5352,Occur (action),Maxillary Sinus Adenocarcinoma,0
5353,90 - 100%,Chronic Myelomonocytic Leukemia-2,0
5354,Much,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5355,Chemotherapy,embryonal rhabdomyosarcoma of prostate,0
5356,Pelvis,Intraepithelial Melanocytic Hyperplasia,0
5357,Use of,Recurrent Uveal Melanoma,0
5358,Persistent embryonic structure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5359,Pathological Dilatation,Medulloblastoma,0
5360,Mammals,Primary Cutaneous Plasmablastic Lymphoma,0
5361,Hemorrhage,Anterior Urethral Malignant Neoplasm,0
5362,Tissue of urinary bladder,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5363,Manufactured form,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5364,Times,Pancreatic Intraepithelial Neoplasia-3,0
5365,Analysis of substances,Grade 3a Malignant Neoplasm,0
5366,Removal of bladder,Choroid Necrotic Melanoma,0
5367,65,Undifferentiated Endocervical Sarcoma,0
5368,Pure Spanish horse breed (organism),Undifferentiated Endocervical Sarcoma,0
5369,Entity,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5370,Most,Childhood Central Nervous System Immature Teratoma,0
5371,Term Birth,Mixed parotid tumor,0
5372,Subject Risk,Diffuse malignant mesothelioma,0
5373,Reaching,Metastatic Neoplasm to the Gallbladder,0
5374,Oropharyngeal Carcinoma,squamous cell carcinoma of the thyroid gland,0
5375,Smear - instruction imperative,Metastatic Carcinoma in the Lung,0
5376,More,sarcoma of spinal cord,0
5377,Obesity,Thymic Clear Cell Carcinoma,0
5378,depend,Childhood Fibrillary Astrocytoma,0
5379,Time (foundation metadata concept),Undifferentiated Endocervical Sarcoma,0
5380,Time,Undifferentiated Endocervical Sarcoma,0
5381,Exposure to radiation,Heavy Chain Deposition Disease,0
5382,Type A,Stage IB Pancreatic Cancer AJCC v8,0
5383,Body tissue,Unfavorable Non-Hodgkin Lymphoma,0
5384,Young Adult,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5385,Abnormally high,Localized Askin Tumor,0
5386,Levels (qualifier value),mucinous adenocarcinoma of gallbladder,0
5387,alpha 1-Antitrypsin Deficiency,Recurrent Testicular Lymphoma,0
5388,Therapeutic radiology procedure,Pancreatic Intraepithelial Neoplasia-3,0
5389,Multiple Partners,Testicular cancer metastatic,0
5390,Administration procedure,Metastatic Malignant Neoplasm in the Sellar Region,0
5391,Make - Instruction Imperative,Recurrent Testicular Lymphoma,0
5392,Agreement,Mucinous adenocarcinoma gastric,0
5393,Two,Testicular cancer metastatic,0
5394,Two,Cartilaginous exostosis,0
5395,Established,Stage III Adult Immunoblastic Lymphoma,0
5396,Less often,Breast Ductal Adenoma,0
5397,International Classification of Diseases,Lung squamous cell carcinoma stage I,0
5398,New,Acantholytic squamous cell carcinoma,0
5399,Population Mean,Pancreatic Intraepithelial Neoplasia-3,0
5400,90%,Stage III Adult Immunoblastic Lymphoma,0
5401,Malignant neoplasm of skin,Cancer of Urinary Tract,0
5402,Cell (compartment),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
5403,therapeutic aspects,Clonal Hematopoiesis of Indeterminate Potential,0
5404,Togo,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5405,Genus Cygnus,Stage IB Pancreatic Cancer AJCC v8,0
5406,Clinical Effectiveness,High Grade Glandular Intraepithelial Neoplasia,0
5407,Including (qualifier),Undifferentiated Neuroblastoma,0
5408,adaptive,Intestinal Metaplasia of Bladder Urothelium,0
5409,Anatomic Site,Pancreatic Intraepithelial Neoplasia-3,0
5410,Diagnosis Study,Malignant neoplasm of choroid,0
5411,Germ cell tumor,Intracortical osteosarcoma,0
5412,True primary (qualifier value),Primary Cutaneous Plasmablastic Lymphoma,0
5413,More,Diffuse malignant mesothelioma,0
5414,control aspects,Xeroderma pigmentosum,0
5415,General surgery specialty,Localized Askin Tumor,0
5416,Basis - conceptual entity,Stage IB Pancreatic Cancer AJCC v8,0
5417,Source,Diffuse malignant mesothelioma,0
5418,Tryptophanase,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5419,heart inflammation,FIGO Stage II Ovarian Cancer,0
5420,Percent Activity,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5421,Infratentorial,Stage III Adult Immunoblastic Lymphoma,0
5422,500,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5423,Compresses (device),Colorectal High Grade B-Cell Lymphoma,0
5424,United States Military Commissioned Officer O4,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5425,Childhood Neuroblastoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5426,Palliative Care,Mucinous adenocarcinoma gastric,0
5427,Major,Noninfiltrating Intraductal Carcinoma,0
5428,Science of Etiology,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5429,59,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5430,Infantile hemangioma,Malignant melanoma of eyelid,0
5431,error,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5432,Simulate composite resin,Stage IB Pancreatic Cancer AJCC v8,0
5433,Approximate,Childhood Fibrillary Astrocytoma,0
5434,Arising in,Acantholytic squamous cell carcinoma,0
5435,Poor - grade value,Benign neoplasm of thorax,0
5436,Bladder Cancer Pathway,Cartilaginous exostosis,0
5437,Occur (action),Acute lymphadenitis,0
5438,Highest,Giant cell angiofibroma,0
5439,Biomaterial Treatment,Neonatal leukemia,0
5440,Scientific Control,Noninfiltrating Intraductal Carcinoma,0
5441,PSA Level Greater than Fifty,Mucinous adenocarcinoma gastric,0
5442,Experimental Result,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5443,Exposure to asbestos,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5444,include - SetOperator,FIGO Stage II Ovarian Cancer,0
5445,Options,Bladder squamous cell carcinoma stage I,0
5446,United States,Grade 1 Clear Cell Renal Cell Carcinoma,0
5447,Negative Charge,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5448,Malignant tumor of cervix,Testicular cancer metastatic,0
5449,Suspected diagnosis,Childhood Choriocarcinoma,0
5450,List,Adult Hepatocellular Carcinoma,0
5451,combination - answer to question,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5452,Usual,adenosquamous carcinoma of breast,0
5453,Macrophage count,Extra-Adrenal Paraganglioma,0
5454,Usually,Carcinoma of urinary bladder,0
5455,Cumulative Survival Rate,gliosarcoma,0
5456,Papillomaviridae,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5457,Free of (attribute),BRCA2 Syndrome,0
5458,Deferred,Blepharal carcinoma,0
5459,Scientific Publication,Germinoma,0
5460,International Classification of Diseases,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5461,Swollen Lymph Node,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5462,Neoplasms,Maxillary Sinus Adenocarcinoma,0
5463,Reside,malignant lymphoma of pancreatic lymph nodes,0
5464,Body structure,Recurrent Testicular Lymphoma,0
5465,Table Cell Horizontal Align - left,Grade 3a Malignant Neoplasm,0
5466,depend,Acute Undifferentiated Leukemia,0
5467,Rare,Endometrial Small Cell Carcinoma,0
5468,% Ercs,Testicular cancer metastatic,0
5469,Epithelial ovarian cancer,Lipoma of small intestine,0
5470,Income,Benign tumor of eyelid,0
5471,Nucleotide Excision Repair,Leptomeningeal sarcoma,0
5472,New Zealand Rabbits,Cancer of Urinary Tract,0
5473,include - SetOperator,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5474,Type A,Malignant neoplasm of choroid,0
5475,radiotherapeutic,Cancer of Urinary Tract,0
5476,Case unit dose,Acute Undifferentiated Leukemia,0
5477,Case (situation),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5478,Primary,Sarcomatoid Renal Cell Carcinoma,0
5479,Course,Bladder squamous cell carcinoma stage I,0
5480,Specimen Source Codes - Lesion,Mucinous adenocarcinoma gastric,0
5481,radiotherapeutic,FIGO Stage II Ovarian Cancer,0
5482,Tryptophanase,Recurrent Uveal Melanoma,0
5483,<50,Adult Brain Stem Mixed Glioma,0
5484,Immunotherapy for cancer,Hemangioma,0
5485,Secretory Vesicles,Carcinoma of urinary bladder,0
5486,Medical Imaging,Locally Advanced Soft Tissue Sarcoma,0
5487,Route of Administration - Mucous Membrane,Carcinoma of urinary bladder,0
5488,DNA,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5489,Platelets,Carcinoma of urinary bladder,0
5490,Therapeutic procedure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5491,Endodermal,Testicular cancer metastatic,0
5492,Hormonal,Refractory Barrett Esophagus,0
5493,rituximab,Thymic Atypical Carcinoid Tumor,0
5494,Solitary leiomyoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5495,Qualitative form,Colorectal Neuroendocrine Tumor G2,0
5496,Approximate,Tonsillar Carcinoma,0
5497,treatment - ActInformationManagementReason,Rhabdomyosarcoma with ganglionic differentiation,0
5498,therapeutic aspects,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5499,Histology Procedure,Anterior Urethral Malignant Neoplasm,0
5500,Tumor cells,Malignant neoplasm of thalamus,0
5501,Acute leukemia,Recurrent Testicular Lymphoma,0
5502,Continuance of life,Chronic Myelomonocytic Leukemia-2,0
5503,Diagnosis,Malignant melanoma of eyelid,0
5504,Derived value,Ovarian germ cell choriocarcinoma stage IV,0
5505,Togo,Noninfiltrating Intraductal Carcinoma,0
5506,macromolecule,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5507,Treating,Intestinal Metaplasia of Bladder Urothelium,0
5508,Cervical dysplasia,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5509,Cells,Lung squamous cell carcinoma stage I,0
5510,Western Europe,embryonal rhabdomyosarcoma of prostate,0
5511,Biomaterial Treatment,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5512,Renal collecting tube,Mucinous adenocarcinoma gastric,0
5513,Cerebellar Hypoplasia,Chronic Myelomonocytic Leukemia-2,0
5514,Primary malignant neoplasm,malignant lymphoma of pancreatic lymph nodes,0
5515,Body tissue,Small cell neuroendocrine carcinoma of bladder,0
5516,Common (qualifier value),Adult Alveolar Soft Part Sarcoma,0
5517,Effective,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5518,Substance,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5519,Esophageal Stricture,Undifferentiated Endocervical Sarcoma,0
5520,Due to,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5521,Slightly Able,Human Papillomavirus-Related Carcinoma,0
5522,melanoma,Acute lymphadenitis,0
5523,status - In progress,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5524,human AVP protein,Cerebral Primitive Neuroectodermal Tumor,0
5525,survival aspects,benign mature teratoma of pancreas,0
5526,Exposure to,BRCA2 Syndrome,0
5527,Microcyst,Hodgkin lymphoma,0
5528,Aspect (characteristic),adenosquamous carcinoma of breast,0
5529,Metastasis,Undifferentiated Neuroblastoma,0
5530,High risk,embryonal rhabdomyosarcoma of prostate,0
5531,combination of objects,Liver Lymphangioma,0
5532,common procedures,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5533,high - ActExposureLevelCode,Grade 3a Malignant Neoplasm,0
5534,pregnancy related,Adrenal Rest Tumor,0
5535,Incidental Findings,Cerebral Primitive Neuroectodermal Tumor,0
5536,Feel Pain,non-Hodgkin's lymphoma of spleen,0
5537,include - SetOperator,Chronic Myelomonocytic Leukemia-2,0
5538,combination - answer to question,BRCA2 Syndrome,0
5539,Vaginal wall,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5540,The Cancer Genome Atlas,Xeroderma pigmentosum,0
5541,NCI CTEP SDC Penile Cancer Sub-Category Terminology,Acantholytic squamous cell carcinoma,0
5542,biopsy characteristics,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
5543,year,Primary Cutaneous Plasmablastic Lymphoma,0
5544,Term (temporal),Stage IV Childhood Non-Hodgkin Lymphoma,0
5545,Rare,Stage IV Penile Cancer AJCC v7,0
5546,Persons,Uterine Cancer,0
5547,Abdomen+,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5548,Sore sensation,Collecting Duct Carcinoma of the Kidney,0
5549,diagnosis aspect,Cancer of Urinary Tract,0
5550,Itchiness,Benign tumor of eyelid,0
5551,Fatigue,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
5552,Woman,Intraepithelial Melanocytic Hyperplasia,0
5553,Entity Determiner - specific,Hodgkin lymphoma,0
5554,Methods,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5555,Deterioration of status,Ovarian Carcinoid Tumor,0
5556,Lower (action),Diffuse malignant mesothelioma,0
5557,Able (finding),Refractory Barrett Esophagus,0
5558,therapeutic aspects,Acantholytic squamous cell carcinoma,0
5559,Good,Human Papillomavirus-Related Carcinoma,0
5560,Symptoms aspect,Intraepithelial Melanocytic Hyperplasia,0
5561,Tryptophanase,Neoplasms,0
5562,Slightly Able,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5563,One,Platinum-Resistant Lung Small Cell Carcinoma,0
5564,cancer risk,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5565,Uterus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5566,Recipient,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5567,Symptoms,Carcinoma of urinary bladder,0
5568,100%,Recurrent Uveal Melanoma,0
5569,Estimated,Cerebral Primitive Neuroectodermal Tumor,0
5570,various other nasal preparations in ATC,benign mature teratoma of pancreas,0
5571,Highest,Thymic Atypical Carcinoid Tumor,0
5572,Persons,Malignant Testicular Sertoli Cell Tumor,0
5573,Endodermal,Hodgkin lymphoma,0
5574,Experimental Result,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5575,Acquisition (action),Pilocytic astrocytoma of cerebellum,0
5576,Primary,Deep Leiomyoma,0
5577,Pelvic Pain,Colorectal Neuroendocrine Tumor G2,0
5578,T-Cell Receptor,Hodgkin lymphoma,0
5579,Genetic Heterogeneity,Angiosarcoma of liver,0
5580,Form:Finding:Point in time:{Setting}:Document:{Role},Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
5581,Malignant lymphoma,Diffuse malignant mesothelioma,0
5582,Cell (compartment),Familial Hemophagocytic Lymphocytosis,0
5583,Continuance of life,Cartilaginous exostosis,0
5584,risk factors - observation list,Tonsillar Carcinoma,0
5585,2+ Score,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5586,Disease,Neonatal leukemia,0
5587,Feelings,BRCA2 Syndrome,0
5588,Benign,Cancer of Urinary Tract,0
5589,Negative Finding,Colorectal cancer,0
5590,Teens,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5591,Lymphocyte component of blood,Uterine Cancer,0
5592,Dermatologic disorders,Small cell neuroendocrine carcinoma of bladder,0
5593,Biopsy,Granular Cell Leiomyosarcoma,0
5594,Involvement with,Stage III Adult Immunoblastic Lymphoma,0
5595,include - SetOperator,Human Papillomavirus-Related Carcinoma,0
5596,Complication,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5597,Have Weight Loss,Bladder squamous cell carcinoma stage I,0
5598,combination of objects,Carcinoma of urinary bladder,0
5599,Malignant neoplasm of large intestine,Leiomyoma of Gallbladder,0
5600,Liver carcinoma,Stage IB Lung Cancer AJCC v7,0
5601,Fever,Chronic Myelomonocytic Leukemia-2,0
5602,operate <remove>,Childhood Thyroid Gland Follicular Carcinoma,0
5603,1+ Score,Localized Askin Tumor,0
5604,Scaly skin,Benign Apocrine Neoplasm,0
5605,various other intestinal adsorbents in ATC,Metastatic Malignant Neoplasm in the Sellar Region,0
5606,Asymptomatic,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
5607,Numbers,Cartilaginous exostosis,0
5608,Irritant (disposition),Recurrent Uveal Melanoma,0
5609,Mass,Giant cell angiofibroma,0
5610,B-Lymphocytes,Mucinous cystadenofibroma,0
5611,Usual Severity Nausea,Angiosarcoma of liver,0
5612,Case unit dose,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5613,High risk of,Stage II Carcinoma of Penis,0
5614,Science of Etiology,Female Breast Carcinoma,0
5615,Small cell carcinoma of lung,Carcinoma ex pleomorphic adenoma of parotid gland,0
5616,Mass of body region,Bladder squamous cell carcinoma stage I,0
5617,BLNK gene,Fourth Ventricle and Brain Stem Ependymal Tumor,0
5618,Epithelial Cells,Testicular cancer metastatic,0
5619,Pediculus humanus capitis (eukaryote),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5620,Blue color,Collecting Duct Carcinoma of the Kidney,0
5621,Precursor Cell Lymphoblastic Leukemia Lymphoma,Chondrosarcoma,0
5622,Normal tissue morphology,Intraepithelial Melanocytic Hyperplasia,0
5623,Malignant Childhood Neoplasm,Carcinoma of urinary bladder,0
5624,Specimen Source Codes - Respiratory,embryonal rhabdomyosarcoma of prostate,0
5625,Cellular Debris,carcinoma of middle ear,0
5626,Exposure to,Mucinous neoplasm,0
5627,Form:Finding:Point in time:{Setting}:Document:{Role},Diffuse malignant mesothelioma,0
5628,neural,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5629,Age,Low Grade Squamous Intraepithelial Neoplasia,0
5630,Tissue membrane,Recurrent Testicular Lymphoma,0
5631,Surgical advancement - action,papillary carcinoma of penis,0
5632,Response (communication),Human Papillomavirus-Related Carcinoma,0
5633,Antimicrobial Intermediate Susceptibility Result,Anterior Urethral Malignant Neoplasm,0
5634,Hodgkin Disease,Human Papillomavirus-Related Carcinoma,0
5635,Stem cell transplant,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5636,Process (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
5637,Categories,Cartilaginous exostosis,0
5638,Treatment Epoch,Malignant Testicular Sertoli Cell Tumor,0
5639,Dorsal,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5640,Australia,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5641,Dust,Uterine Cancer,0
5642,Diagnosis,Liver Lymphangioma,0
5643,Infection,Stage II Fallopian Tube Cancer,0
5644,Used by,Liver Lymphangioma,0
5645,Occurrence Indicator,Malignant melanoma of eyelid,0
5646,Proliferation,Spongiotic dermatitis,0
5647,Genetic Marker Expression,Malignant Neoplasm with Regional Lymph Node Involvement,0
5648,Requirement,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5649,Viruses ingredient,Uterine Cancer,0
5650,Pathogenesis,Airway Hemangioma,0
5651,Caucasians,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5652,Human Papillomavirus,Grade 3a Malignant Neoplasm,0
5653,Logical Condition,Carcinoma of urinary bladder,0
5654,Usually,Bladder squamous cell carcinoma stage I,0
5655,TP53 wt Allele,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
5656,Treatment Effectiveness,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5657,Benign,Stage III Adult Immunoblastic Lymphoma,0
5658,Disseminated Malignant Neoplasm,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5659,Enneking Low Surgical Grade,Thymoma malignant recurrent,0
5660,Mass of body region,Acute Undifferentiated Leukemia,0
5661,diagnostic accuracy,Mucinous adenocarcinoma gastric,0
5662,Mumps,Mastocytosis,0
5663,Contrast Media,Acantholytic squamous cell carcinoma,0
5664,Malignant tumor of cervix,Localized Askin Tumor,0
5665,Condition:Find:Pt:^Patient:Nom,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
5666,Name,mucinous adenocarcinoma of gallbladder,0
5667,Group A (blood group),Intestinal Neuroendocrine Carcinoma,0
5668,2+,Recurrent Uveal Melanoma,0
5669,Malignant Central Nervous System Neoplasm,Mucinous adenocarcinoma gastric,0
5670,Abnormal Reference Range,Intracortical osteosarcoma,0
5671,Body Site Modifier - Lower,Tonsillar Carcinoma,0
5672,Line Unit of Length,Stage 0 Penile Cancer AJCC v8,0
5673,Occurrence,Mucinous adenocarcinoma gastric,0
5674,Contain (action),FIGO Stage II Ovarian Cancer,0
5675,Intestines,Intestinal Metaplasia of Bladder Urothelium,0
5676,Post Device,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5677,Cancer Genus,Metastatic Ductal Breast Carcinoma,0
5678,Common (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5679,In Blood,Airway Hemangioma,0
5680,Make - Instruction Imperative,Undifferentiated Endocervical Sarcoma,0
5681,Numerous,Medulloblastoma,0
5682,Increase,Low Grade Squamous Intraepithelial Neoplasia,0
5683,Seventh,Cancer of Urinary Tract,0
5684,combination of objects,Pilocytic astrocytoma of cerebellum,0
5685,Etiology aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5686,Subject Risk,Pilocytic astrocytoma of cerebellum,0
5687,Help document,Choroid Necrotic Melanoma,0
5688,Buccal smear procedure,adenosquamous carcinoma of breast,0
5689,Fetal Ultrasonography,Ovarian germ cell choriocarcinoma stage IV,0
5690,Birth,Stage 0 Lip Carcinoma,0
5691,Obesity,Human Papillomavirus-Related Carcinoma,0
5692,Childhood Solid Neoplasm,Stage II Carcinoma of Penis,0
5693,Active,Platinum-Resistant Lung Small Cell Carcinoma,0
5694,Adenocarcinoma,Refractory Barrett Esophagus,0
5695,Digestive Enzymes,Refractory Barrett Esophagus,0
5696,Presentation,Mucinous adenocarcinoma gastric,0
5697,Neoplasms,Adult Brain Stem Mixed Glioma,0
5698,Midline (qualifier value),embryonal rhabdomyosarcoma of prostate,0
5699,Adipose tissue,Extracranial Neuroblastoma,0
5700,Squamocolumnar junction of cervix,Localized Ewing Sarcoma,0
5701,Human papillomavirus types,Malignant melanoma of eyelid,0
5702,Nose,Bladder squamous cell carcinoma stage I,0
5703,Call (Instruction),embryonal rhabdomyosarcoma of prostate,0
5704,Poor - qualifier,Blepharal carcinoma,0
5705,Better,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5706,Interstitial Fluid,Maxillary Sinus Adenocarcinoma,0
5707,Greater,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5708,year,Cartilaginous exostosis,0
5709,Mast Cell Count,Primary Cutaneous Plasmablastic Lymphoma,0
5710,Adult Subependymal Giant Cell Astrocytoma,Malignant neoplasm of thalamus,0
5711,Abnormal host response,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5712,Specialized,Neonatal leukemia,0
5713,Affecting,Cerebral Primitive Neuroectodermal Tumor,0
5714,Occurrence,papillary carcinoma of penis,0
5715,CYP19A1 wt Allele,Stage IB Pancreatic Cancer AJCC v8,0
5716,Adult,Cerebral hemangioma,0
5717,To,Colorectal cancer,0
5718,week,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5719,More common in males,Benign tumor of eyelid,0
5720,CD40LG wt Allele,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5721,Firstly,Hemangioma,0
5722,Death (finding),Childhood Lymphoma,0
5723,Dermis,Thymic Clear Cell Carcinoma,0
5724,Ulcer,Blepharal carcinoma,0
5725,Administration procedure,Metastatic Lung Small Cell Carcinoma,0
5726,50%,Diffuse malignant mesothelioma,0
5727,Arising in,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5728,MS gene,Metastatic Carcinoma in the Lung,0
5729,Mutation,Advanced Lung Carcinoma,0
5730,VARIOUS DRUG CLASSES IN ATC,Recurrent Testicular Lymphoma,0
5731,Diagnostic Imaging,Anterior Urethral Malignant Neoplasm,0
5732,Derivation,Non-Metastatic Gestational Trophoblastic Tumor,0
5733,Certain (qualifier value),Localized Askin Tumor,0
5734,incomplete spinal cord injury,Recurrent Uveal Melanoma,0
5735,Pelvic Pain,Heavy Chain Deposition Disease,0
5736,Malignant neoplasm of breast,Acute Undifferentiated Leukemia,0
5737,Sarcoma - category (morphologic abnormality),Mucinous adenocarcinoma gastric,0
5738,Smaller,Digestive System Hodgkin Lymphoma,0
5739,high - ActExposureLevelCode,Mucinous adenocarcinoma gastric,0
5740,photoreactivating enzyme activity,High Grade Glandular Intraepithelial Neoplasia,0
5741,Older Population,Germinoma,0
5742,ovarian,Colorectal High Grade B-Cell Lymphoma,0
5743,Major <insect>,sarcoma of spinal cord,0
5744,Persons,Acute Undifferentiated Leukemia,0
5745,Bio-Informatics,Uterine Cancer,0
5746,Primary malignant neoplasm,Acute lymphadenitis,0
5747,Grouping,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5748,Cell division,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5749,Beginning,Stage IB Lung Cancer AJCC v7,0
5750,With intensity,Germinoma,0
5751,Adult human body,Heavy Chain Deposition Disease,0
5752,Location,Localized Askin Tumor,0
5753,Thoracic Duct,Chondrosarcoma,0
5754,Delta (difference),Adult Fibrolamellar Carcinoma,0
5755,Tryptophanase,carcinoma of middle ear,0
5756,Pelvic pain female,mucinous adenocarcinoma of gallbladder,0
5757,newly,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5758,40%,Ampulla of Vater Tubular Adenoma,0
5759,site-specific telomere resolvase activity,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
5760,Reported,Malignant neoplasm of choroid,0
5761,Eye lid,Localized Ewing Sarcoma,0
5762,Have Weight Loss,Recurrent Uveal Melanoma,0
5763,Mass of body structure,Serous cystadenocarcinoma ovary,0
5764,Abnormal cell,Malignant melanoma of eyelid,0
5765,Weight Loss,Medulloblastoma,0
5766,Therapeutic radiology procedure,Secondary malignant neoplasm of lymph node,0
5767,N not otherwise specified Antibody,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5768,Have Diarrhea,Uterine Cancer,0
5769,Frequently,Methotrexate-Associated Hodgkin Lymphoma,0
5770,Follicular,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5771,Childhood Lymphoma,embryonal rhabdomyosarcoma of prostate,0
5772,Main,Localized Askin Tumor,0
5773,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Pancreatic Intraepithelial Neoplasia-3,0
5774,Apply (instruction),Digestive System Hodgkin Lymphoma,0
5775,Endogenous,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5776,Cancer Genus,Chronic Myelomonocytic Leukemia-2,0
5777,Term Birth,Testicular cancer metastatic,0
5778,Cervix Uteri,Lung squamous cell carcinoma stage I,0
5779,Infection,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5780,Outer cortex of kidney,Uterine Cancer,0
5781,Cessation of life,Non-Metastatic Gestational Trophoblastic Tumor,0
5782,Erythropoiesis,adenosquamous carcinoma of breast,0
5783,Cells,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5784,Weight Loss,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5785,Pharmacotherapy,Recurrent Uveal Melanoma,0
5786,Covered (qualifier value),Female Breast Carcinoma,0
5787,13q12,FIGO Stage II Ovarian Cancer,0
5788,Highest,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5789,Formation,Stage IB Pancreatic Cancer AJCC v8,0
5790,Most,Xeroderma pigmentosum,0
5791,Endometrium,Stage IB Pancreatic Cancer AJCC v8,0
5792,90%,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5793,Occurrence,Refractory Glioma,0
5794,Anaplasia,Airway Hemangioma,0
5795,Personal appearance,Colorectal High Grade B-Cell Lymphoma,0
5796,M+ (tumor staging),Medulloblastoma,0
5797,Initial (abbreviation),Bladder squamous cell carcinoma stage I,0
5798,Lymphoma,Malignant melanoma of eyelid,0
5799,Leading,BRCA2 Syndrome,0
5800,Inflammatory Breast Carcinoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5801,South,Small cell neuroendocrine carcinoma of bladder,0
5802,Closure,Mixed parotid tumor,0
5803,Diagnosis Study,Localized Ewing Sarcoma,0
5804,Lymphatic System,embryonal rhabdomyosarcoma of prostate,0
5805,Death (finding),Stage IB Pancreatic Cancer AJCC v8,0
5806,include - SetOperator,Malignant neoplasm of thalamus,0
5807,High Level,FIGO Stage II Ovarian Cancer,0
5808,Formation,Unresectable Rhabdomyosarcoma,0
5809,Benign Vascular Neoplasm,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5810,Qualitative form,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5811,Melanocytic nevus,Digestive System Hodgkin Lymphoma,0
5812,Firstly,Low Grade Squamous Intraepithelial Neoplasia,0
5813,Good,Benign neoplasm of thorax,0
5814,Most,Xeroderma pigmentosum,0
5815,Involvement with,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5816,genetic risk factors,Mucinous adenocarcinoma gastric,0
5817,Overall Survival,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5818,Affecting,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5819,Abdomen+,Non-Metastatic Gestational Trophoblastic Tumor,0
5820,Chemotherapy,Rhabdomyosarcoma with ganglionic differentiation,0
5821,Often - answer to question,Choroid Necrotic Melanoma,0
5822,Imaging Techniques,Tonsillar Carcinoma,0
5823,various other intestinal adsorbents in ATC,Recurrent Uveal Melanoma,0
5824,Index,Female Breast Carcinoma,0
5825,Account number:Identifier:Point in time:^Patient:Nominal,Endometrial Small Cell Carcinoma,0
5826,Symptom:Find:Pt:^Patient:Nom,Carcinoma of urinary bladder,0
5827,Greater,Atypical Lobular Breast Hyperplasia,0
5828,body system,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5829,Age,Clonal Hematopoiesis of Indeterminate Potential,0
5830,Definitive,Acute Undifferentiated Leukemia,0
5831,Congenital phimosis,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5832,+2,Intraepithelial Melanocytic Hyperplasia,0
5833,Chemotherapy,Carcinoma of urinary bladder,0
5834,Specific qualifier value,Cancer of Urinary Tract,0
5835,Night sweats,Granular Cell Leiomyosarcoma,0
5836,Geographic Locations,Angiosarcoma of liver,0
5837,treatment options,Uterine Cancer,0
5838,As Much as Desired,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5839,Internal,Malignant neoplasm of choroid,0
5840,Immune System Processes,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5841,Pap smear,Xeroderma pigmentosum,0
5842,Line Specimen,Prostate Lymphoma,0
5843,Include (action),Uterine Cancer,0
5844,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
5845,Relational and Item-Specific Encoding Task,Intraepithelial Melanocytic Hyperplasia,0
5846,High,Angiosarcoma of liver,0
5847,gene therapy,Cerebral hemangioma,0
5848,child survival,Stage I Adult Non-Hodgkin Lymphoma,0
5849,Malignant neoplasm of endometrium,Mucinous cystadenofibroma,0
5850,90%,Thymoma malignant recurrent,0
5851,Diagnosis,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5852,Human papilloma virus infection,Anterior Urethral Malignant Neoplasm,0
5853,Smear - instruction imperative,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5854,Vocal articulation,Lipoma of small intestine,0
5855,Lymphoma,Xeroderma pigmentosum,0
5856,Manual pelvic examination (procedure),High Grade Glandular Intraepithelial Neoplasia,0
5857,Spreading (qualifier value),Malignant neoplasm of thalamus,0
5858,Gamma globulin,Digestive System Hodgkin Lymphoma,0
5859,Pylorus,Undifferentiated Endocervical Sarcoma,0
5860,Elderly (population group),Malignant melanoma of eyelid,0
5861,Hodgkin Disease,Neoplasms,0
5862,68,Non-Metastatic Gestational Trophoblastic Tumor,0
5863,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Clonal Hematopoiesis of Indeterminate Potential,0
5864,Skin,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5865,Containing (qualifier),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5866,Tumor Mass,Ichthyosis,0
5867,Skin Erosion,Extracranial Neuroblastoma,0
5868,Yellow color,adenosquamous carcinoma of breast,0
5869,Providing presence (regime/therapy),Thymic Clear Cell Carcinoma,0
5870,Skin,Human Papillomavirus-Related Carcinoma,0
5871,World Health Organization,Anterior Urethral Malignant Neoplasm,0
5872,Order (taxonomic),BRCA2 Syndrome,0
5873,Urinary Diversion,Cerebral Primitive Neuroectodermal Tumor,0
5874,Second Primary Cancers,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5875,Neuroendocrine Tumors,Airway Hemangioma,0
5876,Cancer Genus,Ampulla of Vater Tubular Adenoma,0
5877,Prophylactic treatment,Benign Carotid Body Paraganglioma,0
5878,Stem cell transplant,Metastatic Ductal Breast Carcinoma,0
5879,Code,Liver Lymphangioma,0
5880,Sun Exposure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5881,Treating,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5882,Volume Measurement,Acantholytic squamous cell carcinoma,0
5883,shared attribute,Lung Mucinous Cystadenoma,0
5884,Skin,Tonsillar Carcinoma,0
5885,White Blood Cell Count procedure,Acantholytic squamous cell carcinoma,0
5886,b cell differentiation,Thymic Atypical Carcinoid Tumor,0
5887,Cartilaginous exostosis,FIGO Stage II Ovarian Cancer,0
5888,Formation,Female Breast Carcinoma,0
5889,65+,Lung Mucinous Cystadenoma,0
5890,PSA Level Less than Two,Childhood Fibrillary Astrocytoma,0
5891,risk factors,Clonal Hematopoiesis of Indeterminate Potential,0
5892,diagnosis aspect,Intraepithelial Melanocytic Hyperplasia,0
5893,Call (Instruction),FIGO Stage II Ovarian Cancer,0
5894,Cystic,Unfavorable Non-Hodgkin Lymphoma,0
5895,Usually,Bladder squamous cell carcinoma stage I,0
5896,Associated with,Xeroderma pigmentosum,0
5897,Enlargement procedure,Giant cell angiofibroma,0
5898,Affecting,Malignant Testicular Sertoli Cell Tumor,0
5899,Aflatoxins,Recurrent Testicular Lymphoma,0
5900,Combined,Primary Cutaneous Plasmablastic Lymphoma,0
5901,Feel Tired question,sarcoma of spinal cord,0
5902,Pharmacotherapy,Granular Cell Leiomyosarcoma,0
5903,Sometimes,Localized Ewing Sarcoma,0
5904,foreign,Mastocytosis,0
5905,Qualitative form,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5906,Removed,Stage IB Pancreatic Cancer AJCC v8,0
5907,Manufactured form,Female Breast Carcinoma,0
5908,Ovary,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5909,Severe (severity modifier),Liver Lymphangioma,0
5910,Part of,FIGO Stage II Ovarian Cancer,0
5911,include - SetOperator,Deep Leiomyoma,0
5912,Kidney Tubules,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
5913,Greeks,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5914,Lymphangioma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5915,Disease Management,Medulloblastoma,0
5916,Secondary Neoplasm,Blepharal carcinoma,0
5917,Adult,Cerebral Primitive Neuroectodermal Tumor,0
5918,Area,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5919,Tanning of leather,Lung Mucinous Cystadenoma,0
5920,Dark color,FIGO Stage II Ovarian Cancer,0
5921,Fordyce's disease,Xeroderma pigmentosum,0
5922,production,Malignant neoplasm of choroid,0
5923,Cold Temperature,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5924,active (HL7 RoleLink),Leptomeningeal sarcoma,0
5925,Swelling,Low Grade Squamous Intraepithelial Neoplasia,0
5926,Financial Account,Acute Undifferentiated Leukemia,0
5927,95,Adrenal Rest Tumor,0
5928,Known,Diffuse malignant mesothelioma,0
5929,transport (device),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5930,Prognosis:Find:Pt:^Patient:Nom,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5931,System,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5932,shared attribute,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5933,Response Likelihood,Acantholytic squamous cell carcinoma,0
5934,Adult,adenoid cystic carcinoma of lung,0
5935,In situ neoplasm (morphology),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5936,Cure (remedy),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5937,Oral region,Acute lymphadenitis,0
5938,Simple,Chronic Myelomonocytic Leukemia-2,0
5939,Sufficiently defined concept definition status (core metadata concept),Stage IB Pancreatic Cancer AJCC v8,0
5940,Malignant neoplasm of lung,Thymic Clear Cell Carcinoma,0
5941,Pharmaceutical Preparations,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5942,Intracranial Hypertension,Benign Apocrine Neoplasm,0
5943,Infection,Medulloblastoma,0
5944,Science of Etiology,Childhood Thyroid Gland Follicular Carcinoma,0
5945,Duct system,Familial Hemophagocytic Lymphocytosis,0
5946,More,Lipoma of small intestine,0
5947,Treatment Epoch,Diffuse malignant mesothelioma,0
5948,Electromagnetic Radiation,Childhood Fibrillary Astrocytoma,0
5949,Body Site Modifier - Lower,Recurrent Uveal Melanoma,0
5950,month,Undifferentiated Endocervical Sarcoma,0
5951,Time (foundation metadata concept),Intestinal Metaplasia of Bladder Urothelium,0
5952,Occurrence Indicator,Stage IV Penile Cancer AJCC v7,0
5953,*Relative,Endometrial Small Cell Carcinoma,0
5954,Malignant neoplasm of pancreas,Angiosarcoma of liver,0
5955,Skin Pigmentation Disorder,Cancer of Urinary Tract,0
5956,Sore Throat,Acute Undifferentiated Leukemia,0
5957,Pancreas,Rhabdomyosarcoma with ganglionic differentiation,0
5958,Affecting,Carcinoma of urinary bladder,0
5959,Therapeutic procedure,Diffuse malignant mesothelioma,0
5960,Unit of radiation dose,Non-Metastatic Gestational Trophoblastic Tumor,0
5961,Abnormal,Stage II Carcinoma of Penis,0
5962,Experimental Result,Mucinous adenocarcinoma gastric,0
5963,Therapeutic procedure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5964,classic behavior,Adult Alveolar Soft Part Sarcoma,0
5965,Dilate procedure,Acute Undifferentiated Leukemia,0
5966,Primary malignant neoplasm,Locally Advanced Soft Tissue Sarcoma,0
5967,Together,Malignant melanoma of eyelid,0
5968,Group A (qualifier value),Acute Undifferentiated Leukemia,0
5969,Common (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5970,Including (qualifier),Acute Undifferentiated Leukemia,0
5971,Include (action),Cancer of Urinary Tract,0
5972,Call (Instruction),Fourth Ventricle and Brain Stem Ependymal Tumor,0
5973,Sarcoma of soft tissue,Locally Advanced Soft Tissue Sarcoma,0
5974,Filter (function),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5975,Skin,Advanced Lung Carcinoma,0
5976,Pharmacotherapy,Noninfiltrating Intraductal Carcinoma,0
5977,200,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5978,Science of Etiology,FIGO Stage II Ovarian Cancer,0
5979,Body tissue,Giant cell angiofibroma,0
5980,Seventh,Xeroderma pigmentosum,0
5981,Levels (qualifier value),Liver Lymphangioma,0
5982,Foot British,Acantholytic squamous cell carcinoma,0
5983,ABCB1 protein,Testicular cancer metastatic,0
5984,oncology field,Anterior Urethral Malignant Neoplasm,0
5985,Fish Flavor,Intestinal Metaplasia of Bladder Urothelium,0
5986,Singular,Platinum-Resistant Lung Small Cell Carcinoma,0
5987,body system,Acute Undifferentiated Leukemia,0
5988,Adult Soft Tissue Sarcoma,Acantholytic squamous cell carcinoma,0
5989,Unconscious State,Ovarian germ cell choriocarcinoma stage IV,0
5990,Pigment cell,Intracortical osteosarcoma,0
5991,Etiology aspects,Chondrosarcoma,0
5992,combination - answer to question,Airway Hemangioma,0
5993,diagnosis aspect,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5994,metaplastic cell transformation,Maxillary Sinus Adenocarcinoma,0
5995,Value Above Reference Range,Intraepithelial Melanocytic Hyperplasia,0
5996,100%,Spongiotic dermatitis,0
5997,Enhance (action),adenosquamous carcinoma of breast,0
5998,Trial Screening,High Grade Glandular Intraepithelial Neoplasia,0
5999,Physical findings,Acantholytic squamous cell carcinoma,0
6000,Table Rules - groups,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6001,Fever,Malignant neoplasm of thalamus,0
6002,Pelvic cavity structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6003,Best Case Imputation Technique,Giant cell angiofibroma,0
6004,Therapeutic radiology procedure,Blepharal carcinoma,0
6005,Include (action),Benign Carotid Body Paraganglioma,0
6006,Chromosome Aberrations,Recurrent Uveal Melanoma,0
6007,Pages,Anaplastic large cell lymphoma,0
6008,Carcinoma with osteoclast-like giant cells,Breast Ductal Adenoma,0
6009,Sore sensation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6010,400,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6011,Sample Median,Mucinous adenocarcinoma gastric,0
6012,Process (qualifier value),Atypical Lobular Breast Hyperplasia,0
6013,Localized,Adult Alveolar Soft Part Sarcoma,0
6014,Old,Liver Cavernous Hemangioma,0
6015,Goes <invertebrate>,Breast Ductal Adenoma,0
6016,Removed,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6017,Infrequent,Tonsillar Carcinoma,0
6018,Fasting,embryonal rhabdomyosarcoma of prostate,0
6019,Type A,Xeroderma pigmentosum,0
6020,Smear - instruction imperative,Tonsillar Carcinoma,0
6021,Rare Diseases,embryonal rhabdomyosarcoma of prostate,0
6022,Carcinoma of bladder,FIGO Stage II Ovarian Cancer,0
6023,High,Giant cell angiofibroma,0
6024,Treatment Effectiveness,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6025,More,Acute lymphadenitis,0
6026,Tryptophanase,Localized Askin Tumor,0
6027,Excision,non-Hodgkin's lymphoma of spleen,0
6028,Population Group,Cerebral Primitive Neuroectodermal Tumor,0
6029,Hematology (discipline),Familial Hemophagocytic Lymphocytosis,0
6030,Uterine Cancer,Mucinous adenocarcinoma gastric,0
6031,disease history,BRCA2 Syndrome,0
6032,Domain (area of knowledge),Locally Advanced Soft Tissue Sarcoma,0
6033,Base - General Qualifier,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6034,Spread by direct extension,Hemangioma,0
6035,Benign,Adult Hepatocellular Carcinoma,0
6036,Smaller,Malignant Neoplasm with Regional Lymph Node Involvement,0
6037,Followed by,Hodgkin lymphoma,0
6038,Childhood Lymphoma,Adult Alveolar Soft Part Sarcoma,0
6039,year,Methotrexate-Associated Hodgkin Lymphoma,0
6040,fish - non-drug agent,Serous cystadenocarcinoma ovary,0
6041,Apply,Mucinous adenocarcinoma gastric,0
6042,Include (action),Metastatic Malignant Neoplasm in the Sellar Region,0
6043,Age,Childhood Thyroid Gland Follicular Carcinoma,0
6044,Usual,Malignant neoplasm of choroid,0
6045,Morphology,Non-Metastatic Gestational Trophoblastic Tumor,0
6046,Erythropoietin,Benign tumor of eyelid,0
6047,Connection,Grade 1 Clear Cell Renal Cell Carcinoma,0
6048,Only - dosing instruction fragment,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6049,Part Dosing Unit,Acantholytic squamous cell carcinoma,0
6050,More,Breast Ductal Adenoma,0
6051,Sharing (Social Behavior),Tonsillar Carcinoma,0
6052,Usual Severity Weight Loss,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6053,Uterus,Malignant Testicular Sertoli Cell Tumor,0
6054,Childhood Alveolar Soft Part Sarcoma,Digestive System Hodgkin Lymphoma,0
6055,Philadelphia Chromosome,Neonatal leukemia,0
6056,Occur (action),Sarcomatoid Renal Cell Carcinoma,0
6057,pharmacotherapeutic,Choroid Necrotic Melanoma,0
6058,Proliferation,Neoplasms,0
6059,Tissue Specimen Code,Stage IV Penile Cancer AJCC v7,0
6060,Coding,Stage II Fallopian Tube Cancer,0
6061,Government,Recurrent Uveal Melanoma,0
6062,M NOS ANTIBODY,Localized Ewing Sarcoma,0
6063,Hospitalization,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6064,QPCT wt Allele,Undifferentiated Endocervical Sarcoma,0
6065,To,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6066,World,Stage III Adult Immunoblastic Lymphoma,0
6067,Weight measurement scales,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6068,Abnormal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6069,Provide (product),Intraepithelial Melanocytic Hyperplasia,0
6070,Common Specifications in HL7 V3 Publishing,Contact dermatitis due to alkali,0
6071,Lymphoma,benign mature teratoma of pancreas,0
6072,Electromagnetic Spectrum,Placental aromatase deficiency,0
6073,Ultrasonic,Chronic Myelomonocytic Leukemia-2,0
6074,N+ (tumor staging),Adult Alveolar Soft Part Sarcoma,0
6075,Age-Years,Familial Hemophagocytic Lymphocytosis,0
6076,To,Recurrent Uveal Melanoma,0
6077,Connecticut,Ichthyosis,0
6078,85,Cerebral Primitive Neuroectodermal Tumor,0
6079,Known,Heavy Chain Deposition Disease,0
6080,Lymphadenitis,Lung squamous cell carcinoma stage I,0
6081,Human body structure,Acute lymphadenitis,0
6082,Life threatening - Event Consequence,embryonal rhabdomyosarcoma of prostate,0
6083,Loss of appetite (finding),Blepharal carcinoma,0
6084,Retinoic Acid Response Element,Thymoma malignant recurrent,0
6085,How Often Felt Normal question,Benign neoplasm of thorax,0
6086,year,Cerebral Primitive Neuroectodermal Tumor,0
6087,Weight decreased,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6088,70%,Malignant Neoplasm with Regional Lymph Node Involvement,0
6089,year,Refractory Barrett Esophagus,0
6090,Neurofibromatosis 1,Mucinous adenocarcinoma gastric,0
6091,Radiation,Intraepithelial Melanocytic Hyperplasia,0
6092,Used by,Acantholytic squamous cell carcinoma,0
6093,Specific qualifier value,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6094,50%,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6095,apply - action,Stage 0 Penile Cancer AJCC v8,0
6096,Nicotiana,Recurrent Testicular Lymphoma,0
6097,World,Undifferentiated Endocervical Sarcoma,0
6098,Low Level,Larynx carcinoma recurrent,0
6099,Occurrence,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6100,Location of Pharyngeal Residue Following Swallowing,Intestinal Neuroendocrine Carcinoma,0
6101,Cell Device,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6102,Type - attribute,Stage 0 Penile Cancer AJCC v8,0
6103,20%,Thymic Atypical Carcinoid Tumor,0
6104,Frequently,Acantholytic squamous cell carcinoma,0
6105,Scaling,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6106,Universal,Hemangioma,0
6107,Concept model range (foundation metadata concept),Leptomeningeal sarcoma,0
6108,Etiology aspects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6109,Physical findings:Finding:Point in time:^Patient:Nominal:Observed,Localized Ewing Sarcoma,0
6110,shared attribute,Mucinous neoplasm,0
6111,PSA Level Less than Five,Acantholytic squamous cell carcinoma,0
6112,Administration procedure,Female Breast Carcinoma,0
6113,preference,Malignant melanoma of eyelid,0
6114,Relative,sarcoma of spinal cord,0
6115,Primary malignant neoplasm,Acantholytic squamous cell carcinoma,0
6116,Symptoms aspect,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6117,Rare,Cartilaginous exostosis,0
6118,Diffuse Large B-Cell Lymphoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6119,animal allergen extracts,Mucinous adenocarcinoma gastric,0
6120,Valid,Anterior Urethral Malignant Neoplasm,0
6121,Left,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6122,Males,Colorectal cancer,0
6123,Clear,Giant cell angiofibroma,0
6124,Characterization,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6125,Including (qualifier),Clonal Hematopoiesis of Indeterminate Potential,0
6126,Controlled by,Diffuse malignant mesothelioma,0
6127,Original,Cerebral Primitive Neuroectodermal Tumor,0
6128,Direct Extension,Maxillary Sinus Adenocarcinoma,0
6129,Frequently,papillary carcinoma of penis,0
6130,Array Feature,Angiosarcoma of liver,0
6131,Procedure findings:Finding:Point in time:^Patient:Narrative,Intestinal Neuroendocrine Carcinoma,0
6132,Immature Cell Count (laboratory procedure),Carcinoma ex pleomorphic adenoma of parotid gland,0
6133,Atypical Ductal Breast Hyperplasia,Adenocarcinoma of the prostate metastatic,0
6134,27,Non-Metastatic Gestational Trophoblastic Tumor,0
6135,Cancer Genus,Acantholytic squamous cell carcinoma,0
6136,Common Specifications in HL7 V3 Publishing,Unresectable Rhabdomyosarcoma,0
6137,Malignant Neoplasms,Heavy Chain Deposition Disease,0
6138,Biopsy,Cerebral hemangioma,0
6139,Container status - Identified,squamous cell carcinoma of the thyroid gland,0
6140,Mathematical Operator,Intraepithelial Melanocytic Hyperplasia,0
6141,Slow Growing,FIGO Stage II Ovarian Cancer,0
6142,Dietary Arsenic,Locally Advanced Soft Tissue Sarcoma,0
6143,With intensity,Human Papillomavirus-Related Carcinoma,0
6144,Axilla,Thymic Atypical Carcinoid Tumor,0
6145,Experimental Result,Hemangioma,0
6146,Known,Human Papillomavirus-Related Carcinoma,0
6147,Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,Neonatal leukemia,0
6148,Tears - SpecimenType,Adult Brain Stem Mixed Glioma,0
6149,Surgical aspects,Tonsillar Carcinoma,0
6150,Then,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6151,Thymus Neoplasms,Thymic Clear Cell Carcinoma,0
6152,>5,Pancreatic Intraepithelial Neoplasia-3,0
6153,Histologic type,Non-Metastatic Gestational Trophoblastic Tumor,0
6154,Form:Finding:Point in time:{Setting}:Document:{Role},Leiomyoma of Gallbladder,0
6155,HLA Complex,Metastatic Lung Small Cell Carcinoma,0
6156,Major,sarcoma of spinal cord,0
6157,Disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6158,Person 1,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
6159,Portion of urine,malignant lymphoma of pancreatic lymph nodes,0
6160,Well,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6161,artesunate,non-Hodgkin's lymphoma of spleen,0
6162,Hand,Choroid Necrotic Melanoma,0
6163,Usual Severity Vomiting,Ichthyosis,0
6164,Attenuated by (contextual qualifier),BRCA2 Syndrome,0
6165,Adult Hodgkin Lymphoma,Pancreatic Intraepithelial Neoplasia-3,0
6166,Worsening pattern,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6167,Transmitted by,gliosarcoma,0
6168,Label (document),Colorectal High Grade B-Cell Lymphoma,0
6169,Male population group,Acute Undifferentiated Leukemia,0
6170,Hearing Loss,Recurrent Uveal Melanoma,0
6171,removal technique,Bladder squamous cell carcinoma stage I,0
6172,Two,Breast Ductal Adenoma,0
6173,Liquid Tumor,FIGO Stage II Ovarian Cancer,0
6174,Have Pain,Carcinoma of urinary bladder,0
6175,Normal hair follicles,Hodgkin lymphoma,0
6176,20%,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6177,Males,Recurrent Uveal Melanoma,0
6178,Half,Mucinous adenocarcinoma gastric,0
6179,Universal restriction modifier (core metadata concept),Neonatal leukemia,0
6180,Disease,Heavy Chain Deposition Disease,0
6181,Secondary Neoplasm,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6182,Genus Anemia,Chronic Myelomonocytic Leukemia-2,0
6183,Practice Experience,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6184,row - Table,Stage IV Childhood Non-Hodgkin Lymphoma,0
6185,Blink Reflexes,Thymic Clear Cell Carcinoma,0
6186,Order (document),Testicular cancer metastatic,0
6187,Gastric Acid,Ovarian germ cell choriocarcinoma stage IV,0
6188,Entity Determiner - specific,Larynx carcinoma recurrent,0
6189,metastatic qualifier,Unresectable Rhabdomyosarcoma,0
6190,Arsenic measurement,Advanced Lung Carcinoma,0
6191,Common Specifications in HL7 V3 Publishing,Anterior Urethral Malignant Neoplasm,0
6192,Hearing,Fourth Ventricle and Brain Stem Ependymal Tumor,0
6193,Sternum,Stage II Carcinoma of Penis,0
6194,Present,Adult Alveolar Soft Part Sarcoma,0
6195,Variety (taxon),Heavy Chain Deposition Disease,0
6196,leukemia,Diffuse malignant mesothelioma,0
6197,Have Nausea,Ovarian germ cell choriocarcinoma stage IV,0
6198,Therapeutic procedure,Rhabdomyosarcoma with ganglionic differentiation,0
6199,Screening,Clonal Hematopoiesis of Indeterminate Potential,0
6200,Links List,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6201,High Mitosis-Karyorrhexis Index,Metastatic Malignant Neoplasm in the Sellar Region,0
6202,Symptoms aspect,Uterine Cancer,0
6203,Present,Metastatic Carcinoma in the Lung,0
6204,Cell Count,Adult Alveolar Soft Part Sarcoma,0
6205,Infrequent,Malignant Neoplasm with Regional Lymph Node Involvement,0
6206,Therapeutic radiology procedure,Intraepithelial Melanocytic Hyperplasia,0
6207,Help document,benign mature teratoma of pancreas,0
6208,set (group),Cerebral hemangioma,0
6209,Offspring,Stage IB Pancreatic Cancer AJCC v8,0
6210,associated disease,Intraepithelial Melanocytic Hyperplasia,0
6211,protein body,Malignant Neoplasm of Lung - Multiple Primary Sites,0
6212,Classification,Platinum-Resistant Lung Small Cell Carcinoma,0
6213,Lymphoma,Ovarian germ cell choriocarcinoma stage IV,0
6214,Acute leukemia,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6215,Occur (action),FIGO Stage II Ovarian Cancer,0
6216,PSA Level Greater than Fifty,Maxillary Sinus Adenocarcinoma,0
6217,Possible diagnosis,Diffuse malignant mesothelioma,0
6218,Membrane,Malignant Testicular Sertoli Cell Tumor,0
6219,Silent,Acantholytic squamous cell carcinoma,0
6220,Impaired skin integrity,Childhood Fibrillary Astrocytoma,0
6221,Poor - grade value,Unfavorable Non-Hodgkin Lymphoma,0
6222,Metastatic Neoplasm,Giant cell angiofibroma,0
6223,Financial Account,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6224,Capsule (unit of presentation),Lung Mucinous Cystadenoma,0
6225,65+,Pilocytic astrocytoma of cerebellum,0
6226,Significant,Adult Hepatocellular Carcinoma,0
6227,Infrequent,Intraepithelial Melanocytic Hyperplasia,0
6228,Appearance,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6229,DNA,sarcoma of spinal cord,0
6230,Distention of blood vessel,Acantholytic squamous cell carcinoma,0
6231,Manufactured form,Primary Cutaneous Plasmablastic Lymphoma,0
6232,Include (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6233,cell growth,Cerebral Primitive Neuroectodermal Tumor,0
6234,year,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6235,Autoimmune Diseases,Adenocarcinoma of the prostate metastatic,0
6236,Primary malignant neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6237,Outward,Thymic Clear Cell Carcinoma,0
6238,Centrocytic lymphoma,non-Hodgkin's lymphoma of spleen,0
6239,2+ Score,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6240,Diagnosis Study,Cancer of Urinary Tract,0
6241,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6242,Fraction of,Leptomeningeal sarcoma,0
6243,Cause of death.underlying,embryonal rhabdomyosarcoma of prostate,0
6244,Participation Type - origin,Intraepithelial Melanocytic Hyperplasia,0
6245,Transformation,Mucinous adenocarcinoma gastric,0
6246,Spreading (qualifier value),Malignant neoplasm of choroid,0
6247,Extravasation,BRCA2 Syndrome,0
6248,Linear,Recurrent Testicular Lymphoma,0
6249,Maybe,Adenocarcinoma of the prostate metastatic,0
6250,Include (action),Fourth Ventricle and Brain Stem Ependymal Tumor,0
6251,Symptoms aspect,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6252,cell growth,Heavy Chain Deposition Disease,0
6253,include - SetOperator,Malignant melanoma of eyelid,0
6254,Legal Adult,Cancer of Urinary Tract,0
6255,Personal appearance,Endometrial Small Cell Carcinoma,0
6256,Times,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6257,Five,sarcoma of spinal cord,0
6258,Togo,Mucinous cystadenofibroma,0
6259,Body structure,Malignant melanoma of eyelid,0
6260,Dominant,Ovarian germ cell choriocarcinoma stage IV,0
6261,Population Group,Undifferentiated Endocervical Sarcoma,0
6262,ICD-9,Acantholytic squamous cell carcinoma,0
6263,Multiple malignancy,Digestive System Hodgkin Lymphoma,0
6264,Purpose,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6265,Nausea:Presence or Threshold:Point in time:^Patient:Ordinal,Stage IB Pancreatic Cancer AJCC v8,0
6266,therapeutic aspects,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6267,Oropharyngeal,Stage IV Childhood Non-Hodgkin Lymphoma,0
6268,Tests (qualifier value),Benign tumor of eyelid,0
6269,Lung,Human Papillomavirus-Related Carcinoma,0
6270,Lung,Digestive System Hodgkin Lymphoma,0
6271,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6272,Occurrence,Xeroderma pigmentosum,0
6273,Cancer Genus,gliosarcoma,0
6274,Fighting,Intraepithelial Melanocytic Hyperplasia,0
6275,Biomaterial Treatment,Stage II Hepatocellular Carcinoma AJCC v8,0
6276,Object Relationship,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6277,History of previous events,Localized Ewing Sarcoma,0
6278,Source (property) (qualifier value),Ovarian germ cell choriocarcinoma stage IV,0
6279,Third,Recurrent Uveal Melanoma,0
6280,ovarian,Childhood Fibrillary Astrocytoma,0
6281,Device Spring,adenosquamous carcinoma of breast,0
6282,Free (available (qualifier)),Angiosarcoma of liver,0
6283,Participation Type - origin,FIGO Stage II Ovarian Cancer,0
6284,Occurrence Indicator,Anterior Urethral Malignant Neoplasm,0
6285,Vagina Carcinoma,Localized Ewing Sarcoma,0
6286,geographic population,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6287,Adult,Recurrent Diffuse Intrinsic Pontine Glioma,0
6288,Life Threatening,Acute lymphadenitis,0
6289,Occurrence,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6290,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Anaplastic large cell lymphoma,0
6291,Donor person,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6292,Result,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6293,Decrease,Malignant melanoma of eyelid,0
6294,Oral region,Thymoma malignant recurrent,0
6295,Basis - conceptual entity,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6296,Lymphatic,Primary Cutaneous Plasmablastic Lymphoma,0
6297,Urinary tract,Methotrexate-Associated Hodgkin Lymphoma,0
6298,obsolete,Undifferentiated Neuroblastoma,0
6299,Inferior,Acantholytic squamous cell carcinoma,0
6300,Therapeutic procedure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6301,Treatment Epoch,Intraepithelial Melanocytic Hyperplasia,0
6302,Prophylactic treatment,benign mature teratoma of pancreas,0
6303,Account number:Identifier:Point in time:^Patient:Nominal,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6304,Body tissue,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6305,diagnosis aspect,Rhabdomyosarcoma with ganglionic differentiation,0
6306,Pediculus humanus capitis (eukaryote),Unfavorable Non-Hodgkin Lymphoma,0
6307,therapeutic aspects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6308,Completely Able,Benign neoplasm of thorax,0
6309,Account number:Identifier:Point in time:^Patient:Nominal,Adult Hepatocellular Carcinoma,0
6310,Operative Surgical Procedures,Medulloblastoma,0
6311,Unconscious State,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
6312,GDF15 protein,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6313,Country,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6314,Belgium,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6315,Tryptophanase,Leptomeningeal sarcoma,0
6316,Part of,Stage IV Penile Cancer AJCC v7,0
6317,Permutation,Benign Carotid Body Paraganglioma,0
6318,Stomach,Mucinous adenocarcinoma gastric,0
6319,Slow Growing Mass,Xeroderma pigmentosum,0
6320,Primary malignant neoplasm,High Grade Glandular Intraepithelial Neoplasia,0
6321,Inguinal region,Methotrexate-Associated Hodgkin Lymphoma,0
6322,Biopsy,Benign tumor of eyelid,0
6323,Pharyngitis,Thymic Clear Cell Carcinoma,0
6324,Better than Others,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6325,Therapeutic procedure,benign mature teratoma of pancreas,0
6326,Lead,Cartilaginous exostosis,0
6327,Line Specimen,Recurrent Testicular Lymphoma,0
6328,Risk,Carcinoma of urinary bladder,0
6329,Numerous,Digestive System Hodgkin Lymphoma,0
6330,Human body structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6331,Experimental Result,Pilocytic astrocytoma of cerebellum,0
6332,Accounting (activity),Tonsillar Carcinoma,0
6333,Feelings,Pancreatic Intraepithelial Neoplasia-3,0
6334,Formation,Recurrent Testicular Lymphoma,0
6335,Cell Count,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6336,Giant Cell Fibroblastoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6337,/40,Uterine Cancer,0
6338,excessive growth,Benign tumor of eyelid,0
6339,Symptoms aspect,Adult Hepatocellular Carcinoma,0
6340,Others - Allergy,Localized Askin Tumor,0
6341,General health,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6342,Used by,Medulloblastoma,0
6343,Primary,Adenocarcinoma of the prostate metastatic,0
6344,Hair,Mucinous cystadenofibroma,0
6345,Due to,Colorectal Neuroendocrine Tumor G2,0
6346,How Much Distress Weight Loss,Recurrent Uveal Melanoma,0
6347,Biologic Development,FIGO Stage II Ovarian Cancer,0
6348,risk factors - observation list,Acantholytic squamous cell carcinoma,0
6349,Treating,Recurrent Uveal Melanoma,0
6350,Historical aspects qualifier,Malignant neoplasm of thalamus,0
6351,Disease,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6352,Chicken laying egg for human food,Adult Alveolar Soft Part Sarcoma,0
6353,Cystic,Lipoma of small intestine,0
6354,occurrence characteristics,Anterior Urethral Malignant Neoplasm,0
6355,Cutaneous (intended site),Recurrent Testicular Lymphoma,0
6356,Present,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6357,various antiseptic throat preparations,Undifferentiated Neuroblastoma,0
6358,National origin,Childhood Lymphoma,0
6359,Very Much,Undifferentiated Endocervical Sarcoma,0
6360,Adult Lymphoma,Endometrial Small Cell Carcinoma,0
6361,Treatment Effectiveness,mucinous adenocarcinoma of gallbladder,0
6362,Referring,Blepharal carcinoma,0
6363,Taxonomic,Intestinal Metaplasia of Bladder Urothelium,0
6364,Two,Recurrent Uveal Melanoma,0
6365,Hemorrhagic,Cerebral Primitive Neuroectodermal Tumor,0
6366,Growth abnormality,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6367,Occurrence Indicator,Breast Ductal Adenoma,0
6368,Device system,Recurrent Uveal Melanoma,0
6369,Cell (compartment),Endometrial Small Cell Carcinoma,0
6370,Endocervical epithelium,Uterine Cancer,0
6371,Significant,Childhood Fibrillary Astrocytoma,0
6372,Coding,Bladder squamous cell carcinoma stage I,0
6373,Present,Intestinal Metaplasia of Bladder Urothelium,0
6374,Container status - Identified,Metastatic Kidney Carcinoma,0
6375,epithelial,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6376,Body tissue,Localized Askin Tumor,0
6377,Autosomal recessive inheritance,Digestive System Hodgkin Lymphoma,0
6378,shared attribute,Blepharal carcinoma,0
6379,Taxonomic,Testicular cancer metastatic,0
6380,Benign melanocytic nevus,Benign Apocrine Neoplasm,0
6381,Reporting,Serous cystadenocarcinoma ovary,0
6382,Pallor,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6383,Alcohol consumption,Colorectal High Grade B-Cell Lymphoma,0
6384,Rapid,Recurrent Testicular Lymphoma,0
6385,Screening for cancer,Malignant melanoma of eyelid,0
6386,Associated with,Heavy Chain Deposition Disease,0
6387,newly,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6388,Ephrin Type-B Receptor 1,Mucinous adenocarcinoma gastric,0
6389,Notable,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6390,Sound - physical agent,Mastocytosis,0
6391,Togo,Methotrexate-Associated Hodgkin Lymphoma,0
6392,Smear - instruction imperative,Endometrial Small Cell Carcinoma,0
6393,Chromosomal translocation,Mastocytosis,0
6394,Cancer Other,Acute Undifferentiated Leukemia,0
6395,Immature Lymphocytes Measurement,FIGO Stage II Ovarian Cancer,0
6396,Primary malignant neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6397,Fever,Stage II Carcinoma of Penis,0
6398,Supine Position,Thymic Clear Cell Carcinoma,0
6399,B-Cell Lymphomas,Carcinoma of urinary bladder,0
6400,What subject filter - Result,Xeroderma pigmentosum,0
6401,risk factors - observation list,Mucinous adenocarcinoma gastric,0
6402,Reported Term,Placental aromatase deficiency,0
6403,Division (action),Adult Fibrolamellar Carcinoma,0
6404,Proliferation,Pilocytic astrocytoma of cerebellum,0
6405,Plasma Cell Neoplasm,Intraepithelial Melanocytic Hyperplasia,0
6406,enzyme activity,Digestive System Hodgkin Lymphoma,0
6407,Serum,Cerebral Primitive Neuroectodermal Tumor,0
6408,Fatigue,Recurrent Uveal Melanoma,0
6409,Common Cold,Chondrosarcoma,0
6410,Secondary Cause of Death,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6411,Cure (remedy),Cerebral Primitive Neuroectodermal Tumor,0
6412,Code,Stage I Adult Non-Hodgkin Lymphoma,0
6413,Image Feature,Localized Askin Tumor,0
6414,Previous,Stage IV Penile Cancer AJCC v7,0
6415,Presence (property),Extracranial Neuroblastoma,0
6416,Classification,Acute Undifferentiated Leukemia,0
6417,Cold Sensation,Stage IB Lung Cancer AJCC v7,0
6418,Cells,Stage IV Penile Cancer AJCC v7,0
6419,Well Differentiated,Acute lymphadenitis,0
6420,*Type - Kind of quantity,Adenocarcinoma,0
6421,Primary malignant neoplasm of endometrium,Carcinoma ex pleomorphic adenoma of parotid gland,0
6422,Blood,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6423,3+ Score,Unresectable Rhabdomyosarcoma,0
6424,Testicular mass,Clonal Hematopoiesis of Indeterminate Potential,0
6425,50%,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6426,Prevalence aspects,Mastocytosis,0
6427,Conditional,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6428,Left,Non-Metastatic Gestational Trophoblastic Tumor,0
6429,Often - answer to question,Heavy Chain Deposition Disease,0
6430,Effectiveness,Recurrent Uveal Melanoma,0
6431,Cells,Thymic Atypical Carcinoid Tumor,0
6432,Childhood Lymphoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6433,Age of Onset,Airway Hemangioma,0
6434,Cohort Studies,Heavy Chain Deposition Disease,0
6435,Formation,Tonsillar Carcinoma,0
6436,abnormal growth by tissue,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6437,Food,Colorectal cancer,0
6438,Main,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6439,Part,Bladder squamous cell carcinoma stage I,0
6440,Together,Malignant Neoplasm of Lung - Multiple Primary Sites,0
6441,Tumor grade G3,FIGO Stage II Ovarian Cancer,0
6442,Adverse Event Associated with Vascular,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6443,Occurrence,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6444,Form:Finding:Point in time:{Setting}:Document:{Role},Liver Cavernous Hemangioma,0
6445,Geographic Locations,Adenocarcinoma,0
6446,Relationships,Metastatic Malignant Neoplasm in the Sellar Region,0
6447,Skin,Spongiotic dermatitis,0
6448,Formation,FIGO Stage II Ovarian Cancer,0
6449,Adenocarcinoma,Metastatic Malignant Neoplasm in the Sellar Region,0
6450,metaplastic cell transformation,Malignant Testicular Sertoli Cell Tumor,0
6451,Malignant neoplasm of lung,Intestinal Neuroendocrine Carcinoma,0
6452,child survival,Acantholytic squamous cell carcinoma,0
6453,House (environment),Mucinous adenocarcinoma gastric,0
6454,True primary (qualifier value),Benign Apocrine Neoplasm,0
6455,Esophageal,Granular Cell Leiomyosarcoma,0
6456,Irritants,Human Papillomavirus-Related Carcinoma,0
6457,Result,Human Papillomavirus-Related Carcinoma,0
6458,Neoplasm Metastasis,Xeroderma pigmentosum,0
6459,Sexually Transmitted Diseases,Stage II Carcinoma of Penis,0
6460,Often - answer to question,Thymoma malignant recurrent,0
6461,Pharmacotherapy,FIGO Stage II Ovarian Cancer,0
6462,Breaking down,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6463,Common Specifications in HL7 V3 Publishing,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6464,Examination,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6465,Time,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6466,Increased,Stage I Adult Non-Hodgkin Lymphoma,0
6467,Appearance,Cerebral Primitive Neuroectodermal Tumor,0
6468,Fish (substance),Intraepithelial Melanocytic Hyperplasia,0
6469,Common (qualifier value),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6470,*Type - Kind of quantity,Chronic Myelomonocytic Leukemia-2,0
6471,Suspected qualifier,Anterior Urethral Malignant Neoplasm,0
6472,Array Feature,FIGO Stage II Ovarian Cancer,0
6473,One,Acantholytic squamous cell carcinoma,0
6474,Child,Thymic Atypical Carcinoid Tumor,0
6475,1+,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6476,Affect (mental function),Stage II Fallopian Tube Cancer,0
6477,Onset of (contextual qualifier),Endometrial Small Cell Carcinoma,0
6478,Extrinsic,Recurrent Uveal Melanoma,0
6479,Relationships,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
6480,Cell (compartment),Acantholytic squamous cell carcinoma,0
6481,Absence (morphologic abnormality),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6482,Primary malignant neoplasm,Intraepithelial Melanocytic Hyperplasia,0
6483,International Classification of Diseases for Oncology,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6484,Deletion (action),Colorectal Neuroendocrine Tumor G2,0
6485,Fast Growing,Low Grade Squamous Intraepithelial Neoplasia,0
6486,Neoplasm Metastasis,Breast Ductal Adenoma,0
6487,Repaired,Liver Cavernous Hemangioma,0
6488,cell type,Methotrexate-Associated Hodgkin Lymphoma,0
6489,Decision,Liver Lymphangioma,0
6490,fish - non-drug agent,Adult Hepatocellular Carcinoma,0
6491,set (group),Intracortical osteosarcoma,0
6492,Unknown GENC,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6493,favor,FIGO Stage II Ovarian Cancer,0
6494,Diffuse Large B-Cell Lymphoma,Intestinal Metaplasia of Bladder Urothelium,0
6495,Tissue Specimen Code,Thymic Clear Cell Carcinoma,0
6496,Post Device,Giant cell angiofibroma,0
6497,Occur (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6498,Known,Methotrexate-Associated Hodgkin Lymphoma,0
6499,Code,embryonal rhabdomyosarcoma of prostate,0
6500,Percent of Bacteria,Neoplasms,0
6501,Slow,Mucinous adenocarcinoma gastric,0
6502,Departure - action,Spongiotic dermatitis,0
6503,Child,Adult Hepatocellular Carcinoma,0
6504,Analysis,Cartilaginous exostosis,0
6505,Malignant neoplasm of soft tissue,Recurrent Uveal Melanoma,0
6506,Cell Device,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6507,Malignant Neoplasms,Cerebral Primitive Neuroectodermal Tumor,0
6508,Management procedure,Stage IB Pancreatic Cancer AJCC v8,0
6509,cell type,BRCA2 Syndrome,0
6510,Third grade in elementary school,Intraepithelial Melanocytic Hyperplasia,0
6511,trophoblast,Childhood Central Nervous System Immature Teratoma,0
6512,Mechanism (attribute),GIANT PIGMENTED HAIRY NEVUS,0
6513,Presentation,Xeroderma pigmentosum,0
6514,Age of Onset,Stage IV Childhood Non-Hodgkin Lymphoma,0
6515,Distention of blood vessel,Neonatal leukemia,0
6516,Negation,Endometrial Small Cell Carcinoma,0
6517,Consistency,Lipoma of small intestine,0
6518,Head and neck structure,Benign tumor of eyelid,0
6519,Endocrine,Lipoma of small intestine,0
6520,Tryptophanase,Adult Hepatocellular Carcinoma,0
6521,Body structure,Airway Hemangioma,0
6522,Knowledge,embryonal rhabdomyosarcoma of prostate,0
6523,Minor (person),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6524,Nevus,Pancreatic Intraepithelial Neoplasia-3,0
6525,Linear,Benign Carotid Body Paraganglioma,0
6526,Classification,Testicular cancer metastatic,0
6527,Squamous cell carcinoma - category,Xeroderma pigmentosum,0
6528,Plumbum metallicum,Extra-Adrenal Paraganglioma,0
6529,combination of objects,Mucinous adenocarcinoma gastric,0
6530,Structure of posterior fossa of cranial cavity,Malignant melanoma of eyelid,0
6531,Good,Human Papillomavirus-Related Carcinoma,0
6532,Subject Risk,Stage IV Penile Cancer AJCC v7,0
6533,Area,Cartilaginous exostosis,0
6534,Specimen Source Codes - tumor,Primary Cutaneous Plasmablastic Lymphoma,0
6535,Azacitidine,Advanced Uterine Corpus Carcinosarcoma,0
6536,Disease remission,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
6537,Case (situation),Choroid Necrotic Melanoma,0
6538,Common Specifications in HL7 V3 Publishing,Endometrial Small Cell Carcinoma,0
6539,Spreading (qualifier value),Bladder squamous cell carcinoma stage I,0
6540,Primary malignant neoplasm,Low Grade Squamous Intraepithelial Neoplasia,0
6541,Table Cell Horizontal Align - left,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6542,Known,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6543,Approximate,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6544,Histocompatibility Testing,Mucinous adenocarcinoma gastric,0
6545,filtration,Stage IV Childhood Non-Hodgkin Lymphoma,0
6546,Cancer Genus,Contact dermatitis due to alkali,0
6547,Common (qualifier value),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6548,Substance,Diffuse malignant mesothelioma,0
6549,Young Child [Disease/Finding],Carcinoma ex pleomorphic adenoma of parotid gland,0
6550,AKR1A1 wt Allele,Acute lymphadenitis,0
6551,Egg of order Phthiraptera,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6552,Component (part),Breast Ductal Adenoma,0
6553,Targeted Therapy,mucinous adenocarcinoma of gallbladder,0
6554,Fever symptoms (finding),Childhood Fibrillary Astrocytoma,0
6555,Plasma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6556,Lymphoid system structure,Tonsillar Carcinoma,0
6557,FAMILIAL ADENOMATOUS POLYPOSIS,Stage III Adult Immunoblastic Lymphoma,0
6558,Retinoic Acid Response Element,Stage II Carcinoma of Penis,0
6559,Known,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6560,Orbital region,mucinous adenocarcinoma of gallbladder,0
6561,History,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6562,Male population group,Benign tumor of eyelid,0
6563,Most,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
6564,800,Endometrial Small Cell Carcinoma,0
6565,Bacteria,Xeroderma pigmentosum,0
6566,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6567,Hemorrhage,Neonatal leukemia,0
6568,Make - Instruction Imperative,Blepharal carcinoma,0
6569,Maintenance,High Grade Glandular Intraepithelial Neoplasia,0
6570,various antiseptic throat preparations,Ovarian Carcinoid Tumor,0
6571,parent,Unresectable Rhabdomyosarcoma,0
6572,Infertility,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6573,Arising in,Stage IB Lung Cancer AJCC v7,0
6574,Overall Publication Type,Giant cell angiofibroma,0
6575,Tissue Specimen Code,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6576,Occurrence,Ampulla of Vater Tubular Adenoma,0
6577,Test - temporal region,Maxillary Sinus Adenocarcinoma,0
6578,Rare Diseases,Thymic Clear Cell Carcinoma,0
6579,Uterus,Female Breast Carcinoma,0
6580,Etiology aspects,Recurrent Testicular Lymphoma,0
6581,Smear - instruction imperative,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6582,Reported Term,Deep Leiomyoma,0
6583,Primary malignant neoplasm,Intraepithelial Melanocytic Hyperplasia,0
6584,Numerous,Cancer of Urinary Tract,0
6585,Antibiotics for systemic use,Acantholytic squamous cell carcinoma,0
6586,Time,Cancer of Urinary Tract,0
6587,Malignant neoplasm of thymus,Cancer of Urinary Tract,0
6588,Myeloid,Ovarian germ cell choriocarcinoma stage IV,0
6589,CDISC SDTM Procedure Terminology,Fourth Ventricle and Brain Stem Ependymal Tumor,0
6590,Pain Distress Question,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6591,genome sequencing,Atypical Mesothelial Hyperplasia,0
6592,Occurrence Indicator,Ichthyosis,0
6593,diagnosis aspect,Localized Ewing Sarcoma,0
6594,Frequently,Hodgkin lymphoma,0
6595,Lymphocyte,Cartilaginous exostosis,0
6596,Frequency of Pain Question,Mucinous adenocarcinoma gastric,0
6597,Determined by,Malignant melanoma of eyelid,0
6598,Experimental Finding,Bladder squamous cell carcinoma stage I,0
6599,Case unit dose,Sarcomatoid Renal Cell Carcinoma,0
6600,Symptoms,Adult Hepatocellular Carcinoma,0
6601,Similarity,Stage IB Pancreatic Cancer AJCC v8,0
6602,Mechanism (attribute),Childhood Thyroid Gland Follicular Carcinoma,0
6603,Then,Malignant melanoma of eyelid,0
6604,How Much Distress Weight Loss,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6605,Most,Stage III Adult Immunoblastic Lymphoma,0
6606,Colloid,Recurrent Testicular Lymphoma,0
6607,Sore skin,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6608,Decision,Xeroderma pigmentosum,0
6609,Secreted,Mucinous adenocarcinoma gastric,0
6610,Neoplasms,Female Breast Carcinoma,0
6611,More,Low Grade Squamous Intraepithelial Neoplasia,0
6612,Metastatic Neoplasm,Metastatic Carcinoma in the Lung,0
6613,SLC35G1 gene,Metastatic Neoplasm to the Gallbladder,0
6614,Diagnosis Study,Hemangioma,0
6615,Data Transformation,Leptomeningeal sarcoma,0
6616,Person 1,Colorectal High Grade B-Cell Lymphoma,0
6617,seconds,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6618,Case (situation),Metastatic Lung Small Cell Carcinoma,0
6619,survival aspects,Malignant Neoplasm with Regional Lymph Node Involvement,0
6620,Including (qualifier),Mixed parotid tumor,0
6621,Tissue Specimen Code,Secondary malignant neoplasm of lymph node,0
6622,A1CF wt Allele,Adult Fibrolamellar Carcinoma,0
6623,Subtype (attribute),Liver Lymphangioma,0
6624,risk factors,Adult Alveolar Soft Part Sarcoma,0
6625,Smear - instruction imperative,Giant cell angiofibroma,0
6626,Areas <moth>,Pancreatic Intraepithelial Neoplasia-3,0
6627,Cancer Genus,Blepharal carcinoma,0
6628,Resolution,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6629,Etiology aspects,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6630,Entity Determiner - specific,Activated B-cell type diffuse large B-cell lymphoma,0
6631,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6632,subscriber - self,Human Papillomavirus-Related Carcinoma,0
6633,Concept History,Malignant Testicular Sertoli Cell Tumor,0
6634,Human body,Mucinous cystadenofibroma,0
6635,Blood group antibody I,Non-Metastatic Gestational Trophoblastic Tumor,0
6636,65,Diffuse malignant mesothelioma,0
6637,Used by,mucinous adenocarcinoma of gallbladder,0
6638,Out (direction),Stage IB Pancreatic Cancer AJCC v8,0
6639,Round cell tumor,non-Hodgkin's lymphoma of spleen,0
6640,Type - attribute,Chronic Myelomonocytic Leukemia-2,0
6641,Tumor site,Medulloblastoma,0
6642,Skin Specimen,Werner Syndrome,0
6643,Use of,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6644,lymphatic cancer,Localized Askin Tumor,0
6645,Prognosis:Find:Pt:^Patient:Nom,Xeroderma pigmentosum,0
6646,Equine laminitis,Maxillary Sinus Adenocarcinoma,0
6647,bony process,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6648,Nervous system structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6649,How Often Weight Loss,papillary carcinoma of penis,0
6650,Metastatic Neoplasm,mucinous adenocarcinoma of gallbladder,0
6651,Lymphadenopathy,Anaplastic large cell lymphoma,0
6652,Astrocytes,Acute Undifferentiated Leukemia,0
6653,Weight Loss,Stage IB Lung Cancer AJCC v7,0
6654,Treating,Cartilaginous exostosis,0
6655,Death (finding),Liver Lymphangioma,0
6656,How Often Vomiting,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6657,uti symptoms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6658,Image Feature,Lung squamous cell carcinoma stage I,0
6659,Clear,Colorectal High Grade B-Cell Lymphoma,0
6660,Deoxyribonucleic Acid Measurement,Blepharal carcinoma,0
6661,Uncontrolled,Benign Apocrine Neoplasm,0
6662,Usual,squamous cell carcinoma of the thyroid gland,0
6663,Nervous system problem,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6664,Act Relationship Subset - previous,Intestinal Metaplasia of Bladder Urothelium,0
6665,Obesity,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6666,Management Occupations,FIGO Stage II Ovarian Cancer,0
6667,Well,Angiosarcoma of liver,0
6668,Involvement with,Localized Askin Tumor,0
6669,Occurrence,Unfavorable Non-Hodgkin Lymphoma,0
6670,Image Feature,Stage IV Childhood Non-Hodgkin Lymphoma,0
6671,german race,Mucinous adenocarcinoma gastric,0
6672,Fatigue,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
6673,Exist,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6674,Vaginal wall,Grade 3a Malignant Neoplasm,0
6675,Cardiac Lead Procedure,Platinum-Resistant Lung Small Cell Carcinoma,0
6676,How Much Distress Itching,Metastatic Neoplasm to the Gallbladder,0
6677,Bladder Continence Question,Thymic Clear Cell Carcinoma,0
6678,Involvement with,Chondrosarcoma,0
6679,Tube - unit dose,adenoid cystic carcinoma of lung,0
6680,Arising in,Malignant Testicular Sertoli Cell Tumor,0
6681,Adolescent (age group),Recurrent Testicular Lymphoma,0
6682,Ability,Cancer of Urinary Tract,0
6683,Surgery specialty,FIGO Stage II Ovarian Cancer,0
6684,Population Group,Anaplastic large cell lymphoma,0
6685,Arising in,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6686,Pleural effusion fluid,Bladder squamous cell carcinoma stage I,0
6687,All of the Time,Carcinoma of urinary bladder,0
6688,geographic population,Malignant melanoma of eyelid,0
6689,Surgical aspects,FIGO Stage II Ovarian Cancer,0
6690,Derived value,Diffuse malignant mesothelioma,0
6691,Social group,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6692,Interventional procedure,Mucinous adenocarcinoma gastric,0
6693,Pathological Dilatation,Pilocytic astrocytoma of cerebellum,0
6694,Anorexia,Rhabdomyosarcoma with ganglionic differentiation,0
6695,Infrequent,Breast Ductal Adenoma,0
6696,Include (action),Angiosarcoma of liver,0
6697,Experimental Result,Cartilaginous exostosis,0
6698,Others - Allergy,Grade 3a Malignant Neoplasm,0
6699,Tryptophanase,Anterior Urethral Malignant Neoplasm,0
6700,Time,Locally Advanced Soft Tissue Sarcoma,0
6701,Series - set of composite instances,Human Papillomavirus-Related Carcinoma,0
6702,Type of device,Xeroderma pigmentosum,0
6703,Chemotherapy Regimen,Lipoma of small intestine,0
6704,Hemoptysis,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6705,Percent normal,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6706,Genetic Markers,Recurrent Testicular Lymphoma,0
6707,Prognosis:Find:Pt:^Patient:Nom,Refractory Barrett Esophagus,0
6708,True Control Status,Anterior Urethral Malignant Neoplasm,0
6709,Increase in size since previous mammogram,Familial Hemophagocytic Lymphocytosis,0
6710,eTMF Content Model Code,Intraepithelial Melanocytic Hyperplasia,0
6711,Correct (qualifier),Digestive System Hodgkin Lymphoma,0
6712,Poor - grade value,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6713,Reported Term,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6714,Pickled food,Acute Undifferentiated Leukemia,0
6715,Left sided,Stage IB Pancreatic Cancer AJCC v8,0
6716,Hemochromatosis,Diffuse malignant mesothelioma,0
6717,Cell Differentiation process,Noninfiltrating Intraductal Carcinoma,0
6718,To,Adult Hepatocellular Carcinoma,0
6719,Japanese language,Lipoma of small intestine,0
6720,Manufactured form,Malignant melanoma of eyelid,0
6721,Basal Cell Carcinoma Pathway,Noninfiltrating Intraductal Carcinoma,0
6722,Lead,Benign Apocrine Neoplasm,0
6723,Swallowing:-:Point in time:^Patient:-,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6724,Prognosis:Find:Pt:^Patient:Nom,Recurrent Testicular Lymphoma,0
6725,Cover (physical object),Advanced Uterine Corpus Carcinosarcoma,0
6726,Randomization,Neonatal leukemia,0
6727,Previously Treated Childhood Rhabdomyosarcoma,Methotrexate-Associated Hodgkin Lymphoma,0
6728,Temporal Lobe,Acute Undifferentiated Leukemia,0
6729,Death NOS,Giant cell angiofibroma,0
6730,Body structure,Unresectable Rhabdomyosarcoma,0
6731,Cause of Death,Malignant Neoplasm of Lung - Multiple Primary Sites,0
6732,Carcinoma of bladder,Pancreatic Intraepithelial Neoplasia-3,0
6733,Metastasis,Anterior Urethral Malignant Neoplasm,0
6734,Malignant Testicular Germ Cell Tumor,Extra-Adrenal Paraganglioma,0
6735,PDGFRB gene,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6736,Hematological Disease,GIANT PIGMENTED HAIRY NEVUS,0
6737,high - ActExposureLevelCode,Mucinous adenocarcinoma gastric,0
6738,Approximate,Uterine Cancer,0
6739,95,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6740,Include (action),embryonal rhabdomyosarcoma of prostate,0
6741,90%,Metastatic Malignant Neoplasm in the Sellar Region,0
6742,Overall Survival,Spongiotic dermatitis,0
6743,Physical findings:Finding:Point in time:^Patient:Nominal:Observed,Cerebral Primitive Neuroectodermal Tumor,0
6744,Severe (severity modifier),Testicular cancer metastatic,0
6745,First (number),Adult Alveolar Soft Part Sarcoma,0
6746,Weight Loss,Malignant Neoplasm with Regional Lymph Node Involvement,0
6747,Reaching,Angiosarcoma of liver,0
6748,Biomaterial Treatment,gliosarcoma,0
6749,solid substance,Malignant neoplasm of choroid,0
6750,Disease,Localized Ewing Sarcoma,0
6751,Photon Correlation Spectroscopy,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6752,Risk,Recurrent Testicular Lymphoma,0
6753,Occurrence Indicator,malignant lymphoma of pancreatic lymph nodes,0
6754,PSA Level Less than Five,Secondary malignant neoplasm of lymph node,0
6755,Chemotherapy Regimen,Cancer of Urinary Tract,0
6756,Aspect - Kind of quantity,Undifferentiated Endocervical Sarcoma,0
6757,Form:Finding:Point in time:{Setting}:Document:{Role},Testicular cancer metastatic,0
6758,year,Endometrial Small Cell Carcinoma,0
6759,Linear,Serous cystadenocarcinoma ovary,0
6760,Code,Intraepithelial Melanocytic Hyperplasia,0
6761,Solid Neoplasm,Intraepithelial Melanocytic Hyperplasia,0
6762,Common (qualifier value),Uterine Cancer,0
6763,physiological aspects,Intraepithelial Melanocytic Hyperplasia,0
6764,Germ cell tumor,Localized Ewing Sarcoma,0
6765,include - SetOperator,Acute Undifferentiated Leukemia,0
6766,analysis aspect,Stage IB Lung Cancer AJCC v7,0
6767,Aggressive course,benign mature teratoma of pancreas,0
6768,Papule,Choroid Necrotic Melanoma,0
6769,Specific qualifier value,Malignant Testicular Sertoli Cell Tumor,0
6770,Classification,Low Grade Squamous Intraepithelial Neoplasia,0
6771,Occurrence Indicator,Adenocarcinoma,0
6772,Pelvic pain female,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6773,Biopsy,Cerebral Primitive Neuroectodermal Tumor,0
6774,Malignant neoplasm of skin,Collecting Duct Carcinoma of the Kidney,0
6775,Anterior chest wall structure,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6776,Genes,Mucinous adenocarcinoma gastric,0
6777,Vagina,Chronic Myelomonocytic Leukemia-2,0
6778,Surgical aspects,Digestive System Hodgkin Lymphoma,0
6779,Long-term,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6780,Reside,Malignant Neoplasm with Regional Lymph Node Involvement,0
6781,Substance,Stage II Carcinoma of Penis,0
6782,Primary malignant neoplasm,Maxillary Sinus Adenocarcinoma,0
6783,Difficult (qualifier value),mucinous adenocarcinoma of gallbladder,0
6784,Cancer Registry,FIGO Stage II Ovarian Cancer,0
6785,Urinary Bladder,Undifferentiated Endocervical Sarcoma,0
6786,Postmenopausal state,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6787,Macrophage Activation Syndrome,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6788,Abdominal bloating,Medulloblastoma,0
6789,New Zealand Rabbits,Pancreatic Intraepithelial Neoplasia-3,0
6790,Family,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6791,Myoepithelial,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6792,Lifetime,Malignant neoplasm of thalamus,0
6793,Valid,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6794,melanotic,Atypical Lobular Breast Hyperplasia,0
6795,Etiology aspects,Undifferentiated Endocervical Sarcoma,0
6796,NCI CTEP SDC Myeloma Sub-Category Terminology,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6797,risk factors,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
6798,include - SetOperator,Anaplastic large cell lymphoma,0
6799,Medications:-:Point in time:^Patient:-,Chronic Myelomonocytic Leukemia-2,0
6800,First (number),Mucinous adenocarcinoma gastric,0
6801,Cells,FIGO Stage II Ovarian Cancer,0
6802,Order (record artifact),Hemangioma,0
6803,Disease,Angiosarcoma of liver,0
6804,Location,Xeroderma pigmentosum,0
6805,Adoptive Immunotherapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6806,prevention aspects,Intestinal Metaplasia of Bladder Urothelium,0
6807,Medical History,Malignant neoplasm of choroid,0
6808,Thymoma,Advanced Uterine Corpus Carcinosarcoma,0
6809,Before,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6810,Common (qualifier value),Ovarian germ cell choriocarcinoma stage IV,0
6811,Cancer Genus,Ichthyosis,0
6812,CD5 Positive,Ovarian Carcinoid Tumor,0
6813,Coitus,Human Papillomavirus-Related Carcinoma,0
6814,Coating (film),Angiosarcoma of liver,0
6815,gene therapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6816,Tumor cells,Stage IB Lung Cancer AJCC v7,0
6817,Symptoms aspect,Childhood Cerebellar Neoplasm,0
6818,Sweat,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6819,Case (situation),Localized Ewing Sarcoma,0
6820,Recurrence,Undifferentiated Endocervical Sarcoma,0
6821,Thyroid carcinoma,Bladder squamous cell carcinoma stage I,0
6822,Preventable,Cartilaginous exostosis,0
6823,Known,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6824,How Often Sweats,Recurrent Testicular Lymphoma,0
6825,Contain (action),Undifferentiated Endocervical Sarcoma,0
6826,Physical Medical Procedure,Mucinous adenocarcinoma gastric,0
6827,Have Sweats,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6828,Pineal germinoma,Recurrent Testicular Lymphoma,0
6829,Closed,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6830,Leukocytes,Malignant Testicular Sertoli Cell Tumor,0
6831,Swallowing:-:Point in time:^Patient:-,Extracranial Neuroblastoma,0
6832,Congenital ichthyosis,Childhood Choriocarcinoma,0
6833,Occurrence Indicator,Adenocarcinoma of the prostate metastatic,0
6834,Neonatal (qualifier value),Digestive System Hodgkin Lymphoma,0
6835,Common (qualifier value),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6836,Asia,Acute Undifferentiated Leukemia,0
6837,World,Stage IB Lung Cancer AJCC v7,0
6838,Beginning,Non-Metastatic Gestational Trophoblastic Tumor,0
6839,Negation,Childhood Fibrillary Astrocytoma,0
6840,Tryptophanase,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
6841,Five-year Survival Rate,Medulloblastoma,0
6842,High risk,Female Breast Carcinoma,0
6843,Metastatic to,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6844,Fever,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
6845,Term Source,Thymoma malignant recurrent,0
6846,Malignant Neoplasms,FIGO Stage II Ovarian Cancer,0
6847,Adult,Endometrial Small Cell Carcinoma,0
6848,Metastatic to,Thymic Atypical Carcinoid Tumor,0
6849,CDISC SEND Tumor Findings Results Terminology,Cerebral Primitive Neuroectodermal Tumor,0
6850,Symptoms aspect,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6851,Possibly Related to Intervention,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6852,Refrigeration,Refractory Barrett Esophagus,0
6853,Retinoic Acid Response Element,Refractory Barrett Esophagus,0
6854,All,Anaplastic large cell lymphoma,0
6855,Operative Surgical Procedures,embryonal rhabdomyosarcoma of prostate,0
6856,Malignant Neoplasms,Acute lymphadenitis,0
6857,Disease Screening,Intraepithelial Melanocytic Hyperplasia,0
6858,40%,Malignant neoplasm of thalamus,0
6859,Condition,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6860,Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6861,85,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6862,Small cell carcinoma of lung,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6863,System (unit of presentation),Familial Adenomatous Polyposis Associated Medulloblastoma,0
6864,Less Than,Mucinous adenocarcinoma gastric,0
6865,Only - dosing instruction fragment,Benign Apocrine Neoplasm,0
6866,Smooth Muscle Tumor,Benign neoplasm of thorax,0
6867,Count,Digestive System Hodgkin Lymphoma,0
6868,Screening Study,Low Grade Squamous Intraepithelial Neoplasia,0
6869,Negation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6870,Development,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6871,per year,Ovarian germ cell choriocarcinoma stage IV,0
6872,Necrosis,Childhood Fibrillary Astrocytoma,0
6873,Function Axis,Metastatic Malignant Neoplasm in the Sellar Region,0
6874,lymph nodes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6875,Rest,Heavy Chain Deposition Disease,0
6876,Stage,Digestive System Hodgkin Lymphoma,0
6877,skin color,Cerebral Primitive Neuroectodermal Tumor,0
6878,disease markers,Malignant melanoma of eyelid,0
6879,Malignant neoplasm of soft tissue,Placental aromatase deficiency,0
6880,Reduced,Acute lymphadenitis,0
6881,Taken,Testicular cancer metastatic,0
6882,Head - Component of Device,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6883,Unknown GENC,Clonal Hematopoiesis of Indeterminate Potential,0
6884,Mass,Recurrent Testicular Lymphoma,0
6885,Tryptophanase,FIGO Stage II Ovarian Cancer,0
6886,MM genotype,Undifferentiated Endocervical Sarcoma,0
6887,Eye foreign bodies,embryonal rhabdomyosarcoma of prostate,0
6888,+5,Chronic Myelomonocytic Leukemia-2,0
6889,New,Childhood Central Nervous System Immature Teratoma,0
6890,Deoxyribonucleic Acid Measurement,Metastatic Neoplasm to the Gallbladder,0
6891,Surrounding (qualifier value),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6892,epithelial,Recurrent Testicular Lymphoma,0
6893,Before,Recurrent Uveal Melanoma,0
6894,Occur (action),Female Breast Carcinoma,0
6895,Make - Instruction Imperative,Liver Cavernous Hemangioma,0
6896,Term Birth,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6897,Europe,Grade 3a Malignant Neoplasm,0
6898,Ultraviolet Light Sterilization,mucinous adenocarcinoma of gallbladder,0
6899,Lead,Thymic Atypical Carcinoid Tumor,0
6900,Females,Xeroderma pigmentosum,0
6901,Pleomorphic,Malignant melanoma of eyelid,0
6902,shared attribute,Childhood Fibrillary Astrocytoma,0
6903,Tissue Specimen Code,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
6904,Initially,Rhabdomyosarcoma with ganglionic differentiation,0
6905,Feature,Digestive System Hodgkin Lymphoma,0
6906,Color change,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6907,Cessation of life,Breast Ductal Adenoma,0
6908,Before values,Recurrent Testicular Lymphoma,0
6909,Group A (blood group),FIGO Stage II Ovarian Cancer,0
6910,Skin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6911,Case unit dose,Low Grade Squamous Intraepithelial Neoplasia,0
6912,Kissing,adenoid cystic carcinoma of lung,0
6913,Normal pregnancy,Intestinal Metaplasia of Bladder Urothelium,0
6914,Greater,Heavy Chain Deposition Disease,0
6915,Male population group,Liver Cavernous Hemangioma,0
6916,Infant,Stage II Carcinoma of Penis,0
6917,Most,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6918,Tryptophanase,Benign tumor of eyelid,0
6919,Rare,Low Grade Squamous Intraepithelial Neoplasia,0
6920,Femur length,Acute Undifferentiated Leukemia,0
6921,Present,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6922,Most,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6923,Tumor cells,Cancer of Urinary Tract,0
6924,China,Endometrial Small Cell Carcinoma,0
6925,United States,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6926,Most,Adult Alveolar Soft Part Sarcoma,0
6927,Genetic,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6928,Shapes,Lipoma of small intestine,0
6929,alone - group size,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6930,Response (statement),Unfavorable Non-Hodgkin Lymphoma,0
6931,combination - answer to question,Xeroderma pigmentosum,0
6932,anatomical layer,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6933,Present,Hodgkin lymphoma,0
6934,Multifocal,Localized Ewing Sarcoma,0
6935,Skin cell,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6936,Diagnosis,Heavy Chain Deposition Disease,0
6937,Biomaterial Treatment,BRCA2 Syndrome,0
6938,pharmacotherapeutic,Testicular cancer metastatic,0
6939,radiotherapeutic,Cerebral Primitive Neuroectodermal Tumor,0
6940,Neoplasm Metastasis,Stage IB Lung Cancer AJCC v7,0
6941,Superior mediastinum,Liver Lymphangioma,0
6942,Absence (morphologic abnormality),Advanced Uterine Corpus Carcinosarcoma,0
6943,Multiple sexual contacts,Cancer of Urinary Tract,0
6944,Specialized,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6945,CDISC SDTM Disease Outcome Terminology,Breast Ductal Adenoma,0
6946,Periungual fibroma,Choroid Necrotic Melanoma,0
6947,Red blood cells,malignant lymphoma of pancreatic lymph nodes,0
6948,Long,Carcinoma of urinary bladder,0
6949,Childhood Diffuse Large B-Cell Lymphoma,Clonal Hematopoiesis of Indeterminate Potential,0
6950,Approximate,Cancer of Urinary Tract,0
6951,Left sided,embryonal rhabdomyosarcoma of prostate,0
6952,Cessation of life,Uterine Cancer,0
6953,Loss of Appetite question,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6954,Cancer Genus,Clonal Hematopoiesis of Indeterminate Potential,0
6955,Include (action),Collecting Duct Carcinoma of the Kidney,0
6956,Death NOS,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6957,Fever,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6958,Cells,FIGO Stage II Ovarian Cancer,0
6959,Easy,Pilocytic astrocytoma of cerebellum,0
6960,Dorsal,Liver Cavernous Hemangioma,0
6961,Precursor Cell Lymphoblastic Leukemia Lymphoma,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6962,CDISC Relationship Class,Cerebral Primitive Neuroectodermal Tumor,0
6963,Adapt (substance),Benign tumor of eyelid,0
6964,curettage specimen,Stage 0 Penile Cancer AJCC v8,0
6965,Neoplasms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6966,Metabolic Syndrome X,Female Breast Carcinoma,0
6967,Carcinoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6968,Long Variable,Adult Alveolar Soft Part Sarcoma,0
6969,Integumentary scale,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6970,Night sweats,Clonal Hematopoiesis of Indeterminate Potential,0
6971,Light Microscopy,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6972,Experimental Result,Heavy Chain Deposition Disease,0
6973,Detection,Digestive System Hodgkin Lymphoma,0
6974,Abdominal Cavity,gliosarcoma,0
6975,Menopause,Blepharal carcinoma,0
6976,Immune,Recurrent Testicular Lymphoma,0
6977,East,Malignant melanoma of eyelid,0
6978,United States,Diffuse malignant mesothelioma,0
6979,Sunburn,Medulloblastoma,0
6980,Social Role,non-Hodgkin's lymphoma of spleen,0
6981,Benign Neoplasm,Stage IB Lung Cancer AJCC v7,0
6982,Count of entities,Choroid Necrotic Melanoma,0
6983,Bothered by Night Sweats,Localized Ewing Sarcoma,0
6984,PER1 gene,Low Grade Squamous Intraepithelial Neoplasia,0
6985,Adapt (substance),Neoplasms,0
6986,Homo sapiens,Platinum-Resistant Lung Small Cell Carcinoma,0
6987,year,Leptomeningeal sarcoma,0
6988,Lobe of cerebellum,Chronic Myelomonocytic Leukemia-2,0
6989,CEL gene,Mucinous cystadenofibroma,0
6990,Similarity,Thymic Atypical Carcinoid Tumor,0
6991,Eye,Diffuse malignant mesothelioma,0
6992,Greater than one,Contact dermatitis due to alkali,0
6993,In Urine,Recurrent Uveal Melanoma,0
6994,Immature,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6995,diagnosis aspect,Airway Hemangioma,0
6996,Seizures,Acantholytic squamous cell carcinoma,0
6997,Complication Aspects,Carcinoma of urinary bladder,0
6998,Diffuse Large B-Cell Lymphoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6999,Biomaterial Treatment,Chronic Myelomonocytic Leukemia-2,0
7000,Call (Instruction),Extracranial Neuroblastoma,0
7001,Infrequent,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7002,Patient Reported Outcome Stem,Diffuse malignant mesothelioma,0
7003,Groups,Cartilaginous exostosis,0
7004,Study Variable,Refractory Barrett Esophagus,0
7005,Major <insect>,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7006,Smoking,Undifferentiated Endocervical Sarcoma,0
7007,Primary operation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7008,Macrophage Activation Syndrome,Platinum-Resistant Lung Small Cell Carcinoma,0
7009,Diagnosis,de novo Myelodysplastic Syndrome,0
7010,Average,Xeroderma pigmentosum,0
7011,Include (action),Intraepithelial Melanocytic Hyperplasia,0
7012,Division (surgical procedure),Medulloblastoma,0
7013,Manufactured form,Chronic Myelomonocytic Leukemia-2,0
7014,Occur (action),Human Papillomavirus-Related Carcinoma,0
7015,include - SetOperator,Stage I Adult Non-Hodgkin Lymphoma,0
7016,Primary malignant neoplasm,ALK positive large B-cell lymphoma,0
7017,unknown vaccine or immune globulin,non-Hodgkin's lymphoma of spleen,0
7018,Small cell carcinoma of lung,Stage III Adult Immunoblastic Lymphoma,0
7019,Initially,Atypical Mesothelial Hyperplasia,0
7020,Taxonomic,Blepharal carcinoma,0
7021,Chicken laying egg for human food,Benign Carotid Body Paraganglioma,0
7022,Patient Reported Outcome Stem,FIGO Stage II Ovarian Cancer,0
7023,Immune System Finding,Spongiotic dermatitis,0
7024,Examined,Spermatocytic seminoma,0
7025,Case unit dose,Liver Cavernous Hemangioma,0
7026,CYP19A1 gene,Thymic Clear Cell Carcinoma,0
7027,macrophage,mucinous adenocarcinoma of gallbladder,0
7028,Etiology,Intraepithelial Melanocytic Hyperplasia,0
7029,Tissue Specimen Code,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7030,Specimen Source Codes - Genital,non-Hodgkin's lymphoma of spleen,0
7031,Hydatidiform Mole,adenosquamous carcinoma of breast,0
7032,Approach,Refractory Barrett Esophagus,0
7033,Clear,Pancreatic Intraepithelial Neoplasia-3,0
7034,Associated with,Colorectal High Grade B-Cell Lymphoma,0
7035,Feel Tired question,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7036,Cancer Genus,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
7037,Most,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7038,Treating,Unresectable Rhabdomyosarcoma,0
7039,Secondary Neoplasm,Clonal Hematopoiesis of Indeterminate Potential,0
7040,removal technique,BRCA2 Syndrome,0
7041,Three,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7042,Poverty,Stage IV Penile Cancer AJCC v7,0
7043,Patient Visit,Pilocytic astrocytoma of cerebellum,0
7044,Primary Malignant Liver Neoplasm,Localized Askin Tumor,0
7045,kill - ActRelationshipJoin,Recurrent Uveal Melanoma,0
7046,Diameter (qualifier value),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7047,Administration occupational activities,Mucinous adenocarcinoma gastric,0
7048,Central Nervous System Neoplasms,Stage 0 Penile Cancer AJCC v8,0
7049,Carcinoma,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7050,Primary,Clonal Hematopoiesis of Indeterminate Potential,0
7051,Within,Childhood Fibrillary Astrocytoma,0
7052,betel quid,Adult Alveolar Soft Part Sarcoma,0
7053,Microscopes,Stage II Fallopian Tube Cancer,0
7054,Surface,Malignant neoplasm of choroid,0
7055,Autosomal recessive inheritance,Intestinal Metaplasia of Bladder Urothelium,0
7056,Time (foundation metadata concept),Localized Askin Tumor,0
7057,Type - attribute,Recurrent Uveal Melanoma,0
7058,Case (situation),Neonatal leukemia,0
7059,Approximate,Lipoma of small intestine,0
7060,Protein antibody,Blepharal carcinoma,0
7061,Low probability,Stage II Carcinoma of Penis,0
7062,Disease remission,Xeroderma pigmentosum,0
7063,User Group,Intraepithelial Melanocytic Hyperplasia,0
7064,Small cell carcinoma of lung,mucinous adenocarcinoma of gallbladder,0
7065,include - SetOperator,Collecting Duct Carcinoma of the Kidney,0
7066,Targeted Therapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7067,Togo,Female Breast Carcinoma,0
7068,Including (qualifier),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7069,follow-up,Undifferentiated Endocervical Sarcoma,0
7070,triclocarban,Lung squamous cell carcinoma stage I,0
7071,How Much Distress Sweats,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7072,Surface of skin,Liver Cavernous Hemangioma,0
7073,Togo,Advanced Uterine Corpus Carcinosarcoma,0
7074,Spreading (qualifier value),Female Breast Carcinoma,0
7075,Abnormal cell,Mixed parotid tumor,0
7076,Occur (action),Undifferentiated Endocervical Sarcoma,0
7077,Reduced,Sarcomatoid Renal Cell Carcinoma,0
7078,Hodgkin Disease,Bladder squamous cell carcinoma stage I,0
7079,Cancer Genus,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7080,Egg of order Phthiraptera,Acute Undifferentiated Leukemia,0
7081,Diagnosis Study,Extra-Adrenal Paraganglioma,0
7082,Frequently,Cartilaginous exostosis,0
7083,Surface,Thymic Atypical Carcinoid Tumor,0
7084,Neoplasms,BRCA2 Syndrome,0
7085,clinical syndromes,Adenocarcinoma,0
7086,Supportive assistance,Small cell neuroendocrine carcinoma of bladder,0
7087,Approximate,Noninfiltrating Intraductal Carcinoma,0
7088,Neck,Acantholytic squamous cell carcinoma,0
7089,Persons,Childhood Fibrillary Astrocytoma,0
7090,Radiation Ionizing Radiotherapy,Leiomyoma of Gallbladder,0
7091,Probability,Testicular cancer metastatic,0
7092,Ultrasonography,Acute Undifferentiated Leukemia,0
7093,Jack Device,Intestinal Metaplasia of Bladder Urothelium,0
7094,Uterus,Tonsillar Carcinoma,0
7095,Therapeutic radiology procedure,Liver Lymphangioma,0
7096,Name,Recurrent Uveal Melanoma,0
7097,New,Contact dermatitis due to alkali,0
7098,Age at menopause:Time:Point in time:^Patient:Quantitative,Malignant melanoma of eyelid,0
7099,Stop (qualifier value),Localized Ewing Sarcoma,0
7100,Regurgitation,Acute Undifferentiated Leukemia,0
7101,Small,mucinous adenocarcinoma of gallbladder,0
7102,Cervical lymph node group,benign mature teratoma of pancreas,0
7103,Increased risk for cancer,Atypical Lobular Breast Hyperplasia,0
7104,Childhood Lymphoma,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7105,Manufactured form,Refractory Barrett Esophagus,0
7106,Base - General Qualifier,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
7107,Line Unit of Length,Placental aromatase deficiency,0
7108,Specialized Stand Alone Plan - Vision,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7109,International Classification of Diseases for Oncology,Acantholytic squamous cell carcinoma,0
7110,Along edge (qualifier value),Thymic Clear Cell Carcinoma,0
7111,Smear - instruction imperative,adenosquamous carcinoma of breast,0
7112,Usually Need Help from Another Person for Arising,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7113,Test Method,Xeroderma pigmentosum,0
7114,Immunoproliferative Disorders,Thymic Clear Cell Carcinoma,0
7115,Vomiting,Childhood Fibrillary Astrocytoma,0
7116,Often - answer to question,Anterior Urethral Malignant Neoplasm,0
7117,Tumor cells,Childhood Choriocarcinoma,0
7118,Very high,Stage 0 Penile Cancer AJCC v8,0
7119,Entity Determiner - specific,Stage IV Penile Cancer AJCC v7,0
7120,Vaginal Hemorrhage,adenoid cystic carcinoma of lung,0
7121,Deterioration of status,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7122,Decision,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7123,Ultraviolet Light Sterilization,Low Grade Squamous Intraepithelial Neoplasia,0
7124,Medications,Malignant melanoma of eyelid,0
7125,Malignant Neoplasms,Malignant neoplasm of thalamus,0
7126,Occurrence,Advanced Uterine Corpus Carcinosarcoma,0
7127,Version,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7128,2+ Score,Human Papillomavirus-Related Carcinoma,0
7129,Container status - Identified,Advanced Lung Carcinoma,0
7130,Disease,Primary Cutaneous Plasmablastic Lymphoma,0
7131,Used by,Localized Askin Tumor,0
7132,T-Lymphocytopenia,Giant cell angiofibroma,0
7133,Interferes with,Acute Undifferentiated Leukemia,0
7134,Medical Device Emits Smoke,Clonal Hematopoiesis of Indeterminate Potential,0
7135,Status post,Malignant Testicular Sertoli Cell Tumor,0
7136,Congenital chromosomal disease,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7137,Usually,Low Grade Squamous Intraepithelial Neoplasia,0
7138,Consortium or Network,Breast Ductal Adenoma,0
7139,Myasthenia Gravis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7140,Beginning,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
7141,Forecast of outcome,Metastatic Carcinoma in the Lung,0
7142,Tissue membrane,Human Papillomavirus-Related Carcinoma,0
7143,NCI CTEP SDC Gestational Trophoblastic Disease Sub-Category Terminology,Hodgkin lymphoma,0
7144,Term (temporal),embryonal rhabdomyosarcoma of prostate,0
7145,Definitely Related to Intervention,Lung squamous cell carcinoma stage I,0
7146,Adult human body,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7147,Degree or extent,Adenocarcinoma of the prostate metastatic,0
7148,Malignant Neoplasms,Malignant Testicular Sertoli Cell Tumor,0
7149,Plasma,Methotrexate-Associated Hodgkin Lymphoma,0
7150,Unknown,Thymic Clear Cell Carcinoma,0
7151,biomedical tube device,Platinum-Resistant Lung Small Cell Carcinoma,0
7152,Homo sapiens,Unfavorable Non-Hodgkin Lymphoma,0
7153,Thought,Heavy Chain Deposition Disease,0
7154,Multiple Partners,Adult Alveolar Soft Part Sarcoma,0
7155,Coding,Metastatic Neoplasm to the Gallbladder,0
7156,Eccrine Glands,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7157,Often - answer to question,Adult Alveolar Soft Part Sarcoma,0
7158,To,Digestive System Hodgkin Lymphoma,0
7159,Route,malignant lymphoma of pancreatic lymph nodes,0
7160,Electromagnetic Fields,Recurrent Testicular Lymphoma,0
7161,Type - attribute,Testicular cancer metastatic,0
7162,Benign disorder,Grade 3a Malignant Neoplasm,0
7163,Gastroesophageal Reflux Disease,adenoid cystic carcinoma of lung,0
7164,Case unit dose,Thymoma malignant recurrent,0
7165,Comparison,Stage I Adult Non-Hodgkin Lymphoma,0
7166,Ancestry-Informative Marker,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7167,Tissue Specimen Code,Fourth Ventricle and Brain Stem Ependymal Tumor,0
7168,Syndrome,Ovarian germ cell choriocarcinoma stage IV,0
7169,Papillomaviridae,Mucinous adenocarcinoma gastric,0
7170,Chest Wall Pain,Extracranial Neuroblastoma,0
7171,Imaging Techniques,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7172,Regulatory Application,Atypical Lobular Breast Hyperplasia,0
7173,Blood group A (finding),Methotrexate-Associated Hodgkin Lymphoma,0
7174,World,Adult Alveolar Soft Part Sarcoma,0
7175,Variety (taxon),Lung squamous cell carcinoma stage I,0
7176,Combined,Female Breast Carcinoma,0
7177,Third,Spongiotic dermatitis,0
7178,Occlusion of artery (disorder),Grade 3a Malignant Neoplasm,0
7179,Return to (contextual qualifier) (qualifier value),FIGO Stage II Ovarian Cancer,0
7180,Females,Liver Cavernous Hemangioma,0
7181,Vomiting,Ichthyoses,0
7182,Cover - action,sarcoma of spinal cord,0
7183,Type - attribute,Undifferentiated Endocervical Sarcoma,0
7184,Occur (action),Methotrexate-Associated Hodgkin Lymphoma,0
7185,Degree or extent,BRCA2 Syndrome,0
7186,Side,Localized Ewing Sarcoma,0
7187,Population Group,Clonal Hematopoiesis of Indeterminate Potential,0
7188,Skeletal bone,Intestinal Metaplasia of Bladder Urothelium,0
7189,Skin condition (observable entity),Hodgkin lymphoma,0
7190,Entity,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7191,Microplate Well,Metastatic Carcinoma in the Lung,0
7192,Late stage,Metastatic Lung Small Cell Carcinoma,0
7193,Primary operation,Localized Askin Tumor,0
7194,Genetic Marker Expression,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7195,Atypical,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7196,Malignant Squamous Cell Neoplasm,Giant cell angiofibroma,0
7197,Characterization,FIGO Stage II Ovarian Cancer,0
7198,Fatigue,Adult Hepatocellular Carcinoma,0
7199,Common (qualifier value),Extracranial Neuroblastoma,0
7200,Round shape,Benign neoplasm of thorax,0
7201,+2,Breast Ductal Adenoma,0
7202,In Blood,Endometrial Small Cell Carcinoma,0
7203,Determined by,Methotrexate-Associated Hodgkin Lymphoma,0
7204,Urinary Bladder,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7205,Difficult (qualifier value),malignant lymphoma of pancreatic lymph nodes,0
7206,Glioblastoma Multiforme Pathway,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7207,Syndrome,Endometrial Small Cell Carcinoma,0
7208,Telencephalon,Mucinous adenocarcinoma gastric,0
7209,Pain of lymph node,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7210,Rare,Chronic Myelomonocytic Leukemia-2,0
7211,Severe (severity modifier),Serous cystadenocarcinoma ovary,0
7212,Ichthyoses,Thymic Atypical Carcinoid Tumor,0
7213,Body tissue,Recurrent Uveal Melanoma,0
7214,Result,Benign tumor of eyelid,0
7215,Destruction (action),Xeroderma pigmentosum,0
7216,(City) Block,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7217,Data,Stage IV Penile Cancer AJCC v7,0
7218,Late,carcinoma of middle ear,0
7219,Tent - Recreation Equipment,Undifferentiated Neuroblastoma,0
7220,World,Adult Hepatocellular Carcinoma,0
7221,site-specific telomere resolvase activity,Ichthyoses,0
7222,Primary malignant neoplasm,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7223,Contain (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7224,Stomach Carcinoma,Stage I Adult Non-Hodgkin Lymphoma,0
7225,Current (present time),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7226,Stroma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7227,Medical History,Spongiotic dermatitis,0
7228,Lymphocyte component of blood,Methotrexate-Associated Hodgkin Lymphoma,0
7229,Mean Percent of Normal,Adenocarcinoma,0
7230,Disc Shape,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7231,Long,Human Papillomavirus-Related Carcinoma,0
7232,Blocking,Childhood Lymphoma,0
7233,Appearance Distress Question,Intraepithelial Melanocytic Hyperplasia,0
7234,50%,Female Breast Carcinoma,0
7235,Bacteria,Medulloblastoma,0
7236,Early,Benign tumor of eyelid,0
7237,Fever,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
7238,Involvement with,Malignant melanoma of eyelid,0
7239,Intestines,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7240,Treating,Mixed parotid tumor,0
7241,BBS9 wt Allele,Anaplastic large cell lymphoma,0
7242,Laser Device Component,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7243,Highest,Digestive System Hodgkin Lymphoma,0
7244,shared attribute,Adult Alveolar Soft Part Sarcoma,0
7245,peripheral blood,gliosarcoma,0
7246,Targeted Therapy,Papillary cystic tumor,0
7247,Skin,Lipoma of small intestine,0
7248,Main,Bladder squamous cell carcinoma stage I,0
7249,Pain NOS,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7250,described,Uterine Cancer,0
7251,Fasting,Adenocarcinoma,0
7252,Logical Condition,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7253,Experimental Result,Childhood Lymphoma,0
7254,Carcinoma of lung,Cartilaginous exostosis,0
7255,3+ Answer to Question,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7256,Malignant neoplasm of larynx,Medulloblastoma,0
7257,Dermatitis,Medulloblastoma,0
7258,Adipose tissue,Familial Hemophagocytic Lymphocytosis,0
7259,Occur (action),Breast Ductal Adenoma,0
7260,Retinoic Acid Response Element,Ichthyosis,0
7261,Childhood Myelodysplastic Syndrome,mucinous adenocarcinoma of gallbladder,0
7262,Common Specifications in HL7 V3 Publishing,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7263,Adult Gliosarcoma,Maxillary Sinus Adenocarcinoma,0
7264,brain cell,Colorectal cancer,0
7265,Cancer Genus,Bladder squamous cell carcinoma stage I,0
7266,Fix,Neoplasms,0
7267,Glioblastoma Multiforme Pathway,Grade 3a Malignant Neoplasm,0
7268,Reported Term,Undifferentiated Endocervical Sarcoma,0
7269,Usually,papillary carcinoma of penis,0
7270,Result,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7271,Continuance of life,Recurrent Uveal Melanoma,0
7272,Array Feature,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7273,Juvenile Myelomonocytic Leukemia,BRCA2 Syndrome,0
7274,survival aspects,Localized Askin Tumor,0
7275,Diagnosis,Low Grade Squamous Intraepithelial Neoplasia,0
7276,Proteins,Childhood Central Nervous System Immature Teratoma,0
7277,Hormonal,Ovarian germ cell choriocarcinoma stage IV,0
7278,Mathematical Factor,Endometrial Small Cell Carcinoma,0
7279,IPSS Risk Category Low,Intraepithelial Melanocytic Hyperplasia,0
7280,Persons,Locally Advanced Soft Tissue Sarcoma,0
7281,CDISC SEND Tumor Findings Results Terminology,Small cell neuroendocrine carcinoma of bladder,0
7282,Vaginal clear cell adenocarcinoma,Endometrial Small Cell Carcinoma,0
7283,Certainties,Ichthyoses,0
7284,Case (situation),FIGO Stage II Ovarian Cancer,0
7285,Benign tumor of salivary gland,Testicular cancer metastatic,0
7286,include - SetOperator,Hemangioma,0
7287,Abdominal Cavity,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7288,Dangerousness,Stage II Carcinoma of Penis,0
7289,0%,Neoplasms,0
7290,Case unit dose,FIGO Stage II Ovarian Cancer,0
7291,To,Intestinal Neuroendocrine Carcinoma,0
7292,Carrying,Cancer of Urinary Tract,0
7293,Tryptophanase,Xeroderma pigmentosum,0
7294,Pancreas part,Colorectal Neuroendocrine Tumor G2,0
7295,Include (action),High Grade Glandular Intraepithelial Neoplasia,0
7296,Filters,Hemangioma,0
7297,Malignant - descriptor,Locally Advanced Soft Tissue Sarcoma,0
7298,per year,Diffuse malignant mesothelioma,0
7299,Precancerous Conditions,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7300,Recent,Acantholytic squamous cell carcinoma,0
7301,Approximate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7302,Contrast Media,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7303,CD5L wt Allele,Recurrent Testicular Lymphoma,0
7304,Epstein-Barr Virus,Pilocytic astrocytoma of cerebellum,0
7305,Include (action),Neoplasms,0
7306,Human body,Pilocytic astrocytoma of cerebellum,0
7307,Spreading (qualifier value),Familial Adenomatous Polyposis Associated Medulloblastoma,0
7308,Always (frequency),Stage IB Lung Cancer AJCC v7,0
7309,Folded structure,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7310,Very,Carcinoma of urinary bladder,0
7311,Affect (mental function),adenoid cystic carcinoma of lung,0
7312,Nevus,Colorectal High Grade B-Cell Lymphoma,0
7313,treatment - ActInformationManagementReason,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7314,/40,Bladder squamous cell carcinoma stage I,0
7315,Linear,Diffuse malignant mesothelioma,0
7316,Limited stage (cancer stage),Metastatic Kidney Carcinoma,0
7317,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,embryonal rhabdomyosarcoma of prostate,0
7318,Tests (qualifier value),Collecting Duct Carcinoma of the Kidney,0
7319,Microvolt,Bladder squamous cell carcinoma stage I,0
7320,Tobacco,squamous cell carcinoma of the thyroid gland,0
7321,2+,Malignant melanoma of eyelid,0
7322,Lower (action),Diffuse malignant mesothelioma,0
7323,Sweat,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7324,Adult Teratoma,Liver Lymphangioma,0
7325,Base - General Qualifier,Carcinoma of urinary bladder,0
7326,Container status - Identified,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7327,Cancer Genus,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7328,Swab,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7329,Myelodysplastic Syndrome,Adult Hepatocellular Carcinoma,0
7330,Loss of Appetite question,benign mature teratoma of pancreas,0
7331,Severe (severity modifier),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7332,DNA Repair,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7333,2000,Malignant melanoma of eyelid,0
7334,Quantity,Anterior Urethral Malignant Neoplasm,0
7335,Negative,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7336,Sclerotherapy,Diffuse malignant mesothelioma,0
7337,Lower (action),Bladder squamous cell carcinoma stage I,0
7338,Asp snake,Recurrent Testicular Lymphoma,0
7339,Treating,Rhabdomyosarcoma with ganglionic differentiation,0
7340,Appearance,Blepharal carcinoma,0
7341,Specimen Source Codes - tumor,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7342,Soft,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7343,Transection (procedure),Unfavorable Non-Hodgkin Lymphoma,0
7344,Age-Years,Female Breast Carcinoma,0
7345,Symptoms,Chondrosarcoma,0
7346,Range,Malignant Neoplasm with Regional Lymph Node Involvement,0
7347,Time (foundation metadata concept),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7348,Removed,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7349,Observation of attack,Undifferentiated Endocervical Sarcoma,0
7350,Smear - instruction imperative,Clonal Hematopoiesis of Indeterminate Potential,0
7351,Subtype (attribute),FIGO Stage II Ovarian Cancer,0
7352,day,Localized Ewing Sarcoma,0
7353,Hematoxylin and eosin stain method,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7354,Life Expectancy Greater than Twenty Years,FIGO Stage II Ovarian Cancer,0
7355,Sore Throat,Anaplastic large cell lymphoma,0
7356,Occurrence Indicator,Contact dermatitis due to alkali,0
7357,shared attribute,Acute lymphadenitis,0
7358,depend,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7359,Reclassified,Acantholytic squamous cell carcinoma,0
7360,risk factors,Malignant melanoma of eyelid,0
7361,Blood Cells,Locally Advanced Soft Tissue Sarcoma,0
7362,Soft,Recurrent Testicular Lymphoma,0
7363,Unmarried person,Intracortical osteosarcoma,0
7364,Fatigue,Hodgkin lymphoma,0
7365,Renal Cell Carcinoma,Acute lymphadenitis,0
7366,Hematologic Tests,embryonal rhabdomyosarcoma of prostate,0
7367,Autosomal Recessive Disorder,Blepharal carcinoma,0
7368,Genome,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7369,Fever symptoms (finding),Undifferentiated Neuroblastoma,0
7370,Show,Mastocytosis,0
7371,Regurgitates after swallowing,Childhood Fibrillary Astrocytoma,0
7372,The Sun,Intraepithelial Melanocytic Hyperplasia,0
7373,survive,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7374,Rate,Atypical Lobular Breast Hyperplasia,0
7375,Glandular stomach,Angiosarcoma of liver,0
7376,Supratentorial Embryonal Tumor,Recurrent Uveal Melanoma,0
7377,Pancreatic Hormones,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7378,Smell Perception,Liver Lymphangioma,0
7379,Usually Need Help from Another Person for Arising,Cancer of Urinary Tract,0
7380,posterior fossa,Metastatic Carcinoma in the Lung,0
7381,Acute monocytic leukemia,Blepharal carcinoma,0
7382,Neoplasms,Airway Hemangioma,0
7383,Providing presence (regime/therapy),Benign Apocrine Neoplasm,0
7384,Percent normal,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7385,IV number:ID:Pt:^Patient:Nom,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7386,Cancer Genus,Stage II Hepatocellular Carcinoma AJCC v8,0
7387,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
7388,Changing,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7389,Process,Grade 3a Malignant Neoplasm,0
7390,Incidence,Adult Alveolar Soft Part Sarcoma,0
7391,Sunlight,Diffuse malignant mesothelioma,0
7392,Diet,Mucinous adenocarcinoma gastric,0
7393,Manufactured sign,Atypical Mesothelial Hyperplasia,0
7394,Pancreatic ductal cell,Benign neoplasm of thorax,0
7395,Including (qualifier),Benign neoplasm of thorax,0
7396,Unknown GENC,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7397,Mixed Tumor,Serous cystadenocarcinoma ovary,0
7398,Organ,FIGO Stage II Ovarian Cancer,0
7399,Childhood Myelodysplastic Syndrome,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7400,Borg Category-Ratio 10 Perceived Exertion Score 5,Acantholytic squamous cell carcinoma,0
7401,Age at diagnosis:Time:Pt:^Patient:Qn,Lung Mucinous Cystadenoma,0
7402,Controlling (action),Female Breast Carcinoma,0
7403,Woman,Metastatic Carcinoma in the Lung,0
7404,Benign,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7405,Common (qualifier value),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
7406,Condition,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7407,Course,Cartilaginous exostosis,0
7408,Minor (person),Childhood Central Nervous System Immature Teratoma,0
7409,diagnosis aspect,benign mature teratoma of pancreas,0
7410,Common (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7411,Approach,FIGO Stage II Ovarian Cancer,0
7412,Pediculus humanus capitis (eukaryote),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7413,APC gene,Thymic Atypical Carcinoid Tumor,0
7414,transmission process,Stage II Hepatocellular Carcinoma AJCC v8,0
7415,Childhood Lymphoma,Breast Ductal Adenoma,0
7416,Specimen Source Codes - Lesion,Advanced Uterine Corpus Carcinosarcoma,0
7417,Cytogenetics,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7418,Either,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7419,SHORT STATURE,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7420,Rare,Cerebral hemangioma,0
7421,Infrequent,Mixed parotid tumor,0
7422,Chemotherapy,Human Papillomavirus-Related Carcinoma,0
7423,PSA Level Less than Five,Undifferentiated Endocervical Sarcoma,0
7424,Adenoma,Acute lymphadenitis,0
7425,Formation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7426,Hematology procedure,Diffuse malignant mesothelioma,0
7427,Pancreatic Cyst,Giant cell angiofibroma,0
7428,Cause of death:Find:Pt:^Patient:Nom,Childhood Central Nervous System Immature Teratoma,0
7429,Formation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7430,Aggressive Non-Hodgkin Lymphoma,sarcoma of spinal cord,0
7431,Alveolar,Benign neoplasm of thorax,0
7432,Cultured Cell Line,Angiosarcoma of liver,0
7433,Hodgkin Disease,Lung squamous cell carcinoma stage I,0
7434,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Clonal Hematopoiesis of Indeterminate Potential,0
7435,Mass of body structure,Digestive System Hodgkin Lymphoma,0
7436,Liver carcinoma,Recurrent Testicular Lymphoma,0
7437,Survival Rate,Refractory Barrett Esophagus,0
7438,Electrical Current,Prostate Lymphoma,0
7439,combination of objects,embryonal rhabdomyosarcoma of prostate,0
7440,Difficult (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
7441,Image Feature,non-Hodgkin's lymphoma of spleen,0
7442,Lymphocyte,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7443,Long Variable,Intestinal Metaplasia of Bladder Urothelium,0
7444,Risk,Undifferentiated Endocervical Sarcoma,0
7445,Pancreatitis,Childhood Fibrillary Astrocytoma,0
7446,Symptoms aspect,Malignant Testicular Sertoli Cell Tumor,0
7447,Make - Instruction Imperative,Refractory Barrett Esophagus,0
7448,Interruption,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7449,Duplicate,Platinum-Resistant Lung Small Cell Carcinoma,0
7450,Make - Instruction Imperative,Maxillary Sinus Adenocarcinoma,0
7451,Physical shape,sarcoma of spinal cord,0
7452,Half,Adult Alveolar Soft Part Sarcoma,0
7453,Usual Severity Weight Loss,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7454,Associated with,Leptomeningeal sarcoma,0
7455,Onset of illness,Cancer of Urinary Tract,0
7456,Malignant Neoplasms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7457,Presacral,Granular Cell Leiomyosarcoma,0
7458,Firstly,Cartilaginous exostosis,0
7459,Detached,Tonsillar Carcinoma,0
7460,bony process,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7461,Tumor type,Neonatal leukemia,0
7462,Disease,Hemangioma,0
7463,Neoplasms,Advanced Uterine Corpus Carcinosarcoma,0
7464,Qualitative form,Pancreatic Intraepithelial Neoplasia-3,0
7465,Diagnosis,Acute lymphadenitis,0
7466,combination of objects,Benign tumor of eyelid,0
7467,United States,FIGO Stage II Ovarian Cancer,0
7468,Pediatric,Cerebral Primitive Neuroectodermal Tumor,0
7469,Indication of (contextual qualifier),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7470,Skin Specimen,Heavy Chain Deposition Disease,0
7471,Suspected qualifier,Malignant neoplasm of choroid,0
7472,Morphology,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7473,Plants,Rhabdomyosarcoma with ganglionic differentiation,0
7474,1+,gliosarcoma,0
7475,Salivary Gland Neoplasms,Stage IV Penile Cancer AJCC v7,0
7476,Cumulative,Giant cell angiofibroma,0
7477,Occurrence Indicator,Undifferentiated Endocervical Sarcoma,0
7478,Occurrence Indicator,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
7479,Qualitative form,Endometrial Small Cell Carcinoma,0
7480,Precancerous Conditions,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7481,Therapeutic procedure,Placental aromatase deficiency,0
7482,Name (property) (qualifier value),Anterior Urethral Malignant Neoplasm,0
7483,Inguinal part of abdomen,Activated B-cell type diffuse large B-cell lymphoma,0
7484,64,Adult Alveolar Soft Part Sarcoma,0
7485,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Grade 1 Clear Cell Renal Cell Carcinoma,0
7486,CDISC SEND Tumor Findings Results Terminology,High Grade Glandular Intraepithelial Neoplasia,0
7487,Carcinoma of lung,High Grade Glandular Intraepithelial Neoplasia,0
7488,Far East,Hair nevus,0
7489,Organ,Extra-Adrenal Paraganglioma,0
7490,Weight Loss,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7491,Classification,Cerebral hemangioma,0
7492,Grade,Mucinous neoplasm,0
7493,Immunotherapy,Malignant Testicular Sertoli Cell Tumor,0
7494,Small cell carcinoma of lung,Recurrent Uveal Melanoma,0
7495,Extrinsic,Intestinal Metaplasia of Bladder Urothelium,0
7496,View Tunnel,Airway Hemangioma,0
7497,Neuroblastoma,Undifferentiated Neuroblastoma,0
7498,Symptoms,Thymic Clear Cell Carcinoma,0
7499,Southern Europe,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7500,How Often Nausea,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7501,Age,Malignant melanoma of eyelid,0
7502,Myeloproliferative disease,Mastocytosis,0
7503,Means,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7504,therapeutic aspects,Pilocytic astrocytoma of cerebellum,0
7505,Skin,Choroid Necrotic Melanoma,0
7506,Cell Count,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7507,eTMF Content Model Code,adenosquamous carcinoma of breast,0
7508,professional occupation status,Choroid Necrotic Melanoma,0
7509,Fever,Intestinal Metaplasia of Bladder Urothelium,0
7510,Menstruation,FIGO Stage II Ovarian Cancer,0
7511,Retraction (finding),Leptomeningeal sarcoma,0
7512,PREVENT (product),Benign tumor of eyelid,0
7513,Synonym,Cerebral Primitive Neuroectodermal Tumor,0
7514,Northern Europe,Intraepithelial Melanocytic Hyperplasia,0
7515,indolent,Hemangioma,0
7516,Tumor Antigens,Breast Ductal Adenoma,0
7517,Tissue Specimen Code,Bladder squamous cell carcinoma stage I,0
7518,Body tissue,embryonal rhabdomyosarcoma of prostate,0
7519,Only - dosing instruction fragment,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7520,Formation,Cancer of Urinary Tract,0
7521,depend,Extracranial Neuroblastoma,0
7522,Hormonal,Cerebral Primitive Neuroectodermal Tumor,0
7523,Case (situation),Fourth Ventricle and Brain Stem Ependymal Tumor,0
7524,Have Itch,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7525,peripheral blood,Bladder squamous cell carcinoma stage I,0
7526,Age,Lipoma of small intestine,0
7527,Type - attribute,Benign Carotid Body Paraganglioma,0
7528,Hydrocephalus,Ovarian germ cell choriocarcinoma stage IV,0
7529,shared attribute,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7530,Symptoms,Anterior Urethral Malignant Neoplasm,0
7531,Primary,Blepharal carcinoma,0
7532,Completely - dosing instruction fragment,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7533,Lacrimal canaliculus structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7534,throat cancer,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7535,Left sided,Airway Hemangioma,0
7536,Measured Tumor Identification,Acute Undifferentiated Leukemia,0
7537,Form:Finding:Point in time:{Setting}:Document:{Role},Botryoid-Type Embryonal Rhabdomyosarcoma,0
7538,research subject screening,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7539,Degree or extent,Collecting Duct Carcinoma of the Kidney,0
7540,Code,Testicular cancer metastatic,0
7541,Embryonic tissue,Grade 3a Malignant Neoplasm,0
7542,include - SetOperator,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7543,Numerous,Anaplastic large cell lymphoma,0
7544,status - In progress,Stage IB Pancreatic Cancer AJCC v8,0
7545,Result,Cancer of Urinary Tract,0
7546,More,Thymic Clear Cell Carcinoma,0
7547,Usually,Female Breast Carcinoma,0
7548,Characteristics,Recurrent Testicular Lymphoma,0
7549,MYELODYSPLASTIC SYNDROME,Angiosarcoma of liver,0
7550,Usual,Recurrent Diffuse Intrinsic Pontine Glioma,0
7551,Present,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7552,Togo,Undifferentiated Neuroblastoma,0
7553,Contain (action),Chondrosarcoma,0
7554,Initially,Mastocytosis,0
7555,Infection,Cerebral Primitive Neuroectodermal Tumor,0
7556,photoreactivating enzyme activity,Prostate Lymphoma,0
7557,United States,Hodgkin lymphoma,0
7558,Decreased,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7559,Brain,Placental aromatase deficiency,0
7560,Strong,sarcoma of spinal cord,0
7561,History of previous events,Recurrent Testicular Lymphoma,0
7562,Enlarged,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7563,Area,embryonal rhabdomyosarcoma of prostate,0
7564,Uterine Fibroids,embryonal rhabdomyosarcoma of prostate,0
7565,Confirmed by,Endometrial Small Cell Carcinoma,0
7566,Neuroglia,Extracranial Neuroblastoma,0
7567,Beginning,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7568,Empty (qualifier),Malignant melanoma of eyelid,0
7569,Associated topography,FIGO Stage II Ovarian Cancer,0
7570,Persons,Intestinal Metaplasia of Bladder Urothelium,0
7571,Very,Endometrial Small Cell Carcinoma,0
7572,Deep Resection Margin,Cerebral Primitive Neuroectodermal Tumor,0
7573,Science of Etiology,Deep Leiomyoma,0
7574,advanced disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7575,Specimen Source Codes - Mucus,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7576,CD5L wt Allele,BRCA2 Syndrome,0
7577,Before,Bladder squamous cell carcinoma stage I,0
7578,Human papillomavirus 11,Undifferentiated Neuroblastoma,0
7579,SPINK5 gene,Malignant Testicular Sertoli Cell Tumor,0
7580,Poor - grade value,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7581,Tryptophanase,FIGO Stage II Ovarian Cancer,0
7582,Frequently,Adult Hepatocellular Carcinoma,0
7583,Relate - vinyl resin,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7584,Cavitation,Hodgkin lymphoma,0
7585,CEL gene,Childhood Fibrillary Astrocytoma,0
7586,pharmacotherapeutic,Acantholytic squamous cell carcinoma,0
7587,South East Asian,Malignant melanoma of eyelid,0
7588,Source of radiation (attribute),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7589,Shortened,Malignant melanoma of eyelid,0
7590,Increase,Locally Advanced Soft Tissue Sarcoma,0
7591,Tumor cells,de novo Myelodysplastic Syndrome,0
7592,Lesion,Chondrosarcoma,0
7593,Application procedure,Acute lymphadenitis,0
7594,other medicated shampoos in ATC,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7595,Cancer Remission,Anaplastic large cell lymphoma,0
7596,General surgery specialty,Malignant melanoma of eyelid,0
7597,Area,Pilocytic astrocytoma of cerebellum,0
7598,Normal function,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7599,Gonadal structure,FIGO Stage II Ovarian Cancer,0
7600,Females,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
7601,Offspring,Primary Cutaneous Plasmablastic Lymphoma,0
7602,Term Birth,Malignant Neoplasm with Regional Lymph Node Involvement,0
7603,Relocation of home or business,Chondrosarcoma,0
7604,Diagnosis,Heavy Chain Deposition Disease,0
7605,Historical aspects qualifier,Testicular cancer metastatic,0
7606,Persons,Colorectal cancer,0
7607,Two,mucinous adenocarcinoma of gallbladder,0
7608,development aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7609,Kissing,Adult Alveolar Soft Part Sarcoma,0
7610,Similarity,Colorectal cancer,0
7611,Case (situation),Stage IB Pancreatic Cancer AJCC v8,0
7612,peripheral blood,Atypical Mesothelial Hyperplasia,0
7613,Pain control,Grade 3a Malignant Neoplasm,0
7614,erythropoietin activity,Extra-Adrenal Paraganglioma,0
7615,Cancer Biology,Childhood Fibrillary Astrocytoma,0
7616,Mismatch Repair,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7617,Code System Type - Internal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7618,The Sun,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7619,Occur (action),FIGO Stage II Ovarian Cancer,0
7620,Diabetes Mellitus,Intestinal Neuroendocrine Carcinoma,0
7621,Injury cause:Type:Point in time:^Patient:Nominal,Adrenal Rest Tumor,0
7622,Physical shape,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7623,Decision,Childhood Fibrillary Astrocytoma,0
7624,Entity Determiner - specific,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7625,Diagnostic Imaging,Recurrent Testicular Lymphoma,0
7626,Continuance of life,Testicular cancer metastatic,0
7627,Chemotherapy,Stage I Adult Non-Hodgkin Lymphoma,0
7628,Near,Stage IV Childhood Non-Hodgkin Lymphoma,0
7629,Human body structure,Primary Cutaneous Plasmablastic Lymphoma,0
7630,Usually,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7631,Include (action),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7632,Fever,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7633,Tumor cells,Unfavorable Non-Hodgkin Lymphoma,0
7634,CDISC SEND Body System Terminology,FIGO Stage II Ovarian Cancer,0
7635,low exposure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7636,Cells,Metastatic Carcinoma in the Lung,0
7637,Form:Finding:Point in time:{Setting}:Document:{Role},High Grade Glandular Intraepithelial Neoplasia,0
7638,fluid - substance,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7639,Rest,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7640,Abnormal Reference Range,Metastatic Carcinoma in the Lung,0
7641,Menopause present (finding),Pancreatic Intraepithelial Neoplasia-3,0
7642,Entity Determiner - specific,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7643,Probably,Recurrent Testicular Lymphoma,0
7644,Present,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7645,Devices,Recurrent Testicular Lymphoma,0
7646,Neoplasms,Cerebral Primitive Neuroectodermal Tumor,0
7647,Insecticides,Undifferentiated Neuroblastoma,0
7648,Pediatrics,Digestive System Hodgkin Lymphoma,0
7649,Further,Intestinal Metaplasia of Bladder Urothelium,0
7650,Financial Account,Intraepithelial Melanocytic Hyperplasia,0
7651,Bothered by Nausea,benign mature teratoma of pancreas,0
7652,Endometrial scraping,Heavy Chain Deposition Disease,0
7653,Bowen's Disease,Carcinoma of urinary bladder,0
7654,Known,Stage IV Childhood Non-Hodgkin Lymphoma,0
7655,Premalignant Cell,Colorectal High Grade B-Cell Lymphoma,0
7656,Certain (qualifier value),Mucinous adenocarcinoma gastric,0
7657,Administration procedure,Stage II Carcinoma of Penis,0
7658,Common Specifications in HL7 V3 Publishing,Neonatal leukemia,0
7659,Management Occupations,Cancer of Urinary Tract,0
7660,Prior Chemotherapy,Cancer of Urinary Tract,0
7661,Exposure to,sarcoma of spinal cord,0
7662,Manufactured form,mucinous adenocarcinoma of gallbladder,0
7663,Adrenal Cortex,Blepharal carcinoma,0
7664,inflammatory,Cartilaginous exostosis,0
7665,Age at diagnosis,Pilocytic astrocytoma of cerebellum,0
7666,Process (qualifier value),Platinum-Resistant Lung Small Cell Carcinoma,0
7667,Lymphoid organ structure,Collecting Duct Carcinoma of the Kidney,0
7668,Including (qualifier),Ovarian Carcinoid Tumor,0
7669,Estrogen (disposition),Ichthyosis,0
7670,Fragment of (qualifier value),Human Papillomavirus-Related Carcinoma,0
7671,Neuroectodermal Tumor,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7672,Diagnosis,Human Papillomavirus-Related Carcinoma,0
7673,Abnormal Reference Range,Leptomeningeal sarcoma,0
7674,Two,Adrenal Rest Tumor,0
7675,Pharmacotherapy,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
7676,Initial Usage,Thymic Clear Cell Carcinoma,0
7677,Physical shape,Cartilaginous exostosis,0
7678,Data operation - complete,Metastatic Lung Small Cell Carcinoma,0
7679,Molecular Mass,adenosquamous carcinoma of breast,0
7680,development aspects,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7681,Abnormally high,Stage 0 Lip Carcinoma,0
7682,Biomaterial Treatment,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7683,Common Specifications in HL7 V3 Publishing,Intracortical osteosarcoma,0
7684,Removed,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7685,Type - attribute,Breast Ductal Adenoma,0
7686,Add - instruction imperative,Grade 1 Clear Cell Renal Cell Carcinoma,0
7687,Type - attribute,Metastatic Malignant Neoplasm in the Sellar Region,0
7688,Case unit dose,Malignant neoplasm of choroid,0
7689,Symptoms,Breast Ductal Adenoma,0
7690,year,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7691,Polyglandular Type I Autoimmune Syndrome,Testicular cancer metastatic,0
7692,International Classification of Disease for Oncology,Mucinous cystadenofibroma,0
7693,Very Much,Low Grade Squamous Intraepithelial Neoplasia,0
7694,Necrotic changes (finding),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7695,Treatment Epoch,Xeroderma pigmentosum,0
7696,Immature Lymphocytes Measurement,BRCA2 Syndrome,0
7697,Divide,Thymic Clear Cell Carcinoma,0
7698,Caucasoid Race,FIGO Stage II Ovarian Cancer,0
7699,African American,embryonal rhabdomyosarcoma of prostate,0
7700,Smear - instruction imperative,Pancreatic Intraepithelial Neoplasia-3,0
7701,Lighter device,Pancreatic Intraepithelial Neoplasia-3,0
7702,Classes - encounter,Childhood Fibrillary Astrocytoma,0
7703,Oral cavity,Chondrosarcoma,0
7704,Treatment Epoch,Fourth Ventricle and Brain Stem Ependymal Tumor,0
7705,Severe (severity modifier),Advanced Lung Carcinoma,0
7706,Glycation End Products,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7707,Tumor Suppressor Genes,Stage IB Pancreatic Cancer AJCC v8,0
7708,Heightened,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7709,Often - answer to question,embryonal rhabdomyosarcoma of prostate,0
7710,Specimen Source Codes - tumor,Benign tumor of eyelid,0
7711,Drop Metastasis,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7712,Combined,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7713,macrophage,Stage II Carcinoma of Penis,0
7714,M Protein,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7715,Complication Aspects,Giant cell angiofibroma,0
7716,Symptoms aspect,FIGO Stage II Ovarian Cancer,0
7717,risk factors,Acantholytic squamous cell carcinoma,0
7718,Including (qualifier),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7719,Dorsal,mucinous adenocarcinoma of gallbladder,0
7720,6/3,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7721,Age at diagnosis:Time:Pt:^Patient:Qn,Adult Alveolar Soft Part Sarcoma,0
7722,Extreme,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7723,Structure of thyroid parafollicular cell,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7724,Cell (compartment),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7725,Neoadjuvant Therapy Clinical Trial Setting,Bladder squamous cell carcinoma stage I,0
7726,Version,Undifferentiated Endocervical Sarcoma,0
7727,Neoplasm Metastasis,Childhood Central Nervous System Immature Teratoma,0
7728,High Level,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7729,Grade IV Childhood Astrocytic Neoplasm,Human Papillomavirus-Related Carcinoma,0
7730,Most,Human Papillomavirus-Related Carcinoma,0
7731,Doubling Time,Metastatic Ductal Breast Carcinoma,0
7732,Malignant neoplasm of breast,Benign neoplasm of thorax,0
7733,treatment - ActInformationManagementReason,Heavy Chain Deposition Disease,0
7734,Possibly Related to Intervention,Neonatal leukemia,0
7735,Hearing examination finding,Liver Cavernous Hemangioma,0
7736,Chemotherapy Regimen,Acantholytic squamous cell carcinoma,0
7737,Source,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7738,Treating,Localized Askin Tumor,0
7739,Common Specifications in HL7 V3 Publishing,Anterior Urethral Malignant Neoplasm,0
7740,Referring,Adult Alveolar Soft Part Sarcoma,0
7741,Exclusion,Benign Carotid Body Paraganglioma,0
7742,Low Level,Recurrent Testicular Lymphoma,0
7743,Cosmetic procedure,adenoid cystic carcinoma of lung,0
7744,Histology aspects,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7745,Known,Heavy Chain Deposition Disease,0
7746,Administration procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7747,shared attribute,Human Papillomavirus-Related Carcinoma,0
7748,early disease,Cancer of Urinary Tract,0
7749,International Statistical Classification of Diseases and Related Health Problems,Digestive System Hodgkin Lymphoma,0
7750,Corner Plus,papillary carcinoma of penis,0
7751,Malignant Neoplasms,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
7752,To,Intestinal Metaplasia of Bladder Urothelium,0
7753,Certain (qualifier value),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7754,Concept model domain,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7755,Ancestry-Informative Marker,Mucinous adenocarcinoma gastric,0
7756,Short,Angiosarcoma of liver,0
7757,CD44 wt Allele,Stage II Hepatocellular Carcinoma AJCC v8,0
7758,Nausea,Mucinous adenocarcinoma gastric,0
7759,Immunotherapy,Adult Hepatocellular Carcinoma,0
7760,Adverse Event Associated with Vascular,Female Breast Carcinoma,0
7761,Nodule,Digestive System Hodgkin Lymphoma,0
7762,Inguinal region,Sarcomatoid Renal Cell Carcinoma,0
7763,Platelet Glycoprotein 4,Placental aromatase deficiency,0
7764,Beginning,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7765,Name,Colorectal High Grade B-Cell Lymphoma,0
7766,Interferes with,Lipoma of small intestine,0
7767,Genetic Heterogeneity,Childhood Thyroid Gland Follicular Carcinoma,0
7768,Occurrence,Breast Ductal Adenoma,0
7769,Used by,Stage 0 Penile Cancer AJCC v8,0
7770,Patient Condition Code - Stable,Locally Advanced Soft Tissue Sarcoma,0
7771,Malignant Childhood Neoplasm,Xeroderma pigmentosum,0
7772,Forecast of outcome,Localized Ewing Sarcoma,0
7773,Body tissue,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7774,Cystitis,Anaplastic large cell lymphoma,0
7775,Specific qualifier value,embryonal rhabdomyosarcoma of prostate,0
7776,Classification,Ovarian germ cell choriocarcinoma stage IV,0
7777,Count of entities,Larynx carcinoma recurrent,0
7778,Type A,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7779,Inflammatory cell,Chronic Myelomonocytic Leukemia-2,0
7780,Biologic Development,Localized Askin Tumor,0
7781,Immune,Malignant neoplasm of thalamus,0
7782,Surgical aspects,Stage II Carcinoma of Penis,0
7783,Vertebrates,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7784,Clinical Study Follow-up,Diffuse malignant mesothelioma,0
7785,Form:Finding:Point in time:{Setting}:Document:{Role},BRCA2 Syndrome,0
7786,/mm3,Testicular cancer metastatic,0
7787,Chest wall pain,malignant lymphoma of pancreatic lymph nodes,0
7788,Hydranencephaly with Renal Aplasia-Dysplasia,Stage II Carcinoma of Penis,0
7789,Immune,Primary Cutaneous Plasmablastic Lymphoma,0
7790,Indication,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7791,filter information process,Stage IB Lung Cancer AJCC v7,0
7792,Surrounding (qualifier value),Advanced Uterine Corpus Carcinosarcoma,0
7793,Primary malignant neoplasm,adenoid cystic carcinoma of lung,0
7794,Death Related to Adverse Event,Ovarian Carcinoid Tumor,0
7795,Abdominal mass,Airway Hemangioma,0
7796,Retinoic Acid Response Element,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7797,Sinus - general anatomical term,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
7798,Shortness of breath:-:Point in time:^Patient:-,Stage IV Childhood Non-Hodgkin Lymphoma,0
7799,Tumor Mass,Intraepithelial Melanocytic Hyperplasia,0
7800,Main,Human Papillomavirus-Related Carcinoma,0
7801,Symptoms aspect,Intraepithelial Melanocytic Hyperplasia,0
7802,Golden retriever,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7803,Continuance of life,adenosquamous carcinoma of breast,0
7804,Stellate,Diffuse malignant mesothelioma,0
7805,Study Control,Intraepithelial Melanocytic Hyperplasia,0
7806,floor (object),Blepharal carcinoma,0
7807,Limited (extensiveness),Adult Hepatocellular Carcinoma,0
7808,Hyperplasia,Malignant melanoma of eyelid,0
7809,Pallor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7810,Early disease stage,Prostate Lymphoma,0
7811,Type A,BRCA2 Syndrome,0
7812,majority,High Grade Glandular Intraepithelial Neoplasia,0
7813,Escherichia coli,embryonal rhabdomyosarcoma of prostate,0
7814,Prevention Study,embryonal rhabdomyosarcoma of prostate,0
7815,Widespread,Spermatocytic seminoma,0
7816,Negation,Angiosarcoma of liver,0
7817,Then,Localized Askin Tumor,0
7818,Offspring,Ovarian germ cell choriocarcinoma stage IV,0
7819,Problems - What subject filter,Benign neoplasm of thorax,0
7820,English Language,Papillary cystic tumor,0
7821,Initially,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7822,Neoplasm Metastasis,Digestive System Hodgkin Lymphoma,0
7823,Human body,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7824,Therapeutic radiology procedure,Liver Lymphangioma,0
7825,risk factors,Human Papillomavirus-Related Carcinoma,0
7826,Skin Specimen,Germinoma,0
7827,Administration procedure,squamous cell carcinoma of the thyroid gland,0
7828,Blue color,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7829,Qualitative form,Intestinal Metaplasia of Bladder Urothelium,0
7830,Occurrence,Intestinal Metaplasia of Bladder Urothelium,0
7831,Lymphocyte,Cancer of Urinary Tract,0
7832,Males,Localized Ewing Sarcoma,0
7833,Human Cells,High Grade Glandular Intraepithelial Neoplasia,0
7834,Mathematical Operator,adenoid cystic carcinoma of lung,0
7835,Cover (physical object),Maxillary Sinus Adenocarcinoma,0
7836,Occurrence Indicator,Female Breast Carcinoma,0
7837,Dietary Lead,Thymic Clear Cell Carcinoma,0
7838,Cancer Genus,Recurrent Uveal Melanoma,0
7839,Skin,Thymoma malignant recurrent,0
7840,Infrequent,Rhabdomyosarcoma with ganglionic differentiation,0
7841,Including (qualifier),Recurrent Testicular Lymphoma,0
7842,Alcohols,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7843,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Adrenal Rest Tumor,0
7844,Squamous cell carcinoma - category,High Grade Glandular Intraepithelial Neoplasia,0
7845,Blood Vessel,Acute Undifferentiated Leukemia,0
7846,Neoplasms,Clonal Hematopoiesis of Indeterminate Potential,0
7847,Sweating,Intestinal Neuroendocrine Carcinoma,0
7848,40%,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7849,Infrequent,Clonal Hematopoiesis of Indeterminate Potential,0
7850,Scheme,Blepharal carcinoma,0
7851,Thymus <angiosperm>,Undifferentiated Neuroblastoma,0
7852,Ethanol,Contact dermatitis due to alkali,0
7853,Set scale,embryonal rhabdomyosarcoma of prostate,0
7854,Chemotherapy Regimen,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7855,Life Threatening or Disabling Adverse Event,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7856,Negation,Malignant melanoma of eyelid,0
7857,Rate,Primary Cutaneous Plasmablastic Lymphoma,0
7858,Followed by,Chondrosarcoma,0
7859,Separate,Cancer of Urinary Tract,0
7860,Observation Interpretation - intermediate,Intestinal Metaplasia of Bladder Urothelium,0
7861,Rest,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7862,Dysplasia,Stage IB Pancreatic Cancer AJCC v8,0
7863,Location of Oral Residue Following Swallowing,Female Breast Carcinoma,0
7864,Name,Human Papillomavirus-Related Carcinoma,0
7865,Unknown (origin) (qualifier value),Liver Lymphangioma,0
7866,Carcinoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7867,Overall Publication Type,FIGO Stage II Ovarian Cancer,0
7868,Egg of order Phthiraptera,Non-Metastatic Gestational Trophoblastic Tumor,0
7869,Childhood Lymphoma,Colorectal Neuroendocrine Tumor G2,0
7870,Type A,Female Breast Carcinoma,0
7871,Condyloma,Stage III Adult Immunoblastic Lymphoma,0
7872,Intellectual scale,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
7873,Primary operation,Human Papillomavirus-Related Carcinoma,0
7874,Body site,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7875,New,Medulloblastoma,0
7876,Radiation,Acute Undifferentiated Leukemia,0
7877,Similarity,Metastatic Neoplasm to the Gallbladder,0
7878,combination of objects,Ovarian Carcinoid Tumor,0
7879,Rapid disease progression,Childhood Fibrillary Astrocytoma,0
7880,Two,Familial Hemophagocytic Lymphocytosis,0
7881,Blood Cells,Advanced Uterine Corpus Carcinosarcoma,0
7882,Artificial (qualifier value),Localized Ewing Sarcoma,0
7883,Fever,Maxillary Sinus Adenocarcinoma,0
7884,year,Airway Hemangioma,0
7885,cell transformation,Locally Advanced Soft Tissue Sarcoma,0
7886,Type A,Undifferentiated Endocervical Sarcoma,0
7887,Epithelial Cells,Giant cell angiofibroma,0
7888,Neck,Undifferentiated Endocervical Sarcoma,0
7889,Status post,gliosarcoma,0
7890,Result,papillary carcinoma of penis,0
7891,Genitourinary system,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7892,Abnormally high,Angiosarcoma of liver,0
7893,Publishing,Mucinous cystadenofibroma,0
7894,Include (action),Familial Adenomatous Polyposis Associated Medulloblastoma,0
7895,Diagnosis Study,embryonal rhabdomyosarcoma of prostate,0
7896,Mean Percent of Normal,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7897,Obese build,Stage IB Pancreatic Cancer AJCC v8,0
7898,Usually,Anaplastic large cell lymphoma,0
7899,Broken skin,Refractory Barrett Esophagus,0
7900,spring (season),Grade 3a Malignant Neoplasm,0
7901,Cell Differentiation process,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7902,Immune,Adult Alveolar Soft Part Sarcoma,0
7903,Pediatric Neoplasm,Stage IB Pancreatic Cancer AJCC v8,0
7904,Childhood Acute Megakaryoblastic Leukemia,Breast Ductal Adenoma,0
7905,Rare,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7906,Including (qualifier),Acute lymphadenitis,0
7907,Blood Vessel,Carcinoma of urinary bladder,0
7908,Folded structure,Malignant Testicular Sertoli Cell Tumor,0
7909,Decreasing,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7910,activate biological process,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7911,Malignant Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
7912,Chemotherapy,Prostate Lymphoma,0
7913,Late,Adult Alveolar Soft Part Sarcoma,0
7914,Classification,Stage II Carcinoma of Penis,0
7915,Measured Tumor Identification,Thymoma malignant recurrent,0
7916,To,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7917,Entity Determiner - specific,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7918,health and disease,Localized Ewing Sarcoma,0
7919,Most,Malignant Testicular Sertoli Cell Tumor,0
7920,Pesticides,adenoid cystic carcinoma of lung,0
7921,Identified,Stage IB Pancreatic Cancer AJCC v8,0
7922,Appearance,Advanced Uterine Corpus Carcinosarcoma,0
7923,Aggressive behavior,Xeroderma pigmentosum,0
7924,Malignant neoplasm of breast,Low Grade Squamous Intraepithelial Neoplasia,0
7925,Age of Onset,Childhood Central Nervous System Immature Teratoma,0
7926,Adult Hodgkin Lymphoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7927,Patient need for (contextual qualifier),Neoplasms,0
7928,Flow,Prostate Lymphoma,0
7929,Forecast of outcome,Benign Apocrine Neoplasm,0
7930,Include (action),Undifferentiated Endocervical Sarcoma,0
7931,Due to,Collecting Duct Carcinoma of the Kidney,0
7932,Adult human body,Metastatic Lung Small Cell Carcinoma,0
7933,Twice (Numerical Qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7934,What subject filter - Result,Benign tumor of eyelid,0
7935,Type - attribute,Testicular cancer metastatic,0
7936,Infection,Hodgkin lymphoma,0
7937,Germ Cells,Metastatic Lung Small Cell Carcinoma,0
7938,Surrounding (qualifier value),Cancer of Urinary Tract,0
7939,Tryptophanase,Localized Ewing Sarcoma,0
7940,United States,Maxillary Sinus Adenocarcinoma,0
7941,World Health Organization,FIGO Stage II Ovarian Cancer,0
7942,Congenital defects,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7943,risk factors,Grade 3a Malignant Neoplasm,0
7944,Non-Small Cell Lung Carcinoma,Childhood Lymphoma,0
7945,Sweating,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7946,SLC6A2 protein,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7947,Assortment,Endometrial Small Cell Carcinoma,0
7948,Two,Malignant melanoma of eyelid,0
7949,various antiinfectives and antiseptics for local oral treatment,Stage III Adult Immunoblastic Lymphoma,0
7950,Metastatic Neoplasm,Stage I Adult Non-Hodgkin Lymphoma,0
7951,Account number:Identifier:Point in time:^Patient:Nominal,embryonal rhabdomyosarcoma of prostate,0
7952,Hair follicle structure,Breast Ductal Adenoma,0
7953,Case unit dose,Human Papillomavirus-Related Carcinoma,0
7954,Testing,Malignant Testicular Sertoli Cell Tumor,0
7955,Hemangioma,Rhabdomyosarcoma with ganglionic differentiation,0
7956,pharmacotherapeutic,Hemangioma,0
7957,Groups,Adult Hepatocellular Carcinoma,0
7958,Female,Spongiotic dermatitis,0
7959,Epithelial Cells,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7960,diagnosis aspect,Human Papillomavirus-Related Carcinoma,0
7961,Include (action),Childhood Cerebellar Neoplasm,0
7962,Menstruation,Testicular cancer metastatic,0
7963,Groups,Mucinous adenocarcinoma gastric,0
7964,Tryptophanase,Platinum-Resistant Lung Small Cell Carcinoma,0
7965,United States,Atypical Lobular Breast Hyperplasia,0
7966,Smear - instruction imperative,Medulloblastoma,0
7967,Antigens,Spongiotic dermatitis,0
7968,Previously Treated Childhood Rhabdomyosarcoma,Undifferentiated Endocervical Sarcoma,0
7969,DNA,Metastatic Carcinoma in the Lung,0
7970,Usual,sarcoma of spinal cord,0
7971,Activity (animal life circumstance),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7972,shared attribute,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7973,Cancer Etiology,Acantholytic squamous cell carcinoma,0
7974,Further,Carcinoma of urinary bladder,0
7975,Rare,Lipoma of small intestine,0
7976,pharmacotherapeutic,Stage 0 Lip Carcinoma,0
7977,Scar Tissue,benign mature teratoma of pancreas,0
7978,Lung,Blepharal carcinoma,0
7979,Associated with,Primary Cutaneous Plasmablastic Lymphoma,0
7980,Malignant - descriptor,Hemangioma,0
7981,Condition:Find:Pt:^Patient:Nom,Grade 3a Malignant Neoplasm,0
7982,+5,Localized Ewing Sarcoma,0
7983,include - SetOperator,Rhabdomyosarcoma with ganglionic differentiation,0
7984,Monitoring Device,Pilocytic astrocytoma of cerebellum,0
7985,Polyvinyl Chloride,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7986,Europe,Spermatocytic seminoma,0
7987,Mobility aid,Breast Ductal Adenoma,0
7988,Blood Platelets,Refractory Barrett Esophagus,0
7989,<50,Localized Ewing Sarcoma,0
7990,Parotid salivary apparatus,Neonatal leukemia,0
7991,Estimated,Chronic Myelomonocytic Leukemia-2,0
7992,Lacking,Stage IB Pancreatic Cancer AJCC v8,0
7993,Did not receive therapy or drug for,Clonal Hematopoiesis of Indeterminate Potential,0
7994,Frequently,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7995,Antibiotics,Malignant melanoma of eyelid,0
7996,Immune,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7997,Abnormal,Stage IV Childhood Non-Hodgkin Lymphoma,0
7998,Pain,Grade 3a Malignant Neoplasm,0
7999,Administration procedure,Tonsillar Carcinoma,0
8000,Filter - medical device,Thymoma malignant recurrent,0
8001,Hereditary Diseases,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8002,Medical Imaging,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8003,Synonym,Acute Undifferentiated Leukemia,0
8004,Delight,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8005,therapeutic aspects,Refractory Barrett Esophagus,0
8006,Human body,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
8007,Exposure to,Placental aromatase deficiency,0
8008,Symptoms aspect,Acute Undifferentiated Leukemia,0
8009,Colonic Polyps,Mucinous adenocarcinoma gastric,0
8010,Characterization,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8011,Occurrence,Recurrent Testicular Lymphoma,0
8012,More Often than Once a Day,Testicular cancer metastatic,0
8013,Corner Plus,Benign Carotid Body Paraganglioma,0
8014,mast cell,Childhood Fibrillary Astrocytoma,0
8015,Fungus (lab result),Liver Lymphangioma,0
8016,Arsenic measurement,Ovarian germ cell choriocarcinoma stage IV,0
8017,Etiology aspects,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8018,Loss of appetite (finding),Acantholytic squamous cell carcinoma,0
8019,National origin,Breast Ductal Adenoma,0
8020,1960s,Stage IB Lung Cancer AJCC v7,0
8021,Usual Severity Itching,Extracranial Neuroblastoma,0
8022,Death Rate,Intraepithelial Melanocytic Hyperplasia,0
8023,Benign,Primary Cutaneous Plasmablastic Lymphoma,0
8024,CYREN gene,Liver Lymphangioma,0
8025,Unique,BRCA2 Syndrome,0
8026,List,mucinous adenocarcinoma of gallbladder,0
8027,Acute Undifferentiated Leukemia,Ovarian germ cell choriocarcinoma stage IV,0
8028,Anemia,embryonal rhabdomyosarcoma of prostate,0
8029,Different,Malignant melanoma of eyelid,0
8030,How Much Distress Sweats,Testicular cancer metastatic,0
8031,Body tissue,Recurrent Uveal Melanoma,0
8032,Upper urinary tract structure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8033,Controlled by,Bladder squamous cell carcinoma stage I,0
8034,Stage 3 lower case b,Anaplastic large cell lymphoma,0
8035,Known,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8036,Adenoid Cystic Carcinoma,Anterior Urethral Malignant Neoplasm,0
8037,per second,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8038,Survival Rate,Blepharal carcinoma,0
8039,Exposure to,Intraepithelial Melanocytic Hyperplasia,0
8040,Type A,Clonal Hematopoiesis of Indeterminate Potential,0
8041,Lower - spatial qualifier,Endometrial Small Cell Carcinoma,0
8042,Gastrointestinal tract structure,Xeroderma pigmentosum,0
8043,Usual,Unresectable Rhabdomyosarcoma,0
8044,CDISC SEND Tumor Findings Results Terminology,Mucinous adenocarcinoma gastric,0
8045,Due to,Bladder squamous cell carcinoma stage I,0
8046,Block Specimens,Acantholytic squamous cell carcinoma,0
8047,Diagnostic Imaging,Chronic Myelomonocytic Leukemia-2,0
8048,Mathematical Operator,Childhood Fibrillary Astrocytoma,0
8049,Malignant Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8050,Tears - SpecimenType,Localized Askin Tumor,0
8051,Reaction,Acute lymphadenitis,0
8052,Well,Digestive System Hodgkin Lymphoma,0
8053,Leading,Uterine Cancer,0
8054,Contain (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8055,More Often than Once a Day,mucinous adenocarcinoma of gallbladder,0
8056,Several,Testicular cancer metastatic,0
8057,Detected (finding),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8058,Form:Finding:Point in time:{Setting}:Document:{Role},Adenocarcinoma of the prostate metastatic,0
8059,How Much Distress Weight Loss,mucinous adenocarcinoma of gallbladder,0
8060,Used by,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8061,Affecting,Xeroderma pigmentosum,0
8062,Science of Etiology,Undifferentiated Neuroblastoma,0
8063,Antacids,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8064,Ability,Refractory Barrett Esophagus,0
8065,Widening,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8066,New,Low Grade Squamous Intraepithelial Neoplasia,0
8067,Death (finding),Chronic Myelomonocytic Leukemia-2,0
8068,various antiseptic throat preparations,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8069,Sequence Data Type,Recurrent Uveal Melanoma,0
8070,Intrinsic origin,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8071,Left sided,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8072,Adult,Intestinal Metaplasia of Bladder Urothelium,0
8073,Decision,Childhood Fibrillary Astrocytoma,0
8074,Representation (action),Clonal Hematopoiesis of Indeterminate Potential,0
8075,metastatic qualifier,Mucinous adenocarcinoma gastric,0
8076,Primary malignant neoplasm of bladder,Undifferentiated Endocervical Sarcoma,0
8077,Coughing,Carcinoma of urinary bladder,0
8078,Reaching,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8079,Physical Activity Measurement,Liver Lymphangioma,0
8080,Main,adenosquamous carcinoma of breast,0
8081,shared attribute,Metastatic Lung Small Cell Carcinoma,0
8082,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8083,Financial Account,Extra-Adrenal Paraganglioma,0
8084,Reported Term,Breast Ductal Adenoma,0
8085,Term Birth,Mucinous neoplasm,0
8086,Mechanism Component of Device,Noninfiltrating Intraductal Carcinoma,0
8087,risk factors - observation list,Recurrent Uveal Melanoma,0
8088,Proton pump inhibitors for peptic ulcer and GORD,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8089,Uveal melanoma,Recurrent Testicular Lymphoma,0
8090,Fertility,Intraepithelial Melanocytic Hyperplasia,0
8091,Surgical aspects,Malignant Testicular Sertoli Cell Tumor,0
8092,Further,Benign tumor of eyelid,0
8093,Head,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8094,Anatomic Site,Undifferentiated Endocervical Sarcoma,0
8095,Severe (severity modifier),Giant cell angiofibroma,0
8096,Process (qualifier value),Digestive System Hodgkin Lymphoma,0
8097,Sexually active,Digestive System Hodgkin Lymphoma,0
8098,Death (finding),Stage 0 Lip Carcinoma,0
8099,Australia,Pancreatic Intraepithelial Neoplasia-3,0
8100,Inguinal part of abdomen,Breast Ductal Adenoma,0
8101,Disease Outcome,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8102,Patterns,Unfavorable Non-Hodgkin Lymphoma,0
8103,Category Type,Cartilaginous exostosis,0
8104,Hepatitis C virus,Human Papillomavirus-Related Carcinoma,0
8105,Purpose,Female Breast Carcinoma,0
8106,Term Birth,Clonal Hematopoiesis of Indeterminate Potential,0
8107,Stage Grouping,FIGO Stage II Ovarian Cancer,0
8108,Long-term,Recurrent Uveal Melanoma,0
8109,Spreading (qualifier value),Ichthyoses,0
8110,Cardiovascular System Part,Airway Hemangioma,0
8111,Present,Atypical Lobular Breast Hyperplasia,0
8112,Sequence Arm,Recurrent Testicular Lymphoma,0
8113,Sore skin,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8114,Autoimmune Diseases,Acute Undifferentiated Leukemia,0
8115,Togo,Xeroderma pigmentosum,0
8116,Science of Etiology,Stage III Adult Immunoblastic Lymphoma,0
8117,Slow Growing,Childhood Fibrillary Astrocytoma,0
8118,Increased,Benign tumor of eyelid,0
8119,Mixed Neoplasm,Neoplasms,0
8120,Cause of death:Find:Pt:^Patient:Nom,Acute lymphadenitis,0
8121,To,Acute Undifferentiated Leukemia,0
8122,Togo,Childhood Fibrillary Astrocytoma,0
8123,Complete Agreement,adenoid cystic carcinoma of lung,0
8124,Massive,High Grade Glandular Intraepithelial Neoplasia,0
8125,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Pancreatic Intraepithelial Neoplasia-3,0
8126,Five,Anterior Urethral Malignant Neoplasm,0
8127,Genes,Neonatal leukemia,0
8128,child survival,Breast Ductal Adenoma,0
8129,Unintentional Material Aspiration,Giant cell angiofibroma,0
8130,SPINK5 gene,Anterior Urethral Malignant Neoplasm,0
8131,One,Anterior Urethral Malignant Neoplasm,0
8132,35,Bladder squamous cell carcinoma stage I,0
8133,Only - dosing instruction fragment,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8134,pharmacotherapeutic,Familial Hemophagocytic Lymphocytosis,0
8135,How Much Distress Vomiting,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8136,Manufactured sign,Heavy Chain Deposition Disease,0
8137,Support,Undifferentiated Neuroblastoma,0
8138,Anatomic Structure,Human Papillomavirus-Related Carcinoma,0
8139,Pathway (interactions),Ovarian germ cell choriocarcinoma stage IV,0
8140,Visible,Childhood Central Nervous System Immature Teratoma,0
8141,chronic,Testicular cancer metastatic,0
8142,Males,Extra-Adrenal Paraganglioma,0
8143,biopsy characteristics,mucinous adenocarcinoma of gallbladder,0
8144,Neoplasms,Leiomyoma of Gallbladder,0
8145,Etiology aspects,Low Grade Squamous Intraepithelial Neoplasia,0
8146,Classification,Platinum-Resistant Lung Small Cell Carcinoma,0
8147,Malignant Carcinoid Syndrome,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8148,Overall Publication Type,Adult Hepatocellular Carcinoma,0
8149,Malignant neoplasm of skin,Platinum-Resistant Lung Small Cell Carcinoma,0
8150,Include (action),Familial Adenomatous Polyposis Associated Medulloblastoma,0
8151,Nephron brand of racepinephrine hydrochloride,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8152,Percent of Bacteria,Malignant melanoma of eyelid,0
8153,Pelvic pain female,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8154,VARIOUS DRUG CLASSES IN ATC,Human Papillomavirus-Related Carcinoma,0
8155,Alphabet,non-Hodgkin's lymphoma of spleen,0
8156,Characteristics,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8157,One,Giant cell angiofibroma,0
8158,Hemorrhage,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8159,Relationships,Hodgkin lymphoma,0
8160,Esophagitis,Extracranial Neuroblastoma,0
8161,Negation,Stage II Carcinoma of Penis,0
8162,Management procedure,Childhood Lymphoma,0
8163,Pineal gland,Cerebral Primitive Neuroectodermal Tumor,0
8164,Involvement with,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8165,Combined,Mucinous adenocarcinoma gastric,0
8166,ALLERGENS IDENTIFIED:PRESENCE OR IDENTITY:POINT IN TIME:SERUM:NOMINAL,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8167,Vagina,Heavy Chain Deposition Disease,0
8168,Result,FIGO Stage II Ovarian Cancer,0
8169,Fever symptoms (finding),Acute Undifferentiated Leukemia,0
8170,Minor (value),Refractory Barrett Esophagus,0
8171,Common (qualifier value),BRCA2 Syndrome,0
8172,Top (position),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8173,Urothelium,Angiosarcoma of liver,0
8174,TP53 gene,Mastocytosis,0
8175,Time (foundation metadata concept),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8176,Breast Carcinoma,Human Papillomavirus-Related Carcinoma,0
8177,Support,Granular Cell Leiomyosarcoma,0
8178,Biospecimen,Collecting Duct Carcinoma of the Kidney,0
8179,Adenomatous Polyposis Coli,Mucinous adenocarcinoma gastric,0
8180,How Often Shortness of Breath,benign mature teratoma of pancreas,0
8181,Subject Risk,Keratoderma,0
8182,Weight Loss,Cartilaginous exostosis,0
8183,Smell Perception,Metastatic Kidney Carcinoma,0
8184,Malignant Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
8185,Embryonic Germ Cells,Malignant neoplasm of thalamus,0
8186,Abdomen+,Intraepithelial Melanocytic Hyperplasia,0
8187,leukemia,Malignant melanoma of eyelid,0
8188,Night sweats,Recurrent Testicular Lymphoma,0
8189,shared attribute,Stage IB Pancreatic Cancer AJCC v8,0
8190,Contusions,Ampulla of Vater Tubular Adenoma,0
8191,Representation (action),Malignant melanoma of eyelid,0
8192,Skin tanning,Stage III Adult Immunoblastic Lymphoma,0
8193,Beginning,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8194,90%,Human Papillomavirus-Related Carcinoma,0
8195,Table Cell Horizontal Align - left,Human Papillomavirus-Related Carcinoma,0
8196,low exposure,Acute Undifferentiated Leukemia,0
8197,Anterior chest wall structure,Carcinoma of urinary bladder,0
8198,Lower (action),Unfavorable Non-Hodgkin Lymphoma,0
8199,Cell Count,Endometrial Small Cell Carcinoma,0
8200,Immunoproliferative Disorders,Advanced Lung Carcinoma,0
8201,Body tissue,Lipoma of small intestine,0
8202,Associated with,Heavy Chain Deposition Disease,0
8203,How Much Distress Weight Loss,Giant cell angiofibroma,0
8204,Array Feature,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8205,Sweat Glands,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8206,Adult,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8207,Cancer Genus,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
8208,Fibroid Tumor,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8209,Child,Stage II Fallopian Tube Cancer,0
8210,unknown vaccine or immune globulin,Mucinous adenocarcinoma gastric,0
8211,60%,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8212,Occur (action),Noninfiltrating Intraductal Carcinoma,0
8213,Type A,Acantholytic squamous cell carcinoma,0
8214,Parenchyma,gliosarcoma,0
8215,Smear - instruction imperative,Mucinous adenocarcinoma gastric,0
8216,Varies,Liver Lymphangioma,0
8217,Prognosis:Find:Pt:^Patient:Nom,Metastatic Carcinoma in the Lung,0
8218,Base - General Qualifier,Leptomeningeal sarcoma,0
8219,High Grade Cervical Squamous Intraepithelial Neoplasia,Childhood Fibrillary Astrocytoma,0
8220,Malignant Neoplasms,Carcinoma of urinary bladder,0
8221,Include (action),Metastatic Kidney Carcinoma,0
8222,Mucous body substance,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8223,Tubal Ligation,Unresectable Rhabdomyosarcoma,0
8224,peripheral blood,Ovarian germ cell choriocarcinoma stage IV,0
8225,potential,Mucinous neoplasm,0
8226,Lymphoid leukemia,Granular Cell Leiomyosarcoma,0
8227,Comment,Liver Cavernous Hemangioma,0
8228,Show,Acantholytic squamous cell carcinoma,0
8229,Togo,Blepharal carcinoma,0
8230,Renal carcinoma,Spongiotic dermatitis,0
8231,Sole of Foot,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8232,Basal Cell Carcinoma Pathway,Low Grade Squamous Intraepithelial Neoplasia,0
8233,Diagnosis Study,adenoid cystic carcinoma of lung,0
8234,Benign,Anterior Urethral Malignant Neoplasm,0
8235,Formation,Mucinous neoplasm,0
8236,Carcinoma,Xeroderma pigmentosum,0
8237,To,Atypical Lobular Breast Hyperplasia,0
8238,nonmetastatic,Digestive System Hodgkin Lymphoma,0
8239,Lymphoma,Cancer of Urinary Tract,0
8240,Call (Instruction),Benign Carotid Body Paraganglioma,0
8241,Including (qualifier),Benign neoplasm of thorax,0
8242,*Activity (kind of quantity),Familial Adenomatous Polyposis Associated Medulloblastoma,0
8243,Pharmacotherapy,FIGO Stage II Ovarian Cancer,0
8244,Rating (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8245,Intestines,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8246,Humoralism,Mucinous neoplasm,0
8247,Pharmacotherapy,FIGO Stage II Ovarian Cancer,0
8248,Treatment Epoch,Recurrent Testicular Lymphoma,0
8249,Taken,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8250,N+ (tumor staging),Localized Ewing Sarcoma,0
8251,Physical findings,papillary carcinoma of penis,0
8252,Term (temporal),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8253,Act Relationship Type - occurrence,Intracortical osteosarcoma,0
8254,Childhood Diffuse Large B-Cell Lymphoma,Undifferentiated Endocervical Sarcoma,0
8255,Chemotherapy Regimen,Grade 3a Malignant Neoplasm,0
8256,include - SetOperator,Cerebral Primitive Neuroectodermal Tumor,0
8257,seen,Thymic Clear Cell Carcinoma,0
8258,Benign Vascular Neoplasm,Localized Askin Tumor,0
8259,Lymphatic System,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8260,Group A (blood group),Cancer of Urinary Tract,0
8261,Activities,Lung squamous cell carcinoma stage I,0
8262,Standard Treatment,mucinous adenocarcinoma of gallbladder,0
8263,Fever symptoms (finding),FIGO Stage II Ovarian Cancer,0
8264,Occurrence Indicator,Extra-Adrenal Paraganglioma,0
8265,Study Element,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8266,Encounter,Malignant neoplasm of thalamus,0
8267,unknown vaccine or immune globulin,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8268,Delta (difference),Grade 1 Clear Cell Renal Cell Carcinoma,0
8269,Case (situation),Refractory Barrett Esophagus,0
8270,Administration procedure,Localized Ewing Sarcoma,0
8271,Primary malignant neoplasm,Small cell neuroendocrine carcinoma of bladder,0
8272,Process,Primary Cutaneous Plasmablastic Lymphoma,0
8273,Classification of information,Stage III Adult Immunoblastic Lymphoma,0
8274,Bayer Visual Acuity Changes Grade 3,Clonal Hematopoiesis of Indeterminate Potential,0
8275,Entity Name Part Qualifier - birth,Pilocytic astrocytoma of cerebellum,0
8276,Pancreas,Human Papillomavirus-Related Carcinoma,0
8277,Class,Prostate Lymphoma,0
8278,Much,Medulloblastoma,0
8279,Wounds - qualifier,Extracranial Neuroblastoma,0
8280,To,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8281,NCI CTEP SDC Small Cell Lung Cancer Sub-Category Terminology,Angiosarcoma of liver,0
8282,Painless,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8283,Function (attribute),Chondrosarcoma,0
8284,Antibiotic Resistance,Mastocytosis,0
8285,Germ cell tumor,Ovarian germ cell choriocarcinoma stage IV,0
8286,2+ Score,Stage IB Pancreatic Cancer AJCC v8,0
8287,Biomaterial Treatment,Diffuse malignant mesothelioma,0
8288,Pruritus,Acute lymphadenitis,0
8289,Feature,Cerebral Primitive Neuroectodermal Tumor,0
8290,Symptoms aspect,Cancer of Urinary Tract,0
8291,Following,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8292,Neck,FIGO Stage II Ovarian Cancer,0
8293,Part of,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8294,Shapes,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8295,Treatment Epoch,Familial Hemophagocytic Lymphocytosis,0
8296,Divide,Low Grade Squamous Intraepithelial Neoplasia,0
8297,Cardiac Arrest,Benign Apocrine Neoplasm,0
8298,Different,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8299,Togo,FIGO Stage II Ovarian Cancer,0
8300,Test - temporal region,Pilocytic astrocytoma of cerebellum,0
8301,Treatment Epoch,Adult Alveolar Soft Part Sarcoma,0
8302,Prolonged menses,Diffuse malignant mesothelioma,0
8303,Cells,Adenocarcinoma,0
8304,Genetic,Mucinous neoplasm,0
8305,Body tissue,Clonal Hematopoiesis of Indeterminate Potential,0
8306,Infarction,Stage III Adult Immunoblastic Lymphoma,0
8307,Out (direction),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8308,Ultrasonography,Childhood Central Nervous System Immature Teratoma,0
8309,Usual Severity Sweats,malignant lymphoma of pancreatic lymph nodes,0
8310,Insecticides,Malignant neoplasm of choroid,0
8311,Lymphoma cells,Carcinoma of urinary bladder,0
8312,Biologic Development,Diffuse malignant mesothelioma,0
8313,Melanoma Pathway,Colorectal Neuroendocrine Tumor G2,0
8314,Involvement with,Liver Lymphangioma,0
8315,Approximate,Intraepithelial Melanocytic Hyperplasia,0
8316,Tumor Mass,Contact dermatitis due to alkali,0
8317,Singular,Mucinous cystadenofibroma,0
8318,Screening procedure,Mucinous adenocarcinoma gastric,0
8319,Pain,Malignant melanoma of eyelid,0
8320,analysis aspect,Pilocytic astrocytoma of cerebellum,0
8321,Risk,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8322,Dorsal,squamous cell carcinoma of the thyroid gland,0
8323,Administration procedure,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8324,Set of regional lymph nodes,Lipoma of small intestine,0
8325,Fluid behavior,Pilocytic astrocytoma of cerebellum,0
8326,Floor (anatomic),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8327,radiotherapeutic,Acantholytic squamous cell carcinoma,0
8328,metaplastic cell transformation,Adrenal Rest Tumor,0
8329,Tumor stage,Pancreatic Intraepithelial Neoplasia-3,0
8330,survival aspects,Malignant melanoma of eyelid,0
8331,Show,Hodgkin lymphoma,0
8332,Monitor,Intracortical osteosarcoma,0
8333,Disease,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8334,Continuance of life,Mucinous adenocarcinoma gastric,0
8335,Present,Localized Askin Tumor,0
8336,Multiplication,Choroid Necrotic Melanoma,0
8337,Intestines,Digestive System Hodgkin Lymphoma,0
8338,Cervical lymph node group,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8339,Covers (device),embryonal rhabdomyosarcoma of prostate,0
8340,photoreactivating enzyme activity,Adult Alveolar Soft Part Sarcoma,0
8341,Very rare,Leiomyoma of Gallbladder,0
8342,Case unit dose,Breast Ductal Adenoma,0
8343,Statistical Prevalence,papillary carcinoma of penis,0
8344,Shortness of breath:-:Point in time:^Patient:-,Neoplasms,0
8345,Financial Account,Leptomeningeal sarcoma,0
8346,risk factors - observation list,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8347,Often - answer to question,Mucinous adenocarcinoma gastric,0
8348,per second,Acute Undifferentiated Leukemia,0
8349,New,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
8350,Involvement with,Adult Alveolar Soft Part Sarcoma,0
8351,consideration,Ichthyoses,0
8352,Psyche structure,Acantholytic squamous cell carcinoma,0
8353,diabetic,Thymic Clear Cell Carcinoma,0
8354,Balance,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8355,Image Feature,Refractory Barrett Esophagus,0
8356,Treating,FIGO Stage II Ovarian Cancer,0
8357,Infiltration (procedure),Blepharal carcinoma,0
8358,LYMPHOID Cancers,Cerebral Primitive Neuroectodermal Tumor,0
8359,Established,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8360,Geographic Locations,Recurrent Diffuse Intrinsic Pontine Glioma,0
8361,*Type - Kind of quantity,Airway Hemangioma,0
8362,Basis - conceptual entity,Colorectal cancer,0
8363,What subject filter - Result,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8364,Certain (qualifier value),Benign tumor of eyelid,0
8365,More,Malignant neoplasm of choroid,0
8366,Exposure to radiation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8367,Cartilage,Localized Askin Tumor,0
8368,Cervical Squamous Cell Carcinoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8369,Appearance Distress Question,Heavy Chain Deposition Disease,0
8370,Malignant neoplasm of lung,Mucinous adenocarcinoma gastric,0
8371,Qualitative form,Grade 3a Malignant Neoplasm,0
8372,Age,Liver Lymphangioma,0
8373,Reflecting,Blepharal carcinoma,0
8374,Diagnosis,Undifferentiated Neuroblastoma,0
8375,Function (attribute),Stage II Hepatocellular Carcinoma AJCC v8,0
8376,Cessation of life,Liver Lymphangioma,0
8377,Subtype (attribute),Acute Undifferentiated Leukemia,0
8378,Table Frame - above,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8379,Asthma Control Test Questionnaire,Metastatic Malignant Neoplasm in the Sellar Region,0
8380,vinyl chloride,papillary carcinoma of penis,0
8381,Blood,adenosquamous carcinoma of breast,0
8382,Mass,Intestinal Metaplasia of Bladder Urothelium,0
8383,Occur (action),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8384,History of present illness,Malignant neoplasm of choroid,0
8385,Proliferation,Acantholytic squamous cell carcinoma,0
8386,Benign,Spongiotic dermatitis,0
8387,Abnormal cell,Tonsillar Carcinoma,0
8388,Cells,Intraepithelial Melanocytic Hyperplasia,0
8389,month,Hair nevus,0
8390,Primary malignant neoplasm of lung,Localized Ewing Sarcoma,0
8391,Urothelial Carcinoma,Platinum-Resistant Lung Small Cell Carcinoma,0
8392,Middle,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8393,20%,Heavy Chain Deposition Disease,0
8394,Firstly,Xeroderma pigmentosum,0
8395,Primary malignant neoplasm,Platinum-Resistant Lung Small Cell Carcinoma,0
8396,Large,benign mature teratoma of pancreas,0
8397,Togo,Metastatic Lung Small Cell Carcinoma,0
8398,Second Primary Cancers,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8399,Linear,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8400,Call (Instruction),Xeroderma pigmentosum,0
8401,Publishing,Secondary malignant neoplasm of lymph node,0
8402,Diagnosis Study,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8403,More Often than Once a Day,benign mature teratoma of pancreas,0
8404,Term (temporal),Cerebral Primitive Neuroectodermal Tumor,0
8405,white blood cell type,Xeroderma pigmentosum,0
8406,Affecting,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8407,Face (spatial concept),Xeroderma pigmentosum,0
8408,RMS,Choroid Necrotic Melanoma,0
8409,Common Specifications in HL7 V3 Publishing,Rhabdomyosarcoma with ganglionic differentiation,0
8410,Bladder Cancer Pathway,Acute lymphadenitis,0
8411,T lymphocyte marker,Adult Hepatocellular Carcinoma,0
8412,Tube - unit dose,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8413,Beginning,Grade 3a Malignant Neoplasm,0
8414,Known,Xeroderma pigmentosum,0
8415,Complete,Mucinous adenocarcinoma gastric,0
8416,Congenital Abnormality,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8417,Progress,Testicular cancer metastatic,0
8418,International Statistical Classification of Diseases and Related Health Problems,Testicular cancer metastatic,0
8419,STS gene,Stage I Adult Non-Hodgkin Lymphoma,0
8420,Tumor type,Choroid Necrotic Melanoma,0
8421,Diagnosis,benign mature teratoma of pancreas,0
8422,Compression,Undifferentiated Endocervical Sarcoma,0
8423,Possible diagnosis,Stage III Adult Immunoblastic Lymphoma,0
8424,In Blood,Digestive System Hodgkin Lymphoma,0
8425,CEL gene,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8426,Usual,Low Grade Squamous Intraepithelial Neoplasia,0
8427,HLA Class II Histocompatibility Antigen Gamma Chain,Benign Carotid Body Paraganglioma,0
8428,Specific qualifier value,Neonatal leukemia,0
8429,Biospecimen,Childhood Thyroid Gland Follicular Carcinoma,0
8430,Site,BRCA2 Syndrome,0
8431,Multiple Myeloma,Contact dermatitis due to alkali,0
8432,Morning,Malignant neoplasm of thalamus,0
8433,Erythropoiesis,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
8434,Pediculus (eukaryote),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8435,Walled,Rhabdomyosarcoma with ganglionic differentiation,0
8436,Routine Contract,FIGO Stage II Ovarian Cancer,0
8437,factor A,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8438,Positive Selection,Digestive System Hodgkin Lymphoma,0
8439,Treating,Neonatal leukemia,0
8440,Head - Component of Device,Endometrial Small Cell Carcinoma,0
8441,2+ Score,Primary Cutaneous Plasmablastic Lymphoma,0
8442,Occur (action),Clonal Hematopoiesis of Indeterminate Potential,0
8443,Neoplastic disease,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8444,Rate,Papillary cystic tumor,0
8445,activate - Data Operation,Malignant Neoplasm with Regional Lymph Node Involvement,0
8446,Diagnosis Study,Atypical Mesothelial Hyperplasia,0
8447,Body cavities,Keratoderma,0
8448,Body tissue,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8449,Sarcoma - category (morphologic abnormality),Secondary malignant neoplasm of lymph node,0
8450,How Often Weight Loss,Female Breast Carcinoma,0
8451,Active License,Granular Cell Leiomyosarcoma,0
8452,Treating,Anaplastic large cell lymphoma,0
8453,Adenocarcinoma,Thymoma malignant recurrent,0
8454,Percent normal,Cartilaginous exostosis,0
8455,Including (qualifier),Botryoid-Type Embryonal Rhabdomyosarcoma,0
8456,Rule (guideline),Recurrent Testicular Lymphoma,0
8457,Presentation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8458,Type - attribute,FIGO Stage II Ovarian Cancer,0
8459,Bothered by Nausea,FIGO Stage II Ovarian Cancer,0
8460,pharmacotherapeutic,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8461,Body tissue,Hodgkin lymphoma,0
8462,To,Chondrosarcoma,0
8463,Disruptive,Intestinal Metaplasia of Bladder Urothelium,0
8464,Alternating,Methotrexate-Associated Hodgkin Lymphoma,0
8465,various antiseptic throat preparations,Locally Advanced Soft Tissue Sarcoma,0
8466,Case unit dose,Stage IB Lung Cancer AJCC v7,0
8467,Frequently,Heavy Chain Deposition Disease,0
8468,Chemotherapy Regimen,Metastatic Kidney Carcinoma,0
8469,Age at diagnosis,Platinum-Resistant Lung Small Cell Carcinoma,0
8470,Soft Tissue Route of Drug Administration,Medulloblastoma,0
8471,Lymphoplasmacytoid Cell,Rhabdomyosarcoma with ganglionic differentiation,0
8472,Contraceptives,Stage 0 Lip Carcinoma,0
8473,shared attribute,Blepharal carcinoma,0
8474,Cystadenocarcinoma,Unresectable Rhabdomyosarcoma,0
8475,Tryptophanase,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8476,Often - answer to question,Adult Brain Stem Mixed Glioma,0
8477,Medical Drop,Tonsillar Carcinoma,0
8478,Specimen Source Codes - Macrophages,Intraepithelial Melanocytic Hyperplasia,0
8479,Irregular,Grade 3a Malignant Neoplasm,0
8480,Participation Type - origin,Intraepithelial Melanocytic Hyperplasia,0
8481,Macrophage count,Metastatic Lung Small Cell Carcinoma,0
8482,Thinking,Primary Cutaneous Plasmablastic Lymphoma,0
8483,Relationships,Cancer of Urinary Tract,0
8484,Gait normal,Intestinal Metaplasia of Bladder Urothelium,0
8485,Affect (mental function),Small cell neuroendocrine carcinoma of bladder,0
8486,campbell,Spongiotic dermatitis,0
8487,Did not receive therapy or drug for,Benign Apocrine Neoplasm,0
8488,Tests (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8489,cell growth,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8490,Categories,Mastocytosis,0
8491,Combined Modality Therapy,Metastatic Ductal Breast Carcinoma,0
8492,Choriocarcinoma,Cartilaginous exostosis,0
8493,Blast count procedure,Carcinoma of urinary bladder,0
8494,RMS,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8495,CDISC SEND Tumor Findings Results Terminology,Benign neoplasm of thorax,0
8496,Electrolytes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8497,B-Lymphocytes,Platinum-Resistant Lung Small Cell Carcinoma,0
8498,Identity,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8499,Type - attribute,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8500,Malignant - descriptor,Familial Hemophagocytic Lymphocytosis,0
8501,Deoxyribonucleic Acid Measurement,Metastatic Carcinoma in the Lung,0
8502,Third revision,Noninfiltrating Intraductal Carcinoma,0
8503,Topical Cream,Testicular cancer metastatic,0
8504,Radiotherapy Research,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8505,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,mucinous adenocarcinoma of gallbladder,0
8506,ASIP wt Allele,Angiosarcoma of liver,0
8507,Icterus,Atypical Lobular Breast Hyperplasia,0
8508,Etiology aspects,sarcoma of spinal cord,0
8509,Elderly (population group),FIGO Stage II Ovarian Cancer,0
8510,Formed,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8511,Hematopoietic Neoplasms,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8512,Known,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8513,Providing presence (regime/therapy),Malignant neoplasm of choroid,0
8514,Science of Etiology,Xeroderma pigmentosum,0
8515,Leg,Mastocytosis,0
8516,Only - dosing instruction fragment,Chronic Myelomonocytic Leukemia-2,0
8517,Mixed Salivary Gland Tumor,FIGO Stage II Ovarian Cancer,0
8518,Condyloma,Small cell neuroendocrine carcinoma of bladder,0
8519,Family history,Angiosarcoma of liver,0
8520,Diagnosis Study,Benign Carotid Body Paraganglioma,0
8521,Publishing,Recurrent Uveal Melanoma,0
8522,Adult Rhabdomyosarcoma,Spongiotic dermatitis,0
8523,Vague,Metastatic Kidney Carcinoma,0
8524,Most,Adult Alveolar Soft Part Sarcoma,0
8525,Complication,non-Hodgkin's lymphoma of spleen,0
8526,True primary (qualifier value),malignant lymphoma of pancreatic lymph nodes,0
8527,Patient Reported Outcome Stem,Mucinous adenocarcinoma gastric,0
8528,diagnosis aspect,Uterine Cancer,0
8529,Abnormal Cell Count,Intraepithelial Melanocytic Hyperplasia,0
8530,World,Stage IB Pancreatic Cancer AJCC v8,0
8531,Cancer Genus,FIGO Stage II Ovarian Cancer,0
8532,Bone pain,Ovarian germ cell choriocarcinoma stage IV,0
8533,low exposure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8534,20%,BRCA2 Syndrome,0
8535,Lymphocyte component of blood,Neoplasms,0
8536,Togo,High Grade Glandular Intraepithelial Neoplasia,0
8537,Squamous,Refractory Barrett Esophagus,0
8538,Togo,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
8539,Scrofula,Small cell neuroendocrine carcinoma of bladder,0
8540,Anterior portion of neck,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8541,In Blood,Colorectal Neuroendocrine Tumor G2,0
8542,Usual,Testicular cancer metastatic,0
8543,Usual Severity Difficulty Swallowing,Carcinoma of urinary bladder,0
8544,Undifferentiated Neuroblastoma,Adult Alveolar Soft Part Sarcoma,0
8545,seen,Cartilaginous exostosis,0
8546,Poor - grade value,Stage 0 Lip Carcinoma,0
8547,diagnosis aspect,Anterior Urethral Malignant Neoplasm,0
8548,Skeletal system,High Grade Glandular Intraepithelial Neoplasia,0
8549,Vulva,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8550,Together,Platinum-Resistant Lung Small Cell Carcinoma,0
8551,week,Endometrial Small Cell Carcinoma,0
8552,Sore to touch,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8553,consider,Stage IB Pancreatic Cancer AJCC v8,0
8554,Report (document),Advanced Uterine Corpus Carcinosarcoma,0
8555,Concern,Leiomyoma of Gallbladder,0
8556,Chemotherapy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8557,Surgical aspects,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8558,Sequence Arm,Thymic Clear Cell Carcinoma,0
8559,Blood Platelets,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
8560,Lymphocyte,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8561,Different,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8562,Primary operation,Spongiotic dermatitis,0
8563,English race,Human Papillomavirus-Related Carcinoma,0
8564,occurrence characteristics,Carcinoma of urinary bladder,0
8565,Gum of mandible,Localized Askin Tumor,0
8566,Classical Hodgkin's Lymphoma,Hodgkin lymphoma,0
8567,Hyperplastic Polyp,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8568,Mass of body structure,Diffuse malignant mesothelioma,0
8569,Classical Hodgkin's Lymphoma,Recurrent Testicular Lymphoma,0
8570,Fetal Tissue,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8571,Immunoglobulin M,Childhood Fibrillary Astrocytoma,0
8572,seconds,Human Papillomavirus-Related Carcinoma,0
8573,Aluminum measurement,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8574,Section (object),Recurrent Testicular Lymphoma,0
8575,Gastric Adenocarcinoma,Intestinal Neuroendocrine Carcinoma,0
8576,Unknown,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8577,structure,mucinous adenocarcinoma of gallbladder,0
8578,Cell surface,Carcinoma ex pleomorphic adenoma of parotid gland,0
8579,Canada,embryonal rhabdomyosarcoma of prostate,0
8580,Symptoms aspect,Maxillary Sinus Adenocarcinoma,0
8581,Lip structure,embryonal rhabdomyosarcoma of prostate,0
8582,Illness (finding),Malignant Neoplasm with Regional Lymph Node Involvement,0
8583,Cells,Undifferentiated Endocervical Sarcoma,0
8584,Immunotherapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8585,Secretory Vesicles,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8586,Lateral ventricle structure,Liver Lymphangioma,0
8587,risk factors,papillary carcinoma of penis,0
8588,Occurrence,Benign tumor of eyelid,0
8589,Either,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8590,Childhood Non-Hodgkin Lymphoma,Localized Ewing Sarcoma,0
8591,Containing (qualifier),papillary carcinoma of penis,0
8592,Liver Flavor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8593,Publications,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8594,Has difficulty doing (qualifier value),Stage I Adult Non-Hodgkin Lymphoma,0
8595,Bone structure of rib,Angiosarcoma of liver,0
8596,section sample,BRCA2 Syndrome,0
8597,Childhood,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8598,Malignant - descriptor,Lipoma of small intestine,0
8599,Hospice and Palliative Care Nursing,de novo Myelodysplastic Syndrome,0
8600,risk factors,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8601,Include (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8602,Meningitis,Low Grade Squamous Intraepithelial Neoplasia,0
8603,per year,Placental aromatase deficiency,0
8604,Intestines,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
8605,Multiply - dosing instruction fragment,Adrenal Rest Tumor,0
8606,Lung Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8607,Form of bone,Werner Syndrome,0
8608,Removal of bladder,Stage IB Pancreatic Cancer AJCC v8,0
8609,Anatomic Site,Stage IB Lung Cancer AJCC v7,0
8610,Northern Europe,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8611,Mesenchymal Stem Cells,Adult Alveolar Soft Part Sarcoma,0
8612,Myasthenia Gravis,Breast Ductal Adenoma,0
8613,Cessation of life,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8614,SLC35G1 gene,FIGO Stage II Ovarian Cancer,0
8615,Immature Lymphocytes Measurement,papillary carcinoma of penis,0
8616,soft tissue,Cerebral Primitive Neuroectodermal Tumor,0
8617,Dairy Cream,Lung Mucinous Cystadenoma,0
8618,Absent,Human Papillomavirus-Related Carcinoma,0
8619,Tumor cells,Ovarian germ cell choriocarcinoma stage IV,0
8620,Occurrence,Recurrent Uveal Melanoma,0
8621,Online Mendelian Inheritance In Man,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
8622,Common (qualifier value),Testicular cancer metastatic,0
8623,risk factors - observation list,Intestinal Metaplasia of Bladder Urothelium,0
8624,Biomaterial Treatment,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8625,Lead,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8626,Derived value,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8627,Frequently,Bladder squamous cell carcinoma stage I,0
8628,Call (Instruction),adenosquamous carcinoma of breast,0
8629,Sounds device,Mucinous adenocarcinoma gastric,0
8630,include - SetOperator,Childhood Lymphoma,0
8631,Diagnostic Neoplasm Staging,Mucinous adenocarcinoma gastric,0
8632,Poverty,Childhood Central Nervous System Immature Teratoma,0
8633,Malignant lymphoma,Angiosarcoma of liver,0
8634,One,Malignant Neoplasm with Regional Lymph Node Involvement,0
8635,Intestines,Recurrent Testicular Lymphoma,0
8636,Focal,Methotrexate-Associated Hodgkin Lymphoma,0
8637,Parotid Neoplasms,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
8638,Pap smear,Xeroderma pigmentosum,0
8639,Name (property) (qualifier value),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
8640,Irritation - emotion,Intestinal Neuroendocrine Carcinoma,0
8641,>90,Leiomyoma of Gallbladder,0
8642,Manual pelvic examination (procedure),Maxillary Sinus Adenocarcinoma,0
8643,Sometimes,Malignant melanoma of eyelid,0
8644,Area,Undifferentiated Endocervical Sarcoma,0
8645,Record - QueryRequestLimit,Human Papillomavirus-Related Carcinoma,0
8646,adaptive,squamous cell carcinoma of the thyroid gland,0
8647,Reporting,Neoplasms,0
8648,Occurrence,Intestinal Metaplasia of Bladder Urothelium,0
8649,Disease,Breast Ductal Adenoma,0
8650,Lymphocyte,Childhood Central Nervous System Immature Teratoma,0
8651,Slow progression,Granular Cell Leiomyosarcoma,0
8652,Asia,Diffuse malignant mesothelioma,0
8653,Malignant neoplasm of endometrium,Neonatal leukemia,0
8654,2+ Score,Leptomeningeal sarcoma,0
8655,H NOS Antibodies,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8656,Blood,Benign tumor of eyelid,0
8657,Diagnosis,Acantholytic squamous cell carcinoma,0
8658,World Health Organization,Malignant Neoplasm with Regional Lymph Node Involvement,0
8659,Normal hemostatic function,Benign Carotid Body Paraganglioma,0
8660,Life Threatening,Cartilaginous exostosis,0
8661,Myeloid,FIGO Stage II Ovarian Cancer,0
8662,Pelvic pain female,Hodgkin lymphoma,0
8663,>5,Stage IV Childhood Non-Hodgkin Lymphoma,0
8664,NBL1 gene,Lung squamous cell carcinoma stage I,0
8665,Skin,Diffuse malignant mesothelioma,0
8666,Affect (mental function),Malignant neoplasm of choroid,0
8667,Act Mood - intent,Stage II Fallopian Tube Cancer,0
8668,Volume,Benign tumor of eyelid,0
8669,Facial swelling (finding),Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
8670,year,Neonatal leukemia,0
8671,Liver,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8672,Tryptophanase,Spermatocytic seminoma,0
8673,Histopathologic Grade differentiation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8674,Monitoring - action,Malignant melanoma of eyelid,0
8675,MUTYH gene,Blepharal carcinoma,0
8676,Entity Determiner - specific,Ampulla of Vater Tubular Adenoma,0
8677,Chemotherapy Regimen,benign mature teratoma of pancreas,0
8678,200,Localized Ewing Sarcoma,0
8679,Tumor Mass,Cartilaginous exostosis,0
8680,Americas Ethnicity,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8681,Occur (action),FIGO Stage II Ovarian Cancer,0
8682,Upper arm,Metastatic Ductal Breast Carcinoma,0
8683,Histopathology,Extracranial Neuroblastoma,0
8684,Manufactured form,Colorectal High Grade B-Cell Lymphoma,0
8685,Reported Term,Cartilaginous exostosis,0
8686,Used by,High Grade Glandular Intraepithelial Neoplasia,0
8687,Surface,Adenocarcinoma,0
8688,Bothered by Vomiting,Rhabdomyosarcoma with ganglionic differentiation,0
8689,Extraction,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8690,radiotherapeutic,sarcoma of spinal cord,0
8691,Call (Instruction),Metastatic Ductal Breast Carcinoma,0
8692,Back Pain,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8693,member,Airway Hemangioma,0
8694,Case (situation),Rhabdomyosarcoma with ganglionic differentiation,0
8695,Certain (qualifier value),Recurrent Uveal Melanoma,0
8696,Areas <moth>,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
8697,Primary malignant neoplasm,FIGO Stage II Ovarian Cancer,0
8698,Physical findings,Acute Undifferentiated Leukemia,0
8699,Confirmed by,Secondary malignant neoplasm of lymph node,0
8700,Back structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8701,Cell Device,Metastatic Malignant Neoplasm in the Sellar Region,0
8702,cure of disease,Diffuse malignant mesothelioma,0
8703,Malignant neoplasm of pancreas,Spongiotic dermatitis,0
8704,Common (qualifier value),Xeroderma pigmentosum,0
8705,Estimated,Childhood Central Nervous System Immature Teratoma,0
8706,Aromatase deficiency,Localized Ewing Sarcoma,0
8707,Togo,Spongiotic dermatitis,0
8708,Frequently,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8709,Vision,Undifferentiated Endocervical Sarcoma,0
8710,Age-Years,Intracortical osteosarcoma,0
8711,Human Study Subject,Neonatal leukemia,0
8712,Numerous,Female Breast Carcinoma,0
8713,Adult,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8714,Mutation,Rhabdomyosarcoma with ganglionic differentiation,0
8715,Certain (qualifier value),Localized Askin Tumor,0
8716,Methods,Recurrent Uveal Melanoma,0
8717,Feel Tired question,Secondary malignant neoplasm of lymph node,0
8718,Chemotherapy,mucinous adenocarcinoma of gallbladder,0
8719,3+ Score,Lipoma of small intestine,0
8720,Communicable Diseases,Colorectal Neuroendocrine Tumor G2,0
8721,Increase,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8722,Referring,Human Papillomavirus-Related Carcinoma,0
8723,veterans alcoholism screening test (VAST),Breast Ductal Adenoma,0
8724,Contain (action),Liver Lymphangioma,0
8725,Helper-Inducer T-Lymphocyte,Grade 3a Malignant Neoplasm,0
8726,Science of Etiology,Undifferentiated Endocervical Sarcoma,0
8727,Swelling,Diffuse malignant mesothelioma,0
8728,Structure of isthmus of thyroid gland,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8729,Inferior esophageal sphincter structure,Hair nevus,0
8730,Worse,Mucinous adenocarcinoma gastric,0
8731,Abnormal Reference Range,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8732,Cerebral Cavernous Hemangioma,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8733,Childhood Non-Hodgkin Lymphoma,Childhood Cerebellar Neoplasm,0
8734,Mechanism Component of Device,Intraepithelial Melanocytic Hyperplasia,0
8735,Weight Loss,Localized Ewing Sarcoma,0
8736,prior radiation therapy,Advanced Lung Carcinoma,0
8737,95,Rhabdomyosarcoma with ganglionic differentiation,0
8738,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Larynx carcinoma recurrent,0
8739,Life Expectancy Less than Five Years,Ovarian germ cell choriocarcinoma stage IV,0
8740,Type - attribute,Xeroderma pigmentosum,0
8741,Control function,Bladder squamous cell carcinoma stage I,0
8742,Immunization,Acantholytic squamous cell carcinoma,0
8743,Australia,Thymic Clear Cell Carcinoma,0
8744,Neoplasms,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8745,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Malignant Testicular Sertoli Cell Tumor,0
8746,Vaginal Hemorrhage,Heavy Chain Deposition Disease,0
8747,Epstein-Barr Virus Early RNA,Cerebral Primitive Neuroectodermal Tumor,0
8748,Application Context,Adult Alveolar Soft Part Sarcoma,0
8749,Vaginal (intended site),Neonatal leukemia,0
8750,Ephrin Type-B Receptor 1,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8751,Lung,sarcoma of spinal cord,0
8752,common types,Liver Cavernous Hemangioma,0
8753,diagnosis aspect,Breast Ductal Adenoma,0
8754,Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
8755,diagnostic image,Malignant melanoma of eyelid,0
8756,Complete Trisomy 21 Syndrome,Uterine Cancer,0
8757,include - SetOperator,Acantholytic squamous cell carcinoma,0
8758,Orbit (brand of fungicide),Mucinous adenocarcinoma gastric,0
8759,Renal Cell Carcinoma,Granular Cell Leiomyosarcoma,0
8760,Gastrointestinal tract structure,Testicular cancer metastatic,0
8761,Then,FIGO Stage II Ovarian Cancer,0
8762,Nervous system structure,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8763,Physical findings,embryonal rhabdomyosarcoma of prostate,0
8764,Pelvis+,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8765,Fever symptoms (finding),Localized Ewing Sarcoma,0
8766,combination - answer to question,Neonatal leukemia,0
8767,Subtype (attribute),Non-Metastatic Gestational Trophoblastic Tumor,0
8768,insensitivity,Diffuse malignant mesothelioma,0
8769,Exposure to radiation,Mucinous adenocarcinoma gastric,0
8770,PSA Level Greater than Fifty,Ampulla of Vater Tubular Adenoma,0
8771,Basis - conceptual entity,Acantholytic squamous cell carcinoma,0
8772,Group A (qualifier value),Primary Cutaneous Plasmablastic Lymphoma,0
8773,Long-term Follow-up,Xeroderma pigmentosum,0
8774,Neoadjuvant Therapy,Mucinous neoplasm,0
8775,Wall of lymphatic vessel,Recurrent Uveal Melanoma,0
8776,Screening Study,Adenocarcinoma of the prostate metastatic,0
8777,Primary malignant neoplasm,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8778,Result,Recurrent Uveal Melanoma,0
8779,FAT1 wt Allele,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8780,Vertebral column,Neonatal leukemia,0
8781,risk factors - observation list,High Grade Glandular Intraepithelial Neoplasia,0
8782,/40,Thymic Clear Cell Carcinoma,0
8783,Intention - mental process,Ovarian Carcinoid Tumor,0
8784,incidence of cases,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8785,To,Anaplastic large cell lymphoma,0
8786,Left sided,Intraepithelial Melanocytic Hyperplasia,0
8787,Diabetes Mellitus,Breast Ductal Adenoma,0
8788,Anterior mediastinum,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8789,Advanced phase,Contact dermatitis due to alkali,0
8790,Reduced,embryonal rhabdomyosarcoma of prostate,0
8791,Treatment Epoch,embryonal rhabdomyosarcoma of prostate,0
8792,Neoplasm Metastasis,Breast Ductal Adenoma,0
8793,Chest Pain,Localized Ewing Sarcoma,0
8794,Population Median,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8795,Degree or extent,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8796,Type - attribute,Anaplastic large cell lymphoma,0
8797,risk factors,Anterior Urethral Malignant Neoplasm,0
8798,Chemotherapy Regimen,Benign Apocrine Neoplasm,0
8799,Interventional procedure,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8800,Rating (action),Clonal Hematopoiesis of Indeterminate Potential,0
8801,95,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8802,Different,Germinoma,0
8803,Negation,Digestive System Hodgkin Lymphoma,0
8804,Biological Response Modifier Therapy,Uterine Cancer,0
8805,Adult Lymphoma,Acantholytic squamous cell carcinoma,0
8806,Tooth Wear,Female Breast Carcinoma,0
8807,NCI CTEP SDC Astrocytoma,Mucinous cystadenofibroma,0
8808,Often - answer to question,Cerebral hemangioma,0
8809,Smear test,Stage IV Penile Cancer AJCC v7,0
8810,Anterior mediastinum,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8811,Pigment cell,Noninfiltrating Intraductal Carcinoma,0
8812,Make - Instruction Imperative,Benign Carotid Body Paraganglioma,0
8813,Continuance of life,Undifferentiated Endocervical Sarcoma,0
8814,Structure of great blood vessel (organ),Anterior Urethral Malignant Neoplasm,0
8815,winter,Malignant Testicular Sertoli Cell Tumor,0
8816,Leads (device),Grade 1 Clear Cell Renal Cell Carcinoma,0
8817,color additive,Low Grade Squamous Intraepithelial Neoplasia,0
8818,European Medicines Agency,Atypical Lobular Breast Hyperplasia,0
8819,Pancreatic Hormones,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8820,Frequently,Malignant Neoplasm with Regional Lymph Node Involvement,0
8821,Control function,Liver Cavernous Hemangioma,0
8822,Togo,Benign Apocrine Neoplasm,0
8823,Gastrointestinal tract structure,Female Breast Carcinoma,0
8824,Structure of primordial sex cell,GIANT PIGMENTED HAIRY NEVUS,0
8825,Not Otherwise Specified,Metastatic Ductal Breast Carcinoma,0
8826,Ingestible alcohol,Hemangioma,0
8827,Five,Cerebral Primitive Neuroectodermal Tumor,0
8828,Decision,Undifferentiated Endocervical Sarcoma,0
8829,Anterior,Mastocytosis,0
8830,Longitudinal Studies,Childhood Lymphoma,0
8831,Naive Pregerminal Center B-Lymphocyte,Lipoma of small intestine,0
8832,Common (qualifier value),Digestive System Hodgkin Lymphoma,0
8833,Appearance,Metastatic Lung Small Cell Carcinoma,0
8834,Case (situation),Extra-Adrenal Paraganglioma,0
8835,Function (attribute),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8836,Description,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8837,Malignant neoplasm of skin,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8838,DNA Breaks,Unresectable Rhabdomyosarcoma,0
8839,Pancreas,Adult Alveolar Soft Part Sarcoma,0
8840,Treating,Liver Lymphangioma,0
8841,Placenta Specimen,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8842,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8843,Fraction of,Liver Cavernous Hemangioma,0
8844,Confirmation,adenoid cystic carcinoma of lung,0
8845,2+,Intraepithelial Melanocytic Hyperplasia,0
8846,biomedical tube device,Metastatic Malignant Neoplasm in the Sellar Region,0
8847,Response to treatment,Recurrent Uveal Melanoma,0
8848,therapeutic aspects,embryonal rhabdomyosarcoma of prostate,0
8849,Common (qualifier value),Stage III Adult Immunoblastic Lymphoma,0
8850,Stomach,Low Grade Squamous Intraepithelial Neoplasia,0
8851,include - SetOperator,Pancreatic Intraepithelial Neoplasia-3,0
8852,First (number),gliosarcoma,0
8853,Early,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8854,Affecting,Undifferentiated Endocervical Sarcoma,0
8855,How Often Weight Loss,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8856,consider,Endometrial Small Cell Carcinoma,0
8857,Type - attribute,Carcinoma of urinary bladder,0
8858,Body part,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8859,Often - answer to question,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8860,One,Localized Ewing Sarcoma,0
8861,Neoadjuvant Therapy,Thymic Clear Cell Carcinoma,0
8862,Blood Vessel,Unresectable Rhabdomyosarcoma,0
8863,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8864,Back structure,Secondary malignant neoplasm of lymph node,0
8865,In Urine,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8866,Type - attribute,Extra-Adrenal Paraganglioma,0
8867,Support,Medulloblastoma,0
8868,Primary malignant neoplasm,Serous cystadenocarcinoma ovary,0
8869,Bothered by Vomiting,Cerebral Primitive Neuroectodermal Tumor,0
8870,Diffuse Large B-Cell Lymphoma,Low Grade Squamous Intraepithelial Neoplasia,0
8871,Definition,Intestinal Metaplasia of Bladder Urothelium,0
8872,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8873,Progress,Chronic Myelomonocytic Leukemia-2,0
8874,Face,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
8875,Most Recent,FIGO Stage II Ovarian Cancer,0
8876,Include (action),Adult Hepatocellular Carcinoma,0
8877,Occur (action),Spongiotic dermatitis,0
8878,3+ Score,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8879,Natural,Adult Alveolar Soft Part Sarcoma,0
8880,Common Specifications in HL7 V3 Publishing,Thymoma malignant recurrent,0
8881,Unusual,Unfavorable Non-Hodgkin Lymphoma,0
8882,Malignant - descriptor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8883,Risk,Breast Ductal Adenoma,0
8884,Mechanism Component of Device,Mixed parotid tumor,0
8885,Experimental Result,Benign tumor of eyelid,0
8886,Protein complex,Acantholytic squamous cell carcinoma,0
8887,Remetinostat,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8888,Exposure to,Contact dermatitis due to alkali,0
8889,Life Threatening or Disabling Adverse Event,adenosquamous carcinoma of breast,0
8890,A Codes,Contact dermatitis due to alkali,0
8891,Malignant Neoplasms,Undifferentiated Endocervical Sarcoma,0
8892,Gram per Deciliter,Stage IB Lung Cancer AJCC v7,0
8893,Therapeutic procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8894,Specimen Source Codes - tumor,adenoid cystic carcinoma of lung,0
8895,Nicotiana tabacum,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8896,Smear - instruction imperative,Diffuse malignant mesothelioma,0
8897,shared attribute,GIANT PIGMENTED HAIRY NEVUS,0
8898,Lymphatic vessel,Undifferentiated Endocervical Sarcoma,0
8899,Trauma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8900,Metastasis,Childhood Fibrillary Astrocytoma,0
8901,THM gene,Stage IB Pancreatic Cancer AJCC v8,0
8902,Aggressive behavior,gliosarcoma,0
8903,Type - attribute,Granular Cell Leiomyosarcoma,0
8904,Food allergenic extracts,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8905,Important,Malignant neoplasm of choroid,0
8906,Cicatrix,Mucinous adenocarcinoma gastric,0
8907,Shoulder,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8908,Disseminated Malignant Neoplasm,Digestive System Hodgkin Lymphoma,0
8909,Primary malignant neoplasm,Localized Askin Tumor,0
8910,Squamous cell carcinoma - category,Thymic Clear Cell Carcinoma,0
8911,Cure (remedy),Localized Askin Tumor,0
8912,Male population group,embryonal rhabdomyosarcoma of prostate,0
8913,Diagnosis,Lipoma of small intestine,0
8914,Organ,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8915,Choose (action),Non-Metastatic Gestational Trophoblastic Tumor,0
8916,Carcinoma,Locally Advanced Soft Tissue Sarcoma,0
8917,Damage,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8918,Form:Finding:Point in time:{Setting}:Document:{Role},Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8919,research subject screening,Undifferentiated Endocervical Sarcoma,0
8920,Lock Device,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8921,Assisted (qualifier value),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
8922,Life Expectancy Less than Ten Years,sarcoma of spinal cord,0
8923,Possible,Diffuse malignant mesothelioma,0
8924,To,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8925,per year,Pancreatic Intraepithelial Neoplasia-3,0
8926,Night sweats,Ovarian germ cell choriocarcinoma stage IV,0
8927,Large,Malignant Neoplasm with Regional Lymph Node Involvement,0
8928,LATS1 wt Allele,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8929,Common Specifications in HL7 V3 Publishing,Benign Carotid Body Paraganglioma,0
8930,Epithelial cell count (procedure),Human Papillomavirus-Related Carcinoma,0
8931,Adult Diffuse Large B-Cell Lymphoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8932,PSA Level Less than Two,Stage IV Penile Cancer AJCC v7,0
8933,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Testicular Lymphoma,0
8934,Immunotherapy,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8935,United States,Intraepithelial Melanocytic Hyperplasia,0
8936,Neoplasms,Acute lymphadenitis,0
8937,Mathematical Factor,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8938,Manufactured sign,Acantholytic squamous cell carcinoma,0
8939,Linear,Liver Lymphangioma,0
8940,Neoplasm Metastasis,Benign neoplasm of thorax,0
8941,Neuron spine,Acute Undifferentiated Leukemia,0
8942,Carcinoma,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8943,Chronic inflammation,Mucinous adenocarcinoma gastric,0
8944,Connect,Heavy Chain Deposition Disease,0
8945,Health,Liver Cavernous Hemangioma,0
8946,Subject Risk,Pancreatic Intraepithelial Neoplasia-3,0
8947,Primary,Primary Cutaneous Plasmablastic Lymphoma,0
8948,Type - attribute,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8949,Old,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8950,Sufficiently defined concept definition status (core metadata concept),Intraepithelial Melanocytic Hyperplasia,0
8951,Epithelium of vagina,Malignant Neoplasm with Regional Lymph Node Involvement,0
8952,Medical Device Emits Smoke,High Grade Glandular Intraepithelial Neoplasia,0
8953,Pharyngitis,Lipoma of small intestine,0
8954,Offspring,Testicular cancer metastatic,0
8955,Mediate,Recurrent Uveal Melanoma,0
8956,Negation,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
8957,Family member,Undifferentiated Endocervical Sarcoma,0
8958,Views survey,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8959,leukemia,Recurrent Uveal Melanoma,0
8960,Neither Satisfied nor Dissatisfied,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8961,isolation aspects,Chondrosarcoma,0
8962,Body part,Mastocytosis,0
8963,Pediculus (eukaryote),Rhabdomyosarcoma with ganglionic differentiation,0
8964,seen,Advanced Uterine Corpus Carcinosarcoma,0
8965,Malignant neoplasm of thymus,Childhood Lymphoma,0
8966,Biogenic Amines,Recurrent Testicular Lymphoma,0
8967,Part Dosing Unit,Refractory Barrett Esophagus,0
8968,presently,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8969,Cure (remedy),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8970,Negation,Benign tumor of eyelid,0
8971,Known,Liver Lymphangioma,0
8972,Specimen Source Codes - Tube,Cerebral Primitive Neuroectodermal Tumor,0
8973,Condition,Undifferentiated Endocervical Sarcoma,0
8974,Malignant Neoplasms,Adult Brain Stem Mixed Glioma,0
8975,Woman,Stage IB Pancreatic Cancer AJCC v8,0
8976,Ovary,Breast Ductal Adenoma,0
8977,Surface of bone,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8978,No Application Type,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8979,Age,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8980,Common (qualifier value),Granular Cell Leiomyosarcoma,0
8981,Image Feature,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8982,allowing,Primary Cutaneous Plasmablastic Lymphoma,0
8983,Continuance of life,Ichthyosis,0
8984,Central,Small cell neuroendocrine carcinoma of bladder,0
8985,pharmacotherapeutic,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8986,Palate,Ampulla of Vater Tubular Adenoma,0
8987,Invasive Ductal Breast Carcinoma,Diffuse malignant mesothelioma,0
8988,Result,Collecting Duct Carcinoma of the Kidney,0
8989,70%,Neonatal leukemia,0
8990,Metastasis,Diffuse malignant mesothelioma,0
8991,Young Adult,Heavy Chain Deposition Disease,0
8992,Disease,Bladder squamous cell carcinoma stage I,0
8993,Bacteria,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8994,Primary lymphoid organ,Acute Undifferentiated Leukemia,0
8995,Over (spatial),FIGO Stage II Ovarian Cancer,0
8996,Small,Endometrial Small Cell Carcinoma,0
8997,Blue - answer to question,Low Grade Squamous Intraepithelial Neoplasia,0
8998,Negation,squamous cell carcinoma of the thyroid gland,0
8999,Singular,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9000,Malignant neoplasm of ovary,Carcinoma of urinary bladder,0
9001,Edema,papillary carcinoma of penis,0
9002,Birth defects diagnosis:Find:Pt:^Patient:Nar,Stage IB Lung Cancer AJCC v7,0
9003,Sore to touch,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9004,Tumor Mass,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9005,Estimated,Undifferentiated Endocervical Sarcoma,0
9006,Leading,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9007,Major <insect>,embryonal rhabdomyosarcoma of prostate,0
9008,Body structure,Stage IB Lung Cancer AJCC v7,0
9009,Raised,Cerebral hemangioma,0
9010,Increase,Methotrexate-Associated Hodgkin Lymphoma,0
9011,Administration procedure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9012,Females,FIGO Stage II Ovarian Cancer,0
9013,Precision - temporal,Tonsillar Carcinoma,0
9014,Adult,Human Papillomavirus-Related Carcinoma,0
9015,Primary malignant neoplasm,Clonal Hematopoiesis of Indeterminate Potential,0
9016,Chemotherapy Regimen,Childhood Lymphoma,0
9017,white blood cell type,Metastatic Kidney Carcinoma,0
9018,majority,embryonal rhabdomyosarcoma of prostate,0
9019,Malignant Neoplasms,Recurrent Uveal Melanoma,0
9020,white blood cell type,Medulloblastoma,0
9021,Estrogens,Stage IV Penile Cancer AJCC v7,0
9022,Survival Rate,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9023,pharmacotherapeutic,Bladder squamous cell carcinoma stage I,0
9024,Carcinoma,Acute Undifferentiated Leukemia,0
9025,Critical,Pancreatic Intraepithelial Neoplasia-3,0
9026,Malignant neoplasm of brain,Cancer of Urinary Tract,0
9027,Percent Activity,Germinoma,0
9028,Neck,Testicular cancer metastatic,0
9029,AMINO ACIDS/PROTEINS,Colorectal Neuroendocrine Tumor G2,0
9030,Involvement with,Cerebral Primitive Neuroectodermal Tumor,0
9031,Genetic syndrome,adenosquamous carcinoma of breast,0
9032,Cell secretion,Cerebral Primitive Neuroectodermal Tumor,0
9033,Manufactured form,Extracranial Neuroblastoma,0
9034,Cancer Genus,Recurrent Uveal Melanoma,0
9035,Bounded by,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9036,Malignant Neoplasms,Metastatic Lung Small Cell Carcinoma,0
9037,To,Recurrent Uveal Melanoma,0
9038,Upper urinary tract structure,benign mature teratoma of pancreas,0
9039,Include (action),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9040,year,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9041,40%,Testicular cancer metastatic,0
9042,Operative Surgical Procedures,Recurrent Testicular Lymphoma,0
9043,NCI CTEP SDC Melanoma Sub-Category Terminology,Cancer of Urinary Tract,0
9044,Pure Spanish horse breed (organism),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9045,Usual,Intraepithelial Melanocytic Hyperplasia,0
9046,Often - answer to question,Xeroderma pigmentosum,0
9047,Examined,Malignant Neoplasm with Regional Lymph Node Involvement,0
9048,Well Differentiated,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9049,Cancer Genus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9050,Lymphocyte component of blood,Malignant Testicular Sertoli Cell Tumor,0
9051,Tired,Locally Advanced Soft Tissue Sarcoma,0
9052,Term (lexical),Placental aromatase deficiency,0
9053,Extension,Stage IB Pancreatic Cancer AJCC v8,0
9054,Benign,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9055,Mutation Abnormality,Human Papillomavirus-Related Carcinoma,0
9056,Statistical mean,Endometrial Small Cell Carcinoma,0
9057,Manufactured form,Non-Metastatic Gestational Trophoblastic Tumor,0
9058,Biopsy,Malignant Testicular Sertoli Cell Tumor,0
9059,Five,embryonal rhabdomyosarcoma of prostate,0
9060,Occurrence,Malignant melanoma of eyelid,0
9061,Age of Onset,Stage III Adult Immunoblastic Lymphoma,0
9062,Surgical aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9063,Occurrence,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9064,Lymphadenopathy,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9065,NCI CTEP SDC Penile Cancer Sub-Category Terminology,Mucinous adenocarcinoma gastric,0
9066,Destruction (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
9067,Cells,Unfavorable Non-Hodgkin Lymphoma,0
9068,Fluid overload,benign mature teratoma of pancreas,0
9069,Relationships,Undifferentiated Endocervical Sarcoma,0
9070,Aggressive behavior,Larynx carcinoma recurrent,0
9071,pharmacotherapeutic,Diffuse malignant mesothelioma,0
9072,Comparison,Carcinoma of urinary bladder,0
9073,Retinoic Acid Response Element,Testicular cancer metastatic,0
9074,Cancer Genus,non-Hodgkin's lymphoma of spleen,0
9075,Progress,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9076,Stop (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9077,Precision - second,Cartilaginous exostosis,0
9078,Proteins,Intestinal Metaplasia of Bladder Urothelium,0
9079,CEL gene,Malignant melanoma of eyelid,0
9080,therapeutic aspects,embryonal rhabdomyosarcoma of prostate,0
9081,Data (eukaryote),Malignant melanoma of eyelid,0
9082,Including (qualifier),Endometrial Small Cell Carcinoma,0
9083,History,Adult Alveolar Soft Part Sarcoma,0
9084,Logical Condition,Bladder squamous cell carcinoma stage I,0
9085,Cancer Genus,Malignant Testicular Sertoli Cell Tumor,0
9086,Urinary Bladder,Cerebral Primitive Neuroectodermal Tumor,0
9087,Benign melanocytic nevus,Chronic Myelomonocytic Leukemia-2,0
9088,Hemorrhage,Breast Ductal Adenoma,0
9089,AS virus,Recurrent Diffuse Intrinsic Pontine Glioma,0
9090,Linear,Acute Undifferentiated Leukemia,0
9091,Presentation,Thymic Clear Cell Carcinoma,0
9092,Infection,Refractory Barrett Esophagus,0
9093,Pain,Thymic Clear Cell Carcinoma,0
9094,Subgroup,Angiosarcoma of liver,0
9095,Basis - conceptual entity,Bladder squamous cell carcinoma stage I,0
9096,Surgery specialty,papillary carcinoma of penis,0
9097,60%,Acute Undifferentiated Leukemia,0
9098,Unknown,benign mature teratoma of pancreas,0
9099,Presentation,Xeroderma pigmentosum,0
9100,Cancer Genus,Stage 0 Penile Cancer AJCC v8,0
9101,Skin,Malignant Testicular Sertoli Cell Tumor,0
9102,*Type - Kind of quantity,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9103,Human papillomavirus types,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9104,Together,Childhood Cerebellar Neoplasm,0
9105,United States Military Commissioned Officer O4,Anaplastic large cell lymphoma,0
9106,Tentorium cerebelli,Acantholytic squamous cell carcinoma,0
9107,Patient observation,Colorectal High Grade B-Cell Lymphoma,0
9108,Certainties,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9109,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Neonatal leukemia,0
9110,Average,ALK positive large B-cell lymphoma,0
9111,Malignant neoplasm of skin,Intraepithelial Melanocytic Hyperplasia,0
9112,AS virus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9113,Lumen,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9114,Thymic Tissue,Digestive System Hodgkin Lymphoma,0
9115,Common Specifications in HL7 V3 Publishing,Xeroderma pigmentosum,0
9116,Worsening pattern,Tonsillar Carcinoma,0
9117,Group A (blood group),Malignant melanoma of eyelid,0
9118,Smooth muscle (tissue),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9119,artesunate,Endometrial Small Cell Carcinoma,0
9120,Skin symptom,Noninfiltrating Intraductal Carcinoma,0
9121,Several,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9122,Togo,Adrenal Rest Tumor,0
9123,Include (action),Localized Ewing Sarcoma,0
9124,Homo sapiens,Cancer of Urinary Tract,0
9125,Infrequent,Cerebral Primitive Neuroectodermal Tumor,0
9126,Skeletal bone,Stage 0 Lip Carcinoma,0
9127,Anterior portion of neck,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9128,Point,Diffuse malignant mesothelioma,0
9129,To,Acantholytic squamous cell carcinoma,0
9130,foreign,Intracortical osteosarcoma,0
9131,Elements,Non-Metastatic Gestational Trophoblastic Tumor,0
9132,Progress,Intraepithelial Melanocytic Hyperplasia,0
9133,Survival Rate,Mucinous adenocarcinoma gastric,0
9134,Human body,Giant cell angiofibroma,0
9135,Formation,Lung Mucinous Cystadenoma,0
9136,Sometimes,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9137,Elbow joint structure,Liver Lymphangioma,0
9138,Occur (action),non-Hodgkin's lymphoma of spleen,0
9139,Completely Able,Cancer of Urinary Tract,0
9140,United States,Localized Askin Tumor,0
9141,How Much Distress Itching,High Grade Glandular Intraepithelial Neoplasia,0
9142,Experimental Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9143,Occur (action),Benign neoplasm of thorax,0
9144,Pathogenic,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9145,Renal Cell Carcinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9146,Etiology aspects,Ovarian germ cell choriocarcinoma stage IV,0
9147,BRCA2 protein,Stage IV Penile Cancer AJCC v7,0
9148,Common (qualifier value),Unresectable Rhabdomyosarcoma,0
9149,Tryptophanase,Localized Askin Tumor,0
9150,Common (qualifier value),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9151,Cerebellum,Liver Lymphangioma,0
9152,Weight Loss,Recurrent Uveal Melanoma,0
9153,Rare Diseases,Cerebral Primitive Neuroectodermal Tumor,0
9154,Data Compression,Human Papillomavirus-Related Carcinoma,0
9155,Fasting,Childhood Choriocarcinoma,0
9156,Present,Medulloblastoma,0
9157,Beginning,Acantholytic squamous cell carcinoma,0
9158,Chemotherapy Regimen,Liver Cavernous Hemangioma,0
9159,Pain,Refractory Barrett Esophagus,0
9160,Fibrosis Assessment,Liver Lymphangioma,0
9161,newly,Undifferentiated Neuroblastoma,0
9162,Linear,Adenocarcinoma,0
9163,Circumscribe (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9164,Disease,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9165,Tryptophanase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9166,Code System Type - Internal,Stage III Adult Immunoblastic Lymphoma,0
9167,Malignant Neoplasms,Cerebral Primitive Neuroectodermal Tumor,0
9168,Adult,Bladder squamous cell carcinoma stage I,0
9169,Vomiting,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9170,Science of Etiology,High Grade Glandular Intraepithelial Neoplasia,0
9171,lymph nodes,Liver Lymphangioma,0
9172,other medicated shampoos in ATC,Recurrent Uveal Melanoma,0
9173,Malignant Neoplasms,Neoplasms,0
9174,In Blood,Hemangioma,0
9175,Endometrial Carcinoma,Lipoma of small intestine,0
9176,Symptoms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9177,Known,Metastatic Malignant Neoplasm in the Sellar Region,0
9178,High Level,embryonal rhabdomyosarcoma of prostate,0
9179,Cells,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9180,Long-term,embryonal rhabdomyosarcoma of prostate,0
9181,Stem cells,Intracortical osteosarcoma,0
9182,Cessation of life,Unfavorable Non-Hodgkin Lymphoma,0
9183,Vision,Cancer of Urinary Tract,0
9184,Case (situation),Botryoid-Type Embryonal Rhabdomyosarcoma,0
9185,Most,Metastatic Neoplasm to the Gallbladder,0
9186,second (number),Metastatic Ductal Breast Carcinoma,0
9187,Human Age Group,Malignant melanoma of eyelid,0
9188,Occurrence,Giant cell angiofibroma,0
9189,Neoplasms,Thymic Clear Cell Carcinoma,0
9190,Stem of Organ,Medulloblastoma,0
9191,High Level,Acute Undifferentiated Leukemia,0
9192,Person Name,Pilocytic astrocytoma of cerebellum,0
9193,Loss,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9194,Intervention regimes,Mastocytosis,0
9195,risk factors - observation list,Anterior Urethral Malignant Neoplasm,0
9196,Hepatobiliary System,Mucinous neoplasm,0
9197,Malignant Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
9198,Fever,Mucinous adenocarcinoma gastric,0
9199,Talpidae,Chronic Myelomonocytic Leukemia-2,0
9200,Neoplasms,Ovarian Carcinoid Tumor,0
9201,Vision,BRCA2 Syndrome,0
9202,Current (present time),Choroid Necrotic Melanoma,0
9203,include - SetOperator,Acantholytic squamous cell carcinoma,0
9204,Skin Specimen,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9205,Options,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9206,Aspects of disease screening,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9207,Cell Count,Metastatic Kidney Carcinoma,0
9208,Both ovaries,Pancreatic Intraepithelial Neoplasia-3,0
9209,Lymphoma,Thymic Atypical Carcinoid Tumor,0
9210,sex,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9211,Qualitative form,Grade 3a Malignant Neoplasm,0
9212,Late,BRCA2 Syndrome,0
9213,Human papilloma virus infection,Thymoma malignant recurrent,0
9214,NCI CTEP SDC Mesothelioma Sub-Category Terminology,Malignant Testicular Sertoli Cell Tumor,0
9215,Shortness of breath:-:Point in time:^Patient:-,Granular Cell Leiomyosarcoma,0
9216,Diabetes Mellitus,Platinum-Resistant Lung Small Cell Carcinoma,0
9217,Lesion,Grade 3a Malignant Neoplasm,0
9218,Count of entities,Choroid Necrotic Melanoma,0
9219,analysis aspect,Digestive System Hodgkin Lymphoma,0
9220,Specimen Source Codes - Macrophages,Mastocytosis,0
9221,New,Stage IV Childhood Non-Hodgkin Lymphoma,0
9222,Colon <insect>,Acute Undifferentiated Leukemia,0
9223,<90,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9224,Tumor Mass,Metastatic Kidney Carcinoma,0
9225,Death (finding),Carcinoma ex pleomorphic adenoma of parotid gland,0
9226,Phimosis,Stage IB Lung Cancer AJCC v7,0
9227,Resolution,Bladder squamous cell carcinoma stage I,0
9228,Lower - spatial qualifier,Malignant melanoma of eyelid,0
9229,Family (taxonomic),Urethral Carcinoma,0
9230,Lung,Grade 1 Clear Cell Renal Cell Carcinoma,0
9231,Etiology,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
9232,Clinical Item,Human Papillomavirus-Related Carcinoma,0
9233,Sounding,Werner Syndrome,0
9234,Africa,Stage IB Pancreatic Cancer AJCC v8,0
9235,Sharing (Social Behavior),Stage I Adult Non-Hodgkin Lymphoma,0
9236,Sequence Arm,Endometrial Small Cell Carcinoma,0
9237,Stem of plant,Colorectal High Grade B-Cell Lymphoma,0
9238,Object Attribute,Rhabdomyosarcoma with ganglionic differentiation,0
9239,Treating,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9240,Call (Instruction),Digestive System Hodgkin Lymphoma,0
9241,Limb structure,Methotrexate-Associated Hodgkin Lymphoma,0
9242,90%,Choroid Necrotic Melanoma,0
9243,Inguinal part of abdomen,Benign Apocrine Neoplasm,0
9244,Occur (action),FIGO Stage II Ovarian Cancer,0
9245,Cervical Intraepithelial Neoplasia,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9246,alone - group size,Angiosarcoma of liver,0
9247,Young,Refractory Barrett Esophagus,0
9248,Genetic Markers,Diffuse malignant mesothelioma,0
9249,Segmental Mastectomy,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
9250,Have Weight Loss,Intestinal Metaplasia of Bladder Urothelium,0
9251,Condylomata Acuminata,Intestinal Metaplasia of Bladder Urothelium,0
9252,To,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9253,Identifier,Primary Cutaneous Plasmablastic Lymphoma,0
9254,consider,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9255,Study,Intraepithelial Melanocytic Hyperplasia,0
9256,Science of Etiology,Diffuse malignant mesothelioma,0
9257,therapeutic aspects,Placental aromatase deficiency,0
9258,Woolly hair nevus,Mastocytosis,0
9259,photoreactivating enzyme activity,Granular Cell Leiomyosarcoma,0
9260,Death (finding),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9261,Back Pain,Mucinous cystadenofibroma,0
9262,Targeted Therapy,Digestive System Hodgkin Lymphoma,0
9263,History of previous events,Localized Ewing Sarcoma,0
9264,shared attribute,Adenocarcinoma of the prostate metastatic,0
9265,Device system,Human Papillomavirus-Related Carcinoma,0
9266,IPSS Risk Category High,Stage IB Lung Cancer AJCC v7,0
9267,Hidrocystoma,Human Papillomavirus-Related Carcinoma,0
9268,Human body structure,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9269,Imaging Techniques,Localized Ewing Sarcoma,0
9270,Age-Years,Xeroderma pigmentosum,0
9271,Beginning,Familial Hemophagocytic Lymphocytosis,0
9272,Painless,non-Hodgkin's lymphoma of spleen,0
9273,Operative Surgical Procedures,Non-Metastatic Gestational Trophoblastic Tumor,0
9274,Benign Neoplasm,Thymic Clear Cell Carcinoma,0
9275,Unknown GENC,Metastatic Neoplasm to the Gallbladder,0
9276,Primary operation,Adrenal Rest Tumor,0
9277,Form:Finding:Point in time:{Setting}:Document:{Role},Cartilaginous exostosis,0
9278,7.2,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9279,Medical History,Malignant melanoma of eyelid,0
9280,bacteria aspects,Recurrent Testicular Lymphoma,0
9281,Histology Procedure,Acute Undifferentiated Leukemia,0
9282,Reported,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9283,Case (situation),Undifferentiated Neuroblastoma,0
9284,status - In progress,Childhood Fibrillary Astrocytoma,0
9285,Population Group,Adenocarcinoma,0
9286,Left,Refractory Barrett Esophagus,0
9287,Form:Finding:Point in time:{Setting}:Document:{Role},Liver Lymphangioma,0
9288,Precision - temporal,Adrenal Rest Tumor,0
9289,Urinary Bladder,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9290,Dominant,adenoid cystic carcinoma of lung,0
9291,pharmacotherapeutic,Adenocarcinoma,0
9292,Nictitating Membrane,Liver Lymphangioma,0
9293,Along edge (qualifier value),Cartilaginous exostosis,0
9294,To,Intestinal Neuroendocrine Carcinoma,0
9295,Present,Neonatal leukemia,0
9296,More,Recurrent Uveal Melanoma,0
9297,Moist,Malignant melanoma of eyelid,0
9298,Primary malignant neoplasm,Cerebral hemangioma,0
9299,Biomaterial Treatment,FIGO Stage II Ovarian Cancer,0
9300,Wound Healing,Intraepithelial Melanocytic Hyperplasia,0
9301,Interventional procedure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9302,Gland,Lipoma of small intestine,0
9303,Three,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9304,Growth action,FIGO Stage II Ovarian Cancer,0
9305,Palatine Tonsil,Methotrexate-Associated Hodgkin Lymphoma,0
9306,Including (qualifier),Lipoma of small intestine,0
9307,biopsy characteristics,Childhood Lymphoma,0
9308,Neoplasms,malignant lymphoma of pancreatic lymph nodes,0
9309,Internal,gliosarcoma,0
9310,Most,Ichthyoses,0
9311,Therapeutic procedure,BRCA2 Syndrome,0
9312,Complete Pharyngeal Contraction,Benign neoplasm of thorax,0
9313,Anabolism,Benign Carotid Body Paraganglioma,0
9314,Form:Finding:Point in time:{Setting}:Document:{Role},Low Grade Squamous Intraepithelial Neoplasia,0
9315,Taxonomic,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9316,Togo,Stage IB Lung Cancer AJCC v7,0
9317,NCI CTEP SDC Melanoma Sub-Category Terminology,Female Breast Carcinoma,0
9318,Diagnostic Imaging,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9319,Major <insect>,Unfavorable Non-Hodgkin Lymphoma,0
9320,Person Name,Stage 0 Penile Cancer AJCC v8,0
9321,year,Undifferentiated Endocervical Sarcoma,0
9322,60%,papillary carcinoma of penis,0
9323,Death (finding),Colorectal cancer,0
9324,Two,Low Grade Squamous Intraepithelial Neoplasia,0
9325,Percent (qualifier value),Atypical Mesothelial Hyperplasia,0
9326,Immune System Processes,Mastocytosis,0
9327,Used by,Acantholytic squamous cell carcinoma,0
9328,Initial (abbreviation),Acute Undifferentiated Leukemia,0
9329,Free (available (qualifier)),Placental aromatase deficiency,0
9330,Variant,Xeroderma pigmentosum,0
9331,As Much as Desired,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9332,Primary,Xeroderma pigmentosum,0
9333,Persons,Liver Lymphangioma,0
9334,Decision,Metastatic Neoplasm to the Gallbladder,0
9335,Salivary Glands,Low Grade Squamous Intraepithelial Neoplasia,0
9336,Human body,Methotrexate-Associated Hodgkin Lymphoma,0
9337,Country,Breast Ductal Adenoma,0
9338,Administration procedure,Metastatic Ductal Breast Carcinoma,0
9339,FAT1 wt Allele,Diffuse malignant mesothelioma,0
9340,Topical Corticosteroid Therapy,Malignant neoplasm of thalamus,0
9341,Cancer Genus,Small cell neuroendocrine carcinoma of bladder,0
9342,year,mucinous adenocarcinoma of gallbladder,0
9343,International Aspects,Cancer of Urinary Tract,0
9344,Ovary,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9345,Image Feature,Cartilaginous exostosis,0
9346,Involvement with,Mucinous adenocarcinoma gastric,0
9347,Infrequent,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9348,MALIGNANT benign,Intraepithelial Melanocytic Hyperplasia,0
9349,Development,Intraepithelial Melanocytic Hyperplasia,0
9350,Including (qualifier),Stage 0 Lip Carcinoma,0
9351,Records,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9352,Magnetic Resonance Imaging,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9353,Contiguous gene syndrome,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9354,Trial Screening,Recurrent Uveal Melanoma,0
9355,Genes,Mucinous adenocarcinoma gastric,0
9356,Gait normal,Pilocytic astrocytoma of cerebellum,0
9357,Condition:Find:Pt:^Patient:Nom,Localized Ewing Sarcoma,0
9358,Entity Determiner - specific,Xeroderma pigmentosum,0
9359,Present,Giant cell angiofibroma,0
9360,Tissue Specimen Code,Uterine Cancer,0
9361,Aspartic Acid Measurement,Benign Carotid Body Paraganglioma,0
9362,Representation (action),Digestive System Hodgkin Lymphoma,0
9363,soft tissue,Digestive System Hodgkin Lymphoma,0
9364,Negation,Localized Ewing Sarcoma,0
9365,Primary,Intestinal Neuroendocrine Carcinoma,0
9366,Animals,Pancreatic Intraepithelial Neoplasia-3,0
9367,Collections (publication),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9368,Reduction (chemical),Malignant Testicular Sertoli Cell Tumor,0
9369,Person Name,Cartilaginous exostosis,0
9370,Personal appearance,Liver Lymphangioma,0
9371,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9372,Poles,Adult Hepatocellular Carcinoma,0
9373,Malignant - descriptor,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
9374,Have Been Coughing,benign mature teratoma of pancreas,0
9375,Dependent - ability,Diffuse malignant mesothelioma,0
9376,Renal Cell Carcinoma Pathway,Recurrent Testicular Lymphoma,0
9377,per year,Neonatal leukemia,0
9378,Changing,Advanced Uterine Corpus Carcinosarcoma,0
9379,Usually,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9380,shared attribute,Diffuse malignant mesothelioma,0
9381,Rhabdomyosarcoma,Placental aromatase deficiency,0
9382,Epithelial cell count (procedure),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9383,High grade (lymphoma grade) (finding),Carcinoma of urinary bladder,0
9384,Tryptophanase,Small cell neuroendocrine carcinoma of bladder,0
9385,Occurrence,Malignant Neoplasm with Regional Lymph Node Involvement,0
9386,Entire primordial sex cell,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9387,Skin pigmentation - finding,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9388,described,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9389,WHO tumor classification,Mixed parotid tumor,0
9390,Ability,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9391,NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9392,Taking of swab,Acantholytic squamous cell carcinoma,0
9393,Internal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9394,contextual factors,Adult Hepatocellular Carcinoma,0
9395,And/Or,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9396,High Level,Acantholytic squamous cell carcinoma,0
9397,Accumulation,Cerebral Primitive Neuroectodermal Tumor,0
9398,Gastroenterologist,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9399,Symptoms aspect,Cancer of Urinary Tract,0
9400,structure,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
9401,Agreement,Diffuse malignant mesothelioma,0
9402,Medical Device Material Separation,Mucinous adenocarcinoma gastric,0
9403,Application Context,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9404,Predominate,Bladder squamous cell carcinoma stage I,0
9405,Most,mucinous adenocarcinoma of gallbladder,0
9406,Present,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9407,Base - General Qualifier,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9408,Body Site Modifier - Lower,FIGO Stage II Ovarian Cancer,0
9409,Specific qualifier value,embryonal rhabdomyosarcoma of prostate,0
9410,Patients,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9411,Normal,Cerebral Primitive Neuroectodermal Tumor,0
9412,Along edge (qualifier value),Malignant neoplasm of thalamus,0
9413,Malignant neoplasm of urinary bladder,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9414,Swelling,Adult Fibrolamellar Carcinoma,0
9415,Plain chest X-ray,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9416,Therapeutic procedure,Intracortical osteosarcoma,0
9417,Greater than one,Choroid Necrotic Melanoma,0
9418,Severe (severity modifier),Uterine Cancer,0
9419,Frequently,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9420,Adrenal Cortical Adenoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9421,Hematologic Tests,Liver Lymphangioma,0
9422,Liver,Blepharal carcinoma,0
9423,Manufactured form,Tonsillar Carcinoma,0
9424,Twice - dosing instruction fragment,Medulloblastoma,0
9425,biopsy characteristics,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9426,Negation,Xeroderma pigmentosum,0
9427,Plasma Product,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9428,Common Specifications in HL7 V3 Publishing,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9429,Result,Liver Cavernous Hemangioma,0
9430,Combined,Acantholytic squamous cell carcinoma,0
9431,Including (qualifier),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9432,various other nasal preparations in ATC,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9433,Glycation End Products,Stage I Adult Non-Hodgkin Lymphoma,0
9434,Treating,Mucinous cystadenofibroma,0
9435,Vegetables,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9436,Negation,Recurrent Testicular Lymphoma,0
9437,Vocal cord structure,Cancer of Urinary Tract,0
9438,Able (finding),Liver Lymphangioma,0
9439,Aim (idea),Cerebral hemangioma,0
9440,Cyclophosphamide,Acantholytic squamous cell carcinoma,0
9441,Sunscreening Agents,Low Grade Squamous Intraepithelial Neoplasia,0
9442,Death Related to Adverse Event,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9443,treatment - ActInformationManagementReason,Childhood Fibrillary Astrocytoma,0
9444,Treatment Epoch,Blepharal carcinoma,0
9445,shared attribute,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9446,Child,Breast Ductal Adenoma,0
9447,Usually Need Help from Another Person for Reach,Malignant Neoplasm with Regional Lymph Node Involvement,0
9448,Involvement with,FIGO Stage II Ovarian Cancer,0
9449,Negation,Adult Hepatocellular Carcinoma,0
9450,Tryptophanase,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9451,Nausea:Presence or Threshold:Point in time:^Patient:Ordinal,papillary carcinoma of penis,0
9452,Vitamin supplementation,Xeroderma pigmentosum,0
9453,Reported Term,Angiosarcoma of liver,0
9454,Chest wall structure,High Grade Glandular Intraepithelial Neoplasia,0
9455,Painful intercourse female,Chronic Myelomonocytic Leukemia-2,0
9456,Meningitis,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9457,CDISC SDTM Procedure Terminology,Metastatic Neoplasm to the Gallbladder,0
9458,Persons,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9459,Vasopressins,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9460,Abnormally high,Neonatal leukemia,0
9461,Change in voice (finding),Stage I Adult Non-Hodgkin Lymphoma,0
9462,Talc,Advanced Uterine Corpus Carcinosarcoma,0
9463,Case (situation),embryonal rhabdomyosarcoma of prostate,0
9464,Aspects of signs,Benign Carotid Body Paraganglioma,0
9465,Statistical Significance,Cancer of Urinary Tract,0
9466,Multiplicative Product,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9467,Primary malignant neoplasm,Atypical Lobular Breast Hyperplasia,0
9468,Following,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9469,Anterior portion of neck,Bladder squamous cell carcinoma stage I,0
9470,Cover - action,Unresectable Rhabdomyosarcoma,0
9471,Lymphatic,Heavy Chain Deposition Disease,0
9472,Various patch test substance,embryonal rhabdomyosarcoma of prostate,0
9473,Immunotherapy,Werner Syndrome,0
9474,Immunoproliferative Disorders,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9475,per day,Methotrexate-Associated Hodgkin Lymphoma,0
9476,Tissue of central nervous system,Adult Fibrolamellar Carcinoma,0
9477,Anatomic Site,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9478,Immature,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9479,Etiology,FIGO Stage II Ovarian Cancer,0
9480,What subject filter - Result,Cancer of Urinary Tract,0
9481,Common (qualifier value),Breast Ductal Adenoma,0
9482,Cervical Intraepithelial Neoplasia,Malignant Neoplasm with Regional Lymph Node Involvement,0
9483,Experimental Organism Basal Cell Carcinoma,Intracortical osteosarcoma,0
9484,Mass of body structure,Familial Hemophagocytic Lymphocytosis,0
9485,Sharing (Social Behavior),Stage IV Penile Cancer AJCC v7,0
9486,Relate - vinyl resin,Malignant melanoma of eyelid,0
9487,Tumor Mass,Refractory Barrett Esophagus,0
9488,Spreading (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9489,Specimen Source Codes - tumor,Stage II Carcinoma of Penis,0
9490,<90,Childhood Fibrillary Astrocytoma,0
9491,therapeutic aspects,Recurrent Testicular Lymphoma,0
9492,Occurrence Indicator,Malignant melanoma of eyelid,0
9493,CDISC SEND Tumor Findings Results Terminology,Clonal Hematopoiesis of Indeterminate Potential,0
9494,Neoplasms by Site,Adult Hepatocellular Carcinoma,0
9495,Shortened,Childhood Fibrillary Astrocytoma,0
9496,Liquid Tumor,Human Papillomavirus-Related Carcinoma,0
9497,therapeutic aspects,Malignant Testicular Sertoli Cell Tumor,0
9498,Classification of information,Acute Undifferentiated Leukemia,0
9499,Taste Perception,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9500,Providing presence (regime/therapy),Malignant melanoma of eyelid,0
9501,Mathematical Operator,Mucinous adenocarcinoma gastric,0
9502,Congenital MeSH qualifier,Carcinoma of urinary bladder,0
9503,Non-Small Cell Lung Carcinoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9504,Spreading (qualifier value),Non-Metastatic Gestational Trophoblastic Tumor,0
9505,Decision,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9506,Residential flat,Malignant Testicular Sertoli Cell Tumor,0
9507,Logical Condition,Diffuse malignant mesothelioma,0
9508,Pain Distress Question,Mucinous adenocarcinoma gastric,0
9509,Histopathologic Grade,Digestive System Hodgkin Lymphoma,0
9510,Evidence,Extracranial Neuroblastoma,0
9511,Human body structure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9512,Affecting,Digestive System Hodgkin Lymphoma,0
9513,Pain management,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9514,Pelvic Pain,Mucinous neoplasm,0
9515,One,Hemangioma,0
9516,How Much Distress Weight Loss,Endometrial Small Cell Carcinoma,0
9517,Subject Risk,Ovarian Carcinoid Tumor,0
9518,Place,High Grade Glandular Intraepithelial Neoplasia,0
9519,T-Lymphocytopenia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9520,Risk,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9521,Mutation,Acantholytic squamous cell carcinoma,0
9522,Both ovaries,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9523,Usual Severity Itching,Neonatal leukemia,0
9524,Tears - SpecimenType,Lipoma of small intestine,0
9525,Statistical Significance,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9526,aggressive cancer,FIGO Stage II Ovarian Cancer,0
9527,Excision,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9528,Curettage procedure,Intestinal Metaplasia of Bladder Urothelium,0
9529,Synonym (core metadata concept),FIGO Stage II Ovarian Cancer,0
9530,SLC6A2 wt Allele,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9531,Kind of quantity - Taste,Ovarian germ cell choriocarcinoma stage IV,0
9532,Imaging Techniques,sarcoma of spinal cord,0
9533,Possibly Related to Intervention,Unresectable Rhabdomyosarcoma,0
9534,Recurrent infections,Hodgkin lymphoma,0
9535,Hereditary,Xeroderma pigmentosum,0
9536,Shortened,Localized Askin Tumor,0
9537,Symptoms,High Grade Glandular Intraepithelial Neoplasia,0
9538,Sweat,High Grade Glandular Intraepithelial Neoplasia,0
9539,Administration procedure,Heavy Chain Deposition Disease,0
9540,Hollow shape,Recurrent Uveal Melanoma,0
9541,Approximate,Familial Hemophagocytic Lymphocytosis,0
9542,Occur (action),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9543,Aspects of signs,Digestive System Hodgkin Lymphoma,0
9544,Biologic Development,Maxillary Sinus Adenocarcinoma,0
9545,Carcinoid Tumor,Localized Askin Tumor,0
9546,per second,Choroid Necrotic Melanoma,0
9547,Age,Thymoma malignant recurrent,0
9548,Deglutition,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9549,Administration occupational activities,embryonal rhabdomyosarcoma of prostate,0
9550,Known,Malignant melanoma of eyelid,0
9551,Patient Outcome,Secondary malignant neoplasm of lymph node,0
9552,100%,Airway Hemangioma,0
9553,Laboratory Procedures,Angiosarcoma of liver,0
9554,Spreading (qualifier value),Blepharal carcinoma,0
9555,Smoking,Placental aromatase deficiency,0
9556,Structure of subclavian vein,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9557,Immature,Breast Ductal Adenoma,0
9558,Manufactured form,Noninfiltrating Intraductal Carcinoma,0
9559,Treatment intent,Recurrent Uveal Melanoma,0
9560,Childhood diseases,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9561,include - SetOperator,Blepharal carcinoma,0
9562,therapeutic aspects,embryonal rhabdomyosarcoma of prostate,0
9563,Occurrence,Adult Alveolar Soft Part Sarcoma,0
9564,Progress,Intestinal Neuroendocrine Carcinoma,0
9565,Shortness of Breath Visual Analogue Scale,Undifferentiated Endocervical Sarcoma,0
9566,physiological aspects,Acute Undifferentiated Leukemia,0
9567,Australia,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9568,Help document,Cartilaginous exostosis,0
9569,Progress,Malignant Testicular Sertoli Cell Tumor,0
9570,Symptoms,Unresectable Rhabdomyosarcoma,0
9571,Communicable Diseases,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9572,Similarity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9573,Position of phenotypic abnormality,non-Hodgkin's lymphoma of spleen,0
9574,Affecting,Female Breast Carcinoma,0
9575,IPSS Risk Category High,Spermatocytic seminoma,0
9576,Science of Statistics,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9577,Elbow,Small cell neuroendocrine carcinoma of bladder,0
9578,Treating,Unresectable Rhabdomyosarcoma,0
9579,cell type,Recurrent Diffuse Intrinsic Pontine Glioma,0
9580,Cystoscopy,Lipoma of small intestine,0
9581,Study Variable,Stage III Adult Immunoblastic Lymphoma,0
9582,combination of objects,Collecting Duct Carcinoma of the Kidney,0
9583,Top (position),Breast Ductal Adenoma,0
9584,Metastasis,adenoid cystic carcinoma of lung,0
9585,Stage,Adult Brain Stem Mixed Glioma,0
9586,Appearance,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9587,Links List,Adenocarcinoma,0
9588,International Classification of Disease,Acute Undifferentiated Leukemia,0
9589,Genitourinary organs,Mixed parotid tumor,0
9590,Occur (action),Acantholytic squamous cell carcinoma,0
9591,Neuroglia,Human Papillomavirus-Related Carcinoma,0
9592,NCI Thesaurus Qualifier,Intraepithelial Melanocytic Hyperplasia,0
9593,Persons,Refractory Barrett Esophagus,0
9594,PSA Level Less than Two,Ovarian germ cell choriocarcinoma stage IV,0
9595,Ovarian Carcinoma,Neoplasms,0
9596,Development,Spermatocytic seminoma,0
9597,Heart Failure,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
9598,Removed,Uterine Cancer,0
9599,Type A,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9600,include - SetOperator,Lung squamous cell carcinoma stage I,0
9601,68,Methotrexate-Associated Hodgkin Lymphoma,0
9602,Apply (administration method),Anterior Urethral Malignant Neoplasm,0
9603,high - ActExposureLevelCode,Metastatic Carcinoma in the Lung,0
9604,Individual,Liver Lymphangioma,0
9605,Cells,Familial Hemophagocytic Lymphocytosis,0
9606,Detected (finding),Recurrent Testicular Lymphoma,0
9607,Followed by,Pancreatic Intraepithelial Neoplasia-3,0
9608,MDFAttributeType - Fraction,Clonal Hematopoiesis of Indeterminate Potential,0
9609,Singular,Childhood Central Nervous System Immature Teratoma,0
9610,Including (qualifier),Acantholytic squamous cell carcinoma,0
9611,Only - dosing instruction fragment,Childhood Fibrillary Astrocytoma,0
9612,CDISC ADAS-Cog - Commands Summary Score,Werner Syndrome,0
9613,4+ Answer to question,Childhood Thyroid Gland Follicular Carcinoma,0
9614,Reduced,Acute Undifferentiated Leukemia,0
9615,Liquid Tumor,Malignant Testicular Sertoli Cell Tumor,0
9616,Administration procedure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9617,Accident due to exposure to weather conditions,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9618,Europe,Angiosarcoma of liver,0
9619,Means,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9620,Polymerization,Intraepithelial Melanocytic Hyperplasia,0
9621,removal technique,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9622,Metastatic Neoplasm,Childhood Choriocarcinoma,0
9623,Use of,Recurrent Testicular Lymphoma,0
9624,Genomics,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9625,300,FIGO Stage II Ovarian Cancer,0
9626,Term (lexical),Undifferentiated Neuroblastoma,0
9627,Rare,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9628,Mutation,Xeroderma pigmentosum,0
9629,trend,Fourth Ventricle and Brain Stem Ependymal Tumor,0
9630,Including (qualifier),Refractory Barrett Esophagus,0
9631,Flat shape,Localized Askin Tumor,0
9632,Southern Europe,Colorectal Neuroendocrine Tumor G2,0
9633,Needs,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9634,Negative Surgical Margin,Undifferentiated Endocervical Sarcoma,0
9635,transport (device),Diffuse malignant mesothelioma,0
9636,Negation,Giant cell angiofibroma,0
9637,Compressed structure,Refractory Barrett Esophagus,0
9638,Result,Mucinous cystadenofibroma,0
9639,Two,Anaplastic large cell lymphoma,0
9640,Rare,Benign tumor of eyelid,0
9641,Professional Occupation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9642,cancer therapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9643,Physical shape,Refractory Barrett Esophagus,0
9644,Entity Determiner - specific,Adult Alveolar Soft Part Sarcoma,0
9645,PREVENT (product),Metastatic Kidney Carcinoma,0
9646,Auditory pitch,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9647,Endometrial biopsy,Cerebral hemangioma,0
9648,Carcinoma,Advanced Lung Carcinoma,0
9649,Characteristics,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9650,Persistent embryonic structure,Refractory Barrett Esophagus,0
9651,Subtype (attribute),Acute Undifferentiated Leukemia,0
9652,Biomaterial Treatment,Localized Askin Tumor,0
9653,Methods aspects,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9654,Adult human body,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9655,Interaction,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9656,Second edition,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9657,Laparoscopy,Adenocarcinoma of the prostate metastatic,0
9658,International Classification of Diseases,Undifferentiated Endocervical Sarcoma,0
9659,Deafness,Anaplastic large cell lymphoma,0
9660,Back,gliosarcoma,0
9661,Small,Malignant melanoma of eyelid,0
9662,Removed,Recurrent Uveal Melanoma,0
9663,Secretory Vesicles,Blepharal carcinoma,0
9664,PREVENT (product),FIGO Stage II Ovarian Cancer,0
9665,Result,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9666,Metaplasia,Primary Cutaneous Plasmablastic Lymphoma,0
9667,Procedure (set of actions),Thymic Clear Cell Carcinoma,0
9668,Primary,Ovarian germ cell choriocarcinoma stage IV,0
9669,Type A,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9670,Tissue Specimen Code,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9671,Anabolism,Medulloblastoma,0
9672,Causing,Adrenal Rest Tumor,0
9673,Fever,papillary carcinoma of penis,0
9674,Due to,Anterior Urethral Malignant Neoplasm,0
9675,treatment - ActInformationManagementReason,Choroid Necrotic Melanoma,0
9676,Science of Morphology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9677,Upper back structure,Endometrial Small Cell Carcinoma,0
9678,Anatomic Site,adenoid cystic carcinoma of lung,0
9679,Third revision,Cancer of Urinary Tract,0
9680,Cell Count,Thymic Clear Cell Carcinoma,0
9681,Bone pain,Chronic Myelomonocytic Leukemia-2,0
9682,Occurrence Indicator,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9683,Present,squamous cell carcinoma of the thyroid gland,0
9684,Linear,Mucinous cystadenofibroma,0
9685,physiological aspects,Cancer of Urinary Tract,0
9686,Respiration,Adult Hepatocellular Carcinoma,0
9687,Body tissue patch material,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9688,Back,embryonal rhabdomyosarcoma of prostate,0
9689,Frequently,Digestive System Hodgkin Lymphoma,0
9690,Subject Risk,Mucinous adenocarcinoma gastric,0
9691,Tissue damage,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9692,Scientific Publication,Benign neoplasm of thorax,0
9693,Malignant neoplasm of skin,FIGO Stage II Ovarian Cancer,0
9694,1+ Score,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
9695,Pelvic cavity structure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9696,Leg,Stage II Hepatocellular Carcinoma AJCC v8,0
9697,Occur (action),Malignant melanoma of eyelid,0
9698,Largest,Metastatic Carcinoma in the Lung,0
9699,Trauma,Blepharal carcinoma,0
9700,Pain,Childhood Lymphoma,0
9701,Aspects of signs,Intestinal Metaplasia of Bladder Urothelium,0
9702,Swelling,Small cell neuroendocrine carcinoma of bladder,0
9703,Most,Non-Metastatic Gestational Trophoblastic Tumor,0
9704,Infant,gliosarcoma,0
9705,Numerous,Werner Syndrome,0
9706,Primary malignant neoplasm,Pancreatic Intraepithelial Neoplasia-3,0
9707,At risk of infection,Uterine Cancer,0
9708,Lung,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9709,Body part,Stage II Hepatocellular Carcinoma AJCC v8,0
9710,Case (situation),Mucinous adenocarcinoma gastric,0
9711,Group A (blood group),Adult Alveolar Soft Part Sarcoma,0
9712,Telephone Extension Number,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9713,30%,Collecting Duct Carcinoma of the Kidney,0
9714,Exogenous Factors,Benign Apocrine Neoplasm,0
9715,Rare,Neonatal leukemia,0
9716,Sequence Data Type,Leptomeningeal sarcoma,0
9717,Transformation,Anterior Urethral Malignant Neoplasm,0
9718,Central neuroblastoma,High Grade Glandular Intraepithelial Neoplasia,0
9719,second (number),Malignant Testicular Sertoli Cell Tumor,0
9720,Often - answer to question,Spermatocytic seminoma,0
9721,Time (foundation metadata concept),Contact dermatitis due to alkali,0
9722,shared attribute,Tonsillar Carcinoma,0
9723,Malignant Head and Neck Neoplasm,Adrenal Rest Tumor,0
9724,Family illness,Adenocarcinoma of the prostate metastatic,0
9725,Include (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9726,Varies,Non-Metastatic Gestational Trophoblastic Tumor,0
9727,metaplastic cell transformation,Breast Ductal Adenoma,0
9728,Computed Tomography Study File,Carcinoma of urinary bladder,0
9729,Life,Advanced Lung Carcinoma,0
9730,Insect Bite Specimen Code,Mucinous adenocarcinoma gastric,0
9731,T prime,Stage 0 Lip Carcinoma,0
9732,Virilization,Methotrexate-Associated Hodgkin Lymphoma,0
9733,Liver Cirrhosis,Benign tumor of eyelid,0
9734,Decreasing,Testicular cancer metastatic,0
9735,Burkina Faso,Xeroderma pigmentosum,0
9736,Meaning,Medulloblastoma,0
9737,Surrounding (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
9738,Obesity,Liver Lymphangioma,0
9739,Exposure to toxin,Non-Metastatic Gestational Trophoblastic Tumor,0
9740,ethnic european,Granular Cell Leiomyosarcoma,0
9741,Blood Products Laboratory Testing,Secondary malignant neoplasm of lymph node,0
9742,body system,Cerebral hemangioma,0
9743,Better,Platinum-Resistant Lung Small Cell Carcinoma,0
9744,Therapeutic radiology procedure,Malignant Neoplasm with Regional Lymph Node Involvement,0
9745,Corner Minus,Colorectal cancer,0
9746,<90,Carcinoma of urinary bladder,0
9747,Place,Heavy Chain Deposition Disease,0
9748,Pharmacologic Substance,Granular Cell Leiomyosarcoma,0
9749,Systemic disease,Maxillary Sinus Adenocarcinoma,0
9750,Optical filter,Blepharal carcinoma,0
9751,Relationships,Ichthyosis,0
9752,More,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9753,To,Xeroderma pigmentosum,0
9754,Coins,Adult Hepatocellular Carcinoma,0
9755,Cessation of life,Secondary malignant neoplasm of lymph node,0
9756,Death (finding),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9757,Frequently,BRCA2 Syndrome,0
9758,Retinoic Acid Response Element,Ovarian germ cell choriocarcinoma stage IV,0
9759,Desmoplastic fibroblastoma,Unfavorable Non-Hodgkin Lymphoma,0
9760,Have Shortness of Breath question,Maxillary Sinus Adenocarcinoma,0
9761,Brain Neoplasms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9762,Sodium Chloride,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9763,Usual Severity Weight Loss,Intestinal Metaplasia of Bladder Urothelium,0
9764,Both kidneys,Stage IV Penile Cancer AJCC v7,0
9765,Infection,Malignant melanoma of eyelid,0
9766,Thymus Gland,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9767,Occurrence Indicator,Uterine Cancer,0
9768,Females,Noninfiltrating Intraductal Carcinoma,0
9769,Body tissue,Ampulla of Vater Tubular Adenoma,0
9770,Ovary,Spongiotic dermatitis,0
9771,Direct (qualifier),Neoplasms,0
9772,United States,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9773,PERMANENT DEAFNESS,Giant cell angiofibroma,0
9774,Appearance of breast,benign mature teratoma of pancreas,0
9775,Relational and Item-Specific Encoding Task,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9776,Percent (qualifier value),Testicular cancer metastatic,0
9777,NBL1 wt Allele,Unresectable Rhabdomyosarcoma,0
9778,Only - dosing instruction fragment,Endometrial Small Cell Carcinoma,0
9779,>90,Atypical Lobular Breast Hyperplasia,0
9780,Long-term Follow-up,Intraepithelial Melanocytic Hyperplasia,0
9781,Advanced phase,Benign neoplasm of thorax,0
9782,Administration procedure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9783,Chronic myeloproliferative disorder,Malignant melanoma of eyelid,0
9784,Living Alone,Breast Ductal Adenoma,0
9785,Parameterized Data Type - Set,FIGO Stage II Ovarian Cancer,0
9786,Chemical Association,Tonsillar Carcinoma,0
9787,70%,Uterine Cancer,0
9788,Symptoms,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9789,Manifest,embryonal rhabdomyosarcoma of prostate,0
9790,Skin fold,Acute Undifferentiated Leukemia,0
9791,Occurrence Indicator,Malignant neoplasm of choroid,0
9792,Nausea,Mucinous cystadenofibroma,0
9793,Myalgia,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9794,+2,Digestive System Hodgkin Lymphoma,0
9795,Cell Count,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9796,Benign Smooth Muscle Neoplasm,Clonal Hematopoiesis of Indeterminate Potential,0
9797,radiotherapeutic,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
9798,per year,Cancer of Urinary Tract,0
9799,Cell Count,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9800,Tumor type,Unfavorable Non-Hodgkin Lymphoma,0
9801,Frequently,Liver Lymphangioma,0
9802,Neoplasm Metastasis,Xeroderma pigmentosum,0
9803,risk factors,Stage IB Lung Cancer AJCC v7,0
9804,parent,Localized Askin Tumor,0
9805,Greatly,Liver Lymphangioma,0
9806,Stratified squamous epithelium,Spongiotic dermatitis,0
9807,Screening procedure,Malignant melanoma of eyelid,0
9808,Pruritus,Colorectal cancer,0
9809,Secondary Neoplasm,Bladder squamous cell carcinoma stage I,0
9810,TP53 gene,Anterior Urethral Malignant Neoplasm,0
9811,Gland,Chronic Myelomonocytic Leukemia-2,0
9812,Call (Instruction),Intraepithelial Melanocytic Hyperplasia,0
9813,Primary malignant neoplasm,Low Grade Squamous Intraepithelial Neoplasia,0
9814,Tissue Specimen Code,Spongiotic dermatitis,0
9815,Sunlight,Pilocytic astrocytoma of cerebellum,0
9816,Glandular stomach,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9817,Rare,Clonal Hematopoiesis of Indeterminate Potential,0
9818,Symptoms,Anaplastic large cell lymphoma,0
9819,Study Variable,Cancer of Urinary Tract,0
9820,Oral region,Clonal Hematopoiesis of Indeterminate Potential,0
9821,Brain,Recurrent Testicular Lymphoma,0
9822,Tryptophanase,Fourth Ventricle and Brain Stem Ependymal Tumor,0
9823,Complete,Small cell neuroendocrine carcinoma of bladder,0
9824,diagnosis aspect,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9825,400,Stage IB Lung Cancer AJCC v7,0
9826,Manufactured sign,BRCA2 Syndrome,0
9827,Secondary Neoplasm,Childhood Fibrillary Astrocytoma,0
9828,Stem cell transplant,Mucinous adenocarcinoma gastric,0
9829,Formation,Ichthyoses,0
9830,Affect (mental function),adenosquamous carcinoma of breast,0
9831,Similarity,Benign tumor of eyelid,0
9832,Left,Undifferentiated Endocervical Sarcoma,0
9833,Version (morphologic abnormality),Low Grade Squamous Intraepithelial Neoplasia,0
9834,95,Malignant melanoma of eyelid,0
9835,Tryptophanase,Cartilaginous exostosis,0
9836,Skin,Localized Askin Tumor,0
9837,Money or percentage indicator - Percentage,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9838,Diagnosis Study,Endometrial Small Cell Carcinoma,0
9839,Indication of (contextual qualifier),Choroid Necrotic Melanoma,0
9840,World,Stage I Adult Non-Hodgkin Lymphoma,0
9841,Term (lexical),Angiosarcoma of liver,0
9842,Array Feature,Recurrent Testicular Lymphoma,0
9843,/40,Stage II Carcinoma of Penis,0
9844,Disk Dosing Unit,Medulloblastoma,0
9845,Materials,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9846,Disease,Grade 1 Clear Cell Renal Cell Carcinoma,0
9847,Associated topography,Cerebral hemangioma,0
9848,Thoracic spinal cord structure,Refractory Barrett Esophagus,0
9849,Low Level,Intracortical osteosarcoma,0
9850,Individual,Angiosarcoma of liver,0
9851,Stem of Organ,Breast Ductal Adenoma,0
9852,<90,Stage IB Pancreatic Cancer AJCC v8,0
9853,Money or percentage indicator - Percentage,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9854,Social group,Maxillary Sinus Adenocarcinoma,0
9855,respiratory,Stage I Adult Non-Hodgkin Lymphoma,0
9856,Cytoplasm,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9857,Involvement with,Childhood Fibrillary Astrocytoma,0
9858,Mesothelioma,Stage 0 Penile Cancer AJCC v8,0
9859,Causing,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9860,Similarity,Acantholytic squamous cell carcinoma,0
9861,Linear,Benign Carotid Body Paraganglioma,0
9862,Specimen Source Codes - Lesion,gliosarcoma,0
9863,Cessation of life,Childhood Fibrillary Astrocytoma,0
9864,Segmental Mastectomy,Lipoma of small intestine,0
9865,Sequence Data Type,Uterine Cancer,0
9866,Tryptophanase,Cerebral Primitive Neuroectodermal Tumor,0
9867,Mesothelium,Medulloblastoma,0
9868,year,squamous cell carcinoma of the thyroid gland,0
9869,*Type - Kind of quantity,Localized Askin Tumor,0
9870,Most,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9871,Leads (device),Localized Askin Tumor,0
9872,described,Stage II Hepatocellular Carcinoma AJCC v8,0
9873,Formation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9874,Term (lexical),Unresectable Rhabdomyosarcoma,0
9875,Special,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9876,Lymphocyte,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
9877,Central Minus,Blepharal carcinoma,0
9878,shared attribute,Cerebral Primitive Neuroectodermal Tumor,0
9879,Patient Reported Outcome Stem,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9880,Hodgkin Disease,Metastatic Ductal Breast Carcinoma,0
9881,Cervical Squamous Cell Carcinoma,Unfavorable Non-Hodgkin Lymphoma,0
9882,Platelet-Derived Growth Factor Receptor Alpha,FIGO Stage II Ovarian Cancer,0
9883,General surgery specialty,Granular Cell Leiomyosarcoma,0
9884,Age of Onset,ALK positive large B-cell lymphoma,0
9885,Sharing (Social Behavior),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9886,Etiology aspects,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9887,Increased,Collecting Duct Carcinoma of the Kidney,0
9888,Human body structure,Undifferentiated Neuroblastoma,0
9889,Morphology,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
9890,Pharmaceutical Preparations,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9891,Laser-generated electromagnetic radiation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9892,Common Specifications in HL7 V3 Publishing,Refractory Barrett Esophagus,0
9893,>90,Uterine Cancer,0
9894,survival aspects,Chondrosarcoma,0
9895,Diagnosis,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9896,Fracture,Tonsillar Carcinoma,0
9897,Small,Female Breast Carcinoma,0
9898,cancer immunology,embryonal rhabdomyosarcoma of prostate,0
9899,Bothered by Night Sweats,Urethral Carcinoma,0
9900,Dry,Neoplasms,0
9901,VARIOUS DRUG CLASSES IN ATC,Chondrosarcoma,0
9902,diagnosis aspect,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9903,Smear - instruction imperative,Endometrial Small Cell Carcinoma,0
9904,Iodides,Primary Cutaneous Plasmablastic Lymphoma,0
9905,anatomical layer,Uterine Cancer,0
9906,Body Parts - Canal,Malignant melanoma of eyelid,0
9907,Supportive assistance,Adenocarcinoma,0
9908,risk factors - observation list,Adult Hepatocellular Carcinoma,0
9909,Occurrence Indicator,Acute lymphadenitis,0
9910,Genetic syndrome,Small cell neuroendocrine carcinoma of bladder,0
9911,Case (situation),Uterine Cancer,0
9912,Removed,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9913,Articular system,Locally Advanced Soft Tissue Sarcoma,0
9914,Ovary,Childhood Central Nervous System Immature Teratoma,0
9915,Therapeutic radiology procedure,Methotrexate-Associated Hodgkin Lymphoma,0
9916,Patients,Cerebral Primitive Neuroectodermal Tumor,0
9917,therapeutic aspects,Thymic Clear Cell Carcinoma,0
9918,low confidentiality,Uterine Cancer,0
9919,Used by,Liver Lymphangioma,0
9920,Cervical lymph node group,Ovarian Carcinoid Tumor,0
9921,Cell Device,Chronic Myelomonocytic Leukemia-2,0
9922,Publishing,Extracranial Neuroblastoma,0
9923,Antibodies,Mucinous adenocarcinoma gastric,0
9924,Contain (action),Cerebral Primitive Neuroectodermal Tumor,0
9925,motor movement,Cancer of Urinary Tract,0
9926,Stem of Organ,Adult Hepatocellular Carcinoma,0
9927,Operation excision,Pilocytic astrocytoma of cerebellum,0
9928,bacteria aspects,mucinous adenocarcinoma of gallbladder,0
9929,Groups,Childhood Thyroid Gland Follicular Carcinoma,0
9930,Screening,Leiomyoma of Gallbladder,0
9931,Non-Secretory Plasma Cell Myeloma,Liver Lymphangioma,0
9932,Including (qualifier),Pancreatic Intraepithelial Neoplasia-3,0
9933,One,Noninfiltrating Intraductal Carcinoma,0
9934,Smear - instruction imperative,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9935,suggestion,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9936,Togo,Acute Undifferentiated Leukemia,0
9937,90%,Uterine Cancer,0
9938,Make - Instruction Imperative,Diffuse malignant mesothelioma,0
9939,United States Military Commissioned Officer O4,Cancer of Urinary Tract,0
9940,Cancer Genus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9941,Hodgkin Disease,FIGO Stage II Ovarian Cancer,0
9942,Biological Response Modifiers,Extracranial Neuroblastoma,0
9943,Base - General Qualifier,Platinum-Resistant Lung Small Cell Carcinoma,0
9944,Deterioration of status,Giant cell angiofibroma,0
9945,Occurrence,Cancer of Urinary Tract,0
9946,Neoplasms,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
9947,2+,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9948,Bacteria present,Neonatal leukemia,0
9949,Used by,Malignant Testicular Sertoli Cell Tumor,0
9950,negative regulation of biological process,Chronic Myelomonocytic Leukemia-2,0
9951,Pharyngeal structure,Human Papillomavirus-Related Carcinoma,0
9952,history (of) disease family,High Grade Glandular Intraepithelial Neoplasia,0
9953,Benign Neoplasm,Hodgkin lymphoma,0
9954,Usually,Carcinoma of urinary bladder,0
9955,Infrequent,Familial Hemophagocytic Lymphocytosis,0
9956,Surgery specialty,Recurrent Uveal Melanoma,0
9957,Group A (qualifier value),Benign tumor of eyelid,0
9958,Symptoms,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9959,include - SetOperator,Childhood Fibrillary Astrocytoma,0
9960,Either,Diffuse malignant mesothelioma,0
9961,Brain part,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9962,Include (action),Spermatocytic seminoma,0
9963,Aspects of signs,FIGO Stage II Ovarian Cancer,0
9964,shared attribute,Female Breast Carcinoma,0
9965,Term Birth,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9966,Rare Diseases,Recurrent Testicular Lymphoma,0
9967,peripheral blood,Carcinoma ex pleomorphic adenoma of parotid gland,0
9968,seen,Undifferentiated Neuroblastoma,0
9969,Unlikely Related to Intervention,Undifferentiated Endocervical Sarcoma,0
9970,occurrence characteristics,BRCA2 Syndrome,0
9971,Medical Device Emits Smoke,Digestive System Hodgkin Lymphoma,0
9972,Endometrial Carcinoma,Benign Carotid Body Paraganglioma,0
9973,Carcinoma,papillary carcinoma of penis,0
9974,combination - answer to question,gliosarcoma,0
9975,Group A (blood group),Leiomyoma of Gallbladder,0
9976,High risk of,Familial Hemophagocytic Lymphocytosis,0
9977,Feel Tired question,Recurrent Uveal Melanoma,0
9978,chapter,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9979,Upper arm,Advanced Uterine Corpus Carcinosarcoma,0
9980,Stomach,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
9981,Thrombocythemia,Intraepithelial Melanocytic Hyperplasia,0
9982,Treating,Stage II Carcinoma of Penis,0
9983,Immunotherapy,Intraepithelial Melanocytic Hyperplasia,0
9984,Call (Instruction),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9985,Biomaterial Treatment,Endometrial Small Cell Carcinoma,0
9986,Dryness of eye,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9987,Common (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
9988,South,Refractory Barrett Esophagus,0
9989,European race,Benign Apocrine Neoplasm,0
9990,Brain Neoplasms,Undifferentiated Endocervical Sarcoma,0
9991,Structure of zygote,Clonal Hematopoiesis of Indeterminate Potential,0
9992,morphological,Mucinous adenocarcinoma gastric,0
9993,Pharmacotherapy,Giant cell angiofibroma,0
9994,Nursing interventions,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9995,thymocyte,Cerebral Primitive Neuroectodermal Tumor,0
9996,Paracel Islands,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9997,Including (qualifier),Pancreatic Intraepithelial Neoplasia-3,0
9998,diagnosis aspect,squamous cell carcinoma of the thyroid gland,0
9999,Sharing (Social Behavior),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10000,N not otherwise specified Antibody,Blepharal carcinoma,0
10001,Due to,Benign Carotid Body Paraganglioma,0
10002,Cure (remedy),Platinum-Resistant Lung Small Cell Carcinoma,0
10003,How Much Distress Weight Loss,Uterine Cancer,0
10004,Sufficiently defined concept definition status (core metadata concept),Undifferentiated Endocervical Sarcoma,0
10005,HL7PublishingSubSection <practice>,Malignant Testicular Sertoli Cell Tumor,0
10006,Lead,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10007,Dermatitis,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10008,Milliampere second,Female Breast Carcinoma,0
10009,Bone Marrow,Mucinous adenocarcinoma gastric,0
10010,Beginning,Refractory Barrett Esophagus,0
10011,Various patch test substance,Adult Alveolar Soft Part Sarcoma,0
10012,Pleural effusion fluid,Clonal Hematopoiesis of Indeterminate Potential,0
10013,Intact,Undifferentiated Endocervical Sarcoma,0
10014,Rating (action),Ovarian germ cell choriocarcinoma stage IV,0
10015,Worker,Non-Metastatic Gestational Trophoblastic Tumor,0
10016,Symptoms aspect,BRCA2 Syndrome,0
10017,Medical pathologist,Human Papillomavirus-Related Carcinoma,0
10018,Precision - second,non-Hodgkin's lymphoma of spleen,0
10019,Recurrent fevers,Grade 1 Clear Cell Renal Cell Carcinoma,0
10020,Second Suffix,Recurrent Testicular Lymphoma,0
10021,Offspring,Non-Metastatic Gestational Trophoblastic Tumor,0
10022,Screening - general NOS (finding),Lipoma of small intestine,0
10023,Point,adenoid cystic carcinoma of lung,0
10024,Form of bone,Neonatal leukemia,0
10025,Peripheral T-Cell Lymphoma,Lipoma of small intestine,0
10026,Occur (action),Endometrial Small Cell Carcinoma,0
10027,Combined,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10028,Chest Pain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10029,Pruritus,Localized Ewing Sarcoma,0
10030,Worker,Advanced Lung Carcinoma,0
10031,Female of child bearing age,Larynx carcinoma recurrent,0
10032,Tired,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10033,Infrequent,Ampulla of Vater Tubular Adenoma,0
10034,One,Diffuse malignant mesothelioma,0
10035,Carcinoma,Anaplastic large cell lymphoma,0
10036,Include (action),Choroid Necrotic Melanoma,0
10037,Inguinal part of abdomen,Secondary malignant neoplasm of lymph node,0
10038,Immune system,Medulloblastoma,0
10039,Australia,Colorectal cancer,0
10040,Formation,Xeroderma pigmentosum,0
10041,Chemotherapy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10042,Adult human body,Ovarian germ cell choriocarcinoma stage IV,0
10043,shared attribute,adenosquamous carcinoma of breast,0
10044,Genus Homo,Serous cystadenocarcinoma ovary,0
10045,Person Name,Cartilaginous exostosis,0
10046,Support,Adenocarcinoma,0
10047,Ki-1+ Anaplastic Large Cell Lymphoma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10048,Body tissue,Intraepithelial Melanocytic Hyperplasia,0
10049,Malignant - descriptor,Carcinoma of urinary bladder,0
10050,Rate,Acantholytic squamous cell carcinoma,0
10051,Less Than,Spongiotic dermatitis,0
10052,New,Adult Hepatocellular Carcinoma,0
10053,Pain,Spermatocytic seminoma,0
10054,In Blood,Endometrial Small Cell Carcinoma,0
10055,Pharmaceutical Preparations,Tonsillar Carcinoma,0
10056,Indication of (contextual qualifier),Recurrent Uveal Melanoma,0
10057,Human Papillomavirus Positive,Localized Ewing Sarcoma,0
10058,Appearance Distress Question,Digestive System Hodgkin Lymphoma,0
10059,Type A,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10060,Often - answer to question,Xeroderma pigmentosum,0
10061,Endometrial scraping,Stage IV Penile Cancer AJCC v7,0
10062,Polypeptide Hormones,Mucinous adenocarcinoma gastric,0
10063,Sometimes,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10064,Alveolar Soft Part Sarcoma,Advanced Lung Carcinoma,0
10065,Five-year Survival Rate,Medulloblastoma,0
10066,pharmacotherapeutic,Acute Undifferentiated Leukemia,0
10067,Cell Count,Neoplasms,0
10068,Greater Than,Recurrent Uveal Melanoma,0
10069,Exposure to,Undifferentiated Endocervical Sarcoma,0
10070,Abnormal cellular component of blood,Cartilaginous exostosis,0
10071,acute,Endometrial Small Cell Carcinoma,0
10072,Intimate (qualifier value),Childhood Choriocarcinoma,0
10073,Radiofrequency Ablation,Acute Undifferentiated Leukemia,0
10074,Gases,malignant lymphoma of pancreatic lymph nodes,0
10075,Treating,Chronic Myelomonocytic Leukemia-2,0
10076,Associated with,Benign tumor of eyelid,0
10077,Cardiovascular system,Stage II Hepatocellular Carcinoma AJCC v8,0
10078,During,Non-Metastatic Gestational Trophoblastic Tumor,0
10079,Diagnosis Study,Acantholytic squamous cell carcinoma,0
10080,CD96 gene,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10081,Structure of parenchyma of lung,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10082,Then,Clonal Hematopoiesis of Indeterminate Potential,0
10083,Ninein,Intraepithelial Melanocytic Hyperplasia,0
10084,Cyst,Endometrial Small Cell Carcinoma,0
10085,Forecast of outcome,Human Papillomavirus-Related Carcinoma,0
10086,Weight decreased,Acantholytic squamous cell carcinoma,0
10087,Inferior Colliculus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10088,85,Malignant melanoma of eyelid,0
10089,Skin,Intraepithelial Melanocytic Hyperplasia,0
10090,Child,Diffuse malignant mesothelioma,0
10091,Chemotherapy Regimen,Anaplastic large cell lymphoma,0
10092,Thick,Thymic Atypical Carcinoid Tumor,0
10093,Nausea,Carcinoma of urinary bladder,0
10094,Manufactured sign,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10095,Common Specifications in HL7 V3 Publishing,Cancer of Urinary Tract,0
10096,74,Liver Lymphangioma,0
10097,Type - attribute,Benign Apocrine Neoplasm,0
10098,interstitial,Liver Cavernous Hemangioma,0
10099,Often - answer to question,Malignant Neoplasm with Regional Lymph Node Involvement,0
10100,Rapid,Rhabdomyosarcoma with ganglionic differentiation,0
10101,Young,Non-Metastatic Gestational Trophoblastic Tumor,0
10102,Assortment,Airway Hemangioma,0
10103,Current (present time),Non-Metastatic Gestational Trophoblastic Tumor,0
10104,Part of,Neonatal leukemia,0
10105,Primary lymphoid organ,Blepharal carcinoma,0
10106,Occurrence Indicator,Childhood Lymphoma,0
10107,Virus Diseases,Stage 0 Penile Cancer AJCC v8,0
10108,status - In progress,Stage II Carcinoma of Penis,0
10109,Symptoms,Xeroderma pigmentosum,0
10110,Term (lexical),Secondary malignant neoplasm of lymph node,0
10111,Contain (action),Stage III Adult Immunoblastic Lymphoma,0
10112,Disease,Medulloblastoma,0
10113,Additional,High Grade Glandular Intraepithelial Neoplasia,0
10114,Practice Experience,Stage IV Penile Cancer AJCC v7,0
10115,Bothered by Night Sweats,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10116,Ductal Breast Carcinoma,Heavy Chain Deposition Disease,0
10117,Compressed structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10118,Treatment Epoch,Human Papillomavirus-Related Carcinoma,0
10119,Affect (mental function),Lipoma of small intestine,0
10120,Age,Childhood Thyroid Gland Follicular Carcinoma,0
10121,chapter,Testicular cancer metastatic,0
10122,Formation,Diffuse malignant mesothelioma,0
10123,Dietary Factors,Methotrexate-Associated Hodgkin Lymphoma,0
10124,Mechanism Component of Device,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10125,Increase,Werner Syndrome,0
10126,Characterization,Thymic Clear Cell Carcinoma,0
10127,Tobacco smoking behavior,Carcinoma of urinary bladder,0
10128,Administration occupational activities,Angiosarcoma of liver,0
10129,Aspect - Kind of quantity,Undifferentiated Endocervical Sarcoma,0
10130,Pain Distress Question,Maxillary Sinus Adenocarcinoma,0
10131,Dependent for dressing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10132,Nevus,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10133,Experimental Result,Stage 0 Penile Cancer AJCC v8,0
10134,Frequently,Intestinal Neuroendocrine Carcinoma,0
10135,Myasthenia Gravis,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10136,white blood cell type,Refractory Glioma,0
10137,Mutation,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10138,Frequently,Breast Ductal Adenoma,0
10139,Cell Count,Neonatal leukemia,0
10140,Individual,Sarcomatoid Renal Cell Carcinoma,0
10141,Immunoglobulin complex location,Extracranial Neuroblastoma,0
10142,Malignant - descriptor,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10143,Post Device,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10144,Lymphocyte,Endometrial Small Cell Carcinoma,0
10145,Parotid inflammation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10146,70%,Stage IB Lung Cancer AJCC v7,0
10147,Version,Adenocarcinoma of the prostate metastatic,0
10148,Slightly (qualifier value),Colorectal Mucin Poor Hyperplastic Polyp,0
10149,Decision,Endometrial Small Cell Carcinoma,0
10150,Specimen,Tonsillar Carcinoma,0
10151,What subject filter - Result,Diffuse malignant mesothelioma,0
10152,color additive,Metastatic Malignant Neoplasm in the Sellar Region,0
10153,Lock - Remote control command,Mixed parotid tumor,0
10154,Physical shape,carcinoma of middle ear,0
10155,Cancer Genus,Keratoderma,0
10156,Follicle,Cerebral Primitive Neuroectodermal Tumor,0
10157,Strikes,BRCA2 Syndrome,0
10158,Structure of cortex of kidney,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10159,Include (action),mucinous adenocarcinoma of gallbladder,0
10160,Diffuse Large B-Cell Lymphoma,Breast Ductal Adenoma,0
10161,Enlargement procedure,Familial Hemophagocytic Lymphocytosis,0
10162,Granulocyte count,Mixed parotid tumor,0
10163,Aggressive behavior,Female Breast Carcinoma,0
10164,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Adult Alveolar Soft Part Sarcoma,0
10165,Human body structure,Female Breast Carcinoma,0
10166,Effectiveness,Angiosarcoma of liver,0
10167,Tissue Specimen Code,Intraepithelial Melanocytic Hyperplasia,0
10168,survival aspects,Heavy Chain Deposition Disease,0
10169,Half,Undifferentiated Endocervical Sarcoma,0
10170,Three,Malignant Testicular Sertoli Cell Tumor,0
10171,Approximate,Bladder squamous cell carcinoma stage I,0
10172,Including (qualifier),Mucinous adenocarcinoma gastric,0
10173,Object Class,Advanced Uterine Corpus Carcinosarcoma,0
10174,Ephrin Type-B Receptor 1,Testicular cancer metastatic,0
10175,Include (action),Sarcomatoid Renal Cell Carcinoma,0
10176,Make - Instruction Imperative,Childhood Fibrillary Astrocytoma,0
10177,Excision,Cerebral hemangioma,0
10178,Smooth muscle (tissue),Human Papillomavirus-Related Carcinoma,0
10179,History of previous events,Stage III Adult Immunoblastic Lymphoma,0
10180,Most,Thymic Atypical Carcinoid Tumor,0
10181,Obese build,Bladder squamous cell carcinoma stage I,0
10182,Kidney Infection,Xeroderma pigmentosum,0
10183,Subject Risk,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10184,Examination of pharynx,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10185,Referring,Metastatic Carcinoma in the Lung,0
10186,Malignant Neoplasms,Stage II Carcinoma of Penis,0
10187,Subject is Randomized,Blepharal carcinoma,0
10188,300,Testicular cancer metastatic,0
10189,penis,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10190,Both ovaries,Stage IV Penile Cancer AJCC v7,0
10191,Malignant lymphangioma,Malignant Neoplasm of Lung - Multiple Primary Sites,0
10192,*Type - Kind of quantity,Mucinous adenocarcinoma gastric,0
10193,More,Acantholytic squamous cell carcinoma,0
10194,Biochemical Pathway,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
10195,Highest,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10196,Have Been Vomiting,Tonsillar Carcinoma,0
10197,Medical,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
10198,Cervical Atlas,Giant cell angiofibroma,0
10199,Surrounding (qualifier value),squamous cell carcinoma of the thyroid gland,0
10200,Recurrence,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10201,Arising in,Uterine Cancer,0
10202,Plasma,Low Grade Squamous Intraepithelial Neoplasia,0
10203,Swallowing G-code,Malignant melanoma of eyelid,0
10204,Capsule Dosing Unit,Stage 0 Lip Carcinoma,0
10205,Clear,non-Hodgkin's lymphoma of spleen,0
10206,Location of Oral Residue Following Swallowing,Cancer of Urinary Tract,0
10207,2+ Score,Contact dermatitis due to alkali,0
10208,Measures (attribute),Endometrial Small Cell Carcinoma,0
10209,Common (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
10210,Tumor Mass,Localized Ewing Sarcoma,0
10211,Experimental Result,Adult Alveolar Soft Part Sarcoma,0
10212,Usual Severity Sweats,Diffuse malignant mesothelioma,0
10213,Stains,Extracranial Neuroblastoma,0
10214,Sometimes,Female Breast Carcinoma,0
10215,CD69 protein,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
10216,Togo,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10217,Viola tricolor,Mastocytosis,0
10218,2+ Score,Digestive System Hodgkin Lymphoma,0
10219,Severe atopic dermatitis,Childhood Cerebellar Neoplasm,0
10220,thiocolchicoside,Carcinoma of urinary bladder,0
10221,Histopathologic Grade,Lipoma of small intestine,0
10222,Human body,Acute Undifferentiated Leukemia,0
10223,Etiology aspects,Anaplastic large cell lymphoma,0
10224,What subject filter - Result,Xeroderma pigmentosum,0
10225,Immune System Finding,Bladder squamous cell carcinoma stage I,0
10226,Circumscribe (action),Intraepithelial Melanocytic Hyperplasia,0
10227,More,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10228,Extension,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10229,Definitely Related to Intervention,Colorectal High Grade B-Cell Lymphoma,0
10230,associated disease,Acute Undifferentiated Leukemia,0
10231,Time,Unresectable Rhabdomyosarcoma,0
10232,Treatment intent,Female Breast Carcinoma,0
10233,Biologic Development,Recurrent Uveal Melanoma,0
10234,Fever symptoms (finding),Intraepithelial Melanocytic Hyperplasia,0
10235,Childhood Lymphoma,non-Hodgkin's lymphoma of spleen,0
10236,Mass of pancreas,Diffuse malignant mesothelioma,0
10237,Epithelial Cells,Breast Ductal Adenoma,0
10238,Structure of thyroid follicle,Placental aromatase deficiency,0
10239,Blue color,Malignant Neoplasm with Regional Lymph Node Involvement,0
10240,Yellow complexion,Pancreatic Intraepithelial Neoplasia-3,0
10241,Value Above Reference Range,Unfavorable Non-Hodgkin Lymphoma,0
10242,Medulloblastoma,Pancreatic Intraepithelial Neoplasia-3,0
10243,High Mitosis-Karyorrhexis Index,adenosquamous carcinoma of breast,0
10244,What subject filter - Result,Acantholytic squamous cell carcinoma,0
10245,Homo sapiens,Adult Hepatocellular Carcinoma,0
10246,Related personal status,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10247,Stem cell transplant,Lipoma of small intestine,0
10248,Primary malignant neoplasm,Cancer of Urinary Tract,0
10249,Part of,Acantholytic squamous cell carcinoma,0
10250,Continuance of life,Stage IV Penile Cancer AJCC v7,0
10251,Often - answer to question,Refractory Barrett Esophagus,0
10252,Low Mitosis-Karyorrhexis Index,Giant cell angiofibroma,0
10253,Reporting,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10254,Condition:Find:Pt:^Patient:Nom,Breast Ductal Adenoma,0
10255,Cell Invasion,Methotrexate-Associated Hodgkin Lymphoma,0
10256,Neoplastic Glandular Cell,BRCA2 Syndrome,0
10257,One,Atypical Lobular Breast Hyperplasia,0
10258,Symptoms,Familial Hemophagocytic Lymphocytosis,0
10259,Diffuse Large B-Cell Lymphoma,Localized Ewing Sarcoma,0
10260,Entire dorsal spinal cord,Localized Askin Tumor,0
10261,Patients,Acantholytic squamous cell carcinoma,0
10262,Antineoplastic Chemotherapy Protocols,Lipoma of small intestine,0
10263,Diagnosis Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10264,Asleep,Female Breast Carcinoma,0
10265,Medical Device Emits Smoke,Spongiotic dermatitis,0
10266,Original Regulatory Submission,Localized Ewing Sarcoma,0
10267,Cancer Genus,Human Papillomavirus-Related Carcinoma,0
10268,Tryptophanase,Malignant melanoma of eyelid,0
10269,Adult Lymphoma,benign mature teratoma of pancreas,0
10270,Linear,Intraepithelial Melanocytic Hyperplasia,0
10271,Graph Node,Localized Askin Tumor,0
10272,Lymphoma,Methotrexate-Associated Hodgkin Lymphoma,0
10273,CD69 protein,Medulloblastoma,0
10274,Fused structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10275,State,Colorectal High Grade B-Cell Lymphoma,0
10276,Bone Growth,Advanced Uterine Corpus Carcinosarcoma,0
10277,metaplastic cell transformation,Benign tumor of eyelid,0
10278,year,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10279,Human body,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10280,Most,Cerebral Primitive Neuroectodermal Tumor,0
10281,Adult Acute Megakaryoblastic Leukemia,Malignant melanoma of eyelid,0
10282,Basis,High Grade Glandular Intraepithelial Neoplasia,0
10283,Skin Specimen,Neonatal leukemia,0
10284,Blood Circulation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10285,Administration procedure,Malignant Testicular Sertoli Cell Tumor,0
10286,Cancer Genus,Undifferentiated Endocervical Sarcoma,0
10287,Simian virus 40,Recurrent Testicular Lymphoma,0
10288,Screens (device),Benign tumor of eyelid,0
10289,Etiology aspects,Intraepithelial Melanocytic Hyperplasia,0
10290,Two,Angiosarcoma of liver,0
10291,Esophagus,Platinum-Resistant Lung Small Cell Carcinoma,0
10292,Experimental Result,Breast Ductal Adenoma,0
10293,Second edition,Liver Lymphangioma,0
10294,Drop British,Liver Lymphangioma,0
10295,Absence of Signs or Symptoms,Ovarian Carcinoid Tumor,0
10296,Bothered by Night Sweats,embryonal rhabdomyosarcoma of prostate,0
10297,Common (qualifier value),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
10298,Abnormal number of nucleoli,Refractory Glioma,0
10299,Common Specifications in HL7 V3 Publishing,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10300,TableCellVerticalAlign - bottom,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10301,white blood cell type,Stage III Adult Immunoblastic Lymphoma,0
10302,Approximate,Localized Ewing Sarcoma,0
10303,Primary malignant neoplasm of appendix,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10304,Consistency,Malignant Testicular Sertoli Cell Tumor,0
10305,Five-year Survival Rate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10306,Irritation,Diffuse malignant mesothelioma,0
10307,With shape,Childhood Central Nervous System Immature Teratoma,0
10308,Group A (qualifier value),Colorectal Neuroendocrine Tumor G2,0
10309,regional,Metastatic Neoplasm to the Gallbladder,0
10310,Form of muscle,Uterine Cancer,0
10311,Vaginal (intended site),Mucinous adenocarcinoma gastric,0
10312,algorithm,Stage IB Pancreatic Cancer AJCC v8,0
10313,Volume Measurement,Benign tumor of eyelid,0
10314,Requirement,Metastatic Carcinoma in the Lung,0
10315,How Often Itching,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10316,Due to,Cancer of Urinary Tract,0
10317,Include (action),Xeroderma pigmentosum,0
10318,Carcinoma breast stage IV,Testicular cancer metastatic,0
10319,various antiinfectives and antiseptics for local oral treatment,Blepharal carcinoma,0
10320,combination of objects,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
10321,Histologic type,Childhood Lymphoma,0
10322,Upper Extremity,Endometrial Small Cell Carcinoma,0
10323,Horns,Unresectable Rhabdomyosarcoma,0
10324,Cancer Genus,BRCA2 Syndrome,0
10325,Place - dosing instruction imperative,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10326,Males,Anaplastic large cell lymphoma,0
10327,Rare,Intraepithelial Melanocytic Hyperplasia,0
10328,Disease,Pancreatic Intraepithelial Neoplasia-3,0
10329,*Type - Kind of quantity,Mucinous adenocarcinoma gastric,0
10330,Connective Tissue,Xeroderma pigmentosum,0
10331,peripheral blood,Giant cell angiofibroma,0
10332,Excision,Mucinous adenocarcinoma gastric,0
10333,god,Xeroderma pigmentosum,0
10334,Square Mile,Cerebral Primitive Neuroectodermal Tumor,0
10335,Vaginal Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
10336,Tryptophanase,Uterine Cancer,0
10337,Type A,Unfavorable Non-Hodgkin Lymphoma,0
10338,Medicine,Ampulla of Vater Tubular Adenoma,0
10339,Scaling,Diffuse malignant mesothelioma,0
10340,Neoadjuvant Therapy,Recurrent Testicular Lymphoma,0
10341,Malignant Neoplasms,Recurrent Testicular Lymphoma,0
10342,Language Ability - Sign,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10343,B-Cell Activation,Stage III Adult Immunoblastic Lymphoma,0
10344,To,Primary Cutaneous Plasmablastic Lymphoma,0
10345,Fever,Malignant melanoma of eyelid,0
10346,Mathematical Factor,Advanced Lung Carcinoma,0
10347,Result,Malignant neoplasm of choroid,0
10348,radiotherapeutic,Recurrent Uveal Melanoma,0
10349,Primary malignant neoplasm,Human Papillomavirus-Related Carcinoma,0
10350,Pharmacotherapy,Thymic Clear Cell Carcinoma,0
10351,Appearance,Human Papillomavirus-Related Carcinoma,0
10352,Extrinsic,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10353,Specimen Source Codes - tumor,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10354,Abnormal Cell Count,Stage II Carcinoma of Penis,0
10355,Glioblastoma Multiforme Pathway,Adult Hepatocellular Carcinoma,0
10356,radiotherapeutic,Benign neoplasm of thorax,0
10357,Historical aspects qualifier,Stage IV Penile Cancer AJCC v7,0
10358,Poverty,Diffuse malignant mesothelioma,0
10359,Eye,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10360,Squamous cell carcinoma,Ichthyoses,0
10361,per period (qualifier value),sarcoma of spinal cord,0
10362,Providing presence (regime/therapy),Malignant melanoma of eyelid,0
10363,With shape,FIGO Stage II Ovarian Cancer,0
10364,Excision,Localized Ewing Sarcoma,0
10365,<3 (qualifier value),Benign tumor of eyelid,0
10366,Usual,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10367,Status post,adenoid cystic carcinoma of lung,0
10368,Average,Stage IB Pancreatic Cancer AJCC v8,0
10369,Numbers,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10370,Lymphatic,embryonal rhabdomyosarcoma of prostate,0
10371,Unmarried person,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10372,Adult human body,Mucinous adenocarcinoma gastric,0
10373,Togo,Endometrial Small Cell Carcinoma,0
10374,Burkina Faso,Recurrent Testicular Lymphoma,0
10375,N not otherwise specified Antibody,Human Papillomavirus-Related Carcinoma,0
10376,LMOD1 gene,Recurrent Uveal Melanoma,0
10377,Lung,Carcinoma of urinary bladder,0
10378,Document completion status - Documented,Angiosarcoma of liver,0
10379,Bruising,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10380,Two,Cerebral Primitive Neuroectodermal Tumor,0
10381,Analysis of substances,non-Hodgkin's lymphoma of spleen,0
10382,Extreme Response,Carcinoma ex pleomorphic adenoma of parotid gland,0
10383,Palmitic Acid,Malignant melanoma of eyelid,0
10384,Optic Nerve Glioma,Malignant neoplasm of choroid,0
10385,Retinoic Acid Response Element,Small cell neuroendocrine carcinoma of bladder,0
10386,Capsule Shape,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
10387,Bladder Continence Question,GIANT PIGMENTED HAIRY NEVUS,0
10388,Pelvis,squamous cell carcinoma of the thyroid gland,0
10389,Lymphocyte component of blood,Cancer of Urinary Tract,0
10390,Lacking,Female Breast Carcinoma,0
10391,Progress,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10392,Human body,Childhood Choriocarcinoma,0
10393,Neoplasms,Malignant melanoma of eyelid,0
10394,Borg Category-Ratio 10 Perceived Exertion Score 5,Localized Ewing Sarcoma,0
10395,Does stand alone,Heavy Chain Deposition Disease,0
10396,How Often Weight Loss,Maxillary Sinus Adenocarcinoma,0
10397,Variety (taxon),Malignant melanoma of eyelid,0
10398,Decrease,benign mature teratoma of pancreas,0
10399,Serum blood tests,Placental aromatase deficiency,0
10400,Including (qualifier),Recurrent Testicular Lymphoma,0
10401,include - SetOperator,Malignant Neoplasm with Regional Lymph Node Involvement,0
10402,Arranged (transportation),Heavy Chain Deposition Disease,0
10403,Freezing,Cancer of Urinary Tract,0
10404,Papillary,Papillary cystic tumor,0
10405,Cells,Childhood Cerebellar Neoplasm,0
10406,Determined by,Extracranial Neuroblastoma,0
10407,Plaque (lesion),Malignant Testicular Sertoli Cell Tumor,0
10408,Most,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10409,Therapeutic procedure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10410,Time,Thymic Clear Cell Carcinoma,0
10411,Tumor cells,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10412,Greeks,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10413,International Classification of Disease for Oncology,Intestinal Neuroendocrine Carcinoma,0
10414,described,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10415,Classification,Intraepithelial Melanocytic Hyperplasia,0
10416,Name (property) (qualifier value),Liver Cavernous Hemangioma,0
10417,Variety (taxon),malignant lymphoma of pancreatic lymph nodes,0
10418,Body site,Digestive System Hodgkin Lymphoma,0
10419,Procedure (set of actions),Unfavorable Non-Hodgkin Lymphoma,0
10420,Cancer Registry,Low Grade Squamous Intraepithelial Neoplasia,0
10421,Very,Ovarian Carcinoid Tumor,0
10422,Include (action),Choroid Necrotic Melanoma,0
10423,HUGO Gene Nomenclature Committee,Clonal Hematopoiesis of Indeterminate Potential,0
10424,Breast,Liver Lymphangioma,0
10425,Childhood Hodgkin Lymphoma,Localized Askin Tumor,0
10426,Smear - instruction imperative,Recurrent Testicular Lymphoma,0
10427,Occur (action),Liver Lymphangioma,0
10428,Cancer Genus,Stage I Adult Non-Hodgkin Lymphoma,0
10429,Etiology aspects,squamous cell carcinoma of the thyroid gland,0
10430,Alkalies,Intestinal Metaplasia of Bladder Urothelium,0
10431,Gene Mutation,Mucinous adenocarcinoma gastric,0
10432,Nodule,FIGO Stage II Ovarian Cancer,0
10433,Adult Hodgkin Lymphoma,Benign Apocrine Neoplasm,0
10434,Layer of dermis,Female Breast Carcinoma,0
10435,Blood group antibody I,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10436,Benign Neoplasm,Hemangioma,0
10437,Body part,Chondrosarcoma,0
10438,Sequence Arm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10439,Sufficient,Atypical Lobular Breast Hyperplasia,0
10440,Usually,Liver Cavernous Hemangioma,0
10441,Malignant Neoplasms,Recurrent Testicular Lymphoma,0
10442,Cervical dysplasia,Cerebral hemangioma,0
10443,british,Localized Askin Tumor,0
10444,Metaplasia,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10445,Ephrin Type-B Receptor 1,Childhood Fibrillary Astrocytoma,0
10446,Entity Determiner - specific,BRCA2 Syndrome,0
10447,Metastatic Disease Clinical Trial Setting,Stage IV Childhood Non-Hodgkin Lymphoma,0
10448,newly,embryonal rhabdomyosarcoma of prostate,0
10449,Universal - VocabularyDomainQualifier,Small cell neuroendocrine carcinoma of bladder,0
10450,Medial collateral ligament,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
10451,Term (temporal),Medulloblastoma,0
10452,Time,sarcoma of spinal cord,0
10453,Qualitative form,Intraepithelial Melanocytic Hyperplasia,0
10454,Release - action (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
10455,90%,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10456,Sarcoma,Spermatocytic seminoma,0
10457,Brain,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10458,Include (action),Malignant Neoplasm with Regional Lymph Node Involvement,0
10459,Biomaterial Treatment,Stage IB Lung Cancer AJCC v7,0
10460,Weight measurement scales,Undifferentiated Endocervical Sarcoma,0
10461,Disruptive,Low Grade Squamous Intraepithelial Neoplasia,0
10462,Malignant mesothelioma,Carcinoma ex pleomorphic adenoma of parotid gland,0
10463,Benign neoplasm of paraganglion,Stage I Adult Non-Hodgkin Lymphoma,0
10464,Operation excision,Liver Lymphangioma,0
10465,Bibliographic Reference,Breast Ductal Adenoma,0
10466,Therapeutic procedure,Ovarian germ cell choriocarcinoma stage IV,0
10467,Skin,Benign Carotid Body Paraganglioma,0
10468,Factor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10469,Immune system,Stage 0 Penile Cancer AJCC v8,0
10470,Caucasoid Race,Ovarian germ cell choriocarcinoma stage IV,0
10471,Visible,Endometrial Small Cell Carcinoma,0
10472,Back Pain,Primary Cutaneous Plasmablastic Lymphoma,0
10473,Lymphocyte component of blood,Mucinous adenocarcinoma gastric,0
10474,consider,Acute lymphadenitis,0
10475,Metastasis,Neonatal leukemia,0
10476,Occurrence Indicator,Undifferentiated Neuroblastoma,0
10477,Embryo,Recurrent Uveal Melanoma,0
10478,Infrequent,Acantholytic squamous cell carcinoma,0
10479,Refractory Cytopenia of Childhood,Malignant Testicular Sertoli Cell Tumor,0
10480,Area,FIGO Stage II Ovarian Cancer,0
10481,Lymphadenopathy,Leptomeningeal sarcoma,0
10482,Neuroendocrine Tumors,Adenocarcinoma,0
10483,Use of,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10484,Account number:Identifier:Point in time:^Patient:Nominal,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10485,Dyspareunia,Carcinoma of urinary bladder,0
10486,Class (taxonomic),Cerebral Primitive Neuroectodermal Tumor,0
10487,>5,Werner Syndrome,0
10488,Occurrence Indicator,BRCA2 Syndrome,0
10489,Metastatic to,FIGO Stage II Ovarian Cancer,0
10490,Adult Ependymoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10491,Greater than one,Stage IB Pancreatic Cancer AJCC v8,0
10492,3+ Score,malignant lymphoma of pancreatic lymph nodes,0
10493,Superkingdom (taxonomic category),Adenocarcinoma,0
10494,Adult Rhabdomyosarcoma,Angiosarcoma of liver,0
10495,Five-year Survival Rate,Anterior Urethral Malignant Neoplasm,0
10496,Role,Advanced Uterine Corpus Carcinosarcoma,0
10497,Administered Component Designation,Adenocarcinoma,0
10498,Lung,Recurrent Uveal Melanoma,0
10499,Growth pattern,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10500,Continuance of life,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10501,Domain (area of knowledge),papillary carcinoma of penis,0
10502,Corticosteroid [EPC],Adenocarcinoma,0
10503,Established,Primary Cutaneous Plasmablastic Lymphoma,0
10504,Scab,non-Hodgkin's lymphoma of spleen,0
10505,Common Specifications in HL7 V3 Publishing,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10506,Ovarian mucinous tumor,Digestive System Hodgkin Lymphoma,0
10507,Paraplegia,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10508,Throat,Platinum-Resistant Lung Small Cell Carcinoma,0
10509,Hemorrhage,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10510,Disruption,Human Papillomavirus-Related Carcinoma,0
10511,Known,Giant cell angiofibroma,0
10512,Angioma,Metastatic Lung Small Cell Carcinoma,0
10513,Bronchoconstriction [PE],Malignant Testicular Sertoli Cell Tumor,0
10514,Asleep,Extracranial Neuroblastoma,0
10515,Intercellular Junctions,Refractory Barrett Esophagus,0
10516,Include (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10517,Beds,Uterine Cancer,0
10518,Type - attribute,Human Papillomavirus-Related Carcinoma,0
10519,Poor - qualifier,Refractory Glioma,0
10520,Group Object,Breast Ductal Adenoma,0
10521,Malignant Vaginal Neoplasm,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10522,Disease,Extracranial Neuroblastoma,0
10523,Polyglandular Type I Autoimmune Syndrome,High Grade Glandular Intraepithelial Neoplasia,0
10524,Very rare,Granular Cell Leiomyosarcoma,0
10525,Michigan alcoholism screening test,Diffuse malignant mesothelioma,0
10526,ASIP protein,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10527,Common (qualifier value),Metastatic Carcinoma in the Lung,0
10528,depend,Blepharal carcinoma,0
10529,Worsening pattern,Intraepithelial Melanocytic Hyperplasia,0
10530,History of present illness,Malignant Neoplasm with Regional Lymph Node Involvement,0
10531,Determined by,Malignant neoplasm of thalamus,0
10532,Mumps virus,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10533,site-specific telomere resolvase activity,Chronic Myelomonocytic Leukemia-2,0
10534,Hematologic Tests,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10535,<50,Werner Syndrome,0
10536,Manipulation procedure,Blepharal carcinoma,0
10537,Greater,Medulloblastoma,0
10538,Case Study,Recurrent Uveal Melanoma,0
10539,control aspects,Secondary malignant neoplasm of lymph node,0
10540,Type - attribute,Choroid Necrotic Melanoma,0
10541,Negation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10542,Associated with,Leiomyoma of Gallbladder,0
10543,high - ActExposureLevelCode,Endometrial Small Cell Carcinoma,0
10544,removal technique,Thymic Clear Cell Carcinoma,0
10545,Nevus,benign mature teratoma of pancreas,0
10546,failed,Deep Leiomyoma,0
10547,Include (action),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10548,Intellectual scale,Stage IV Penile Cancer AJCC v7,0
10549,Biomaterial Treatment,Localized Ewing Sarcoma,0
10550,Complete,Endometrial Small Cell Carcinoma,0
10551,Derivation,papillary carcinoma of penis,0
10552,Extrinsic,Liver Cavernous Hemangioma,0
10553,Cover - action,Benign tumor of eyelid,0
10554,Tryptophanase,Thymic Clear Cell Carcinoma,0
10555,Menopause,Anterior Urethral Malignant Neoplasm,0
10556,Persons,Human Papillomavirus-Related Carcinoma,0
10557,Therapy Object (animal model),Acantholytic squamous cell carcinoma,0
10558,treatment - ActInformationManagementReason,Testicular cancer metastatic,0
10559,Leading,Testicular cancer metastatic,0
10560,More Often than Once a Day,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10561,Type A,Adult Fibrolamellar Carcinoma,0
10562,Study,Cancer of Urinary Tract,0
10563,Due to,non-Hodgkin's lymphoma of spleen,0
10564,Historical aspects qualifier,Refractory Barrett Esophagus,0
10565,Disease,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10566,Location of Oral Residue Following Swallowing,Uterine Cancer,0
10567,Common Specifications in HL7 V3 Publishing,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
10568,Two,papillary carcinoma of penis,0
10569,Manufactured form,Pancreatic Intraepithelial Neoplasia-3,0
10570,Severe (severity modifier),Mucinous adenocarcinoma gastric,0
10571,Occurrence,High Grade Glandular Intraepithelial Neoplasia,0
10572,Including (qualifier),Xeroderma pigmentosum,0
10573,Useful,Thymic Clear Cell Carcinoma,0
10574,Diagnosis,Larynx carcinoma recurrent,0
10575,Application Context,Intracortical osteosarcoma,0
10576,Mastocytosis,Localized Askin Tumor,0
10577,Occur (action),Localized Askin Tumor,0
10578,Immature,Carcinoma of urinary bladder,0
10579,Mesenchymal Stem Cells,Advanced Lung Carcinoma,0
10580,N+ (tumor staging),Endometrial Small Cell Carcinoma,0
10581,Area,Childhood Thyroid Gland Follicular Carcinoma,0
10582,Feature,Mucinous adenocarcinoma gastric,0
10583,Often - answer to question,Cerebral Primitive Neuroectodermal Tumor,0
10584,MUTYH-Associate Polyposis,Uterine Cancer,0
10585,Development,Testicular cancer metastatic,0
10586,Pass (indicator),Noninfiltrating Intraductal Carcinoma,0
10587,Fetus,Neonatal leukemia,0
10588,kidneys and collecting system,Stage IB Pancreatic Cancer AJCC v8,0
10589,Marketing basis - Transitional,Chronic Myelomonocytic Leukemia-2,0
10590,Telling untruths,Stage IB Pancreatic Cancer AJCC v8,0
10591,pharmacotherapeutic,Granular Cell Leiomyosarcoma,0
10592,Decrease in appetite,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10593,Chemotherapy,Undifferentiated Endocervical Sarcoma,0
10594,White blood cells urine (lab test),Pilocytic astrocytoma of cerebellum,0
10595,Availability of,FIGO Stage II Ovarian Cancer,0
10596,Li-Fraumeni Syndrome,benign mature teratoma of pancreas,0
10597,Malignancy,Hodgkin lymphoma,0
10598,Ephrin Type-B Receptor 1,Clonal Hematopoiesis of Indeterminate Potential,0
10599,Urine looks dark,Pancreatic Intraepithelial Neoplasia-3,0
10600,True,Localized Askin Tumor,0
10601,Testis,Collecting Duct Carcinoma of the Kidney,0
10602,Include (action),Locally Advanced Soft Tissue Sarcoma,0
10603,Proteins,Recurrent Testicular Lymphoma,0
10604,Squamous cell carcinoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10605,Neoplasm Metastasis,FIGO Stage II Ovarian Cancer,0
10606,Intestines,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10607,Screening,Bladder squamous cell carcinoma stage I,0
10608,Publications,Digestive System Hodgkin Lymphoma,0
10609,Base - General Qualifier,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10610,Epidemiology,Stage IB Pancreatic Cancer AJCC v8,0
10611,per year,Cancer of Urinary Tract,0
10612,Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,0
10613,Term (lexical),Cartilaginous exostosis,0
10614,Decision,Recurrent Testicular Lymphoma,0
10615,Operative Surgical Procedures,Malignant melanoma of eyelid,0
10616,Usual,Digestive System Hodgkin Lymphoma,0
10617,include - SetOperator,Liver Lymphangioma,0
10618,Abdomen,Breast Ductal Adenoma,0
10619,Telephone Extension Number,Advanced Uterine Corpus Carcinosarcoma,0
10620,Treating,Endometrial Small Cell Carcinoma,0
10621,Occurrence,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10622,Severe Extremity Pain,Platinum-Resistant Lung Small Cell Carcinoma,0
10623,Stop (qualifier value),Mucinous adenocarcinoma gastric,0
10624,Secondary to,Primary Cutaneous Plasmablastic Lymphoma,0
10625,Infected,Mucinous neoplasm,0
10626,Malignant Neoplasms,Acute lymphadenitis,0
10627,Specimen Source Codes - tumor,Undifferentiated Endocervical Sarcoma,0
10628,100%,Pancreatic Intraepithelial Neoplasia-3,0
10629,Generalization (Psychology),Atypical Lobular Breast Hyperplasia,0
10630,Antimicrobial Intermediate Susceptibility Result,Breast Ductal Adenoma,0
10631,Fever,Keratoderma,0
10632,Human body,Locally Advanced Soft Tissue Sarcoma,0
10633,Linear,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10634,Extension,Hemangioma,0
10635,Specimen Source Codes - Lesion,Lipoma of small intestine,0
10636,Category Type,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10637,Family (taxonomic),mucinous adenocarcinoma of gallbladder,0
10638,Common (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10639,Magnetic Resonance Imaging Study File,Neonatal leukemia,0
10640,Kinked,Urethral Carcinoma,0
10641,Sequence Arm,Placental aromatase deficiency,0
10642,Firstly,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10643,Birth defects diagnosis:Find:Pt:^Patient:Nar,Keratoderma,0
10644,Observation of color of skin,Malignant neoplasm of thalamus,0
10645,Face (spatial concept),Localized Ewing Sarcoma,0
10646,Including (qualifier),Deep Leiomyoma,0
10647,Two,Ovarian germ cell choriocarcinoma stage IV,0
10648,Breast,FIGO Stage II Ovarian Cancer,0
10649,Hemorrhage,Stage IB Pancreatic Cancer AJCC v8,0
10650,Palpebronasal fold,Advanced Uterine Corpus Carcinosarcoma,0
10651,Symptoms,Heavy Chain Deposition Disease,0
10652,Blood,Stage II Carcinoma of Penis,0
10653,Living Alone,Cerebral Primitive Neuroectodermal Tumor,0
10654,Common (qualifier value),Lung squamous cell carcinoma stage I,0
10655,Symptoms aspect,Metastatic Ductal Breast Carcinoma,0
10656,BRCA1 protein,Adult Alveolar Soft Part Sarcoma,0
10657,Mutation,Stage 0 Penile Cancer AJCC v8,0
10658,Science of Etiology,Cerebral hemangioma,0
10659,Singular,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10660,Relationship by association,Mucinous cystadenofibroma,0
10661,Reinfection,Bladder squamous cell carcinoma stage I,0
10662,Responsible to,Thymic Clear Cell Carcinoma,0
10663,Medulloblastoma,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10664,Only - dosing instruction fragment,Stage I Adult Non-Hodgkin Lymphoma,0
10665,Lung,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10666,Upper,Ovarian germ cell choriocarcinoma stage IV,0
10667,How Often Itching,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10668,Glioma,Mucinous adenocarcinoma gastric,0
10669,Completely - dosing instruction fragment,mucinous adenocarcinoma of gallbladder,0
10670,Present,Heavy Chain Deposition Disease,0
10671,CD5L wt Allele,Malignant melanoma of eyelid,0
10672,Therapy Object (animal model),Diffuse malignant mesothelioma,0
10673,Removed,Atypical Lobular Breast Hyperplasia,0
10674,Type A,Intracortical osteosarcoma,0
10675,Asia,Small cell neuroendocrine carcinoma of bladder,0
10676,Presence of cells,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10677,Regular,Acute Undifferentiated Leukemia,0
10678,Malignant epithelioma,Undifferentiated Endocervical Sarcoma,0
10679,Type - attribute,Acute Undifferentiated Leukemia,0
10680,Diagnostic Imaging,Methotrexate-Associated Hodgkin Lymphoma,0
10681,Body part,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10682,Lacking,Neoplasms,0
10683,Common Specifications in HL7 V3 Publishing,Thymic Clear Cell Carcinoma,0
10684,Usual,Benign tumor of eyelid,0
10685,Medications,Carcinoma of urinary bladder,0
10686,In addition to,Stage IV Childhood Non-Hodgkin Lymphoma,0
10687,Primitive Streak,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10688,Infective cystitis,Female Breast Carcinoma,0
10689,Bothered by Vomiting,Neonatal leukemia,0
10690,Personal appearance,Diffuse malignant mesothelioma,0
10691,Allergen (brand of diphenylpyraline),Pancreatic Intraepithelial Neoplasia-3,0
10692,Often - answer to question,Primary Cutaneous Plasmablastic Lymphoma,0
10693,Oral cavity,Mucinous neoplasm,0
10694,Malignant Neoplasms,Colorectal Neuroendocrine Tumor G2,0
10695,Related personal status,mucinous adenocarcinoma of gallbladder,0
10696,Neuroendocrine Tumors,High Grade Glandular Intraepithelial Neoplasia,0
10697,Upper arm,Liver Lymphangioma,0
10698,Increased,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10699,Aim,embryonal rhabdomyosarcoma of prostate,0
10700,Ovary,Fourth Ventricle and Brain Stem Ependymal Tumor,0
10701,In Situ Follicular Neoplasia,Anterior Urethral Malignant Neoplasm,0
10702,Approximate,Childhood Thyroid Gland Follicular Carcinoma,0
10703,shared attribute,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10704,Changing,Refractory Barrett Esophagus,0
10705,Areas <moth>,Human Papillomavirus-Related Carcinoma,0
10706,cervical cancer,Rhabdomyosarcoma with ganglionic differentiation,0
10707,Stomach,Methotrexate-Associated Hodgkin Lymphoma,0
10708,status - In progress,Childhood Fibrillary Astrocytoma,0
10709,Major,Carcinoma of urinary bladder,0
10710,Often - answer to question,Cartilaginous exostosis,0
10711,other medicated shampoos in ATC,Digestive System Hodgkin Lymphoma,0
10712,Cultured Cell Line,Endometrial Small Cell Carcinoma,0
10713,Disease Outbreaks,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10714,Specific qualifier value,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10715,Characteristics,mucinous adenocarcinoma of gallbladder,0
10716,Carcinoma,Carcinoma of urinary bladder,0
10717,Coloring Excipient,Cartilaginous exostosis,0
10718,Cell Count,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10719,Presentation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10720,Spinal Cord,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10721,Involvement with,Thymic Clear Cell Carcinoma,0
10722,Data Compression,Metastatic Malignant Neoplasm in the Sellar Region,0
10723,VARIOUS DRUG CLASSES IN ATC,Female Breast Carcinoma,0
10724,Immune System Processes,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10725,Adult,Liver Lymphangioma,0
10726,Staging system,Localized Askin Tumor,0
10727,IPSS Risk Category High,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10728,penis,Colorectal Neuroendocrine Tumor G2,0
10729,Plumbum metallicum,Angiosarcoma of liver,0
10730,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Acantholytic squamous cell carcinoma,0
10731,65,de novo Myelodysplastic Syndrome,0
10732,Formation,mucinous adenocarcinoma of gallbladder,0
10733,Ability to balance,Neoplasms,0
10734,1000000,Stage IV Childhood Non-Hodgkin Lymphoma,0
10735,Homo sapiens,Intestinal Neuroendocrine Carcinoma,0
10736,Skeletal bone,Malignant Neoplasm of Lung - Multiple Primary Sites,0
10737,Intravascular line,Keratoderma,0
10738,Q13,Testicular cancer metastatic,0
10739,Ability,Stage IV Childhood Non-Hodgkin Lymphoma,0
10740,Binding (Molecular Function),Endometrial Small Cell Carcinoma,0
10741,Supportive assistance,Unresectable Rhabdomyosarcoma,0
10742,Either,Small cell neuroendocrine carcinoma of bladder,0
10743,Abdominal Cavity,Hodgkin lymphoma,0
10744,Name,Maxillary Sinus Adenocarcinoma,0
10745,1000000,Benign tumor of eyelid,0
10746,Carcinoma of lung,Granular Cell Leiomyosarcoma,0
10747,Cessation of life,Secondary malignant neoplasm of lymph node,0
10748,Affecting,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10749,Fever,Lipoma of small intestine,0
10750,Feel Tired question,Hodgkin lymphoma,0
10751,Blood Platelets,Thymic Clear Cell Carcinoma,0
10752,Growth abnormality,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10753,Clone,Unresectable Rhabdomyosarcoma,0
10754,Urinary tract,Mixed parotid tumor,0
10755,>90,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10756,Spreading (qualifier value),BRCA2 Syndrome,0
10757,combination - answer to question,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10758,Subject Risk,Benign Apocrine Neoplasm,0
10759,Basis - conceptual entity,Acantholytic squamous cell carcinoma,0
10760,Poor - qualifier,Refractory Barrett Esophagus,0
10761,Containing (qualifier),Lipoma of small intestine,0
10762,*Type - Kind of quantity,Keratoderma,0
10763,Non-Small Cell Lung Carcinoma,Rhabdomyosarcoma with ganglionic differentiation,0
10764,CD69 wt Allele,Secondary malignant neoplasm of lymph node,0
10765,Process,sarcoma of spinal cord,0
10766,Before,Malignant neoplasm of thalamus,0
10767,Biologic Development,Recurrent Uveal Melanoma,0
10768,Increase,Thymic Atypical Carcinoid Tumor,0
10769,Usual,Mucinous adenocarcinoma gastric,0
10770,Comparison,Granular Cell Leiomyosarcoma,0
10771,described,squamous cell carcinoma of the thyroid gland,0
10772,Colon <insect>,Non-Metastatic Gestational Trophoblastic Tumor,0
10773,bony process,Intestinal Neuroendocrine Carcinoma,0
10774,Type - attribute,Undifferentiated Neuroblastoma,0
10775,Linear,Mucinous cystadenofibroma,0
10776,Study Control,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10777,Symptoms,FIGO Stage II Ovarian Cancer,0
10778,Have Weight Loss,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10779,Body structure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10780,Used by,carcinoma of middle ear,0
10781,Including (qualifier),Neonatal leukemia,0
10782,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Medulloblastoma,0
10783,United Kingdom,Non-Metastatic Gestational Trophoblastic Tumor,0
10784,bony process,Atypical Mesothelial Hyperplasia,0
10785,Treating,Cancer of Urinary Tract,0
10786,To,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
10787,Active License,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10788,Primary,Acantholytic squamous cell carcinoma,0
10789,What subject filter - Result,Refractory Barrett Esophagus,0
10790,Painless,Pilocytic astrocytoma of cerebellum,0
10791,Include (action),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10792,Congenital Abnormality,Localized Ewing Sarcoma,0
10793,Fatigue,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10794,High,Human Papillomavirus-Related Carcinoma,0
10795,Paraganglioma,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10796,Central,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10797,Rating (action),Human Papillomavirus-Related Carcinoma,0
10798,Fragment,Mucinous cystadenofibroma,0
10799,Including (qualifier),Noninfiltrating Intraductal Carcinoma,0
10800,Categories,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10801,Including (qualifier),Acantholytic squamous cell carcinoma,0
10802,Premature aging syndrome,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10803,depend,Cerebral Primitive Neuroectodermal Tumor,0
10804,Physical Examination,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10805,Feelings,Localized Askin Tumor,0
10806,Death Related to Adverse Event,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10807,Time (foundation metadata concept),Acantholytic squamous cell carcinoma,0
10808,Hyperlink,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10809,medication - HL7 publishing domain,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10810,Area,Human Papillomavirus-Related Carcinoma,0
10811,Due to,Malignant Neoplasm with Regional Lymph Node Involvement,0
10812,Seventh,Colorectal Neuroendocrine Tumor G2,0
10813,Nausea Visual Analogue Scale,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10814,size,Thymoma malignant recurrent,0
10815,Make - Instruction Imperative,Blepharal carcinoma,0
10816,Table Rules - groups,BRCA2 Syndrome,0
10817,Kidney Tubules,adenoid cystic carcinoma of lung,0
10818,Condition,sarcoma of spinal cord,0
10819,unknown vaccine or immune globulin,Intestinal Neuroendocrine Carcinoma,0
10820,Rare,Intestinal Neuroendocrine Carcinoma,0
10821,Reported Term,Granular Cell Leiomyosarcoma,0
10822,Source,Recurrent Uveal Melanoma,0
10823,Dysplasia,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10824,Qualitative form,Stage IB Lung Cancer AJCC v7,0
10825,intrathecal chemotherapy,Diffuse malignant mesothelioma,0
10826,Gastrointestinal tract structure,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10827,Treating,Mucinous adenocarcinoma gastric,0
10828,physiological aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10829,True,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10830,Formation,Intraepithelial Melanocytic Hyperplasia,0
10831,Biological Response Modifiers,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10832,Histology,Intestinal Metaplasia of Bladder Urothelium,0
10833,Aggressive course,Cancer of Urinary Tract,0
10834,ACACA wt Allele,Unresectable Rhabdomyosarcoma,0
10835,Decision,Localized Askin Tumor,0
10836,Primary malignant neoplasm,Diffuse malignant mesothelioma,0
10837,Recommendation,Human Papillomavirus-Related Carcinoma,0
10838,Lymphocyte component of blood,squamous cell carcinoma of the thyroid gland,0
10839,include - SetOperator,de novo Myelodysplastic Syndrome,0
10840,Coitus,mucinous adenocarcinoma of gallbladder,0
10841,symbol,Extra-Adrenal Paraganglioma,0
10842,Smear - instruction imperative,adenoid cystic carcinoma of lung,0
10843,Persons,Benign neoplasm of thorax,0
10844,NCI CTEP SDC Melanoma Sub-Category Terminology,Malignant melanoma of eyelid,0
10845,treatment - ActInformationManagementReason,embryonal rhabdomyosarcoma of prostate,0
10846,Documented,Adult Alveolar Soft Part Sarcoma,0
10847,Diagnosis,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10848,Anterior,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10849,Virus,Intraepithelial Melanocytic Hyperplasia,0
10850,Include (action),Adult Hepatocellular Carcinoma,0
10851,Comparison,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10852,Study Site,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10853,biopsy characteristics,Recurrent Uveal Melanoma,0
10854,Incidence,Liver Lymphangioma,0
10855,Pallor of skin,Colorectal High Grade B-Cell Lymphoma,0
10856,Capsule Dosing Unit,Extra-Adrenal Paraganglioma,0
10857,Publications,GIANT PIGMENTED HAIRY NEVUS,0
10858,Treating,Adult Fibrolamellar Carcinoma,0
10859,Specimen Source Codes - tumor,Childhood Fibrillary Astrocytoma,0
10860,Immune system,Uterine Cancer,0
10861,Retinoic Acid Response Element,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10862,Germ Cells,Breast Ductal Adenoma,0
10863,Brain,Unfavorable Non-Hodgkin Lymphoma,0
10864,Reported,Maxillary Sinus Adenocarcinoma,0
10865,Formation,Xeroderma pigmentosum,0
10866,Primary malignant neoplasm,Xeroderma pigmentosum,0
10867,Smaller,Carcinoma of urinary bladder,0
10868,Diagnosis,de novo Myelodysplastic Syndrome,0
10869,Main,Locally Advanced Soft Tissue Sarcoma,0
10870,granulocyte,adenosquamous carcinoma of breast,0
10871,Act Relationship Type - occurrence,Uterine Cancer,0
10872,alone - group size,Childhood Central Nervous System Immature Teratoma,0
10873,Affect (mental function),Choroid Necrotic Melanoma,0
10874,Ulcer,Digestive System Hodgkin Lymphoma,0
10875,+2,Carcinoma of urinary bladder,0
10876,Manufactured sign,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10877,Part Dosing Unit,Cerebral Primitive Neuroectodermal Tumor,0
10878,Hematologic Tests,benign mature teratoma of pancreas,0
10879,Generation (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10880,Case (situation),papillary carcinoma of penis,0
10881,Similarity,Tonsillar Carcinoma,0
10882,Tumor cells,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10883,Aspiration-action,Low Grade Squamous Intraepithelial Neoplasia,0
10884,European race,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10885,Childhood Diffuse Large B-Cell Lymphoma,Endometrial Small Cell Carcinoma,0
10886,Placenta,Clonal Hematopoiesis of Indeterminate Potential,0
10887,Domain (area of knowledge),Giant cell angiofibroma,0
10888,Weight decreased,Hemangioma,0
10889,analysis aspect,Childhood Thyroid Gland Follicular Carcinoma,0
10890,Squamous cell carcinoma,Chondrosarcoma,0
10891,Anterior,FIGO Stage II Ovarian Cancer,0
10892,Spreading (qualifier value),de novo Myelodysplastic Syndrome,0
10893,Occurrence Indicator,Stage II Hepatocellular Carcinoma AJCC v8,0
10894,Sarcoma - category (morphologic abnormality),FIGO Stage II Ovarian Cancer,0
10895,Exertion,Unresectable Rhabdomyosarcoma,0
10896,Packaging Case,Cancer of Urinary Tract,0
10897,Diabetes,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
10898,Plasmacytoma - category,sarcoma of spinal cord,0
10899,Evidence,embryonal rhabdomyosarcoma of prostate,0
10900,Chemotherapy,Recurrent Testicular Lymphoma,0
10901,fluid - substance,Ampulla of Vater Tubular Adenoma,0
10902,Various patch test substance,Carcinoma of urinary bladder,0
10903,Surgery specialty,Acute Undifferentiated Leukemia,0
10904,Human Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10905,Table Rules - groups,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10906,Science of Etiology,Neonatal leukemia,0
10907,Pathologic,Thymic Atypical Carcinoid Tumor,0
10908,Two,Malignant melanoma of eyelid,0
10909,Aspects of disease screening,Malignant melanoma of eyelid,0
10910,General surgery specialty,Airway Hemangioma,0
10911,low exposure,Diffuse malignant mesothelioma,0
10912,Symptoms,Adenocarcinoma of the prostate metastatic,0
10913,Critical,Xeroderma pigmentosum,0
10914,Transection (procedure),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
10915,Contain (action),Intraepithelial Melanocytic Hyperplasia,0
10916,Supportive assistance,Ichthyosis,0
10917,Active License,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10918,Ivory Coast,Choroid Necrotic Melanoma,0
10919,Operative Surgical Procedures,Mucinous adenocarcinoma gastric,0
10920,Attack behavior,Recurrent Testicular Lymphoma,0
10921,Malignant Neoplasms,Carcinoma of urinary bladder,0
10922,Short Value,Placental aromatase deficiency,0
10923,High Mitosis-Karyorrhexis Index,Human Papillomavirus-Related Carcinoma,0
10924,Name (property) (qualifier value),Localized Ewing Sarcoma,0
10925,Usually,Stage III Adult Immunoblastic Lymphoma,0
10926,Used by,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10927,Lung,Acute Undifferentiated Leukemia,0
10928,Money or percentage indicator - Percentage,sarcoma of spinal cord,0
10929,Five,Benign neoplasm of thorax,0
10930,Lymphocyte component of blood,Liver Cavernous Hemangioma,0
10931,pharmacotherapeutic,Unresectable Rhabdomyosarcoma,0
10932,Muscle (organ),Mucinous adenocarcinoma gastric,0
10933,Classical (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
10934,Solid Dose Form,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10935,Malignant Vaginal Neoplasm,Lipoma of small intestine,0
10936,put - instruction imperative,Pilocytic astrocytoma of cerebellum,0
10937,Adult Classical Hodgkin Lymphoma,Pancreatic Intraepithelial Neoplasia-3,0
10938,Electromagnetic Fields,Acute Undifferentiated Leukemia,0
10939,How Often Sweats,Metastatic Neoplasm to the Gallbladder,0
10940,Vaccinated at,Unresectable Rhabdomyosarcoma,0
10941,Known,Human Papillomavirus-Related Carcinoma,0
10942,Eczema,Endometrial Small Cell Carcinoma,0
10943,Tissue Specimen Code,adenoid cystic carcinoma of lung,0
10944,lymph nodes,Metastatic Neoplasm to the Gallbladder,0
10945,Diffuse Large B-Cell Lymphoma,Acute Undifferentiated Leukemia,0
10946,Pancreatitis,Stage 0 Penile Cancer AJCC v8,0
10947,Orbital region,Uterine Cancer,0
10948,Only - dosing instruction fragment,Mucinous adenocarcinoma gastric,0
10949,Pain,Acute Undifferentiated Leukemia,0
10950,Account number:Identifier:Point in time:^Patient:Nominal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10951,Result,Stage IV Penile Cancer AJCC v7,0
10952,Japan,Localized Askin Tumor,0
10953,Classification of information,Chondrosarcoma,0
10954,Immune System Part,Childhood Lymphoma,0
10955,Fever,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10956,Specific qualifier value,Granular Cell Leiomyosarcoma,0
10957,CD69 wt Allele,Undifferentiated Neuroblastoma,0
10958,Obesity,Localized Askin Tumor,0
10959,20%,Malignant Neoplasm with Regional Lymph Node Involvement,0
10960,physiological aspects,Anterior Urethral Malignant Neoplasm,0
10961,Curative - procedure intent,Metastatic Carcinoma in the Lung,0
10962,Biopsy,Digestive System Hodgkin Lymphoma,0
10963,Thymoma,Endometrial Small Cell Carcinoma,0
10964,Due to,Ichthyosis,0
10965,1000000,Placental aromatase deficiency,0
10966,Reported Term,Stage IV Penile Cancer AJCC v7,0
10967,Personal appearance,Carcinoma ex pleomorphic adenoma of parotid gland,0
10968,Help document,Mucinous cystadenofibroma,0
10969,Cancer Genus,Hemangioma,0
10970,Location of Pharyngeal Residue Following Swallowing,Stage IB Pancreatic Cancer AJCC v8,0
10971,One,Diffuse malignant mesothelioma,0
10972,Females,squamous cell carcinoma of the thyroid gland,0
10973,Malignant neoplasm of larynx,Intraepithelial Melanocytic Hyperplasia,0
10974,Cells,Metastatic Ductal Breast Carcinoma,0
10975,30%,Tonsillar Carcinoma,0
10976,survive,Acantholytic squamous cell carcinoma,0
10977,Family history,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10978,combination of objects,Anaplastic large cell lymphoma,0
10979,Males,Human Papillomavirus-Related Carcinoma,0
10980,Bladder Neoplasm,Unresectable Rhabdomyosarcoma,0
10981,Person Name,Spongiotic dermatitis,0
10982,Disease,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10983,Human papilloma virus infection,Anterior Urethral Malignant Neoplasm,0
10984,include - SetOperator,Hodgkin lymphoma,0
10985,Primary operation,malignant lymphoma of pancreatic lymph nodes,0
10986,site-specific telomere resolvase activity,Spermatocytic seminoma,0
10987,geographic population,Malignant melanoma of eyelid,0
10988,Neuron spine,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10989,Mathematical Operator,Adult Alveolar Soft Part Sarcoma,0
10990,Metastatic Disease Clinical Trial Setting,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10991,Etiology aspects,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10992,Linear,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10993,Deletion 1p36,Acantholytic squamous cell carcinoma,0
10994,Genus Homo,Unfavorable Non-Hodgkin Lymphoma,0
10995,risk factors - observation list,Recurrent Uveal Melanoma,0
10996,Present,Malignant melanoma of eyelid,0
10997,radiotherapeutic,Human Papillomavirus-Related Carcinoma,0
10998,Legal Adult,Localized Ewing Sarcoma,0
10999,Usual Severity Weight Loss,Atypical Lobular Breast Hyperplasia,0
11000,Infrequent,Acute Undifferentiated Leukemia,0
11001,Occurrence Indicator,FIGO Stage II Ovarian Cancer,0
11002,Surveys,Mucinous neoplasm,0
11003,Tissue Specimen Code,Adenocarcinoma,0
11004,Preventive intent,Extra-Adrenal Paraganglioma,0
11005,Two,Larynx carcinoma recurrent,0
11006,control substance,Breast Ductal Adenoma,0
11007,Condition,Anterior Urethral Malignant Neoplasm,0
11008,Cervix carcinoma,Clonal Hematopoiesis of Indeterminate Potential,0
11009,Exertion,Anterior Urethral Malignant Neoplasm,0
11010,Further,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11011,Vision,Female Breast Carcinoma,0
11012,Beginning,non-Hodgkin's lymphoma of spleen,0
11013,Easy,Heavy Chain Deposition Disease,0
11014,various antiinfectives and antiseptics for local oral treatment,Human Papillomavirus-Related Carcinoma,0
11015,Occur (action),Benign tumor of eyelid,0
11016,Status post,Collecting Duct Carcinoma of the Kidney,0
11017,lymph nodes,Malignant melanoma of eyelid,0
11018,Good,Pilocytic astrocytoma of cerebellum,0
11019,Following,non-Hodgkin's lymphoma of spleen,0
11020,Body Fluids,Stage II Hepatocellular Carcinoma AJCC v8,0
11021,Age,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11022,Beginning,Ovarian Carcinoid Tumor,0
11023,Smudge cell,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11024,Pancreatitis,Metastatic Neoplasm to the Gallbladder,0
11025,50%,Spermatocytic seminoma,0
11026,>90,Uterine Cancer,0
11027,Face,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11028,Second edition,FIGO Stage II Ovarian Cancer,0
11029,Tobacco smoking behavior,Adenocarcinoma,0
11030,year,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11031,Form:Finding:Point in time:{Setting}:Document:{Role},Malignant melanoma of eyelid,0
11032,Ductal Breast Carcinoma,Stage I Adult Non-Hodgkin Lymphoma,0
11033,SLC6A2 wt Allele,Endometrial Small Cell Carcinoma,0
11034,Leads (device),Human Papillomavirus-Related Carcinoma,0
11035,Malignant Neoplasms,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11036,One,Anterior Urethral Malignant Neoplasm,0
11037,Evidence,Choroid Necrotic Melanoma,0
11038,Characterization,Childhood Fibrillary Astrocytoma,0
11039,Communication Contact,Anaplastic large cell lymphoma,0
11040,Acute Myeloid Leukemia Pathway,Atypical Mesothelial Hyperplasia,0
11041,Mutation Abnormality,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11042,1+ Score,Metastatic Ductal Breast Carcinoma,0
11043,Ninein,embryonal rhabdomyosarcoma of prostate,0
11044,Clonality,Childhood Thyroid Gland Follicular Carcinoma,0
11045,Nictitating Membrane,Recurrent Testicular Lymphoma,0
11046,Stage Grouping,Digestive System Hodgkin Lymphoma,0
11047,Benign tumor of salivary gland,Methotrexate-Associated Hodgkin Lymphoma,0
11048,Irritation (finding),Malignant Testicular Sertoli Cell Tumor,0
11049,error,Stage I Adult Non-Hodgkin Lymphoma,0
11050,Chronic myeloproliferative disorder,Human Papillomavirus-Related Carcinoma,0
11051,Follow,Non-Metastatic Gestational Trophoblastic Tumor,0
11052,Cancer Genus,Extra-Adrenal Paraganglioma,0
11053,Cystadenoma,Tonsillar Carcinoma,0
11054,Disease Steps Questionnaire,Neonatal leukemia,0
11055,In Urine,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11056,Neoplasms,Metastatic Lung Small Cell Carcinoma,0
11057,intrathecal chemotherapy,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11058,Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,Recurrent Uveal Melanoma,0
11059,Mechanism Component of Device,Maxillary Sinus Adenocarcinoma,0
11060,Fever,Anterior Urethral Malignant Neoplasm,0
11061,Tissue Type Code - Basal cell carcinoma,Clonal Hematopoiesis of Indeterminate Potential,0
11062,Fertility Agents,Benign tumor of eyelid,0
11063,early detection of cervical cancer,Contact dermatitis due to alkali,0
11064,South Korea,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11065,physiological aspects,embryonal rhabdomyosarcoma of prostate,0
11066,shared attribute,Neoplasms,0
11067,Have Weight Loss,Adenocarcinoma,0
11068,Most,FIGO Stage II Ovarian Cancer,0
11069,Ependymoma,Cancer of Urinary Tract,0
11070,Adult Anaplastic Large Cell Lymphoma,Non-Metastatic Gestational Trophoblastic Tumor,0
11071,Entity Determiner - specific,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11072,Etiology aspects,Diffuse malignant mesothelioma,0
11073,Body Fluids,Angiosarcoma of liver,0
11074,Tissue Specimen Code,embryonal rhabdomyosarcoma of prostate,0
11075,Pale color saturation,Recurrent Testicular Lymphoma,0
11076,Concept model domain,Stage IV Penile Cancer AJCC v7,0
11077,Bands,Tonsillar Carcinoma,0
11078,Better than Others,Colorectal Neuroendocrine Tumor G2,0
11079,Current (present time),Maxillary Sinus Adenocarcinoma,0
11080,Occurrence Indicator,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11081,High,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11082,Occur (action),Mucinous adenocarcinoma gastric,0
11083,Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11084,Cause of death:Find:Pt:^Patient:Nom,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11085,Malignant Neoplasms,Fourth Ventricle and Brain Stem Ependymal Tumor,0
11086,Reaching,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11087,Internal,Cartilaginous exostosis,0
11088,Pain NOS,Mastocytosis,0
11089,Lymphoma,adenoid cystic carcinoma of lung,0
11090,>90,Bladder squamous cell carcinoma stage I,0
11091,Rare,Malignant melanoma of eyelid,0
11092,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Urethral Carcinoma,0
11093,Time,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11094,Atlases,non-Hodgkin's lymphoma of spleen,0
11095,Type - attribute,Extracranial Neuroblastoma,0
11096,cell activation,Medulloblastoma,0
11097,Hemopoietic tissue,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11098,Base,Cancer of Urinary Tract,0
11099,80%,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11100,Known,Chronic Myelomonocytic Leukemia-2,0
11101,Cystitis,Methotrexate-Associated Hodgkin Lymphoma,0
11102,Status post,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11103,Involvement with,Thymoma malignant recurrent,0
11104,Follicle,Recurrent Uveal Melanoma,0
11105,South East Asian,Xeroderma pigmentosum,0
11106,Entity,BRCA2 Syndrome,0
11107,Third grade in elementary school,Stage II Carcinoma of Penis,0
11108,Polypeptide Hormones,Undifferentiated Endocervical Sarcoma,0
11109,Lacking,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11110,See,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11111,Primary malignant neoplasm,Deep Leiomyoma,0
11112,What subject filter - Result,Adult Hepatocellular Carcinoma,0
11113,Condition:Find:Pt:^Patient:Nom,FIGO Stage II Ovarian Cancer,0
11114,Manufactured form,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
11115,Western Europe,adenoid cystic carcinoma of lung,0
11116,Anatomic Site,Ovarian germ cell choriocarcinoma stage IV,0
11117,Form:Finding:Point in time:{Setting}:Document:{Role},Endometrial Small Cell Carcinoma,0
11118,described,BRCA2 Syndrome,0
11119,Direct type of relationship,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11120,Brain part,Colorectal cancer,0
11121,nonmyeloablative allogeneic hematopoietic stem cell transplantation,Adenocarcinoma,0
11122,Ultraviolet Rays,Unresectable Rhabdomyosarcoma,0
11123,metastatic qualifier,Stage IV Childhood Non-Hodgkin Lymphoma,0
11124,Synonym (core metadata concept),Methotrexate-Associated Hodgkin Lymphoma,0
11125,Including (qualifier),Endometrial Small Cell Carcinoma,0
11126,Genetic Risk,Secondary malignant neoplasm of lymph node,0
11127,diagnosis aspect,Endometrial Small Cell Carcinoma,0
11128,Array Feature,Cancer of Urinary Tract,0
11129,Age of Onset,Xeroderma pigmentosum,0
11130,3+ Score,Stage II Carcinoma of Penis,0
11131,Biopsy,Unfavorable Non-Hodgkin Lymphoma,0
11132,Accurate (qualifier),Digestive System Hodgkin Lymphoma,0
11133,Immune system,mucinous adenocarcinoma of gallbladder,0
11134,Have Weight Loss,Childhood Thyroid Gland Follicular Carcinoma,0
11135,Precipitating Factors,Acute Undifferentiated Leukemia,0
11136,Death (finding),Familial Adenomatous Polyposis Associated Medulloblastoma,0
11137,Tumor grade G3,non-Hodgkin's lymphoma of spleen,0
11138,Rare,Undifferentiated Neuroblastoma,0
11139,Intravascular line,Colorectal High Grade B-Cell Lymphoma,0
11140,Part of,mucinous adenocarcinoma of gallbladder,0
11141,Cover - action,Adult Alveolar Soft Part Sarcoma,0
11142,Have Weight Loss,Childhood Lymphoma,0
11143,Value Above Reference Range,Malignant neoplasm of choroid,0
11144,Pathogenic organism,Recurrent Testicular Lymphoma,0
11145,Acquired (qualifier value),Mucinous adenocarcinoma gastric,0
11146,Often - answer to question,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11147,Three,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
11148,Set (Psychology),gliosarcoma,0
11149,Combined Modality Therapy,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11150,2+ Score,Diffuse malignant mesothelioma,0
11151,Childhood Non-Hodgkin Lymphoma,Benign tumor of eyelid,0
11152,Variable (uniformity),Cerebral Primitive Neuroectodermal Tumor,0
11153,structure,Unfavorable Non-Hodgkin Lymphoma,0
11154,Common (qualifier value),Maxillary Sinus Adenocarcinoma,0
11155,eTMF Content Model Code,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11156,Slightly Agree,Female Breast Carcinoma,0
11157,More,Adult Alveolar Soft Part Sarcoma,0
11158,Arising,Intestinal Neuroendocrine Carcinoma,0
11159,Approximate,Low Grade Squamous Intraepithelial Neoplasia,0
11160,Tissue damage,Clonal Hematopoiesis of Indeterminate Potential,0
11161,Moveable,Acute Undifferentiated Leukemia,0
11162,Warts,Xeroderma pigmentosum,0
11163,Protection,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11164,Base - General Qualifier,embryonal rhabdomyosarcoma of prostate,0
11165,Phenazopyridine,Xeroderma pigmentosum,0
11166,Malignant Childhood Neoplasm,Tonsillar Carcinoma,0
11167,Accidental Falls,benign mature teratoma of pancreas,0
11168,Links List,Secondary malignant neoplasm of lymph node,0
11169,Cells,Cancer of Urinary Tract,0
11170,Different,Heavy Chain Deposition Disease,0
11171,Li-Fraumeni Syndrome,Chronic Myelomonocytic Leukemia-2,0
11172,Including (qualifier),Breast Ductal Adenoma,0
11173,Secondary Neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11174,Similarity,Cerebral Primitive Neuroectodermal Tumor,0
11175,Cause of Death,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11176,Fever,Cerebral Primitive Neuroectodermal Tumor,0
11177,Occurrence Indicator,Giant cell angiofibroma,0
11178,Grade,Recurrent Testicular Lymphoma,0
11179,Skin Specimen,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
11180,Old,Mucinous adenocarcinoma gastric,0
11181,Referring,Leptomeningeal sarcoma,0
11182,Did not receive therapy or drug for,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11183,Endocervical epithelium,Adult Fibrolamellar Carcinoma,0
11184,Cancer Genus,Recurrent Uveal Melanoma,0
11185,Striated muscle cell,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11186,Financial Account,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11187,Direct (qualifier),Rhabdomyosarcoma with ganglionic differentiation,0
11188,Use of,malignant lymphoma of pancreatic lymph nodes,0
11189,10%,Intraepithelial Melanocytic Hyperplasia,0
11190,various other agents for local oral treatment in ATC,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11191,Oral cavity,Undifferentiated Endocervical Sarcoma,0
11192,Symptoms aspect,Cancer of Urinary Tract,0
11193,Type A,Recurrent Testicular Lymphoma,0
11194,Striated muscle cell,Malignant Neoplasm with Regional Lymph Node Involvement,0
11195,Annual,Malignant melanoma of eyelid,0
11196,Sectioning technique,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11197,Person 1,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11198,risk factors,Stage II Hepatocellular Carcinoma AJCC v8,0
11199,Update,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11200,Hereditary Diffuse Gastric Cancer,Localized Ewing Sarcoma,0
11201,Malignant Neoplasms,Giant cell angiofibroma,0
11202,N+ (tumor staging),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11203,Tryptophanase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11204,Therapeutic radiology procedure,Unresectable Rhabdomyosarcoma,0
11205,All,embryonal rhabdomyosarcoma of prostate,0
11206,Infection of kidney,Metastatic Carcinoma in the Lung,0
11207,Numbers,Benign tumor of eyelid,0
11208,Adult human body,mucinous adenocarcinoma of gallbladder,0
11209,Flank Pain,Localized Askin Tumor,0
11210,MALIGNANT benign,Anterior Urethral Malignant Neoplasm,0
11211,Pelvic Pain,Adult Hepatocellular Carcinoma,0
11212,Adenocarcinoma,Ovarian germ cell choriocarcinoma stage IV,0
11213,Infrequent,Acute Undifferentiated Leukemia,0
11214,Body Fluids,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
11215,Process (qualifier value),Liver Lymphangioma,0
11216,depend,Medulloblastoma,0
11217,Occurrence Indicator,Malignant neoplasm of choroid,0
11218,Beginning,squamous cell carcinoma of the thyroid gland,0
11219,Genitalia,Testicular cancer metastatic,0
11220,Hepatic Involvement,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11221,Skin Specimen,papillary carcinoma of penis,0
11222,Togo,Mucinous neoplasm,0
11223,Malignant Neoplasms,BRCA2 Syndrome,0
11224,Pleomorphic carcinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11225,Name Given at Birth,Liver Cavernous Hemangioma,0
11226,membrane attack complex location,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11227,Benign Vascular Neoplasm,Keratoderma,0
11228,health and disease,benign mature teratoma of pancreas,0
11229,Red Blood Cell Count measurement,Endometrial Small Cell Carcinoma,0
11230,atypia morphology,Stage II Carcinoma of Penis,0
11231,rapid diagnosis,Liver Lymphangioma,0
11232,Near,Stage IB Pancreatic Cancer AJCC v8,0
11233,Lead,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11234,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Benign Apocrine Neoplasm,0
11235,Human papilloma virus infection,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11236,Primary malignant neoplasm,Childhood Cerebellar Neoplasm,0
11237,Usual Severity Pain,Recurrent Uveal Melanoma,0
11238,Genes,Stage IB Pancreatic Cancer AJCC v8,0
11239,therapeutic aspects,Non-Metastatic Gestational Trophoblastic Tumor,0
11240,Make - Instruction Imperative,Childhood Thyroid Gland Follicular Carcinoma,0
11241,Activation action,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11242,Others - Allergy,Pilocytic astrocytoma of cerebellum,0
11243,More,Heavy Chain Deposition Disease,0
11244,Numbers,BRCA2 Syndrome,0
11245,Malignant neoplasm of kidney,BRCA2 Syndrome,0
11246,Subject Risk,Extracranial Neuroblastoma,0
11247,Africa,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11248,Singular,Mixed parotid tumor,0
11249,Common (qualifier value),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11250,World Health Organization,Acantholytic squamous cell carcinoma,0
11251,International Classification of Diseases for Oncology,Chronic Myelomonocytic Leukemia-2,0
11252,Net (qualifier),Breast Ductal Adenoma,0
11253,Affecting,Familial Hemophagocytic Lymphocytosis,0
11254,Secondary to,Stage IB Pancreatic Cancer AJCC v8,0
11255,Frequently,Adult Fibrolamellar Carcinoma,0
11256,Derivation,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11257,Proliferation (morphologic abnormality),Familial Adenomatous Polyposis Associated Medulloblastoma,0
11258,Leukemia (category),Stage IB Pancreatic Cancer AJCC v8,0
11259,Levator palpebrae superioris structure,Benign Apocrine Neoplasm,0
11260,Morphology,Liver Cavernous Hemangioma,0
11261,Possible,Cartilaginous exostosis,0
11262,Smear - instruction imperative,papillary carcinoma of penis,0
11263,Dorsal funiculus,embryonal rhabdomyosarcoma of prostate,0
11264,AMACR wt Allele,Extracranial Neuroblastoma,0
11265,How Often Weight Loss,Clonal Hematopoiesis of Indeterminate Potential,0
11266,Include (action),Refractory Barrett Esophagus,0
11267,Feature,embryonal rhabdomyosarcoma of prostate,0
11268,diagnosis aspect,Angiosarcoma of liver,0
11269,Human Papilloma Virus Vaccine,Tonsillar Carcinoma,0
11270,Pharmacologic Substance,Methotrexate-Associated Hodgkin Lymphoma,0
11271,2+ Score,Small cell neuroendocrine carcinoma of bladder,0
11272,Cancer Genus,Acantholytic squamous cell carcinoma,0
11273,Malignant - descriptor,Ampulla of Vater Tubular Adenoma,0
11274,Eye protection,Extra-Adrenal Paraganglioma,0
11275,Lower - spatial qualifier,Anterior Urethral Malignant Neoplasm,0
11276,Subacute,Xeroderma pigmentosum,0
11277,International Classification of Diseases for Oncology,Advanced Lung Carcinoma,0
11278,Disease Management,Malignant melanoma of eyelid,0
11279,Genes,Clonal Hematopoiesis of Indeterminate Potential,0
11280,Brain Neoplasms,Carcinoma of urinary bladder,0
11281,Cessation of life,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11282,Treatment Epoch,Refractory Glioma,0
11283,In Blood,Intraepithelial Melanocytic Hyperplasia,0
11284,Update,Human Papillomavirus-Related Carcinoma,0
11285,Including (qualifier),Angiosarcoma of liver,0
11286,Elderly (population group),High Grade Glandular Intraepithelial Neoplasia,0
11287,Aim,Primary Cutaneous Plasmablastic Lymphoma,0
11288,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Acantholytic squamous cell carcinoma,0
11289,Patient Discharge,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11290,High Grade Ovarian Serous Adenocarcinoma,Colorectal Neuroendocrine Tumor G2,0
11291,{Setting},Acute Undifferentiated Leukemia,0
11292,Common (qualifier value),Adult Hepatocellular Carcinoma,0
11293,PGAP3 gene,Stage IB Pancreatic Cancer AJCC v8,0
11294,Negation,Childhood Thyroid Gland Follicular Carcinoma,0
11295,Descent,FIGO Stage II Ovarian Cancer,0
11296,Affecting,Rhabdomyosarcoma with ganglionic differentiation,0
11297,High Level,Endometrial Small Cell Carcinoma,0
11298,Post,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
11299,Count of entities,Childhood Lymphoma,0
11300,Operative Surgical Procedures,Stage IV Penile Cancer AJCC v7,0
11301,Side,Intraepithelial Melanocytic Hyperplasia,0
11302,HLA Class II Histocompatibility Antigen Gamma Chain,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11303,Concept model domain,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11304,Acquired lymphangioma,Hair nevus,0
11305,Human Cells,Tonsillar Carcinoma,0
11306,Therapeutic procedure,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
11307,diagnosis aspect,Intestinal Metaplasia of Bladder Urothelium,0
11308,Smear - instruction imperative,Cartilaginous exostosis,0
11309,Science of Etiology,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11310,United States,Serous cystadenocarcinoma ovary,0
11311,Sweat gland cyst,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
11312,Most,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11313,protein expression,Benign tumor of eyelid,0
11314,Secondary Neoplasm,Atypical Lobular Breast Hyperplasia,0
11315,Neoplastic disease,Locally Advanced Soft Tissue Sarcoma,0
11316,product,FIGO Stage II Ovarian Cancer,0
11317,High risk,Neonatal leukemia,0
11318,Sequence Arm,Malignant Testicular Sertoli Cell Tumor,0
11319,Motor Neuron and Pancreas Homeobox Protein 1,Intestinal Metaplasia of Bladder Urothelium,0
11320,Biomaterial Treatment,Intraepithelial Melanocytic Hyperplasia,0
11321,Neoplasms by Site,Stage IB Lung Cancer AJCC v7,0
11322,Free (available (qualifier)),Primary Cutaneous Plasmablastic Lymphoma,0
11323,intent,Cerebral Primitive Neuroectodermal Tumor,0
11324,Acute monocytic leukemia,Stage II Carcinoma of Penis,0
11325,In Blood,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11326,Room of building - Study,Neonatal leukemia,0
11327,Abnormal host response,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
11328,Bone Marrow Cells,embryonal rhabdomyosarcoma of prostate,0
11329,Human body,Cartilaginous exostosis,0
11330,Including (qualifier),Liver Lymphangioma,0
11331,Pleomorphism,Stage IB Lung Cancer AJCC v7,0
11332,Blood Cells,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11333,Cutaneous Melanoma,Bladder squamous cell carcinoma stage I,0
11334,survival aspects,Benign tumor of eyelid,0
11335,Imaging Techniques,Unfavorable Non-Hodgkin Lymphoma,0
11336,Zone,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11337,SERPINA3 wt Allele,Malignant neoplasm of choroid,0
11338,Treatment Epoch,Granular Cell Leiomyosarcoma,0
11339,Blood,Uterine Cancer,0
11340,Woman,Low Grade Squamous Intraepithelial Neoplasia,0
11341,Occurrence Indicator,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11342,Table Cell Horizontal Align - left,Cancer of Urinary Tract,0
11343,Eyelid structure,Serous cystadenocarcinoma ovary,0
11344,Characteristics,Adenocarcinoma,0
11345,Array Feature,Mixed parotid tumor,0
11346,Thinking,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11347,Disease Outcome,Cerebral hemangioma,0
11348,Testing,benign mature teratoma of pancreas,0
11349,Common (qualifier value),Tonsillar Carcinoma,0
11350,Tired,Localized Ewing Sarcoma,0
11351,Rare,Stage IV Childhood Non-Hodgkin Lymphoma,0
11352,More,Benign tumor of eyelid,0
11353,Cancer Genus,Cancer of Urinary Tract,0
11354,biopsy characteristics,Mucinous adenocarcinoma gastric,0
11355,Determined by,Werner Syndrome,0
11356,General surgery specialty,Cancer of Urinary Tract,0
11357,Infrequent,Childhood Fibrillary Astrocytoma,0
11358,Facial edema,Spermatocytic seminoma,0
11359,Specimen Source Codes - tumor,Unresectable Rhabdomyosarcoma,0
11360,Sufficient,Hemangioma,0
11361,Trachea (moth),Mixed parotid tumor,0
11362,Internal,FIGO Stage II Ovarian Cancer,0
11363,Very good,BRCA2 Syndrome,0
11364,Acquired phimosis,High Grade Glandular Intraepithelial Neoplasia,0
11365,Circulating,papillary carcinoma of penis,0
11366,Cancer Genus,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11367,survival aspects,Digestive System Hodgkin Lymphoma,0
11368,Science of Etiology,Benign tumor of eyelid,0
11369,Percent of Abnormal Cells,gliosarcoma,0
11370,Including (qualifier),Lung squamous cell carcinoma stage I,0
11371,predictive factor,Malignant melanoma of eyelid,0
11372,4+ Answer to question,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11373,> 2 years,Acute Undifferentiated Leukemia,0
11374,Metastatic Disease Clinical Trial Setting,Airway Hemangioma,0
11375,Sequence Data Type,Pilocytic astrocytoma of cerebellum,0
11376,Breast tissue sample,embryonal rhabdomyosarcoma of prostate,0
11377,Major <insect>,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11378,Skin tag,Mastocytosis,0
11379,Primary malignant neoplasm,adenoid cystic carcinoma of lung,0
11380,Obesity,Malignant melanoma of eyelid,0
11381,Therapeutic procedure,Adult Hepatocellular Carcinoma,0
11382,spells (neurological symptom),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11383,Treating,Secondary malignant neoplasm of lymph node,0
11384,teratologic,Endometrial Small Cell Carcinoma,0
11385,Firstly,benign mature teratoma of pancreas,0
11386,Population Group,non-Hodgkin's lymphoma of spleen,0
11387,Greece,Larynx carcinoma recurrent,0
11388,therapeutic aspects,Recurrent Uveal Melanoma,0
11389,Asia,Digestive System Hodgkin Lymphoma,0
11390,Developed Countries,Cartilaginous exostosis,0
11391,Foreskin of penis,Placental aromatase deficiency,0
11392,Beginning,Adult Hepatocellular Carcinoma,0
11393,Call (Instruction),Refractory Barrett Esophagus,0
11394,Cell (compartment),Refractory Barrett Esophagus,0
11395,Mass of body region,Cerebral Primitive Neuroectodermal Tumor,0
11396,Techniques,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11397,Brain Stem,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11398,Poor - grade value,Ovarian germ cell choriocarcinoma stage IV,0
11399,Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11400,high - ActExposureLevelCode,Human Papillomavirus-Related Carcinoma,0
11401,Autosomal dominant hereditary disorder,Chronic Myelomonocytic Leukemia-2,0
11402,Money or percentage indicator - Percentage,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11403,Aspects of signs,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11404,Disease Management,Adult Alveolar Soft Part Sarcoma,0
11405,Better,Refractory Barrett Esophagus,0
11406,Unknown GENC,Refractory Barrett Esophagus,0
11407,Dryness (characteristic),mucinous adenocarcinoma of gallbladder,0
11408,MOSTLY,Malignant Neoplasm with Regional Lymph Node Involvement,0
11409,Second Suffix,Adult Alveolar Soft Part Sarcoma,0
11410,mononuclear cells,Stage 0 Lip Carcinoma,0
11411,Poverty,Benign neoplasm of thorax,0
11412,Taxonomic,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
11413,How Often Felt Normal question,Localized Askin Tumor,0
11414,Treatment Epoch,Female Breast Carcinoma,0
11415,Often - answer to question,Secondary malignant neoplasm of lymph node,0
11416,Area,Primary Cutaneous Plasmablastic Lymphoma,0
11417,Aim,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11418,Repeat Surgery,Chronic Myelomonocytic Leukemia-2,0
11419,Seminoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
11420,Dangerousness,Malignant melanoma of eyelid,0
11421,Adult human body,sarcoma of spinal cord,0
11422,Human body,Mucinous adenocarcinoma gastric,0
11423,Therapeutic procedure,Thymoma malignant recurrent,0
11424,Doubling Time,Digestive System Hodgkin Lymphoma,0
11425,Round cell tumor,Refractory Barrett Esophagus,0
11426,Generations,Methotrexate-Associated Hodgkin Lymphoma,0
11427,Sweating,FIGO Stage II Ovarian Cancer,0
11428,Case (situation),BRCA2 Syndrome,0
11429,More,Acantholytic squamous cell carcinoma,0
11430,Adult Non-Hodgkin Lymphoma,Liver Cavernous Hemangioma,0
11431,Slow,Acute Undifferentiated Leukemia,0
11432,Finding,Angiosarcoma of liver,0
11433,Hodgkin Disease,Ichthyoses,0
11434,Analysis of substances,Female Breast Carcinoma,0
11435,Cervical lymph node group,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11436,East,Methotrexate-Associated Hodgkin Lymphoma,0
11437,Treatment Epoch,Primary Cutaneous Plasmablastic Lymphoma,0
11438,Blood Circulation,Localized Ewing Sarcoma,0
11439,Very Much,Recurrent Testicular Lymphoma,0
11440,Root Mean Square,Neonatal leukemia,0
11441,Discharge,Recurrent Testicular Lymphoma,0
11442,Fill,gliosarcoma,0
11443,Body structure,Medulloblastoma,0
11444,Rare,Recurrent Testicular Lymphoma,0
11445,Primary malignant neoplasm,Malignant Testicular Sertoli Cell Tumor,0
11446,include - SetOperator,Female Breast Carcinoma,0
11447,Lower - spatial qualifier,Intraepithelial Melanocytic Hyperplasia,0
11448,Abnormally high,Intestinal Neuroendocrine Carcinoma,0
11449,Have Itch,Tonsillar Carcinoma,0
11450,What subject filter - Result,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11451,Aim,Small cell neuroendocrine carcinoma of bladder,0
11452,Tryptophanase,Adult Hepatocellular Carcinoma,0
11453,Value Above Reference Range,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11454,Pediatric Neoplasm,Spermatocytic seminoma,0
11455,Contain (action),mucinous adenocarcinoma of gallbladder,0
11456,Fever,Malignant neoplasm of choroid,0
11457,Case unit dose,Metastatic Lung Small Cell Carcinoma,0
11458,Account number:Identifier:Point in time:^Patient:Nominal,Pancreatic Intraepithelial Neoplasia-3,0
11459,Malignant Neoplasms,Malignant Neoplasm with Regional Lymph Node Involvement,0
11460,Common Specifications in HL7 V3 Publishing,Uterine Cancer,0
11461,Include (action),Xeroderma pigmentosum,0
11462,Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11463,Life Expectancy,Clonal Hematopoiesis of Indeterminate Potential,0
11464,Fasting Status Indicator,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11465,Malignant Neoplasms,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11466,development aspects,Placental aromatase deficiency,0
11467,Females,Carcinoma of urinary bladder,0
11468,Low Level,Anaplastic large cell lymphoma,0
11469,Subject Risk,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11470,Personal appearance,Breast Ductal Adenoma,0
11471,First (number),Cartilaginous exostosis,0
11472,Malignant Childhood Neoplasm,Cancer of Urinary Tract,0
11473,Contrast,Endometrial Small Cell Carcinoma,0
11474,Abnormal,Undifferentiated Neuroblastoma,0
11475,Increased risk,Cerebral Primitive Neuroectodermal Tumor,0
11476,Singular,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11477,Sore to touch,Mucinous adenocarcinoma gastric,0
11478,Psychological inhibition,Neonatal leukemia,0
11479,Review [Publication Type],Spermatocytic seminoma,0
11480,Immature,Malignant melanoma of eyelid,0
11481,1000000,mucinous adenocarcinoma of gallbladder,0
11482,allowing,Pilocytic astrocytoma of cerebellum,0
11483,Increase,Testicular cancer metastatic,0
11484,Location of Oral Residue Following Swallowing,Cerebral Primitive Neuroectodermal Tumor,0
11485,Neoplasm Metastasis,BRCA2 Syndrome,0
11486,Radiotherapy Research,Intraepithelial Melanocytic Hyperplasia,0
11487,Poor - qualifier,Mucinous cystadenofibroma,0
11488,Malignant neoplasm of lung,Childhood Fibrillary Astrocytoma,0
11489,Shapes,Secondary malignant neoplasm of lymph node,0
11490,Affecting,Refractory Barrett Esophagus,0
11491,Negation,Giant cell angiofibroma,0
11492,PREVENT (product),Human Papillomavirus-Related Carcinoma,0
11493,survival aspects,Intestinal Metaplasia of Bladder Urothelium,0
11494,spinal,Pancreatic Intraepithelial Neoplasia-3,0
11495,Base - General Qualifier,Acute lymphadenitis,0
11496,Deterioration of status,Acantholytic squamous cell carcinoma,0
11497,Part of,mucinous adenocarcinoma of gallbladder,0
11498,Human patch material,BRCA2 Syndrome,0
11499,Young Adult,Mucinous adenocarcinoma gastric,0
11500,Feelings,Thymic Clear Cell Carcinoma,0
11501,Carbohydrates,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11502,Benign neoplasm of paraganglion,Deep Leiomyoma,0
11503,Site of,Cerebral Primitive Neuroectodermal Tumor,0
11504,Specimen Source Codes - Lesion,Cancer of Urinary Tract,0
11505,Intestinal Obstruction,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11506,Condition,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11507,Three,Uterine Cancer,0
11508,Lymphatic System,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11509,High,Papillary cystic tumor,0
11510,Lymphoma,Adrenal Rest Tumor,0
11511,Prostate,Digestive System Hodgkin Lymphoma,0
11512,Determined by,Testicular cancer metastatic,0
11513,Throat,Unresectable Rhabdomyosarcoma,0
11514,Circulatory Process,Intracortical osteosarcoma,0
11515,Manufactured form,Refractory Barrett Esophagus,0
11516,Scientific Publication,Benign Apocrine Neoplasm,0
11517,therapeutic aspects,Unfavorable Non-Hodgkin Lymphoma,0
11518,Sixty,Endometrial Small Cell Carcinoma,0
11519,Drainage procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11520,Cancer Genus,adenosquamous carcinoma of breast,0
11521,700,Benign tumor of eyelid,0
11522,Color,Thymic Clear Cell Carcinoma,0
11523,Risk,Extracranial Neuroblastoma,0
11524,Most,Malignant neoplasm of choroid,0
11525,Werner Syndrome,Intraepithelial Melanocytic Hyperplasia,0
11526,Pancreatic carcinoma,Atypical Lobular Breast Hyperplasia,0
11527,Aim (idea),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11528,Two,Stage IV Penile Cancer AJCC v7,0
11529,Common Specifications in HL7 V3 Publishing,Lipoma of small intestine,0
11530,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Airway Hemangioma,0
11531,Within,Chronic Myelomonocytic Leukemia-2,0
11532,Group Object,Granular Cell Leiomyosarcoma,0
11533,shared attribute,embryonal rhabdomyosarcoma of prostate,0
11534,Image Feature,Stage 0 Penile Cancer AJCC v8,0
11535,Primary operation,Female Breast Carcinoma,0
11536,With shape,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11537,Constant (qualifier),Chronic Myelomonocytic Leukemia-2,0
11538,Etiology aspects,Undifferentiated Endocervical Sarcoma,0
11539,Diagnosis Study,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11540,Randomization,Liver Cavernous Hemangioma,0
11541,Geographic state,Refractory Barrett Esophagus,0
11542,Unintentional,Liver Cavernous Hemangioma,0
11543,Overall Well Being,Cancer of Urinary Tract,0
11544,Malignant Neoplasms,Childhood Fibrillary Astrocytoma,0
11545,Cancer Genus,Mucinous adenocarcinoma gastric,0
11546,Hematopoietic Neoplasms,Atypical Lobular Breast Hyperplasia,0
11547,Neuromuscular,squamous cell carcinoma of the thyroid gland,0
11548,Qualitative form,Neoplasms,0
11549,Used by,Anaplastic large cell lymphoma,0
11550,Overall,Benign neoplasm of thorax,0
11551,Aim (idea),Recurrent Uveal Melanoma,0
11552,Kidney,Colorectal Neuroendocrine Tumor G2,0
11553,Line Unit of Length,Lipoma of small intestine,0
11554,60%,Angiosarcoma of liver,0
11555,Communicable Diseases,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11556,Most,Malignant Testicular Sertoli Cell Tumor,0
11557,Cover - action,Heavy Chain Deposition Disease,0
11558,low confidentiality,adenosquamous carcinoma of breast,0
11559,Three,Acute Undifferentiated Leukemia,0
11560,Importance Rating Score 0,FIGO Stage II Ovarian Cancer,0
11561,Tissue Specimen Code,Thymic Clear Cell Carcinoma,0
11562,Squamous,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11563,Measurement,Adult Hepatocellular Carcinoma,0
11564,treatment - ActInformationManagementReason,Undifferentiated Endocervical Sarcoma,0
11565,Group A (blood group),Digestive System Hodgkin Lymphoma,0
11566,Colorectal Carcinoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11567,Lymphatic vessel,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11568,How Often Weight Loss,FIGO Stage II Ovarian Cancer,0
11569,2+ Score,Ovarian germ cell choriocarcinoma stage IV,0
11570,year,FIGO Stage II Ovarian Cancer,0
11571,Result,Childhood Fibrillary Astrocytoma,0
11572,Primary,Cerebral Primitive Neuroectodermal Tumor,0
11573,Positioning Attribute,Deep Leiomyoma,0
11574,During,Xeroderma pigmentosum,0
11575,transcription factor activity,Advanced Uterine Corpus Carcinosarcoma,0
11576,Malignant neoplasm of submandibular gland,Endometrial Small Cell Carcinoma,0
11577,Pediculus humanus capitis (eukaryote),Noninfiltrating Intraductal Carcinoma,0
11578,Include (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11579,Aspects of disease screening,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11580,International Aspects,Bladder squamous cell carcinoma stage I,0
11581,Present,Recurrent Diffuse Intrinsic Pontine Glioma,0
11582,Child,Grade 1 Clear Cell Renal Cell Carcinoma,0
11583,Standard Treatment,Neonatal leukemia,0
11584,SLC35G1 gene,FIGO Stage II Ovarian Cancer,0
11585,Neoplasms,Mucinous adenocarcinoma gastric,0
11586,Differentiation,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
11587,therapeutic aspects,BRCA2 Syndrome,0
11588,Sharing (Social Behavior),Chronic Myelomonocytic Leukemia-2,0
11589,Early,squamous cell carcinoma of the thyroid gland,0
11590,Usual Severity Vomiting,Acute Undifferentiated Leukemia,0
11591,Adrenal Cortex Hormones,Digestive System Hodgkin Lymphoma,0
11592,Both ovaries,Lipoma of small intestine,0
11593,Fasting Status Indicator,Bladder squamous cell carcinoma stage I,0
11594,Palpebral margin,Airway Hemangioma,0
11595,Polypeptide Hormones,Anaplastic large cell lymphoma,0
11596,Target Awareness - partial,Clonal Hematopoiesis of Indeterminate Potential,0
11597,Metastatic Neoplasm,Heavy Chain Deposition Disease,0
11598,Tumor Mass,Small cell neuroendocrine carcinoma of bladder,0
11599,Testis,Xeroderma pigmentosum,0
11600,Uncontrolled,Colorectal High Grade B-Cell Lymphoma,0
11601,Histology aspects,GIANT PIGMENTED HAIRY NEVUS,0
11602,Science of Morphology,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11603,Orbital region,Diffuse malignant mesothelioma,0
11604,Wall of colon,Anterior Urethral Malignant Neoplasm,0
11605,Primary malignant neoplasm,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11606,Future,Cancer of Urinary Tract,0
11607,Microplate Well,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11608,Intention - mental process,Xeroderma pigmentosum,0
11609,Medications:-:Point in time:^Patient:-,Unresectable Rhabdomyosarcoma,0
11610,Presentation,Benign Carotid Body Paraganglioma,0
11611,Sacrifice,Airway Hemangioma,0
11612,Cough,Hemangioma,0
11613,Tissue Specimen Code,Acute lymphadenitis,0
11614,United States,Neonatal leukemia,0
11615,Limited (extensiveness),sarcoma of spinal cord,0
11616,SLC6A2 wt Allele,Localized Askin Tumor,0
11617,Hour,Lung squamous cell carcinoma stage I,0
11618,Abnormal,Adult Hepatocellular Carcinoma,0
11619,Smear - instruction imperative,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11620,Ultraviolet Light Sterilization,Adult Hepatocellular Carcinoma,0
11621,Common (qualifier value),Adult Hepatocellular Carcinoma,0
11622,Providing presence (regime/therapy),Human Papillomavirus-Related Carcinoma,0
11623,treatment - ActInformationManagementReason,Platinum-Resistant Lung Small Cell Carcinoma,0
11624,Study,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11625,Childhood Rhabdomyosarcoma,Xeroderma pigmentosum,0
11626,Human papilloma virus infection,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11627,Rating (action),Blepharal carcinoma,0
11628,Benign,Adrenal Rest Tumor,0
11629,Ultra-violet,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11630,diagnosis aspect,benign mature teratoma of pancreas,0
11631,Poliosis,Acute lymphadenitis,0
11632,Together,ALK positive large B-cell lymphoma,0
11633,Feature,Atypical Lobular Breast Hyperplasia,0
11634,Lower (action),Heavy Chain Deposition Disease,0
11635,Complete Trisomy 21 Syndrome,Recurrent Uveal Melanoma,0
11636,human AVP protein,Anterior Urethral Malignant Neoplasm,0
11637,Weight decreased,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11638,Removing (action),Granular Cell Leiomyosarcoma,0
11639,Symptoms,Recurrent Testicular Lymphoma,0
11640,Certain (qualifier value),Diffuse malignant mesothelioma,0
11641,Prognosis:Find:Pt:^Patient:Nom,Atypical Mesothelial Hyperplasia,0
11642,Endotracheal aspiration,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11643,Very Much,Colorectal High Grade B-Cell Lymphoma,0
11644,Intervention regimes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11645,Cessation of life,Diffuse malignant mesothelioma,0
11646,Treating,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11647,Enlargement procedure,Liver Lymphangioma,0
11648,Include (action),Colorectal Neuroendocrine Tumor G2,0
11649,Better than Others,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11650,True primary (qualifier value),FIGO Stage II Ovarian Cancer,0
11651,Two,Uterine Cancer,0
11652,1000000,Chondrosarcoma,0
11653,Symptoms aspect,Spongiotic dermatitis,0
11654,Able (finding),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11655,Most,Digestive System Hodgkin Lymphoma,0
11656,Adolescent (age group),Refractory Barrett Esophagus,0
11657,Type A,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11658,Pelvic Pain,Cerebral hemangioma,0
11659,Antibiotics,Localized Ewing Sarcoma,0
11660,Including (qualifier),Xeroderma pigmentosum,0
11661,Greater,Breast Ductal Adenoma,0
11662,Offspring,Lipoma of small intestine,0
11663,What subject filter - Result,Stage II Hepatocellular Carcinoma AJCC v8,0
11664,Ethanol,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
11665,Females,Deep Leiomyoma,0
11666,Control function,Testicular cancer metastatic,0
11667,PSA Level Less than Two,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11668,Increased,Cerebral Primitive Neuroectodermal Tumor,0
11669,Merkel cell carcinoma,Undifferentiated Endocervical Sarcoma,0
11670,As Much as Desired,Adrenal Rest Tumor,0
11671,row - Table,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11672,Adverse Event by CTCAE Category,Intraepithelial Melanocytic Hyperplasia,0
11673,Surgery specialty,Giant cell angiofibroma,0
11674,Genetic,Acantholytic squamous cell carcinoma,0
11675,Flushing,gliosarcoma,0
11676,Enlarged,Adult Hepatocellular Carcinoma,0
11677,Greater,Secondary malignant neoplasm of lymph node,0
11678,Acetic Acids,Adult Alveolar Soft Part Sarcoma,0
11679,Treating,Human Papillomavirus-Related Carcinoma,0
11680,Skin Lymphangiosarcoma,Testicular cancer metastatic,0
11681,lobe,High Grade Glandular Intraepithelial Neoplasia,0
11682,Accurate (qualifier),Malignant melanoma of eyelid,0
11683,Divide,Colorectal High Grade B-Cell Lymphoma,0
11684,Overall Publication Type,Blepharal carcinoma,0
11685,Retinoic Acid Response Element,Mucinous adenocarcinoma gastric,0
11686,Injury due to exposure to external cause,Thymic Atypical Carcinoid Tumor,0
11687,Worsening pattern,Stage IB Lung Cancer AJCC v7,0
11688,Confirmation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11689,Mixed Tumor,Werner Syndrome,0
11690,Contain (action),Malignant Neoplasm with Regional Lymph Node Involvement,0
11691,Mammary Gland Parenchyma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11692,Cause of Death,Giant cell angiofibroma,0
11693,types of infections,Stage IV Childhood Non-Hodgkin Lymphoma,0
11694,Continuance of life,Malignant Neoplasm of Lung - Multiple Primary Sites,0
11695,Etiology aspects,Mastocytosis,0
11696,Surgical extraction,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11697,Subgroup,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11698,Fatigue,Recurrent Uveal Melanoma,0
11699,Image Feature,Mucinous neoplasm,0
11700,1000000,Locally Advanced Soft Tissue Sarcoma,0
11701,Adult human body,Low Grade Squamous Intraepithelial Neoplasia,0
11702,epithelial,Grade 3a Malignant Neoplasm,0
11703,Bone Pain,Stage 0 Penile Cancer AJCC v8,0
11704,per year,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11705,Specimen Source Codes - Serum,Cancer of Urinary Tract,0
11706,therapeutic aspects,Small cell neuroendocrine carcinoma of bladder,0
11707,Tryptophanase,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11708,Togo,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11709,Rating (action),Endometrial Small Cell Carcinoma,0
11710,Point Name,Undifferentiated Endocervical Sarcoma,0
11711,User Group,Stage IB Pancreatic Cancer AJCC v8,0
11712,Smooth Muscle Tumor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11713,Tract,Grade 3a Malignant Neoplasm,0
11714,Common (qualifier value),Extracranial Neuroblastoma,0
11715,mesenchymal,embryonal rhabdomyosarcoma of prostate,0
11716,Two,Locally Advanced Soft Tissue Sarcoma,0
11717,Form:Finding:Point in time:{Setting}:Document:{Role},non-Hodgkin's lymphoma of spleen,0
11718,Cerebral hemisphere structure (body structure),Mucinous adenocarcinoma gastric,0
11719,Bodily secretions,Platinum-Resistant Lung Small Cell Carcinoma,0
11720,Different,Stage IB Pancreatic Cancer AJCC v8,0
11721,Have Pain,Maxillary Sinus Adenocarcinoma,0
11722,Malignant neoplasm of salivary gland,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
11723,Present,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11724,Present,embryonal rhabdomyosarcoma of prostate,0
11725,Distal (qualifier value),Stage 0 Lip Carcinoma,0
11726,Precipitating Factors,Extra-Adrenal Paraganglioma,0
11727,Increased,Xeroderma pigmentosum,0
11728,high - ActExposureLevelCode,Placental aromatase deficiency,0
11729,predictive factor,Larynx carcinoma recurrent,0
11730,One,Diffuse malignant mesothelioma,0
11731,Physical findings,Anterior Urethral Malignant Neoplasm,0
11732,How Often Shortness of Breath,Endometrial Small Cell Carcinoma,0
11733,Location,Stage 0 Penile Cancer AJCC v8,0
11734,Condition:Find:Pt:^Patient:Nom,Recurrent Testicular Lymphoma,0
11735,External exotoses,Anaplastic large cell lymphoma,0
11736,Subtype (attribute),Primary Cutaneous Plasmablastic Lymphoma,0
11737,Often - answer to question,Cerebral hemangioma,0
11738,Human body structure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11739,Often - answer to question,Acantholytic squamous cell carcinoma,0
11740,Diagnosis Study,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11741,Tired,Endometrial Small Cell Carcinoma,0
11742,Referring,Ovarian germ cell choriocarcinoma stage IV,0
11743,A Codes,Cerebral Primitive Neuroectodermal Tumor,0
11744,Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11745,Sufficiently defined concept definition status (core metadata concept),Grade 1 Clear Cell Renal Cell Carcinoma,0
11746,Germ Layers,Cancer of Urinary Tract,0
11747,Publications,Human Papillomavirus-Related Carcinoma,0
11748,Young Adult,Choroid Necrotic Melanoma,0
11749,Fish Flavor,Recurrent Uveal Melanoma,0
11750,Africa South of the Sahara,Cerebral Primitive Neuroectodermal Tumor,0
11751,Taxonomic,Localized Askin Tumor,0
11752,Human papillomavirus typing (procedure),Mucinous cystadenofibroma,0
11753,Clear,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11754,To,Metastatic Neoplasm to the Gallbladder,0
11755,Progress,Stage III Adult Immunoblastic Lymphoma,0
11756,Penetrance,Breast Ductal Adenoma,0
11757,Transurethral Resection,Stage II Hepatocellular Carcinoma AJCC v8,0
11758,Usual Severity Sweats,Diffuse malignant mesothelioma,0
11759,Precision - characteristic,Digestive System Hodgkin Lymphoma,0
11760,Base - General Qualifier,Childhood Thyroid Gland Follicular Carcinoma,0
11761,High,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11762,Breast Feeding,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11763,Immunotherapy,embryonal rhabdomyosarcoma of prostate,0
11764,Group A (qualifier value),Stage II Hepatocellular Carcinoma AJCC v8,0
11765,point - UnitsOfMeasure,mucinous adenocarcinoma of gallbladder,0
11766,Full,Chondrosarcoma,0
11767,Administration procedure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
11768,Particle,Recurrent Testicular Lymphoma,0
11769,United States Military Commissioned Officer O4,Testicular cancer metastatic,0
11770,Replacement - supply,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
11771,Fever,embryonal rhabdomyosarcoma of prostate,0
11772,Complete Pharyngeal Contraction,Acantholytic squamous cell carcinoma,0
11773,*Type - Kind of quantity,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11774,pathologic fistula,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11775,Age,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11776,Breast tissue sample,Collecting Duct Carcinoma of the Kidney,0
11777,*Type - Kind of quantity,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11778,International Aspects,Testicular cancer metastatic,0
11779,Primary malignant neoplasm,Giant cell angiofibroma,0
11780,Section - Geographic Area,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11781,Primary malignant neoplasm,Pancreatic Intraepithelial Neoplasia-3,0
11782,Symptoms,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11783,Largest,Cancer of Urinary Tract,0
11784,[AA000] INTRODUCTION,Adenocarcinoma of the prostate metastatic,0
11785,Unknown,Stage I Adult Non-Hodgkin Lymphoma,0
11786,Type - attribute,Malignant melanoma of eyelid,0
11787,TP53 gene,Cerebral Primitive Neuroectodermal Tumor,0
11788,Aspiration of food,Breast Ductal Adenoma,0
11789,Solid organ transplant,Pancreatic Intraepithelial Neoplasia-3,0
11790,Stomach Diseases,Thymic Clear Cell Carcinoma,0
11791,Genus Homo,Stage II Hepatocellular Carcinoma AJCC v8,0
11792,Sensory organ,Thymic Atypical Carcinoid Tumor,0
11793,Gestational trophoblastic disease,Neoplasms,0
11794,Malignant - descriptor,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11795,Rapid,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11796,Operative Surgical Procedures,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11797,history (of) disease family,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11798,Labrador retriever,Cancer of Urinary Tract,0
11799,Call (Instruction),Uterine Cancer,0
11800,How Much Distress Difficulty Swallowing,Heavy Chain Deposition Disease,0
11801,How Often Weight Loss,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11802,Bloating,Human Papillomavirus-Related Carcinoma,0
11803,low confidentiality,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11804,Recommendation,Breast Ductal Adenoma,0
11805,In Blood,Clonal Hematopoiesis of Indeterminate Potential,0
11806,Metastatic Neoplasm,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11807,Uterine Cancer,Clonal Hematopoiesis of Indeterminate Potential,0
11808,SPINK5 gene,Metastatic Lung Small Cell Carcinoma,0
11809,Formation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11810,newly,Adenocarcinoma,0
11811,Thick,Deep Leiomyoma,0
11812,IPSS Risk Category Low,Diffuse malignant mesothelioma,0
11813,Post,Cancer of Urinary Tract,0
11814,Leading,Chondrosarcoma,0
11815,Tumor cells,Cerebral hemangioma,0
11816,Stage,Intraepithelial Melanocytic Hyperplasia,0
11817,Further,Noninfiltrating Intraductal Carcinoma,0
11818,Distant,Anterior Urethral Malignant Neoplasm,0
11819,Fatigue,High Grade Glandular Intraepithelial Neoplasia,0
11820,Symptoms aspect,embryonal rhabdomyosarcoma of prostate,0
11821,Cure (remedy),Tonsillar Carcinoma,0
11822,Neuroendocrine Tumors,Digestive System Hodgkin Lymphoma,0
11823,Preventive monitoring,Deep Leiomyoma,0
11824,Arrested progression,Lipoma of small intestine,0
11825,Less Than,Thymoma malignant recurrent,0
11826,High risk of,Xeroderma pigmentosum,0
11827,Regurgitation - mechanism,Spongiotic dermatitis,0
11828,Known,Mucinous adenocarcinoma gastric,0
11829,Definitely Related to Intervention,Undifferentiated Endocervical Sarcoma,0
11830,Negation,Primary Cutaneous Plasmablastic Lymphoma,0
11831,Gonadal structure,High Grade Glandular Intraepithelial Neoplasia,0
11832,Relative (related person),BRCA2 Syndrome,0
11833,include - SetOperator,Intraepithelial Melanocytic Hyperplasia,0
11834,Frequency of Pain Question,Anterior Urethral Malignant Neoplasm,0
11835,Circulating Tumor Cell Count,Stage IB Lung Cancer AJCC v7,0
11836,Pancreatic carcinoma,Unfavorable Non-Hodgkin Lymphoma,0
11837,2+ Score,Recurrent Uveal Melanoma,0
11838,Immunotherapy,Ichthyoses,0
11839,Recurrence (disease attribute),Intraepithelial Melanocytic Hyperplasia,0
11840,Racial group,Uterine Cancer,0
11841,Tracheal aspiration,Lipoma of small intestine,0
11842,Leading,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11843,Categories,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11844,Neoplasms,Digestive System Hodgkin Lymphoma,0
11845,intent,Medulloblastoma,0
11846,Outlines (document),Airway Hemangioma,0
11847,Precipitating Factors,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11848,Primary,Leiomyoma of Gallbladder,0
11849,Risk,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11850,Subject Risk,Acute Undifferentiated Leukemia,0
11851,Inhibition,Thymic Atypical Carcinoid Tumor,0
11852,Blood Transfusion,High Grade Glandular Intraepithelial Neoplasia,0
11853,Call (Instruction),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11854,Digital Content Category,FIGO Stage II Ovarian Cancer,0
11855,Example,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11856,Adult Lymphoma,Localized Ewing Sarcoma,0
11857,Cause of death.underlying,Benign tumor of eyelid,0
11858,Cyclin A,Malignant melanoma of eyelid,0
11859,Occurrence Indicator,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11860,Rapid,Localized Askin Tumor,0
11861,Call (Instruction),Endometrial Small Cell Carcinoma,0
11862,Increase,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11863,include - SetOperator,Human Papillomavirus-Related Carcinoma,0
11864,Adult human body,Primary Cutaneous Plasmablastic Lymphoma,0
11865,Abnormally high,Anterior Urethral Malignant Neoplasm,0
11866,Accident due to exposure to weather conditions,Recurrent Uveal Melanoma,0
11867,Symptoms,Placental aromatase deficiency,0
11868,Melanoma Pathway,Ichthyosis,0
11869,Aspects of signs,malignant lymphoma of pancreatic lymph nodes,0
11870,Numerous,Acute Undifferentiated Leukemia,0
11871,Increase,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11872,Sixty,Localized Askin Tumor,0
11873,Make - Instruction Imperative,Stage 0 Penile Cancer AJCC v8,0
11874,CD44 wt Allele,Malignant neoplasm of thalamus,0
11875,National Academy of Sciences (U.S.),Undifferentiated Endocervical Sarcoma,0
11876,therapeutic aspects,Maxillary Sinus Adenocarcinoma,0
11877,Manufactured sign,Undifferentiated Endocervical Sarcoma,0
11878,Primary malignant neoplasm,Recurrent Uveal Melanoma,0
11879,Term Birth,Anterior Urethral Malignant Neoplasm,0
11880,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11881,Two,Spermatocytic seminoma,0
11882,Topical surface,Low Grade Squamous Intraepithelial Neoplasia,0
11883,Neoplasms,Hemangioma,0
11884,Treatment Epoch,squamous cell carcinoma of the thyroid gland,0
11885,Young Adult,papillary carcinoma of penis,0
11886,Sensation quality,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11887,Homo sapiens,Recurrent Testicular Lymphoma,0
11888,Characteristics,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11889,Usual,Stage III Adult Immunoblastic Lymphoma,0
11890,Promegakaryocytes,Anaplastic large cell lymphoma,0
11891,Count of entities,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11892,Indication of (contextual qualifier),Mixed parotid tumor,0
11893,Links List,Malignant melanoma of eyelid,0
11894,depend,Placental aromatase deficiency,0
11895,Immune System Processes,Ichthyosis,0
11896,Functional,High Grade Glandular Intraepithelial Neoplasia,0
11897,adaptive,Benign Apocrine Neoplasm,0
11898,liter,Thymic Clear Cell Carcinoma,0
11899,Cultured Cell Line,Human Papillomavirus-Related Carcinoma,0
11900,Manifested by,Angiosarcoma of liver,0
11901,Tryptophanase,Ichthyosis,0
11902,Continuous,Lipoma of small intestine,0
11903,Usually Need Help from Another Person for Eating,Refractory Barrett Esophagus,0
11904,Epithelial cell count (procedure),Malignant Neoplasm with Regional Lymph Node Involvement,0
11905,Eyelid structure,Hemangioma,0
11906,Malignant Central Nervous System Neoplasm,Cartilaginous exostosis,0
11907,Present,Tonsillar Carcinoma,0
11908,Age,Cancer of Urinary Tract,0
11909,therapeutic aspects,Female Breast Carcinoma,0
11910,Future,Liver Lymphangioma,0
11911,Official,Testicular cancer metastatic,0
11912,Point,Unfavorable Non-Hodgkin Lymphoma,0
11913,Monitor Device,Testicular cancer metastatic,0
11914,*Type - Kind of quantity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11915,Body structure,Cerebral Primitive Neuroectodermal Tumor,0
11916,Pregnancy,Adenocarcinoma,0
11917,Occurrence Indicator,Unresectable Rhabdomyosarcoma,0
11918,Diagnosis,Malignant Testicular Sertoli Cell Tumor,0
11919,Fever,Hair nevus,0
11920,Infant,FIGO Stage II Ovarian Cancer,0
11921,Pain,Unfavorable Non-Hodgkin Lymphoma,0
11922,Tissue Specimen Code,BRCA2 Syndrome,0
11923,Decreasing,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11924,Cell Device,Acantholytic squamous cell carcinoma,0
11925,development aspects,Locally Advanced Soft Tissue Sarcoma,0
11926,Persons,Digestive System Hodgkin Lymphoma,0
11927,Large,Primary Cutaneous Plasmablastic Lymphoma,0
11928,Thymus <angiosperm>,Unfavorable Non-Hodgkin Lymphoma,0
11929,World,Stage 0 Penile Cancer AJCC v8,0
11930,Percent of Abnormal Cells,Intestinal Metaplasia of Bladder Urothelium,0
11931,Several,Breast Ductal Adenoma,0
11932,Adenocarcinoma,Malignant neoplasm of thalamus,0
11933,How Often Weight Loss,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11934,Symptoms,Refractory Barrett Esophagus,0
11935,Evidence,Non-Metastatic Gestational Trophoblastic Tumor,0
11936,shared attribute,Giant cell angiofibroma,0
11937,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
11938,Vision:-:Point in time:^Patient:-,Endometrial Small Cell Carcinoma,0
11939,Rating (action),Intraepithelial Melanocytic Hyperplasia,0
11940,Immunotherapy,Mixed parotid tumor,0
11941,Chemotherapy,Advanced Uterine Corpus Carcinosarcoma,0
11942,Metastatic Disease Clinical Trial Setting,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
11943,Common (qualifier value),Spongiotic dermatitis,0
11944,Name Given at Birth,Colorectal cancer,0
11945,Measures,Heavy Chain Deposition Disease,0
11946,Western Europe,Maxillary Sinus Adenocarcinoma,0
11947,Medical Imaging,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11948,Indeterminate,Airway Hemangioma,0
11949,Combined,Malignant Testicular Sertoli Cell Tumor,0
11950,How Much Distress Weight Loss,sarcoma of spinal cord,0
11951,GCFC2 gene,Stage III Adult Immunoblastic Lymphoma,0
11952,diagnosis aspect,Spermatocytic seminoma,0
11953,10%,sarcoma of spinal cord,0
11954,Receptors,Malignant neoplasm of choroid,0
11955,Reported Term,Endometrial Small Cell Carcinoma,0
11956,Short,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11957,Two,Atypical Mesothelial Hyperplasia,0
11958,Tentorium <eukaryote>,Childhood Lymphoma,0
11959,Ascites,Spongiotic dermatitis,0
11960,Diagnosis Study,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11961,Etiology aspects,Stage I Adult Non-Hodgkin Lymphoma,0
11962,Count of entities,Advanced Uterine Corpus Carcinosarcoma,0
11963,Surgical repair,embryonal rhabdomyosarcoma of prostate,0
11964,best (quality),High Grade Glandular Intraepithelial Neoplasia,0
11965,development aspects,Adult Fibrolamellar Carcinoma,0
11966,Form:Finding:Point in time:{Setting}:Document:{Role},Female Breast Carcinoma,0
11967,Notable,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11968,T-Lymphocyte,Acantholytic squamous cell carcinoma,0
11969,A Codes,papillary carcinoma of penis,0
11970,Often - answer to question,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11971,Benign,Tonsillar Carcinoma,0
11972,Togo,Stage IB Lung Cancer AJCC v7,0
11973,Human body structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11974,20%,Secondary malignant neoplasm of lymph node,0
11975,Central Nervous System,Atypical Lobular Breast Hyperplasia,0
11976,Metastatic malignant neoplasm to brain,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11977,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,squamous cell carcinoma of the thyroid gland,0
11978,Act Status - obsolete,Mucinous adenocarcinoma gastric,0
11979,Subject Risk,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11980,High expression,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11981,Spreading (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
11982,exception - ResponseLevel,Airway Hemangioma,0
11983,Tissue Specimen Code,Malignant Testicular Sertoli Cell Tumor,0
11984,Run-in Period,Cartilaginous exostosis,0
11985,Estimated,Maxillary Sinus Adenocarcinoma,0
11986,Epithelial Cells,Liver Cavernous Hemangioma,0
11987,Carcinoma of bladder,FIGO Stage II Ovarian Cancer,0
11988,Weight decreased,Localized Askin Tumor,0
11989,Often - answer to question,Acantholytic squamous cell carcinoma,0
11990,SLC6A2 protein,Intraepithelial Melanocytic Hyperplasia,0
11991,Etiology aspects,Choroid Necrotic Melanoma,0
11992,Coding,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11993,include - SetOperator,Thymic Atypical Carcinoid Tumor,0
11994,Communicable Diseases,Methotrexate-Associated Hodgkin Lymphoma,0
11995,Bronchoconstriction,Thymic Clear Cell Carcinoma,0
11996,Associated with,Metastatic Ductal Breast Carcinoma,0
11997,Twice - dosing instruction fragment,Acute Undifferentiated Leukemia,0
11998,Five-year Survival Rate,embryonal rhabdomyosarcoma of prostate,0
11999,Squamous Epithelial Cells,Platinum-Resistant Lung Small Cell Carcinoma,0
12000,Retained,Xeroderma pigmentosum,0
12001,New,Medulloblastoma,0
12002,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Noninfiltrating Intraductal Carcinoma,0
12003,Body structure,Lipoma of small intestine,0
12004,Pale color,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12005,Nervous system structure,FIGO Stage II Ovarian Cancer,0
12006,Involvement with,Leiomyoma of Gallbladder,0
12007,Malignant Central Nervous System Neoplasm,Female Breast Carcinoma,0
12008,Neoplasms,Endometrial Small Cell Carcinoma,0
12009,Oral,Refractory Barrett Esophagus,0
12010,Pesticides,Stage IB Lung Cancer AJCC v7,0
12011,How Often Sweats,Childhood Lymphoma,0
12012,Few,Refractory Barrett Esophagus,0
12013,Adult human body,Childhood Fibrillary Astrocytoma,0
12014,Swelling,Diffuse malignant mesothelioma,0
12015,Term (lexical),Ovarian germ cell choriocarcinoma stage IV,0
12016,Result,Carcinoma of urinary bladder,0
12017,Tumor cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12018,Tears body substance,Cerebral hemangioma,0
12019,Receive,Adult Alveolar Soft Part Sarcoma,0
12020,Cancer Genus,Diffuse malignant mesothelioma,0
12021,Mammal liver preparation,Stage IB Lung Cancer AJCC v7,0
12022,Unexplained weight loss,Stage 0 Penile Cancer AJCC v8,0
12023,Divide,Collecting Duct Carcinoma of the Kidney,0
12024,research subject screening,Adult Hepatocellular Carcinoma,0
12025,Common Specifications in HL7 V3 Publishing,Carcinoma of urinary bladder,0
12026,Adult Classical Hodgkin Lymphoma,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
12027,Malignant neoplasm of kidney,Non-Metastatic Gestational Trophoblastic Tumor,0
12028,radiotherapeutic,Malignant melanoma of eyelid,0
12029,Usually Need Help from Another Person for Reach,Undifferentiated Endocervical Sarcoma,0
12030,Including (qualifier),Adenocarcinoma,0
12031,Smoking,Xeroderma pigmentosum,0
12032,Certainties,Cancer of Urinary Tract,0
12033,lymph nodes,Intestinal Metaplasia of Bladder Urothelium,0
12034,Nausea,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12035,Dorsal,Cartilaginous exostosis,0
12036,Occurrence,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
12037,Value Above Reference Range,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12038,Erythrocytes,Carcinoma of urinary bladder,0
12039,Occurrence Indicator,Blepharal carcinoma,0
12040,Form:Finding:Point in time:{Setting}:Document:{Role},Stage IV Childhood Non-Hodgkin Lymphoma,0
12041,BRAF gene,Leiomyoma of Gallbladder,0
12042,Area,Stage IV Childhood Non-Hodgkin Lymphoma,0
12043,Laparotomy,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12044,Person 1,Leiomyoma of Gallbladder,0
12045,Term (lexical),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12046,Clinical Study Case,Colorectal High Grade B-Cell Lymphoma,0
12047,Time,Cartilaginous exostosis,0
12048,Options,Digestive System Hodgkin Lymphoma,0
12049,Social group,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12050,combination - answer to question,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12051,Diagnosis,Endometrial Small Cell Carcinoma,0
12052,Tobacco smoking behavior,Medulloblastoma,0
12053,Initial Usage,Adult Hepatocellular Carcinoma,0
12054,Lower - spatial qualifier,Bladder squamous cell carcinoma stage I,0
12055,Treatment Epoch,Localized Ewing Sarcoma,0
12056,90%,Neoplasms,0
12057,Encounter due to family history of colonic polyps,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12058,Usually,Malignant neoplasm of thalamus,0
12059,Protein Glycosylation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12060,Oral,Primary Cutaneous Plasmablastic Lymphoma,0
12061,Item Collection,Ovarian germ cell choriocarcinoma stage IV,0
12062,Newly Diagnosed Childhood Ependymoma,Xeroderma pigmentosum,0
12063,Malignant Neoplasms,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12064,Infrequent,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12065,Persons,Heavy Chain Deposition Disease,0
12066,combination of objects,Testicular cancer metastatic,0
12067,Male population group,Undifferentiated Endocervical Sarcoma,0
12068,How Often Weight Loss,Intracortical osteosarcoma,0
12069,Fourth ventricle structure,Non-Metastatic Gestational Trophoblastic Tumor,0
12070,System (unit of presentation),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12071,IPSS Risk Category High,Xeroderma pigmentosum,0
12072,Total thymectomy,Spermatocytic seminoma,0
12073,Sample Range,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12074,How Often Weight Loss,Locally Advanced Soft Tissue Sarcoma,0
12075,Cell Count,Intraepithelial Melanocytic Hyperplasia,0
12076,Containing (qualifier),Bladder squamous cell carcinoma stage I,0
12077,Appearance Distress Question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12078,75,Blepharal carcinoma,0
12079,KIAA1549L gene,Stage IB Pancreatic Cancer AJCC v8,0
12080,Genes,papillary carcinoma of penis,0
12081,various other intestinal adsorbents in ATC,Hemangioma,0
12082,Persons,Recurrent Uveal Melanoma,0
12083,Singular,Localized Ewing Sarcoma,0
12084,Therapeutic procedure,Leptomeningeal sarcoma,0
12085,Usual Severity Weight Loss,Stage IB Pancreatic Cancer AJCC v8,0
12086,Abdominal Cavity,Localized Ewing Sarcoma,0
12087,Collecting system,Recurrent Uveal Melanoma,0
12088,Carcinoma of bladder,Giant cell angiofibroma,0
12089,More,Mucinous adenocarcinoma gastric,0
12090,Classification,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12091,Neuropathy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12092,Within,Breast Ductal Adenoma,0
12093,pathogenic aspects,Refractory Barrett Esophagus,0
12094,include - SetOperator,Adult Alveolar Soft Part Sarcoma,0
12095,Metastatic to,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12096,ASPM wt Allele,Chondrosarcoma,0
12097,Uveal melanoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12098,Frequently,BRCA2 Syndrome,0
12099,Treated with,Intraepithelial Melanocytic Hyperplasia,0
12100,Slow Growing,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12101,Platelets,Localized Ewing Sarcoma,0
12102,Exclude,Liver Lymphangioma,0
12103,Decision,Benign tumor of eyelid,0
12104,Surface of skin,Anterior Urethral Malignant Neoplasm,0
12105,lymph nodes,Hemangioma,0
12106,Plumbum metallicum,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12107,bony process,FIGO Stage II Ovarian Cancer,0
12108,Surface,Hemangioma,0
12109,Case (situation),Extra-Adrenal Paraganglioma,0
12110,*Susceptibility,Thymic Clear Cell Carcinoma,0
12111,Common Specifications in HL7 V3 Publishing,Endometrial Small Cell Carcinoma,0
12112,Tears body substance,Advanced Lung Carcinoma,0
12113,Statistical Significance,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12114,Primary malignant neoplasm,Blepharal carcinoma,0
12115,pharmacotherapeutic,Acantholytic squamous cell carcinoma,0
12116,Negative Surgical Margin,Lung squamous cell carcinoma stage I,0
12117,Osteoporosis,Mucinous cystadenofibroma,0
12118,Characteristics,Noninfiltrating Intraductal Carcinoma,0
12119,Mantle Zone,BRCA2 Syndrome,0
12120,Anabolism,Liver Lymphangioma,0
12121,Acid reflux SYMPTOMS,Recurrent Uveal Melanoma,0
12122,Aggressive course,FIGO Stage II Ovarian Cancer,0
12123,FDA Establishment Activity Terminology,embryonal rhabdomyosarcoma of prostate,0
12124,Prior Medication Usage,adenoid cystic carcinoma of lung,0
12125,Mental concentration,Intraepithelial Melanocytic Hyperplasia,0
12126,brain cell,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12127,Spreading (qualifier value),Undifferentiated Endocervical Sarcoma,0
12128,Two,Mucinous adenocarcinoma gastric,0
12129,newly,Digestive System Hodgkin Lymphoma,0
12130,Following,Advanced Lung Carcinoma,0
12131,active (HL7 RoleLink),Undifferentiated Neuroblastoma,0
12132,Chemotherapy,Anterior Urethral Malignant Neoplasm,0
12133,Complication Aspects,Undifferentiated Neuroblastoma,0
12134,Result,Stage II Carcinoma of Penis,0
12135,Probability,Secondary malignant neoplasm of lymph node,0
12136,Treating,Adenocarcinoma,0
12137,Example,Cerebral hemangioma,0
12138,Malignant - descriptor,Unresectable Rhabdomyosarcoma,0
12139,Malignant neoplasm of salivary gland,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12140,Certain (qualifier value),Localized Askin Tumor,0
12141,risk factors - observation list,Familial Adenomatous Polyposis Associated Medulloblastoma,0
12142,Neuroglia,Intraepithelial Melanocytic Hyperplasia,0
12143,Formed,Fourth Ventricle and Brain Stem Ependymal Tumor,0
12144,Upper,Malignant melanoma of eyelid,0
12145,Adult Lymphoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12146,Childbirth,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12147,tumor growth,gliosarcoma,0
12148,Can Do Very Little,Unfavorable Non-Hodgkin Lymphoma,0
12149,1000000,Testicular cancer metastatic,0
12150,Malignant - descriptor,Adult Alveolar Soft Part Sarcoma,0
12151,Blood capillaries,Childhood Choriocarcinoma,0
12152,Grouping,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12153,Representation (action),Intraepithelial Melanocytic Hyperplasia,0
12154,appendiceal,embryonal rhabdomyosarcoma of prostate,0
12155,Debris,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12156,City of Boston,Benign Carotid Body Paraganglioma,0
12157,Autosomal dominant hereditary disorder,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12158,Entity Determiner - specific,Digestive System Hodgkin Lymphoma,0
12159,Benign,Low Grade Squamous Intraepithelial Neoplasia,0
12160,PELVIS irradiation,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12161,International Classification of Diseases for Oncology,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12162,Skeletal bone,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12163,Limited stage (cancer stage),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12164,Chemotherapy Regimen,Stage IV Penile Cancer AJCC v7,0
12165,Medications,Xeroderma pigmentosum,0
12166,Agent,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12167,penis,Bladder squamous cell carcinoma stage I,0
12168,Result,Intraepithelial Melanocytic Hyperplasia,0
12169,Liver,Intestinal Metaplasia of Bladder Urothelium,0
12170,Known,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12171,Disease,Fourth Ventricle and Brain Stem Ependymal Tumor,0
12172,Twice (Numerical Qualifier),Human Papillomavirus-Related Carcinoma,0
12173,Line Specimen,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12174,Imbrication (procedure),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12175,Hemangiosarcoma,Lipoma of small intestine,0
12176,teratologic,Localized Askin Tumor,0
12177,Primary malignant neoplasm,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12178,Fatal,Cartilaginous exostosis,0
12179,Colon structure (body structure),Locally Advanced Soft Tissue Sarcoma,0
12180,Radiotherapy Research,Hodgkin lymphoma,0
12181,blood neoplasm,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12182,Sebaceous Glands,Chondrosarcoma,0
12183,How Much Nausea During This Period,Benign tumor of eyelid,0
12184,Woman,Human Papillomavirus-Related Carcinoma,0
12185,Anatomic Site,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12186,Retinoic Acid Response Element,Advanced Uterine Corpus Carcinosarcoma,0
12187,Data Type - Point In Time,Testicular cancer metastatic,0
12188,include - SetOperator,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12189,Present,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12190,Abnormal,Anterior Urethral Malignant Neoplasm,0
12191,Nuclear pleomorphism,Chondrosarcoma,0
12192,Biogenic Amines,Benign Carotid Body Paraganglioma,0
12193,Part,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12194,Location of Oral Residue Following Swallowing,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12195,Cisplatin,Neonatal leukemia,0
12196,Providing presence (regime/therapy),Stage IB Lung Cancer AJCC v7,0
12197,Ultraviolet Light Sterilization,Cerebral hemangioma,0
12198,Increased,Metastatic Malignant Neoplasm in the Sellar Region,0
12199,Chemotherapy Regimen,Digestive System Hodgkin Lymphoma,0
12200,3+ Score,Atypical Lobular Breast Hyperplasia,0
12201,Insect Bites,Metastatic Lung Small Cell Carcinoma,0
12202,Abdomen+,Unfavorable Non-Hodgkin Lymphoma,0
12203,Usual Severity Shortness of Breath,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12204,Brain,Cancer of Urinary Tract,0
12205,Neoplasms,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12206,Control function,BRCA2 Syndrome,0
12207,Expression (foundation metadata concept),Maxillary Sinus Adenocarcinoma,0
12208,Cell division,Colorectal cancer,0
12209,Lysergic acid diethylamide measurement,Localized Ewing Sarcoma,0
12210,Compleat Liquid Nutrition,Ichthyoses,0
12211,Have Itch,Carcinoma of urinary bladder,0
12212,Family member,Recurrent Testicular Lymphoma,0
12213,Does carry,sarcoma of spinal cord,0
12214,Primary,Atypical Lobular Breast Hyperplasia,0
12215,Cancer Genus,Anterior Urethral Malignant Neoplasm,0
12216,Tissue damage,Acantholytic squamous cell carcinoma,0
12217,Rating (action),Endometrial Small Cell Carcinoma,0
12218,Surgery specialty,Recurrent Uveal Melanoma,0
12219,Present,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12220,Cosmetics,Benign Apocrine Neoplasm,0
12221,Feel Tired question,Malignant neoplasm of choroid,0
12222,Office Visits,Pilocytic astrocytoma of cerebellum,0
12223,pemetrexed,Female Breast Carcinoma,0
12224,Use of,Anterior Urethral Malignant Neoplasm,0
12225,high - ActExposureLevelCode,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12226,How Much Distress Vomiting,Stage IB Lung Cancer AJCC v7,0
12227,Including (qualifier),Thymic Atypical Carcinoid Tumor,0
12228,PREVENT (product),Thymoma malignant recurrent,0
12229,Human body structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12230,Affecting,Human Papillomavirus-Related Carcinoma,0
12231,Known,squamous cell carcinoma of the thyroid gland,0
12232,Small cell carcinoma of lung,Low Grade Squamous Intraepithelial Neoplasia,0
12233,95,Cartilaginous exostosis,0
12234,Liver,benign mature teratoma of pancreas,0
12235,Occur (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12236,Main,sarcoma of spinal cord,0
12237,Reported Term,Granular Cell Leiomyosarcoma,0
12238,Division (surgical procedure),Endometrial Small Cell Carcinoma,0
12239,Symptoms aspect,Maxillary Sinus Adenocarcinoma,0
12240,Pharyngeal structure,Primary Cutaneous Plasmablastic Lymphoma,0
12241,Papanicolaou Test,Maxillary Sinus Adenocarcinoma,0
12242,Cell Device,non-Hodgkin's lymphoma of spleen,0
12243,Original,Airway Hemangioma,0
12244,High,Extra-Adrenal Paraganglioma,0
12245,Neoplasms,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12246,Group A (blood group),Unresectable Rhabdomyosarcoma,0
12247,Cells,Choroid Necrotic Melanoma,0
12248,Progress,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12249,Used by,Adult Hepatocellular Carcinoma,0
12250,Pharmacotherapy,Malignant Testicular Sertoli Cell Tumor,0
12251,Frequently,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12252,Asia,Digestive System Hodgkin Lymphoma,0
12253,Death (finding),Anterior Urethral Malignant Neoplasm,0
12254,French-American-British Classification,Digestive System Hodgkin Lymphoma,0
12255,Result,Female Breast Carcinoma,0
12256,Less Than,Secondary malignant neoplasm of lymph node,0
12257,Geographic Locations,Intestinal Metaplasia of Bladder Urothelium,0
12258,Malignant Neoplasms,Adult Brain Stem Mixed Glioma,0
12259,Hypothalamic structure,Clonal Hematopoiesis of Indeterminate Potential,0
12260,Multilaminar epithelium,Intestinal Metaplasia of Bladder Urothelium,0
12261,Positive,Larynx carcinoma recurrent,0
12262,Person Observer,BRCA2 Syndrome,0
12263,gastrointestinal,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
12264,Diagnosis Study,Locally Advanced Soft Tissue Sarcoma,0
12265,majority,de novo Myelodysplastic Syndrome,0
12266,Neoplasm Metastasis,BRCA2 Syndrome,0
12267,Full,Digestive System Hodgkin Lymphoma,0
12268,Ovary,Endometrial Small Cell Carcinoma,0
12269,Spreading (qualifier value),Pilocytic astrocytoma of cerebellum,0
12270,Recommendation,Giant cell angiofibroma,0
12271,Etiology aspects,Blepharal carcinoma,0
12272,Decision,Collecting Duct Carcinoma of the Kidney,0
12273,Including (qualifier),Platinum-Resistant Lung Small Cell Carcinoma,0
12274,Frequently,Uterine Cancer,0
12275,include - SetOperator,Cartilaginous exostosis,0
12276,Slow,Unresectable Rhabdomyosarcoma,0
12277,Before,Spongiotic dermatitis,0
12278,Percent of Abnormal Cells,Undifferentiated Endocervical Sarcoma,0
12279,Estrogen [EPC],Ichthyosis,0
12280,Biomaterial Treatment,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12281,Flowers,Recurrent Testicular Lymphoma,0
12282,Mass of body region,Childhood Fibrillary Astrocytoma,0
12283,Needs,Pancreatic Intraepithelial Neoplasia-3,0
12284,Appearance of eyelid,Mucinous adenocarcinoma gastric,0
12285,mast-,Neonatal leukemia,0
12286,NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology,Stage IB Pancreatic Cancer AJCC v8,0
12287,Symptoms aspect,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12288,High Mitosis-Karyorrhexis Index,Human Papillomavirus-Related Carcinoma,0
12289,Rare,Acute Undifferentiated Leukemia,0
12290,1000000,Adult Hepatocellular Carcinoma,0
12291,Very High Level,High Grade Glandular Intraepithelial Neoplasia,0
12292,Manufactured form,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12293,Account number:Identifier:Point in time:^Patient:Nominal,Grade 3a Malignant Neoplasm,0
12294,Fever,Atypical Lobular Breast Hyperplasia,0
12295,Precision - second,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12296,Most,Malignant neoplasm of choroid,0
12297,Pharmacologic Substance,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
12298,Lymphoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12299,Aspects of signs,Maxillary Sinus Adenocarcinoma,0
12300,nonspecific,Localized Askin Tumor,0
12301,Main,Adrenal Rest Tumor,0
12302,*Type - Kind of quantity,Malignant melanoma of eyelid,0
12303,High Mitosis-Karyorrhexis Index,Stage IB Lung Cancer AJCC v7,0
12304,Primary,Low Grade Squamous Intraepithelial Neoplasia,0
12305,Including (qualifier),Female Breast Carcinoma,0
12306,Subcategory,Intraepithelial Melanocytic Hyperplasia,0
12307,Cerebrum,mucinous adenocarcinoma of gallbladder,0
12308,35,Testicular cancer metastatic,0
12309,factor A,Mucinous adenocarcinoma gastric,0
12310,Sharing (Social Behavior),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12311,Therapy Object (animal model),Bladder squamous cell carcinoma stage I,0
12312,Electromagnetic Radiation,Urethral Carcinoma,0
12313,Generic Role,Acute lymphadenitis,0
12314,Extension,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12315,Gene Cluster Text Format,Chronic Myelomonocytic Leukemia-2,0
12316,Pallor,Adult Hepatocellular Carcinoma,0
12317,Involvement with,Liver Lymphangioma,0
12318,Premalignant,Mucinous adenocarcinoma gastric,0
12319,Primary malignant neoplasm,Childhood Fibrillary Astrocytoma,0
12320,Divide,Intestinal Metaplasia of Bladder Urothelium,0
12321,condom use,Tonsillar Carcinoma,0
12322,Malignant tumor of cervix,Intestinal Metaplasia of Bladder Urothelium,0
12323,International Statistical Classification of Diseases and Related Health Problems,Breast Ductal Adenoma,0
12324,Dosing Days to Detection,Refractory Barrett Esophagus,0
12325,Reduced,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12326,Abdomen,Leiomyoma of Gallbladder,0
12327,Occurrence Indicator,Recurrent Uveal Melanoma,0
12328,Life threatening - Event Consequence,Grade 1 Clear Cell Renal Cell Carcinoma,0
12329,Positive,Acute lymphadenitis,0
12330,Neoplasms,Stage III Adult Immunoblastic Lymphoma,0
12331,WHO Central Nervous System Grade I,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12332,Location of Pharyngeal Residue Following Swallowing,Uterine Cancer,0
12333,Pharmacotherapy,Familial Adenomatous Polyposis Associated Medulloblastoma,0
12334,Tryptophanase,Maxillary Sinus Adenocarcinoma,0
12335,Skin Specimen,Metastatic Ductal Breast Carcinoma,0
12336,Person 1,Neoplasms,0
12337,Acrospiroma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12338,Cystoscopy,Angiosarcoma of liver,0
12339,Usual,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12340,Tobacco smoking behavior,Stage II Carcinoma of Penis,0
12341,Acute leukemia,Uterine Cancer,0
12342,Spreading (qualifier value),Adrenal Rest Tumor,0
12343,2+ Score,Human Papillomavirus-Related Carcinoma,0
12344,Persons,Advanced Uterine Corpus Carcinosarcoma,0
12345,Common Specifications in HL7 V3 Publishing,Clonal Hematopoiesis of Indeterminate Potential,0
12346,Somatic mutation,Childhood Lymphoma,0
12347,How Often Vomiting,embryonal rhabdomyosarcoma of prostate,0
12348,Vasopressin (USP),Xeroderma pigmentosum,0
12349,Common (qualifier value),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12350,Malignant Neoplasms,Carcinoma of urinary bladder,0
12351,Genus Anemia,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12352,Retinoic Acid Response Element,Endometrial Small Cell Carcinoma,0
12353,Occurrence Indicator,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12354,Percent of Abnormal Cells,non-Hodgkin's lymphoma of spleen,0
12355,Thin (qualifier value),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12356,Number of birth,embryonal rhabdomyosarcoma of prostate,0
12357,Physical findings,Uterine Cancer,0
12358,Cornea,Pancreatic Intraepithelial Neoplasia-3,0
12359,IPSS Risk Category High,Pilocytic astrocytoma of cerebellum,0
12360,Genetic,Grade 3a Malignant Neoplasm,0
12361,Seizures,Granular Cell Leiomyosarcoma,0
12362,Occurrence,Angiosarcoma of liver,0
12363,Together,Tonsillar Carcinoma,0
12364,genetic risk factors,Endometrial Small Cell Carcinoma,0
12365,inferiority,FIGO Stage II Ovarian Cancer,0
12366,Therapeutic radiology procedure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12367,Benign Vascular Neoplasm,Childhood Thyroid Gland Follicular Carcinoma,0
12368,Talpidae,GIANT PIGMENTED HAIRY NEVUS,0
12369,Accepted,Acute Undifferentiated Leukemia,0
12370,Location of Oral Residue Following Swallowing,Airway Hemangioma,0
12371,red Patches,Benign Carotid Body Paraganglioma,0
12372,Vomiting,Keratoderma,0
12373,Primary,Angiosarcoma of liver,0
12374,Tumor tissue sample,Acute Undifferentiated Leukemia,0
12375,solid Ovarian mass,Stage IV Penile Cancer AJCC v7,0
12376,combination - answer to question,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
12377,Five,Acantholytic squamous cell carcinoma,0
12378,Participation Type - origin,Female Breast Carcinoma,0
12379,Known,Primary Cutaneous Plasmablastic Lymphoma,0
12380,Easy bleeding,Locally Advanced Soft Tissue Sarcoma,0
12381,Endoscopy (procedure),Maxillary Sinus Adenocarcinoma,0
12382,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12383,metastatic qualifier,Cartilaginous exostosis,0
12384,Human body structure,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
12385,Symptom severity level,mucinous adenocarcinoma of gallbladder,0
12386,Osteoporosis,Female Breast Carcinoma,0
12387,shared attribute,Intestinal Neuroendocrine Carcinoma,0
12388,Then,Choroid Necrotic Melanoma,0
12389,Block Unit of Distance,Mixed parotid tumor,0
12390,Lifestyle changes,Neoplasms,0
12391,Approved,Intracortical osteosarcoma,0
12392,NCI CTEP SDC Melanoma Sub-Category Terminology,Cerebral Primitive Neuroectodermal Tumor,0
12393,Growth abnormality,Stage IB Lung Cancer AJCC v7,0
12394,System - kit,Cerebral Primitive Neuroectodermal Tumor,0
12395,Common Specifications in HL7 V3 Publishing,Lipoma of small intestine,0
12396,Degree or extent,Intestinal Metaplasia of Bladder Urothelium,0
12397,Neoplasms,Recurrent Testicular Lymphoma,0
12398,North America,High Grade Glandular Intraepithelial Neoplasia,0
12399,Subgroup A Nepoviruses,Malignant neoplasm of choroid,0
12400,Anorexia,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12401,Component object,Lung squamous cell carcinoma stage I,0
12402,Application Context,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12403,Plumbum metallicum,mucinous adenocarcinoma of gallbladder,0
12404,Body Fluids,Cerebral Primitive Neuroectodermal Tumor,0
12405,Intention - mental process,Endometrial Small Cell Carcinoma,0
12406,Usual,Undifferentiated Endocervical Sarcoma,0
12407,Etiology aspects,Undifferentiated Endocervical Sarcoma,0
12408,Treated with,embryonal rhabdomyosarcoma of prostate,0
12409,Venous system,Pilocytic astrocytoma of cerebellum,0
12410,Preventive monitoring,Atypical Lobular Breast Hyperplasia,0
12411,device aspects,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12412,Benign Neoplasm,Stage III Adult Immunoblastic Lymphoma,0
12413,Neuron spine,High Grade Glandular Intraepithelial Neoplasia,0
12414,Spinal Cord,Liver Lymphangioma,0
12415,European race,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12416,PSA Level Less than Two,Carcinoma of urinary bladder,0
12417,Overall Publication Type,Malignant Testicular Sertoli Cell Tumor,0
12418,Seeding,Low Grade Squamous Intraepithelial Neoplasia,0
12419,Night time,Cerebral Primitive Neuroectodermal Tumor,0
12420,application of research,Leiomyoma of Gallbladder,0
12421,Half,Familial Adenomatous Polyposis Associated Medulloblastoma,0
12422,Common (qualifier value),Malignant melanoma of eyelid,0
12423,gastrointestinal,Platinum-Resistant Lung Small Cell Carcinoma,0
12424,Childhood Embryonal Rhabdomyosarcoma,Pancreatic Intraepithelial Neoplasia-3,0
12425,85,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12426,Increased,BRCA2 Syndrome,0
12427,Primary malignant neoplasm,Grade 3a Malignant Neoplasm,0
12428,3+ Score,Malignant Testicular Sertoli Cell Tumor,0
12429,Additional,Recurrent Testicular Lymphoma,0
12430,To,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12431,Suspected diagnosis,Secondary malignant neoplasm of lymph node,0
12432,Development,Testicular cancer metastatic,0
12433,control aspects,squamous cell carcinoma of the thyroid gland,0
12434,Etiology aspects,Localized Ewing Sarcoma,0
12435,% bound (qualifier value),Recurrent Uveal Melanoma,0
12436,Chemotherapy,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12437,Family history,adenoid cystic carcinoma of lung,0
12438,Body part,Clonal Hematopoiesis of Indeterminate Potential,0
12439,peripheral blood,Malignant melanoma of eyelid,0
12440,Therapeutic procedure,Stage IV Penile Cancer AJCC v7,0
12441,Chemotherapy,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12442,FAP protein,Small cell neuroendocrine carcinoma of bladder,0
12443,Persons,Small cell neuroendocrine carcinoma of bladder,0
12444,Togo,Thymic Clear Cell Carcinoma,0
12445,PREMATURE CHROMATID SEPARATION TRAIT,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12446,Pharmaceutical Preparations,Adrenal Rest Tumor,0
12447,Often - answer to question,Advanced Uterine Corpus Carcinosarcoma,0
12448,Fibroid Tumor,Refractory Barrett Esophagus,0
12449,Same,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12450,Aggressive course,Low Grade Squamous Intraepithelial Neoplasia,0
12451,Primary malignant neoplasm,Tonsillar Carcinoma,0
12452,Removed,Acute Undifferentiated Leukemia,0
12453,Equilibrium,Papillary cystic tumor,0
12454,64,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12455,Back Pain,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12456,Make - Instruction Imperative,Rhabdomyosarcoma with ganglionic differentiation,0
12457,Slow,Human Papillomavirus-Related Carcinoma,0
12458,Negative Selection,Cerebral Primitive Neuroectodermal Tumor,0
12459,Usually,Uterine Cancer,0
12460,various other agents for local oral treatment in ATC,Diffuse malignant mesothelioma,0
12461,Pleural Effusion,Malignant Neoplasm with Regional Lymph Node Involvement,0
12462,Entity,Hodgkin lymphoma,0
12463,Frequently,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12464,antibiotics,Acantholytic squamous cell carcinoma,0
12465,Operative Surgical Procedures,Intestinal Metaplasia of Bladder Urothelium,0
12466,Tryptophanase,Werner Syndrome,0
12467,Notable,Blepharal carcinoma,0
12468,Pharmaceutical Preparations,Adult Alveolar Soft Part Sarcoma,0
12469,1.1,Unresectable Rhabdomyosarcoma,0
12470,Body structure,Thymic Atypical Carcinoid Tumor,0
12471,per year,Localized Askin Tumor,0
12472,Fasting,Thymic Atypical Carcinoid Tumor,0
12473,XK wt Allele,Chronic Myelomonocytic Leukemia-2,0
12474,Used by,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12475,Type - attribute,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12476,dendritic spine neck,Intraepithelial Melanocytic Hyperplasia,0
12477,Cancer of Lip,Extracranial Neuroblastoma,0
12478,Low Grade,Cancer of Urinary Tract,0
12479,Personal appearance,embryonal rhabdomyosarcoma of prostate,0
12480,Symptoms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12481,Common Specifications in HL7 V3 Publishing,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12482,Diabetes,Neonatal leukemia,0
12483,Previous,benign mature teratoma of pancreas,0
12484,Supportive assistance,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12485,Chemotherapy Regimen,sarcoma of spinal cord,0
12486,MYOT gene,embryonal rhabdomyosarcoma of prostate,0
12487,Current (present time),Colorectal Neuroendocrine Tumor G2,0
12488,Astrocytoma,Stage III Adult Immunoblastic Lymphoma,0
12489,United States,Female Breast Carcinoma,0
12490,Negative Surgical Margin,Airway Hemangioma,0
12491,per year,Bladder squamous cell carcinoma stage I,0
12492,Qualitative form,Neonatal leukemia,0
12493,Telephone Extension Number,Stage IB Lung Cancer AJCC v7,0
12494,Inflammatory Breast Carcinoma,Secondary malignant neoplasm of lymph node,0
12495,Antibiotics,Extra-Adrenal Paraganglioma,0
12496,Recommendation,Malignant melanoma of eyelid,0
12497,World Health Organization,Xeroderma pigmentosum,0
12498,Superkingdom (taxonomic category),Acute Undifferentiated Leukemia,0
12499,Acute Undifferentiated Leukemia,Childhood Lymphoma,0
12500,Concept Attribute,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12501,Clone Cells,Malignant Neoplasm with Regional Lymph Node Involvement,0
12502,Followed by,Hemangioma,0
12503,90%,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12504,Time,Medulloblastoma,0
12505,Aspects of signs,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12506,Apply,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12507,derivation calculation,benign mature teratoma of pancreas,0
12508,bony process,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12509,active (HL7 RoleLink),Medulloblastoma,0
12510,Type A,Mucinous cystadenofibroma,0
12511,Inguinal region,Colorectal High Grade B-Cell Lymphoma,0
12512,Clinical Study Case,Stage II Hepatocellular Carcinoma AJCC v8,0
12513,Then,Metastatic Carcinoma in the Lung,0
12514,Most,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12515,Medications,Non-Metastatic Gestational Trophoblastic Tumor,0
12516,Make - Instruction Imperative,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12517,metaplastic cell transformation,Diffuse malignant mesothelioma,0
12518,Only - dosing instruction fragment,Mastocytosis,0
12519,Retained,Malignant Testicular Sertoli Cell Tumor,0
12520,Surface,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12521,Sodium Tetradecyl Sulfate,malignant lymphoma of pancreatic lymph nodes,0
12522,Myelodysplastic Syndrome,Colorectal Neuroendocrine Tumor G2,0
12523,Pregnancy,Lung squamous cell carcinoma stage I,0
12524,Body tissue,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12525,Neck,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12526,Fibrous layer,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12527,Increased,Leiomyoma of Gallbladder,0
12528,Lesion,Leptomeningeal sarcoma,0
12529,Financial Account,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12530,Negation,Cerebral Primitive Neuroectodermal Tumor,0
12531,68,Malignant Testicular Sertoli Cell Tumor,0
12532,Pitch - substance,Non-Metastatic Gestational Trophoblastic Tumor,0
12533,Enneking High Surgical Grade,Small cell neuroendocrine carcinoma of bladder,0
12534,Malignant - descriptor,Contact dermatitis due to alkali,0
12535,Time (foundation metadata concept),Rhabdomyosarcoma with ganglionic differentiation,0
12536,Tissue Specimen Code,Childhood Thyroid Gland Follicular Carcinoma,0
12537,Mathematical Operator,Undifferentiated Endocervical Sarcoma,0
12538,Metabolic Syndrome X,Neonatal leukemia,0
12539,Fatigue,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
12540,Serous,Localized Ewing Sarcoma,0
12541,1+,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12542,Immature Lymphocytes Measurement,Adult Alveolar Soft Part Sarcoma,0
12543,Only - dosing instruction fragment,Mucinous adenocarcinoma gastric,0
12544,Experimental Result,Neonatal leukemia,0
12545,Human body,Clonal Hematopoiesis of Indeterminate Potential,0
12546,Sometimes,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12547,Case unit dose,Stage IV Childhood Non-Hodgkin Lymphoma,0
12548,majority,mucinous adenocarcinoma of gallbladder,0
12549,Genetic,adenosquamous carcinoma of breast,0
12550,Areas <moth>,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12551,Very rare,Tonsillar Carcinoma,0
12552,Internal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12553,Frequently,Adrenal Rest Tumor,0
12554,Pharmacotherapy,Malignant Testicular Sertoli Cell Tumor,0
12555,Ductal Carcinoma,Stage II Hepatocellular Carcinoma AJCC v8,0
12556,Reported Term,Neoplasms,0
12557,Empty (qualifier),Papillary cystic tumor,0
12558,Pathology,Locally Advanced Soft Tissue Sarcoma,0
12559,Sacrifice,Colorectal cancer,0
12560,Surgical service,Intraepithelial Melanocytic Hyperplasia,0
12561,MYOT gene,Mucinous adenocarcinoma gastric,0
12562,Malignant neoplasm of pancreas,Atypical Mesothelial Hyperplasia,0
12563,Simple,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12564,Problems - What subject filter,embryonal rhabdomyosarcoma of prostate,0
12565,Term Birth,Spongiotic dermatitis,0
12566,Pharmaceutical Preparations,Testicular cancer metastatic,0
12567,Merkel cell carcinoma,Female Breast Carcinoma,0
12568,900,Xeroderma pigmentosum,0
12569,Lower eyelid,adenosquamous carcinoma of breast,0
12570,Sunscreening Agents,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12571,1930s,Extracranial Neuroblastoma,0
12572,Life Expectancy Less than Five Years,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12573,Smell Perception,Acute Undifferentiated Leukemia,0
12574,curettage specimen,Chronic Myelomonocytic Leukemia-2,0
12575,Human Cells,Pancreatic Intraepithelial Neoplasia-3,0
12576,Xp,High Grade Glandular Intraepithelial Neoplasia,0
12577,Myeloma Proteins,Tonsillar Carcinoma,0
12578,Usually,Human Papillomavirus-Related Carcinoma,0
12579,Records,benign mature teratoma of pancreas,0
12580,Operative Surgical Procedures,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12581,pharmacotherapeutic,Childhood Thyroid Gland Follicular Carcinoma,0
12582,Reported Term,Malignant Neoplasm with Regional Lymph Node Involvement,0
12583,Infrequent,Low Grade Squamous Intraepithelial Neoplasia,0
12584,Numbers,Spongiotic dermatitis,0
12585,Never (frequency),Hodgkin lymphoma,0
12586,Period Circadian Protein Homolog 1,Stage III Adult Immunoblastic Lymphoma,0
12587,Decision,Choroid Necrotic Melanoma,0
12588,Y base,Angiosarcoma of liver,0
12589,To,Recurrent Uveal Melanoma,0
12590,Anatomic Site,Small cell neuroendocrine carcinoma of bladder,0
12591,Body tissue,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12592,Mass of body region,Cartilaginous exostosis,0
12593,Cough Frequency,Localized Askin Tumor,0
12594,84,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12595,lymph nodes,Metastatic Neoplasm to the Gallbladder,0
12596,Present,Liver Lymphangioma,0
12597,Determined by,Adult Alveolar Soft Part Sarcoma,0
12598,Ultraviolet Rays,Digestive System Hodgkin Lymphoma,0
12599,Environmental risk factor,Collecting Duct Carcinoma of the Kidney,0
12600,Ovulation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12601,protein expression,Testicular cancer metastatic,0
12602,Qualitative form,Mucinous adenocarcinoma gastric,0
12603,Certainties,Intraepithelial Melanocytic Hyperplasia,0
12604,Therapeutic procedure,Metastatic Lung Small Cell Carcinoma,0
12605,Manufactured form,Breast Ductal Adenoma,0
12606,Immunization Domain,Hodgkin lymphoma,0
12607,Bacteria present,Bladder squamous cell carcinoma stage I,0
12608,Post Device,Intestinal Metaplasia of Bladder Urothelium,0
12609,Set scale,Childhood Fibrillary Astrocytoma,0
12610,Human body structure,Secondary malignant neoplasm of lymph node,0
12611,B-Cell Receptor Complex,Diffuse malignant mesothelioma,0
12612,Combined,Clonal Hematopoiesis of Indeterminate Potential,0
12613,1+ Score,Chondrosarcoma,0
12614,Genetic,Digestive System Hodgkin Lymphoma,0
12615,Carcinoma of lung,Mucinous adenocarcinoma gastric,0
12616,Spreading (qualifier value),Malignant melanoma of eyelid,0
12617,Time,Metastatic Lung Small Cell Carcinoma,0
12618,95,Mucinous adenocarcinoma gastric,0
12619,Disease Response,Digestive System Hodgkin Lymphoma,0
12620,Derivation,Cerebral Primitive Neuroectodermal Tumor,0
12621,treatment - ActInformationManagementReason,Familial Hemophagocytic Lymphocytosis,0
12622,Weight decreased,Childhood Fibrillary Astrocytoma,0
12623,therapeutic aspects,Recurrent Testicular Lymphoma,0
12624,Tryptophanase,Unfavorable Non-Hodgkin Lymphoma,0
12625,Glioblastoma Multiforme,Diffuse malignant mesothelioma,0
12626,mole changes,Cancer of Urinary Tract,0
12627,Sun Exposure,Intestinal Metaplasia of Bladder Urothelium,0
12628,65+,Stage IV Childhood Non-Hodgkin Lymphoma,0
12629,Observation - diagnostic procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12630,Seven,Urethral Carcinoma,0
12631,Dietary Lead,Carcinoma ex pleomorphic adenoma of parotid gland,0
12632,NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12633,Possibly Related to Intervention,Intracortical osteosarcoma,0
12634,Cell Count,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12635,Symptoms,FIGO Stage II Ovarian Cancer,0
12636,Thymus <angiosperm>,Malignant melanoma of eyelid,0
12637,Congenital qualifier,Adenocarcinoma of the prostate metastatic,0
12638,Fever,Colorectal High Grade B-Cell Lymphoma,0
12639,Disease,Giant cell angiofibroma,0
12640,Malignancy,Platinum-Resistant Lung Small Cell Carcinoma,0
12641,United States,Recurrent Testicular Lymphoma,0
12642,Leg,Childhood Lymphoma,0
12643,>90,Blepharal carcinoma,0
12644,CD44 wt Allele,Thymic Atypical Carcinoid Tumor,0
12645,Taken,Deep Leiomyoma,0
12646,Appearance Distress Question,Mucinous adenocarcinoma gastric,0
12647,Fibrolamellar Hepatocellular Carcinoma,Ampulla of Vater Tubular Adenoma,0
12648,Heart,Recurrent Uveal Melanoma,0
12649,Hemopoietic tissue,Childhood Lymphoma,0
12650,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12651,Surgical extraction,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12652,Surgical aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12653,Qualitative form,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12654,Injury cause,Low Grade Squamous Intraepithelial Neoplasia,0
12655,Therapeutic procedure,Xeroderma pigmentosum,0
12656,Body Site Modifier - Lower,Benign Carotid Body Paraganglioma,0
12657,Lung,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12658,Worsening pattern,Papillary cystic tumor,0
12659,300,Cancer of Urinary Tract,0
12660,Interstitial Fluid,Pancreatic Intraepithelial Neoplasia-3,0
12661,Table Cell Horizontal Align - left,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12662,Etiology aspects,Airway Hemangioma,0
12663,Cells,Metastatic Lung Small Cell Carcinoma,0
12664,40%,Childhood Lymphoma,0
12665,rituximab,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12666,2+ Score,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12667,Appearance,Hemangioma,0
12668,Has difficulty doing (qualifier value),Anterior Urethral Malignant Neoplasm,0
12669,Lymphadenopathy,Adult Fibrolamellar Carcinoma,0
12670,Latin America,Tonsillar Carcinoma,0
12671,Part of,Extracranial Neuroblastoma,0
12672,Gastroesophageal reflux disease,Stage II Carcinoma of Penis,0
12673,Curative - procedure intent,embryonal rhabdomyosarcoma of prostate,0
12674,Borg Category-Ratio 10 Perceived Exertion Score 5,Breast Ductal Adenoma,0
12675,Neoplasm Metastasis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12676,Providing presence (regime/therapy),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12677,Membrane Device,Childhood Cerebellar Neoplasm,0
12678,75,BRCA2 Syndrome,0
12679,Relationships,Undifferentiated Endocervical Sarcoma,0
12680,Bloody,Giant cell angiofibroma,0
12681,Primary,Mucinous adenocarcinoma gastric,0
12682,BRCA2 gene,Pancreatic Intraepithelial Neoplasia-3,0
12683,Classification,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12684,Smear - instruction imperative,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12685,Tumor site,Malignant neoplasm of choroid,0
12686,Duct (organ) structure,Thymic Clear Cell Carcinoma,0
12687,Widening,Lipoma of small intestine,0
12688,Medical service,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12689,Web Site,Mucinous cystadenofibroma,0
12690,Hormone Therapy,Human Papillomavirus-Related Carcinoma,0
12691,Coding,Adult Brain Stem Mixed Glioma,0
12692,Food Consumption,Ovarian Carcinoid Tumor,0
12693,% live,Ichthyosis,0
12694,Cure (remedy),Uterine Cancer,0
12695,rapid diagnosis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12696,Most,Chronic Myelomonocytic Leukemia-2,0
12697,Associated with,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12698,treatment - ActInformationManagementReason,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12699,Chemotherapy Regimen,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12700,Decision,Small cell neuroendocrine carcinoma of bladder,0
12701,Immunoglobulins,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12702,35,BRCA2 Syndrome,0
12703,Negation,de novo Myelodysplastic Syndrome,0
12704,Smaller,Recurrent Uveal Melanoma,0
12705,/40,Cartilaginous exostosis,0
12706,Released (action),Liver Lymphangioma,0
12707,Treated with,Digestive System Hodgkin Lymphoma,0
12708,Sensory (qualifier value),Colorectal cancer,0
12709,Fungal,Childhood Fibrillary Astrocytoma,0
12710,Adult Myelodysplastic Syndrome,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12711,2+,Granular Cell Leiomyosarcoma,0
12712,Endometrial biopsy,Female Breast Carcinoma,0
12713,Good,Chondrosarcoma,0
12714,Formations,Malignant Testicular Sertoli Cell Tumor,0
12715,Secondary Neoplasm,Thymic Clear Cell Carcinoma,0
12716,March (month),Acute Undifferentiated Leukemia,0
12717,Extent of disease,Endometrial Small Cell Carcinoma,0
12718,>90,Low Grade Squamous Intraepithelial Neoplasia,0
12719,Common (qualifier value),Familial Adenomatous Polyposis Associated Medulloblastoma,0
12720,Smear - instruction imperative,BRCA2 Syndrome,0
12721,Patient Reported Outcome,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12722,Abnormal result,Malignant melanoma of eyelid,0
12723,Togo,Giant cell angiofibroma,0
12724,chronic,Testicular cancer metastatic,0
12725,Stomach structure,mucinous adenocarcinoma of gallbladder,0
12726,Has focus,Diffuse malignant mesothelioma,0
12727,therapeutic aspects,Intracortical osteosarcoma,0
12728,2+,Ovarian germ cell choriocarcinoma stage IV,0
12729,Support,Stage II Hepatocellular Carcinoma AJCC v8,0
12730,Drain number:ID:Pt:^Patient:Nom,Stage IB Pancreatic Cancer AJCC v8,0
12731,Laryngeal prominence,Adult Brain Stem Mixed Glioma,0
12732,Contact with,Intraepithelial Melanocytic Hyperplasia,0
12733,Lymphoid Tissue,Endometrial Small Cell Carcinoma,0
12734,Case unit dose,High Grade Glandular Intraepithelial Neoplasia,0
12735,International Classification of Disease for Oncology,Metastatic Neoplasm to the Gallbladder,0
12736,Average of Value Derivation Technique,Digestive System Hodgkin Lymphoma,0
12737,Basis - conceptual entity,Uterine Cancer,0
12738,Surgical reduction,embryonal rhabdomyosarcoma of prostate,0
12739,Weight Loss,Intestinal Metaplasia of Bladder Urothelium,0
12740,World,Diffuse malignant mesothelioma,0
12741,Evaluation,Angiosarcoma of liver,0
12742,Bayer Visual Acuity Changes Grade 3,Unfavorable Non-Hodgkin Lymphoma,0
12743,Near,Childhood Choriocarcinoma,0
12744,Body Fluids,Metastatic Ductal Breast Carcinoma,0
12745,Poverty,Pancreatic Intraepithelial Neoplasia-3,0
12746,Disease Screening,Metastatic Malignant Neoplasm in the Sellar Region,0
12747,More,Childhood Fibrillary Astrocytoma,0
12748,Spreading (qualifier value),Benign Apocrine Neoplasm,0
12749,Base - General Qualifier,Breast Ductal Adenoma,0
12750,White Blood Cell Count procedure,Digestive System Hodgkin Lymphoma,0
12751,Autosomal recessive inheritance,Undifferentiated Endocervical Sarcoma,0
12752,Publishing,Refractory Barrett Esophagus,0
12753,majority,malignant lymphoma of pancreatic lymph nodes,0
12754,True Control Status,Stage IB Lung Cancer AJCC v7,0
12755,Overall,Diffuse malignant mesothelioma,0
12756,Risk,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12757,Lymphoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12758,Malignant Neoplasms,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12759,include - SetOperator,carcinoma of middle ear,0
12760,VIPR1 wt Allele,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12761,Prognosis:Find:Pt:^Patient:Nom,Mucinous adenocarcinoma gastric,0
12762,Container status - Identified,Familial Adenomatous Polyposis Associated Medulloblastoma,0
12763,Occur (action),Intraepithelial Melanocytic Hyperplasia,0
12764,dendritic spine neck,Undifferentiated Endocervical Sarcoma,0
12765,Primary,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12766,MALIGNANT benign,Xeroderma pigmentosum,0
12767,Representation (action),Recurrent Testicular Lymphoma,0
12768,Case (situation),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12769,Pressure (finding),Recurrent Uveal Melanoma,0
12770,Entity Determiner - specific,Collecting Duct Carcinoma of the Kidney,0
12771,Legal Adult,Diffuse malignant mesothelioma,0
12772,Type - attribute,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12773,Act Relationship Subset - previous,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12774,combination of objects,Tonsillar Carcinoma,0
12775,Large blood vessel structure,GIANT PIGMENTED HAIRY NEVUS,0
12776,Diagnosis,Adult Alveolar Soft Part Sarcoma,0
12777,Case unit dose,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12778,Feelings,Intraepithelial Melanocytic Hyperplasia,0
12779,Usual Severity Weight Loss,Collecting Duct Carcinoma of the Kidney,0
12780,Osteophyte,Acute Undifferentiated Leukemia,0
12781,Posterior cord syndrome,Intestinal Metaplasia of Bladder Urothelium,0
12782,failed,Undifferentiated Endocervical Sarcoma,0
12783,Alleles,Carcinoma of urinary bladder,0
12784,Operation excision,Airway Hemangioma,0
12785,Esophagus,Malignant melanoma of eyelid,0
12786,combination of objects,Chronic Myelomonocytic Leukemia-2,0
12787,Does run (finding),Tonsillar Carcinoma,0
12788,Therapy Object (animal model),embryonal rhabdomyosarcoma of prostate,0
12789,Numerous,Digestive System Hodgkin Lymphoma,0
12790,Administration procedure,embryonal rhabdomyosarcoma of prostate,0
12791,Tanning of leather,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12792,active (HL7 RoleLink),Bladder squamous cell carcinoma stage I,0
12793,aspects of adverse effects,squamous cell carcinoma of the thyroid gland,0
12794,Clinical,Cerebral hemangioma,0
12795,Chewing,FIGO Stage II Ovarian Cancer,0
12796,Tumor Mass,Human Papillomavirus-Related Carcinoma,0
12797,Reported Term,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12798,Increase,squamous cell carcinoma of the thyroid gland,0
12799,radiotherapeutic,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12800,Proliferation (morphologic abnormality),Malignant Testicular Sertoli Cell Tumor,0
12801,Pelvic Pain,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12802,Small,Serous cystadenocarcinoma ovary,0
12803,Diffuse Large B-Cell Lymphoma,Germinoma,0
12804,Sexual Partners,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12805,Most,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12806,Bladder Continence Question,Low Grade Squamous Intraepithelial Neoplasia,0
12807,Nervous system structure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12808,Structure of minor calyx,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12809,Diagnostic Neoplasm Staging,Bladder squamous cell carcinoma stage I,0
12810,Diagnosis Study,Human Papillomavirus-Related Carcinoma,0
12811,Symptoms aspect,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12812,A Codes,Stage III Adult Immunoblastic Lymphoma,0
12813,dendritic spine neck,Cartilaginous exostosis,0
12814,Large,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12815,combination - answer to question,Cancer of Urinary Tract,0
12816,Together,Colorectal cancer,0
12817,Walls of a building,Localized Ewing Sarcoma,0
12818,Abnormal size,Human Papillomavirus-Related Carcinoma,0
12819,Bone Marrow Examination,Unfavorable Non-Hodgkin Lymphoma,0
12820,Occur (action),Localized Ewing Sarcoma,0
12821,Body site,Stage IB Lung Cancer AJCC v7,0
12822,Etiology aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12823,Administration occupational activities,Cartilaginous exostosis,0
12824,Intention - mental process,Extracranial Neuroblastoma,0
12825,Peripheral,Low Grade Squamous Intraepithelial Neoplasia,0
12826,20%,Female Breast Carcinoma,0
12827,Ewings sarcoma,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
12828,Data Transformation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12829,Mutation,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12830,More Often than Once a Day,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12831,Stomach structure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12832,Household composition,Human Papillomavirus-Related Carcinoma,0
12833,Focal,embryonal rhabdomyosarcoma of prostate,0
12834,Night sweats,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12835,Numerous,adenosquamous carcinoma of breast,0
12836,Feelings,Malignant melanoma of eyelid,0
12837,Feelings,Leiomyoma of Gallbladder,0
12838,Smear - instruction imperative,gliosarcoma,0
12839,cancer genetics,Uterine Cancer,0
12840,Further,Mucinous adenocarcinoma gastric,0
12841,Most,Undifferentiated Endocervical Sarcoma,0
12842,Measured,gliosarcoma,0
12843,Treating,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12844,Squamous cell carcinoma,FIGO Stage II Ovarian Cancer,0
12845,Metastatic to,Recurrent Testicular Lymphoma,0
12846,<3 (qualifier value),FIGO Stage II Ovarian Cancer,0
12847,Negation,Low Grade Squamous Intraepithelial Neoplasia,0
12848,Multiply - dosing instruction fragment,Malignant melanoma of eyelid,0
12849,photoreactivating enzyme activity,Benign tumor of eyelid,0
12850,low exposure,Clonal Hematopoiesis of Indeterminate Potential,0
12851,therapeutic aspects,Thymic Clear Cell Carcinoma,0
12852,Precipitating Factors,Choroid Necrotic Melanoma,0
12853,Megakaryoblasts,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
12854,Due to,Locally Advanced Soft Tissue Sarcoma,0
12855,Bilateral complete salpingectomy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12856,Screening - general (procedure),Ovarian germ cell choriocarcinoma stage IV,0
12857,Polypeptide Hormones,Thymic Clear Cell Carcinoma,0
12858,Show,Breast Ductal Adenoma,0
12859,Biomaterial Treatment,Neonatal leukemia,0
12860,Base - General Qualifier,Mucinous cystadenofibroma,0
12861,Life Expectancy Less than Twenty Years,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12862,Symptomatic,Cartilaginous exostosis,0
12863,Relationships,Carcinoma of urinary bladder,0
12864,low confidentiality,Maxillary Sinus Adenocarcinoma,0
12865,Fever,Methotrexate-Associated Hodgkin Lymphoma,0
12866,Subgroup A Nepoviruses,Malignant melanoma of eyelid,0
12867,Involvement with,Ichthyosis,0
12868,shared attribute,BRCA2 Syndrome,0
12869,Nicotiana,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12870,Meningocele,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12871,Relationships,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12872,pharmacotherapeutic,Werner Syndrome,0
12873,Less Than,Human Papillomavirus-Related Carcinoma,0
12874,International Statistical Classification of Diseases and Related Health Problems,Clonal Hematopoiesis of Indeterminate Potential,0
12875,Malignant Neoplasms,Malignant neoplasm of thalamus,0
12876,Did not receive therapy or drug for,Malignant neoplasm of thalamus,0
12877,Low Mitosis-Karyorrhexis Index,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12878,Prior Chemotherapy,Hodgkin lymphoma,0
12879,Scar Tissue,Mucinous cystadenofibroma,0
12880,International Classification of Disease for Oncology,Cerebral Primitive Neuroectodermal Tumor,0
12881,Deglutition,Benign tumor of eyelid,0
12882,Tumor type,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12883,Universal restriction modifier (core metadata concept),Ovarian Carcinoid Tumor,0
12884,Frequently,Malignant melanoma of eyelid,0
12885,Malignant neoplasm of penis,Stage 0 Lip Carcinoma,0
12886,Beginning,Acute Undifferentiated Leukemia,0
12887,Qualitative form,Adult Hepatocellular Carcinoma,0
12888,non-recurrent,Recurrent Uveal Melanoma,0
12889,Preventive intent,Larynx carcinoma recurrent,0
12890,Type - attribute,Non-Metastatic Gestational Trophoblastic Tumor,0
12891,Abnormal,Acute Undifferentiated Leukemia,0
12892,Injury due to exposure to external cause,Recurrent Uveal Melanoma,0
12893,skin color,Spongiotic dermatitis,0
12894,Night sweats,Pancreatic Intraepithelial Neoplasia-3,0
12895,Teens,Diffuse malignant mesothelioma,0
12896,Basis - conceptual entity,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12897,<90,Chronic Myelomonocytic Leukemia-2,0
12898,Therapeutic radiology procedure,Stage 0 Penile Cancer AJCC v8,0
12899,Eating,Blepharal carcinoma,0
12900,suggestion,Neoplasms,0
12901,Domain (area of knowledge),Stage III Adult Immunoblastic Lymphoma,0
12902,Non-Seminomatous Lesion,Endometrial Small Cell Carcinoma,0
12903,Before,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12904,Lymphocyte,Intestinal Metaplasia of Bladder Urothelium,0
12905,Membrane,Giant cell angiofibroma,0
12906,Histologic,Ovarian Carcinoid Tumor,0
12907,Count of entities,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12908,1+ Score,Localized Ewing Sarcoma,0
12909,Offspring,Acantholytic squamous cell carcinoma,0
12910,More,Keratoderma,0
12911,Pediculus (eukaryote),Leiomyoma of Gallbladder,0
12912,Infection caused by Helicobacter pylori,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12913,Liver Flavor,Recurrent Uveal Melanoma,0
12914,Array Feature,Adenocarcinoma,0
12915,Sharing (Social Behavior),Intraepithelial Melanocytic Hyperplasia,0
12916,Severe (severity modifier),Malignant Neoplasm with Regional Lymph Node Involvement,0
12917,Autoimmune Diseases,Cerebral Primitive Neuroectodermal Tumor,0
12918,Pelvic Pain,Stage III Adult Immunoblastic Lymphoma,0
12919,Probable diagnosis,non-Hodgkin's lymphoma of spleen,0
12920,Pharmacotherapy,Malignant Neoplasm with Regional Lymph Node Involvement,0
12921,Approximate,sarcoma of spinal cord,0
12922,Cells,adenoid cystic carcinoma of lung,0
12923,Bone pain,Stage 0 Lip Carcinoma,0
12924,Primary operation,Pancreatic Intraepithelial Neoplasia-3,0
12925,Medulla,Thymoma malignant recurrent,0
12926,Togo,Medulloblastoma,0
12927,Age of Onset,Adenocarcinoma,0
12928,Type - attribute,Endometrial Small Cell Carcinoma,0
12929,Dermatologist,mucinous adenocarcinoma of gallbladder,0
12930,Adult human body,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12931,Body tissue,Ichthyosis,0
12932,Term (temporal),Endometrial Small Cell Carcinoma,0
12933,Abnormal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12934,Very Much,Mucinous cystadenofibroma,0
12935,Medical,Unfavorable Non-Hodgkin Lymphoma,0
12936,NIN gene,adenosquamous carcinoma of breast,0
12937,Death (finding),Recurrent Uveal Melanoma,0
12938,Family member,Methotrexate-Associated Hodgkin Lymphoma,0
12939,Rare,Adult Alveolar Soft Part Sarcoma,0
12940,Anus,squamous cell carcinoma of the thyroid gland,0
12941,Frequently,Werner Syndrome,0
12942,Edema,Primary Cutaneous Plasmablastic Lymphoma,0
12943,View,Acute lymphadenitis,0
12944,White color,Neoplasms,0
12945,Sore skin,adenosquamous carcinoma of breast,0
12946,Squamous Epithelial Cells,Mucinous adenocarcinoma gastric,0
12947,Contain (action),Acute lymphadenitis,0
12948,Oral region,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12949,Spreading (qualifier value),Mucinous cystadenofibroma,0
12950,Cure (remedy),Stage IB Pancreatic Cancer AJCC v8,0
12951,Dictionary [Publication Type],Stage III Adult Immunoblastic Lymphoma,0
12952,Major,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12953,Ductal Carcinoma,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
12954,Pale color,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12955,Treatment Epoch,Stage IV Childhood Non-Hodgkin Lymphoma,0
12956,Primary malignant neoplasm,Spongiotic dermatitis,0
12957,National origin,Human Papillomavirus-Related Carcinoma,0
12958,Treating,Human Papillomavirus-Related Carcinoma,0
12959,Left,Acantholytic squamous cell carcinoma,0
12960,Ovarian Carcinoma,Clonal Hematopoiesis of Indeterminate Potential,0
12961,Endocrine Cells,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12962,Type - attribute,Pancreatic Intraepithelial Neoplasia-3,0
12963,Apply (administration method),Anterior Urethral Malignant Neoplasm,0
12964,Comparison,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12965,Oral cavity,Collecting Duct Carcinoma of the Kidney,0
12966,Unknown,Refractory Barrett Esophagus,0
12967,Greater than one,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12968,Phenotype,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12969,Spinal Cord,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12970,Entity Name Part Qualifier - birth,mucinous adenocarcinoma of gallbladder,0
12971,Pharmacotherapy,Anterior Urethral Malignant Neoplasm,0
12972,Incidence,Leptomeningeal sarcoma,0
12973,Act Relationship Subset - previous,embryonal rhabdomyosarcoma of prostate,0
12974,year,Ichthyosis,0
12975,Act Class - review,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12976,3+ Score,adenoid cystic carcinoma of lung,0
12977,Tissue Specimen Code,Thymic Clear Cell Carcinoma,0
12978,Dyspareunia,Ovarian Carcinoid Tumor,0
12979,Two,Diffuse malignant mesothelioma,0
12980,Last,Intracortical osteosarcoma,0
12981,Gastrointestinal tract structure,Pancreatic Intraepithelial Neoplasia-3,0
12982,Surgical service,Heavy Chain Deposition Disease,0
12983,Solar Erythema,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12984,Vulva,Grade 3a Malignant Neoplasm,0
12985,Usually,Granular Cell Leiomyosarcoma,0
12986,Three,Stage II Carcinoma of Penis,0
12987,Usual Severity Weight Loss,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12988,diagnosis aspect,Cancer of Urinary Tract,0
12989,Benign,Cancer of Urinary Tract,0
12990,cancer risk,Acute Undifferentiated Leukemia,0
12991,Increasing,Endometrial Small Cell Carcinoma,0
12992,treatment - ActInformationManagementReason,Neoplasms,0
12993,Usual Severity Cough,BRCA2 Syndrome,0
12994,Infertility risk,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12995,Type - attribute,FIGO Stage II Ovarian Cancer,0
12996,Rate,Mucinous adenocarcinoma gastric,0
12997,Cancer Genus,Human Papillomavirus-Related Carcinoma,0
12998,Choriocarcinoma,Platinum-Resistant Lung Small Cell Carcinoma,0
12999,Infection of bone,Chondrosarcoma,0
13000,Fever symptoms (finding),Cerebral Primitive Neuroectodermal Tumor,0
13001,Known,Acute Undifferentiated Leukemia,0
13002,Including (qualifier),Childhood Fibrillary Astrocytoma,0
13003,Smooth muscle (tissue),Carcinoma ex pleomorphic adenoma of parotid gland,0
13004,Angiofibroma,Airway Hemangioma,0
13005,Operative Surgical Procedures,Medulloblastoma,0
13006,Abdomen,Pilocytic astrocytoma of cerebellum,0
13007,Etiology,Endometrial Small Cell Carcinoma,0
13008,therapeutic aspects,Digestive System Hodgkin Lymphoma,0
13009,School Grade,Acute lymphadenitis,0
13010,Ninth,embryonal rhabdomyosarcoma of prostate,0
13011,Bladder Cancer Pathway,Intestinal Neuroendocrine Carcinoma,0
13012,various other nasal preparations in ATC,High Grade Glandular Intraepithelial Neoplasia,0
13013,Qualitative form,Ichthyosis,0
13014,Including (qualifier),Medulloblastoma,0
13015,Capsule Shape,Stage I Adult Non-Hodgkin Lymphoma,0
13016,Categories,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13017,How Often Weight Loss,Intracortical osteosarcoma,0
13018,Aim (idea),Cancer of Urinary Tract,0
13019,Skin,Medulloblastoma,0
13020,Genus Labia,Metastatic Lung Small Cell Carcinoma,0
13021,Morbidity - disease rate,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13022,Financial Account,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
13023,Rare,mucinous adenocarcinoma of gallbladder,0
13024,Removed,Intestinal Metaplasia of Bladder Urothelium,0
13025,Teratoma,FIGO Stage II Ovarian Cancer,0
13026,Twice (Numerical Qualifier),Metastatic Kidney Carcinoma,0
13027,Weight Loss,GIANT PIGMENTED HAIRY NEVUS,0
13028,Europe,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13029,Including (qualifier),Ovarian germ cell choriocarcinoma stage IV,0
13030,Neoplasms,Collecting Duct Carcinoma of the Kidney,0
13031,Tumor Cell Invasion,Refractory Barrett Esophagus,0
13032,Malignant neoplasm of urinary bladder,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13033,various allergen extracts,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13034,Act Reason - Error,Cancer of Urinary Tract,0
13035,Childhood Hodgkin Lymphoma,Small cell neuroendocrine carcinoma of bladder,0
13036,Atla (fungus),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13037,Location of Pharyngeal Residue Following Swallowing,Cancer of Urinary Tract,0
13038,Primary malignant neoplasm,Undifferentiated Neuroblastoma,0
13039,Effect,Intraepithelial Melanocytic Hyperplasia,0
13040,Childhood Lymphoma,Intraepithelial Melanocytic Hyperplasia,0
13041,Limited stage (cancer stage),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13042,Increased,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13043,Colon Carcinoma,Familial Hemophagocytic Lymphocytosis,0
13044,Lipoma,malignant lymphoma of pancreatic lymph nodes,0
13045,Treatment Epoch,Human Papillomavirus-Related Carcinoma,0
13046,Body part,papillary carcinoma of penis,0
13047,Object Class,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13048,Does carry,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13049,Etiology aspects,gliosarcoma,0
13050,Hydatidiform Mole,Clonal Hematopoiesis of Indeterminate Potential,0
13051,Penetration,Maxillary Sinus Adenocarcinoma,0
13052,Use of,Recurrent Uveal Melanoma,0
13053,Smoking,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13054,Togo,Childhood Fibrillary Astrocytoma,0
13055,Specimen Source Codes - tumor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13056,Egg of order Phthiraptera,Localized Ewing Sarcoma,0
13057,Common Specifications in HL7 V3 Publishing,Chondrosarcoma,0
13058,Surgery specialty,Mastocytosis,0
13059,Leading,Extra-Adrenal Paraganglioma,0
13060,Open,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13061,Third revision,Childhood Thyroid Gland Follicular Carcinoma,0
13062,United States Military Commissioned Officer O4,BRCA2 Syndrome,0
13063,Most,Human Papillomavirus-Related Carcinoma,0
13064,ethnic european,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13065,Progress,Adenocarcinoma,0
13066,Portion of urine,Metastatic Carcinoma in the Lung,0
13067,Associated with,Recurrent Testicular Lymphoma,0
13068,Tissue damage,Locally Advanced Soft Tissue Sarcoma,0
13069,Others - Allergy,Grade 3a Malignant Neoplasm,0
13070,described,Spongiotic dermatitis,0
13071,Astrocytes,Human Papillomavirus-Related Carcinoma,0
13072,Before values,Endometrial Small Cell Carcinoma,0
13073,Genetic Markers,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13074,Forecast of outcome,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13075,Chemical Association,adenosquamous carcinoma of breast,0
13076,Treating,Neonatal leukemia,0
13077,Facial edema,Childhood Choriocarcinoma,0
13078,International Aspects,Refractory Barrett Esophagus,0
13079,Tissue Specimen Code,Tonsillar Carcinoma,0
13080,Percent (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13081,Main,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13082,Metastatic to,Grade 3a Malignant Neoplasm,0
13083,Extrinsic,Prostate Lymphoma,0
13084,Primary malignant neoplasm,Primary Cutaneous Plasmablastic Lymphoma,0
13085,Multiple malignancy,Methotrexate-Associated Hodgkin Lymphoma,0
13086,320,Mastocytosis,0
13087,Forecast of outcome,Undifferentiated Endocervical Sarcoma,0
13088,Percent of Abnormal Cells,Clonal Hematopoiesis of Indeterminate Potential,0
13089,Benign neoplasm of paraganglion,Colorectal High Grade B-Cell Lymphoma,0
13090,+2,Cancer of Urinary Tract,0
13091,abnormal growth by tissue,squamous cell carcinoma of the thyroid gland,0
13092,98,FIGO Stage II Ovarian Cancer,0
13093,10%,Granular Cell Leiomyosarcoma,0
13094,Primary malignant neoplasm,Recurrent Diffuse Intrinsic Pontine Glioma,0
13095,Channel,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13096,Known,squamous cell carcinoma of the thyroid gland,0
13097,therapeutic aspects,Placental aromatase deficiency,0
13098,Targeted Therapy,GIANT PIGMENTED HAIRY NEVUS,0
13099,More common in women,Recurrent Testicular Lymphoma,0
13100,Two,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13101,penis,Serous cystadenocarcinoma ovary,0
13102,Cancer Other,Acantholytic squamous cell carcinoma,0
13103,Glycation End Products,Neoplasms,0
13104,per year,non-Hodgkin's lymphoma of spleen,0
13105,Changing,Recurrent Testicular Lymphoma,0
13106,Lymphocyte production,Intestinal Metaplasia of Bladder Urothelium,0
13107,Condylomata Acuminata,Metastatic Kidney Carcinoma,0
13108,Changing,Malignant Neoplasm with Regional Lymph Node Involvement,0
13109,Women's Health,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13110,Type - attribute,Advanced Uterine Corpus Carcinosarcoma,0
13111,include - SetOperator,Benign tumor of eyelid,0
13112,A Codes,Malignant melanoma of eyelid,0
13113,Endometrial Carcinoma,Stage I Adult Non-Hodgkin Lymphoma,0
13114,Numbers,FIGO Stage II Ovarian Cancer,0
13115,Biological Response Modifiers,sarcoma of spinal cord,0
13116,Body tissue,Pilocytic astrocytoma of cerebellum,0
13117,Packaging Case,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13118,Dyspnea,Colorectal cancer,0
13119,Management procedure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13120,Complicated,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13121,Very,Pancreatic Intraepithelial Neoplasia-3,0
13122,Eating,Malignant Testicular Sertoli Cell Tumor,0
13123,Mammal liver preparation,Low Grade Squamous Intraepithelial Neoplasia,0
13124,Mechanism Component of Device,Carcinoma of urinary bladder,0
13125,Protective Clothing,Metastatic Ductal Breast Carcinoma,0
13126,Continuous,Childhood Fibrillary Astrocytoma,0
13127,Reduced,Intraepithelial Melanocytic Hyperplasia,0
13128,Desiccation,Cerebral hemangioma,0
13129,4+ Answer to question,Small cell neuroendocrine carcinoma of bladder,0
13130,Brain Neoplasms,Atypical Lobular Breast Hyperplasia,0
13131,Symptoms aspect,Atypical Mesothelial Hyperplasia,0
13132,Occurrence,Neonatal leukemia,0
13133,lymph nodes,Colorectal High Grade B-Cell Lymphoma,0
13134,Tests (qualifier value),Stage III Adult Immunoblastic Lymphoma,0
13135,combination - answer to question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13136,Percent of Abnormal Cells,Intracortical osteosarcoma,0
13137,*Type - Kind of quantity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13138,Dermatitis,Malignant melanoma of eyelid,0
13139,Call (Instruction),Primary Cutaneous Plasmablastic Lymphoma,0
13140,Percent normal,High Grade Glandular Intraepithelial Neoplasia,0
13141,20%,Intraepithelial Melanocytic Hyperplasia,0
13142,Negative - answer,Localized Ewing Sarcoma,0
13143,Rare Diseases,Recurrent Testicular Lymphoma,0
13144,Fishes,Thymic Clear Cell Carcinoma,0
13145,Frequently,Cancer of Urinary Tract,0
13146,Scientific Publication,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13147,Walled,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13148,Skin Specimen,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
13149,Progress,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13150,10%,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13151,The Sun,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
13152,pharmacotherapeutic,Pilocytic astrocytoma of cerebellum,0
13153,Aging,Stage I Adult Non-Hodgkin Lymphoma,0
13154,High risk of,Liver Lymphangioma,0
13155,Dermatitis,Localized Askin Tumor,0
13156,Adult Hodgkin Lymphoma,Secondary malignant neoplasm of lymph node,0
13157,Abdomen,Secondary malignant neoplasm of lymph node,0
13158,Person 1,Atypical Lobular Breast Hyperplasia,0
13159,Risk,Acantholytic squamous cell carcinoma,0
13160,Dilate procedure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13161,Ten,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13162,+2,Mastocytosis,0
13163,Third revision,Cancer of Urinary Tract,0
13164,Code,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
13165,Adult Classical Hodgkin Lymphoma,Mucinous neoplasm,0
13166,Percent of Abnormal Cells,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13167,Abdomen,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13168,Specimen Source Codes - tumor,Spermatocytic seminoma,0
13169,include - SetOperator,Adult Alveolar Soft Part Sarcoma,0
13170,unknown vaccine or immune globulin,Benign tumor of eyelid,0
13171,Persons,Cerebral Primitive Neuroectodermal Tumor,0
13172,Show,embryonal rhabdomyosarcoma of prostate,0
13173,insensitivity,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13174,Contain (action),Mucinous adenocarcinoma gastric,0
13175,Vaginal Sarcoma,Digestive System Hodgkin Lymphoma,0
13176,Extension,Cartilaginous exostosis,0
13177,Common Specifications in HL7 V3 Publishing,Heavy Chain Deposition Disease,0
13178,Person Name,Digestive System Hodgkin Lymphoma,0
13179,low,Xeroderma pigmentosum,0
13180,Often - answer to question,Xeroderma pigmentosum,0
13181,IPSS Risk Category Low,Refractory Barrett Esophagus,0
13182,year,Adult Alveolar Soft Part Sarcoma,0
13183,depend,Mucinous adenocarcinoma gastric,0
13184,Occurrence,Heavy Chain Deposition Disease,0
13185,Diagnosis,Werner Syndrome,0
13186,Microbial anatomical capsule structure,BRCA2 Syndrome,0
13187,Beginning,Stage IB Pancreatic Cancer AJCC v8,0
13188,Tryptophanase,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13189,Statistical Prevalence,Localized Askin Tumor,0
13190,Lineage,Spongiotic dermatitis,0
13191,Usual,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13192,epithelial,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13193,body system,Malignant melanoma of eyelid,0
13194,Decision,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13195,Early stage,Acantholytic squamous cell carcinoma,0
13196,Spreading (qualifier value),Mucinous adenocarcinoma gastric,0
13197,Location,Liver Lymphangioma,0
13198,Monocyte count procedure,Thymic Atypical Carcinoid Tumor,0
13199,Risk,Angiosarcoma of liver,0
13200,Cerebral hemisphere structure (body structure),Airway Hemangioma,0
13201,How Much Distress Itching,Human Papillomavirus-Related Carcinoma,0
13202,Cystadenocarcinoma,Lung Mucinous Cystadenoma,0
13203,Ultraviolet Rays,Unresectable Rhabdomyosarcoma,0
13204,Hemorrhage,Ovarian germ cell choriocarcinoma stage IV,0
13205,Involvement with,embryonal rhabdomyosarcoma of prostate,0
13206,Approximate,Noninfiltrating Intraductal Carcinoma,0
13207,Follow-Up Report,Malignant neoplasm of choroid,0
13208,Hereditary Nonpolyposis Colorectal Cancer,mucinous adenocarcinoma of gallbladder,0
13209,Building structure,Human Papillomavirus-Related Carcinoma,0
13210,NR0B1 wt Allele,Childhood Choriocarcinoma,0
13211,35,Deep Leiomyoma,0
13212,Make - Instruction Imperative,adenoid cystic carcinoma of lung,0
13213,Chemotherapy,Angiosarcoma of liver,0
13214,Severe Extremity Pain,Refractory Barrett Esophagus,0
13215,various antiseptic throat preparations,Digestive System Hodgkin Lymphoma,0
13216,CD69 wt Allele,Thymic Clear Cell Carcinoma,0
13217,National origin,Pilocytic astrocytoma of cerebellum,0
13218,Moved from,Acantholytic squamous cell carcinoma,0
13219,Oral (intended site),FIGO Stage II Ovarian Cancer,0
13220,Primary malignant neoplasm,Metastatic Carcinoma in the Lung,0
13221,Publications,gliosarcoma,0
13222,Five-year Survival Rate,Keratoderma,0
13223,Cancer Genus,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13224,Currarino triad,Larynx carcinoma recurrent,0
13225,Subject Risk,Pancreatic Intraepithelial Neoplasia-3,0
13226,54,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13227,include - SetOperator,Mucinous adenocarcinoma gastric,0
13228,English [International Organization for Standardization 639-1 code en] language reference set,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13229,Type A,Acantholytic squamous cell carcinoma,0
13230,Bacteria present,Acantholytic squamous cell carcinoma,0
13231,New Zealand,Localized Ewing Sarcoma,0
13232,Feelings,Placental aromatase deficiency,0
13233,Ultrasonography,Cerebral hemangioma,0
13234,More,High Grade Glandular Intraepithelial Neoplasia,0
13235,Smoking,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13236,Carcinoma of lung,Stage IB Pancreatic Cancer AJCC v8,0
13237,Rare,Breast Ductal Adenoma,0
13238,Beginning,Adult Hepatocellular Carcinoma,0
13239,CD69 protein,High Grade Glandular Intraepithelial Neoplasia,0
13240,United States,Atypical Lobular Breast Hyperplasia,0
13241,per year,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
13242,Human body,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13243,Childhood Lymphoma,malignant lymphoma of pancreatic lymph nodes,0
13244,Antifungal Antibiotics,Small cell neuroendocrine carcinoma of bladder,0
13245,Commercial Lot,gliosarcoma,0
13246,Prostate,Stage IV Penile Cancer AJCC v7,0
13247,Alternative,Localized Askin Tumor,0
13248,Symptoms aspect,Collecting Duct Carcinoma of the Kidney,0
13249,Occurrence Indicator,Fourth Ventricle and Brain Stem Ependymal Tumor,0
13250,diagnosis aspect,Adult Hepatocellular Carcinoma,0
13251,Scientific Control,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13252,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Recurrent Uveal Melanoma,0
13253,Urine,Platinum-Resistant Lung Small Cell Carcinoma,0
13254,Two,Adult Fibrolamellar Carcinoma,0
13255,Malignant neoplasm of testis,Anterior Urethral Malignant Neoplasm,0
13256,United States Military Commissioned Officer O4,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13257,High,Lung squamous cell carcinoma stage I,0
13258,Interventional procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13259,Did not receive therapy or drug for,High Grade Glandular Intraepithelial Neoplasia,0
13260,Diagnosis,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13261,PSA Level Less than Two,Endometrial Small Cell Carcinoma,0
13262,English race,Hair nevus,0
13263,Complication Aspects,Ichthyosis,0
13264,Edema,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13265,Airway structure,Metastatic Ductal Breast Carcinoma,0
13266,Clinical Study Case,High Grade Glandular Intraepithelial Neoplasia,0
13267,Malignant tumor of colon,Tonsillar Carcinoma,0
13268,Ultraviolet Light Sterilization,Benign tumor of eyelid,0
13269,Less Than,Malignant melanoma of eyelid,0
13270,Childhood Hodgkin Lymphoma,Acantholytic squamous cell carcinoma,0
13271,Either,Metastatic Neoplasm to the Gallbladder,0
13272,Short Value,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13273,Closed,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13274,anatomical layer,Childhood Fibrillary Astrocytoma,0
13275,Formation,Acantholytic squamous cell carcinoma,0
13276,Neoplasm Metastasis,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13277,Irregular,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13278,Regular,Digestive System Hodgkin Lymphoma,0
13279,Administration procedure,Female Breast Carcinoma,0
13280,Salivary Glands,Acute Undifferentiated Leukemia,0
13281,Stem of plant,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13282,Subtype (attribute),mucinous adenocarcinoma of gallbladder,0
13283,Enlarged,Recurrent Uveal Melanoma,0
13284,Inguinal region,Benign neoplasm of thorax,0
13285,Gene Mutation,Malignant Neoplasm with Regional Lymph Node Involvement,0
13286,depend,Ovarian germ cell choriocarcinoma stage IV,0
13287,Form:Finding:Point in time:{Setting}:Document:{Role},Breast Ductal Adenoma,0
13288,DNA,Diffuse malignant mesothelioma,0
13289,Secondary Neoplasm,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13290,Radiation,Malignant Testicular Sertoli Cell Tumor,0
13291,Premalignant Cell,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13292,Therapeutic radiology procedure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13293,Obesity,Stage IB Pancreatic Cancer AJCC v8,0
13294,Cancer Genus,Cerebral hemangioma,0
13295,Following,Malignant neoplasm of thalamus,0
13296,Hepatitis,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13297,Blood,Acute Undifferentiated Leukemia,0
13298,Case unit dose,Extra-Adrenal Paraganglioma,0
13299,To,Angiosarcoma of liver,0
13300,Asia,Primary Cutaneous Plasmablastic Lymphoma,0
13301,Type A,Benign Apocrine Neoplasm,0
13302,common types,Thymic Clear Cell Carcinoma,0
13303,Short,Extra-Adrenal Paraganglioma,0
13304,Surgical aspects,Diffuse malignant mesothelioma,0
13305,Anemia,Endometrial Small Cell Carcinoma,0
13306,point - UnitsOfMeasure,FIGO Stage II Ovarian Cancer,0
13307,Histopathologic Grade,FIGO Stage II Ovarian Cancer,0
13308,Pharmacotherapy,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13309,Sex Cord-Stromal Tumor,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
13310,Concept model range (foundation metadata concept),Malignant Neoplasm of Lung - Multiple Primary Sites,0
13311,Tests (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
13312,metaplastic cell transformation,Benign neoplasm of thorax,0
13313,1+,Localized Ewing Sarcoma,0
13314,Egg of order Phthiraptera,non-Hodgkin's lymphoma of spleen,0
13315,Stage Grouping,BRCA2 Syndrome,0
13316,Specific qualifier value,Ovarian germ cell choriocarcinoma stage IV,0
13317,CDISC SDTM Route of Administration Terminology,Testicular cancer metastatic,0
13318,Blood Vessel,Lipoma of small intestine,0
13319,Splenomegaly,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13320,Sex Behavior,Intraepithelial Melanocytic Hyperplasia,0
13321,Severe (severity modifier),Uterine Cancer,0
13322,Childhood Extracranial Germ Cell Tumor,Recurrent Testicular Lymphoma,0
13323,Function (attribute),Neonatal leukemia,0
13324,Science of Etiology,Methotrexate-Associated Hodgkin Lymphoma,0
13325,Balanced - adjective,Hodgkin lymphoma,0
13326,Very Much,Mastocytosis,0
13327,Zone,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13328,Chew (administration method),Acute lymphadenitis,0
13329,Common Specifications in HL7 V3 Publishing,Primary Cutaneous Plasmablastic Lymphoma,0
13330,General surgery specialty,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
13331,Most Recent,Small cell neuroendocrine carcinoma of bladder,0
13332,Amount type - Percentage,Mucinous cystadenofibroma,0
13333,Adult Lymphoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13334,Hypertensive disease,Recurrent Uveal Melanoma,0
13335,Name Given at Birth,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13336,Bloating,Cerebral Primitive Neuroectodermal Tumor,0
13337,Manifest,Secondary malignant neoplasm of lymph node,0
13338,Symptoms,Chronic Myelomonocytic Leukemia-2,0
13339,Oral region,Noninfiltrating Intraductal Carcinoma,0
13340,Morbidity - disease rate,Liver Cavernous Hemangioma,0
13341,Malignant Neoplasms,Adult Hepatocellular Carcinoma,0
13342,Negation,Cancer of Urinary Tract,0
13343,shared attribute,papillary carcinoma of penis,0
13344,Staining method,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13345,Definitely Related to Intervention,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13346,biopsy characteristics,mucinous adenocarcinoma of gallbladder,0
13347,allowing,Human Papillomavirus-Related Carcinoma,0
13348,Cell Count,Xeroderma pigmentosum,0
13349,Version,Digestive System Hodgkin Lymphoma,0
13350,Uncontrolled,Undifferentiated Endocervical Sarcoma,0
13351,Gestational trophoblastic disease,Locally Advanced Soft Tissue Sarcoma,0
13352,Weight decreased,Blepharal carcinoma,0
13353,One,Advanced Uterine Corpus Carcinosarcoma,0
13354,LINC01194 gene,Neonatal leukemia,0
13355,Component object,sarcoma of spinal cord,0
13356,Elderly (population group),Heavy Chain Deposition Disease,0
13357,Population Group,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13358,Specific qualifier value,Diffuse malignant mesothelioma,0
13359,Common Specifications in HL7 V3 Publishing,Methotrexate-Associated Hodgkin Lymphoma,0
13360,More,Stage II Carcinoma of Penis,0
13361,Participation Type - origin,Recurrent Testicular Lymphoma,0
13362,hearing impairment,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13363,*Type - Kind of quantity,Placental aromatase deficiency,0
13364,Type - attribute,Cancer of Urinary Tract,0
13365,Feel Pain,Mucinous cystadenofibroma,0
13366,unknown vaccine or immune globulin,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13367,Sore Throat,Anterior Urethral Malignant Neoplasm,0
13368,Down Syndrome,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
13369,Lung,Unresectable Rhabdomyosarcoma,0
13370,Face,Female Breast Carcinoma,0
13371,Usual,Platinum-Resistant Lung Small Cell Carcinoma,0
13372,Fasting Status Indicator,Liver Lymphangioma,0
13373,Primary malignant neoplasm,Localized Askin Tumor,0
13374,Pruritus,Primary Cutaneous Plasmablastic Lymphoma,0
13375,Body cavities,Undifferentiated Endocervical Sarcoma,0
13376,Usual Severity Weight Loss,Human Papillomavirus-Related Carcinoma,0
13377,Cause of death.underlying,Clonal Hematopoiesis of Indeterminate Potential,0
13378,Subtype (attribute),Adult Fibrolamellar Carcinoma,0
13379,Comparison,Localized Askin Tumor,0
13380,Singular,Refractory Barrett Esophagus,0
13381,Uterus,embryonal rhabdomyosarcoma of prostate,0
13382,AMACR wt Allele,Grade 3a Malignant Neoplasm,0
13383,Weight decreased,Spermatocytic seminoma,0
13384,Abnormal Cell Count,Heavy Chain Deposition Disease,0
13385,Rapid,Non-Metastatic Gestational Trophoblastic Tumor,0
13386,Microplate Well,Mucinous adenocarcinoma gastric,0
13387,Malignant Neoplasms,Liver Lymphangioma,0
13388,Never (frequency),Cerebral hemangioma,0
13389,How Much Distress Weight Loss,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13390,Rating (action),Placental aromatase deficiency,0
13391,Progress,BRCA2 Syndrome,0
13392,Net (qualifier),FIGO Stage II Ovarian Cancer,0
13393,Primary operation,Malignant melanoma of eyelid,0
13394,Fatty Liver Disease,Benign Apocrine Neoplasm,0
13395,Aspects of signs,Undifferentiated Endocervical Sarcoma,0
13396,Spur - plant part,Lipoma of small intestine,0
13397,Communicable Diseases,Ovarian germ cell choriocarcinoma stage IV,0
13398,Present,Hodgkin lymphoma,0
13399,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Mucinous cystadenofibroma,0
13400,Common (qualifier value),Carcinoma of urinary bladder,0
13401,Near,Carcinoma ex pleomorphic adenoma of parotid gland,0
13402,Sometimes,Diffuse malignant mesothelioma,0
13403,Life,Recurrent Testicular Lymphoma,0
13404,Survival Rate,Recurrent Testicular Lymphoma,0
13405,morphological,Small cell neuroendocrine carcinoma of bladder,0
13406,Line Unit of Length,Lipoma of small intestine,0
13407,Adenocarcinoma,Stage II Hepatocellular Carcinoma AJCC v8,0
13408,Sometimes,Testicular cancer metastatic,0
13409,Rapid,Clonal Hematopoiesis of Indeterminate Potential,0
13410,Precancerous Conditions,Stage IB Pancreatic Cancer AJCC v8,0
13411,Structure of germinal center of lymph node,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13412,Oral cavity,Advanced Lung Carcinoma,0
13413,Destruction (action),Intestinal Neuroendocrine Carcinoma,0
13414,Lower lip structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13415,Involvement with,Fourth Ventricle and Brain Stem Ependymal Tumor,0
13416,Administration procedure,Undifferentiated Endocervical Sarcoma,0
13417,Blood group antibody I,Intestinal Metaplasia of Bladder Urothelium,0
13418,Burkitt Lymphoma,High Grade Glandular Intraepithelial Neoplasia,0
13419,Feelings,Intraepithelial Melanocytic Hyperplasia,0
13420,Observation of color of skin,Localized Askin Tumor,0
13421,Tissue Specimen Code,Hemangioma,0
13422,Sarcoma,Carcinoma ex pleomorphic adenoma of parotid gland,0
13423,School Grade,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13424,Histocompatibility Testing,Benign neoplasm of thorax,0
13425,TRANSCRIPTION FACTOR,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13426,Type A,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13427,therapeutic aspects,mucinous adenocarcinoma of gallbladder,0
13428,Liquid substance,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13429,Organ,Cerebral Primitive Neuroectodermal Tumor,0
13430,70%,Cerebral Primitive Neuroectodermal Tumor,0
13431,Precision - characteristic,Metastatic Lung Small Cell Carcinoma,0
13432,Count of entities,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13433,Virus,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13434,Childhood Lymphoma,Undifferentiated Endocervical Sarcoma,0
13435,6/3,Placental aromatase deficiency,0
13436,Malignant Neoplasms,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13437,high - ActExposureLevelCode,Clonal Hematopoiesis of Indeterminate Potential,0
13438,Male Reproductive System Part,Malignant melanoma of eyelid,0
13439,Primary malignant neoplasm of lung,Medulloblastoma,0
13440,Diagnosis,Malignant Neoplasm with Regional Lymph Node Involvement,0
13441,Structure of germinal center of lymph node,Leptomeningeal sarcoma,0
13442,Adenocarcinoma,Human Papillomavirus-Related Carcinoma,0
13443,Presentation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13444,Death (finding),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13445,Major,Locally Advanced Soft Tissue Sarcoma,0
13446,Diagnostic Imaging,FIGO Stage II Ovarian Cancer,0
13447,65+,Human Papillomavirus-Related Carcinoma,0
13448,Lymphatic Capillaries,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13449,Development,Acute Undifferentiated Leukemia,0
13450,Cystadenoma,Low Grade Squamous Intraepithelial Neoplasia,0
13451,Approximate,Grade 1 Clear Cell Renal Cell Carcinoma,0
13452,Favorable,Recurrent Uveal Melanoma,0
13453,Initially,Diffuse malignant mesothelioma,0
13454,Continuance of life,Atypical Mesothelial Hyperplasia,0
13455,control substance,adenoid cystic carcinoma of lung,0
13456,Arising,Benign neoplasm of thorax,0
13457,VARIOUS DRUG CLASSES IN ATC,Ovarian germ cell choriocarcinoma stage IV,0
13458,Tetraploidy,Intestinal Metaplasia of Bladder Urothelium,0
13459,Circulating,Human Papillomavirus-Related Carcinoma,0
13460,Physical Examination,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13461,include - SetOperator,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13462,High Level,Locally Advanced Soft Tissue Sarcoma,0
13463,Biomaterial Treatment,Diffuse malignant mesothelioma,0
13464,Have Weight Loss,Colorectal Neuroendocrine Tumor G2,0
13465,What subject filter - Result,mucinous adenocarcinoma of gallbladder,0
13466,Problems - What subject filter,Blepharal carcinoma,0
13467,Carcinoid Tumor,Platinum-Resistant Lung Small Cell Carcinoma,0
13468,Common Specifications in HL7 V3 Publishing,Leptomeningeal sarcoma,0
13469,pharmacotherapeutic,Choroid Necrotic Melanoma,0
13470,Scientist,Grade 3a Malignant Neoplasm,0
13471,Did not receive therapy or drug for,Intraepithelial Melanocytic Hyperplasia,0
13472,Protection Element Attribute,Childhood Fibrillary Astrocytoma,0
13473,Skin lesion,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13474,cell transformation,Childhood Lymphoma,0
13475,Disease,Airway Hemangioma,0
13476,Advanced phase,Benign tumor of eyelid,0
13477,Tryptophanase,Benign neoplasm of thorax,0
13478,Veins,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13479,Including (qualifier),sarcoma of spinal cord,0
13480,Adult Lymphoma,Adenocarcinoma of the prostate metastatic,0
13481,Fifth,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13482,Academic degree,mucinous adenocarcinoma of gallbladder,0
13483,Home environment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13484,Retinoids,Primary Cutaneous Plasmablastic Lymphoma,0
13485,Common Specifications in HL7 V3 Publishing,Leiomyoma of Gallbladder,0
13486,High Grade Cervical Squamous Intraepithelial Neoplasia,Recurrent Uveal Melanoma,0
13487,Adverse effects,Pancreatic Intraepithelial Neoplasia-3,0
13488,Cystic,embryonal rhabdomyosarcoma of prostate,0
13489,Internal,Xeroderma pigmentosum,0
13490,Unusual,Pancreatic Intraepithelial Neoplasia-3,0
13491,First (number),Atypical Lobular Breast Hyperplasia,0
13492,Body part,Extracranial Neuroblastoma,0
13493,Common Specifications in HL7 V3 Publishing,Cancer of Urinary Tract,0
13494,Row (arrangement),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13495,Body tissue,gliosarcoma,0
13496,Risk,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13497,Endocrine Cells,Refractory Barrett Esophagus,0
13498,Screening procedure,Primary Cutaneous Plasmablastic Lymphoma,0
13499,More Often than Once a Day,Malignant melanoma of eyelid,0
13500,/40,FIGO Stage II Ovarian Cancer,0
13501,65,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13502,Progress,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13503,Old,Localized Ewing Sarcoma,0
13504,Known,Intraepithelial Melanocytic Hyperplasia,0
13505,Aspects of disease screening,Metastatic Malignant Neoplasm in the Sellar Region,0
13506,include - SetOperator,Primary Cutaneous Plasmablastic Lymphoma,0
13507,Adolescent (age group),papillary carcinoma of penis,0
13508,stage,Metastatic Neoplasm to the Gallbladder,0
13509,Surgical aspects,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13510,One,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13511,Resolution,Acute Undifferentiated Leukemia,0
13512,6000,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13513,Present,Placental aromatase deficiency,0
13514,Therapeutic procedure,embryonal rhabdomyosarcoma of prostate,0
13515,Uterine Corpus Sarcoma,sarcoma of spinal cord,0
13516,Pleomorphism,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13517,70%,Refractory Barrett Esophagus,0
13518,Manual pelvic examination (procedure),Intraepithelial Melanocytic Hyperplasia,0
13519,Only - dosing instruction fragment,Benign neoplasm of thorax,0
13520,consider,embryonal rhabdomyosarcoma of prostate,0
13521,Immunotherapy,Cancer of Urinary Tract,0
13522,Togo,Malignant Neoplasm with Regional Lymph Node Involvement,0
13523,Infection,Cancer of Urinary Tract,0
13524,Adult Diffuse Large B-Cell Lymphoma,Acantholytic squamous cell carcinoma,0
13525,Correlation,Colorectal cancer,0
13526,Wall of lymphatic vessel,Malignant Testicular Sertoli Cell Tumor,0
13527,Immune system,Stage IB Pancreatic Cancer AJCC v8,0
13528,Malignant Neoplasms,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13529,Onset of (contextual qualifier),Undifferentiated Neuroblastoma,0
13530,Ability,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13531,Dysuria,Hair nevus,0
13532,Injury due to exposure to external cause,Mucinous neoplasm,0
13533,Pathology report,Breast Ductal Adenoma,0
13534,Treatment Epoch,Choroid Necrotic Melanoma,0
13535,Combined,adenosquamous carcinoma of breast,0
13536,1000000,Benign Carotid Body Paraganglioma,0
13537,Divide,Localized Ewing Sarcoma,0
13538,Concentration measurement,Recurrent Uveal Melanoma,0
13539,Cavern,Metastatic Malignant Neoplasm in the Sellar Region,0
13540,Dental Base,Digestive System Hodgkin Lymphoma,0
13541,Males,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13542,Spreading (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
13543,System - kit,Anaplastic large cell lymphoma,0
13544,human MUC1 protein,Pancreatic Intraepithelial Neoplasia-3,0
13545,Tumor cells,Neoplasms,0
13546,Common Specifications in HL7 V3 Publishing,Localized Ewing Sarcoma,0
13547,Body tissue,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13548,International Unit,Adult Alveolar Soft Part Sarcoma,0
13549,Negative Surgical Margin,Intraepithelial Melanocytic Hyperplasia,0
13550,Account number:Identifier:Point in time:^Patient:Nominal,Neoplasms,0
13551,Eye,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13552,Legal Adult,Female Breast Carcinoma,0
13553,Ovarian Follicle,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13554,Often - answer to question,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13555,Usual,Adenocarcinoma of the prostate metastatic,0
13556,Cancer Genus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13557,Tired,Blepharal carcinoma,0
13558,Diagnosis,Localized Ewing Sarcoma,0
13559,Cause of death:Find:Pt:^Patient:Nom,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13560,Volume (publication),Stage I Adult Non-Hodgkin Lymphoma,0
13561,<90,Colorectal Neuroendocrine Tumor G2,0
13562,Childhood Ependymoma,Pancreatic Intraepithelial Neoplasia-3,0
13563,Breaking down,Childhood Fibrillary Astrocytoma,0
13564,Diagnosis,Intestinal Metaplasia of Bladder Urothelium,0
13565,Trial Screening,Stage 0 Penile Cancer AJCC v8,0
13566,Blood Circulation,sarcoma of spinal cord,0
13567,During,Adult Hepatocellular Carcinoma,0
13568,Trial Subject Replacement,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13569,Mild (qualifier value),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
13570,Species,Mucinous neoplasm,0
13571,bony process,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13572,Etiology aspects,BRCA2 Syndrome,0
13573,>90,Larynx carcinoma recurrent,0
13574,Cancer invasiveness,Liver Cavernous Hemangioma,0
13575,Including (qualifier),Endometrial Small Cell Carcinoma,0
13576,United States Military Commissioned Officer O4,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13577,Infrequent,Liver Lymphangioma,0
13578,Multiple Myeloma,Methotrexate-Associated Hodgkin Lymphoma,0
13579,Medical Devices,embryonal rhabdomyosarcoma of prostate,0
13580,Imaging Techniques,Acute Undifferentiated Leukemia,0
13581,Have Nausea,Malignant melanoma of eyelid,0
13582,High risk of,Refractory Barrett Esophagus,0
13583,Laboratory Procedures,Unfavorable Non-Hodgkin Lymphoma,0
13584,Possible,Benign Carotid Body Paraganglioma,0
13585,1960s,Atypical Lobular Breast Hyperplasia,0
13586,cell transformation,Ovarian germ cell choriocarcinoma stage IV,0
13587,betel quid,Spermatocytic seminoma,0
13588,Common Specifications in HL7 V3 Publishing,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13589,Confirmed by,Neoplasms,0
13590,Formation,Cerebral hemangioma,0
13591,Constant (qualifier),Refractory Glioma,0
13592,Metastatic Neoplasm,Recurrent Testicular Lymphoma,0
13593,Survival Rate,Cerebral Primitive Neuroectodermal Tumor,0
13594,Decision,Acute Undifferentiated Leukemia,0
13595,Not Otherwise Specified,Uterine Cancer,0
13596,Etiology aspects,Lipoma of small intestine,0
13597,Geographic Locations,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13598,Description,Hemangioma,0
13599,Cardiac Lead Procedure,Endometrial Small Cell Carcinoma,0
13600,Disease,Carcinoma ex pleomorphic adenoma of parotid gland,0
13601,Cells,Secondary malignant neoplasm of lymph node,0
13602,Physical findings,Malignant melanoma of eyelid,0
13603,Malignant Neoplasms,Benign tumor of eyelid,0
13604,Treating,Localized Askin Tumor,0
13605,Before values,Heavy Chain Deposition Disease,0
13606,/40,Metastatic Malignant Neoplasm in the Sellar Region,0
13607,Form:Finding:Point in time:{Setting}:Document:{Role},Mucinous adenocarcinoma gastric,0
13608,melanocyte,Bladder squamous cell carcinoma stage I,0
13609,Occurrence,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13610,Case (situation),Intraepithelial Melanocytic Hyperplasia,0
13611,Enlarged,Female Breast Carcinoma,0
13612,Taxonomic,Unresectable Rhabdomyosarcoma,0
13613,Age of onset of symptoms:Time:Pt:^Patient:Qn,Ampulla of Vater Tubular Adenoma,0
13614,Activity (animal life circumstance),Leptomeningeal sarcoma,0
13615,Tryptophanase,non-Hodgkin's lymphoma of spleen,0
13616,Human body,Platinum-Resistant Lung Small Cell Carcinoma,0
13617,antibiotics,Stage IV Penile Cancer AJCC v7,0
13618,Most,Neoplasms,0
13619,Call (Instruction),Childhood Thyroid Gland Follicular Carcinoma,0
13620,Cancer Other,Malignant Neoplasm of Lung - Multiple Primary Sites,0
13621,Count of entities,Mucinous adenocarcinoma gastric,0
13622,Ovulation,Recurrent Testicular Lymphoma,0
13623,Cells,Testicular cancer metastatic,0
13624,Poor function,Endometrial Small Cell Carcinoma,0
13625,Occurrence,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13626,+2,Xeroderma pigmentosum,0
13627,floor (object),Childhood Choriocarcinoma,0
13628,Pharmacologic Substance,Liver Lymphangioma,0
13629,Repair,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13630,Occur (action),Primary Cutaneous Plasmablastic Lymphoma,0
13631,Genetic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13632,Malignant tumor of cervix,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13633,Increase in size since previous mammogram,Malignant neoplasm of thalamus,0
13634,Tract,Cancer of Urinary Tract,0
13635,radiotherapeutic,Cancer of Urinary Tract,0
13636,Tryptophanase,Adrenal Rest Tumor,0
13637,Back,Benign Apocrine Neoplasm,0
13638,Diagnosis,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13639,Pancreatic Cancer Pathway,Neoplasms,0
13640,Personal appearance,Childhood Thyroid Gland Follicular Carcinoma,0
13641,Formation,Chondrosarcoma,0
13642,Most,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13643,Tryptophanase,Recurrent Uveal Melanoma,0
13644,Falls,Metastatic Neoplasm to the Gallbladder,0
13645,<3 (qualifier value),Stage II Carcinoma of Penis,0
13646,Related personal status,Acute Undifferentiated Leukemia,0
13647,Well Differentiated,Childhood Fibrillary Astrocytoma,0
13648,Covered (qualifier value),Granular Cell Leiomyosarcoma,0
13649,Present,Primary Cutaneous Plasmablastic Lymphoma,0
13650,Twice - dosing instruction fragment,Cancer of Urinary Tract,0
13651,Resolution,Localized Askin Tumor,0
13652,Disease Screening,Spongiotic dermatitis,0
13653,include - SetOperator,Human Papillomavirus-Related Carcinoma,0
13654,Type - attribute,FIGO Stage II Ovarian Cancer,0
13655,Lymphoma,Xeroderma pigmentosum,0
13656,1+ Score,Anterior Urethral Malignant Neoplasm,0
13657,Regulation,Uterine Cancer,0
13658,Moon,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13659,>90,Cancer of Urinary Tract,0
13660,Case unit dose,Childhood Thyroid Gland Follicular Carcinoma,0
13661,Malignant Neoplasms,Heavy Chain Deposition Disease,0
13662,Used by,Cerebral Primitive Neuroectodermal Tumor,0
13663,Primary malignant neoplasm,Carcinoma of urinary bladder,0
13664,Deoxyribonucleic Acid Measurement,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13665,Males,Intraepithelial Melanocytic Hyperplasia,0
13666,Affecting,Benign tumor of eyelid,0
13667,Occurrence,Recurrent Uveal Melanoma,0
13668,Item Collection,Stage IB Pancreatic Cancer AJCC v8,0
13669,Biomaterial Treatment,Breast Ductal Adenoma,0
13670,Orbital region,Pancreatic Intraepithelial Neoplasia-3,0
13671,Usual Severity Weight Loss,Testicular cancer metastatic,0
13672,Study Site,BRCA2 Syndrome,0
13673,Presentation,Extra-Adrenal Paraganglioma,0
13674,Body part,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13675,Symptoms aspect,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13676,Metastatic Neoplasm,Stage I Adult Non-Hodgkin Lymphoma,0
13677,Symptoms aspect,Benign neoplasm of thorax,0
13678,Biopsy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13679,Various patch test substance,Endometrial Small Cell Carcinoma,0
13680,Pure Spanish horse breed (organism),Bladder squamous cell carcinoma stage I,0
13681,Including (qualifier),Cartilaginous exostosis,0
13682,Malignant Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13683,Superior mediastinum,Unresectable Rhabdomyosarcoma,0
13684,1000000,Liver Lymphangioma,0
13685,Lung,Benign Apocrine Neoplasm,0
13686,Taxonomic,Leptomeningeal sarcoma,0
13687,DNA,embryonal rhabdomyosarcoma of prostate,0
13688,Mode of inheritance,Intestinal Metaplasia of Bladder Urothelium,0
13689,Referring,Cancer of Urinary Tract,0
13690,Usual,Anterior Urethral Malignant Neoplasm,0
13691,white blood cell type,Benign neoplasm of thorax,0
13692,Distal (qualifier value),Carcinoma of urinary bladder,0
13693,Known,Bladder squamous cell carcinoma stage I,0
13694,900,Acantholytic squamous cell carcinoma,0
13695,Appearance,de novo Myelodysplastic Syndrome,0
13696,Call (Instruction),Diffuse malignant mesothelioma,0
13697,10%,Collecting Duct Carcinoma of the Kidney,0
13698,Carcinoma,Carcinoma of urinary bladder,0
13699,Nodulus cerebelli,Platinum-Resistant Lung Small Cell Carcinoma,0
13700,Case unit dose,Human Papillomavirus-Related Carcinoma,0
13701,Left sided,Malignant Neoplasm with Regional Lymph Node Involvement,0
13702,Anatomic Structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13703,VARIOUS DRUG CLASSES IN ATC,Mucinous adenocarcinoma gastric,0
13704,Childhood Lymphoma,Endometrial Small Cell Carcinoma,0
13705,Renal carcinoma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13706,Type A,Undifferentiated Endocervical Sarcoma,0
13707,Original Regulatory Submission,Methotrexate-Associated Hodgkin Lymphoma,0
13708,+5,Cerebral hemangioma,0
13709,MYELODYSPLASTIC SYNDROME,adenosquamous carcinoma of breast,0
13710,Lung,Intestinal Metaplasia of Bladder Urothelium,0
13711,Major <insect>,Female Breast Carcinoma,0
13712,Means,embryonal rhabdomyosarcoma of prostate,0
13713,Spreading (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13714,Unmarried,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13715,Diabetes Mellitus,Childhood Central Nervous System Immature Teratoma,0
13716,Sharing (Social Behavior),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13717,Anal Sex,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13718,Areas <moth>,Breast Ductal Adenoma,0
13719,Approximate,Benign tumor of eyelid,0
13720,Negation,Non-Metastatic Gestational Trophoblastic Tumor,0
13721,Mass of body structure,Spongiotic dermatitis,0
13722,Code System Type - Internal,Small cell neuroendocrine carcinoma of bladder,0
13723,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Airway Hemangioma,0
13724,Health,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13725,Feelings,Non-Metastatic Gestational Trophoblastic Tumor,0
13726,Line Specimen,Lipoma of small intestine,0
13727,described,Non-Metastatic Gestational Trophoblastic Tumor,0
13728,Brain,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13729,Including (qualifier),Cerebral Primitive Neuroectodermal Tumor,0
13730,Logical Condition,Cerebral Primitive Neuroectodermal Tumor,0
13731,Radiological Exposure Device,Breast Ductal Adenoma,0
13732,Main,Pancreatic Intraepithelial Neoplasia-3,0
13733,United States,Sarcomatoid Renal Cell Carcinoma,0
13734,Lipomatosis,Anaplastic large cell lymphoma,0
13735,Esophagus,Blepharal carcinoma,0
13736,Cancer Etiology,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13737,risk factors,Adrenal Rest Tumor,0
13738,Manufactured sign,Hair nevus,0
13739,Animals,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13740,60%,Ichthyosis,0
13741,Primary,Ovarian germ cell choriocarcinoma stage IV,0
13742,Abnormal cell,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13743,Active License,Carcinoma ex pleomorphic adenoma of parotid gland,0
13744,Persons,Carcinoma of urinary bladder,0
13745,Anatomic Site,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13746,seen,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13747,Electromagnetic Fields,Human Papillomavirus-Related Carcinoma,0
13748,Primary,Lipoma of small intestine,0
13749,>40 years,Localized Ewing Sarcoma,0
13750,Include (action),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
13751,Form:Finding:Point in time:{Setting}:Document:{Role},Testicular cancer metastatic,0
13752,Junctional,Placental aromatase deficiency,0
13753,Sectioning technique,Anterior Urethral Malignant Neoplasm,0
13754,Include (action),Digestive System Hodgkin Lymphoma,0
13755,Subject Risk,Medulloblastoma,0
13756,Logical Condition,Benign Apocrine Neoplasm,0
13757,Inguinal region,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13758,3+ Score,Adenocarcinoma,0
13759,trauma qualifier,Malignant melanoma of eyelid,0
13760,Asia,de novo Myelodysplastic Syndrome,0
13761,90 - 100%,Childhood Lymphoma,0
13762,Antibodies,BRCA2 Syndrome,0
13763,Treating,Maxillary Sinus Adenocarcinoma,0
13764,Soluble (qualifier),Recurrent Testicular Lymphoma,0
13765,Person present,Carcinoma of urinary bladder,0
13766,Base - General Qualifier,Acute Undifferentiated Leukemia,0
13767,Screening,Intraepithelial Melanocytic Hyperplasia,0
13768,Responsible to,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13769,Blood in stool,Undifferentiated Endocervical Sarcoma,0
13770,Head,Small cell neuroendocrine carcinoma of bladder,0
13771,Benign melanocytic nevus,adenoid cystic carcinoma of lung,0
13772,Disease,Atypical Mesothelial Hyperplasia,0
13773,Type A,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13774,Nuclear (nucleus),Rhabdomyosarcoma with ganglionic differentiation,0
13775,contact exposure to arsenic (history),Anterior Urethral Malignant Neoplasm,0
13776,Illness: Cannot describe symptoms,Endometrial Small Cell Carcinoma,0
13777,Proline,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13778,site-specific telomere resolvase activity,Placental aromatase deficiency,0
13779,Feelings,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13780,Infection,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13781,lymph nodes,Methotrexate-Associated Hodgkin Lymphoma,0
13782,Benign,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13783,International Statistical Classification of Diseases and Related Health Problems,Endometrial Small Cell Carcinoma,0
13784,Epithelium,embryonal rhabdomyosarcoma of prostate,0
13785,Cure (remedy),Recurrent Uveal Melanoma,0
13786,suggestion,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13787,Skull,Recurrent Testicular Lymphoma,0
13788,New Zealand,Chronic Myelomonocytic Leukemia-2,0
13789,Specimen Source Codes - Mucosa,Intestinal Neuroendocrine Carcinoma,0
13790,High Mitosis-Karyorrhexis Index,embryonal rhabdomyosarcoma of prostate,0
13791,Administration procedure,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13792,Symptoms aspect,Malignant Testicular Sertoli Cell Tumor,0
13793,risk factors,Ichthyosis,0
13794,Upper,Refractory Barrett Esophagus,0
13795,Hair follicle structure,Advanced Uterine Corpus Carcinosarcoma,0
13796,Microvolt,Rhabdomyosarcoma with ganglionic differentiation,0
13797,Divide,Xeroderma pigmentosum,0
13798,General Health:Find:Pt:^Patient:Ord,GIANT PIGMENTED HAIRY NEVUS,0
13799,Screening procedure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13800,Group A (blood group),Intestinal Neuroendocrine Carcinoma,0
13801,About The Same,Carcinoma ex pleomorphic adenoma of parotid gland,0
13802,X-linked inheritance,Adrenal Rest Tumor,0
13803,Beginning,Secondary malignant neoplasm of lymph node,0
13804,Test Result,embryonal rhabdomyosarcoma of prostate,0
13805,10%,Adenocarcinoma,0
13806,pharmacotherapeutic,Diffuse malignant mesothelioma,0
13807,What subject filter - Result,Malignant melanoma of eyelid,0
13808,Abdomen distended,Breast Ductal Adenoma,0
13809,Superfamily,Atypical Lobular Breast Hyperplasia,0
13810,Cessation of life,Bladder squamous cell carcinoma stage I,0
13811,3+ Answer to Question,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
13812,Tongue,Metastatic Ductal Breast Carcinoma,0
13813,Childhood Renal Cell Carcinoma,Localized Askin Tumor,0
13814,Architecture,Cartilaginous exostosis,0
13815,Secondary Neoplasm,Childhood Lymphoma,0
13816,Dyspareunia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13817,Usual,Thymic Clear Cell Carcinoma,0
13818,Tumor site,gliosarcoma,0
13819,Formations,Advanced Lung Carcinoma,0
13820,Neoadjuvant Therapy Clinical Trial Setting,Heavy Chain Deposition Disease,0
13821,Phase,Mucinous adenocarcinoma gastric,0
13822,Meaning,Localized Ewing Sarcoma,0
13823,Retinoic Acid Response Element,adenoid cystic carcinoma of lung,0
13824,Endocrine system,Thymic Clear Cell Carcinoma,0
13825,Lifetime,Diffuse malignant mesothelioma,0
13826,Smear - instruction imperative,Intestinal Metaplasia of Bladder Urothelium,0
13827,Probably,Acantholytic squamous cell carcinoma,0
13828,Cell Count,Stage IV Penile Cancer AJCC v7,0
13829,Secondary Neoplasm,Breast Ductal Adenoma,0
13830,Lymphoma,Pilocytic astrocytoma of cerebellum,0
13831,Symptoms,Recurrent Testicular Lymphoma,0
13832,Lymphoid Cell Count,Carcinoma ex pleomorphic adenoma of parotid gland,0
13833,Urinary system,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13834,Advance -- medical device,Stage IB Lung Cancer AJCC v7,0
13835,Adult human body,Acute Undifferentiated Leukemia,0
13836,include - SetOperator,Extra-Adrenal Paraganglioma,0
13837,Keratoconjunctivitis Sicca,Pancreatic Intraepithelial Neoplasia-3,0
13838,Sunscreening Agents,papillary carcinoma of penis,0
13839,Biomaterial Treatment,Childhood Lymphoma,0
13840,ACTG2 wt Allele,benign mature teratoma of pancreas,0
13841,include - SetOperator,Tonsillar Carcinoma,0
13842,Has difficulty doing (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13843,Axilla,Undifferentiated Endocervical Sarcoma,0
13844,Concept model domain,Angiosarcoma of liver,0
13845,Type A,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13846,Ichthyosis,Colorectal High Grade B-Cell Lymphoma,0
13847,Range,Mastocytosis,0
13848,gliosarcoma,Ichthyosis,0
13849,Clinical,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13850,Cure (remedy),Papillary cystic tumor,0
13851,Sore skin,Serous cystadenocarcinoma ovary,0
13852,Decision,Malignant Neoplasm of Lung - Multiple Primary Sites,0
13853,Frequently,Airway Hemangioma,0
13854,Tissue Specimen Code,embryonal rhabdomyosarcoma of prostate,0
13855,Blood,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13856,Include (action),sarcoma of spinal cord,0
13857,Melanocytic nevus,Testicular cancer metastatic,0
13858,Protein Digestion (research activity),Uterine Cancer,0
13859,Useful,gliosarcoma,0
13860,Compression - action,Stage III Adult Immunoblastic Lymphoma,0
13861,Hormone replacement therapy,Human Papillomavirus-Related Carcinoma,0
13862,Count of entities,Low Grade Squamous Intraepithelial Neoplasia,0
13863,Causing,Malignant melanoma of eyelid,0
13864,Retinoic Acid Response Element,Platinum-Resistant Lung Small Cell Carcinoma,0
13865,Fragments,adenosquamous carcinoma of breast,0
13866,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13867,Predisposition -- attribute,Non-Metastatic Gestational Trophoblastic Tumor,0
13868,Scalp structure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13869,Duct (organ) structure,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
13870,Dry,Unfavorable Non-Hodgkin Lymphoma,0
13871,Skin Specimen,adenoid cystic carcinoma of lung,0
13872,Smear - instruction imperative,Medulloblastoma,0
13873,Cause of death:Find:Pt:^Patient:Nom,Extracranial Neuroblastoma,0
13874,Containing (qualifier),Stage IV Penile Cancer AJCC v7,0
13875,Experimental Result,Digestive System Hodgkin Lymphoma,0
13876,Form:Finding:Point in time:{Setting}:Document:{Role},Neonatal leukemia,0
13877,Fever symptoms (finding),Rhabdomyosarcoma with ganglionic differentiation,0
13878,Seed entity,Granular Cell Leiomyosarcoma,0
13879,Tryptophanase,Colorectal High Grade B-Cell Lymphoma,0
13880,Characterization,squamous cell carcinoma of the thyroid gland,0
13881,Neuroendocrine Tumors,Blepharal carcinoma,0
13882,Lung,Malignant Neoplasm with Regional Lymph Node Involvement,0
13883,include - SetOperator,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
13884,Loss of appetite (finding),Endometrial Small Cell Carcinoma,0
13885,Urinary tract,Neoplasms,0
13886,Process of secretion,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13887,T-Lymphocyte,High Grade Glandular Intraepithelial Neoplasia,0
13888,Including (qualifier),Low Grade Squamous Intraepithelial Neoplasia,0
13889,pharmacotherapeutic,Methotrexate-Associated Hodgkin Lymphoma,0
13890,Manufactured form,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13891,Decision,Uterine Cancer,0
13892,Beginning,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13893,complex (molecular entity),Low Grade Squamous Intraepithelial Neoplasia,0
13894,1+ Score,benign mature teratoma of pancreas,0
13895,Occurrence Indicator,Liver Lymphangioma,0
13896,Younger child,Primary Cutaneous Plasmablastic Lymphoma,0
13897,Proportion,Angiosarcoma of liver,0
13898,Togo,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13899,Type - attribute,FIGO Stage II Ovarian Cancer,0
13900,shared attribute,Endometrial Small Cell Carcinoma,0
13901,Common (qualifier value),Intracortical osteosarcoma,0
13902,Cell positive for CD34 antigen,Giant cell angiofibroma,0
13903,75,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13904,Occurrence Indicator,Stage III Adult Immunoblastic Lymphoma,0
13905,Childhood Neuroblastoma,Adult Alveolar Soft Part Sarcoma,0
13906,Cervix carcinoma,Familial Hemophagocytic Lymphocytosis,0
13907,1+ Score,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13908,Less Than,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13909,Neck,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13910,Measles virus genotype D1,Adenocarcinoma,0
13911,Disease Screening,Granular Cell Leiomyosarcoma,0
13912,Occurrence Indicator,papillary carcinoma of penis,0
13913,Sometimes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13914,Comfort,High Grade Glandular Intraepithelial Neoplasia,0
13915,Symptoms aspect,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13916,Biological Response Modifiers,adenosquamous carcinoma of breast,0
13917,low,Giant cell angiofibroma,0
13918,Person 1,Heavy Chain Deposition Disease,0
13919,shared attribute,mucinous adenocarcinoma of gallbladder,0
13920,Surrounding (qualifier value),gliosarcoma,0
13921,Part of,Stage 0 Lip Carcinoma,0
13922,1000000,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13923,Epithelioma,BRCA2 Syndrome,0
13924,low confidentiality,Platinum-Resistant Lung Small Cell Carcinoma,0
13925,Use of,Anterior Urethral Malignant Neoplasm,0
13926,Juice,Localized Askin Tumor,0
13927,Togo,Benign tumor of eyelid,0
13928,Treating,Small cell neuroendocrine carcinoma of bladder,0
13929,Circulating blood,Uterine Cancer,0
13930,Occurrence,Tonsillar Carcinoma,0
13931,vascular inflammations,Liver Lymphangioma,0
13932,Concept model range (foundation metadata concept),Female Breast Carcinoma,0
13933,Genital system,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13934,Lasers,Stage IB Pancreatic Cancer AJCC v8,0
13935,Heightened,Malignant Testicular Sertoli Cell Tumor,0
13936,Trial Screening,Grade 3a Malignant Neoplasm,0
13937,Sound - physical agent,Stage 0 Penile Cancer AJCC v8,0
13938,T-Cell Development,Diffuse malignant mesothelioma,0
13939,Surgical aspects,Mucinous adenocarcinoma gastric,0
13940,Qualitative form,Recurrent Diffuse Intrinsic Pontine Glioma,0
13941,Endothelial Cells,Carcinoma of urinary bladder,0
13942,Drug Administration Routes,Bladder squamous cell carcinoma stage I,0
13943,melanoma,Stage II Carcinoma of Penis,0
13944,Beginning,Stage I Adult Non-Hodgkin Lymphoma,0
13945,Salivary Glands,gliosarcoma,0
13946,Homo sapiens,Colorectal Neuroendocrine Tumor G2,0
13947,shared attribute,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13948,Ability,Malignant melanoma of eyelid,0
13949,Chemotherapy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13950,Feel Nausea,Xeroderma pigmentosum,0
13951,Myoepithelial,Cerebral hemangioma,0
13952,cell type,Anaplastic large cell lymphoma,0
13953,Immunocompromised Host,Intestinal Metaplasia of Bladder Urothelium,0
13954,Follicular,Noninfiltrating Intraductal Carcinoma,0
13955,Worried,Undifferentiated Neuroblastoma,0
13956,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Recurrent Testicular Lymphoma,0
13957,Prostate,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13958,Life,Adenocarcinoma,0
13959,Tissue injury,Extra-Adrenal Paraganglioma,0
13960,Non-Metastatic Childhood Soft Tissue Sarcoma,Recurrent Uveal Melanoma,0
13961,Malignant tumor of cervix,Adult Brain Stem Mixed Glioma,0
13962,During,Prostate Lymphoma,0
13963,Asbestos,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13964,Analysis,Maxillary Sinus Adenocarcinoma,0
13965,Approximate,Localized Ewing Sarcoma,0
13966,Hospital specialist,Diffuse malignant mesothelioma,0
13967,Version,Grade 3a Malignant Neoplasm,0
13968,Overlap,Acantholytic squamous cell carcinoma,0
13969,Singular,papillary carcinoma of penis,0
13970,Primary,Locally Advanced Soft Tissue Sarcoma,0
13971,Associated with,Papillary cystic tumor,0
13972,Viola tricolor extract,Human Papillomavirus-Related Carcinoma,0
13973,Associated with,Granular Cell Leiomyosarcoma,0
13974,Transitional cell morphology,Malignant Testicular Sertoli Cell Tumor,0
13975,Part,Undifferentiated Endocervical Sarcoma,0
13976,Pleural effusion disorder,Placental aromatase deficiency,0
13977,Spreading (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13978,Prominent,Spongiotic dermatitis,0
13979,Singular,Childhood Choriocarcinoma,0
13980,Absence (morphologic abnormality),Malignant melanoma of eyelid,0
13981,Treating,Medulloblastoma,0
13982,Significant,Grade 3a Malignant Neoplasm,0
13983,Posterolateral,Non-Metastatic Gestational Trophoblastic Tumor,0
13984,Row (arrangement),mucinous adenocarcinoma of gallbladder,0
13985,Uncontrolled,papillary carcinoma of penis,0
13986,Value Above Reference Range,embryonal rhabdomyosarcoma of prostate,0
13987,Common Specifications in HL7 V3 Publishing,Endometrial Small Cell Carcinoma,0
13988,Pap smear,Unresectable Rhabdomyosarcoma,0
13989,Numbers,Childhood Central Nervous System Immature Teratoma,0
13990,Deglutition Disorders,Refractory Barrett Esophagus,0
13991,Urinary Diversion,Clonal Hematopoiesis of Indeterminate Potential,0
13992,Turner Syndrome,Cerebral Primitive Neuroectodermal Tumor,0
13993,Treatment Epoch,Placental aromatase deficiency,0
13994,Various patch test substance,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13995,Have Weight Loss,Stage IV Childhood Non-Hodgkin Lymphoma,0
13996,Group A (qualifier value),Undifferentiated Endocervical Sarcoma,0
13997,Recombinant Human Chorionic Gonadotropin,Refractory Barrett Esophagus,0
13998,Posterior Spinal Artery Syndrome,Recurrent Uveal Melanoma,0
13999,Occurrence Indicator,Chronic Myelomonocytic Leukemia-2,0
14000,Tumor Suppression,Anaplastic large cell lymphoma,0
14001,metaplastic cell transformation,Placental aromatase deficiency,0
14002,Breast,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14003,Embryonic Development,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14004,Body structure,Testicular cancer metastatic,0
14005,How Much Distress Vomiting,Ovarian Carcinoid Tumor,0
14006,10%,BRCA2 Syndrome,0
14007,Treating,Mucinous adenocarcinoma gastric,0
14008,HEMOCHROMATOSIS,Recurrent Uveal Melanoma,0
14009,Occur (action),Stage II Hepatocellular Carcinoma AJCC v8,0
14010,cell transformation,Benign tumor of eyelid,0
14011,Leg,Neoplasms,0
14012,Neoplasm Metastasis,Non-Metastatic Gestational Trophoblastic Tumor,0
14013,Antimicrobial Susceptibility Result,Intraepithelial Melanocytic Hyperplasia,0
14014,Bothered by Night Sweats,Digestive System Hodgkin Lymphoma,0
14015,Administration procedure,Primary Cutaneous Plasmablastic Lymphoma,0
14016,Five,FIGO Stage II Ovarian Cancer,0
14017,Sleeping Pills,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14018,Pleomorphic Xanthoastrocytoma,Endometrial Small Cell Carcinoma,0
14019,Cancer Genus,Benign Apocrine Neoplasm,0
14020,Treating,Undifferentiated Endocervical Sarcoma,0
14021,Occurrence,Maxillary Sinus Adenocarcinoma,0
14022,New,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14023,Identified,Adult Alveolar Soft Part Sarcoma,0
14024,Return to (contextual qualifier) (qualifier value),Heavy Chain Deposition Disease,0
14025,1000000,squamous cell carcinoma of the thyroid gland,0
14026,Areas <moth>,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14027,*Type - Kind of quantity,Advanced Uterine Corpus Carcinosarcoma,0
14028,Administration procedure,Unresectable Rhabdomyosarcoma,0
14029,Effective,Mucinous adenocarcinoma gastric,0
14030,Human papilloma virus infection,Mucinous adenocarcinoma gastric,0
14031,Approximate,Cerebral Primitive Neuroectodermal Tumor,0
14032,Usually,Carcinoma of urinary bladder,0
14033,Pure Spanish horse breed (organism),Mucinous adenocarcinoma gastric,0
14034,Non-Small Cell Lung Carcinoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14035,Neoplasm Metastasis,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14036,Pleural effusion disorder,Serous cystadenocarcinoma ovary,0
14037,CSNK1D wt Allele,Diffuse malignant mesothelioma,0
14038,Adenolymphoma,embryonal rhabdomyosarcoma of prostate,0
14039,To,Anterior Urethral Malignant Neoplasm,0
14040,Associated with,Malignant neoplasm of thalamus,0
14041,Tryptophanase,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14042,To,Mucinous adenocarcinoma gastric,0
14043,Mucoepidermoid Carcinoma,Low Grade Squamous Intraepithelial Neoplasia,0
14044,Including (qualifier),embryonal rhabdomyosarcoma of prostate,0
14045,*Type - Kind of quantity,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14046,Known,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14047,True primary (qualifier value),malignant lymphoma of pancreatic lymph nodes,0
14048,consider,Medulloblastoma,0
14049,Person Observer,Cancer of Urinary Tract,0
14050,New,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14051,Scrotum,Intestinal Metaplasia of Bladder Urothelium,0
14052,History of present illness,Childhood Lymphoma,0
14053,Platelets,Refractory Barrett Esophagus,0
14054,Continuance of life,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14055,Worse,Pancreatic Intraepithelial Neoplasia-3,0
14056,Disease,Cartilaginous exostosis,0
14057,Myeloid Progenitor Cells,Metastatic Malignant Neoplasm in the Sellar Region,0
14058,Neoplasms,Uterine Cancer,0
14059,aspects of adverse effects,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14060,PAGR1 wt Allele,Endometrial Small Cell Carcinoma,0
14061,Most of the time,embryonal rhabdomyosarcoma of prostate,0
14062,Communicable Diseases,Intraepithelial Melanocytic Hyperplasia,0
14063,Experimental Result,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
14064,Make - Instruction Imperative,Testicular cancer metastatic,0
14065,Malignant epithelioma,Recurrent Testicular Lymphoma,0
14066,Hemorrhage,Carcinoma of urinary bladder,0
14067,High Level,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14068,Glioma,Lung squamous cell carcinoma stage I,0
14069,Tobacco smoking behavior,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14070,Sebaceous Glands,Secondary malignant neoplasm of lymph node,0
14071,Age of Onset,Unresectable Rhabdomyosarcoma,0
14072,Night time,Mucinous adenocarcinoma gastric,0
14073,Child,Cerebral Primitive Neuroectodermal Tumor,0
14074,Negative Surgical Margin,Xeroderma pigmentosum,0
14075,Antibodies,Human Papillomavirus-Related Carcinoma,0
14076,Treatment Epoch,Refractory Barrett Esophagus,0
14077,How Much Nausea During This Period,Malignant Testicular Sertoli Cell Tumor,0
14078,morphological,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14079,Volume,Cancer of Urinary Tract,0
14080,Affecting,Acantholytic squamous cell carcinoma,0
14081,Surgical reduction,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14082,Life,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14083,To,Medulloblastoma,0
14084,Definitely Related to Intervention,Placental aromatase deficiency,0
14085,Leading,Localized Askin Tumor,0
14086,Form:Finding:Point in time:{Setting}:Document:{Role},Platinum-Resistant Lung Small Cell Carcinoma,0
14087,Lesion,Metastatic Ductal Breast Carcinoma,0
14088,Presentation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14089,Cell (compartment),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14090,Usual,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14091,Blood flow,Testicular cancer metastatic,0
14092,Tanning of leather,Hemangioma,0
14093,Injury due to exposure to external cause,Endometrial Small Cell Carcinoma,0
14094,On (qualifier value),Stage III Adult Immunoblastic Lymphoma,0
14095,Nipples,Acute Undifferentiated Leukemia,0
14096,Class (taxonomic),Diffuse malignant mesothelioma,0
14097,Symptoms aspect,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14098,Neoplasms,malignant lymphoma of pancreatic lymph nodes,0
14099,Detection,Contact dermatitis due to alkali,0
14100,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Localized Ewing Sarcoma,0
14101,CEL gene,Breast Ductal Adenoma,0
14102,Manufactured form,Adult Alveolar Soft Part Sarcoma,0
14103,Descent,Noninfiltrating Intraductal Carcinoma,0
14104,Usual Severity Shortness of Breath,Mucinous adenocarcinoma gastric,0
14105,Code,Extracranial Neuroblastoma,0
14106,Duct (organ) structure,Clonal Hematopoiesis of Indeterminate Potential,0
14107,Damage,Unfavorable Non-Hodgkin Lymphoma,0
14108,Smaller,Lipoma of small intestine,0
14109,What subject filter - Result,Rhabdomyosarcoma with ganglionic differentiation,0
14110,Shapes,Tonsillar Carcinoma,0
14111,Presentation,Stage III Adult Immunoblastic Lymphoma,0
14112,Include (action),Small cell neuroendocrine carcinoma of bladder,0
14113,Acquisition (action),Noninfiltrating Intraductal Carcinoma,0
14114,Homo sapiens,Undifferentiated Endocervical Sarcoma,0
14115,<3 (qualifier value),embryonal rhabdomyosarcoma of prostate,0
14116,Increase,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14117,Site,Acute Undifferentiated Leukemia,0
14118,Swollen Lymph Node,Xeroderma pigmentosum,0
14119,High risk of,Stage IB Pancreatic Cancer AJCC v8,0
14120,Family,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14121,Therapeutic radiology procedure,Collecting Duct Carcinoma of the Kidney,0
14122,Number of birth,FIGO Stage II Ovarian Cancer,0
14123,Childhood diseases,Childhood Fibrillary Astrocytoma,0
14124,Colon Carcinoma,Digestive System Hodgkin Lymphoma,0
14125,Individual,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14126,pharmacotherapeutic,Malignant Neoplasm with Regional Lymph Node Involvement,0
14127,Medulla Oblongata,Localized Askin Tumor,0
14128,survival aspects,FIGO Stage II Ovarian Cancer,0
14129,Triggered by,Granular Cell Leiomyosarcoma,0
14130,Decision,Localized Ewing Sarcoma,0
14131,Covers (device),Locally Advanced Soft Tissue Sarcoma,0
14132,Surgical aspects,gliosarcoma,0
14133,Primary malignant neoplasm,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14134,Symptoms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14135,Lower urinary tract,Leptomeningeal sarcoma,0
14136,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14137,Most,Hair nevus,0
14138,Pigment cell,Low Grade Squamous Intraepithelial Neoplasia,0
14139,Operative Surgical Procedures,Small cell neuroendocrine carcinoma of bladder,0
14140,Reciprocal translocation,Methotrexate-Associated Hodgkin Lymphoma,0
14141,Science of Etiology,Placental aromatase deficiency,0
14142,Study Subject,FIGO Stage II Ovarian Cancer,0
14143,Human Cells,Female Breast Carcinoma,0
14144,Administrative Division,Xeroderma pigmentosum,0
14145,cell type,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14146,3+ Answer to Question,Locally Advanced Soft Tissue Sarcoma,0
14147,white blood cell type,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14148,Confirmed by,Mucinous cystadenofibroma,0
14149,Relational and Item-Specific Encoding Task,Stage 0 Penile Cancer AJCC v8,0
14150,Severe Extremity Pain,Lipoma of small intestine,0
14151,Sarcoma - category (morphologic abnormality),Undifferentiated Endocervical Sarcoma,0
14152,Symptoms,Tonsillar Carcinoma,0
14153,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Pilocytic astrocytoma of cerebellum,0
14154,Overall,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14155,Malignant neoplasm of oropharynx,Recurrent Testicular Lymphoma,0
14156,Consistency,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14157,Classification of information,Recurrent Testicular Lymphoma,0
14158,Only - dosing instruction fragment,benign mature teratoma of pancreas,0
14159,Abdomen+,Small cell neuroendocrine carcinoma of bladder,0
14160,Infant,Colorectal High Grade B-Cell Lymphoma,0
14161,Alternative,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14162,Tumor Mass,High Grade Glandular Intraepithelial Neoplasia,0
14163,10%,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14164,Pelvis,Low Grade Squamous Intraepithelial Neoplasia,0
14165,Hematuria,Clonal Hematopoiesis of Indeterminate Potential,0
14166,Chemotherapy Regimen,Lipoma of small intestine,0
14167,Case unit dose,Bladder squamous cell carcinoma stage I,0
14168,lymph nodes,Mucinous adenocarcinoma gastric,0
14169,Unit of radiation dose,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
14170,Speaking (activity),Placental aromatase deficiency,0
14171,To,Non-Metastatic Gestational Trophoblastic Tumor,0
14172,Chemotherapy,Pancreatic Intraepithelial Neoplasia-3,0
14173,Melanocytic nevus,Angiosarcoma of liver,0
14174,Case unit dose,Grade 1 Clear Cell Renal Cell Carcinoma,0
14175,Tumor type,Stage 0 Lip Carcinoma,0
14176,gastrointestinal gas,de novo Myelodysplastic Syndrome,0
14177,<90,BRCA2 Syndrome,0
14178,polyps,Malignant melanoma of eyelid,0
14179,risk factors,Tonsillar Carcinoma,0
14180,Cerebral cortex,Endometrial Small Cell Carcinoma,0
14181,Multiple Myeloma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14182,Valid,Metastatic Malignant Neoplasm in the Sellar Region,0
14183,Analysis,Cartilaginous exostosis,0
14184,Chromosomes,Stage IB Lung Cancer AJCC v7,0
14185,Colorectal Cancer Pathway,Undifferentiated Endocervical Sarcoma,0
14186,Benign Neoplasm,Lung squamous cell carcinoma stage I,0
14187,Abnormal,Breast Ductal Adenoma,0
14188,Compleat Liquid Nutrition,Acantholytic squamous cell carcinoma,0
14189,Affect (mental function),adenosquamous carcinoma of breast,0
14190,Screening - general (procedure),Clonal Hematopoiesis of Indeterminate Potential,0
14191,Biomedicine,Pilocytic astrocytoma of cerebellum,0
14192,Fetal,Airway Hemangioma,0
14193,Hematologic Neoplasms,Non-Metastatic Gestational Trophoblastic Tumor,0
14194,analysis aspect,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
14195,Etiology aspects,Adenocarcinoma of the prostate metastatic,0
14196,Malignant Neoplasms,Cartilaginous exostosis,0
14197,Cosmetics,Childhood Lymphoma,0
14198,include - SetOperator,Malignant neoplasm of choroid,0
14199,Presence (property),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14200,treatment - ActInformationManagementReason,Bladder squamous cell carcinoma stage I,0
14201,Specimen Source Codes - Tears,High Grade Glandular Intraepithelial Neoplasia,0
14202,Gestational,Stage IV Penile Cancer AJCC v7,0
14203,Human Papillomavirus Positive,Stage IV Childhood Non-Hodgkin Lymphoma,0
14204,Molecular Mass,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14205,Death NOS,Malignant Testicular Sertoli Cell Tumor,0
14206,combination - answer to question,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14207,Classification,Carcinoma ex pleomorphic adenoma of parotid gland,0
14208,Symptoms aspect,Angiosarcoma of liver,0
14209,Mass of body structure,Advanced Uterine Corpus Carcinosarcoma,0
14210,Immature,Refractory Barrett Esophagus,0
14211,Bladder Neoplasm,Low Grade Squamous Intraepithelial Neoplasia,0
14212,Term (temporal),Metastatic Neoplasm to the Gallbladder,0
14213,N not otherwise specified Antibody,Stage 0 Penile Cancer AJCC v8,0
14214,Symptoms,Malignant Testicular Sertoli Cell Tumor,0
14215,Fourth (suffix),Intracortical osteosarcoma,0
14216,Malignant neoplasm of endometrium,Thymic Clear Cell Carcinoma,0
14217,Cells,Acantholytic squamous cell carcinoma,0
14218,Cerebral hemisphere structure (body structure),Intraepithelial Melanocytic Hyperplasia,0
14219,Involvement with,Testicular cancer metastatic,0
14220,risk factors - observation list,benign mature teratoma of pancreas,0
14221,Therapeutic procedure,Human Papillomavirus-Related Carcinoma,0
14222,Does stand alone,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14223,Malignant Neoplasms,Malignant Testicular Sertoli Cell Tumor,0
14224,white blood cell type,Blepharal carcinoma,0
14225,Occur (action),Thymic Clear Cell Carcinoma,0
14226,Cure (remedy),Familial Hemophagocytic Lymphocytosis,0
14227,Smear test,Thymic Clear Cell Carcinoma,0
14228,Arising,Lung squamous cell carcinoma stage I,0
14229,Essential,Intestinal Metaplasia of Bladder Urothelium,0
14230,Area,Colorectal High Grade B-Cell Lymphoma,0
14231,Adult Non-Hodgkin Lymphoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14232,Site,Pancreatic Intraepithelial Neoplasia-3,0
14233,Diagnosis Study,Diffuse malignant mesothelioma,0
14234,Classification,Stage IV Penile Cancer AJCC v7,0
14235,Slow,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14236,Cutaneous Route of Drug Administration,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14237,Table Cell Horizontal Align - left,Fourth Ventricle and Brain Stem Ependymal Tumor,0
14238,Before values,Hodgkin lymphoma,0
14239,Response process,High Grade Glandular Intraepithelial Neoplasia,0
14240,Show,Intestinal Metaplasia of Bladder Urothelium,0
14241,Thymus Neoplasms,Neonatal leukemia,0
14242,Midline (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14243,Publications,Female Breast Carcinoma,0
14244,Ultraviolet Rays,Thymic Clear Cell Carcinoma,0
14245,Large,Mastocytosis,0
14246,Malignant Childhood Neoplasm,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14247,Fatigue,FIGO Stage II Ovarian Cancer,0
14248,Specific qualifier value,Ovarian germ cell choriocarcinoma stage IV,0
14249,NIN gene,Keratoderma,0
14250,Pith - plant part,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14251,Increasing,Hodgkin lymphoma,0
14252,Embryonal Rhabdomyosarcoma,Acantholytic squamous cell carcinoma,0
14253,Case unit dose,Mixed parotid tumor,0
14254,Lung,Intracortical osteosarcoma,0
14255,Death (finding),Fourth Ventricle and Brain Stem Ependymal Tumor,0
14256,Headache,Endometrial Small Cell Carcinoma,0
14257,Catalogs,Localized Ewing Sarcoma,0
14258,Condyloma,Endometrial Small Cell Carcinoma,0
14259,Cell Count,Refractory Glioma,0
14260,Act Class - investigation,Mucinous cystadenofibroma,0
14261,Upper,Stage IV Childhood Non-Hodgkin Lymphoma,0
14262,Usually,Spermatocytic seminoma,0
14263,Lung,Angiosarcoma of liver,0
14264,Amount type - Percentage,Female Breast Carcinoma,0
14265,Malignant - descriptor,Cerebral hemangioma,0
14266,Malignant - descriptor,Noninfiltrating Intraductal Carcinoma,0
14267,Publishing,Localized Ewing Sarcoma,0
14268,New Zealand Rabbits,Extracranial Neuroblastoma,0
14269,survival aspects,Small cell neuroendocrine carcinoma of bladder,0
14270,Nitrofurantoin,Low Grade Squamous Intraepithelial Neoplasia,0
14271,Publications,Digestive System Hodgkin Lymphoma,0
14272,Adult human body,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14273,regional,Breast Ductal Adenoma,0
14274,Collections (publication),sarcoma of spinal cord,0
14275,Characterization,Metastatic Lung Small Cell Carcinoma,0
14276,Breathing Distress Question,Cerebral hemangioma,0
14277,Frequency of Pain Question,Maxillary Sinus Adenocarcinoma,0
14278,Lumpectomy of breast,Mucinous adenocarcinoma gastric,0
14279,Varies,Localized Ewing Sarcoma,0
14280,Percent (qualifier value),Platinum-Resistant Lung Small Cell Carcinoma,0
14281,Grade IV Childhood Astrocytic Neoplasm,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14282,Penis carcinoma,FIGO Stage II Ovarian Cancer,0
14283,Pelvic cavity structure,Breast Ductal Adenoma,0
14284,Signs and Symptoms,benign mature teratoma of pancreas,0
14285,To,Malignant Neoplasm with Regional Lymph Node Involvement,0
14286,Monitor,Angiosarcoma of liver,0
14287,Known,Locally Advanced Soft Tissue Sarcoma,0
14288,BRCA2 Protein,Benign Apocrine Neoplasm,0
14289,Surgical service,Familial Adenomatous Polyposis Associated Medulloblastoma,0
14290,Point in time,Adult Alveolar Soft Part Sarcoma,0
14291,Therapeutic procedure,Metastatic Kidney Carcinoma,0
14292,75,mucinous adenocarcinoma of gallbladder,0
14293,Frequently,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14294,Cells,Extra-Adrenal Paraganglioma,0
14295,Tobacco smoking behavior,High Grade Glandular Intraepithelial Neoplasia,0
14296,Time (foundation metadata concept),Giant cell angiofibroma,0
14297,Reported By,Neonatal leukemia,0
14298,True primary (qualifier value),Grade 3a Malignant Neoplasm,0
14299,Basis - conceptual entity,Childhood Lymphoma,0
14300,More,Acantholytic squamous cell carcinoma,0
14301,Non-invasive,Testicular cancer metastatic,0
14302,Formation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14303,To,Lung squamous cell carcinoma stage I,0
14304,Type - attribute,Diffuse malignant mesothelioma,0
14305,Congenital phimosis,Localized Ewing Sarcoma,0
14306,Chemical or Textual Reference to Actual Test or Parameter,Endometrial Small Cell Carcinoma,0
14307,Salivary Gland Neoplasms,Benign neoplasm of thorax,0
14308,+2,Benign Carotid Body Paraganglioma,0
14309,Redness,Xeroderma pigmentosum,0
14310,Predisposition -- attribute,Carcinoma of urinary bladder,0
14311,Excision,Cartilaginous exostosis,0
14312,Acute Undifferentiated Leukemia,Recurrent Uveal Melanoma,0
14313,Abdomen,Cancer of Urinary Tract,0
14314,Less Than,Ichthyosis,0
14315,Communicable Diseases,Methotrexate-Associated Hodgkin Lymphoma,0
14316,Autumn,Human Papillomavirus-Related Carcinoma,0
14317,Skin,Non-Metastatic Gestational Trophoblastic Tumor,0
14318,Sequence Data Type,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14319,North America,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14320,Occurrence,Ampulla of Vater Tubular Adenoma,0
14321,Five,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14322,Hematogenous spread,sarcoma of spinal cord,0
14323,Infection,Extracranial Neuroblastoma,0
14324,Clothing,Undifferentiated Endocervical Sarcoma,0
14325,Only - dosing instruction fragment,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14326,Usual,Childhood Fibrillary Astrocytoma,0
14327,Body tissue,Collecting Duct Carcinoma of the Kidney,0
14328,Common Specifications in HL7 V3 Publishing,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14329,Lymphoproliferation,Cancer of Urinary Tract,0
14330,Sunglasses (physical object),Adenocarcinoma,0
14331,99,Intraepithelial Melanocytic Hyperplasia,0
14332,Malignant Neoplasms,embryonal rhabdomyosarcoma of prostate,0
14333,Malignant Neoplasms,Digestive System Hodgkin Lymphoma,0
14334,per year,Neonatal leukemia,0
14335,Decision,Recurrent Uveal Melanoma,0
14336,cell growth,Digestive System Hodgkin Lymphoma,0
14337,Main,Recurrent Testicular Lymphoma,0
14338,Removed,Stage II Carcinoma of Penis,0
14339,Cancer Genus,Noninfiltrating Intraductal Carcinoma,0
14340,Closed,Carcinoma of urinary bladder,0
14341,seconds,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14342,CD69 protein,Cancer of Urinary Tract,0
14343,Definition,Maxillary Sinus Adenocarcinoma,0
14344,various other nasal preparations in ATC,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14345,Qualitative form,Cerebral hemangioma,0
14346,Plasmacytoma,Carcinoma of urinary bladder,0
14347,soluble,Stage I Adult Non-Hodgkin Lymphoma,0
14348,Definition,Platinum-Resistant Lung Small Cell Carcinoma,0
14349,Back Pain,Thymic Clear Cell Carcinoma,0
14350,Color change,Undifferentiated Neuroblastoma,0
14351,Tumor stage,Neoplasms,0
14352,Specimen Type - Genital,Contact dermatitis due to alkali,0
14353,Body Site Modifier - Lower,Testicular cancer metastatic,0
14354,CEL gene,Childhood Lymphoma,0
14355,Qualitative form,mucinous adenocarcinoma of gallbladder,0
14356,End,Recurrent Testicular Lymphoma,0
14357,Most,Pancreatic Intraepithelial Neoplasia-3,0
14358,Meaning,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14359,Body Weight,Endometrial Small Cell Carcinoma,0
14360,Treatment intent,Colorectal High Grade B-Cell Lymphoma,0
14361,Feature,Recurrent Testicular Lymphoma,0
14362,Consistency,Xeroderma pigmentosum,0
14363,Resulting in,Placental aromatase deficiency,0
14364,International Classification of Diseases for Oncology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14365,Five,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14366,Taxonomic,Cancer of Urinary Tract,0
14367,Extent of disease,Maxillary Sinus Adenocarcinoma,0
14368,Body part,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14369,Value Above Reference Range,Refractory Barrett Esophagus,0
14370,Genus Homo,Malignant Neoplasm of Lung - Multiple Primary Sites,0
14371,Dominant,Endometrial Small Cell Carcinoma,0
14372,Usual,squamous cell carcinoma of the thyroid gland,0
14373,depend,Malignant Neoplasm with Regional Lymph Node Involvement,0
14374,Symptoms aspect,Malignant melanoma of eyelid,0
14375,Child,Human Papillomavirus-Related Carcinoma,0
14376,Malignant neoplasm of mouth,Refractory Glioma,0
14377,Common Specifications in HL7 V3 Publishing,Localized Ewing Sarcoma,0
14378,Assortment,Colorectal Neuroendocrine Tumor G2,0
14379,Immune System Finding,Refractory Barrett Esophagus,0
14380,Multiply - dosing instruction fragment,Digestive System Hodgkin Lymphoma,0
14381,Better,Digestive System Hodgkin Lymphoma,0
14382,Positron-Emission Tomography,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14383,growth aspects,Liver Lymphangioma,0
14384,Africa,Liver Cavernous Hemangioma,0
14385,Heterogeneity,Cerebral Primitive Neuroectodermal Tumor,0
14386,Folded structure,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
14387,development aspects,Stage IV Childhood Non-Hodgkin Lymphoma,0
14388,Most,Medulloblastoma,0
14389,Papanicolaou Test,FIGO Stage II Ovarian Cancer,0
14390,Containing (qualifier),Intestinal Neuroendocrine Carcinoma,0
14391,Less Than,Non-Metastatic Gestational Trophoblastic Tumor,0
14392,Retinoic Acid Response Element,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14393,Biological Response Modifiers,Female Breast Carcinoma,0
14394,Previous,Anterior Urethral Malignant Neoplasm,0
14395,MNX1 gene,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14396,23,Recurrent Testicular Lymphoma,0
14397,Management procedure,Unfavorable Non-Hodgkin Lymphoma,0
14398,Usually,Medulloblastoma,0
14399,2000,Metastatic Ductal Breast Carcinoma,0
14400,Most,Metastatic Carcinoma in the Lung,0
14401,Progestins,Platinum-Resistant Lung Small Cell Carcinoma,0
14402,Reparative closure,Refractory Barrett Esophagus,0
14403,Neoplasms,Childhood Fibrillary Astrocytoma,0
14404,Syndrome,Testicular cancer metastatic,0
14405,Medical Device Emits Smoke,Heavy Chain Deposition Disease,0
14406,Usual Severity Nausea,Neoplasms,0
14407,Persons,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14408,Blood Vessel,Extra-Adrenal Paraganglioma,0
14409,Structure of lower lobe of lung,BRCA2 Syndrome,0
14410,Cancer Genus,Chronic Myelomonocytic Leukemia-2,0
14411,Classification of information,Adult Hepatocellular Carcinoma,0
14412,Data Change Date,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14413,Divide,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14414,Vomiting,Diffuse malignant mesothelioma,0
14415,Overall Publication Type,Non-Metastatic Gestational Trophoblastic Tumor,0
14416,Often - answer to question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14417,Short,Recurrent Uveal Melanoma,0
14418,Thyroid Gland,Lipoma of small intestine,0
14419,General surgery specialty,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14420,Examination,Digestive System Hodgkin Lymphoma,0
14421,Infrequent,Chondrosarcoma,0
14422,Biopsy,Blepharal carcinoma,0
14423,Intravascular line,Lipoma of small intestine,0
14424,Major,gliosarcoma,0
14425,Entity,Spermatocytic seminoma,0
14426,Upper arm,Testicular cancer metastatic,0
14427,Person Observer,Recurrent Testicular Lymphoma,0
14428,Cell Count,Extracranial Neuroblastoma,0
14429,Digestion,Metastatic Carcinoma in the Lung,0
14430,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14431,Skin Pigmentation,mucinous adenocarcinoma of gallbladder,0
14432,Brain Neoplasms,Diffuse malignant mesothelioma,0
14433,Exposure to radiation,Choroid Necrotic Melanoma,0
14434,Eyelid structure,Heavy Chain Deposition Disease,0
14435,Cerebral hemisphere structure (body structure),Mucinous cystadenofibroma,0
14436,Smear - instruction imperative,Stage III Adult Immunoblastic Lymphoma,0
14437,Mechanism (attribute),Female Breast Carcinoma,0
14438,Participation Type - origin,mucinous adenocarcinoma of gallbladder,0
14439,/hour,Stage III Adult Immunoblastic Lymphoma,0
14440,Absent,BRCA2 Syndrome,0
14441,Biopsy,Recurrent Uveal Melanoma,0
14442,Active,Malignant Testicular Sertoli Cell Tumor,0
14443,Function Axis,carcinoma of middle ear,0
14444,Debris,Extra-Adrenal Paraganglioma,0
14445,Body structure,Contact dermatitis due to alkali,0
14446,Population Group,Anterior Urethral Malignant Neoplasm,0
14447,Pancreas part,Human Papillomavirus-Related Carcinoma,0
14448,Cancer Other,Digestive System Hodgkin Lymphoma,0
14449,1+,Angiosarcoma of liver,0
14450,Chemotherapy,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14451,Cell Count,Benign Carotid Body Paraganglioma,0
14452,Bone structure of coccyx,Angiosarcoma of liver,0
14453,Grade,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
14454,50%,embryonal rhabdomyosarcoma of prostate,0
14455,Treating,Acute Undifferentiated Leukemia,0
14456,Appearance,Intestinal Neuroendocrine Carcinoma,0
14457,Feature,Extracranial Neuroblastoma,0
14458,Approach,Breast Ductal Adenoma,0
14459,Race,embryonal rhabdomyosarcoma of prostate,0
14460,classical example,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14461,Cause of death.secondary:Find:Pt:^Patient:Nom,Endometrial Small Cell Carcinoma,0
14462,Case (situation),Acute Undifferentiated Leukemia,0
14463,NCI CTEP SDC Salivary Gland Cancer Sub-Category Terminology,Recurrent Uveal Melanoma,0
14464,Firstly,Hodgkin lymphoma,0
14465,diagnosis aspect,Primary Cutaneous Plasmablastic Lymphoma,0
14466,Hematopoietic stem cells,Tonsillar Carcinoma,0
14467,Present,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14468,Germ-Line Mutation,Diffuse malignant mesothelioma,0
14469,Human body structure,Digestive System Hodgkin Lymphoma,0
14470,Central,Chronic Myelomonocytic Leukemia-2,0
14471,lead increased,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14472,United States,Anterior Urethral Malignant Neoplasm,0
14473,Example,Hodgkin lymphoma,0
14474,Antigens,malignant lymphoma of pancreatic lymph nodes,0
14475,Malignant neoplasm of brain,Intraepithelial Melanocytic Hyperplasia,0
14476,Concept Relationship,Human Papillomavirus-Related Carcinoma,0
14477,Filter (function),Mastocytosis,0
14478,Characteristics,Contact dermatitis due to alkali,0
14479,research subject screening,Localized Askin Tumor,0
14480,pharmacotherapeutic,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14481,Mesenchymal Cell Neoplasm,Malignant melanoma of eyelid,0
14482,Surgical patch,Refractory Glioma,0
14483,Treating,Localized Askin Tumor,0
14484,Psychotherapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14485,veterans alcoholism screening test (VAST),Diffuse malignant mesothelioma,0
14486,Biomaterial Treatment,squamous cell carcinoma of the thyroid gland,0
14487,Carcinoid Tumor,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14488,Intervention regimes,FIGO Stage II Ovarian Cancer,0
14489,Visual Accommodation,Testicular cancer metastatic,0
14490,incidence of cases,High Grade Glandular Intraepithelial Neoplasia,0
14491,Delayed Puberty,Cancer of Urinary Tract,0
14492,Neuroendocrine Tumors,Heavy Chain Deposition Disease,0
14493,Chief complaint (finding),Ovarian Carcinoid Tumor,0
14494,Behavior:-:Point in time:^Patient:-,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14495,Ovarian Carcinoma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14496,Line Specimen,Endometrial Small Cell Carcinoma,0
14497,Both kidneys,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14498,Togo,Ovarian germ cell choriocarcinoma stage IV,0
14499,Slow,Undifferentiated Neuroblastoma,0
14500,First (number),Lipoma of small intestine,0
14501,Upper arm,Giant cell angiofibroma,0
14502,Hodgkin Disease,Sarcomatoid Renal Cell Carcinoma,0
14503,Abdominal Cavity,embryonal rhabdomyosarcoma of prostate,0
14504,General surgery specialty,Testicular cancer metastatic,0
14505,Combined,Benign neoplasm of thorax,0
14506,Often - answer to question,Breast Ductal Adenoma,0
14507,research subject screening,FIGO Stage II Ovarian Cancer,0
14508,Out (direction),embryonal rhabdomyosarcoma of prostate,0
14509,Neoplasms,Anterior Urethral Malignant Neoplasm,0
14510,>5,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14511,List,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14512,Abnormal Cell Count,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14513,Country,Refractory Barrett Esophagus,0
14514,Fatigue,Diffuse malignant mesothelioma,0
14515,Patch Dosing Unit,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14516,Variety (taxon),Diffuse malignant mesothelioma,0
14517,Act Relationship Subset - previous,non-Hodgkin's lymphoma of spleen,0
14518,Bone Marrow,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14519,Manufactured sign,Colorectal cancer,0
14520,History of present illness,Lipoma of small intestine,0
14521,Surgical aspects,Undifferentiated Neuroblastoma,0
14522,Sacrococcygeal,Acantholytic squamous cell carcinoma,0
14523,Trachea,Cancer of Urinary Tract,0
14524,year,papillary carcinoma of penis,0
14525,Usually,Bladder squamous cell carcinoma stage I,0
14526,Therapeutic procedure,Leptomeningeal sarcoma,0
14527,Morning,Acantholytic squamous cell carcinoma,0
14528,Beginning,Benign tumor of eyelid,0
14529,Different,Female Breast Carcinoma,0
14530,Malaise,Mucinous adenocarcinoma gastric,0
14531,Fatal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14532,Myeloid Cells,Testicular cancer metastatic,0
14533,Negation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14534,status - In progress,Human Papillomavirus-Related Carcinoma,0
14535,Weight decreased,Advanced Uterine Corpus Carcinosarcoma,0
14536,Pathogenic organism,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
14537,Tobacco,Intracortical osteosarcoma,0
14538,Specific qualifier value,Adult Alveolar Soft Part Sarcoma,0
14539,Usual,Endometrial Small Cell Carcinoma,0
14540,Malignant Neoplasms,Neoplasms,0
14541,Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14542,Adenocarcinoma of pancreas,Mucinous adenocarcinoma gastric,0
14543,chronic,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14544,66,Neonatal leukemia,0
14545,Term (lexical),Intraepithelial Melanocytic Hyperplasia,0
14546,Portion of urine,mucinous adenocarcinoma of gallbladder,0
14547,Hereditary Diseases,Primary Cutaneous Plasmablastic Lymphoma,0
14548,Incomplete spinal cord injury,High Grade Glandular Intraepithelial Neoplasia,0
14549,Site,Mucinous adenocarcinoma gastric,0
14550,Reduction (chemical),Heavy Chain Deposition Disease,0
14551,Patient need for (contextual qualifier),Anterior Urethral Malignant Neoplasm,0
14552,Epithelial ovarian cancer,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14553,Occurrence,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14554,Genitalia,Childhood Lymphoma,0
14555,Leg,Adenocarcinoma,0
14556,T prime,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14557,Congenital Abnormality,Non-Metastatic Gestational Trophoblastic Tumor,0
14558,Tryptophanase,Methotrexate-Associated Hodgkin Lymphoma,0
14559,Application Dosing Unit,Pilocytic astrocytoma of cerebellum,0
14560,High Mitosis-Karyorrhexis Index,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14561,New bone formation (morphologic abnormality),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14562,Chemotherapy,non-Hodgkin's lymphoma of spleen,0
14563,*Type - Kind of quantity,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14564,Goes <invertebrate>,Intraepithelial Melanocytic Hyperplasia,0
14565,Aspects of disease screening,Stage IB Pancreatic Cancer AJCC v8,0
14566,Usually Need Help from Another Person for Arising,Breast Ductal Adenoma,0
14567,geographic population,Female Breast Carcinoma,0
14568,Vagina Carcinoma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14569,Occur (action),Methotrexate-Associated Hodgkin Lymphoma,0
14570,Usual Severity Weight Loss,Adult Alveolar Soft Part Sarcoma,0
14571,bony process,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
14572,1+ Score,Airway Hemangioma,0
14573,Glycation End Products,Grade 3a Malignant Neoplasm,0
14574,Halitosis,Ichthyosis,0
14575,Body tissue,Choroid Necrotic Melanoma,0
14576,Blood group antibody I,Diffuse malignant mesothelioma,0
14577,Definition,Childhood Thyroid Gland Follicular Carcinoma,0
14578,Often - answer to question,Stage IV Penile Cancer AJCC v7,0
14579,Therapeutic procedure,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14580,Chemicals,Maxillary Sinus Adenocarcinoma,0
14581,Acute lymphocytic leukemia,Undifferentiated Endocervical Sarcoma,0
14582,Hour Times Percent,Tonsillar Carcinoma,0
14583,Talpidae,Stage II Hepatocellular Carcinoma AJCC v8,0
14584,Skin Specimen,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
14585,Lesion,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14586,65,Ovarian Carcinoid Tumor,0
14587,Surface,Cartilaginous exostosis,0
14588,First sign,GIANT PIGMENTED HAIRY NEVUS,0
14589,IPSS Risk Category High,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14590,treatment - ActInformationManagementReason,Liver Lymphangioma,0
14591,Following,Childhood Lymphoma,0
14592,Papillary transitional cell carcinoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14593,Qualitative form,Childhood Fibrillary Astrocytoma,0
14594,Weight decreased,Granular Cell Leiomyosarcoma,0
14595,Antibody studies (procedure),Cerebral Primitive Neuroectodermal Tumor,0
14596,Frequently,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14597,United States Military Commissioned Officer O4,Digestive System Hodgkin Lymphoma,0
14598,Tumor cells,Neonatal leukemia,0
14599,Term (temporal),Rhabdomyosarcoma with ganglionic differentiation,0
14600,Presence (property),High Grade Glandular Intraepithelial Neoplasia,0
14601,Portion of urine,ALK positive large B-cell lymphoma,0
14602,LYMPHOID Cancers,Human Papillomavirus-Related Carcinoma,0
14603,Limb structure,Blepharal carcinoma,0
14604,International Classification of Diseases for Oncology,Unresectable Rhabdomyosarcoma,0
14605,Formation,Breast Ductal Adenoma,0
14606,60%,Mucinous adenocarcinoma gastric,0
14607,Spreading (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
14608,shared attribute,Childhood Fibrillary Astrocytoma,0
14609,Duplicate,Undifferentiated Endocervical Sarcoma,0
14610,American College of Cardiology/American Heart Association Lesion Complexity Score C,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14611,Disease Response,Adenocarcinoma of the prostate metastatic,0
14612,QPCT wt Allele,Recurrent Uveal Melanoma,0
14613,Lesion,Heavy Chain Deposition Disease,0
14614,Spreading (qualifier value),Liver Cavernous Hemangioma,0
14615,Science of Etiology,Childhood Choriocarcinoma,0
14616,Adult Rhabdomyosarcoma,Stage IV Penile Cancer AJCC v7,0
14617,include - SetOperator,Acute Undifferentiated Leukemia,0
14618,Family history,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14619,Proton Pump Inhibitors,Primary Cutaneous Plasmablastic Lymphoma,0
14620,Cells,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14621,Malignant neoplasm of lung,adenoid cystic carcinoma of lung,0
14622,Entity Determiner - specific,Platinum-Resistant Lung Small Cell Carcinoma,0
14623,ovarian,Stage I Adult Non-Hodgkin Lymphoma,0
14624,Classification,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14625,Dyspnea,Recurrent Testicular Lymphoma,0
14626,stage,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14627,Five-year Survival Rate,FIGO Stage II Ovarian Cancer,0
14628,Adult Angiosarcoma,Urethral Carcinoma,0
14629,Science of Statistics,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14630,Involvement with,Xeroderma pigmentosum,0
14631,Tube - unit dose,papillary carcinoma of penis,0
14632,Biological Response Modifier Therapy,Ichthyoses,0
14633,Lower (action),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14634,Case unit dose,Chronic Myelomonocytic Leukemia-2,0
14635,Primary malignant neoplasm,Ovarian Carcinoid Tumor,0
14636,Degree Unit of Plane Angle,Cancer of Urinary Tract,0
14637,Known,Collecting Duct Carcinoma of the Kidney,0
14638,Occurrence,Ichthyoses,0
14639,Science of Etiology,Testicular cancer metastatic,0
14640,Fresh (qualifier value),Chronic Myelomonocytic Leukemia-2,0
14641,BRCA2 protein,Refractory Barrett Esophagus,0
14642,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Uveal Melanoma,0
14643,First (number),Small cell neuroendocrine carcinoma of bladder,0
14644,Device system,Localized Ewing Sarcoma,0
14645,Unit device,Uterine Cancer,0
14646,Smear - instruction imperative,Extra-Adrenal Paraganglioma,0
14647,First (number),Human Papillomavirus-Related Carcinoma,0
14648,various antiseptic throat preparations,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14649,Round shape,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14650,described,Diffuse malignant mesothelioma,0
14651,Value Above Reference Range,Platinum-Resistant Lung Small Cell Carcinoma,0
14652,Extremely Agree,embryonal rhabdomyosarcoma of prostate,0
14653,Pharmacotherapy,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
14654,Chemotherapy Regimen,Acantholytic squamous cell carcinoma,0
14655,Coding,Intestinal Neuroendocrine Carcinoma,0
14656,Followed by,Childhood Lymphoma,0
14657,Condition,Diffuse malignant mesothelioma,0
14658,Cancer Genus,Undifferentiated Endocervical Sarcoma,0
14659,Disease remission,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14660,Lymphangitis,Xeroderma pigmentosum,0
14661,Reflux,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14662,800,Human Papillomavirus-Related Carcinoma,0
14663,Clone,Testicular cancer metastatic,0
14664,Make - Instruction Imperative,Female Breast Carcinoma,0
14665,Pregnancy,Neoplasms,0
14666,Optical filter,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
14667,Tumor Mass,Stage III Adult Immunoblastic Lymphoma,0
14668,Long Variable,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14669,Primary malignant neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
14670,Cause of death:Find:Pt:^Patient:Nom,embryonal rhabdomyosarcoma of prostate,0
14671,Feel Tired question,Stage IB Pancreatic Cancer AJCC v8,0
14672,Main,Hemangioma,0
14673,Percent (qualifier value),Colorectal Neuroendocrine Tumor G2,0
14674,70%,Endometrial Small Cell Carcinoma,0
14675,Cell Count,Primary Cutaneous Plasmablastic Lymphoma,0
14676,Rare,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14677,Smear - instruction imperative,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14678,Tumor Mass,Blepharal carcinoma,0
14679,Approximate,Adenocarcinoma,0
14680,treatment - ActInformationManagementReason,Stage I Adult Non-Hodgkin Lymphoma,0
14681,Breast Cancer Type 1 Susceptibility Protein Measurement,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14682,contextual factors,Malignant Testicular Sertoli Cell Tumor,0
14683,Milliampere second,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14684,To,Tonsillar Carcinoma,0
14685,Geographic Locations,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14686,Squamous cell carcinoma of skin,Intestinal Metaplasia of Bladder Urothelium,0
14687,More,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14688,Malignant Neoplasms,Childhood Fibrillary Astrocytoma,0
14689,diagnosis aspect,Cerebral Primitive Neuroectodermal Tumor,0
14690,Tumor cells,Malignant Testicular Sertoli Cell Tumor,0
14691,Lymphocyte,Tonsillar Carcinoma,0
14692,Sacrococcygeal teratoma,Cerebral Primitive Neuroectodermal Tumor,0
14693,*Type - Kind of quantity,Benign Apocrine Neoplasm,0
14694,various antiseptic throat preparations,Cerebral Primitive Neuroectodermal Tumor,0
14695,In Blood,Stage IB Pancreatic Cancer AJCC v8,0
14696,Coding,Metastatic Ductal Breast Carcinoma,0
14697,Array Feature,Cancer of Urinary Tract,0
14698,Males,Undifferentiated Neuroblastoma,0
14699,Appearance Distress Question,Extracranial Neuroblastoma,0
14700,Logical Condition,Anaplastic large cell lymphoma,0
14701,Treating,Childhood Fibrillary Astrocytoma,0
14702,foreign,embryonal rhabdomyosarcoma of prostate,0
14703,Painless,Cerebral Primitive Neuroectodermal Tumor,0
14704,Severities,Acantholytic squamous cell carcinoma,0
14705,Physical shape,Neoplasms,0
14706,Togo,Ovarian germ cell choriocarcinoma stage IV,0
14707,Frequently,Endometrial Small Cell Carcinoma,0
14708,Malignant neoplasm of penis,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14709,One,Colorectal High Grade B-Cell Lymphoma,0
14710,survival aspects,Recurrent Testicular Lymphoma,0
14711,Acquired Name,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
14712,Occurrence,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14713,Direct (qualifier),Benign tumor of eyelid,0
14714,How Much Distress Weight Loss,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
14715,Human Age Group,Hemangioma,0
14716,Unintentional,Stage IB Lung Cancer AJCC v7,0
14717,Device system,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14718,Cavitation,Mucinous adenocarcinoma gastric,0
14719,Epidermal cells,Colorectal cancer,0
14720,Eighth,Leiomyoma of Gallbladder,0
14721,Endometrial scraping,Maxillary Sinus Adenocarcinoma,0
14722,Include (action),embryonal rhabdomyosarcoma of prostate,0
14723,NCI CTEP SDC Melanoma Sub-Category Terminology,Chondrosarcoma,0
14724,Area,Breast Ductal Adenoma,0
14725,Classification,Mucinous adenocarcinoma gastric,0
14726,Disorder of cellular component of blood,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14727,Abnormal Reference Range,Uterine Cancer,0
14728,Well Differentiated,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14729,Malignant neoplasm of lung,Localized Ewing Sarcoma,0
14730,Lower urinary tract infectious disease,Malignant melanoma of eyelid,0
14731,Inhibition,Undifferentiated Endocervical Sarcoma,0
14732,Adult,Giant cell angiofibroma,0
14733,AS virus,Cancer of Urinary Tract,0
14734,Leading,Thymic Clear Cell Carcinoma,0
14735,Negation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14736,Fertility Agents,Tonsillar Carcinoma,0
14737,Scientific Publication,Stage IB Pancreatic Cancer AJCC v8,0
14738,Current (present time),adenoid cystic carcinoma of lung,0
14739,shared attribute,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14740,Primary malignant neoplasm,Benign neoplasm of thorax,0
14741,Intravenous,Lipoma of small intestine,0
14742,Larynx,Grade 1 Clear Cell Renal Cell Carcinoma,0
14743,Medical History,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14744,Agent,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
14745,Unit of radiation dose,Carcinoma of urinary bladder,0
14746,Continuance of life,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14747,Lichenification,Mucinous adenocarcinoma gastric,0
14748,Obesity,Acute Undifferentiated Leukemia,0
14749,Togo,Leptomeningeal sarcoma,0
14750,65+,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14751,Infective cystitis,Placental aromatase deficiency,0
14752,More Often than Once a Day,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14753,Negation,Anterior Urethral Malignant Neoplasm,0
14754,Frequently,Clonal Hematopoiesis of Indeterminate Potential,0
14755,Complex,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14756,Cataract,Small cell neuroendocrine carcinoma of bladder,0
14757,Occurrence,Medulloblastoma,0
14758,Symptoms aspect,Cerebral Primitive Neuroectodermal Tumor,0
14759,Study Variable,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14760,Diagnosis,Collecting Duct Carcinoma of the Kidney,0
14761,classical example,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14762,Malignant Neoplasms,malignant lymphoma of pancreatic lymph nodes,0
14763,Extreme,Anterior Urethral Malignant Neoplasm,0
14764,Bodily secretions,Liver Lymphangioma,0
14765,Hematopoietic stem cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14766,Body tissue,Serous cystadenocarcinoma ovary,0
14767,Greater than one,Heavy Chain Deposition Disease,0
14768,Surface of cervix,Refractory Barrett Esophagus,0
14769,Throat,Angiosarcoma of liver,0
14770,Malignant Head and Neck Neoplasm,Adult Hepatocellular Carcinoma,0
14771,Spreading (qualifier value),Lipoma of small intestine,0
14772,Vasculature,Extracranial Neuroblastoma,0
14773,N not otherwise specified Antibody,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14774,Deep (qualifier value),Undifferentiated Endocervical Sarcoma,0
14775,Kidney,Unresectable Rhabdomyosarcoma,0
14776,Cessation of life,Breast Ductal Adenoma,0
14777,Disease,Larynx carcinoma recurrent,0
14778,Cell Proliferation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14779,Hematoxylin and eosin stain method,Acantholytic squamous cell carcinoma,0
14780,Encounter due to being a donor,Xeroderma pigmentosum,0
14781,<3 (qualifier value),Liver Lymphangioma,0
14782,1+,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14783,Elements,Werner Syndrome,0
14784,Talpidae,Diffuse malignant mesothelioma,0
14785,shared attribute,Neoplasms,0
14786,Risk,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14787,Reference Object,Intracortical osteosarcoma,0
14788,Country number,Chronic Myelomonocytic Leukemia-2,0
14789,System (unit of presentation),Medulloblastoma,0
14790,Cell Count,Mucinous cystadenofibroma,0
14791,Always (frequency),Chronic Myelomonocytic Leukemia-2,0
14792,75,FIGO Stage II Ovarian Cancer,0
14793,Chromosomal deoxyribonucleic acid,Ovarian germ cell choriocarcinoma stage IV,0
14794,Response to treatment,Stage II Carcinoma of Penis,0
14795,intrathecal chemotherapy,Benign Carotid Body Paraganglioma,0
14796,% volume (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
14797,Major <insect>,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14798,Medulla,adenoid cystic carcinoma of lung,0
14799,Cell Count,Clonal Hematopoiesis of Indeterminate Potential,0
14800,Nervous system structure,Primary Cutaneous Plasmablastic Lymphoma,0
14801,Most,High Grade Glandular Intraepithelial Neoplasia,0
14802,Rate,FIGO Stage II Ovarian Cancer,0
14803,health and disease,Recurrent Testicular Lymphoma,0
14804,Including (qualifier),Intestinal Metaplasia of Bladder Urothelium,0
14805,Microbial anatomical capsule structure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14806,Sunlight,Female Breast Carcinoma,0
14807,Condition,Pilocytic astrocytoma of cerebellum,0
14808,Metastatic Neoplasm,Childhood Fibrillary Astrocytoma,0
14809,Diagnosis Study,Metastatic Ductal Breast Carcinoma,0
14810,Period (temporal qualifier),Leptomeningeal sarcoma,0
14811,Pruritus,Stage 0 Lip Carcinoma,0
14812,Back structure,Spongiotic dermatitis,0
14813,All extremities,Papillary cystic tumor,0
14814,Relative Survival,Diffuse malignant mesothelioma,0
14815,Togo,Non-Metastatic Gestational Trophoblastic Tumor,0
14816,Subtype (attribute),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14817,Specific qualifier value,Malignant melanoma of eyelid,0
14818,Hyperlink,Acantholytic squamous cell carcinoma,0
14819,Sexual function,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14820,Sustained,Giant cell angiofibroma,0
14821,Life Expectancy Less than Twenty Years,Mucinous adenocarcinoma gastric,0
14822,Therapy Object (animal model),Intraepithelial Melanocytic Hyperplasia,0
14823,Cerebellum,Liver Lymphangioma,0
14824,shared attribute,BRCA2 Syndrome,0
14825,Light Emitting Diode Device,Cerebral Primitive Neuroectodermal Tumor,0
14826,intent,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14827,/40,Intestinal Neuroendocrine Carcinoma,0
14828,site-specific telomere resolvase activity,Refractory Barrett Esophagus,0
14829,Percent inhibition,Adult Hepatocellular Carcinoma,0
14830,Fibrous papule of nose,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14831,Decision,Small cell neuroendocrine carcinoma of bladder,0
14832,Immune system,Malignant Testicular Sertoli Cell Tumor,0
14833,Packaging Case,Uterine Cancer,0
14834,Qualitative form,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14835,Age at diagnosis:Time:Pt:^Patient:Qn,Ichthyosis,0
14836,Anorexia,Hemangioma,0
14837,Diffuse malignant lymphoma - centroblastic-centrocytic,mucinous adenocarcinoma of gallbladder,0
14838,Males,Uterine Cancer,0
14839,Removing (action),Undifferentiated Endocervical Sarcoma,0
14840,treatment options,Benign tumor of eyelid,0
14841,Improvement,Anaplastic large cell lymphoma,0
14842,High risk,Granular Cell Leiomyosarcoma,0
14843,Patients,Benign Apocrine Neoplasm,0
14844,To,benign mature teratoma of pancreas,0
14845,Edema,Serous cystadenocarcinoma ovary,0
14846,Tears body substance,Neonatal leukemia,0
14847,Second Suffix,Advanced Uterine Corpus Carcinosarcoma,0
14848,Malignant Neoplasms,Childhood Fibrillary Astrocytoma,0
14849,Cauda Equina,Stage IB Pancreatic Cancer AJCC v8,0
14850,Physical assessment findings,Atypical Lobular Breast Hyperplasia,0
14851,Unmarried,Diffuse malignant mesothelioma,0
14852,radiotherapeutic,Adult Hepatocellular Carcinoma,0
14853,Primary malignant neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
14854,Recommendation,Intestinal Metaplasia of Bladder Urothelium,0
14855,Floor - story of building,Giant cell angiofibroma,0
14856,seen,Giant cell angiofibroma,0
14857,Head and neck structure,Metastatic Carcinoma in the Lung,0
14858,Additional,Childhood Fibrillary Astrocytoma,0
14859,Mesenchymal Stem Cells,de novo Myelodysplastic Syndrome,0
14860,A Codes,Intraepithelial Melanocytic Hyperplasia,0
14861,Precision - second,Intraepithelial Melanocytic Hyperplasia,0
14862,Usually Need Help from Another Person for Arising,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14863,RBM12 gene,Neonatal leukemia,0
14864,Bladder Neoplasm,Acute Undifferentiated Leukemia,0
14865,Malignant Neoplasms,Medulloblastoma,0
14866,2+ Score,Locally Advanced Soft Tissue Sarcoma,0
14867,Inguinal region,Recurrent Uveal Melanoma,0
14868,Affecting,Acantholytic squamous cell carcinoma,0
14869,Undescended testis (body structure),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14870,Administrative Division,Cerebral Primitive Neuroectodermal Tumor,0
14871,Life Expectancy Less than Ten Years,Stage III Adult Immunoblastic Lymphoma,0
14872,Skin Specimen,adenoid cystic carcinoma of lung,0
14873,Lymphoma,Small cell neuroendocrine carcinoma of bladder,0
14874,Entity Determiner - specific,BRCA2 Syndrome,0
14875,Use of,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14876,*Type - Kind of quantity,Thymoma malignant recurrent,0
14877,morphological,Uterine Cancer,0
14878,Hormone (disposition),Thymic Clear Cell Carcinoma,0
14879,True Control Status,Intraepithelial Melanocytic Hyperplasia,0
14880,Congenital melanocytic nevus,Pilocytic astrocytoma of cerebellum,0
14881,High risk of,Spongiotic dermatitis,0
14882,Possible diagnosis,Human Papillomavirus-Related Carcinoma,0
14883,Anaphylactic shock,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14884,Removal of bladder,Undifferentiated Endocervical Sarcoma,0
14885,Often - answer to question,Acantholytic squamous cell carcinoma,0
14886,Chemotherapy Regimen,Mucinous neoplasm,0
14887,Loss,embryonal rhabdomyosarcoma of prostate,0
14888,Involvement with,Grade 3a Malignant Neoplasm,0
14889,Tests (qualifier value),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14890,Geographic Locations,Familial Adenomatous Polyposis Associated Medulloblastoma,0
14891,Poor - qualifier,Endometrial Small Cell Carcinoma,0
14892,Togo,Hodgkin lymphoma,0
14893,Referring,Localized Ewing Sarcoma,0
14894,Antibodies,Recurrent Testicular Lymphoma,0
14895,Page (document),Locally Advanced Soft Tissue Sarcoma,0
14896,Primary malignant neoplasm,Metastatic Carcinoma in the Lung,0
14897,Skin,Primary Cutaneous Plasmablastic Lymphoma,0
14898,Filters,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14899,Prognosis bad,Childhood Fibrillary Astrocytoma,0
14900,Carcinoma,BRCA2 Syndrome,0
14901,Skin cell,Choroid Necrotic Melanoma,0
14902,Classification of information,Unresectable Rhabdomyosarcoma,0
14903,Tip,Recurrent Testicular Lymphoma,0
14904,Malignant Neoplasms,Acantholytic squamous cell carcinoma,0
14905,Aggressive Non-Hodgkin Lymphoma,Malignant melanoma of eyelid,0
14906,Separate,Anterior Urethral Malignant Neoplasm,0
14907,Basis,papillary carcinoma of penis,0
14908,Ability,Stage III Adult Immunoblastic Lymphoma,0
14909,Germ cell tumor,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14910,Myasthenia Gravis,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14911,Publications,Clonal Hematopoiesis of Indeterminate Potential,0
14912,Diagnosis,Giant cell angiofibroma,0
14913,Assisted (qualifier value),Adult Hepatocellular Carcinoma,0
14914,Skin Erosion,Stage 0 Lip Carcinoma,0
14915,Pharmacotherapy,Undifferentiated Endocervical Sarcoma,0
14916,Cell of Claudius,Metastatic Neoplasm to the Gallbladder,0
14917,Lymphocyte component of blood,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14918,Blood,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14919,various other agents for local oral treatment in ATC,Bladder squamous cell carcinoma stage I,0
14920,Pediatric,Urethral Carcinoma,0
14921,Northern Europe,Tonsillar Carcinoma,0
14922,status - In progress,Recurrent Uveal Melanoma,0
14923,Carcinoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14924,More,Acute Undifferentiated Leukemia,0
14925,*Type - Kind of quantity,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14926,Possible,Recurrent Uveal Melanoma,0
14927,Person Observer,Stage II Hepatocellular Carcinoma AJCC v8,0
14928,In Urine,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14929,Childhood Non-Hodgkin Lymphoma,Localized Ewing Sarcoma,0
14930,Including (qualifier),Liver Lymphangioma,0
14931,Tired,BRCA2 Syndrome,0
14932,Case (situation),Recurrent Uveal Melanoma,0
14933,Combined,Female Breast Carcinoma,0
14934,Females,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14935,Complete Agreement,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14936,Changed status,Intraepithelial Melanocytic Hyperplasia,0
14937,Collection (action),Digestive System Hodgkin Lymphoma,0
14938,Intercellular Junctions,Bladder squamous cell carcinoma stage I,0
14939,Arising,Malignant Neoplasm with Regional Lymph Node Involvement,0
14940,Cartilage,Recurrent Uveal Melanoma,0
14941,Common Specifications in HL7 V3 Publishing,Human Papillomavirus-Related Carcinoma,0
14942,Form:Finding:Point in time:{Setting}:Document:{Role},Testicular cancer metastatic,0
14943,Malignant Neoplasms,Chronic Myelomonocytic Leukemia-2,0
14944,Symptoms,Ovarian Carcinoid Tumor,0
14945,How Much Distress Weight Loss,Cerebral Primitive Neuroectodermal Tumor,0
14946,year,Undifferentiated Endocervical Sarcoma,0
14947,Hematological Disease,Hodgkin lymphoma,0
14948,SERPINA3 protein,Uterine Cancer,0
14949,Referring,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14950,Value Above Reference Range,Recurrent Testicular Lymphoma,0
14951,Tryptophanase,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14952,Contents,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14953,Late stage,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14954,Frequently,embryonal rhabdomyosarcoma of prostate,0
14955,Then,Localized Askin Tumor,0
14956,Manufactured form,Malignant Neoplasm with Regional Lymph Node Involvement,0
14957,Skin Pigmentation,Mucinous adenocarcinoma gastric,0
14958,Tract,FIGO Stage II Ovarian Cancer,0
14959,Skin,Adult Hepatocellular Carcinoma,0
14960,Bladder Cancer Pathway,FIGO Stage II Ovarian Cancer,0
14961,mucus layer,FIGO Stage II Ovarian Cancer,0
14962,Pentaerythritol Tetranitrate,Mucinous cystadenofibroma,0
14963,Affecting,Low Grade Squamous Intraepithelial Neoplasia,0
14964,Geographic state,Acute lymphadenitis,0
14965,Bloating,FIGO Stage II Ovarian Cancer,0
14966,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Recurrent Uveal Melanoma,0
14967,Stomach structure,non-Hodgkin's lymphoma of spleen,0
14968,Spreading (qualifier value),Testicular cancer metastatic,0
14969,3+ Score,Undifferentiated Neuroblastoma,0
14970,Cells,Metastatic Ductal Breast Carcinoma,0
14971,Polyp of large intestine,embryonal rhabdomyosarcoma of prostate,0
14972,Fever symptoms (finding),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14973,Malignant Neoplasms,Fourth Ventricle and Brain Stem Ependymal Tumor,0
14974,Chemotherapy,Xeroderma pigmentosum,0
14975,factor A,Intraepithelial Melanocytic Hyperplasia,0
14976,How Much Distress Itching,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
14977,Intraepithelial Neoplasia,Diffuse malignant mesothelioma,0
14978,Poor appetite question,Adult Brain Stem Mixed Glioma,0
14979,Neonatal (qualifier value),Liver Lymphangioma,0
14980,Human body structure,BRCA2 Syndrome,0
14981,Poor - qualifier,Lung squamous cell carcinoma stage I,0
14982,Valid,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14983,Epithelial cell count (procedure),Ovarian Carcinoid Tumor,0
14984,Reduced,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14985,Often - answer to question,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14986,Known,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14987,Occur (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14988,Morphology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14989,Malignant neoplasm of penis,Refractory Barrett Esophagus,0
14990,1000000,adenosquamous carcinoma of breast,0
14991,Carcinoid Tumor,Larynx carcinoma recurrent,0
14992,Females,Acute Undifferentiated Leukemia,0
14993,Location,gliosarcoma,0
14994,Thin (qualifier value),Stage 0 Lip Carcinoma,0
14995,Primary malignant neoplasm,Mucinous adenocarcinoma gastric,0
14996,treatment - ActInformationManagementReason,Thymic Clear Cell Carcinoma,0
14997,Immunoglobulins,Airway Hemangioma,0
14998,Dietary Lead,Angiosarcoma of liver,0
14999,Event Seriousness - Significant,Leptomeningeal sarcoma,0
15000,Molecular Mass,Human Papillomavirus-Related Carcinoma,0
15001,Attenuation,Urethral Carcinoma,0
15002,Body part,Carcinoma of urinary bladder,0
15003,Childhood Hodgkin Lymphoma,Angiosarcoma of liver,0
15004,Urinary Diversion,Endometrial Small Cell Carcinoma,0
15005,Chest Wall Pain,FIGO Stage II Ovarian Cancer,0
15006,Viral,Ovarian germ cell choriocarcinoma stage IV,0
15007,55,Undifferentiated Endocervical Sarcoma,0
15008,Used by,Cancer of Urinary Tract,0
15009,Retarded,Childhood Fibrillary Astrocytoma,0
15010,Either,Placental aromatase deficiency,0
15011,Chemotherapy,Recurrent Uveal Melanoma,0
15012,Image Feature,Stage IB Pancreatic Cancer AJCC v8,0
15013,peripheral blood,Malignant Neoplasm with Regional Lymph Node Involvement,0
15014,Usual,Colorectal High Grade B-Cell Lymphoma,0
15015,Term (lexical),Xeroderma pigmentosum,0
15016,Classification of information,High Grade Glandular Intraepithelial Neoplasia,0
15017,3+ Answer to Question,Ovarian germ cell choriocarcinoma stage IV,0
15018,Screening,Mucinous adenocarcinoma gastric,0
15019,Bone Marrow,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15020,Pharmacotherapy,embryonal rhabdomyosarcoma of prostate,0
15021,TNFRSF8 Positive,Adult Hepatocellular Carcinoma,0
15022,Name,Metastatic Lung Small Cell Carcinoma,0
15023,Include (action),Stage I Adult Non-Hodgkin Lymphoma,0
15024,Singular,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15025,Latin America,Malignant melanoma of eyelid,0
15026,Laboratory Procedures,Childhood Lymphoma,0
15027,Lung,Recurrent Uveal Melanoma,0
15028,Type - attribute,Undifferentiated Neuroblastoma,0
15029,P-Glycoprotein,Primary Cutaneous Plasmablastic Lymphoma,0
15030,Contract agreement,Endometrial Small Cell Carcinoma,0
15031,General surgery specialty,Adenocarcinoma,0
15032,SLC6A2 protein,embryonal rhabdomyosarcoma of prostate,0
15033,Pain,Larynx carcinoma recurrent,0
15034,Triggered by,Extra-Adrenal Paraganglioma,0
15035,United States,Cancer of Urinary Tract,0
15036,Decision,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15037,To,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15038,Pathogenic organism,Blepharal carcinoma,0
15039,Numbers,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15040,Medical service,BRCA2 Syndrome,0
15041,adnexal mass,High Grade Glandular Intraepithelial Neoplasia,0
15042,Reciprocal translocation,Female Breast Carcinoma,0
15043,Intravascular line,Malignant Testicular Sertoli Cell Tumor,0
15044,Blast Cell,Metastatic Ductal Breast Carcinoma,0
15045,Pancreatic carcinoma,Malignant melanoma of eyelid,0
15046,Include (action),Thymic Atypical Carcinoid Tumor,0
15047,History of - blood transfusion,squamous cell carcinoma of the thyroid gland,0
15048,Occurrence Indicator,Localized Ewing Sarcoma,0
15049,Science of Etiology,Leiomyoma of Gallbladder,0
15050,per year,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15051,Net (qualifier),Low Grade Squamous Intraepithelial Neoplasia,0
15052,Call (Instruction),adenosquamous carcinoma of breast,0
15053,Early,gliosarcoma,0
15054,Therapeutic procedure,Localized Ewing Sarcoma,0
15055,United States,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15056,Standard (qualifier),Breast Ductal Adenoma,0
15057,Investigative Subject,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15058,Incidence,Malignant neoplasm of thalamus,0
15059,Infected,Benign tumor of eyelid,0
15060,Bladder Continence Question,Xeroderma pigmentosum,0
15061,Head,squamous cell carcinoma of the thyroid gland,0
15062,Occur (action),Uterine Cancer,0
15063,Specimen Source Codes - tumor,Cartilaginous exostosis,0
15064,Case (situation),Recurrent Testicular Lymphoma,0
15065,Science of Etiology,Fourth Ventricle and Brain Stem Ependymal Tumor,0
15066,Pure Spanish horse breed (organism),BRCA2 Syndrome,0
15067,Cardiac Lead Procedure,Malignant Neoplasm of Lung - Multiple Primary Sites,0
15068,Source,Airway Hemangioma,0
15069,Cancer Genus,Metastatic Kidney Carcinoma,0
15070,Epithelial ovarian cancer,Tonsillar Carcinoma,0
15071,Recombinant Erythropoietin,Adult Alveolar Soft Part Sarcoma,0
15072,diagnosis aspect,Diffuse malignant mesothelioma,0
15073,Weight Loss,Neoplasms,0
15074,Location of Pharyngeal Residue Following Swallowing,Rhabdomyosarcoma with ganglionic differentiation,0
15075,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15076,Gene Cluster Text Format,Localized Ewing Sarcoma,0
15077,Injury due to exposure to external cause,Maxillary Sinus Adenocarcinoma,0
15078,Healthy,Cerebral Primitive Neuroectodermal Tumor,0
15079,risk factors - observation list,Undifferentiated Endocervical Sarcoma,0
15080,70%,Female Breast Carcinoma,0
15081,Neoplasms,Recurrent Testicular Lymphoma,0
15082,Experimental Result,Lung squamous cell carcinoma stage I,0
15083,Widening,Childhood Fibrillary Astrocytoma,0
15084,United States,Stage IB Lung Cancer AJCC v7,0
15085,Include (action),Benign neoplasm of thorax,0
15086,Medical Imaging,Mucinous adenocarcinoma gastric,0
15087,Device system,Liver Cavernous Hemangioma,0
15088,Organ,Breast Ductal Adenoma,0
15089,Major <insect>,Airway Hemangioma,0
15090,Context,Larynx carcinoma recurrent,0
15091,Does stand alone,Medulloblastoma,0
15092,foreign,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15093,week,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15094,Before,Medulloblastoma,0
15095,How Often Vomiting,Liver Lymphangioma,0
15096,Limited stage (cancer stage),Noninfiltrating Intraductal Carcinoma,0
15097,Including (qualifier),Stage I Adult Non-Hodgkin Lymphoma,0
15098,True primary (qualifier value),Benign neoplasm of thorax,0
15099,Adult Diffuse Large B-Cell Lymphoma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15100,Structure of spermatogenic epithelium,Human Papillomavirus-Related Carcinoma,0
15101,Condition,Primary Cutaneous Plasmablastic Lymphoma,0
15102,Result,Small cell neuroendocrine carcinoma of bladder,0
15103,Blood,Diffuse malignant mesothelioma,0
15104,Age,Unresectable Rhabdomyosarcoma,0
15105,Three,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15106,Alternative,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
15107,More,Medulloblastoma,0
15108,Pharmacotherapy,Uterine Cancer,0
15109,Architecture,Ichthyoses,0
15110,Breast,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15111,high throughput analysis,Extra-Adrenal Paraganglioma,0
15112,Australia,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15113,International Statistical Classification of Diseases and Related Health Problems,Anterior Urethral Malignant Neoplasm,0
15114,Experimental Result,Primary Cutaneous Plasmablastic Lymphoma,0
15115,Exposure to,Cerebral Primitive Neuroectodermal Tumor,0
15116,High,FIGO Stage II Ovarian Cancer,0
15117,What subject filter - Result,Anterior Urethral Malignant Neoplasm,0
15118,Type - attribute,Colorectal cancer,0
15119,Group A (qualifier value),Benign neoplasm of thorax,0
15120,Severe (severity modifier),Xeroderma pigmentosum,0
15121,Vision:-:Point in time:^Patient:-,Metastatic Neoplasm to the Gallbladder,0
15122,Thought,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15123,Epithelium,Digestive System Hodgkin Lymphoma,0
15124,Feelings,Medulloblastoma,0
15125,Tumor Mass,Benign Carotid Body Paraganglioma,0
15126,Granulomatous,Xeroderma pigmentosum,0
15127,Pharmacotherapy,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15128,Management Occupations,Ovarian germ cell choriocarcinoma stage IV,0
15129,Ethanol,Adenocarcinoma,0
15130,Dyspnea,Acute Undifferentiated Leukemia,0
15131,Aspects of signs,Endometrial Small Cell Carcinoma,0
15132,Therapeutic radiology procedure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
15133,Radiation Ionizing Radiotherapy,Stage II Hepatocellular Carcinoma AJCC v8,0
15134,Breast,Digestive System Hodgkin Lymphoma,0
15135,Cell Count,Stage IV Childhood Non-Hodgkin Lymphoma,0
15136,Surgical aspects,BRCA2 Syndrome,0
15137,year,Uterine Cancer,0
15138,Term (temporal),Clonal Hematopoiesis of Indeterminate Potential,0
15139,Common Specifications in HL7 V3 Publishing,Ovarian Carcinoid Tumor,0
15140,Cessation of life,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15141,suggestion,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15142,Record - QueryRequestLimit,Carcinoma of urinary bladder,0
15143,Associated topography,Blepharal carcinoma,0
15144,American College of Cardiology/American Heart Association Lesion Complexity Score C,Xeroderma pigmentosum,0
15145,Additional,BRCA2 Syndrome,0
15146,Increase,Thymoma malignant recurrent,0
15147,Specimen Source Codes - tumor,papillary carcinoma of penis,0
15148,Involvement with,Stage IB Pancreatic Cancer AJCC v8,0
15149,Infection,Pancreatic Intraepithelial Neoplasia-3,0
15150,ATG5 wt Allele,Anterior Urethral Malignant Neoplasm,0
15151,Squamous cell carcinoma - category,Recurrent Testicular Lymphoma,0
15152,Contribution,Stage IV Penile Cancer AJCC v7,0
15153,Purple,Noninfiltrating Intraductal Carcinoma,0
15154,Type A,Werner Syndrome,0
15155,Life threatening - Event Consequence,Intraepithelial Melanocytic Hyperplasia,0
15156,Sometimes,Malignant Testicular Sertoli Cell Tumor,0
15157,Medical service,Thymic Atypical Carcinoid Tumor,0
15158,Version (morphologic abnormality),Stage II Carcinoma of Penis,0
15159,trauma qualifier,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15160,status - In progress,Hemangioma,0
15161,Benign,Pancreatic Intraepithelial Neoplasia-3,0
15162,Concept History,Deep Leiomyoma,0
15163,gene therapy,Primary Cutaneous Plasmablastic Lymphoma,0
15164,Result,sarcoma of spinal cord,0
15165,Conventional (Clear Cell) Renal Cell Carcinoma,Diffuse malignant mesothelioma,0
15166,Lymphoma,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
15167,Sometimes,Intestinal Metaplasia of Bladder Urothelium,0
15168,Overall Publication Type,Chondrosarcoma,0
15169,Pediculus (eukaryote),Childhood Fibrillary Astrocytoma,0
15170,Blood Vessel,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
15171,Exposure to,Human Papillomavirus-Related Carcinoma,0
15172,Object Relationship,Unresectable Rhabdomyosarcoma,0
15173,Leading,Thymic Atypical Carcinoid Tumor,0
15174,Tumor site:Anat:Pt:Specimen:Nom,Refractory Barrett Esophagus,0
15175,Most,Unfavorable Non-Hodgkin Lymphoma,0
15176,Remaining,Mucinous adenocarcinoma gastric,0
15177,Secondary Neoplasm,Bladder squamous cell carcinoma stage I,0
15178,Malignant Neoplasms,Stage IV Penile Cancer AJCC v7,0
15179,Mechanism (attribute),Neoplasms,0
15180,Death (finding),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15181,Tissue specific,Recurrent Uveal Melanoma,0
15182,1000000,Collecting Duct Carcinoma of the Kidney,0
15183,Malignant Neoplasms,Breast Ductal Adenoma,0
15184,Flank Pain,Giant cell angiofibroma,0
15185,Epitopes,Recurrent Testicular Lymphoma,0
15186,Diagnosis Study,Lung squamous cell carcinoma stage I,0
15187,Adult Non-Hodgkin Lymphoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15188,Including (qualifier),Cancer of Urinary Tract,0
15189,Frequently,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15190,Class,Adult Alveolar Soft Part Sarcoma,0
15191,Affecting,High Grade Glandular Intraepithelial Neoplasia,0
15192,Smaller,Digestive System Hodgkin Lymphoma,0
15193,Cellular infiltrate,Childhood Fibrillary Astrocytoma,0
15194,various allergen extracts,Platinum-Resistant Lung Small Cell Carcinoma,0
15195,Manufactured form,Cerebral hemangioma,0
15196,Skin lesion,ALK positive large B-cell lymphoma,0
15197,Greater than one,Metastatic Lung Small Cell Carcinoma,0
15198,Stop (Instruction Imperative),embryonal rhabdomyosarcoma of prostate,0
15199,Primary,Bladder squamous cell carcinoma stage I,0
15200,Chemotherapy Regimen,Spongiotic dermatitis,0
15201,Microscopes,embryonal rhabdomyosarcoma of prostate,0
15202,Body Site Modifier - Lower,Malignant neoplasm of thalamus,0
15203,Period (temporal qualifier),Medulloblastoma,0
15204,PFDN5 gene,Liver Lymphangioma,0
15205,Certain (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
15206,Affecting,Recurrent Testicular Lymphoma,0
15207,Eighth,Endometrial Small Cell Carcinoma,0
15208,Death Related to Adverse Event,Recurrent Uveal Melanoma,0
15209,How Often Itching,FIGO Stage II Ovarian Cancer,0
15210,Chemotherapy,Mucinous adenocarcinoma gastric,0
15211,Include (action),Adult Fibrolamellar Carcinoma,0
15212,Treating,Colorectal High Grade B-Cell Lymphoma,0
15213,Entity Name Part Qualifier - birth,Stage IB Pancreatic Cancer AJCC v8,0
15214,unknown vaccine or immune globulin,Pancreatic Intraepithelial Neoplasia-3,0
15215,product,Intracortical osteosarcoma,0
15216,Occurrence,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15217,Hereditary,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15218,Mathematical Operator,Bladder squamous cell carcinoma stage I,0
15219,Enzymes,squamous cell carcinoma of the thyroid gland,0
15220,Referring,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15221,Skin fold,gliosarcoma,0
15222,various allergen extracts,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15223,>90,FIGO Stage II Ovarian Cancer,0
15224,Pharmacotherapy,Advanced Lung Carcinoma,0
15225,Take,Childhood Fibrillary Astrocytoma,0
15226,Microplate Well,Heavy Chain Deposition Disease,0
15227,One,Lipoma of small intestine,0
15228,Diagnosis,Low Grade Squamous Intraepithelial Neoplasia,0
15229,Out (direction),Breast Ductal Adenoma,0
15230,Divide,Benign Apocrine Neoplasm,0
15231,Pediculus (eukaryote),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15232,SLC35G1 gene,BRCA2 Syndrome,0
15233,Characterization,Thymic Atypical Carcinoid Tumor,0
15234,Treatment Epoch,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15235,inflammatory,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15236,What subject filter - Result,Benign tumor of eyelid,0
15237,Sternum,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15238,School Grade,Female Breast Carcinoma,0
15239,Symptoms,Cerebral hemangioma,0
15240,Usual Severity Vomiting,High Grade Glandular Intraepithelial Neoplasia,0
15241,Numbers,Childhood Choriocarcinoma,0
15242,Diagnosis,squamous cell carcinoma of the thyroid gland,0
15243,Infertility,FIGO Stage II Ovarian Cancer,0
15244,Result,Colorectal cancer,0
15245,More than 5 years,Malignant Neoplasm of Lung - Multiple Primary Sites,0
15246,Occurrence Indicator,Mucinous adenocarcinoma gastric,0
15247,Definition,Non-Metastatic Gestational Trophoblastic Tumor,0
15248,Renal Cell Carcinoma Pathway,Locally Advanced Soft Tissue Sarcoma,0
15249,Vomiting,Digestive System Hodgkin Lymphoma,0
15250,Characteristics,Thymic Clear Cell Carcinoma,0
15251,protein complex location,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15252,Symptoms,Endometrial Small Cell Carcinoma,0
15253,Loss of Appetite question,Lipoma of small intestine,0
15254,Foreskin of penis,Chondrosarcoma,0
15255,Placental Steroid Sulfatase Deficiency,Childhood Thyroid Gland Follicular Carcinoma,0
15256,Frequently,Endometrial Small Cell Carcinoma,0
15257,Form:Finding:Point in time:{Setting}:Document:{Role},Localized Ewing Sarcoma,0
15258,THM gene,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15259,Pediculus humanus capitis (eukaryote),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15260,Anatomic Site,Undifferentiated Neuroblastoma,0
15261,To,Female Breast Carcinoma,0
15262,Occurrence Indicator,Adult Alveolar Soft Part Sarcoma,0
15263,To,Extracranial Neuroblastoma,0
15264,Percent of Abnormal Cells,Malignant Neoplasm with Regional Lymph Node Involvement,0
15265,Lymphadenopathy,Airway Hemangioma,0
15266,Percent of Abnormal Cells,Airway Hemangioma,0
15267,Term Source,Digestive System Hodgkin Lymphoma,0
15268,PSA Level Less than Five,Intracortical osteosarcoma,0
15269,Tumor stage,Acantholytic squamous cell carcinoma,0
15270,Image Feature,Acantholytic squamous cell carcinoma,0
15271,Rare,Non-Metastatic Gestational Trophoblastic Tumor,0
15272,data type - ratio,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15273,Multiple Sclerosis,Lung squamous cell carcinoma stage I,0
15274,incidence of cases,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15275,Tumor Mass,Secondary malignant neoplasm of lymph node,0
15276,West Haven Hepatic Encephalopathy Grade 3,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15277,multiple pathologies,Primary Cutaneous Plasmablastic Lymphoma,0
15278,Name,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15279,Standard (qualifier),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15280,disease transmission,Localized Askin Tumor,0
15281,Time,Diffuse malignant mesothelioma,0
15282,71,Neonatal leukemia,0
15283,Average of Value Derivation Technique,FIGO Stage II Ovarian Cancer,0
15284,Progress,Breast Ductal Adenoma,0
15285,Science of Statistics,Angiosarcoma of liver,0
15286,Involvement with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15287,Most,Acute Undifferentiated Leukemia,0
15288,Body part,Stage III Adult Immunoblastic Lymphoma,0
15289,More,Diffuse malignant mesothelioma,0
15290,A Codes,Anterior Urethral Malignant Neoplasm,0
15291,Primary malignant neoplasm,adenoid cystic carcinoma of lung,0
15292,Include (action),Grade 3a Malignant Neoplasm,0
15293,Overall Publication Type,Intracortical osteosarcoma,0
15294,Screening,Cartilaginous exostosis,0
15295,per year,Recurrent Testicular Lymphoma,0
15296,Evidence,Collecting Duct Carcinoma of the Kidney,0
15297,Less Than,Medulloblastoma,0
15298,Chemotherapy Regimen,Stage IB Pancreatic Cancer AJCC v8,0
15299,Endocrine Cells,Localized Ewing Sarcoma,0
15300,Hodgkin Disease,Mucinous adenocarcinoma gastric,0
15301,Spur (body structure),FIGO Stage II Ovarian Cancer,0
15302,Trauma,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15303,Manufactured form,Stage 0 Lip Carcinoma,0
15304,Certainties,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
15305,International Classification of Disease for Oncology,Atypical Lobular Breast Hyperplasia,0
15306,Cutaneous leiomyoma,Stage IB Pancreatic Cancer AJCC v8,0
15307,Phimosis,Xeroderma pigmentosum,0
15308,Areas <moth>,squamous cell carcinoma of the thyroid gland,0
15309,Widening,High Grade Glandular Intraepithelial Neoplasia,0
15310,potential,malignant lymphoma of pancreatic lymph nodes,0
15311,Abnormally high,Medulloblastoma,0
15312,Blood,Stage II Carcinoma of Penis,0
15313,Embryonic tissue,Cerebral Primitive Neuroectodermal Tumor,0
15314,Occur (action),Lipoma of small intestine,0
15315,Pharmacotherapy,Stage IB Lung Cancer AJCC v7,0
15316,Testis,Undifferentiated Endocervical Sarcoma,0
15317,Females,Localized Ewing Sarcoma,0
15318,Australia,Cancer of Urinary Tract,0
15319,Pharmacotherapy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15320,Most,Malignant melanoma of eyelid,0
15321,>90,Hodgkin lymphoma,0
15322,Symptoms,Recurrent Uveal Melanoma,0
15323,Empty (qualifier),Thymic Atypical Carcinoid Tumor,0
15324,primary tumor,Pancreatic Intraepithelial Neoplasia-3,0
15325,Suspected diagnosis,Stage 0 Lip Carcinoma,0
15326,Malignant Neoplasms,Fourth Ventricle and Brain Stem Ependymal Tumor,0
15327,peripheral blood,Breast Ductal Adenoma,0
15328,findings aspects,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
15329,Lymphoma,FIGO Stage II Ovarian Cancer,0
15330,prevention aspects,FIGO Stage II Ovarian Cancer,0
15331,Personal appearance,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15332,dendritic spine neck,Unfavorable Non-Hodgkin Lymphoma,0
15333,Act Mood - intent,Cerebral Primitive Neuroectodermal Tumor,0
15334,Intestines,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15335,Skin Pigmentation,Grade 3a Malignant Neoplasm,0
15336,Dana-Farber/Harvard Cancer Center,Cerebral hemangioma,0
15337,Case (situation),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15338,Skeletal bone,carcinoma of middle ear,0
15339,Human body structure,Thymic Clear Cell Carcinoma,0
15340,Cure (remedy),Pancreatic Intraepithelial Neoplasia-3,0
15341,Base - General Qualifier,Unfavorable Non-Hodgkin Lymphoma,0
15342,Term (lexical),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15343,Specimen Source Codes - tumor,Refractory Barrett Esophagus,0
15344,Reactive fibrous tissue proliferation,Uterine Cancer,0
15345,Smaller,Human Papillomavirus-Related Carcinoma,0
15346,Microorganism,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
15347,Fasting Status Indicator,embryonal rhabdomyosarcoma of prostate,0
15348,Possible,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15349,Body tissue,Endometrial Small Cell Carcinoma,0
15350,Used by,Intestinal Neuroendocrine Carcinoma,0
15351,Worse,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15352,Manufactured form,Bladder squamous cell carcinoma stage I,0
15353,Formation,Intracortical osteosarcoma,0
15354,Hormone replacement therapy,Refractory Barrett Esophagus,0
15355,Operative Surgical Procedures,Refractory Barrett Esophagus,0
15356,Fusion procedure,Cartilaginous exostosis,0
15357,Morphology,Recurrent Testicular Lymphoma,0
15358,Admission Level of Care Code - Improved,Mucinous adenocarcinoma gastric,0
15359,Disease Screening,Digestive System Hodgkin Lymphoma,0
15360,Disease,Unresectable Rhabdomyosarcoma,0
15361,Sensation quality,Undifferentiated Endocervical Sarcoma,0
15362,shared attribute,Benign Carotid Body Paraganglioma,0
15363,Head,Lipoma of small intestine,0
15364,Mohs Surgery,Mucinous adenocarcinoma gastric,0
15365,Heart,High Grade Glandular Intraepithelial Neoplasia,0
15366,Screening Study,Recurrent Diffuse Intrinsic Pontine Glioma,0
15367,Anemia,Acantholytic squamous cell carcinoma,0
15368,Screening Study,Adrenal Rest Tumor,0
15369,Spherical shape,Methotrexate-Associated Hodgkin Lymphoma,0
15370,Trimethoprim-Sulfamethoxazole Combination,Advanced Lung Carcinoma,0
15371,Lymphadenopathy,adenosquamous carcinoma of breast,0
15372,Neoplasms,Refractory Glioma,0
15373,Perianal Squamous Intraepithelial Neoplasia,Giant cell angiofibroma,0
15374,System,Neoplasms,0
15375,Finding related to focusing,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15376,Etiology,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15377,Malignant - descriptor,Tonsillar Carcinoma,0
15378,Observation Interpretation - intermediate,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15379,Blood Cells,Cancer of Urinary Tract,0
15380,Function Axis,Primary Cutaneous Plasmablastic Lymphoma,0
15381,various other nasal preparations in ATC,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15382,Hormone Therapy,Recurrent Testicular Lymphoma,0
15383,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Benign tumor of eyelid,0
15384,Organ,Stage 0 Penile Cancer AJCC v8,0
15385,Lymphoma,benign mature teratoma of pancreas,0
15386,Partial,Cancer of Urinary Tract,0
15387,Oral region,Atypical Mesothelial Hyperplasia,0
15388,various allergen extracts,Diffuse malignant mesothelioma,0
15389,Negation,Leiomyoma of Gallbladder,0
15390,Empty (qualifier),Localized Ewing Sarcoma,0
15391,parotid gland swelling,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15392,Presentation,High Grade Glandular Intraepithelial Neoplasia,0
15393,Architecture,Benign tumor of eyelid,0
15394,Condition,Granular Cell Leiomyosarcoma,0
15395,Recurrent infections,Intraepithelial Melanocytic Hyperplasia,0
15396,Surgery specialty,Testicular cancer metastatic,0
15397,Childhood,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15398,Term Birth,FIGO Stage II Ovarian Cancer,0
15399,Recommendation,Acantholytic squamous cell carcinoma,0
15400,Increase,squamous cell carcinoma of the thyroid gland,0
15401,Renal Cell Carcinoma,Recurrent Testicular Lymphoma,0
15402,Human body,Carcinoma of urinary bladder,0
15403,1000000,FIGO Stage II Ovarian Cancer,0
15404,Symptoms,Mucinous neoplasm,0
15405,Useful,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15406,Sexually Transmitted Diseases,Malignant melanoma of eyelid,0
15407,Large,Ovarian germ cell choriocarcinoma stage IV,0
15408,Ursidae Family,Malignant Neoplasm with Regional Lymph Node Involvement,0
15409,Qualitative form,Anterior Urethral Malignant Neoplasm,0
15410,Lung,Colorectal Neuroendocrine Tumor G2,0
15411,Upper Respiratory Infections,Granular Cell Leiomyosarcoma,0
15412,Childhood Extracranial Germ Cell Tumor,Mixed parotid tumor,0
15413,Malignancy,Recurrent Testicular Lymphoma,0
15414,ATLAS Score Clinical Classification,Activated B-cell type diffuse large B-cell lymphoma,0
15415,GORAB gene,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15416,Neoplasms,Testicular cancer metastatic,0
15417,Most Recent,Cancer of Urinary Tract,0
15418,Skin,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15419,Biological Response Modifiers,Bladder squamous cell carcinoma stage I,0
15420,Adolescent (age group),Refractory Barrett Esophagus,0
15421,Rhabdomyosarcoma,Acantholytic squamous cell carcinoma,0
15422,Papillary transitional cell neoplasm of low malignant potential,Recurrent Uveal Melanoma,0
15423,Complete Pharyngeal Contraction,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15424,radiotherapeutic,adenosquamous carcinoma of breast,0
15425,Transformation,Localized Askin Tumor,0
15426,Direct type of relationship,Mucinous adenocarcinoma gastric,0
15427,Weight Loss,Unfavorable Non-Hodgkin Lymphoma,0
15428,Not abnormal,Undifferentiated Neuroblastoma,0
15429,Tissue Specimen Code,Stage IB Lung Cancer AJCC v7,0
15430,Leads (device),Mixed parotid tumor,0
15431,Pharmacotherapy,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
15432,Monoclonal Antibodies,Bladder squamous cell carcinoma stage I,0
15433,Bacterial Infections,Stage II Carcinoma of Penis,0
15434,parent,Cerebral Primitive Neuroectodermal Tumor,0
15435,Biological Response Modifiers,Benign Carotid Body Paraganglioma,0
15436,Often - answer to question,Extracranial Neuroblastoma,0
15437,Skin Specimen,Localized Ewing Sarcoma,0
15438,Type A,FIGO Stage II Ovarian Cancer,0
15439,Result,Unresectable Rhabdomyosarcoma,0
15440,Therapeutic radiology procedure,Colorectal High Grade B-Cell Lymphoma,0
15441,Malignant neoplasm of breast,Female Breast Carcinoma,0
15442,Occurrence,Localized Askin Tumor,0
15443,Thin skin,High Grade Glandular Intraepithelial Neoplasia,0
15444,Presence (property),Angiosarcoma of liver,0
15445,Part,Cancer of Urinary Tract,0
15446,GDF15 protein,Stage IB Lung Cancer AJCC v7,0
15447,Nine,Childhood Lymphoma,0
15448,Biological Response Modifier Therapy,Diffuse malignant mesothelioma,0
15449,Occur (action),Stage II Carcinoma of Penis,0
15450,Free of (attribute),Stage 0 Penile Cancer AJCC v8,0
15451,Malignant Neoplasms,Tonsillar Carcinoma,0
15452,T-Cell Receptor,Localized Ewing Sarcoma,0
15453,Factor,Localized Askin Tumor,0
15454,Prevalence aspects,Benign tumor of eyelid,0
15455,Mass,Stage IV Penile Cancer AJCC v7,0
15456,Medications,Low Grade Squamous Intraepithelial Neoplasia,0
15457,Group Object,Maxillary Sinus Adenocarcinoma,0
15458,Code,Acute Undifferentiated Leukemia,0
15459,Now (temporal qualifier),Locally Advanced Soft Tissue Sarcoma,0
15460,Group A (qualifier value),Adrenal Rest Tumor,0
15461,Numbers,Intestinal Metaplasia of Bladder Urothelium,0
15462,Benign Neoplasm,Stage IV Penile Cancer AJCC v7,0
15463,shared attribute,Childhood Lymphoma,0
15464,Identical,Neoplasms,0
15465,Management procedure,Malignant Testicular Sertoli Cell Tumor,0
15466,National Cancer Institute,Breast Ductal Adenoma,0
15467,Has focus,Adult Alveolar Soft Part Sarcoma,0
15468,At risk of infection,Recurrent Testicular Lymphoma,0
15469,Second edition,Adenocarcinoma,0
15470,Apply,Intestinal Metaplasia of Bladder Urothelium,0
15471,Bone Marrow Examination,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
15472,Including (qualifier),Metastatic Kidney Carcinoma,0
15473,Melanoma Pathway,Cerebral Primitive Neuroectodermal Tumor,0
15474,Time (foundation metadata concept),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15475,How Much Distress Weight Loss,Intestinal Metaplasia of Bladder Urothelium,0
15476,Acute Megakaryocytic Leukemias,Uterine Cancer,0
15477,Pharmacotherapy,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
15478,Heartburn,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15479,Lymphoid Tissue,Small cell neuroendocrine carcinoma of bladder,0
15480,Causing,Malignant Testicular Sertoli Cell Tumor,0
15481,Tumor cells,sarcoma of spinal cord,0
15482,Treating,Malignant neoplasm of thalamus,0
15483,Analysis of substances,Human Papillomavirus-Related Carcinoma,0
15484,SLC6A2 protein,Airway Hemangioma,0
15485,Status post,Diffuse malignant mesothelioma,0
15486,Rare,Collecting Duct Carcinoma of the Kidney,0
15487,Coitus,Localized Askin Tumor,0
15488,Case unit dose,Mucinous adenocarcinoma gastric,0
15489,Malignant Neoplasms,gliosarcoma,0
15490,Occur (action),Malignant melanoma of eyelid,0
15491,Follow - dosing instruction imperative,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15492,Hypertensive disease,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15493,Group A (qualifier value),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15494,>90,Malignant melanoma of eyelid,0
15495,Appearance of eyelid,Hair nevus,0
15496,Manufactured form,Advanced Lung Carcinoma,0
15497,depend,Benign Apocrine Neoplasm,0
15498,Exostosis,Malignant Testicular Sertoli Cell Tumor,0
15499,Lymphatic Abnormalities,Thymic Clear Cell Carcinoma,0
15500,Wash (cleansing action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15501,fluid - substance,Noninfiltrating Intraductal Carcinoma,0
15502,Combined,Adult Alveolar Soft Part Sarcoma,0
15503,Preventive monitoring,Pancreatic Intraepithelial Neoplasia-3,0
15504,Bothered by Night Sweats,Localized Ewing Sarcoma,0
15505,Specific qualifier value,Small cell neuroendocrine carcinoma of bladder,0
15506,Centroblast,Ichthyoses,0
15507,Neoplasms,Metastatic Malignant Neoplasm in the Sellar Region,0
15508,Keratoderma,Pilocytic astrocytoma of cerebellum,0
15509,CD69 protein,Childhood Fibrillary Astrocytoma,0
15510,status - In progress,Ovarian germ cell choriocarcinoma stage IV,0
15511,Base - General Qualifier,Endometrial Small Cell Carcinoma,0
15512,Medullary - body parts,Benign tumor of eyelid,0
15513,Weight decreased,Blepharal carcinoma,0
15514,combination - answer to question,Recurrent Testicular Lymphoma,0
15515,Renal carcinoma,Sarcomatoid Renal Cell Carcinoma,0
15516,Most,Neonatal leukemia,0
15517,Essential,Pilocytic astrocytoma of cerebellum,0
15518,include - SetOperator,Metastatic Malignant Neoplasm in the Sellar Region,0
15519,Chest,Mucinous adenocarcinoma gastric,0
15520,low,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15521,Symptoms aspect,Thymic Clear Cell Carcinoma,0
15522,pharmacotherapeutic,Uterine Cancer,0
15523,Component object,Angiosarcoma of liver,0
15524,What subject filter - Result,Primary Cutaneous Plasmablastic Lymphoma,0
15525,As Much as Desired,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15526,Mature,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15527,One,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15528,International Classification of Diseases for Oncology,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15529,oncology field,Adult Brain Stem Mixed Glioma,0
15530,Blood Platelets,Mixed parotid tumor,0
15531,How Often Felt Normal question,Benign Apocrine Neoplasm,0
15532,Less Than,Choroid Necrotic Melanoma,0
15533,Aspect - Kind of quantity,Ovarian Carcinoid Tumor,0
15534,65,Ichthyosis,0
15535,Mass of body structure,Localized Ewing Sarcoma,0
15536,therapeutic aspects,Female Breast Carcinoma,0
15537,Possible diagnosis,Undifferentiated Endocervical Sarcoma,0
15538,competitive advantage,benign mature teratoma of pancreas,0
15539,Adult Classical Hodgkin Lymphoma,Cerebral Primitive Neuroectodermal Tumor,0
15540,Formation,Intestinal Metaplasia of Bladder Urothelium,0
15541,Cell Count,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15542,IPSS Risk Category Low,Colorectal Neuroendocrine Tumor G2,0
15543,Combined,non-Hodgkin's lymphoma of spleen,0
15544,Call (Instruction),squamous cell carcinoma of the thyroid gland,0
15545,Disruptive,Cerebral Primitive Neuroectodermal Tumor,0
15546,Childhood Lymphoma,Spermatocytic seminoma,0
15547,Body structure,Diffuse malignant mesothelioma,0
15548,Trachea (moth),Diffuse malignant mesothelioma,0
15549,Academic degree,Endometrial Small Cell Carcinoma,0
15550,Usual Severity Weight Loss,Digestive System Hodgkin Lymphoma,0
15551,Dog family,Granular Cell Leiomyosarcoma,0
15552,Metastatic Neoplasm,Metastatic Neoplasm to the Gallbladder,0
15553,Classification,Secondary malignant neoplasm of lymph node,0
15554,Location of Oral Residue Following Swallowing,Placental aromatase deficiency,0
15555,Vaginal mass,Human Papillomavirus-Related Carcinoma,0
15556,PSA Level Greater than Fifty,Malignant Neoplasm of Lung - Multiple Primary Sites,0
15557,Context,Malignant neoplasm of thalamus,0
15558,Room of building - Study,Metastatic Neoplasm to the Gallbladder,0
15559,Etiology,Benign Apocrine Neoplasm,0
15560,Cancer Other,Extra-Adrenal Paraganglioma,0
15561,Country number,Adult Hepatocellular Carcinoma,0
15562,CDISC SEND Tumor Findings Results Terminology,Blepharal carcinoma,0
15563,Specimen Source Codes - tumor,Intraepithelial Melanocytic Hyperplasia,0
15564,Skeletal,Anaplastic large cell lymphoma,0
15565,Part,de novo Myelodysplastic Syndrome,0
15566,Cancer Genus,Intraepithelial Melanocytic Hyperplasia,0
15567,Risk,Stage II Carcinoma of Penis,0
15568,3+ Score,Thymic Clear Cell Carcinoma,0
15569,60%,Localized Askin Tumor,0
15570,Entity,Malignant Testicular Sertoli Cell Tumor,0
15571,List,Low Grade Squamous Intraepithelial Neoplasia,0
15572,Cause of death:Find:Pt:^Patient:Nom,Xeroderma pigmentosum,0
15573,20%,Thymic Clear Cell Carcinoma,0
15574,Biomaterial Treatment,Childhood Lymphoma,0
15575,size,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15576,Oncologists,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15577,Neoplasm Metastasis,Endometrial Small Cell Carcinoma,0
15578,Malignant neoplasm of thyroid,embryonal rhabdomyosarcoma of prostate,0
15579,Malignant Neoplasms,Lipoma of small intestine,0
15580,Dilated,Undifferentiated Endocervical Sarcoma,0
15581,Abnormally high,Undifferentiated Endocervical Sarcoma,0
15582,Use of,Malignant Testicular Sertoli Cell Tumor,0
15583,Arising,Giant cell angiofibroma,0
15584,shared attribute,Medulloblastoma,0
15585,Smear - instruction imperative,Benign tumor of eyelid,0
15586,Lymphangioma,Anterior Urethral Malignant Neoplasm,0
15587,Togo,Sarcomatoid Renal Cell Carcinoma,0
15588,Intraepidermal vesicles,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15589,Sharing (Social Behavior),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15590,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15591,List,Endometrial Small Cell Carcinoma,0
15592,High Mitosis-Karyorrhexis Index,Advanced Lung Carcinoma,0
15593,increasing incidence,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15594,Early,Endometrial Small Cell Carcinoma,0
15595,Unexplained weight loss,Stage I Adult Non-Hodgkin Lymphoma,0
15596,Unmarried person,Contact dermatitis due to alkali,0
15597,Radiation Oncologists,Female Breast Carcinoma,0
15598,contagion,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15599,Relationships,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
15600,Most,High Grade Glandular Intraepithelial Neoplasia,0
15601,More,carcinoma of middle ear,0
15602,Sex Cord-Stromal Tumor,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15603,Live - Specimen Condition,Childhood Thyroid Gland Follicular Carcinoma,0
15604,Oral region,Non-Metastatic Gestational Trophoblastic Tumor,0
15605,How Much Distress Weight Loss,Acute Undifferentiated Leukemia,0
15606,low,Recurrent Uveal Melanoma,0
15607,Smear - instruction imperative,Mucinous cystadenofibroma,0
15608,Childhood Lymphoma,Bladder squamous cell carcinoma stage I,0
15609,Duct (organ) structure,Intestinal Metaplasia of Bladder Urothelium,0
15610,Papillomavirus,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15611,Moveable,Advanced Lung Carcinoma,0
15612,Uncertainty,Refractory Barrett Esophagus,0
15613,Classification,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15614,Residue on Palate,Placental aromatase deficiency,0
15615,Date in time,Ovarian germ cell choriocarcinoma stage IV,0
15616,Early stage,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15617,Age,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15618,Time (foundation metadata concept),Advanced Uterine Corpus Carcinosarcoma,0
15619,Monocyte count result,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15620,SPINK5 gene,Carcinoma of urinary bladder,0
15621,Occurrence,Colorectal High Grade B-Cell Lymphoma,0
15622,Left sided,Endometrial Small Cell Carcinoma,0
15623,Hematological Disease,Diffuse malignant mesothelioma,0
15624,Tryptophanase,Angiosarcoma of liver,0
15625,Present,Hodgkin lymphoma,0
15626,Monitor Device,Benign Apocrine Neoplasm,0
15627,Tobacco smoking behavior,Methotrexate-Associated Hodgkin Lymphoma,0
15628,Magnetic Resonance Imaging,Cerebral Primitive Neuroectodermal Tumor,0
15629,Genetic,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
15630,Prophylactic behavior,Secondary malignant neoplasm of lymph node,0
15631,Advanced phase,Clonal Hematopoiesis of Indeterminate Potential,0
15632,Treating,Adenocarcinoma,0
15633,Spherical shape,Acantholytic squamous cell carcinoma,0
15634,Name (property) (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
15635,Scientific Study,Benign tumor of eyelid,0
15636,Benign Teratoma,Recurrent Uveal Melanoma,0
15637,Transmitted by,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15638,Catch - Finding of sensory dimension of pain,Cerebral hemangioma,0
15639,Entity Determiner - specific,Xeroderma pigmentosum,0
15640,Peeling of skin,Non-Metastatic Gestational Trophoblastic Tumor,0
15641,Type - attribute,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15642,Spreading (qualifier value),Deep Leiomyoma,0
15643,European Union Notified Body,Stage III Adult Immunoblastic Lymphoma,0
15644,Frequently,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15645,Operative Surgical Procedures,Bladder squamous cell carcinoma stage I,0
15646,63,Locally Advanced Soft Tissue Sarcoma,0
15647,Smear test,Adult Hepatocellular Carcinoma,0
15648,Singular,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15649,Financial Account,Collecting Duct Carcinoma of the Kidney,0
15650,Professional guide,papillary carcinoma of penis,0
15651,Mental association,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15652,Arm of chromosome,Cerebral Primitive Neuroectodermal Tumor,0
15653,Neoplasms,Chronic Myelomonocytic Leukemia-2,0
15654,High,Primary Cutaneous Plasmablastic Lymphoma,0
15655,Parenchyma,Acute Undifferentiated Leukemia,0
15656,Shortness of Breath Visual Analogue Scale,embryonal rhabdomyosarcoma of prostate,0
15657,Retraction (finding),Intracortical osteosarcoma,0
15658,Liver Flavor,Bladder squamous cell carcinoma stage I,0
15659,Source (property) (qualifier value),Locally Advanced Soft Tissue Sarcoma,0
15660,Common (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15661,System,Childhood Thyroid Gland Follicular Carcinoma,0
15662,Breast tissue sample,Recurrent Uveal Melanoma,0
15663,Scalp structure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15664,Pruritus,Intestinal Metaplasia of Bladder Urothelium,0
15665,High Grade Lymphoma (neoplasm),Carcinoma of urinary bladder,0
15666,Fever,Colorectal High Grade B-Cell Lymphoma,0
15667,Lymphocyte,Colorectal High Grade B-Cell Lymphoma,0
15668,Present,Mucinous adenocarcinoma gastric,0
15669,device aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15670,Therapeutic procedure,Noninfiltrating Intraductal Carcinoma,0
15671,Third revision,Cerebral Primitive Neuroectodermal Tumor,0
15672,Chemicals,Low Grade Squamous Intraepithelial Neoplasia,0
15673,Blood Cells,Stage II Hepatocellular Carcinoma AJCC v8,0
15674,Study Site,Spongiotic dermatitis,0
15675,70%,Spermatocytic seminoma,0
15676,Chemotherapy,Localized Askin Tumor,0
15677,Sometimes,adenosquamous carcinoma of breast,0
15678,Specimen Source Codes - tumor,Spongiotic dermatitis,0
15679,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Neonatal leukemia,0
15680,Completely Able,Mucinous adenocarcinoma gastric,0
15681,North America,Intraepithelial Melanocytic Hyperplasia,0
15682,Seven-Day Report,adenoid cystic carcinoma of lung,0
15683,Due to,Anterior Urethral Malignant Neoplasm,0
15684,Nobel Prize,Angiosarcoma of liver,0
15685,Cure (remedy),Blepharal carcinoma,0
15686,Signet ring cell,Undifferentiated Endocervical Sarcoma,0
15687,Physical findings,Unresectable Rhabdomyosarcoma,0
15688,Medical pathologist,Small cell neuroendocrine carcinoma of bladder,0
15689,BRCA1 protein,Methotrexate-Associated Hodgkin Lymphoma,0
15690,Less Than,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15691,Most,Human Papillomavirus-Related Carcinoma,0
15692,Fever,Endometrial Small Cell Carcinoma,0
15693,Breaking down,Lung squamous cell carcinoma stage I,0
15694,Probably,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15695,Used by,Stage II Carcinoma of Penis,0
15696,Lung,Neonatal leukemia,0
15697,System (unit of presentation),Adenocarcinoma,0
15698,mole changes,Intraepithelial Melanocytic Hyperplasia,0
15699,Often - answer to question,Urethral Carcinoma,0
15700,Body tissue,Diffuse malignant mesothelioma,0
15701,Age,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15702,Drainage procedure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15703,Rapid,Recurrent Uveal Melanoma,0
15704,Numerous,Diffuse malignant mesothelioma,0
15705,Central Minus,Recurrent Testicular Lymphoma,0
15706,Aggressive course,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15707,Common (qualifier value),Diffuse malignant mesothelioma,0
15708,Keratoconjunctivitis Sicca,Adenocarcinoma of the prostate metastatic,0
15709,Fever symptoms (finding),Childhood Thyroid Gland Follicular Carcinoma,0
15710,Blood group A (finding),Childhood Lymphoma,0
15711,Isolation procedure,Intestinal Neuroendocrine Carcinoma,0
15712,Common (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
15713,Cessation of life,Deep Leiomyoma,0
15714,Surgical aspects,Stage IB Pancreatic Cancer AJCC v8,0
15715,Fever symptoms (finding),Airway Hemangioma,0
15716,Communicable Diseases,Undifferentiated Neuroblastoma,0
15717,Present,Metastatic Malignant Neoplasm in the Sellar Region,0
15718,Immature cells,Malignant neoplasm of thalamus,0
15719,Hematologic Tests,mucinous adenocarcinoma of gallbladder,0
15720,Including (qualifier),Adult Fibrolamellar Carcinoma,0
15721,Adult,Diffuse malignant mesothelioma,0
15722,PCYT1A wt Allele,Recurrent Testicular Lymphoma,0
15723,Risk,Intraepithelial Melanocytic Hyperplasia,0
15724,Primary malignant neoplasm,Childhood Choriocarcinoma,0
15725,Adult human body,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
15726,Skeletal bone,Lipoma of small intestine,0
15727,KAT5 wt Allele,Acute lymphadenitis,0
15728,majority,Recurrent Uveal Melanoma,0
15729,depend,Advanced Uterine Corpus Carcinosarcoma,0
15730,ovarian neoplasm,Endometrial Small Cell Carcinoma,0
15731,Epstein-Barr Virus,Neoplasms,0
15732,Patient Monitoring,Testicular cancer metastatic,0
15733,84,Ichthyoses,0
15734,Retinoic Acid Response Element,Breast Ductal Adenoma,0
15735,In Urine,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15736,Alveolus,Atypical Mesothelial Hyperplasia,0
15737,Treatment Epoch,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15738,Steroids,Clonal Hematopoiesis of Indeterminate Potential,0
15739,Negation,Advanced Lung Carcinoma,0
15740,Percent (qualifier value),Collecting Duct Carcinoma of the Kidney,0
15741,Confirmed by,Anaplastic large cell lymphoma,0
15742,diagnosis aspect,Leptomeningeal sarcoma,0
15743,To,Xeroderma pigmentosum,0
15744,How Much Distress Shortness of Breath,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15745,research subject screening,Adenocarcinoma,0
15746,Separate,Cancer of Urinary Tract,0
15747,Special,Localized Askin Tumor,0
15748,Specimen Source Codes - tumor,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15749,Occur (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15750,Tumor cells,Liver Cavernous Hemangioma,0
15751,treatment - ActInformationManagementReason,Intestinal Neuroendocrine Carcinoma,0
15752,Congenital MeSH qualifier,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15753,Including (qualifier),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15754,Survival Rate,Non-Metastatic Gestational Trophoblastic Tumor,0
15755,Formation,Atypical Lobular Breast Hyperplasia,0
15756,Squamous cell carcinoma,Giant cell angiofibroma,0
15757,Paraneoplastic Syndromes,Chondrosarcoma,0
15758,nonspecific,Carcinoma of urinary bladder,0
15759,Tissue Specimen Code,Methotrexate-Associated Hodgkin Lymphoma,0
15760,risk factors - observation list,Mucinous adenocarcinoma gastric,0
15761,Count of entities,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15762,Cessation of life,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15763,Case (situation),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15764,Chemotherapy Regimen,Pancreatic Intraepithelial Neoplasia-3,0
15765,Medical,Intestinal Metaplasia of Bladder Urothelium,0
15766,Manufactured form,Childhood Fibrillary Astrocytoma,0
15767,3+ Answer to Question,High Grade Glandular Intraepithelial Neoplasia,0
15768,Medulla Oblongata,Non-Metastatic Gestational Trophoblastic Tumor,0
15769,Type - attribute,Spermatocytic seminoma,0
15770,3+ Answer to Question,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
15771,Five-year Survival Rate,Stage 0 Penile Cancer AJCC v8,0
15772,Usually Need Help from Another Person for Eating,Benign neoplasm of thorax,0
15773,*Type - Kind of quantity,Recurrent Uveal Melanoma,0
15774,Skin,Ovarian germ cell choriocarcinoma stage IV,0
15775,Recurrent urinary tract infection,Non-Metastatic Gestational Trophoblastic Tumor,0
15776,Associated with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15777,Presentation,Colorectal cancer,0
15778,Iodides,Spongiotic dermatitis,0
15779,How Much Distress Vomiting,Thymic Clear Cell Carcinoma,0
15780,Night sweats,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15781,Histopathologic Grade,Metastatic Kidney Carcinoma,0
15782,Type - attribute,Clonal Hematopoiesis of Indeterminate Potential,0
15783,Greasy hair,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15784,Brain Neoplasms,Adrenal Rest Tumor,0
15785,Known,Mixed parotid tumor,0
15786,Decision,Mucinous neoplasm,0
15787,Microscopic,Stage III Adult Immunoblastic Lymphoma,0
15788,Sensitive,Cancer of Urinary Tract,0
15789,Nasal sinus,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15790,Base of the Brain,squamous cell carcinoma of the thyroid gland,0
15791,Affecting,Breast Ductal Adenoma,0
15792,Enlargement procedure,Xeroderma pigmentosum,0
15793,Africa,Stage I Adult Non-Hodgkin Lymphoma,0
15794,year,Digestive System Hodgkin Lymphoma,0
15795,Person Name,papillary carcinoma of penis,0
15796,Result,Acute Undifferentiated Leukemia,0
15797,Standard (document),Testicular cancer metastatic,0
15798,Class,Human Papillomavirus-Related Carcinoma,0
15799,Tissue Growth,Mucinous adenocarcinoma gastric,0
15800,Tryptophanase,Carcinoma ex pleomorphic adenoma of parotid gland,0
15801,Divide,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15802,Characteristics,Recurrent Testicular Lymphoma,0
15803,Tryptophanase,Adult Alveolar Soft Part Sarcoma,0
15804,Percent of Abnormal Cells,Ichthyosis,0
15805,Feature,Germinoma,0
15806,Room of building - Study,Stage III Adult Immunoblastic Lymphoma,0
15807,Therapeutic radiology procedure,Lipoma of small intestine,0
15808,Gram per Deciliter,Anterior Urethral Malignant Neoplasm,0
15809,Representation (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15810,Personal appearance,Acute Undifferentiated Leukemia,0
15811,Neuroendocrine Tumors,Recurrent Uveal Melanoma,0
15812,Malignant Neoplasms,Non-Metastatic Gestational Trophoblastic Tumor,0
15813,Bone marrow myeloid dysplasia,Liver Cavernous Hemangioma,0
15814,Tryptophanase,GIANT PIGMENTED HAIRY NEVUS,0
15815,Count of entities,mucinous adenocarcinoma of gallbladder,0
15816,Feature,Metastatic Malignant Neoplasm in the Sellar Region,0
15817,Workplace,Stage 0 Penile Cancer AJCC v8,0
15818,Absent,Anterior Urethral Malignant Neoplasm,0
15819,Endometrial biopsy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15820,CDISC SEND Tumor Findings Results Terminology,Refractory Barrett Esophagus,0
15821,Logical Condition,Diffuse malignant mesothelioma,0
15822,Geographic Locations,Malignant neoplasm of choroid,0
15823,structure,Uterine Cancer,0
15824,Intercellular edema,Stage II Hepatocellular Carcinoma AJCC v8,0
15825,Eyelid Diseases,Carcinoma of urinary bladder,0
15826,Rate,Pancreatic Intraepithelial Neoplasia-3,0
15827,Usually,Liver Lymphangioma,0
15828,Identified,Stage IB Pancreatic Cancer AJCC v8,0
15829,Sometimes,Medulloblastoma,0
15830,Surrounding (qualifier value),Localized Askin Tumor,0
15831,Present,malignant lymphoma of pancreatic lymph nodes,0
15832,Basis - conceptual entity,adenosquamous carcinoma of breast,0
15833,Atypical ductal hyperplasia (qualifier value),Lipoma of small intestine,0
15834,Dust,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
15835,Males,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15836,Pediculus (eukaryote),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15837,Slightly Able,Contact dermatitis due to alkali,0
15838,risk factors - observation list,Adult Alveolar Soft Part Sarcoma,0
15839,Case unit dose,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15840,include - SetOperator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15841,Due to,Undifferentiated Endocervical Sarcoma,0
15842,Biopsy,Medulloblastoma,0
15843,Procedure (set of actions),Chondrosarcoma,0
15844,Point Name,Bladder squamous cell carcinoma stage I,0
15845,treatment options,Malignant melanoma of eyelid,0
15846,Less Than,Benign tumor of eyelid,0
15847,Case (situation),Mucinous adenocarcinoma gastric,0
15848,Immunoglobulins,Benign Apocrine Neoplasm,0
15849,Have Weight Loss,Intraepithelial Melanocytic Hyperplasia,0
15850,Cervix carcinoma,benign mature teratoma of pancreas,0
15851,Treatment Epoch,Undifferentiated Endocervical Sarcoma,0
15852,Common Specifications in HL7 V3 Publishing,Childhood Central Nervous System Immature Teratoma,0
15853,Divide,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15854,Arising,Neonatal leukemia,0
15855,PSA Level Less than Two,Diffuse malignant mesothelioma,0
15856,Ocular orbit,Unresectable Rhabdomyosarcoma,0
15857,Cancer Genus,Benign tumor of eyelid,0
15858,Sexually Transmitted Diseases,Airway Hemangioma,0
15859,Decision,Adrenal Rest Tumor,0
15860,Circumscribe (action),Thymic Clear Cell Carcinoma,0
15861,Administration procedure,Stage IB Pancreatic Cancer AJCC v8,0
15862,Account number:Identifier:Point in time:^Patient:Nominal,Activated B-cell type diffuse large B-cell lymphoma,0
15863,Number of birth,Xeroderma pigmentosum,0
15864,Personal appearance,Adult Alveolar Soft Part Sarcoma,0
15865,Pale feces (finding),Intestinal Neuroendocrine Carcinoma,0
15866,Type of complication,Giant cell angiofibroma,0
15867,Class (taxonomic),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15868,Skeletal bone,Thymic Atypical Carcinoid Tumor,0
15869,Dry skin,Diffuse malignant mesothelioma,0
15870,Fibrous connective tissue,Werner Syndrome,0
15871,Surgery specialty,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15872,genetic risk factors,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15873,Combined,Intestinal Metaplasia of Bladder Urothelium,0
15874,Physical findings,Airway Hemangioma,0
15875,Circulatory System Process,Ovarian Carcinoid Tumor,0
15876,Basal cell carcinoma,Childhood Choriocarcinoma,0
15877,Biopsy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15878,Manufactured sign,Heavy Chain Deposition Disease,0
15879,Rating (action),malignant lymphoma of pancreatic lymph nodes,0
15880,Epidermis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15881,Spreading (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15882,Administration procedure,Stage IB Pancreatic Cancer AJCC v8,0
15883,Age at diagnosis:Time:Pt:^Patient:Qn,Female Breast Carcinoma,0
15884,Esophagus,malignant lymphoma of pancreatic lymph nodes,0
15885,Adult Glioblastoma,Stage II Carcinoma of Penis,0
15886,Term Birth,Benign tumor of eyelid,0
15887,Clinical Observation,Acute Undifferentiated Leukemia,0
15888,2+ Score,Unresectable Rhabdomyosarcoma,0
15889,Known,squamous cell carcinoma of the thyroid gland,0
15890,Most,Stage II Carcinoma of Penis,0
15891,Complete,Diffuse malignant mesothelioma,0
15892,Retinoid [EPC],Adenocarcinoma,0
15893,Greater,Stage IB Pancreatic Cancer AJCC v8,0
15894,include - SetOperator,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15895,include - SetOperator,Stage III Adult Immunoblastic Lymphoma,0
15896,Feel Tired question,Hodgkin lymphoma,0
15897,Present,adenosquamous carcinoma of breast,0
15898,Blood,Refractory Barrett Esophagus,0
15899,Two,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15900,Retinoic Acid Response Element,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15901,gene therapy,Leptomeningeal sarcoma,0
15902,mole changes,FIGO Stage II Ovarian Cancer,0
15903,Usual Severity Diarrhea,Hodgkin lymphoma,0
15904,Blood Circulation,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15905,Pancreas,Cerebral Primitive Neuroectodermal Tumor,0
15906,40%,mucinous adenocarcinoma of gallbladder,0
15907,Sweating,Uterine Cancer,0
15908,Data operation - complete,Collecting Duct Carcinoma of the Kidney,0
15909,Entity Determiner - specific,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15910,How Much Distress Shortness of Breath,Small cell neuroendocrine carcinoma of bladder,0
15911,Premalignant,High Grade Glandular Intraepithelial Neoplasia,0
15912,Therapeutic procedure,Tonsillar Carcinoma,0
15913,Patient Outcome - Died,Secondary malignant neoplasm of lymph node,0
15914,Certain (qualifier value),Heavy Chain Deposition Disease,0
15915,Include (action),Unresectable Rhabdomyosarcoma,0
15916,chance,Ovarian germ cell choriocarcinoma stage IV,0
15917,Slightly Agree,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
15918,Known,Stage IV Penile Cancer AJCC v7,0
15919,Occur (action),Neonatal leukemia,0
15920,Diagnosis,Ichthyosis,0
15921,Cancer Genus,Intestinal Neuroendocrine Carcinoma,0
15922,Bone marrow: lymphocytes (finding),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15923,Appearance of breast,Mastocytosis,0
15924,Early,Benign Apocrine Neoplasm,0
15925,Mediastinum,Lipoma of small intestine,0
15926,Spinal meningocele,Endometrial Small Cell Carcinoma,0
15927,Blood Circulation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15928,Splitting,Childhood Fibrillary Astrocytoma,0
15929,Favorable,Lung squamous cell carcinoma stage I,0
15930,site-specific telomere resolvase activity,Breast Ductal Adenoma,0
15931,Paraneoplastic Syndromes,Leptomeningeal sarcoma,0
15932,Difficulty walking,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15933,Soft,Mucinous adenocarcinoma gastric,0
15934,antigen binding,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15935,Initially,Childhood Lymphoma,0
15936,Nearly,Adult Alveolar Soft Part Sarcoma,0
15937,Decision,Small cell neuroendocrine carcinoma of bladder,0
15938,Development,Stage III Adult Immunoblastic Lymphoma,0
15939,Device tip (physical object),Noninfiltrating Intraductal Carcinoma,0
15940,84,Liver Lymphangioma,0
15941,Reported Term,Hemangioma,0
15942,Ectoderm,Benign Apocrine Neoplasm,0
15943,Within,mucinous adenocarcinoma of gallbladder,0
15944,Volume (publication),Localized Ewing Sarcoma,0
15945,Absence (morphologic abnormality),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15946,defective,Childhood Cerebellar Neoplasm,0
15947,Ulcer,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
15948,Sometimes,Childhood Fibrillary Astrocytoma,0
15949,Diffuse Large B-Cell Lymphoma,Adenocarcinoma,0
15950,shared attribute,Non-Metastatic Gestational Trophoblastic Tumor,0
15951,Point Name,mucinous adenocarcinoma of gallbladder,0
15952,Manufactured form,Angiosarcoma of liver,0
15953,Food,gliosarcoma,0
15954,Soft Tissue Route of Drug Administration,Choroid Necrotic Melanoma,0
15955,Case unit dose,Intraepithelial Melanocytic Hyperplasia,0
15956,What subject filter - Result,embryonal rhabdomyosarcoma of prostate,0
15957,65+,Mastocytosis,0
15958,Hydrocephalus,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15959,Lymphocyte component of blood,Rhabdomyosarcoma with ganglionic differentiation,0
15960,Negation,embryonal rhabdomyosarcoma of prostate,0
15961,Small cell carcinoma of lung,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15962,Special,Childhood Fibrillary Astrocytoma,0
15963,Condition:Find:Pt:^Patient:Nom,Recurrent Uveal Melanoma,0
15964,Americas Ethnicity,Recurrent Testicular Lymphoma,0
15965,Present,Metastatic Malignant Neoplasm in the Sellar Region,0
15966,Causing,Tonsillar Carcinoma,0
15967,School Grade,Heavy Chain Deposition Disease,0
15968,Solid Dose Form,Acute Undifferentiated Leukemia,0
15969,Woman,Benign tumor of eyelid,0
15970,Lacrimal sac,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
15971,Sample Mean,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
15972,Geographic Locations,Refractory Barrett Esophagus,0
15973,UV Radiation,Mucinous cystadenofibroma,0
15974,Spreading (qualifier value),Malignant neoplasm of thalamus,0
15975,radiotherapeutic,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15976,disease transmission qualifier,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15977,Increased,Undifferentiated Endocervical Sarcoma,0
15978,Chromosome band,Chondrosarcoma,0
15979,AKR1A1 wt Allele,Cerebral Primitive Neuroectodermal Tumor,0
15980,NIN gene,Chronic Myelomonocytic Leukemia-2,0
15981,CDISC SEND Body System Terminology,Neonatal leukemia,0
15982,Biomaterial Treatment,Lung squamous cell carcinoma stage I,0
15983,Free of (attribute),Airway Hemangioma,0
15984,Residue on Tongue,Primary Cutaneous Plasmablastic Lymphoma,0
15985,Adult Lymphoma,Childhood Lymphoma,0
15986,Female Reproductive System,Cancer of Urinary Tract,0
15987,Derivation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15988,Primary malignant neoplasm,Acute lymphadenitis,0
15989,Benign Neoplasm,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
15990,Shin,Familial Hemophagocytic Lymphocytosis,0
15991,Symptoms aspect,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15992,Lymphatic Spread,Malignant melanoma of eyelid,0
15993,ocular sphere,Stage 0 Penile Cancer AJCC v8,0
15994,bony process,FIGO Stage II Ovarian Cancer,0
15995,Due to,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15996,Placement action,Metastatic Ductal Breast Carcinoma,0
15997,To,Tonsillar Carcinoma,0
15998,Biopsy,Intestinal Metaplasia of Bladder Urothelium,0
15999,Plasma Cells,Undifferentiated Endocervical Sarcoma,0
16000,Confirmed by,High Grade Glandular Intraepithelial Neoplasia,0
16001,DNA,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16002,metastatic qualifier,Localized Askin Tumor,0
16003,melanocyte,Primary Cutaneous Plasmablastic Lymphoma,0
16004,Unmarried person,Cancer of Urinary Tract,0
16005,Network,Mixed parotid tumor,0
16006,Diabetes,Extracranial Neuroblastoma,0
16007,Cell Device,Prostate Lymphoma,0
16008,Bothered by Night Sweats,Recurrent Uveal Melanoma,0
16009,Skin Aging,Intestinal Metaplasia of Bladder Urothelium,0
16010,Common (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16011,Poor coordination,Localized Ewing Sarcoma,0
16012,Opening,Liver Cavernous Hemangioma,0
16013,Including (qualifier),Acantholytic squamous cell carcinoma,0
16014,Approximate,Mucinous cystadenofibroma,0
16015,development aspects,Refractory Barrett Esophagus,0
16016,Human body,Cartilaginous exostosis,0
16017,Immunotherapy,Human Papillomavirus-Related Carcinoma,0
16018,NCI CTEP SDC Penile Cancer Sub-Category Terminology,FIGO Stage II Ovarian Cancer,0
16019,Specimen Source Codes - tumor,Familial Hemophagocytic Lymphocytosis,0
16020,month,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16021,Cells,Recurrent Testicular Lymphoma,0
16022,Often - answer to question,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16023,Dysuria,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16024,Estimated,Xeroderma pigmentosum,0
16025,Sweat,Metastatic Lung Small Cell Carcinoma,0
16026,criteria,sarcoma of spinal cord,0
16027,Biologic Development,Diffuse malignant mesothelioma,0
16028,Related personal status,Localized Ewing Sarcoma,0
16029,Asians,Mucinous adenocarcinoma gastric,0
16030,Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16031,Common (qualifier value),Mucinous adenocarcinoma gastric,0
16032,See,Diffuse malignant mesothelioma,0
16033,Teratoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16034,Increase,Refractory Barrett Esophagus,0
16035,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,BRCA2 Syndrome,0
16036,Call (Instruction),Low Grade Squamous Intraepithelial Neoplasia,0
16037,Neoplasms,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16038,omit,Localized Ewing Sarcoma,0
16039,Contrast Media,Cerebral Primitive Neuroectodermal Tumor,0
16040,Lymphoma,Ovarian germ cell choriocarcinoma stage IV,0
16041,CDISC SDTM Procedure Terminology,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16042,Related personal status,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16043,Lesion of breast,Hemangioma,0
16044,Including (qualifier),Uterine Cancer,0
16045,Males,Blepharal carcinoma,0
16046,Mammal liver preparation,Cerebral Primitive Neuroectodermal Tumor,0
16047,PSA Level Greater than Fifty,Stage IB Lung Cancer AJCC v7,0
16048,Sounds device,Adult Alveolar Soft Part Sarcoma,0
16049,Immune,Cerebral hemangioma,0
16050,Characteristics,Medulloblastoma,0
16051,Occurrence Indicator,Chronic Myelomonocytic Leukemia-2,0
16052,Palmitic Acid,Malignant Neoplasm with Regional Lymph Node Involvement,0
16053,Precision - second,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
16054,Balance (substance),Adult Alveolar Soft Part Sarcoma,0
16055,Present,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16056,Adult Classical Hodgkin Lymphoma,Stage 0 Lip Carcinoma,0
16057,H/O: malignant neoplasm,Unfavorable Non-Hodgkin Lymphoma,0
16058,Known,Cancer of Urinary Tract,0
16059,Head - Component of Device,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
16060,Human Papilloma Virus Vaccine,Cancer of Urinary Tract,0
16061,Therapeutic procedure,Tonsillar Carcinoma,0
16062,Mean Percent of Normal,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
16063,Problems - What subject filter,Fourth Ventricle and Brain Stem Ependymal Tumor,0
16064,Mutation,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16065,Macrophage Activation Syndrome,Metastatic Neoplasm to the Gallbladder,0
16066,Congenital phimosis,Giant cell angiofibroma,0
16067,Experimental Result,Childhood Fibrillary Astrocytoma,0
16068,Symptoms,Ampulla of Vater Tubular Adenoma,0
16069,Aspects of congenital malformations,Intestinal Metaplasia of Bladder Urothelium,0
16070,Report (document),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16071,Childhood Non-Hodgkin Lymphoma,Ovarian Carcinoid Tumor,0
16072,Probable diagnosis,Germinoma,0
16073,Acquired phimosis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16074,seen,Malignant melanoma of eyelid,0
16075,Weighing patient,Thymic Clear Cell Carcinoma,0
16076,Liquid substance,Stage IV Childhood Non-Hodgkin Lymphoma,0
16077,include - SetOperator,Mucinous adenocarcinoma gastric,0
16078,Immunotherapy,Metastatic Carcinoma in the Lung,0
16079,70%,Deep Leiomyoma,0
16080,100%,Undifferentiated Neuroblastoma,0
16081,OVARIAN SWELLING,Refractory Barrett Esophagus,0
16082,Science of Etiology,Malignant melanoma of eyelid,0
16083,Severe Extremity Pain,Liver Cavernous Hemangioma,0
16084,Benign melanocytic nevus,Carcinoma of urinary bladder,0
16085,School Grade,Neonatal leukemia,0
16086,Pesticides,Localized Askin Tumor,0
16087,DNA Damage,Human Papillomavirus-Related Carcinoma,0
16088,Weight measurement scales,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16089,55,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16090,Early,Female Breast Carcinoma,0
16091,Class (taxonomic),Endometrial Small Cell Carcinoma,0
16092,Male population group,Cancer of Urinary Tract,0
16093,Poverty,Pancreatic Intraepithelial Neoplasia-3,0
16094,Crowding,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16095,diagnosis aspect,Mucinous adenocarcinoma gastric,0
16096,Negation,Recurrent Uveal Melanoma,0
16097,Malignant Childhood Neoplasm,Choroid Necrotic Melanoma,0
16098,Color,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16099,Bone marrow: lymphocytes (finding),Atypical Lobular Breast Hyperplasia,0
16100,75,Anterior Urethral Malignant Neoplasm,0
16101,70%,Liver Lymphangioma,0
16102,Present,Small cell neuroendocrine carcinoma of bladder,0
16103,Togo,Maxillary Sinus Adenocarcinoma,0
16104,Early,Diffuse malignant mesothelioma,0
16105,Sinus - general anatomical term,Contact dermatitis due to alkali,0
16106,Secondary Neoplasm,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
16107,Type A,Stage 0 Lip Carcinoma,0
16108,Gene Deletion Abnormality,Clonal Hematopoiesis of Indeterminate Potential,0
16109,removal technique,Unresectable Rhabdomyosarcoma,0
16110,Possibly Related to Intervention,Mixed parotid tumor,0
16111,Squamous cell carcinoma - category,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16112,Have Weight Loss,Adenocarcinoma,0
16113,Usually,BRCA2 Syndrome,0
16114,Skin,Pilocytic astrocytoma of cerebellum,0
16115,Body site,Neoplasms,0
16116,Skeletal,Childhood Cerebellar Neoplasm,0
16117,Tissue Specimen Code,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16118,Inguinal part of abdomen,Pancreatic Intraepithelial Neoplasia-3,0
16119,Malignant neoplasm of kidney,Advanced Uterine Corpus Carcinosarcoma,0
16120,Malignant Female Reproductive System Neoplasm,Low Grade Squamous Intraepithelial Neoplasia,0
16121,North America,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16122,Abdomen distended,Undifferentiated Endocervical Sarcoma,0
16123,Pediatrics,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
16124,Geographic Locations,Acute Undifferentiated Leukemia,0
16125,Canada,Carcinoma of urinary bladder,0
16126,Early,Childhood Choriocarcinoma,0
16127,Heart,gliosarcoma,0
16128,Membrane Device,Chronic Myelomonocytic Leukemia-2,0
16129,Usual,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16130,Wounds and Injuries,Primary Cutaneous Plasmablastic Lymphoma,0
16131,Cells,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16132,Name (property) (qualifier value),Chondrosarcoma,0
16133,Ectodermal,Familial Hemophagocytic Lymphocytosis,0
16134,Neurofibromatosis 1,Ichthyosis,0
16135,High,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
16136,alone - group size,Metastatic Malignant Neoplasm in the Sellar Region,0
16137,Useful,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16138,prior radiation therapy,Cerebral Primitive Neuroectodermal Tumor,0
16139,depend,Xeroderma pigmentosum,0
16140,Class (taxonomic),Blepharal carcinoma,0
16141,Target Lesion Identification,Thymic Clear Cell Carcinoma,0
16142,radiotherapeutic,Hodgkin lymphoma,0
16143,month,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16144,Anatomy aspects,Extracranial Neuroblastoma,0
16145,Financial Account,Uterine Cancer,0
16146,Detached,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
16147,shared attribute,Cartilaginous exostosis,0
16148,Term Birth,Childhood Thyroid Gland Follicular Carcinoma,0
16149,Coughing,benign mature teratoma of pancreas,0
16150,Melanoma Pathway,Bladder squamous cell carcinoma stage I,0
16151,Present,Diffuse malignant mesothelioma,0
16152,Weight Loss,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16153,Following,Granular Cell Leiomyosarcoma,0
16154,Lymphocyte component of blood,Cerebral Primitive Neuroectodermal Tumor,0
16155,Pelvic cavity structure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
16156,Occurrence Indicator,Angiosarcoma of liver,0
16157,Dietary Factors,Airway Hemangioma,0
16158,Common wart,Metastatic Malignant Neoplasm in the Sellar Region,0
16159,Relationships,Atypical Lobular Breast Hyperplasia,0
16160,Interventional procedure,Malignant melanoma of eyelid,0
16161,Body tissue,Lipoma of small intestine,0
16162,80%,Digestive System Hodgkin Lymphoma,0
16163,>90,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
16164,Time,Undifferentiated Endocervical Sarcoma,0
16165,Edema,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16166,Free (available (qualifier)),Adenocarcinoma,0
16167,Continuance of life,Localized Askin Tumor,0
16168,Glycoproteins,Cartilaginous exostosis,0
16169,Before values,benign mature teratoma of pancreas,0
16170,Infrequent,Chondrosarcoma,0
16171,growth aspects,Human Papillomavirus-Related Carcinoma,0
16172,Firstly,Childhood Fibrillary Astrocytoma,0
16173,Known,Stage IV Penile Cancer AJCC v7,0
16174,Adult Classical Hodgkin Lymphoma,Endometrial Small Cell Carcinoma,0
16175,Blood flow,Benign tumor of eyelid,0
16176,In Urine,Acantholytic squamous cell carcinoma,0
16177,Mobility aid,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
16178,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16179,To,Familial Hemophagocytic Lymphocytosis,0
16180,Classification of information,Spongiotic dermatitis,0
16181,Groups,Human Papillomavirus-Related Carcinoma,0
16182,Death (finding),Benign Apocrine Neoplasm,0
16183,Surgery specialty,Spermatocytic seminoma,0
16184,unknown vaccine or immune globulin,Neonatal leukemia,0
16185,Include (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16186,Edema,Hair nevus,0
16187,Stem of Organ,Sarcomatoid Renal Cell Carcinoma,0
16188,Obesity,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16189,Human body structure,Metastatic Lung Small Cell Carcinoma,0
16190,Therapeutic procedure,Choroid Necrotic Melanoma,0
16191,Lateral column (anatomical descriptor),High Grade Glandular Intraepithelial Neoplasia,0
16192,Dysuria,Liver Cavernous Hemangioma,0
16193,United States,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16194,SLC6A2 wt Allele,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16195,One,Undifferentiated Endocervical Sarcoma,0
16196,Include (action),Primary Cutaneous Plasmablastic Lymphoma,0
16197,Form:Finding:Point in time:{Setting}:Document:{Role},Cancer of Urinary Tract,0
16198,Usual,Diffuse malignant mesothelioma,0
16199,Tired,adenoid cystic carcinoma of lung,0
16200,Basis - conceptual entity,BRCA2 Syndrome,0
16201,Cell (compartment),Extra-Adrenal Paraganglioma,0
16202,Exons,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16203,Inflammation,Lipoma of small intestine,0
16204,Occurrence,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16205,Fever symptoms (finding),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
16206,Behavior,Adult Alveolar Soft Part Sarcoma,0
16207,Functional Relationship,Medulloblastoma,0
16208,Covers (device),FIGO Stage II Ovarian Cancer,0
16209,Tryptophanase,Metastatic Neoplasm to the Gallbladder,0
16210,1960s,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16211,Benign neoplasm of sweat gland,Benign tumor of eyelid,0
16212,Nicotiana tabacum,Recurrent Testicular Lymphoma,0
16213,Classic Histology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16214,Uncomplicated,Diffuse malignant mesothelioma,0
16215,Used by,Stage III Adult Immunoblastic Lymphoma,0
16216,Providing (action),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16217,Taxonomic,squamous cell carcinoma of the thyroid gland,0
16218,One,Cartilaginous exostosis,0
16219,Infant,Adult Alveolar Soft Part Sarcoma,0
16220,year,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16221,Head - Component of Device,Stage IB Lung Cancer AJCC v7,0
16222,Fallopian Tubes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16223,treatment - ActInformationManagementReason,Lipoma of small intestine,0
16224,treatment - ActInformationManagementReason,Tonsillar Carcinoma,0
16225,Retinoic Acid Response Element,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16226,Term (temporal),Human Papillomavirus-Related Carcinoma,0
16227,Decision,Adult Alveolar Soft Part Sarcoma,0
16228,Often - answer to question,Chronic Myelomonocytic Leukemia-2,0
16229,Therapeutic radiology procedure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16230,Participation Type - origin,Medulloblastoma,0
16231,Representation (action),Diffuse malignant mesothelioma,0
16232,Ureter,benign mature teratoma of pancreas,0
16233,Present,Thymic Clear Cell Carcinoma,0
16234,Primary malignant neoplasm,Endometrial Small Cell Carcinoma,0
16235,Severe Extremity Pain,adenosquamous carcinoma of breast,0
16236,Epithelial ovarian cancer,Uterine Cancer,0
16237,Bladder Infection,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16238,Percent (qualifier value),BRCA2 Syndrome,0
16239,Eye lid,malignant lymphoma of pancreatic lymph nodes,0
16240,Neutral - answer to question,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
16241,Universal HL7CMETAttribution,Testicular cancer metastatic,0
16242,radiotherapeutic,Stage IB Lung Cancer AJCC v7,0
16243,Never (frequency),Stage IV Childhood Non-Hodgkin Lymphoma,0
16244,Lymphocyte,Human Papillomavirus-Related Carcinoma,0
16245,Malignant Cell Count,Localized Ewing Sarcoma,0
16246,Pleurodesis,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16247,Rare,Anaplastic large cell lymphoma,0
16248,Male population group,Malignant melanoma of eyelid,0
16249,Primary malignant neoplasm,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16250,Body structure,Breast Ductal Adenoma,0
16251,Tumor cells,FIGO Stage II Ovarian Cancer,0
16252,member,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
16253,Wall of blood vessel,Female Breast Carcinoma,0
16254,Diagnosis,Atypical Mesothelial Hyperplasia,0
16255,Act Mood - intent,Malignant Testicular Sertoli Cell Tumor,0
16256,Related personal status,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16257,Close,Stage III Adult Immunoblastic Lymphoma,0
16258,Food allergenic extracts,Uterine Cancer,0
16259,Manufactured sign,Extra-Adrenal Paraganglioma,0
16260,Family history,Uterine Cancer,0
16261,Occurrence,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
16262,Problems - What subject filter,Stage IB Pancreatic Cancer AJCC v8,0
16263,Fever,Human Papillomavirus-Related Carcinoma,0
16264,epithelial,Malignant Neoplasm of Lung - Multiple Primary Sites,0
16265,Front of neck,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
16266,Drop (unit of presentation),Malignant Neoplasm with Regional Lymph Node Involvement,0
16267,Tubal Ligation,Pilocytic astrocytoma of cerebellum,0
16268,Formation,Recurrent Uveal Melanoma,0
16269,Adult Lymphoma,Non-Metastatic Gestational Trophoblastic Tumor,0
16270,Progestins,Serous cystadenocarcinoma ovary,0
16271,Embryonic Development,Platinum-Resistant Lung Small Cell Carcinoma,0
16272,Brain,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
16273,Symptoms,Primary Cutaneous Plasmablastic Lymphoma,0
16274,Pancreatic Cancer Pathway,Stage II Carcinoma of Penis,0
16275,depend,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16276,Juvenile,Diffuse malignant mesothelioma,0
16277,Pediatric Neoplasm,Platinum-Resistant Lung Small Cell Carcinoma,0
16278,morphological,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16279,Neoplasms,Malignant melanoma of eyelid,0
16280,Unit of Measure,Liver Cavernous Hemangioma,0
16281,0%,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16282,A Codes,Tonsillar Carcinoma,0
16283,Increase,Intestinal Metaplasia of Bladder Urothelium,0
16284,Relationships,Localized Askin Tumor,0
16285,Offspring,Malignant Neoplasm with Regional Lymph Node Involvement,0
16286,low exposure,Noninfiltrating Intraductal Carcinoma,0
16287,Oral region,Recurrent Testicular Lymphoma,0
16288,Neoplasm Metastasis,Cerebral Primitive Neuroectodermal Tumor,0
16289,Science of Etiology,Papillary cystic tumor,0
16290,Suspected diagnosis,Blepharal carcinoma,0
16291,PSA Level Less than Five,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
16292,Normal,Acute Undifferentiated Leukemia,0
16293,Times,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16294,therapeutic aspects,Placental aromatase deficiency,0
16295,Chemotherapy Regimen,High Grade Glandular Intraepithelial Neoplasia,0
16296,Occurrence Indicator,Colorectal cancer,0
16297,laparoscopy (therapeutic),Thymic Clear Cell Carcinoma,0
16298,Caucasians,Intraepithelial Melanocytic Hyperplasia,0
16299,Times,Diffuse malignant mesothelioma,0
16300,Mental Recall,BRCA2 Syndrome,0
16301,Platelets,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
16302,Palpebral margin,Non-Metastatic Gestational Trophoblastic Tumor,0
16303,Source,Neoplasms,0
16304,Abnormal Reference Range,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16305,diagnosis aspect,Localized Ewing Sarcoma,0
16306,Either,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16307,Due to,Recurrent Testicular Lymphoma,0
16308,Beginning,Blepharal carcinoma,0
16309,In Blood,Advanced Uterine Corpus Carcinosarcoma,0
16310,Fluid behavior,Breast Ductal Adenoma,0
16311,Six,Cartilaginous exostosis,0
16312,Out (direction),Intraepithelial Melanocytic Hyperplasia,0
16313,GUCY2C protein,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
16314,Toilet seat,Xeroderma pigmentosum,0
16315,Nodule,Cerebral Primitive Neuroectodermal Tumor,0
16316,AKR1A1 wt Allele,Testicular cancer metastatic,0
16317,treatment - ActInformationManagementReason,Unfavorable Non-Hodgkin Lymphoma,0
16318,Type A,Neonatal leukemia,0
16319,MOSTLY,Digestive System Hodgkin Lymphoma,0
16320,Frequently,Stage IB Pancreatic Cancer AJCC v8,0
16321,include - SetOperator,Tonsillar Carcinoma,0
16322,Weight decreased,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16323,Penis carcinoma,Undifferentiated Endocervical Sarcoma,0
16324,Symptoms aspect,Heavy Chain Deposition Disease,0
16325,Spreading (qualifier value),Small cell neuroendocrine carcinoma of bladder,0
16326,Morphology,Anaplastic large cell lymphoma,0
16327,Grouped (qualifier value),squamous cell carcinoma of the thyroid gland,0
16328,Body tissue,Refractory Barrett Esophagus,0
16329,Specimen Source Codes - tumor,Mucinous cystadenofibroma,0
16330,Before values,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16331,Persons,Ampulla of Vater Tubular Adenoma,0
16332,Analysis,Childhood Fibrillary Astrocytoma,0
16333,Mean Percent of Normal,Childhood Choriocarcinoma,0
16334,90%,Chronic Myelomonocytic Leukemia-2,0
16335,Childhood Lymphoma,Angiosarcoma of liver,0
16336,Trachea,Cartilaginous exostosis,0
16337,Concept model domain,Adenocarcinoma of the prostate metastatic,0
16338,Include (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16339,NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16340,Dietary Lead,Diffuse malignant mesothelioma,0
16341,Tumor cells,Pancreatic Intraepithelial Neoplasia-3,0
16342,Woman,Fourth Ventricle and Brain Stem Ependymal Tumor,0
16343,shared attribute,Bladder squamous cell carcinoma stage I,0
16344,*Type - Kind of quantity,Undifferentiated Endocervical Sarcoma,0
16345,1960s,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16346,Spreading (qualifier value),Primary Cutaneous Plasmablastic Lymphoma,0
16347,Pathological Dilatation,Acantholytic squamous cell carcinoma,0
16348,Smear - instruction imperative,Localized Askin Tumor,0
16349,Common (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16350,Imaging Techniques,Blepharal carcinoma,0
16351,Group Object,Intestinal Metaplasia of Bladder Urothelium,0
16352,Tract,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16353,Histamine Release,Benign tumor of eyelid,0
16354,Cream,Ichthyoses,0
16355,Most,Platinum-Resistant Lung Small Cell Carcinoma,0
16356,Lymphoma,Non-Metastatic Gestational Trophoblastic Tumor,0
16357,Decision,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16358,Age,Mucinous adenocarcinoma gastric,0
16359,Most,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16360,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16361,Third revision,Stage IB Pancreatic Cancer AJCC v8,0
16362,Synonym,Granular Cell Leiomyosarcoma,0
16363,Body Fluid Discharge,Advanced Uterine Corpus Carcinosarcoma,0
16364,10 days,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16365,Units Of Measure - lumen,Metastatic Carcinoma in the Lung,0
16366,Retinoic Acid Response Element,Leptomeningeal sarcoma,0
16367,Separated from cohabitee,Adult Alveolar Soft Part Sarcoma,0
16368,Primary malignant neoplasm,Sarcomatoid Renal Cell Carcinoma,0
16369,Melanins,Unfavorable Non-Hodgkin Lymphoma,0
16370,Child,Stage IB Lung Cancer AJCC v7,0
16371,Neoplasms,Benign neoplasm of thorax,0
16372,ethnic european,Adult Brain Stem Mixed Glioma,0
16373,Bilateral salpingectomy with oophorectomy,Mucinous adenocarcinoma gastric,0
16374,Pedunculated Lesion,Uterine Cancer,0
16375,medication - HL7 publishing domain,Female Breast Carcinoma,0
16376,Entity Determiner - specific,Localized Ewing Sarcoma,0
16377,Genetic Risk,Angiosarcoma of liver,0
16378,Primary,non-Hodgkin's lymphoma of spleen,0
16379,In Blood,Benign tumor of eyelid,0
16380,Case unit dose,Localized Askin Tumor,0
16381,How Much Distress Nausea,Grade 1 Clear Cell Renal Cell Carcinoma,0
16382,Occurrence Indicator,Angiosarcoma of liver,0
16383,Contain (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16384,Age at diagnosis,Mucinous adenocarcinoma gastric,0
16385,Usually,Low Grade Squamous Intraepithelial Neoplasia,0
16386,Normal,Adenocarcinoma of the prostate metastatic,0
16387,size,Mucinous adenocarcinoma gastric,0
16388,Occurrence,Placental aromatase deficiency,0
16389,To,Recurrent Testicular Lymphoma,0
16390,Specific qualifier value,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16391,Metastasis,Heavy Chain Deposition Disease,0
16392,Base Pairing,adenosquamous carcinoma of breast,0
16393,Spleen,Chondrosarcoma,0
16394,Cell Device,Heavy Chain Deposition Disease,0
16395,Financial Account,Colorectal High Grade B-Cell Lymphoma,0
16396,Lung,Human Papillomavirus-Related Carcinoma,0
16397,Management Occupations,Leiomyoma of Gallbladder,0
16398,Neonatal Abstinence Syndrome,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16399,various antiinfectives and antiseptics for local oral treatment,Small cell neuroendocrine carcinoma of bladder,0
16400,Thyroid Gland Follicular Cell,Hair nevus,0
16401,Before,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16402,Disintegration (morphologic abnormality),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16403,Nasolacrimal duct structure,Mucinous neoplasm,0
16404,Intracranial,GIANT PIGMENTED HAIRY NEVUS,0
16405,Present,Malignant neoplasm of thalamus,0
16406,Status post,Angiosarcoma of liver,0
16407,Close,Small cell neuroendocrine carcinoma of bladder,0
16408,Out (direction),Metastatic Kidney Carcinoma,0
16409,Does swallow,Carcinoma of urinary bladder,0
16410,85,Low Grade Squamous Intraepithelial Neoplasia,0
16411,Type - attribute,Undifferentiated Endocervical Sarcoma,0
16412,Regular,Malignant melanoma of eyelid,0
16413,Gestational trophoblastic disease,Angiosarcoma of liver,0
16414,Breast Carcinoma,Liver Lymphangioma,0
16415,Muscle Pain,High Grade Glandular Intraepithelial Neoplasia,0
16416,Precancerous Conditions,Acantholytic squamous cell carcinoma,0
16417,NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology,Werner Syndrome,0
16418,Stage 3B,Xeroderma pigmentosum,0
16419,Upper arm,Airway Hemangioma,0
16420,Aluminum measurement,Intraepithelial Melanocytic Hyperplasia,0
16421,Pediculus humanus capitis (eukaryote),Grade 3a Malignant Neoplasm,0
16422,survival aspects,Refractory Barrett Esophagus,0
16423,Lymphocyte Count measurement,Localized Askin Tumor,0
16424,Universities,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16425,Relationships,Blepharal carcinoma,0
16426,Cicatrix,Spermatocytic seminoma,0
16427,Taxonomic,Pilocytic astrocytoma of cerebellum,0
16428,Two,Xeroderma pigmentosum,0
16429,Sore to touch,Stage IB Pancreatic Cancer AJCC v8,0
16430,Over (spatial),embryonal rhabdomyosarcoma of prostate,0
16431,Carcinoid Tumor,Undifferentiated Endocervical Sarcoma,0
16432,Links List,Stage IB Lung Cancer AJCC v7,0
16433,Coating (film),Deep Leiomyoma,0
16434,Anatomic Site,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16435,Per Millimeter,Stage 0 Penile Cancer AJCC v8,0
16436,1+ Score,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
16437,Used by,Leptomeningeal sarcoma,0
16438,PSA Level Less than Two,Intraepithelial Melanocytic Hyperplasia,0
16439,Benign,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16440,research subject screening,Breast Ductal Adenoma,0
16441,Melanins,Cancer of Urinary Tract,0
16442,Glioblastoma,Stage III Adult Immunoblastic Lymphoma,0
16443,ovarian neoplasm,Methotrexate-Associated Hodgkin Lymphoma,0
16444,Referral placed,papillary carcinoma of penis,0
16445,Phase,Digestive System Hodgkin Lymphoma,0
16446,800,Ichthyosis,0
16447,Respiratory distress,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16448,Gait normal,Diffuse malignant mesothelioma,0
16449,Intraductal papillary mucinous neoplasm,embryonal rhabdomyosarcoma of prostate,0
16450,Cover (physical object),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16451,Change in voice (finding),FIGO Stage II Ovarian Cancer,0
16452,Fever symptoms (finding),Primary Cutaneous Plasmablastic Lymphoma,0
16453,Superkingdom (taxonomic category),Primary Cutaneous Plasmablastic Lymphoma,0
16454,Overall,Refractory Glioma,0
16455,Glioblastoma Multiforme,Stage II Carcinoma of Penis,0
16456,Binding Sites,Methotrexate-Associated Hodgkin Lymphoma,0
16457,Adult Myelodysplastic Syndrome,Clonal Hematopoiesis of Indeterminate Potential,0
16458,Swollen Lymph Node,Endometrial Small Cell Carcinoma,0
16459,Malignant Neoplasms,Secondary malignant neoplasm of lymph node,0
16460,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Tonsillar Carcinoma,0
16461,Availability of,Malignant melanoma of eyelid,0
16462,100%,Extracranial Neuroblastoma,0
16463,Tissue membrane,Intestinal Metaplasia of Bladder Urothelium,0
16464,Laminar,Digestive System Hodgkin Lymphoma,0
16465,Bone Marrow Cells,Stage IB Pancreatic Cancer AJCC v8,0
16466,How Often Itching,Intraepithelial Melanocytic Hyperplasia,0
16467,National origin,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16468,Characteristics,Giant cell angiofibroma,0
16469,Physical findings,Bladder squamous cell carcinoma stage I,0
16470,Tree Node,benign mature teratoma of pancreas,0
16471,Function (attribute),Ampulla of Vater Tubular Adenoma,0
16472,X-linked inheritance,Intraepithelial Melanocytic Hyperplasia,0
16473,Skin Angiosarcoma,Undifferentiated Endocervical Sarcoma,0
16474,Workers,Lipoma of small intestine,0
16475,Group A (blood group),Stage 0 Lip Carcinoma,0
16476,60%,Cerebral Primitive Neuroectodermal Tumor,0
16477,Fluid behavior,Unfavorable Non-Hodgkin Lymphoma,0
16478,1960s,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16479,CEL gene,High Grade Glandular Intraepithelial Neoplasia,0
16480,Treatment Epoch,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16481,Certain (qualifier value),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16482,Extrinsic,Giant cell angiofibroma,0
16483,Symptoms aspect,Neonatal leukemia,0
16484,Exact (qualifier),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16485,Bone Pain,Stage III Adult Immunoblastic Lymphoma,0
16486,Symptoms,Intraepithelial Melanocytic Hyperplasia,0
16487,International Classification of Diseases for Oncology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16488,Chorionic Gonadotropin,Undifferentiated Endocervical Sarcoma,0
16489,Overlap,embryonal rhabdomyosarcoma of prostate,0
16490,Extension,papillary carcinoma of penis,0
16491,Sore sensation,Unresectable Rhabdomyosarcoma,0
16492,Neoplasms,Giant cell angiofibroma,0
16493,Cancer Remission,mucinous adenocarcinoma of gallbladder,0
16494,Small,adenosquamous carcinoma of breast,0
16495,Administration type,Testicular cancer metastatic,0
16496,Laryngeal papillomatosis,embryonal rhabdomyosarcoma of prostate,0
16497,Tonsil,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
16498,Agreement,Intestinal Metaplasia of Bladder Urothelium,0
16499,Complete,Recurrent Testicular Lymphoma,0
16500,Including (qualifier),Pancreatic Intraepithelial Neoplasia-3,0
16501,95,Malignant neoplasm of thalamus,0
16502,Stress,Mucinous cystadenofibroma,0
16503,Front of neck,Neonatal leukemia,0
16504,Blood Vessel,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16505,therapeutic aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16506,Following,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16507,Structure of posterior spinal artery,Mixed parotid tumor,0
16508,Hair Diseases,Cerebral Primitive Neuroectodermal Tumor,0
16509,Infrequent,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
16510,Fifth,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16511,Communicable Diseases,Undifferentiated Neuroblastoma,0
16512,Vertebrates,Acute lymphadenitis,0
16513,Biopsy,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16514,Accessory,Cerebral hemangioma,0
16515,Early,Liver Cavernous Hemangioma,0
16516,Lung,Anaplastic large cell lymphoma,0
16517,Feature,Metastatic Malignant Neoplasm in the Sellar Region,0
16518,Barrett Esophagus,Intraepithelial Melanocytic Hyperplasia,0
16519,Occur (action),Carcinoma of urinary bladder,0
16520,Front of neck,Methotrexate-Associated Hodgkin Lymphoma,0
16521,Asia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16522,Diagnostic Imaging,non-Hodgkin's lymphoma of spleen,0
16523,Introduction procedure,Mucinous adenocarcinoma gastric,0
16524,BRCA2 protein,Cerebral Primitive Neuroectodermal Tumor,0
16525,Daily Living,Mucinous adenocarcinoma gastric,0
16526,World,Uterine Cancer,0
16527,failed,Medulloblastoma,0
16528,Food allergenic extracts,Stage IB Pancreatic Cancer AJCC v8,0
16529,Neoplasms,Extracranial Neuroblastoma,0
16530,Treatment Epoch,Neoplasms,0
16531,Name,Recurrent Testicular Lymphoma,0
16532,Small Cell Lung Cancer Pathway,Acute Undifferentiated Leukemia,0
16533,What subject filter - Result,Intestinal Neuroendocrine Carcinoma,0
16534,Injury wounds,Thymic Clear Cell Carcinoma,0
16535,TARSAL-CARPAL COALITION SYNDROME,Anterior Urethral Malignant Neoplasm,0
16536,Comprehension,Thymic Clear Cell Carcinoma,0
16537,Sex Behavior,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16538,Age,Atypical Lobular Breast Hyperplasia,0
16539,radiotherapeutic,Angiosarcoma of liver,0
16540,Project,Adult Alveolar Soft Part Sarcoma,0
16541,Tumor site,Locally Advanced Soft Tissue Sarcoma,0
16542,Structure of parenchyma of lung,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16543,Removed,Female Breast Carcinoma,0
16544,Cancer Genus,Keratoderma,0
16545,biopsy characteristics,Platinum-Resistant Lung Small Cell Carcinoma,0
16546,Japan,High Grade Glandular Intraepithelial Neoplasia,0
16547,veterans alcoholism screening test (VAST),Spermatocytic seminoma,0
16548,Lymphatic vessel,Chondrosarcoma,0
16549,Ulcer,Stage III Adult Immunoblastic Lymphoma,0
16550,Carcinoma,Childhood Central Nervous System Immature Teratoma,0
16551,Occur (action),Localized Askin Tumor,0
16552,Experimental Result,Adult Hepatocellular Carcinoma,0
16553,Occurrence Indicator,Secondary malignant neoplasm of lymph node,0
16554,VARIOUS DRUG CLASSES IN ATC,Atypical Mesothelial Hyperplasia,0
16555,Unknown GENC,Metastatic Ductal Breast Carcinoma,0
16556,Include (action),Recurrent Testicular Lymphoma,0
16557,Infrequent,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16558,Hematopoietic Neoplasms,Stage IV Childhood Non-Hodgkin Lymphoma,0
16559,Merkel cell carcinoma,Medulloblastoma,0
16560,Lip structure,Liver Lymphangioma,0
16561,DNA Microarray Chip,Colorectal Neuroendocrine Tumor G2,0
16562,Body of penis,Thymic Clear Cell Carcinoma,0
16563,Occurrence,Urethral Carcinoma,0
16564,Usual,Human Papillomavirus-Related Carcinoma,0
16565,Very high,Recurrent Uveal Melanoma,0
16566,Patient Monitoring,Ichthyosis,0
16567,Formation,Breast Ductal Adenoma,0
16568,More,Familial Adenomatous Polyposis Associated Medulloblastoma,0
16569,Cancer Genus,Malignant neoplasm of choroid,0
16570,Foreskin of penis,FIGO Stage II Ovarian Cancer,0
16571,Descending,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16572,Net (qualifier),Recurrent Testicular Lymphoma,0
16573,Symptoms aspect,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16574,Characteristics,High Grade Glandular Intraepithelial Neoplasia,0
16575,morphological,Primary Cutaneous Plasmablastic Lymphoma,0
16576,Dysuria,papillary carcinoma of penis,0
16577,Term (lexical),GIANT PIGMENTED HAIRY NEVUS,0
16578,0%,BRCA2 Syndrome,0
16579,Science of Etiology,Mucinous adenocarcinoma gastric,0
16580,Death (finding),Advanced Uterine Corpus Carcinosarcoma,0
16581,Occurrence,Acute Undifferentiated Leukemia,0
16582,Call (Instruction),Heavy Chain Deposition Disease,0
16583,Therapeutic radiology procedure,Stage 0 Lip Carcinoma,0
16584,Time,Primary Cutaneous Plasmablastic Lymphoma,0
16585,biomedical tube device,Thymic Atypical Carcinoid Tumor,0
16586,Dietary Lead,Colorectal Neuroendocrine Tumor G2,0
16587,Occurrence Indicator,Adult Hepatocellular Carcinoma,0
16588,Subject - topic,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16589,nonmetastatic,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16590,Target Awareness - partial,Acute Undifferentiated Leukemia,0
16591,Swollen Lymph Node,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16592,Sexual Partners,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16593,Eye protection,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16594,Occurrence Indicator,Leptomeningeal sarcoma,0
16595,Show,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16596,Occurrence,Stage IB Pancreatic Cancer AJCC v8,0
16597,Cell Count,Airway Hemangioma,0
16598,Togo,Malignant melanoma of eyelid,0
16599,CEL gene,Metastatic Lung Small Cell Carcinoma,0
16600,Palmitic Acid,Human Papillomavirus-Related Carcinoma,0
16601,Skin Specimen,High Grade Glandular Intraepithelial Neoplasia,0
16602,Diagnosis,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
16603,CLEC4D gene,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16604,shared attribute,Malignant Testicular Sertoli Cell Tumor,0
16605,Tissue Specimen Code,Colorectal cancer,0
16606,Similarity,Collecting Duct Carcinoma of the Kidney,0
16607,Increased cerebrospinal fluid production,Testicular cancer metastatic,0
16608,Funds,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16609,Painful intercourse female,Thymic Clear Cell Carcinoma,0
16610,Does jump,Lipoma of small intestine,0
16611,Hyperlink,Pilocytic astrocytoma of cerebellum,0
16612,include - SetOperator,Mastocytosis,0
16613,Skeletal bone,Colorectal cancer,0
16614,Breast Carcinoma,Pilocytic astrocytoma of cerebellum,0
16615,Both ovaries,Larynx carcinoma recurrent,0
16616,Nursing interventions,adenoid cystic carcinoma of lung,0
16617,Upper surface of body of first segment of coccyx,malignant lymphoma of pancreatic lymph nodes,0
16618,Uterine Fibroids,Malignant melanoma of eyelid,0
16619,Inguinal part of abdomen,Adult Hepatocellular Carcinoma,0
16620,Feature,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16621,User Group,Ichthyoses,0
16622,Neoplasm Metastasis,non-Hodgkin's lymphoma of spleen,0
16623,Occurrence Indicator,Mucinous adenocarcinoma gastric,0
16624,Childhood Non-Hodgkin Lymphoma,Leptomeningeal sarcoma,0
16625,Malignant epithelioma,Undifferentiated Endocervical Sarcoma,0
16626,incidence of cases,Benign Carotid Body Paraganglioma,0
16627,Occur (action),Unfavorable Non-Hodgkin Lymphoma,0
16628,Cancer Genus,Undifferentiated Endocervical Sarcoma,0
16629,True primary (qualifier value),Diffuse malignant mesothelioma,0
16630,<50,Neoplasms,0
16631,Vascular,Metastatic Carcinoma in the Lung,0
16632,Immature Platelet,Extracranial Neuroblastoma,0
16633,One,Lung squamous cell carcinoma stage I,0
16634,Geographic Locations,Cancer of Urinary Tract,0
16635,Failure (biologic function),Malignant Neoplasm with Regional Lymph Node Involvement,0
16636,Tonsil,Malignant Testicular Sertoli Cell Tumor,0
16637,Affecting,Thymoma malignant recurrent,0
16638,diagnosis aspect,Larynx carcinoma recurrent,0
16639,primary tumor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16640,Precursor Cell Lymphoblastic Leukemia Lymphoma,Blepharal carcinoma,0
16641,Thin skin,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16642,High Risk Acute Leukemia,Malignant melanoma of eyelid,0
16643,Including (qualifier),Digestive System Hodgkin Lymphoma,0
16644,Including (qualifier),Lung Mucinous Cystadenoma,0
16645,Borg Category-Ratio 10 Perceived Exertion Score 5,Malignant neoplasm of thalamus,0
16646,Same,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16647,N+ (tumor staging),Cancer of Urinary Tract,0
16648,Hodgkin Disease,Female Breast Carcinoma,0
16649,Coding Subtest (WISC-V),embryonal rhabdomyosarcoma of prostate,0
16650,Present,Atypical Lobular Breast Hyperplasia,0
16651,Anatomic Site,Uterine Cancer,0
16652,Personal Contact,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16653,Name (property) (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16654,Treatment Epoch,Recurrent Uveal Melanoma,0
16655,seen,Uterine Cancer,0
16656,Result,embryonal rhabdomyosarcoma of prostate,0
16657,Diagnosis of exclusion,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16658,Electromagnetic Radiation,Unfavorable Non-Hodgkin Lymphoma,0
16659,Rapid,Carcinoma ex pleomorphic adenoma of parotid gland,0
16660,Variable (uniformity),Cancer of Urinary Tract,0
16661,Occurrence Indicator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16662,Urothelium,Intraepithelial Melanocytic Hyperplasia,0
16663,Actinic keratosis,Liver Lymphangioma,0
16664,Histologic,Stage I Adult Non-Hodgkin Lymphoma,0
16665,Cover (physical object),Carcinoma of urinary bladder,0
16666,60%,Pancreatic Intraepithelial Neoplasia-3,0
16667,Intestines,Undifferentiated Neuroblastoma,0
16668,Means,Digestive System Hodgkin Lymphoma,0
16669,Degree or extent,Acute Undifferentiated Leukemia,0
16670,cell transformation,Intestinal Neuroendocrine Carcinoma,0
16671,Specimen Source Codes - tumor,Unresectable Rhabdomyosarcoma,0
16672,Singular,Platinum-Resistant Lung Small Cell Carcinoma,0
16673,American College of Cardiology/American Heart Association Lesion Complexity Score C,Familial Hemophagocytic Lymphocytosis,0
16674,Chromosomal translocation,Metastatic Lung Small Cell Carcinoma,0
16675,Decrease,mucinous adenocarcinoma of gallbladder,0
16676,cancer location,Pilocytic astrocytoma of cerebellum,0
16677,per second,Intestinal Metaplasia of Bladder Urothelium,0
16678,Malignant epithelioma,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
16679,Term (temporal),Childhood Fibrillary Astrocytoma,0
16680,Involvement with,Endometrial Small Cell Carcinoma,0
16681,Acetaminophen [EPC],Stage I Adult Non-Hodgkin Lymphoma,0
16682,Clinical,FIGO Stage II Ovarian Cancer,0
16683,Abdomen distended,Cerebral Primitive Neuroectodermal Tumor,0
16684,Rate,Malignant melanoma of eyelid,0
16685,Anorexia,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16686,Count of entities,Cerebral hemangioma,0
16687,Diagnosis,High Grade Glandular Intraepithelial Neoplasia,0
16688,Renal Cell Carcinoma Pathway,Benign tumor of eyelid,0
16689,Group Object,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16690,Imaging Techniques,Intestinal Metaplasia of Bladder Urothelium,0
16691,Spreading (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16692,Surgical aspects,FIGO Stage II Ovarian Cancer,0
16693,Therapeutic radiology procedure,Mastocytosis,0
16694,NMYC Gene Amplification dysfunction,Localized Ewing Sarcoma,0
16695,Form of uterus,Human Papillomavirus-Related Carcinoma,0
16696,Arsenic,Benign neoplasm of thorax,0
16697,Basis,Benign neoplasm of thorax,0
16698,Soft Tissue Route of Drug Administration,Breast Ductal Adenoma,0
16699,shared attribute,Endometrial Small Cell Carcinoma,0
16700,Most,Grade 1 Clear Cell Renal Cell Carcinoma,0
16701,Science of Etiology,Benign Apocrine Neoplasm,0
16702,Woman,Mixed parotid tumor,0
16703,Impaired skin integrity,Digestive System Hodgkin Lymphoma,0
16704,Psychotherapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16705,Consultation,Benign Carotid Body Paraganglioma,0
16706,Aspect (characteristic),Chronic Myelomonocytic Leukemia-2,0
16707,Pelvis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16708,Uncontrolled,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16709,Malignant Neoplasms,Granular Cell Leiomyosarcoma,0
16710,Patch - Extended Release Film,Anterior Urethral Malignant Neoplasm,0
16711,Observed,Secondary malignant neoplasm of lymph node,0
16712,Tissue Specimen Code,Atypical Lobular Breast Hyperplasia,0
16713,Both ovaries,Cancer of Urinary Tract,0
16714,Japan,Adenocarcinoma,0
16715,Case unit dose,Metastatic Ductal Breast Carcinoma,0
16716,Chronic inflammation,Advanced Lung Carcinoma,0
16717,Accepted,Chronic Myelomonocytic Leukemia-2,0
16718,Often - answer to question,Colorectal High Grade B-Cell Lymphoma,0
16719,Early disease stage,Localized Ewing Sarcoma,0
16720,Gait normal,Hodgkin lymphoma,0
16721,Mucous body substance,Acute Undifferentiated Leukemia,0
16722,Active,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16723,Cancer Genus,Localized Ewing Sarcoma,0
16724,Immune System Finding,Maxillary Sinus Adenocarcinoma,0
16725,Relative Survival,Low Grade Squamous Intraepithelial Neoplasia,0
16726,Base - General Qualifier,High Grade Glandular Intraepithelial Neoplasia,0
16727,Togo,Carcinoma of urinary bladder,0
16728,Decrease,Malignant Neoplasm with Regional Lymph Node Involvement,0
16729,To,Neoplasms,0
16730,radiotherapeutic,Malignant Neoplasm with Regional Lymph Node Involvement,0
16731,Persistent,Diffuse malignant mesothelioma,0
16732,Call (Instruction),Lung Mucinous Cystadenoma,0
16733,4+ Answer to question,malignant lymphoma of pancreatic lymph nodes,0
16734,Set (Psychology),Liver Lymphangioma,0
16735,Secondary Neoplasm,Acute lymphadenitis,0
16736,geographic population,Bladder squamous cell carcinoma stage I,0
16737,Complete Trisomy 21 Syndrome,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
16738,Out (direction),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16739,Duct Device,Intracortical osteosarcoma,0
16740,Fever symptoms (finding),Uterine Cancer,0
16741,Antibiotics,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
16742,Involvement with,Neoplasms,0
16743,Often - answer to question,Activated B-cell type diffuse large B-cell lymphoma,0
16744,Structure of right thigh,Human Papillomavirus-Related Carcinoma,0
16745,Neoplastic disease,Clonal Hematopoiesis of Indeterminate Potential,0
16746,Dictionaries as Topic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16747,Mass of body region,Undifferentiated Endocervical Sarcoma,0
16748,Africa,Undifferentiated Endocervical Sarcoma,0
16749,Sometimes,Xeroderma pigmentosum,0
16750,Back Pain,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16751,Call (Instruction),Endometrial Small Cell Carcinoma,0
16752,Increase in size since previous mammogram,Acantholytic squamous cell carcinoma,0
16753,Leads (device),Ichthyosis,0
16754,Social Networks,Clonal Hematopoiesis of Indeterminate Potential,0
16755,Advanced phase,Mucinous adenocarcinoma gastric,0
16756,P-Glycoproteins,Locally Advanced Soft Tissue Sarcoma,0
16757,Two,Adult Alveolar Soft Part Sarcoma,0
16758,70%,Malignant melanoma of eyelid,0
16759,Eye,Bladder squamous cell carcinoma stage I,0
16760,Data Transformation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16761,Case unit dose,Endometrial Small Cell Carcinoma,0
16762,Pure Spanish horse breed (organism),FIGO Stage II Ovarian Cancer,0
16763,Mixed Neoplasm,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16764,Time (foundation metadata concept),Stage II Carcinoma of Penis,0
16765,Acid reflux,malignant lymphoma of pancreatic lymph nodes,0
16766,Shortened,FIGO Stage II Ovarian Cancer,0
16767,Numerous,Stage II Carcinoma of Penis,0
16768,Frequently,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16769,Physical findings,Xeroderma pigmentosum,0
16770,Usual Severity Shortness of Breath,squamous cell carcinoma of the thyroid gland,0
16771,What subject filter - Result,Liver Lymphangioma,0
16772,Myeloid neoplasm,Liver Lymphangioma,0
16773,include - SetOperator,Choroid Necrotic Melanoma,0
16774,Choroid plexus of cerebral hemisphere,Endometrial Small Cell Carcinoma,0
16775,month,Recurrent Testicular Lymphoma,0
16776,Excessive,Childhood Choriocarcinoma,0
16777,Similarity,Acute lymphadenitis,0
16778,Constant (qualifier),Grade 3a Malignant Neoplasm,0
16779,fluid - substance,Liver Lymphangioma,0
16780,Hereditary,Localized Askin Tumor,0
16781,90%,Low Grade Squamous Intraepithelial Neoplasia,0
16782,Binding action,Rhabdomyosarcoma with ganglionic differentiation,0
16783,Numbers,Breast Ductal Adenoma,0
16784,Medical Tent,Mixed parotid tumor,0
16785,status - In progress,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16786,Occur (action),Lipoma of small intestine,0
16787,Median (qualifier value),FIGO Stage II Ovarian Cancer,0
16788,Antibiotics,Malignant Neoplasm with Regional Lymph Node Involvement,0
16789,Use of,Neonatal leukemia,0
16790,Biomaterial Treatment,Localized Ewing Sarcoma,0
16791,Stem cell transplant,Intestinal Metaplasia of Bladder Urothelium,0
16792,respiratory gaseous exchange in organisms,Acute Undifferentiated Leukemia,0
16793,Thigh structure,Ovarian germ cell choriocarcinoma stage IV,0
16794,Better than Others,Collecting Duct Carcinoma of the Kidney,0
16795,Corner Minus,Methotrexate-Associated Hodgkin Lymphoma,0
16796,Hyperestrogenism,Adenocarcinoma,0
16797,How Often Weight Loss,Localized Askin Tumor,0
16798,High Risk Acute Leukemia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16799,Mutation,Acantholytic squamous cell carcinoma,0
16800,Well Differentiated,Malignant melanoma of eyelid,0
16801,Carcinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16802,Detectable,Thymic Clear Cell Carcinoma,0
16803,Usual,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16804,capsule (pharmacologic),adenoid cystic carcinoma of lung,0
16805,10%,Intraepithelial Melanocytic Hyperplasia,0
16806,Skin Erosion,Ovarian germ cell choriocarcinoma stage IV,0
16807,Obesity,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16808,Barrett Esophagus,Bladder squamous cell carcinoma stage I,0
16809,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,FIGO Stage II Ovarian Cancer,0
16810,Often - answer to question,Low Grade Squamous Intraepithelial Neoplasia,0
16811,Magnetic Resonance Imaging Study File,Chronic Myelomonocytic Leukemia-2,0
16812,United States,Neonatal leukemia,0
16813,Group Object,Acute Undifferentiated Leukemia,0
16814,Statistical Significance,Benign tumor of eyelid,0
16815,Exist,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16816,Several,Urethral Carcinoma,0
16817,US State,Xeroderma pigmentosum,0
16818,Gingiva,Childhood Fibrillary Astrocytoma,0
16819,Medications:-:Point in time:^Patient:-,Low Grade Squamous Intraepithelial Neoplasia,0
16820,Stensen's duct,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16821,Account number:Identifier:Point in time:^Patient:Nominal,Mucinous adenocarcinoma gastric,0
16822,melanoma,Metastatic Carcinoma in the Lung,0
16823,pharmacotherapeutic,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16824,Diagnosis Study,Liver Lymphangioma,0
16825,Disruptive,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16826,Human body structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16827,Body Fluid Discharge,Adult Alveolar Soft Part Sarcoma,0
16828,Logical Condition,Unfavorable Non-Hodgkin Lymphoma,0
16829,Result,Noninfiltrating Intraductal Carcinoma,0
16830,Eyelash,Human Papillomavirus-Related Carcinoma,0
16831,Divide,mucinous adenocarcinoma of gallbladder,0
16832,Persons,Digestive System Hodgkin Lymphoma,0
16833,Exposure to,sarcoma of spinal cord,0
16834,genetic aspects,Metastatic Malignant Neoplasm in the Sellar Region,0
16835,Time (foundation metadata concept),Diffuse malignant mesothelioma,0
16836,Discharge,Blepharal carcinoma,0
16837,Swollen Lymph Node,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16838,True primary (qualifier value),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16839,Scientific Study,Giant cell angiofibroma,0
16840,Referring,Metastatic Ductal Breast Carcinoma,0
16841,Small cell carcinoma of lung,Recurrent Uveal Melanoma,0
16842,Stable status,Blepharal carcinoma,0
16843,Telephone Extension Number,Recurrent Testicular Lymphoma,0
16844,Sample Range,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16845,MDFAttributeType - Fraction,Unresectable Rhabdomyosarcoma,0
16846,exception - ResponseLevel,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16847,Medical Device Emits Smoke,Malignant Testicular Sertoli Cell Tumor,0
16848,Cancer Genus,Recurrent Uveal Melanoma,0
16849,South,Stage IV Childhood Non-Hodgkin Lymphoma,0
16850,Primary malignant neoplasm of fallopian tube,Intestinal Neuroendocrine Carcinoma,0
16851,Sore sensation,mucinous adenocarcinoma of gallbladder,0
16852,Chemotherapy,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16853,Overall,FIGO Stage II Ovarian Cancer,0
16854,75,BRCA2 Syndrome,0
16855,More,Recurrent Uveal Melanoma,0
16856,Measurement,Childhood Fibrillary Astrocytoma,0
16857,Personal appearance,Acute Undifferentiated Leukemia,0
16858,Cell Count,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
16859,Near,Airway Hemangioma,0
16860,Base - General Qualifier,Ichthyosis,0
16861,Dermoid Cyst,Metastatic Ductal Breast Carcinoma,0
16862,American College of Cardiology/American Heart Association Lesion Complexity Score C,Leptomeningeal sarcoma,0
16863,Science of Etiology,Familial Adenomatous Polyposis Associated Medulloblastoma,0
16864,Often - answer to question,Diffuse malignant mesothelioma,0
16865,shared attribute,Maxillary Sinus Adenocarcinoma,0
16866,Increased tendency to bruise,Diffuse malignant mesothelioma,0
16867,general population,Familial Adenomatous Polyposis Associated Medulloblastoma,0
16868,Point Name,Medulloblastoma,0
16869,research subject screening,Lipoma of small intestine,0
16870,Obesity,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16871,Exogenous Factors,Stage 0 Penile Cancer AJCC v8,0
16872,Misdiagnosis,Placental aromatase deficiency,0
16873,Include (action),Cerebral Primitive Neuroectodermal Tumor,0
16874,Area,Acute Undifferentiated Leukemia,0
16875,Presentation,FIGO Stage II Ovarian Cancer,0
16876,fludarabine,Childhood Fibrillary Astrocytoma,0
16877,Study Control,Medulloblastoma,0
16878,Testiculo-,Diffuse malignant mesothelioma,0
16879,Young,embryonal rhabdomyosarcoma of prostate,0
16880,disease markers,Localized Askin Tumor,0
16881,Known,sarcoma of spinal cord,0
16882,year,Xeroderma pigmentosum,0
16883,Blood group A (finding),Blepharal carcinoma,0
16884,Hormone Therapy,Xeroderma pigmentosum,0
16885,System (unit of presentation),Unresectable Rhabdomyosarcoma,0
16886,Continuance of life,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16887,Percent (qualifier value),Medulloblastoma,0
16888,Followed by,Malignant neoplasm of thalamus,0
16889,Chest,Undifferentiated Endocervical Sarcoma,0
16890,Blue - answer to question,Acute Undifferentiated Leukemia,0
16891,Hematologic Neoplasms,Cerebral Primitive Neuroectodermal Tumor,0
16892,Cessation of life,FIGO Stage II Ovarian Cancer,0
16893,Divide,Low Grade Squamous Intraepithelial Neoplasia,0
16894,Science of Etiology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16895,Oral cavity,Testicular cancer metastatic,0
16896,Childhood Hodgkin Lymphoma,Neonatal leukemia,0
16897,Disease remission,Testicular cancer metastatic,0
16898,Primary,FIGO Stage II Ovarian Cancer,0
16899,Abdominal Cavity,Neonatal leukemia,0
16900,Death (finding),FIGO Stage II Ovarian Cancer,0
16901,Skin,Chronic Myelomonocytic Leukemia-2,0
16902,Operative Surgical Procedures,Acantholytic squamous cell carcinoma,0
16903,Mutation,Hodgkin lymphoma,0
16904,Retinoic Acid Response Element,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16905,Stage IV Breast Cancer AJCC v6 and v7,Ovarian germ cell choriocarcinoma stage IV,0
16906,Show,Tonsillar Carcinoma,0
16907,Type A,Cerebral Primitive Neuroectodermal Tumor,0
16908,Smoking,Leiomyoma of Gallbladder,0
16909,Natural History,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
16910,cancer classification,Metastatic Lung Small Cell Carcinoma,0
16911,Involvement with,Human Papillomavirus-Related Carcinoma,0
16912,biopsy characteristics,Liver Lymphangioma,0
16913,Removed,Testicular cancer metastatic,0
16914,Term (temporal),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16915,Formation,Anterior Urethral Malignant Neoplasm,0
16916,Act Relationship Type - occurrence,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16917,Did not receive therapy or drug for,Endometrial Small Cell Carcinoma,0
16918,Myeloproliferative disease,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16919,Packaging Case,Granular Cell Leiomyosarcoma,0
16920,Greater than one,Adenocarcinoma,0
16921,Order (action),Non-Metastatic Gestational Trophoblastic Tumor,0
16922,CDISC SEND Tumor Findings Results Terminology,Adult Fibrolamellar Carcinoma,0
16923,Ectoderm,Giant cell angiofibroma,0
16924,One,Clonal Hematopoiesis of Indeterminate Potential,0
16925,How Much Distress Pain,Hodgkin lymphoma,0
16926,Sample Range,Pancreatic Intraepithelial Neoplasia-3,0
16927,80%,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16928,Metastatic Neoplasm,Malignant neoplasm of thalamus,0
16929,59,Stage IV Penile Cancer AJCC v7,0
16930,Ability,Medulloblastoma,0
16931,More Often than Once a Day,Bladder squamous cell carcinoma stage I,0
16932,CEL gene,Stage I Adult Non-Hodgkin Lymphoma,0
16933,include - SetOperator,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16934,Severe Extremity Pain,Diffuse malignant mesothelioma,0
16935,Common Specifications in HL7 V3 Publishing,Breast Ductal Adenoma,0
16936,Geographic Locations,Intraepithelial Melanocytic Hyperplasia,0
16937,General surgery specialty,Benign Apocrine Neoplasm,0
16938,Sweat,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16939,epithelial,Placental aromatase deficiency,0
16940,Frequently,Thymic Atypical Carcinoid Tumor,0
16941,Contain (action),Bladder squamous cell carcinoma stage I,0
16942,Slight (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
16943,Biomaterial Treatment,BRCA2 Syndrome,0
16944,Recommendation,Stage IB Pancreatic Cancer AJCC v8,0
16945,Immune,Ovarian Carcinoid Tumor,0
16946,Vermilion border of lip,Benign neoplasm of thorax,0
16947,FAT1 wt Allele,Localized Askin Tumor,0
16948,Often - answer to question,Malignant melanoma of eyelid,0
16949,Term Birth,Leiomyoma of Gallbladder,0
16950,Disease,Neoplasms,0
16951,Etiology aspects,Stage IB Pancreatic Cancer AJCC v8,0
16952,Large,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16953,Breaking down,Stage 0 Penile Cancer AJCC v8,0
16954,Case unit dose,Hemangioma,0
16955,Additional,Stage 0 Penile Cancer AJCC v8,0
16956,Ovarian Carcinoma,Hodgkin lymphoma,0
16957,Mitosis,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16958,Biogenic Amines,BRCA2 Syndrome,0
16959,Tumor type,Acantholytic squamous cell carcinoma,0
16960,Age at menopause,Deep Leiomyoma,0
16961,Superkingdom (taxonomic category),Intracortical osteosarcoma,0
16962,1+ Score,Mucinous adenocarcinoma gastric,0
16963,Metastatic Neoplasm,Human Papillomavirus-Related Carcinoma,0
16964,900,Stage II Carcinoma of Penis,0
16965,How Much Distress Diarrhea,Anterior Urethral Malignant Neoplasm,0
16966,Pentaerythritol Tetranitrate,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16967,Process (qualifier value),Stage I Adult Non-Hodgkin Lymphoma,0
16968,Skin cell,Xeroderma pigmentosum,0
16969,Categories,embryonal rhabdomyosarcoma of prostate,0
16970,Firstly,Cancer of Urinary Tract,0
16971,filter information process,GIANT PIGMENTED HAIRY NEVUS,0
16972,Often - answer to question,Localized Ewing Sarcoma,0
16973,Percent (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
16974,Replaced by,Neonatal leukemia,0
16975,Fever,Benign tumor of eyelid,0
16976,Active,Recurrent Testicular Lymphoma,0
16977,Associated topography,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16978,Surrounding (qualifier value),Recurrent Testicular Lymphoma,0
16979,Acids,Benign Apocrine Neoplasm,0
16980,year,Acantholytic squamous cell carcinoma,0
16981,risk factors,Intraepithelial Melanocytic Hyperplasia,0
16982,Lymphocyte component of blood,embryonal rhabdomyosarcoma of prostate,0
16983,Togo,Xeroderma pigmentosum,0
16984,Adult,Acute Undifferentiated Leukemia,0
16985,Bladder Continence Question,Adult Hepatocellular Carcinoma,0
16986,1+ Score,Keratoderma,0
16987,Linear,Undifferentiated Endocervical Sarcoma,0
16988,development aspects,Stage IV Childhood Non-Hodgkin Lymphoma,0
16989,Swallowing G-code,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
16990,Screening,Larynx carcinoma recurrent,0
16991,Specimen Source Codes - Lesion,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16992,Visual Impairment,benign mature teratoma of pancreas,0
16993,Formed,embryonal rhabdomyosarcoma of prostate,0
16994,leukemia,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16995,Fever,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16996,Body part,Stage IV Penile Cancer AJCC v7,0
16997,potential,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
16998,Two,Grade 3a Malignant Neoplasm,0
16999,Used by,Benign Carotid Body Paraganglioma,0
17000,Body site,Recurrent Testicular Lymphoma,0
17001,Usually,Malignant melanoma of eyelid,0
17002,Workers,Diffuse malignant mesothelioma,0
17003,Adrenal Gland Pheochromocytoma,Mastocytosis,0
17004,Immune system,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17005,Derivative,Intraepithelial Melanocytic Hyperplasia,0
17006,Science of Etiology,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17007,active (HL7 RoleLink),Malignant Neoplasm of Lung - Multiple Primary Sites,0
17008,Overall,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17009,Internal,Breast Ductal Adenoma,0
17010,Including (qualifier),Tonsillar Carcinoma,0
17011,Aggressive behavior,Tonsillar Carcinoma,0
17012,Central Nervous System Neoplasms,Giant cell angiofibroma,0
17013,Varicella Virus Vaccine Live (Oka-Merck) strain,Diffuse malignant mesothelioma,0
17014,Affecting,Undifferentiated Endocervical Sarcoma,0
17015,Enlarged,Spongiotic dermatitis,0
17016,shared attribute,Tonsillar Carcinoma,0
17017,Call (Instruction),Malignant Neoplasm with Regional Lymph Node Involvement,0
17018,Waste Products,Undifferentiated Endocervical Sarcoma,0
17019,Gross (qualifier value),adenoid cystic carcinoma of lung,0
17020,Type - attribute,Thymic Clear Cell Carcinoma,0
17021,Type - attribute,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
17022,Lung,Stage 0 Penile Cancer AJCC v8,0
17023,Togo,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17024,Fungi,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
17025,Shortness of Breath Visual Analogue Scale,Stage IB Lung Cancer AJCC v7,0
17026,Multiple Myeloma,Neonatal leukemia,0
17027,Rate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17028,Hollow shape,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17029,Menopause present (finding),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17030,Calcium Channel Blockers,Intestinal Metaplasia of Bladder Urothelium,0
17031,International Foot,Stage II Carcinoma of Penis,0
17032,Relationships,Mucinous adenocarcinoma gastric,0
17033,Two,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17034,PSA Level Less than Five,Mucinous adenocarcinoma gastric,0
17035,To,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17036,Experimental Result,Recurrent Uveal Melanoma,0
17037,Females,Anterior Urethral Malignant Neoplasm,0
17038,Common Specifications in HL7 V3 Publishing,Carcinoma of urinary bladder,0
17039,NCI CTEP SDC Mastocytosis Sub-Category Terminology,Benign Apocrine Neoplasm,0
17040,Permanent,Adult Alveolar Soft Part Sarcoma,0
17041,Expiration,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17042,Blood,Noninfiltrating Intraductal Carcinoma,0
17043,Frequently,Mucinous adenocarcinoma gastric,0
17044,Cancer Genus,Tonsillar Carcinoma,0
17045,Most,Testicular cancer metastatic,0
17046,Antidepressive Agents,papillary carcinoma of penis,0
17047,Mucinous Adenocarcinoma,Placental aromatase deficiency,0
17048,Have Weight Loss,Childhood Fibrillary Astrocytoma,0
17049,general population,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17050,Increase,Malignant neoplasm of choroid,0
17051,Genetic Heterogeneity,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17052,Primary malignant neoplasm,Digestive System Hodgkin Lymphoma,0
17053,Manifestation of,Digestive System Hodgkin Lymphoma,0
17054,lymph nodes,Refractory Barrett Esophagus,0
17055,Deoxyribonucleic Acid Measurement,Recurrent Testicular Lymphoma,0
17056,Childhood Teratoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17057,Kidney Tubules,Benign Apocrine Neoplasm,0
17058,+5,Diffuse malignant mesothelioma,0
17059,Fallopian Tubes,Human Papillomavirus-Related Carcinoma,0
17060,Common (qualifier value),Undifferentiated Endocervical Sarcoma,0
17061,Smear - instruction imperative,Familial Adenomatous Polyposis Associated Medulloblastoma,0
17062,status - In progress,Human Papillomavirus-Related Carcinoma,0
17063,Type - attribute,Heavy Chain Deposition Disease,0
17064,Two,Female Breast Carcinoma,0
17065,Usually,Intracortical osteosarcoma,0
17066,Include (action),adenoid cystic carcinoma of lung,0
17067,Common (qualifier value),Serous cystadenocarcinoma ovary,0
17068,Paraneoplastic Syndromes,Localized Askin Tumor,0
17069,Main,Clonal Hematopoiesis of Indeterminate Potential,0
17070,Death (finding),papillary carcinoma of penis,0
17071,Estimated,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17072,Bone marrow: lymphocytes (finding),Endometrial Small Cell Carcinoma,0
17073,Histology,Small cell neuroendocrine carcinoma of bladder,0
17074,MOSTLY,Benign tumor of eyelid,0
17075,Used by,Thymic Clear Cell Carcinoma,0
17076,Parotid swelling,Cerebral Primitive Neuroectodermal Tumor,0
17077,cell type,Acantholytic squamous cell carcinoma,0
17078,Skin Specimen,Thymic Clear Cell Carcinoma,0
17079,Skin,Heavy Chain Deposition Disease,0
17080,consider,Malignant Testicular Sertoli Cell Tumor,0
17081,Diagnosis,Blepharal carcinoma,0
17082,Nose,Stage IB Pancreatic Cancer AJCC v8,0
17083,New,Childhood Thyroid Gland Follicular Carcinoma,0
17084,peritoneal,Malignant melanoma of eyelid,0
17085,*Type - Kind of quantity,Uterine Cancer,0
17086,Negation,Colorectal High Grade B-Cell Lymphoma,0
17087,Treatment Epoch,Female Breast Carcinoma,0
17088,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Locally Advanced Soft Tissue Sarcoma,0
17089,Compression,Carcinoma of urinary bladder,0
17090,Chemotherapy,Malignant melanoma of eyelid,0
17091,Disease,Diffuse malignant mesothelioma,0
17092,Poverty,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17093,Referring,Carcinoma of urinary bladder,0
17094,geographic population,Malignant neoplasm of thalamus,0
17095,United States,Digestive System Hodgkin Lymphoma,0
17096,Analysis of substances,Low Grade Squamous Intraepithelial Neoplasia,0
17097,Rare,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17098,Published Comment,Pilocytic astrocytoma of cerebellum,0
17099,Removed,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17100,SLC6A2 wt Allele,Stage II Carcinoma of Penis,0
17101,Therapeutic radiology procedure,papillary carcinoma of penis,0
17102,Appearance,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17103,Chest,Acute Undifferentiated Leukemia,0
17104,Soft Tissue Neoplasms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17105,Common (qualifier value),Mucinous adenocarcinoma gastric,0
17106,True primary (qualifier value),Uterine Cancer,0
17107,Group A (blood group),Undifferentiated Endocervical Sarcoma,0
17108,True,Stage 0 Penile Cancer AJCC v8,0
17109,Used by,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17110,peripheral blood,Malignant Testicular Sertoli Cell Tumor,0
17111,Type A,Malignant Testicular Sertoli Cell Tumor,0
17112,Moved to,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17113,Areas <moth>,Ichthyoses,0
17114,Indexes,Tonsillar Carcinoma,0
17115,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Intracortical osteosarcoma,0
17116,To,Clonal Hematopoiesis of Indeterminate Potential,0
17117,Symptoms,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17118,Building process,Malignant melanoma of eyelid,0
17119,Tired,Leptomeningeal sarcoma,0
17120,T-Cell Development,Medulloblastoma,0
17121,Mathematical Operator,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17122,Structure of choroid plexus,Serous cystadenocarcinoma ovary,0
17123,white blood cell type,FIGO Stage II Ovarian Cancer,0
17124,Include (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
17125,risk factors,BRCA2 Syndrome,0
17126,Have Been Vomiting,Testicular cancer metastatic,0
17127,Array Feature,Blepharal carcinoma,0
17128,Lacrimal duct,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17129,Human body structure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
17130,North America,FIGO Stage II Ovarian Cancer,0
17131,Occurrence,Cancer of Urinary Tract,0
17132,High risk of,Recurrent Testicular Lymphoma,0
17133,Specialized Stand Alone Plan - Vision,Malignant melanoma of eyelid,0
17134,Transection (procedure),Human Papillomavirus-Related Carcinoma,0
17135,Occurrence,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17136,Rest,Childhood Fibrillary Astrocytoma,0
17137,Well,FIGO Stage II Ovarian Cancer,0
17138,Infrequent,Stage III Adult Immunoblastic Lymphoma,0
17139,>90,mucinous adenocarcinoma of gallbladder,0
17140,Biological Transport,Acute Undifferentiated Leukemia,0
17141,+5,squamous cell carcinoma of the thyroid gland,0
17142,shared attribute,adenoid cystic carcinoma of lung,0
17143,Sometimes,Chondrosarcoma,0
17144,Complication Aspects,Anterior Urethral Malignant Neoplasm,0
17145,Presence of cells,Uterine Cancer,0
17146,Negative Selection,Malignant Testicular Sertoli Cell Tumor,0
17147,Occurrence Indicator,Cerebral Primitive Neuroectodermal Tumor,0
17148,majority,Diffuse malignant mesothelioma,0
17149,High risk,Undifferentiated Endocervical Sarcoma,0
17150,Symptoms,Intraepithelial Melanocytic Hyperplasia,0
17151,Pharmacotherapy,Unresectable Rhabdomyosarcoma,0
17152,Percent (qualifier value),Carcinoma ex pleomorphic adenoma of parotid gland,0
17153,Effectiveness,Thymic Clear Cell Carcinoma,0
17154,Decision,Recurrent Testicular Lymphoma,0
17155,Retinoic Acid Response Element,non-Hodgkin's lymphoma of spleen,0
17156,Adrenal Medulla,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17157,Abnormal cell,Metastatic Kidney Carcinoma,0
17158,N not otherwise specified Antibody,Recurrent Uveal Melanoma,0
17159,Cell Count,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
17160,Most,Extra-Adrenal Paraganglioma,0
17161,Decreasing,Xeroderma pigmentosum,0
17162,Intestinal cell,Cancer of Urinary Tract,0
17163,Back structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17164,Several,Malignant Neoplasm of Lung - Multiple Primary Sites,0
17165,Multiple malignancy,mucinous adenocarcinoma of gallbladder,0
17166,Did not receive therapy or drug for,Malignant Testicular Sertoli Cell Tumor,0
17167,Muscle (organ),Digestive System Hodgkin Lymphoma,0
17168,Population Group,embryonal rhabdomyosarcoma of prostate,0
17169,Rest,Unresectable Rhabdomyosarcoma,0
17170,Section (object),Childhood Thyroid Gland Follicular Carcinoma,0
17171,color additive,Larynx carcinoma recurrent,0
17172,Chemotherapy,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17173,Childhood Germ Cell Tumor,non-Hodgkin's lymphoma of spleen,0
17174,How Much Distress Nausea,Adrenal Rest Tumor,0
17175,Cause of Death,Malignant melanoma of eyelid,0
17176,Body structure,Neoplasms,0
17177,Cancer Genus,Uterine Cancer,0
17178,Related personal status,Adult Alveolar Soft Part Sarcoma,0
17179,Exposure to,Digestive System Hodgkin Lymphoma,0
17180,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Ovarian germ cell choriocarcinoma stage IV,0
17181,International Classification of Diseases,Benign Apocrine Neoplasm,0
17182,Examination finding,Recurrent Testicular Lymphoma,0
17183,Type A,Primary Cutaneous Plasmablastic Lymphoma,0
17184,Treating,Uterine Cancer,0
17185,Pale feces (finding),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17186,Germ Layers,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
17187,Buildup,Mixed parotid tumor,0
17188,Visit,Chronic Myelomonocytic Leukemia-2,0
17189,Five-year Survival Rate,Unfavorable Non-Hodgkin Lymphoma,0
17190,Categories,Stage 0 Penile Cancer AJCC v8,0
17191,Stem of Organ,Thymic Clear Cell Carcinoma,0
17192,Malignant Neoplasms,sarcoma of spinal cord,0
17193,Mammary Gland Parenchyma,Endometrial Small Cell Carcinoma,0
17194,Both kidneys,embryonal rhabdomyosarcoma of prostate,0
17195,Social group,Anterior Urethral Malignant Neoplasm,0
17196,various antiinfectives and antiseptics for local oral treatment,Breast Ductal Adenoma,0
17197,Neuroendocrine Tumors,Mucinous neoplasm,0
17198,Affecting,Diffuse malignant mesothelioma,0
17199,Transection (procedure),Clonal Hematopoiesis of Indeterminate Potential,0
17200,Therapeutic procedure,Cancer of Urinary Tract,0
17201,Spreading (qualifier value),Undifferentiated Neuroblastoma,0
17202,Treating,Intraepithelial Melanocytic Hyperplasia,0
17203,Carcinoma of lung,Benign Apocrine Neoplasm,0
17204,Childbirth,Liver Lymphangioma,0
17205,Bulbomembranous Urethra,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17206,Frequently,Female Breast Carcinoma,0
17207,Sore to touch,Grade 3a Malignant Neoplasm,0
17208,Urticaria,Neoplasms,0
17209,Oral contraception,Malignant Testicular Sertoli Cell Tumor,0
17210,Cell Count,sarcoma of spinal cord,0
17211,Diagnosis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17212,Common (qualifier value),Adenocarcinoma,0
17213,1980s,Intraepithelial Melanocytic Hyperplasia,0
17214,Reduced,Tonsillar Carcinoma,0
17215,Head and Neck Carcinoma,Pancreatic Intraepithelial Neoplasia-3,0
17216,How Often Vomiting,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17217,Diagnosis,Female Breast Carcinoma,0
17218,PSA Level Less than Two,Malignant melanoma of eyelid,0
17219,Hemangioma,Granular Cell Leiomyosarcoma,0
17220,Basis - conceptual entity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17221,Coloring Excipient,Liver Lymphangioma,0
17222,Malignant Neoplasms,Tonsillar Carcinoma,0
17223,Concept model range (foundation metadata concept),Botryoid-Type Embryonal Rhabdomyosarcoma,0
17224,Symptoms,Localized Askin Tumor,0
17225,To,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17226,Overall Survival,Pilocytic astrocytoma of cerebellum,0
17227,Different,Carcinoma of urinary bladder,0
17228,Circulatory Process,Low Grade Squamous Intraepithelial Neoplasia,0
17229,Cultured Cell Line,Testicular cancer metastatic,0
17230,Event Seriousness - Significant,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17231,Tobacco smoking behavior,Refractory Barrett Esophagus,0
17232,Histologic,Cancer of Urinary Tract,0
17233,intent,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17234,Assortment,mucinous adenocarcinoma of gallbladder,0
17235,Adult Lymphoma,Localized Ewing Sarcoma,0
17236,Removed,Malignant neoplasm of thalamus,0
17237,Uterus,Cartilaginous exostosis,0
17238,Simple,Spongiotic dermatitis,0
17239,Blood flow,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17240,Human Papillomavirus Positive,Metastatic Kidney Carcinoma,0
17241,metastatic qualifier,Contact dermatitis due to alkali,0
17242,include - SetOperator,benign mature teratoma of pancreas,0
17243,protein body,Mucinous adenocarcinoma gastric,0
17244,Alcohols,Hodgkin lymphoma,0
17245,Cells,Stage III Adult Immunoblastic Lymphoma,0
17246,Malignant Neoplasms,embryonal rhabdomyosarcoma of prostate,0
17247,Adult Diffuse Large B-Cell Lymphoma,Adenocarcinoma,0
17248,Fluid Balance,Stage IB Pancreatic Cancer AJCC v8,0
17249,Tryptophanase,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17250,Overall,Testicular cancer metastatic,0
17251,International Classification of Diseases for Oncology,Stage IB Pancreatic Cancer AJCC v8,0
17252,Have Shortness of Breath question,adenoid cystic carcinoma of lung,0
17253,site-specific telomere resolvase activity,Unfavorable Non-Hodgkin Lymphoma,0
17254,Division (action),Childhood Fibrillary Astrocytoma,0
17255,Did not receive therapy or drug for,Recurrent Testicular Lymphoma,0
17256,Greater than one,Acute Undifferentiated Leukemia,0
17257,Infective cystitis,Secondary malignant neoplasm of lymph node,0
17258,Occurrence Indicator,Xeroderma pigmentosum,0
17259,Leakage,Malignant melanoma of eyelid,0
17260,Retinoic Acid Response Element,Tonsillar Carcinoma,0
17261,0%,embryonal rhabdomyosarcoma of prostate,0
17262,Nose,Colorectal cancer,0
17263,Childbirth,Adult Alveolar Soft Part Sarcoma,0
17264,Cancer Remission,Placental aromatase deficiency,0
17265,Time (foundation metadata concept),Cancer of Urinary Tract,0
17266,Type - attribute,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17267,Prevention Study,Spongiotic dermatitis,0
17268,Exposure to radiation,Low Grade Squamous Intraepithelial Neoplasia,0
17269,Abnormal,Recurrent Testicular Lymphoma,0
17270,Epithelial cell count (procedure),Larynx carcinoma recurrent,0
17271,Specimen Source Codes - tumor,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
17272,Trauma,Blepharal carcinoma,0
17273,Tumor Mass,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17274,Adult Classical Hodgkin Lymphoma,Diffuse malignant mesothelioma,0
17275,Known,Non-Metastatic Gestational Trophoblastic Tumor,0
17276,Third,Localized Askin Tumor,0
17277,Spreading (qualifier value),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17278,Persons,Angiosarcoma of liver,0
17279,Renal carcinoma,Recurrent Testicular Lymphoma,0
17280,To,Stage IV Penile Cancer AJCC v7,0
17281,Death (finding),Human Papillomavirus-Related Carcinoma,0
17282,Solid,Metastatic Ductal Breast Carcinoma,0
17283,Scientific Control,Stage 0 Penile Cancer AJCC v8,0
17284,Used by,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17285,Percent of Bacteria,Adenocarcinoma,0
17286,Squamous Epithelial Cells,Keratoderma,0
17287,Rare,Human Papillomavirus-Related Carcinoma,0
17288,Common Specifications in HL7 V3 Publishing,Cartilaginous exostosis,0
17289,Specific qualifier value,Lipoma of small intestine,0
17290,Hormones,Undifferentiated Endocervical Sarcoma,0
17291,Primary malignant neoplasm,Cancer of Urinary Tract,0
17292,leukemia,Tonsillar Carcinoma,0
17293,Extravasation,benign mature teratoma of pancreas,0
17294,Surgical aspects,Mucinous adenocarcinoma gastric,0
17295,Therapeutic radiology procedure,Primary Cutaneous Plasmablastic Lymphoma,0
17296,Major,Acute Undifferentiated Leukemia,0
17297,Arsenic measurement,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17298,To,Cerebral Primitive Neuroectodermal Tumor,0
17299,Affecting,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17300,Females,Testicular cancer metastatic,0
17301,Exposure to,Mucinous adenocarcinoma gastric,0
17302,Cure (remedy),Acantholytic squamous cell carcinoma,0
17303,Swollen Lymph Node,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17304,Disorder of lymph node,Malignant Neoplasm with Regional Lymph Node Involvement,0
17305,MYELODYSPLASTIC SYNDROME,Female Breast Carcinoma,0
17306,High,Mucinous adenocarcinoma gastric,0
17307,Common (qualifier value),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17308,Main,Liver Lymphangioma,0
17309,Ovarian Carcinoma,Blepharal carcinoma,0
17310,Secondary Neoplasm,Childhood Fibrillary Astrocytoma,0
17311,70%,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17312,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
17313,Agenesis of corpus callosum,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17314,3+ Score,Maxillary Sinus Adenocarcinoma,0
17315,Providing (action),Diffuse malignant mesothelioma,0
17316,Critical,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17317,Rare,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
17318,Aspects of signs,Stage IB Pancreatic Cancer AJCC v8,0
17319,User Group,Clonal Hematopoiesis of Indeterminate Potential,0
17320,How Much Distress Weight Loss,Localized Askin Tumor,0
17321,Cervix Uteri,Familial Adenomatous Polyposis Associated Medulloblastoma,0
17322,Congenital Abnormality,Localized Ewing Sarcoma,0
17323,Aggressive behavior,Malignant neoplasm of choroid,0
17324,Smear - instruction imperative,Angiosarcoma of liver,0
17325,Excision,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17326,Lymphocyte,Benign tumor of eyelid,0
17327,Basis - conceptual entity,Hemangioma,0
17328,Requirement,Acute Undifferentiated Leukemia,0
17329,Cure (remedy),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17330,Plumbum metallicum,Childhood Central Nervous System Immature Teratoma,0
17331,Main,Liver Lymphangioma,0
17332,Qualitative form,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17333,Science of Etiology,Spongiotic dermatitis,0
17334,Urine looks dark,Recurrent Testicular Lymphoma,0
17335,newly,Testicular cancer metastatic,0
17336,Type - attribute,Undifferentiated Endocervical Sarcoma,0
17337,Significant,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
17338,Few minutes,Clonal Hematopoiesis of Indeterminate Potential,0
17339,Body tissue,Spongiotic dermatitis,0
17340,Data operation - complete,Sarcomatoid Renal Cell Carcinoma,0
17341,Persons,Metastatic Neoplasm to the Gallbladder,0
17342,Cornea,Digestive System Hodgkin Lymphoma,0
17343,Administration procedure,Stage 0 Penile Cancer AJCC v8,0
17344,Within,Diffuse malignant mesothelioma,0
17345,World,Childhood Central Nervous System Immature Teratoma,0
17346,Type - attribute,Mucinous adenocarcinoma gastric,0
17347,Diagnosis Study,Undifferentiated Endocervical Sarcoma,0
17348,Adult Non-Hodgkin Lymphoma,Medulloblastoma,0
17349,Known,Digestive System Hodgkin Lymphoma,0
17350,Frequently,Uterine Cancer,0
17351,Fever symptoms (finding),Small cell neuroendocrine carcinoma of bladder,0
17352,Statistical Prevalence,Diffuse malignant mesothelioma,0
17353,Neoplasms,Lipoma of small intestine,0
17354,Subependymal Giant Cell Astrocytoma,Lipoma of small intestine,0
17355,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17356,50%,Methotrexate-Associated Hodgkin Lymphoma,0
17357,Neoplastic disease,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17358,63,Low Grade Squamous Intraepithelial Neoplasia,0
17359,Cyst,Undifferentiated Neuroblastoma,0
17360,Cells,Digestive System Hodgkin Lymphoma,0
17361,Complication Aspects,Stage IB Pancreatic Cancer AJCC v8,0
17362,Lesion,Methotrexate-Associated Hodgkin Lymphoma,0
17363,Cell Device,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17364,Disease,Mucinous adenocarcinoma gastric,0
17365,Malignant Neoplasms,Stage IV Penile Cancer AJCC v7,0
17366,Rate,Adult Alveolar Soft Part Sarcoma,0
17367,Urinary Bladder,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17368,Grade three rank,Adenocarcinoma of the prostate metastatic,0
17369,Contact Dermatitis,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17370,Usual Severity Weight Loss,Airway Hemangioma,0
17371,Decrease,Metastatic Neoplasm to the Gallbladder,0
17372,Qualitative form,Hemangioma,0
17373,Benign Neoplasm,Deep Leiomyoma,0
17374,Form:Finding:Point in time:{Setting}:Document:{Role},Thymic Clear Cell Carcinoma,0
17375,Stage,Methotrexate-Associated Hodgkin Lymphoma,0
17376,Plumbum metallicum,Malignant Neoplasm with Regional Lymph Node Involvement,0
17377,Expanding,Fourth Ventricle and Brain Stem Ependymal Tumor,0
17378,Drain number:ID:Pt:^Patient:Nom,Mucinous adenocarcinoma gastric,0
17379,Tryptophanase,Lipoma of small intestine,0
17380,Second edition,Undifferentiated Endocervical Sarcoma,0
17381,Pregnancy,Cerebral hemangioma,0
17382,Genitourinary system,Grade 3a Malignant Neoplasm,0
17383,Include (action),Acute Undifferentiated Leukemia,0
17384,low exposure,Spongiotic dermatitis,0
17385,Glioblastoma,Acantholytic squamous cell carcinoma,0
17386,Togo,Stage IB Pancreatic Cancer AJCC v8,0
17387,Cancer Genus,Recurrent Testicular Lymphoma,0
17388,Organ,benign mature teratoma of pancreas,0
17389,Rating (action),Atypical Mesothelial Hyperplasia,0
17390,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Stage IB Pancreatic Cancer AJCC v8,0
17391,Tests (qualifier value),Familial Adenomatous Polyposis Associated Medulloblastoma,0
17392,Skin,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17393,Mutation Abnormality,Ichthyoses,0
17394,burrow wound,Malignant Testicular Sertoli Cell Tumor,0
17395,Treating,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17396,Common (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
17397,Tryptophanase,Digestive System Hodgkin Lymphoma,0
17398,Chronic Lymphocytic Leukemia,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17399,20%,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17400,Classification,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17401,Experimental Result,Liver Lymphangioma,0
17402,Primary malignant neoplasm,Choroid Necrotic Melanoma,0
17403,Pharmacotherapy,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17404,Science of Statistics,Non-Metastatic Gestational Trophoblastic Tumor,0
17405,Left,Ovarian germ cell choriocarcinoma stage IV,0
17406,Indication of (contextual qualifier),Stage IB Pancreatic Cancer AJCC v8,0
17407,Antibiotics,Choroid Necrotic Melanoma,0
17408,Icterus,Mucinous adenocarcinoma gastric,0
17409,Iodides,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17410,Congenital qualifier,Malignant melanoma of eyelid,0
17411,Metastatic Neoplasm,sarcoma of spinal cord,0
17412,Foot,Adult Alveolar Soft Part Sarcoma,0
17413,Research Activities,Lung squamous cell carcinoma stage I,0
17414,Orchiectomy,Intraepithelial Melanocytic Hyperplasia,0
17415,United States,Adrenal Rest Tumor,0
17416,Pathogenic organism,Airway Hemangioma,0
17417,*Type - Kind of quantity,Recurrent Uveal Melanoma,0
17418,ethnic european,Thymic Clear Cell Carcinoma,0
17419,Common (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
17420,Child,Colorectal High Grade B-Cell Lymphoma,0
17421,Case unit dose,Diffuse malignant mesothelioma,0
17422,Flank (surface region),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17423,Abnormally high,Breast Ductal Adenoma,0
17424,Present,embryonal rhabdomyosarcoma of prostate,0
17425,Pancreas,Intraepithelial Melanocytic Hyperplasia,0
17426,classical example,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17427,Adult human body,Extracranial Neuroblastoma,0
17428,Expiration,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
17429,Biogenic Amines,Liver Cavernous Hemangioma,0
17430,Location,Acute Undifferentiated Leukemia,0
17431,Diagnosis Study,Benign Apocrine Neoplasm,0
17432,Case (situation),Childhood Thyroid Gland Follicular Carcinoma,0
17433,Eye foreign bodies,Atypical Lobular Breast Hyperplasia,0
17434,Malignant Neoplasms,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17435,Togo,Giant cell angiofibroma,0
17436,treatment - ActInformationManagementReason,Thymic Clear Cell Carcinoma,0
17437,World Health Organization,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17438,Mucins,Maxillary Sinus Adenocarcinoma,0
17439,Referring,Locally Advanced Soft Tissue Sarcoma,0
17440,Tumor Mass,Chronic Myelomonocytic Leukemia-2,0
17441,Childhood,Tonsillar Carcinoma,0
17442,Pharmacotherapy,Pancreatic Intraepithelial Neoplasia-3,0
17443,Racial group,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17444,Communicable Diseases,Familial Adenomatous Polyposis Associated Medulloblastoma,0
17445,health and disease,Leptomeningeal sarcoma,0
17446,Group A (qualifier value),Acute lymphadenitis,0
17447,Negation,Endometrial Small Cell Carcinoma,0
17448,Circulating Neoplastic Cells,Colorectal cancer,0
17449,80%,Leptomeningeal sarcoma,0
17450,Specific qualifier value,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17451,veterans alcoholism screening test (VAST),Digestive System Hodgkin Lymphoma,0
17452,Logical Condition,Angiosarcoma of liver,0
17453,Death NOS,Placental aromatase deficiency,0
17454,Overall Publication Type,Recurrent Testicular Lymphoma,0
17455,Hiatal Hernia,Mucinous adenocarcinoma gastric,0
17456,Sample Range,mucinous adenocarcinoma of gallbladder,0
17457,Chemotherapy,Locally Advanced Soft Tissue Sarcoma,0
17458,Experimental Result,Refractory Barrett Esophagus,0
17459,Family,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17460,Cancer Etiology,Cerebral Primitive Neuroectodermal Tumor,0
17461,Spreading (qualifier value),Cancer of Urinary Tract,0
17462,Mesothelial cell,Contact dermatitis due to alkali,0
17463,Monoclonal Gammopathy of Undetermined Significance,Adenocarcinoma of the prostate metastatic,0
17464,Discover,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17465,Group A (blood group),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17466,Formation,Chondrosarcoma,0
17467,Tumor site:Anat:Pt:Specimen:Nom,Blepharal carcinoma,0
17468,Entity Determiner - specific,Maxillary Sinus Adenocarcinoma,0
17469,Homo sapiens,gliosarcoma,0
17470,Antibodies,Heavy Chain Deposition Disease,0
17471,Disease,Clonal Hematopoiesis of Indeterminate Potential,0
17472,Occurrence Indicator,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17473,Family history,Refractory Barrett Esophagus,0
17474,pharmacotherapeutic,Acute Undifferentiated Leukemia,0
17475,Test Result,Stage III Adult Immunoblastic Lymphoma,0
17476,Primary malignant neoplasm,Mucinous adenocarcinoma gastric,0
17477,treatment - ActInformationManagementReason,Stage II Fallopian Tube Cancer,0
17478,Classification,Malignant Neoplasm with Regional Lymph Node Involvement,0
17479,Call (Instruction),Advanced Lung Carcinoma,0
17480,Bone structure of cranium,Localized Ewing Sarcoma,0
17481,Male population group,Mucinous adenocarcinoma gastric,0
17482,Most,Endometrial Small Cell Carcinoma,0
17483,Smoking,Cancer of Urinary Tract,0
17484,Average,Stage IB Lung Cancer AJCC v7,0
17485,metaplastic cell transformation,Undifferentiated Neuroblastoma,0
17486,Same,Leptomeningeal sarcoma,0
17487,Tryptophanase,embryonal rhabdomyosarcoma of prostate,0
17488,Secretory Vesicles,Childhood Fibrillary Astrocytoma,0
17489,Eye lid,Childhood Lymphoma,0
17490,pharmacotherapeutic,gliosarcoma,0
17491,Thickened,Recurrent Diffuse Intrinsic Pontine Glioma,0
17492,Birthmark,Heavy Chain Deposition Disease,0
17493,Physical findings,Cancer of Urinary Tract,0
17494,Test - temporal region,Carcinoma of urinary bladder,0
17495,Palatine Tonsil,Hemangioma,0
17496,Primary malignant neoplasm,Ichthyosis,0
17497,Feel Tired question,Digestive System Hodgkin Lymphoma,0
17498,Call (Instruction),Cartilaginous exostosis,0
17499,Renal pelvis,Placental aromatase deficiency,0
17500,Most,Thymic Clear Cell Carcinoma,0
17501,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Ovarian germ cell choriocarcinoma stage IV,0
17502,anaphylaxis,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17503,epithelial,sarcoma of spinal cord,0
17504,Joints,Thymic Atypical Carcinoid Tumor,0
17505,Skin,Acute Undifferentiated Leukemia,0
17506,Persons,Medulloblastoma,0
17507,Plumbum metallicum,Stage IV Childhood Non-Hodgkin Lymphoma,0
17508,60%,Endometrial Small Cell Carcinoma,0
17509,Malignant Neoplasms,Cancer of Urinary Tract,0
17510,Metastatic Neoplasm,Recurrent Testicular Lymphoma,0
17511,Five-year Survival Rate,Anterior Urethral Malignant Neoplasm,0
17512,Inguinal part of abdomen,Mucinous cystadenofibroma,0
17513,Serous Membrane,Benign Carotid Body Paraganglioma,0
17514,Sclera,FIGO Stage II Ovarian Cancer,0
17515,Known,Recurrent Uveal Melanoma,0
17516,Measuring ruler,Unresectable Rhabdomyosarcoma,0
17517,Science of Statistics,Fourth Ventricle and Brain Stem Ependymal Tumor,0
17518,Reduction procedure,Benign Apocrine Neoplasm,0
17519,Less Than,Colorectal cancer,0
17520,per year,squamous cell carcinoma of the thyroid gland,0
17521,Carcinoid Tumor,Anaplastic large cell lymphoma,0
17522,Tryptophanase,Pilocytic astrocytoma of cerebellum,0
17523,Cancer Genus,Carcinoma of urinary bladder,0
17524,Usual,Childhood Lymphoma,0
17525,Prognosis good,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17526,Location of Oral Residue Following Swallowing,Digestive System Hodgkin Lymphoma,0
17527,Sweat,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17528,Financial Account,Pancreatic Intraepithelial Neoplasia-3,0
17529,Function Axis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17530,Weight decreased,embryonal rhabdomyosarcoma of prostate,0
17531,Diagnosis Study,Undifferentiated Endocervical Sarcoma,0
17532,Itchiness,Bladder squamous cell carcinoma stage I,0
17533,Occur (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17534,Total thymectomy,squamous cell carcinoma of the thyroid gland,0
17535,Usual,Acute Undifferentiated Leukemia,0
17536,Onset of (contextual qualifier),Liver Lymphangioma,0
17537,Paraplegia,Contact dermatitis due to alkali,0
17538,Glioma,Leptomeningeal sarcoma,0
17539,Nucleated Thrombocyte Count,Advanced Uterine Corpus Carcinosarcoma,0
17540,Primary malignant neoplasm,Keratoderma,0
17541,2+,Localized Askin Tumor,0
17542,described,Malignant melanoma of eyelid,0
17543,Categories,Ovarian germ cell choriocarcinoma stage IV,0
17544,Headache,Pilocytic astrocytoma of cerebellum,0
17545,Major,Stage IV Childhood Non-Hodgkin Lymphoma,0
17546,Part of,Granular Cell Leiomyosarcoma,0
17547,Biogenic Amines,Locally Advanced Soft Tissue Sarcoma,0
17548,CDISC SEND Body System Terminology,Colorectal High Grade B-Cell Lymphoma,0
17549,Malignant - descriptor,Recurrent Testicular Lymphoma,0
17550,Africa,benign mature teratoma of pancreas,0
17551,How Much Distress Shortness of Breath,Unfavorable Non-Hodgkin Lymphoma,0
17552,Main,malignant lymphoma of pancreatic lymph nodes,0
17553,Name,Stage IB Pancreatic Cancer AJCC v8,0
17554,Type - attribute,Refractory Glioma,0
17555,Show,Testicular cancer metastatic,0
17556,Blood Products Laboratory Testing,Rhabdomyosarcoma with ganglionic differentiation,0
17557,Part of,Human Papillomavirus-Related Carcinoma,0
17558,65,Pilocytic astrocytoma of cerebellum,0
17559,Brain,Blepharal carcinoma,0
17560,Neoplasms,Fourth Ventricle and Brain Stem Ependymal Tumor,0
17561,Function (attribute),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17562,31,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17563,Catabolism,embryonal rhabdomyosarcoma of prostate,0
17564,therapeutic aspects,Colorectal cancer,0
17565,Benign neurologic neoplasms,Thymic Clear Cell Carcinoma,0
17566,Lymphoma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17567,Etiology aspects,Recurrent Uveal Melanoma,0
17568,Assortment,Contact dermatitis due to alkali,0
17569,therapeutic aspects,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17570,Characteristics,Cartilaginous exostosis,0
17571,Diffuse Large B-Cell Lymphoma,Recurrent Testicular Lymphoma,0
17572,Malignant Vaginal Neoplasm,Stage IB Lung Cancer AJCC v7,0
17573,Gene Mutant,Granular Cell Leiomyosarcoma,0
17574,Healthy,Extra-Adrenal Paraganglioma,0
17575,Abnormal coordination,Spongiotic dermatitis,0
17576,Medicine,Anterior Urethral Malignant Neoplasm,0
17577,Combined,Stage III Adult Immunoblastic Lymphoma,0
17578,Assisted (qualifier value),Mucinous adenocarcinoma gastric,0
17579,Several,Intraepithelial Melanocytic Hyperplasia,0
17580,Canada,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17581,Flushing,Anterior Urethral Malignant Neoplasm,0
17582,Including (qualifier),Carcinoma of urinary bladder,0
17583,Monoclonal Gammapathies,Blepharal carcinoma,0
17584,Group A (qualifier value),Mixed parotid tumor,0
17585,Non-Small Cell Lung Carcinoma,Mucinous adenocarcinoma gastric,0
17586,Brain part,Unfavorable Non-Hodgkin Lymphoma,0
17587,Application (Document),Primary Cutaneous Plasmablastic Lymphoma,0
17588,Sex Behavior,Hodgkin lymphoma,0
17589,Good,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17590,Initial (abbreviation),Medulloblastoma,0
17591,Blue - answer to question,Colorectal Neuroendocrine Tumor G2,0
17592,Treatment Effectiveness,Primary Cutaneous Plasmablastic Lymphoma,0
17593,Always (frequency),Stage IV Childhood Non-Hodgkin Lymphoma,0
17594,Fever symptoms (finding),Benign Carotid Body Paraganglioma,0
17595,Post,embryonal rhabdomyosarcoma of prostate,0
17596,Bacteria present,Xeroderma pigmentosum,0
17597,Table Cell Horizontal Align - left,Low Grade Squamous Intraepithelial Neoplasia,0
17598,status - In progress,Ovarian germ cell choriocarcinoma stage IV,0
17599,Male population group,Endometrial Small Cell Carcinoma,0
17600,Benign,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17601,Cerebral Cavernous Hemangioma,Benign Carotid Body Paraganglioma,0
17602,Biological Response Modifiers,Carcinoma ex pleomorphic adenoma of parotid gland,0
17603,Lower Urinary Tract Symptoms,Recurrent Uveal Melanoma,0
17604,Persons,Stage III Adult Immunoblastic Lymphoma,0
17605,First (number),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17606,Help document,Adenocarcinoma,0
17607,Rare,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17608,Testis,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17609,Abdominal bloating,Advanced Lung Carcinoma,0
17610,Pleomorphic,Human Papillomavirus-Related Carcinoma,0
17611,1+,Localized Askin Tumor,0
17612,Cause of death.underlying,Leiomyoma of Gallbladder,0
17613,Special,Medulloblastoma,0
17614,various other nasal preparations in ATC,Adult Hepatocellular Carcinoma,0
17615,Leading,Diffuse malignant mesothelioma,0
17616,Over (spatial),Colorectal Neuroendocrine Tumor G2,0
17617,Cause of death.underlying,Female Breast Carcinoma,0
17618,Hematopoiesis,Thymic Atypical Carcinoid Tumor,0
17619,Site of,Acute Undifferentiated Leukemia,0
17620,Treatment Epoch,Low Grade Squamous Intraepithelial Neoplasia,0
17621,Formation,Stage I Adult Non-Hodgkin Lymphoma,0
17622,Onset of (contextual qualifier),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17623,Cryptorchidism,Metastatic Neoplasm to the Gallbladder,0
17624,95,sarcoma of spinal cord,0
17625,With shape,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17626,Physiology,Metastatic Neoplasm to the Gallbladder,0
17627,Persons,Testicular cancer metastatic,0
17628,Experimental Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17629,Cavern,Heavy Chain Deposition Disease,0
17630,Fatigue,Recurrent Testicular Lymphoma,0
17631,Rare,Pancreatic Intraepithelial Neoplasia-3,0
17632,Targeted Therapy,Bladder squamous cell carcinoma stage I,0
17633,Surgery specialty,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17634,BRCA1 protein,adenoid cystic carcinoma of lung,0
17635,Symptoms,Testicular cancer metastatic,0
17636,Status post,Familial Hemophagocytic Lymphocytosis,0
17637,Numerous,Ovarian Carcinoid Tumor,0
17638,Primary malignant neoplasm of lung,Thymic Clear Cell Carcinoma,0
17639,Including (qualifier),Localized Askin Tumor,0
17640,cervical cancer,Anterior Urethral Malignant Neoplasm,0
17641,Usually Need Help from Another Person for Reach,Testicular cancer metastatic,0
17642,Location of Pharyngeal Residue Following Swallowing,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17643,mucosa-associated lymphoid tissue,Recurrent Testicular Lymphoma,0
17644,Negation,Mucinous adenocarcinoma gastric,0
17645,Administration procedure,Angiosarcoma of liver,0
17646,United States,Intraepithelial Melanocytic Hyperplasia,0
17647,Mass of body structure,Chronic Myelomonocytic Leukemia-2,0
17648,Half,Airway Hemangioma,0
17649,Drop - Unit of Volume,Testicular cancer metastatic,0
17650,SLC6A2 protein,Acute Undifferentiated Leukemia,0
17651,Marketing basis - Transitional,Non-Metastatic Gestational Trophoblastic Tumor,0
17652,Skin,Diffuse malignant mesothelioma,0
17653,Referral placed,Recurrent Uveal Melanoma,0
17654,Bathing,Malignant melanoma of eyelid,0
17655,Percent (qualifier value),Medulloblastoma,0
17656,Condition,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17657,Subcutaneous Tissue,Neoplasms,0
17658,Count Dosing Unit,Mastocytosis,0
17659,Occurrence,Non-Metastatic Gestational Trophoblastic Tumor,0
17660,Seizures,Larynx carcinoma recurrent,0
17661,Both ovaries,Acantholytic squamous cell carcinoma,0
17662,Bladder Neoplasm,Intraepithelial Melanocytic Hyperplasia,0
17663,Esthesia,Stage IV Childhood Non-Hodgkin Lymphoma,0
17664,*Type - Kind of quantity,Adenocarcinoma,0
17665,Increase,Blepharal carcinoma,0
17666,Frequently,Mucinous adenocarcinoma gastric,0
17667,1+ Score,Medulloblastoma,0
17668,High Mitosis-Karyorrhexis Index,Adult Alveolar Soft Part Sarcoma,0
17669,Specific qualifier value,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17670,Impaired skin integrity,Activated B-cell type diffuse large B-cell lymphoma,0
17671,Therapeutic radiology procedure,Acute lymphadenitis,0
17672,Sometimes,GIANT PIGMENTED HAIRY NEVUS,0
17673,Have Been Vomiting,Unfavorable Non-Hodgkin Lymphoma,0
17674,Common (qualifier value),Metastatic Ductal Breast Carcinoma,0
17675,Presentation,Acantholytic squamous cell carcinoma,0
17676,survive,Acute Undifferentiated Leukemia,0
17677,Sarcoma of soft tissue,Recurrent Uveal Melanoma,0
17678,Melanoma Pathway,Advanced Uterine Corpus Carcinosarcoma,0
17679,Common (qualifier value),Recurrent Testicular Lymphoma,0
17680,Diabetes Mellitus,Cancer of Urinary Tract,0
17681,Options,Ovarian germ cell choriocarcinoma stage IV,0
17682,point - UnitsOfMeasure,Acantholytic squamous cell carcinoma,0
17683,Options,Intraepithelial Melanocytic Hyperplasia,0
17684,International Classification of Disease for Oncology,papillary carcinoma of penis,0
17685,include - SetOperator,Leiomyoma of Gallbladder,0
17686,Lifetime,Primary Cutaneous Plasmablastic Lymphoma,0
17687,Spreading (qualifier value),Non-Metastatic Gestational Trophoblastic Tumor,0
17688,Polycythemia,Stage I Adult Non-Hodgkin Lymphoma,0
17689,Including (qualifier),Recurrent Uveal Melanoma,0
17690,Copy (object),Endometrial Small Cell Carcinoma,0
17691,Two,Ovarian Carcinoid Tumor,0
17692,Skin,Benign tumor of eyelid,0
17693,Weight decreased,Intraepithelial Melanocytic Hyperplasia,0
17694,Hormones,Granular Cell Leiomyosarcoma,0
17695,Gait normal,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17696,Work,Ichthyosis,0
17697,Cellular fibroma,Low Grade Squamous Intraepithelial Neoplasia,0
17698,Direct (qualifier),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
17699,Body part,Stage IB Pancreatic Cancer AJCC v8,0
17700,cancer therapy,Ovarian Carcinoid Tumor,0
17701,Etiology aspects,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17702,Part,Primary Cutaneous Plasmablastic Lymphoma,0
17703,Stomach structure,embryonal rhabdomyosarcoma of prostate,0
17704,Responsible to,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17705,Empty (qualifier),Chondrosarcoma,0
17706,Linear,Heavy Chain Deposition Disease,0
17707,Symptoms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17708,Males,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17709,Large,Non-Metastatic Gestational Trophoblastic Tumor,0
17710,shared attribute,Intestinal Metaplasia of Bladder Urothelium,0
17711,Malignant neoplasm of appendix,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17712,Vagina Carcinoma,Digestive System Hodgkin Lymphoma,0
17713,Etiology aspects,Lipoma of small intestine,0
17714,Exertion,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17715,Natural Killer Cells,Granular Cell Leiomyosarcoma,0
17716,chronic,Acantholytic squamous cell carcinoma,0
17717,2+ Score,Recurrent Uveal Melanoma,0
17718,Measures,Recurrent Testicular Lymphoma,0
17719,Lower (action),Metastatic Malignant Neoplasm in the Sellar Region,0
17720,Relationships,non-Hodgkin's lymphoma of spleen,0
17721,Growth,Childhood Fibrillary Astrocytoma,0
17722,Endocrine Cells,Female Breast Carcinoma,0
17723,Main,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17724,Cause of death.underlying,BRCA2 Syndrome,0
17725,AKR1A1 wt Allele,Diffuse malignant mesothelioma,0
17726,Greater,Cartilaginous exostosis,0
17727,Since,Familial Hemophagocytic Lymphocytosis,0
17728,Prognostic Factors,Digestive System Hodgkin Lymphoma,0
17729,Weight decreased,Testicular cancer metastatic,0
17730,Primary,Cancer of Urinary Tract,0
17731,Carcinoma in Situ,Mucinous neoplasm,0
17732,Malignant - descriptor,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
17733,Childhood Gliosarcoma,Adult Hepatocellular Carcinoma,0
17734,Confirm,Refractory Barrett Esophagus,0
17735,Location,Adult Alveolar Soft Part Sarcoma,0
17736,Active,Collecting Duct Carcinoma of the Kidney,0
17737,Small cell carcinoma of lung,Stage II Hepatocellular Carcinoma AJCC v8,0
17738,Back structure,Stage IB Lung Cancer AJCC v7,0
17739,depend,Localized Askin Tumor,0
17740,Cessation of life,Diffuse malignant mesothelioma,0
17741,Web Site,Airway Hemangioma,0
17742,Average of Value Derivation Technique,Acute Undifferentiated Leukemia,0
17743,Include (action),Carcinoma of urinary bladder,0
17744,inflammatory,Refractory Barrett Esophagus,0
17745,100%,sarcoma of spinal cord,0
17746,Lymphoid,Thymic Clear Cell Carcinoma,0
17747,Human Papillomavirus,Grade 3a Malignant Neoplasm,0
17748,Abnormal,BRCA2 Syndrome,0
17749,Common (qualifier value),Recurrent Uveal Melanoma,0
17750,One,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17751,Classification,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17752,Immune System Finding,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
17753,eTMF Content Model Code,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17754,TNM Staging System,Adenocarcinoma,0
17755,bony process,Human Papillomavirus-Related Carcinoma,0
17756,Skin,Digestive System Hodgkin Lymphoma,0
17757,Primary,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17758,Hepatitis Viruses,Chondrosarcoma,0
17759,Hematologic Neoplasms,Malignant Neoplasm with Regional Lymph Node Involvement,0
17760,Primary malignant neoplasm,Medulloblastoma,0
17761,65+,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17762,Rest,Benign Carotid Body Paraganglioma,0
17763,Occurrence Indicator,Benign Apocrine Neoplasm,0
17764,<3 (qualifier value),Digestive System Hodgkin Lymphoma,0
17765,High,Benign tumor of eyelid,0
17766,Group A (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17767,Tumor Mass,Anterior Urethral Malignant Neoplasm,0
17768,Age - 16,sarcoma of spinal cord,0
17769,Administration procedure,Carcinoma of urinary bladder,0
17770,Specimen Source Codes - Mucus,Stage IB Pancreatic Cancer AJCC v8,0
17771,Treating,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17772,Overall Well Being,mucinous adenocarcinoma of gallbladder,0
17773,GORAB gene,Recurrent Uveal Melanoma,0
17774,Never (frequency),Diffuse malignant mesothelioma,0
17775,Advanced phase,Placental aromatase deficiency,0
17776,Fatal,Intraepithelial Melanocytic Hyperplasia,0
17777,Fluid behavior,Anterior Urethral Malignant Neoplasm,0
17778,Group A (qualifier value),Non-Metastatic Gestational Trophoblastic Tumor,0
17779,Type A,Small cell neuroendocrine carcinoma of bladder,0
17780,Chemotherapy,Stage 0 Penile Cancer AJCC v8,0
17781,Occur (action),Chondrosarcoma,0
17782,Vision:-:Point in time:^Patient:-,Human Papillomavirus-Related Carcinoma,0
17783,Diabetes Mellitus,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17784,Distention of blood vessel,Adult Alveolar Soft Part Sarcoma,0
17785,Death (finding),Benign neoplasm of thorax,0
17786,Surgery specialty,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17787,To,Anaplastic large cell lymphoma,0
17788,Relationships,Tonsillar Carcinoma,0
17789,Cancer Genus,FIGO Stage II Ovarian Cancer,0
17790,Metastasis,Endometrial Small Cell Carcinoma,0
17791,Structure of lymphatic trunk,Stage 0 Penile Cancer AJCC v8,0
17792,United States,Recurrent Uveal Melanoma,0
17793,Sunlight,Mucinous adenocarcinoma gastric,0
17794,International Classification of Diseases for Oncology,Diffuse malignant mesothelioma,0
17795,Special,Spongiotic dermatitis,0
17796,Severe (severity modifier),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17797,Metastatic Neoplasm,Acute Undifferentiated Leukemia,0
17798,Tobacco smoking behavior,Refractory Barrett Esophagus,0
17799,Medical Device Emits Smoke,Diffuse malignant mesothelioma,0
17800,Leukocytes,adenoid cystic carcinoma of lung,0
17801,Filter - medical device,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17802,CD5L wt Allele,Intestinal Metaplasia of Bladder Urothelium,0
17803,Specific qualifier value,Maxillary Sinus Adenocarcinoma,0
17804,Linear,Intraepithelial Melanocytic Hyperplasia,0
17805,Run action,Childhood Choriocarcinoma,0
17806,Childhood Atypical Teratoid/Rhabdoid Tumor,Malignant melanoma of eyelid,0
17807,Stromal Cells,Colorectal High Grade B-Cell Lymphoma,0
17808,Definitely Related to Intervention,Childhood Lymphoma,0
17809,3+ Score,Recurrent Testicular Lymphoma,0
17810,Prognostic Factors,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17811,Well,Mucinous adenocarcinoma gastric,0
17812,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Breast Ductal Adenoma,0
17813,Phonation,Heavy Chain Deposition Disease,0
17814,Life,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17815,Increased,Granular Cell Leiomyosarcoma,0
17816,Hematochezia,Benign neoplasm of thorax,0
17817,Usual Severity Vomiting,Mucinous adenocarcinoma gastric,0
17818,Li-Fraumeni Syndrome,Neonatal leukemia,0
17819,Illness: Cannot describe symptoms,Giant cell angiofibroma,0
17820,Others - Allergy,Maxillary Sinus Adenocarcinoma,0
17821,Second Look Surgery,Intraepithelial Melanocytic Hyperplasia,0
17822,Firstly,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17823,Formation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
17824,Palm thickening,Benign Carotid Body Paraganglioma,0
17825,Extravasation,Intraepithelial Melanocytic Hyperplasia,0
17826,SHORT STATURE,Familial Hemophagocytic Lymphocytosis,0
17827,Prevalence aspects,Spermatocytic seminoma,0
17828,Close,non-Hodgkin's lymphoma of spleen,0
17829,Study Site,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17830,Event Seriousness - Significant,Maxillary Sinus Adenocarcinoma,0
17831,diagnosis aspect,Neonatal leukemia,0
17832,mesodermal,Stage IV Childhood Non-Hodgkin Lymphoma,0
17833,Females,Advanced Uterine Corpus Carcinosarcoma,0
17834,Scaling,Adenocarcinoma of the prostate metastatic,0
17835,primary tumor,Recurrent Diffuse Intrinsic Pontine Glioma,0
17836,Skin,Cerebral hemangioma,0
17837,Multiple adenomatous polyps,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17838,Clinical Trials,Uterine Cancer,0
17839,Body structure,Recurrent Testicular Lymphoma,0
17840,Cervical lymph node group,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17841,Smoking,Rhabdomyosarcoma with ganglionic differentiation,0
17842,Estimated,Diffuse malignant mesothelioma,0
17843,Deoxyribonucleic Acid Measurement,Platinum-Resistant Lung Small Cell Carcinoma,0
17844,Bartholin Glands,Stage IV Penile Cancer AJCC v7,0
17845,Bone Pain,BRCA2 Syndrome,0
17846,PSA Level Less than Two,Clonal Hematopoiesis of Indeterminate Potential,0
17847,Damage,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17848,Concept model domain,Metastatic Neoplasm to the Gallbladder,0
17849,Shoulder,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17850,point - UnitsOfMeasure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17851,2+ Score,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17852,Identified,Hodgkin lymphoma,0
17853,Improved - answer to question,squamous cell carcinoma of the thyroid gland,0
17854,Neuroectodermal Tumor,Ovarian germ cell choriocarcinoma stage IV,0
17855,Congenital Abnormality,Adult Fibrolamellar Carcinoma,0
17856,Persons,Acute Undifferentiated Leukemia,0
17857,How Often Felt Normal question,Cerebral Primitive Neuroectodermal Tumor,0
17858,Malignant Neoplasms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17859,Two,Fourth Ventricle and Brain Stem Ependymal Tumor,0
17860,glycosylation,Recurrent Diffuse Intrinsic Pontine Glioma,0
17861,Expiration,Stage IV Penile Cancer AJCC v7,0
17862,solid substance,Chronic Myelomonocytic Leukemia-2,0
17863,Name,Liver Cavernous Hemangioma,0
17864,Low Mitosis-Karyorrhexis Index,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17865,Sharing (Social Behavior),BRCA2 Syndrome,0
17866,<3 (qualifier value),BRCA2 Syndrome,0
17867,Skeletal bone,gliosarcoma,0
17868,bony process,Digestive System Hodgkin Lymphoma,0
17869,Frequently,Thymic Clear Cell Carcinoma,0
17870,Time (foundation metadata concept),Intraepithelial Melanocytic Hyperplasia,0
17871,Abdomen distended,Cancer of Urinary Tract,0
17872,List,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17873,99,FIGO Stage II Ovarian Cancer,0
17874,Swelling,Spermatocytic seminoma,0
17875,Embryonic Development,Cancer of Urinary Tract,0
17876,Stable status,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17877,dendritic spine neck,Low Grade Squamous Intraepithelial Neoplasia,0
17878,Function Axis,Carcinoma of urinary bladder,0
17879,Inspiration function,FIGO Stage II Ovarian Cancer,0
17880,Common (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
17881,Numerous,Intraepithelial Melanocytic Hyperplasia,0
17882,Canada,Angiosarcoma of liver,0
17883,General surgery specialty,Extracranial Neuroblastoma,0
17884,Name,Mucinous adenocarcinoma gastric,0
17885,Frequently,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17886,Old,Uterine Cancer,0
17887,treatment - ActInformationManagementReason,Childhood Fibrillary Astrocytoma,0
17888,Autosome,Hair nevus,0
17889,per year,Digestive System Hodgkin Lymphoma,0
17890,Subtype (attribute),Mucinous neoplasm,0
17891,Damage,Primary Cutaneous Plasmablastic Lymphoma,0
17892,Protons,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17893,Dryness of eye,Digestive System Hodgkin Lymphoma,0
17894,Include (action),embryonal rhabdomyosarcoma of prostate,0
17895,Leakage,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17896,pharmacotherapeutic,Testicular cancer metastatic,0
17897,Core needle biopsy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17898,Wounds and Injuries,Stage IB Pancreatic Cancer AJCC v8,0
17899,Dosing Days to Detection,Carcinoma of urinary bladder,0
17900,Vasculature,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17901,Death (finding),Human Papillomavirus-Related Carcinoma,0
17902,Adult Medulloblastoma,Cartilaginous exostosis,0
17903,Repaired,Digestive System Hodgkin Lymphoma,0
17904,Occurrence,Cancer of Urinary Tract,0
17905,Therapeutic procedure,Malignant melanoma of eyelid,0
17906,biopsy characteristics,Malignant melanoma of eyelid,0
17907,Hemorrhage,Xeroderma pigmentosum,0
17908,Childhood Burkitt Lymphoma,Refractory Glioma,0
17909,Susceptible,Adenocarcinoma of the prostate metastatic,0
17910,Usually,Ovarian germ cell choriocarcinoma stage IV,0
17911,Case unit dose,Recurrent Uveal Melanoma,0
17912,Common (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
17913,Biomaterial Treatment,Colorectal High Grade B-Cell Lymphoma,0
17914,Leukemic Cells Measurement,Cerebral Primitive Neuroectodermal Tumor,0
17915,Cells,Digestive System Hodgkin Lymphoma,0
17916,Humor,Intracortical osteosarcoma,0
17917,3+ Score,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17918,C3 gene,Malignant neoplasm of thalamus,0
17919,Intermediate,Tonsillar Carcinoma,0
17920,Symptoms,Acantholytic squamous cell carcinoma,0
17921,Person Name,Intestinal Metaplasia of Bladder Urothelium,0
17922,Cancer Registry,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17923,Phenomenon,Benign tumor of eyelid,0
17924,diagnosis aspect,Atypical Lobular Breast Hyperplasia,0
17925,Common (qualifier value),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17926,regional,Locally Advanced Soft Tissue Sarcoma,0
17927,200,Undifferentiated Endocervical Sarcoma,0
17928,MOSTLY,Localized Ewing Sarcoma,0
17929,Diet Code Specification Type - Preference,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17930,High Grade Ovarian Serous Adenocarcinoma,Pilocytic astrocytoma of cerebellum,0
17931,Bone Marrow,Maxillary Sinus Adenocarcinoma,0
17932,survival aspects,Mucinous adenocarcinoma gastric,0
17933,Often - answer to question,Spermatocytic seminoma,0
17934,Line Specimen,Small cell neuroendocrine carcinoma of bladder,0
17935,What subject filter - Result,adenoid cystic carcinoma of lung,0
17936,Body structure,Serous cystadenocarcinoma ovary,0
17937,Forecast of outcome,Giant cell angiofibroma,0
17938,Interferes with,Recurrent Uveal Melanoma,0
17939,Tobacco smoking behavior,Malignant melanoma of eyelid,0
17940,Cell Device,Endometrial Small Cell Carcinoma,0
17941,2+ Score,Heavy Chain Deposition Disease,0
17942,Neurofibromatosis 1,Non-Metastatic Gestational Trophoblastic Tumor,0
17943,Obese build,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
17944,Gastroesophageal reflux disease,Adult Alveolar Soft Part Sarcoma,0
17945,Offspring,Adult Alveolar Soft Part Sarcoma,0
17946,associated disease,Ovarian Carcinoid Tumor,0
17947,Neck Pain Score 2,Placental aromatase deficiency,0
17948,Administration procedure,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17949,Intellectual scale,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17950,Less Than,Liver Cavernous Hemangioma,0
17951,Overall Publication Type,Localized Askin Tumor,0
17952,Occur (action),Childhood Choriocarcinoma,0
17953,Ductal,Female Breast Carcinoma,0
17954,False Discovery Rate,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17955,PSA Level Less than Two,Ovarian germ cell choriocarcinoma stage IV,0
17956,Mediator brand of benfluorex hydrochloride,Childhood Fibrillary Astrocytoma,0
17957,survive,Carcinoma of urinary bladder,0
17958,1980s,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17959,Thought,Tonsillar Carcinoma,0
17960,Four,Stage I Adult Non-Hodgkin Lymphoma,0
17961,Apocrine Glands,Bladder squamous cell carcinoma stage I,0
17962,Pale color saturation,gliosarcoma,0
17963,Congenital condition,Chronic Myelomonocytic Leukemia-2,0
17964,melanoma,Advanced Uterine Corpus Carcinosarcoma,0
17965,Net (qualifier),papillary carcinoma of penis,0
17966,Measles,Blepharal carcinoma,0
17967,Adult,Benign Apocrine Neoplasm,0
17968,Symptoms aspect,Malignant neoplasm of choroid,0
17969,serotonin secretion,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
17970,Bodily secretions,Liver Cavernous Hemangioma,0
17971,Definitely Related to Intervention,Stage III Adult Immunoblastic Lymphoma,0
17972,Substance amount,Hemangioma,0
17973,Biological Processes,Carcinoma ex pleomorphic adenoma of parotid gland,0
17974,CDISC Relationship Class,Digestive System Hodgkin Lymphoma,0
17975,Ability to Drive,Mucinous adenocarcinoma gastric,0
17976,Lower - spatial qualifier,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17977,Natural,Malignant Testicular Sertoli Cell Tumor,0
17978,Elements,Adult Alveolar Soft Part Sarcoma,0
17979,Persistent,Intestinal Metaplasia of Bladder Urothelium,0
17980,Effective,Malignant Neoplasm of Lung - Multiple Primary Sites,0
17981,year,Cerebral Primitive Neuroectodermal Tumor,0
17982,Cells,Female Breast Carcinoma,0
17983,Lung,Bladder squamous cell carcinoma stage I,0
17984,Referral placed,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
